{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "[nltk_data] Downloading package punkt to /home/gitpod/nltk_data...\n",
      "[nltk_data]   Package punkt is already up-to-date!\n"
     ]
    }
   ],
   "source": [
    "import pubmed_parser as pp\n",
    "import pandas as pd\n",
    "import nltk\n",
    "nltk.download('punkt')\n",
    "import numpy as np\n",
    "from csv import DictWriter\n",
    "import json\n",
    "import math\n",
    "\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer\n",
    "from sklearn.metrics.pairwise import cosine_similarity\n",
    "\n",
    "#Source: https://stackoverflow.com/questions/12118720/python-tf-idf-cosine-to-find-document-similarity"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "path_xml = pp.list_xml_path('../../data/raw') # list all xml paths under directory\n",
    "pubmed_dict = pp.parse_medline_xml(path_xml[0]) # dictionary output"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[{'title': 'Ca2+-Ca2+ exchange catalyzed by the membrane-bound Ca2+, Mg2+-ATPase of sarcoplasmic reticulum vesicles.',\n",
       "  'issue': '24()',\n",
       "  'pages': '423-34',\n",
       "  'abstract': 'Sarcoplasmic reticulum vesicles were preloaded with either 45Ca2+ or unlabeled Ca2+ X 45Ca2+ efflux and influx, together with phosphorylation of the membrane-bound Ca2+, Mg2+-ATPase, were determined in the presence of either ATP and ADP or acetyl phosphate. ATP induced 45Ca2+ efflux. This ATP-induced 45Ca2+ efflux depended on ADP, external Ca2+, and Mg2+. The Ca2+ concentration dependence of the efflux was quite similar to the Ca2+ concentration dependence of the ATP-induced 45Ca2+ influx and the enzyme phosphorylation. The rate of the efflux was proportional to the steady level of the phosphoenzyme. The affinity for free ADP in this efflux was extremely high, being in good agreement with the affinity for free ADP in the transphosphorylation from the phosphoenzyme to ADP. These results show that the ATP-induced 45Ca2+ efflux represents the Ca2+-Ca2+ exchange (between the external medium and the internal medium) mediated by the phosphoenzyme. In this exchange, Mg2+ was essential for the exposure of the bound Ca2+ of the phosphoenzyme to the internal medium. 45Ca2+ efflux and influx were also activated by acetyl phosphate. This acetyl phosphate-induced efflux required the external Ca2+. The Ca2+ concentration dependence of the efflux agreed closely with that of the enzyme phosphorylation by acetyl phosphate. Furthermore, the rate of the efflux was proportional to the steady level of the phosphoenzyme. These and other findings show that the acetyl phosphate-induced 45Ca2+ efflux represents the Ca2+-Ca2+ exchange mediated by the phosphoenzyme and further demonstrate the direct dissociation of Ca2+ from the Ca2+-bound phosphoenzyme to the external medium in this Ca2+-Ca2+ exchange. The rate of the acetyl phosphate-induced, phosphoenzyme-mediated Ca2+ efflux was much slower than that of the ATP-, ADP-induced, phosphoenzyme-mediated Ca2+ efflux. This is consistent with our previous conclusion that the Ca2+ binding site is partially occluded upon the phosphorylation of the enzyme.',\n",
       "  'journal': 'Current topics in cellular regulation',\n",
       "  'authors': 'Kanazawa|T|T|;Takakuwa|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149890',\n",
       "  'mesh_terms': 'D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002118:Calcium; D002132:Calcium Radioisotopes; D000252:Calcium-Transporting ATPases; D007700:Kinetics; D009132:Muscles; D010755:Organophosphates; D010766:Phosphorylation; D011817:Rabbits; D012519:Sarcoplasmic Reticulum',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D002132:Calcium Radioisotopes; D010755:Organophosphates; C011632:acetyl phosphate; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/b978-0-12-152824-9.50044-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Top Cell Regul',\n",
       "  'nlm_unique_id': '2984740R',\n",
       "  'issn_linking': '0070-2137',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The role of extracellular matrices in palatal shelf closure.',\n",
       "  'issue': '19()',\n",
       "  'pages': '17-36',\n",
       "  'abstract': '',\n",
       "  'journal': 'Current topics in developmental biology',\n",
       "  'authors': 'Brinkley|L L|LL|;Morris-Wiman|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149891',\n",
       "  'mesh_terms': 'D000818:Animals; D003094:Collagen; D004848:Epithelium; D005109:Extracellular Matrix; D006025:Glycosaminoglycans; D006820:Hyaluronic Acid; D008648:Mesoderm; D051379:Mice; D009994:Osmolar Concentration; D010159:Palate; D010879:Piperazines',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.; D016454:Review\",\n",
       "  'chemical_list': 'D006025:Glycosaminoglycans; D010879:Piperazines; D006820:Hyaluronic Acid; D003094:Collagen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0070-2153(08)60393-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Top Dev Biol',\n",
       "  'nlm_unique_id': '0163114',\n",
       "  'issn_linking': '0070-2153',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Role of neurotransmitters in palate development.',\n",
       "  'issue': '19()',\n",
       "  'pages': '37-63',\n",
       "  'abstract': '',\n",
       "  'journal': 'Current topics in developmental biology',\n",
       "  'authors': 'Zimmerman|E F|EF|;Wee|E L|EL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149892',\n",
       "  'mesh_terms': 'D000818:Animals; D002395:Catecholamines; D002972:Cleft Palate; D003975:Diazepam; D051379:Mice; D009024:Morphogenesis; D018377:Neurotransmitter Agents; D010159:Palate; D011963:Receptors, GABA-A; D011985:Receptors, Serotonin; D012701:Serotonin; D013723:Teratogens; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D002395:Catecholamines; D018377:Neurotransmitter Agents; D011963:Receptors, GABA-A; D011985:Receptors, Serotonin; D013723:Teratogens; D012701:Serotonin; D005680:gamma-Aminobutyric Acid; D003975:Diazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0070-2153(08)60394-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Top Dev Biol',\n",
       "  'nlm_unique_id': '0163114',\n",
       "  'issn_linking': '0070-2153',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Toxic versus allergic reactions to jellyfish.',\n",
       "  'issue': '34(5)',\n",
       "  'pages': '450-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Cutis',\n",
       "  'authors': 'Fisher|A A|AA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149893',\n",
       "  'mesh_terms': 'D000328:Adult; D000818:Animals; D001733:Bites and Stings; D003063:Cnidaria; D003064:Cnidarian Venoms; D003877:Dermatitis, Contact; D006801:Humans; D008297:Male; D037401:Scyphozoa',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D003064:Cnidarian Venoms',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cutis',\n",
       "  'nlm_unique_id': '0006440',\n",
       "  'issn_linking': '0011-4162',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Tumors of the adrenal gland in childhood. Report of 38 patients].',\n",
       "  'issue': '55(9)',\n",
       "  'pages': '569-74',\n",
       "  'abstract': \"During the past 17 years at the Department für Pediatric Surgery, University of Heidelberg, 38 children aged 1.6 to 14 years were adrenalectomized (unilateral 3.3, bilateral 5). Individual diagnoses were: neuroblastoma 23; pheochromocytoma 5; adrenocortical carcinoma 8; adrenocortical adenoma 4; bilateral nodular hyperplasia 2 cases. Patients with histologically benign lesions are alive and without recurrence more than 5 years after surgery, except one patient who developed Nelson's tumor after bilateral adrenalectomy for Cushing's disease. Of the patients with malignant adrenal tumors 21 died within 18 months after therapy was started, a 7 years old girl with an adrenal carcinoma died after a period of 3.6 years of combined treatment. In most cases of adrenocortical tumors virilization was the prominent feature.\",\n",
       "  'journal': 'Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen',\n",
       "  'authors': 'Bolkenius|M|M|;Heinrich|U H|UH|;Daum|R|R|;Roth|H|H|;Brandeis|W E|WE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149894',\n",
       "  'mesh_terms': 'D000236:Adenoma; D000293:Adolescent; D000310:Adrenal Gland Neoplasms; D000315:Adrenalectomy; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000970:Antineoplastic Agents; D002277:Carcinoma; D002648:Child; D002675:Child, Preschool; D003131:Combined Modality Therapy; D003480:Cushing Syndrome; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D009447:Neuroblastoma; D010673:Pheochromocytoma; D011379:Prognosis',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000970:Antineoplastic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Chirurg',\n",
       "  'nlm_unique_id': '16140410R',\n",
       "  'issn_linking': '0009-4722',\n",
       "  'country': 'Germany'},\n",
       " {'title': \"[Familial Sipple's syndrome. Reflections apropos of 4 cases and a survey on 26 members of a family].\",\n",
       "  'issue': '110(4)',\n",
       "  'pages': '380-9',\n",
       "  'abstract': '',\n",
       "  'journal': \"Chirurgie; memoires de l'Academie de chirurgie\",\n",
       "  'authors': 'Pedinielli|L|L|;Argème|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149895',\n",
       "  'mesh_terms': 'D000310:Adrenal Gland Neoplasms; D000328:Adult; D002277:Carcinoma; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia; D010673:Pheochromocytoma; D013964:Thyroid Neoplasms',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Chirurgie',\n",
       "  'nlm_unique_id': '0236600',\n",
       "  'issn_linking': '0001-4001',\n",
       "  'country': 'France'},\n",
       " {'title': 'Neurochemically specified subsystems in the basal ganglia.',\n",
       "  'issue': '107()',\n",
       "  'pages': '114-49',\n",
       "  'abstract': 'The fibre pathways associated with the basal ganglia include through-conduction lines and side-loops associated with the striatum, pallidum and substantia nigra. Each of these regions is now known to contain subdivisions differing from one another in the neurotransmitter-related compounds they contain. This paper includes an outline of these new findings and a commentary on some of their functional implications.',\n",
       "  'journal': 'Ciba Foundation symposium',\n",
       "  'authors': 'Graybiel|A M|AM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149896',\n",
       "  'mesh_terms': 'D000109:Acetylcholine; D000818:Animals; D001479:Basal Ganglia; D001931:Brain Mapping; D002415:Cats; D002540:Cerebral Cortex; D004298:Dopamine; D004745:Enkephalins; D005116:Extrapyramidal Tracts; D006801:Humans; D018377:Neurotransmitter Agents; D051381:Rats; D013378:Substantia Nigra; D013787:Thalamic Nuclei; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D004745:Enkephalins; D018377:Neurotransmitter Agents; D005680:gamma-Aminobutyric Acid; D000109:Acetylcholine; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/9780470720882.ch7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ciba Found Symp',\n",
       "  'nlm_unique_id': '0356636',\n",
       "  'issn_linking': '0300-5208',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Behavioural effects of manipulation of basal ganglia neurotransmitters.',\n",
       "  'issue': '107()',\n",
       "  'pages': '183-200',\n",
       "  'abstract': \"Topographically organized dopaminergic projections from the extrapyramidal structures of the ventral mesencephalon (substantia nigra and ventral tegmental area) to the dorsal (body of caudate-putamen) and ventral (anterior-ventral caudate, nucleus accumbens, tuberculum olfactorium) striatum subserve sensorimotor integration in the rat. Selective depletion of DA impairs the animal's ability to integrate sensory input with motor output; in the dorsal striatum the exteroceptive sensory input and in the ventral or limbic striatum the interoceptive input principally related to motivation and affect. Grafts of fetal DA neurons to the damaged dorsal striatum reverse sensorimotor asymmetry and sensory neglect. A large number of other excitatory and inhibitory neurotransmitters, including recently discovered neuropeptides, contribute to the functional balance afforded by the DA neurons. This chemical heterogeneity of the basal ganglia offers the possibility that novel therapeutic approaches with drugs could be used to control the chemical imbalances in basal ganglia that are associated with a number of neurological and psychiatric conditions.\",\n",
       "  'journal': 'Ciba Foundation symposium',\n",
       "  'authors': 'Iversen|S D|SD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149897',\n",
       "  'mesh_terms': 'D000109:Acetylcholine; D000818:Animals; D001479:Basal Ganglia; D001522:Behavior, Animal; D003342:Corpus Striatum; D004298:Dopamine; D005971:Glutamates; D018698:Glutamic Acid; D000882:Haplorhini; D008032:Limbic System; D009434:Neural Pathways; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D051381:Rats; D012701:Serotonin; D013681:Tegmentum Mesencephali; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D005971:Glutamates; D018377:Neurotransmitter Agents; D012701:Serotonin; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/9780470720882.ch10',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ciba Found Symp',\n",
       "  'nlm_unique_id': '0356636',\n",
       "  'issn_linking': '0300-5208',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Local regulation of transmitter release in the basal ganglia.',\n",
       "  'issue': '107()',\n",
       "  'pages': '258-68',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ciba Foundation symposium',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149898',\n",
       "  'mesh_terms': 'D000818:Animals; D001479:Basal Ganglia; D002415:Cats; D006801:Humans; D018377:Neurotransmitter Agents; D051381:Rats; D009435:Synaptic Transmission',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ciba Found Symp',\n",
       "  'nlm_unique_id': '0356636',\n",
       "  'issn_linking': '0300-5208',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Synapses of identified neurons in the neostriatum.',\n",
       "  'issue': '107()',\n",
       "  'pages': '30-47',\n",
       "  'abstract': 'Studies of the basal ganglia and particularly the neostriatum have described a complex array of neuron types, synapses and putative transmitters. One approach to the study of such an area is to examine identified neurons and thus establish the neural circuits that underlie function. Striatal neurons have been identified under the light microscope by one or more of the following methods: (1) structure, based on Golgi impregnation or the intracellular injection of horseradish peroxidase (HRP); (2) projection area, by the retrograde transport of HRP or the tracing of HRP-injected or Golgi-impregnated axons; (3) chemistry, by immunocytochemistry, histochemistry or autoradiography, to reveal the presence of a selective uptake system for a putative transmitter. Examination of identified neurons in the electron microscope allows the characterization of their afferent synapses (by immunocytochemistry or anterograde degeneration) and their local synaptic output. The afferent and efferent synapses of five classes of identified striatal neurons are discussed: (1) those neurons described in Golgi preparations as medium-size and densely spiny; (2) a large type of striatonigral neuron; (3) GABAergic interneurons; (4) cholinergic neurons; (5) somatostatin-immunoreactive neurons. It is concluded that medium-size densely spiny neurons provide the basic framework of the neural circuits of the neostriatum.',\n",
       "  'journal': 'Ciba Foundation symposium',\n",
       "  'authors': 'Bolam|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149899',\n",
       "  'mesh_terms': 'D000344:Afferent Pathways; D000818:Animals; D002415:Cats; D002799:Cholinergic Fibers; D003342:Corpus Striatum; D004525:Efferent Pathways; D000882:Haplorhini; D007395:Interneurons; D051381:Rats; D013004:Somatostatin; D013569:Synapses; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D016454:Review\",\n",
       "  'chemical_list': 'D013004:Somatostatin; D005680:gamma-Aminobutyric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/9780470720882.ch3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ciba Found Symp',\n",
       "  'nlm_unique_id': '0356636',\n",
       "  'issn_linking': '0300-5208',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Affinity modification of acetyl CoA carboxylase from the rat liver by alkylating ATP gamma-amide].',\n",
       "  'issue': '277(5)',\n",
       "  'pages': '1256-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Doklady Akademii nauk SSSR',\n",
       "  'authors': 'Buneva|V N|VN|;Rabinkov|A G|AG|;Iatsenko|I A|IA|;Libinzon|R E|RE|;Goriachenkova|E V|EV|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149900',\n",
       "  'mesh_terms': 'D000103:Acetyl-CoA Carboxylase; D000255:Adenosine Triphosphate; D000345:Affinity Labels; D000478:Alkylation; D000818:Animals; D066298:In Vitro Techniques; D007700:Kinetics; D008025:Ligases; D008099:Liver; D051381:Rats; D013696:Temperature',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000345:Affinity Labels; C025165:ATP-gamma-4-(N-2-chloroethyl-N-methylamino)benzylamidate; D000255:Adenosine Triphosphate; D008025:Ligases; D000103:Acetyl-CoA Carboxylase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dokl Akad Nauk SSSR',\n",
       "  'nlm_unique_id': '7505465',\n",
       "  'issn_linking': '0002-3264',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Comparison of the pharmacokinetics of several polychlorinated biphenyls in mouse, rat, dog, and monkey by means of a physiological pharmacokinetic model.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '527-35',\n",
       "  'abstract': \"Physiologic pharmacokinetic analysis of 4,4'-dichlorobiphenyl, 2,2',3,3',6,6'-hexachlorobiphenyl, and 2,2',4,4',5,5'-hexachlorobiphenyl is presented for the dog and monkey, and the results are compared with previous similar analyses for the rat and mouse. The normalized clearances (ml/min/kg body weight) vary considerably between the dog and the monkey; the rat and the mouse show less species variation. The equilibrium tissue-to-blood distribution ratios for parent and metabolite are generally similar for all four species. The fat compartment has the highest parent distribution ratio for all four species, and the metabolite distribution ratios are much smaller than the parent distribution ratios. Metabolism appears to be a prerequisite to urinary and biliary excretion for all three compounds in each species. Elimination from the body occurs predominantly by the fecal route. The 2,2',4,4',5,5'-hexachlorobiphenyl is more slowly metabolized than the 2,2',3,3',6,6'-isomer in all species, which supports the contention that two adjacent, unsubstituted carbon atoms on the biphenyl ring promote more rapid metabolism.\",\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Lutz|R J|RJ|;Dedrick|R L|RL|;Tuey|D|D|;Sipes|I G|IG|;Anderson|M W|MW|;Matthews|H B|HB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149901',\n",
       "  'mesh_terms': 'D000818:Animals; D001646:Bile; D004285:Dogs; D007700:Kinetics; D008252:Macaca fascicularis; D008297:Male; D051379:Mice; D008954:Models, Biological; D011078:Polychlorinated Biphenyls; D051381:Rats; D013045:Species Specificity; D014018:Tissue Distribution',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D011078:Polychlorinated Biphenyls',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effect of plasma protein binding on the uptake of methadone and diazepam in the isolated perfused rat lung.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '536-42',\n",
       "  'abstract': 'The pulmonary uptake of the basic (pKa 9.1) lipophilic amine (methadone) and a nonbasic (pKa 3.4) lipophilic amine (diazepam) was compared in a single pass isolated perfused rat lung (IPL) preparation. The radiolabeled drugs were infused into the IPL for 10 min followed by a 30-min drug-free perfusion. If the perfusate (Krebs-Ringer bicarbonate buffer) contained 4.5% bovine serum albumin, the rapid and extensive uptake observed for methadone (32.4% of infused amount) was similar to that reported for other basic lipophilic amines. Uptake of the nonbasic diazepam was slight (3.4% of infused amount). These results are consistent with the idea that basic amines accumulate in lung tissues to a great extent. However, if the bovine serum albumin was omitted from the perfusate, diazepam uptake in the IPL increased about 10-fold while methadone uptake increased only slightly. This observation, together with the extensive binding of diazepam to plasma albumin, suggested that plasma protein binding was a major factor in limiting the pulmonary accumulation of this nonbasic lipophilic amine. Since many nonbasic drugs are known to have a high affinity for plasma albumin, the observed dependence of pulmonary drug accumulation on basicity of the amine may be related to the plasma protein binding as well as the characteristics of the interaction of amines with pulmonary tissue.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Roerig|D L|DL|;Dahl|R R|RR|;Dawson|C A|CA|;Wang|R I|RI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149902',\n",
       "  'mesh_terms': 'D000818:Animals; D001798:Blood Proteins; D002417:Cattle; D003975:Diazepam; D066298:In Vitro Techniques; D007700:Kinetics; D008168:Lung; D008297:Male; D008691:Methadone; D011485:Protein Binding; D051381:Rats; D011919:Rats, Inbred Strains; D012710:Serum Albumin, Bovine',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': 'D001798:Blood Proteins; D012710:Serum Albumin, Bovine; D003975:Diazepam; D008691:Methadone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Paraquat and putrescine uptake by lung slices of fetal and newborn rats.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '550-2',\n",
       "  'abstract': 'Paraquat is actively taken up by lung slices of mature rats. This uptake seems to occur primarily in the pneumocyte type II cells, and evidence suggests that these cells utilize an active transport system for putrescine to accumulate paraquat. We evaluated the uptake of paraquat and putrescine in lung slices of fetal and newborn rats. An active transport of paraquat and putrescine into lung slices was noted on day 20 of gestation. Putrescine and paraquat accumulation in lung slices increased thereafter and approached concentrations found in adult lung slices by the 2nd and 3rd postnatal week, respectively. Paraquat and putrescine inhibit accumulation of one another by lung slices of fetal rats.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Gaudreault|P|P|;Karl|P I|PI|;Friedman|P A|PA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149903',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D005260:Female; D005333:Fetus; D005865:Gestational Age; D066298:In Vitro Techniques; D008168:Lung; D010269:Paraquat; D011247:Pregnancy; D011700:Putrescine; D051381:Rats',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D010269:Paraquat; D011700:Putrescine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Half-life of oxazaphosphorines in biological fluids.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '553-9',\n",
       "  'abstract': 'Plasma AUC and half-life values for cyclophosphamide were determined in rats manipulated to hydroxylate cyclophosphamide at different rates; plasma AUC and apparent half-life values for two pharmacologically important metabolites of cyclophosphamide, viz. 4-hydroxycyclophosphamide/aldophosphamide and phosphoramide mustard, were also determined in these animals. Apparent plasma half-life values for 4-hydroxycyclophosphamide/aldophosphamide and phosphoramide mustard increased with an increase in plasma half-life values for cyclophosphamide. AUC values for cyclophosphamide increased approximately linearly with an increase in its plasma half-life but AUC values for 4-hydroxycyclophosphamide/aldophosphamide and phosphoramide mustard remained approximately constant with an increase in their respective apparent plasma half-life values. Given that the cytotoxic effects of cyclophosphamide are directly proportional to AUC values for 4-hydroxycyclophosphamide/aldophosphamide and/or phosphoramide mustard, we conclude that changes in the rate of cyclophosphamide hydroxylation will not alter the systemic toxic and therapeutic responses to a given dose of cyclophosphamide. Actual half-life values for 4-hydroxycyclophosphamide/aldophosphamide and phosphoramide mustard after the iv infusion of these agents were also determined. A comparison of the actual plasma half-life values for cyclophosphamide (29 min), 4-hydroxycyclophosphamide/aldophosphamide (14 min), and phosphoramide mustard (14 min) with the apparent plasma half-life values obtained for 4-hydroxycyclophosphamide/aldophosphamide (34 min) and phosphoramide mustard (55 min) following cyclophosphamide administration suggests that the major determinant with regard to the apparent plasma half-life of 4-hydroxycyclophosphamide/aldophosphamide is its rate of formation whereas in the case of phosphoramide mustard, an additional determinant, perhaps efflux from the cell, is operative.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Sladek|N E|NE|;Powers|J F|JF|;Grage|G M|GM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149904',\n",
       "  'mesh_terms': 'D000818:Animals; D001711:Biotransformation; D001826:Body Fluids; D002279:Carcinoma 256, Walker; D003520:Cyclophosphamide; D006207:Half-Life; D006863:Hydrogen-Ion Concentration; D010634:Phenobarbital; D010752:Phosphoramide Mustards; D051381:Rats; D011919:Rats, Inbred Strains; D013050:Spectrometry, Fluorescence',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D010752:Phosphoramide Mustards; D003520:Cyclophosphamide; D010634:Phenobarbital',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Nafimidone, an imidazole anticonvulsant, and its metabolite as potent inhibitors of microsomal metabolism of phenytoin and carbamazepine.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '560-4',\n",
       "  'abstract': 'The effects of nafimidone and its metabolite (reduced nafimidone) on p-hydroxylation of phenytoin were examined by using hepatic microsomes from rats pretreated with phenytoin. Both nafimidone and reduced nafimidone inhibited p-hydroxylation of phenytoin in a concentration-dependent manner and at both high and low affinity metabolic sites. Both compounds were effective inhibitors at submicromolar concentrations. The inhibitory pattern at both metabolic sites was consistent with \"mixed type\" inhibition. The inhibition constants, Ki, calculated for reduced nafimidone, were about 0.2 microM at both sites. Submicromolar concentrations of nafimidone and its metabolite also inhibited carbamazepine epoxidation. Thus, nafimidone and its metabolite were shown to be potent inhibitors of major biotransformation pathways of two important antiepileptic drugs.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Kapetanovic|I M|IM|;Kupferberg|H J|HJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149905',\n",
       "  'mesh_terms': 'D000818:Animals; D000927:Anticonvulsants; D001711:Biotransformation; D002220:Carbamazepine; D055598:Chemical Phenomena; D002621:Chemistry; D002851:Chromatography, High Pressure Liquid; D007093:Imidazoles; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D008862:Microsomes, Liver; D009278:Naphazoline; D010672:Phenytoin; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000927:Anticonvulsants; D007093:Imidazoles; D002220:Carbamazepine; D010672:Phenytoin; D009278:Naphazoline; C038671:nafimidone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': \"The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen.\",\n",
       "  'issue': '12(5)',\n",
       "  'pages': '565-76',\n",
       "  'abstract': \"Incubations of 3'-hydroxyacetanilide (3HAA) with hepatic microsomal preparations from phenobarbital-pretreated mice led to the formation of three products of aromatic hydroxylation, viz. 2',5'-, 3',4'-, and 2',3'-dihydroxyacetanilide, which were identified by GC/MS techniques and quantified by GLC analysis. NADPH-dependent covalent binding of radioactivity from [14C]3HAA to microsomal protein took place at almost four times the rate at which [14C]acetaminophen became irreversibly bound to protein under the same experimental conditions. This binding was inhibited by the addition to incubation media of ascorbate, glutathione, and the soluble proteins bovine serum albumin and bovine alpha s1-casein, but not by superoxide dismutase. Radioactivity from [14C]3HAA also became covalently bound to the added soluble proteins, the extent of which was greatest when the proteins contained a high content of free -SH groups. From an analysis of the effect of ascorbate and glutathione on both the covalent binding of 14C to protein and the production of the noncovalently bound products of 3HAA metabolism, it is concluded that reactive intermediates most likely derive from further oxidation of the primary 3HAA metabolites to electrophilic semiquinone and/or quinone species. Sulfhydryl groups appear to be the principal sites on protein at which covalent binding of these reactive metabolites of 3HAA takes place, a feature shared by the reactive species generated during acetaminophen metabolism.\",\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Streeter|A J|AJ|;Bjorge|S M|SM|;Axworthy|D B|DB|;Nelson|S D|SD|;Baillie|T A|TA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149906',\n",
       "  'mesh_terms': 'D000082:Acetaminophen; D000083:Acetanilides; D000818:Animals; D001205:Ascorbic Acid; D001665:Binding Sites; D001711:Biotransformation; D008401:Gas Chromatography-Mass Spectrometry; D005978:Glutathione; D066298:In Vitro Techniques; D007536:Isomerism; D007700:Kinetics; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008862:Microsomes, Liver; D011485:Protein Binding',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000083:Acetanilides; D000082:Acetaminophen; C026137:3-hydroxyacetanilide; D005978:Glutathione; D001205:Ascorbic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The metabolism and excretion of buprenorphine in humans.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '577-81',\n",
       "  'abstract': 'Buprenorphine, a powerful mixed agonist-antagonist analgesic which shows promise of providing maintenance pharmacotherapy for heroin addicts, is metabolized in male human subjects to norbuprenorphine and to conjugated buprenorphine and norbuprenorphine. Following subcutaneous, sublingual, and oral buprenorphine administration to a single subject, total metabolite excretion in urine was 2, 13.4, and 12.1%, respectively. No free parent drug was detected in urine. The amount of norbuprenorphine metabolite excreted in urine generally exceeded that of conjugated buprenorphine. In contrast, free and conjugated buprenorphine equaled or greatly exceeded total norbuprenorphine content in fecal samples following oral or sublingual administration. The greatest amount of drug and metabolite eliminated in feces occurred at 4 to 6 days following buprenorphine administration at times when there was very little urinary excretion of conjugated buprenorphine. This latter evidence indicates an enterohepatic circulation of buprenorphine in humans.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Cone|E J|EJ|;Gorodetzky|C W|CW|;Yousefnejad|D|D|;Buchwald|W F|WF|;Johnson|R E|RE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149907',\n",
       "  'mesh_terms': 'D000328:Adult; D001711:Biotransformation; D002047:Buprenorphine; D002849:Chromatography, Gas; D005243:Feces; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D008297:Male; D009019:Morphinans',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D009019:Morphinans; D002047:Buprenorphine; C043585:norbuprenorphine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effects of model traumatic injury on hepatic drug metabolism in the rat. II. In vivo metabolism of hexobarbital and zoxazolamine.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '582-7',\n",
       "  'abstract': 'A previously validated small mammal trauma model, hind-limb ischemia secondary to infrarenal aortic ligation in the rat, was utilized to further investigate the effects of traumatic injury on hepatic drug metabolism in vivo. The pharmacokinetic sequelae of the previously observed post-traumatic decrease in cytochrome P-450 content were demonstrated, using hexobarbital and zoxazolamine as model cytochrome P-450-oxidized drugs. Sleeping times after ip or iv administration of these drugs was prolonged by model injury. Longer sleeping times appeared to be caused by a slower elimination of the drugs from the bloodstream rather than to an increased sensitivity to their central nervous system effects or to an alteration in plasma protein-binding. Detailed pharmacokinetic analyses by the two-compartmental open system model revealed that the major alteration in post-traumatic drug metabolism was decreased in vivo elimination rather than a shift in distribution. These studies further confirm the pharmacokinetic utility of this convenient small mammal trauma model in the study of post-traumatic derangements in hepatic drug metabolism and emphasize the toxicologic importance of these derangements.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Griffeth|L K|LK|;Rosen|G M|GM|;Rauckman|E J|EJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149908',\n",
       "  'mesh_terms': 'D000818:Animals; D001798:Blood Proteins; D002851:Chromatography, High Pressure Liquid; D004195:Disease Models, Animal; D006591:Hexobarbital; D006614:Hindlimb; D007511:Ischemia; D007700:Kinetics; D008099:Liver; D008297:Male; D011485:Protein Binding; D051381:Rats; D011916:Rats, Inbred F344; D012890:Sleep; D013997:Time Factors; D014947:Wounds and Injuries; D015049:Zoxazolamine',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001798:Blood Proteins; D015049:Zoxazolamine; D006591:Hexobarbital',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The metabolism and excretion of mononitrotoluenes by Fischer 344 rats.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '596-602',\n",
       "  'abstract': 'The metabolism and excretion of 2-, 3-, and 4-nitrotoluene (2NT, 3NT, and 4NT, respectively) were studied in male Fischer 344 rats. Excreta were collected for 72 hr after an oral dose (200 mg/kg) of radiolabeled 2NT, 3NT, or 4NT. Radiolabel from each NT isomer was rapidly excreted (86, 73 and 74% of the dose for 2NT, 3NT, and 4NT, respectively in 24 hr). The urine was the major route of excretion with 70-85% of the dose being excreted by that route in 72 hr. Five to 13% and 0.0 to 0.1% of the dose was excreted in the feces and expired air, respectively, in 72 hr. The major metabolites excreted in urine in 72 hr after administration of 2NT were 2-nitrobenzoic acid (29% of the dose), an unidentified metabolite (16% of the dose), 2-nitrobenzyl glucuronide (14% of the dose), and S-(2-nitrobenzyl)-N-acetylcysteine (12% of the dose). The major metabolites excreted in urine in 72 hr after administration of 3NT were 3-nitrohippuric acid (24% of the dose), 3-nitrobenzoic acid (21% of the dose), and 3-acetamidobenzoic acid (12% of the dose). The major metabolites excreted in urine in 72 hr after administration of 4NT were 4-nitrobenzoic acid (28% of the dose), 4-acetamidobenzoic acid (27% of the dose), and 4-nitrohippuric acid (13% of the dose). Thus, the major urinary metabolites of 3NT and 4NT differed only quantitatively while those of 2NT were also qualitatively different.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Chism|J P|JP|;Turner|M J|MJ|;Rickert|D E|DE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149910',\n",
       "  'mesh_terms': 'D000818:Animals; D001711:Biotransformation; D005243:Feces; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D013997:Time Factors; D014050:Toluene',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'C029956:3-nitrotoluene; D014050:Toluene; C029955:2-nitrotoluene; C017572:4-nitrotoluene',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effects of model traumatic injury on hepatic drug metabolism in the rat. III. Differential responses of cytochrome P-450 subpopulations.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '588-95',\n",
       "  'abstract': 'A previously validated small mammal trauma model, hind-limb ischemia secondary to infrarenal aortic ligation in the rat, was utilized to further investigate the effects of traumatic injury on the hepatic cytochromes P-450. In vitro drug metabolism studies with hexobarbital and zoxazolamine as substrates confirmed the post-traumatic depression of the cytochrome P-450-catalyzed oxidation of these drugs which was suggested by previous in vivo pharmacokinetic studies. Enzyme kinetic studies revealed diminished Vmax values with no change in Km, a finding which would seem to concur with the previously demonstrated decrease in hepatic cytochrome P-450 content after model trauma. Moreover, a battery of in vitro microsomal monooxygenase assays demonstrated that model trauma exerted a differential effect on various hepatic cytochrome P-450 isoenzymes. This phenomenon was confirmed by anion-exchange HPLC of solubilized hepatic microsomal hemoproteins. One of the most interesting aspects of this selective effect on cytochrome P-450 subtypes was the relative induction of cytochrome P-448 content and activity, in contrast to the variable decrease seen with cytochrome P-450 activities. The potential in vivo sequelae of this differential influence were suggested by changes observed in the urinary metabolic profile of antipyrine after model trauma.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Griffeth|L K|LK|;Rosen|G M|GM|;Rauckman|E J|EJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149909',\n",
       "  'mesh_terms': 'D000633:Aminopyrine N-Demethylase; D000815:Aniline Hydroxylase; D000818:Animals; D000983:Antipyrine; D001571:Benzoflavones; D019363:Cytochrome P-450 CYP1A1; D003577:Cytochrome P-450 Enzyme System; D004195:Disease Models, Animal; D005037:Ethylmorphine-N-Demethylase; D006591:Hexobarbital; D006614:Hindlimb; D007511:Ischemia; D008099:Liver; D008297:Male; D009575:Nitroanisole O-Demethylase; D010084:Oxidation-Reduction; D010088:Oxidoreductases; D004364:Pharmaceutical Preparations; D010634:Phenobarbital; D051381:Rats; D011916:Rats, Inbred F344; D014947:Wounds and Injuries; D015049:Zoxazolamine; D019324:beta-Naphthoflavone',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001571:Benzoflavones; D004364:Pharmaceutical Preparations; D019324:beta-Naphthoflavone; D003577:Cytochrome P-450 Enzyme System; D015049:Zoxazolamine; D006591:Hexobarbital; D009575:Nitroanisole O-Demethylase; D010088:Oxidoreductases; D000815:Aniline Hydroxylase; D019363:Cytochrome P-450 CYP1A1; D000633:Aminopyrine N-Demethylase; D005037:Ethylmorphine-N-Demethylase; D000983:Antipyrine; D010634:Phenobarbital',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Ketoconazole: a potent inhibitor of cytochrome P-450-dependent drug metabolism in rat liver.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '603-6',\n",
       "  'abstract': 'Ketoconazole, an orally active imidazole antimycotic agent, is shown to be a potent inhibitor of drug N-demethylase activities of liver microsomes from rats pretreated with phenobarbital or pregnenolone-16 alpha-carbonitrile, and an inhibitor of 7-ethoxyresorufin O-deethylase activity of liver microsomes from rats pretreated with 5,6-benzoflavone. Spectrophotometric studies reveal that the imidazole compound binds to the cytochrome P-450 component of the monooxygenase complex, and has little effect on NADPH-cytochrome c (P-450) reductase activity. These results are strongly suggestive that cytochrome P-450 is the site of action of this potent inhibitor of drug metabolism in liver microsomes.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Sheets|J J|JJ|;Mason|J I|JI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149911',\n",
       "  'mesh_terms': 'D000818:Animals; D065607:Cytochrome P-450 Enzyme Inhibitors; D003577:Cytochrome P-450 Enzyme System; D005037:Ethylmorphine-N-Demethylase; D066298:In Vitro Techniques; D007654:Ketoconazole; D007700:Kinetics; D008099:Liver; D008297:Male; D009251:NADPH-Ferrihemoprotein Reductase; D010089:Oxidoreductases, N-Demethylating; D004364:Pharmaceutical Preparations; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D065607:Cytochrome P-450 Enzyme Inhibitors; D004364:Pharmaceutical Preparations; D003577:Cytochrome P-450 Enzyme System; C019781:benzphetamine N-demethylase; D010089:Oxidoreductases, N-Demethylating; D005037:Ethylmorphine-N-Demethylase; D009251:NADPH-Ferrihemoprotein Reductase; D007654:Ketoconazole',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Influence of protein binding and metabolic interconversion on the disposition of sulfisoxazole and its N4-acetyl metabolite by the isolated perfused rat kidney.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '607-13',\n",
       "  'abstract': 'The renal clearances of sulfisoxazole (SX) and N4-acetylsulfisoxazole (NSX) were studied in the isolated perfused rat kidney (IPK). Studies were conducted with conventional bovine serum albumin perfusates as well as with dextran perfusates to assess the influence of perfusate protein binding on the disposition of these compounds by the IPK. The results presented herein indicate that the disposition of sulfisoxazole by the IPK involves both metabolism and excretion. The metabolism of SX to NSX is reversible and is influenced by protein binding since metabolism increased with increased free fraction (Ff). The excretion of SX and NSX reflects a complex interaction of filtration, secretion, and reabsorption. A comparison of clearance values between kidneys perfused with bovine serum albumin perfusate (Ff 0.1) and dextran perfusate (Ff 1.0) suggests that tubular secretion of SX is a function of total (unbound plus bound) rather than free (unbound) drug in the perfusate.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Bekersky|I|I|;Popick|A C|AC|;Colburn|W A|WA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149912',\n",
       "  'mesh_terms': 'D000107:Acetylation; D000818:Animals; D001711:Biotransformation; D002417:Cattle; D005919:Glomerular Filtration Rate; D006863:Hydrogen-Ion Concentration; D066298:In Vitro Techniques; D007668:Kidney; D008297:Male; D010477:Perfusion; D011485:Protein Binding; D051381:Rats; D011919:Rats, Inbred Strains; D012710:Serum Albumin, Bovine; D013444:Sulfisoxazole',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D012710:Serum Albumin, Bovine; C022966:N(4)-acetylsulfisoxazole; D013444:Sulfisoxazole',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The nonenzymatic displacement of the sulfamoyl group from different classes of aromatic compounds by glutathione and cysteine.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '614-8',\n",
       "  'abstract': 'The rates of reaction for the nonenzymatic conjugation of reduced glutathione and L-cysteine to a series of 5-substituted 1,3,4-thiadiazole- and 1,3,4-thiadiazoline-2-sulfonamides, ring-fused 1,3,4-thiadiazole-2-sulfonamides, and substituted benzenesulfonamides have been measured under simulated physiological conditions. The reactivities toward conjugation at pH 7.5 within two series of 5-substituted 1,3,4-thiadiazole- and 1,3,4-thiadiazoline-2-sulfonamides (methazolamide derivatives) conformed to the Brønsted relationship, the rate of conjugation increasing as sulfonamide pK, decreased. Reaction rate was found to vary from k = 0.07 X 10(-3) min-1 for X (pKa = 7.7) to k = 275 X 10(-3) min-1 for IX (pKa = 7.05). All substituted benzenesulfonamides and several 1,3,4-thiadiazole-2-sulfonamides with pKa values above 9 were unreactive toward conjugation. The data presumably explain the fate of many of these compounds in vivo, for example the fact that acetazolamide (I) is excreted unchanged while methazolamide (XI) and ethoxolamide (XVII) are partially metabolized.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Conroy|C W|CW|;Schwam|H|H|;Maren|T H|TH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149913',\n",
       "  'mesh_terms': 'D001667:Binding, Competitive; D002257:Carbonic Anhydrase Inhibitors; D055598:Chemical Phenomena; D002621:Chemistry; D003545:Cysteine; D005978:Glutathione; D007700:Kinetics; D013449:Sulfonamides',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002257:Carbonic Anhydrase Inhibitors; D013449:Sulfonamides; D005978:Glutathione; D003545:Cysteine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'In vivo capacity of hepatic and extrahepatic enzymes to conjugate phenol.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '619-24',\n",
       "  'abstract': 'Phenol has a high metabolic clearance in the rat and shows extensive first pass metabolism. The ability of the intestinal mucosa, liver, and lung to conjugate phenol is investigated over a 35-fold dose range by employing a judicious choice of route of administration. Comparison of blood phenol concentration-time profiles, following intravenous administration into the jugular and the hepatic portal veins, indicates extensive hepatic conjugation of phenol at low doses. However, the capacity of the hepatic enzymes is readily saturated. This observation is confirmed in isolated perfused livers. Comparison of blood phenol concentration time profiles, following vascular administration into the carotid artery and the jugular vein, indicates substantial pulmonary conjugation of phenol. Although the extent of pulmonary conjugation is less than the hepatic contribution, it is evident over a wider dose range than the latter organ. Intestinal conjugation of phenol is assessed by comparison of data from intraduodenal and hepatic portal venous administration. At low doses of phenol (less than 1 mg/kg), intestinal and hepatic conjugation are comparable. The capacity of the intestinal conjugating enzymes is remarkably high; at large doses (greater than 5 mg/kg), intestinal conjugation far exceeds the contribution of the hepatic and pulmonary enzymes.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Cassidy|M K|MK|;Houston|J B|JB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149914',\n",
       "  'mesh_terms': 'D000818:Animals; D006207:Half-Life; D066298:In Vitro Techniques; D007413:Intestinal Mucosa; D007700:Kinetics; D008099:Liver; D008168:Lung; D008297:Male; D008657:Metabolic Clearance Rate; D010636:Phenols; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D010636:Phenols',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Influence of cimetidine on bupivacaine disposition in rat and monkey.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '625-30',\n",
       "  'abstract': 'Recent reports have appeared describing a cimetidine-induced alteration in either the input or disposition function for many drugs. The total clearance component of the disposition function is the primary perturbation. In the present investigation, the influence of cimetidine on bupivacaine disposition was studied, using in vitro and in vivo models. Since the extraction ratio for bupivacaine is low, total clearance follows the capacity-limited theory. Hence, the influence of cimetidine on the intrinsic clearance of bupivacaine was assessed using microsome and hepatocyte models. Results for both systems are in excellent agreement and indicate a noncompetitive inhibition. Additionally, the influence of cimetidine on the protein-binding profile of bupivacaine was determined. In the presence of cimetidine, the these findings was assessed in vivo in rhesus monkeys. co-administration of cimetidine resulted in an increase in the volume of distribution at steady state and no change in the total clearance of bupivacaine.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Thompson|G A|GA|;Myers|J A|JA|;Turner|P A|PA|;Denson|D D|DD|;Coyle|D E|DE|;Ritschel|W A|WA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149915',\n",
       "  'mesh_terms': 'D000818:Animals; D002045:Bupivacaine; D002927:Cimetidine; D066298:In Vitro Techniques; D007700:Kinetics; D008253:Macaca mulatta; D008297:Male; D008862:Microsomes, Liver; D011485:Protein Binding; D051381:Rats; D011916:Rats, Inbred F344; D013045:Species Specificity',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002927:Cimetidine; D002045:Bupivacaine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Absorption and excretion of the hydrophobic surfactant, 14C-poloxalene 2930, in the rat.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '631-4',\n",
       "  'abstract': 'Absorption and excretion of 14C-Poloxalene 2930 (PX), a nonionic hydrophobic surfactant of large molecular weight, were studied using bile fistula rats. Approximately half of the dose infused intraduodenally was absorbed and some of the absorbed surfactant was excreted in bile. The remainder was excreted in urine. Only trace quantities of the 14C-PX were recovered in liver and carcass at termination of the study. Two studies were also performed with 14C-PX incorporated into the diet. In the first feeding study of 7 days duration, most of the agent was excreted via the gastrointestinal tract within 72 hr of discontinuing treatment. In the second study, rats were fed dietary 14C-PX for 7, 14, or 23 days to determine whether the surfactant continued to accumulate in the body as the test period was extended. Further accumulation did occur between the 7th and 14th days but not when feeding was continued for a total of 23 days. Of the amount of 14C-PX ingested after 23 days of feeding, essentially all was excreted by the end of 7 days after discontinuing treatment. These studies indicate that despite its large molecular weight of about 3,000 some 14C-PX is absorbed. Furthermore, absorbed material is promptly excreted in bile and urine with little retained in body tissues.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Rodgers|J B|JB|;Friday|S|S|;Bochenek|W J|WJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149916',\n",
       "  'mesh_terms': 'D000818:Animals; D001646:Bile; D004032:Diet; D005243:Feces; D007408:Intestinal Absorption; D007700:Kinetics; D008297:Male; D011060:Poloxalene; D011092:Polyethylene Glycols; D051381:Rats; D011919:Rats, Inbred Strains; D013501:Surface-Active Agents; D014018:Tissue Distribution',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013501:Surface-Active Agents; D011092:Polyethylene Glycols; D011060:Poloxalene',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Metabolism of the neuroleptic agent zetidoline in the rat and the dog.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '635-40',\n",
       "  'abstract': \"The metabolism of zetidoline, a new neuroleptic, in the rat and the dog has been studied. From the urine of rats and dogs given 5 mg/kg of [2-14C] zetidoline orally, unchanged drug and five metabolites were isolated and the structures of four of them assigned by physicochemical analysis. They are: metabolite B, 4'-hydroxy-3'-chlorophenyl zetidoline; metabolite D, zetidoline without the aryl group; metabolite E, the 6'-hydroxy-4'-beta-D-glucuronide of metabolite B, and metabolite F, the 4'-beta-D-glucuronide of metabolite B. The plasma levels of zetidoline and its metabolites after iv administration show that the drug is rapidly excreted and/or metabolized in both animal species. The plasma radioactivity in the dog consists mainly of the pharmacologically active (neuroleptic) metabolite B, whereas in the rat it consists of the more polar metabolites. After oral administration, elimination in both species occurs mostly via the kidneys. In the dog, within a 24-hr period, 6.2 +/- 0.4% of the dose is accounted for as unchanged zetidoline, 7.6 +/- 0.5% as metabolite B, 10.1 +/- 0.7% as the unidentified metabolite C, and 21.4 +/- 1.1% as metabolite F. In the rat, over the same period, zetidoline is present in traces, metabolite B accounts for 6.9 +/- 0.3% of the dose, metabolite D for 6.6 +/- 0.9%, metabolite E for 15.2 +/- 1.4%, and metabolite F for 31.7 +/- 2.2%.\",\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Assandri|A|A|;Perazzi|A|A|;Fontanella|L|L|;Ferrari|P|P|;Ripamonti|A|A|;Tarzia|G|G|;Tuan|G|G|;Martinelli|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149917',\n",
       "  'mesh_terms': 'D000818:Animals; D014150:Antipsychotic Agents; D001646:Bile; D001711:Biotransformation; D002850:Chromatography, Gel; D004285:Dogs; D007093:Imidazoles; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D007093:Imidazoles; C027277:zetidoline',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Pharmacokinetics of gentamicin administered intratracheally or as an inhalation aerosol to guinea pigs.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '641-4',\n",
       "  'abstract': 'The pharmacokinetics of gentamicin were studied after intratracheal, inhalation, and iv administration to guinea pigs. Gentamicin injected intratracheally was almost completely systemically available. The comparison of the gentamicin plasma AUCs after inhalation and iv administration showed that an inhalation exposure lasting 10 min resulted in an absorption of 1.13 mg gentamicin/kg body weight into systemic circulation. This absorbed dose was 40.4 or 67.3% of the amount of gentamicin inhaled, depending on tidal volume assumed, and 1.4% of the amount of gentamicin aerosolized. The postinhalation gentamicin concentration in the lungs decreased with a half-life of 67.3 min. The data differentiate topical pulmonary gentamicin from systemic gentamicin and give a rational basis for study of the mechanism of the therapeutic effect of gentamicin inhalation aerosol in bronchopulmonary infections.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Trnovec|T|T|;Durisová|M|M|;Bezek|S|S|;Kállay|Z|Z|;Navarová|J|J|;Tomcíková|O|O|;Kettner|M|M|;Faltus|F|F|;Erichleb|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149918',\n",
       "  'mesh_terms': 'D000336:Aerosols; D000818:Animals; D005839:Gentamicins; D006168:Guinea Pigs; D007275:Injections, Intravenous; D007442:Intubation, Intratracheal; D007700:Kinetics; D008168:Lung; D008297:Male',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000336:Aerosols; D005839:Gentamicins',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Gastric mucosal polyps--an irrelevant finding? Studies on the incidence and clinical significance].',\n",
       "  'issue': '109(46)',\n",
       "  'pages': '1753-6',\n",
       "  'abstract': \"Among about 20.000 patients who had a gastroscopy in a period of 6 years, 92 had gastric mucosal polyposis, diagnosed by endoscopy and histology, an incidence of 0.46%. Eight patients with an age average of 38 years had familial gastrointestinal adenomatosis, in six of them the criteria of Gardner's disease were fulfilled. The remaining 84 patients had an average age of 62 years. In patients with more than ten polyps the sex ratio (female to male) was 3.9:1. In 56 patients without familial gastrointestinal adenomatosis, coloscopy and(or) proctosigmoidoscopy was performed. In 18 there were polyps in the colon, in three an invasive carcinoma in an adenoma. In three further patients extensive carcinoma of the colon (in two with stenosis) was found. These observations suggest that patients with gastric mucosal polyposis have a higher incidence of colon polyps and carcinoma.\",\n",
       "  'journal': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "  'authors': 'Wörmann|B|B|;Ottenjann|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149921',\n",
       "  'mesh_terms': 'D000328:Adult; D000367:Age Factors; D000368:Aged; D000752:Anemia, Pernicious; D002769:Cholelithiasis; D003110:Colonic Neoplasms; D003424:Crohn Disease; D004379:Duodenal Neoplasms; D005260:Female; D005753:Gastric Mucosa; D005773:Gastroscopy; D006801:Humans; D007417:Intestinal Polyps; D008297:Male; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia; D012737:Sex Factors; D013274:Stomach Neoplasms',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1055/s-2008-1069447',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dtsch Med Wochenschr',\n",
       "  'nlm_unique_id': '0006723',\n",
       "  'issn_linking': '0012-0472',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Aging selectively alters glutathione S-transferase isozyme concentrations in liver and lung cytosol.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '661-71',\n",
       "  'abstract': \"The effects of aging on hepatic and pulmonary cytosolic glutathione S-transferase activities and concentrations were investigated in male Fischer 344 rats 3, 12, and 24 months old. Column isoelectric focusing of liver cytosol indicated that activities, measured with six epoxide substrates, of isozymes E, C, and B increased from 3 to 12 months of age and decreased from 3 to 24 months of age whereas activities of isozyme A were increased in the old group. With lung cytosol, activities of isozymes E, C, and B were decreased whereas isozyme A activities were increased in the old group. Purification to homogeneity of individual isozymes from liver and lung cytosol from each age group indicated that catalytic properties of isozymes were not altered by aging. Immunotitrations of hepatic and pulmonary cytosol from each age group showed that changes in the concentrations of these isozymes occurred with aging: heptic isozymes E, C, and B increased from 3 to 12 months of age and then decreased by 24 months of age, whereas isozymes A and AA were increased by 24 months of age. Pulmonary isozymes E, C, and B followed a pattern of decline from 3 to 24 months of age, whereas isozyme A concentrations were unchanged with increasing age. Analysis of these changes suggested that subunits Ya and Yc as one group and Yb and Y'b as another followed similar increases (from 3 to 12 months) and decreases (from 12 to 24 months) in the liver and that these subunits showed consistent decreases with age in the lung.\",\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Spearman|M E|ME|;Leibman|K C|KC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149920',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D003600:Cytosol; D004591:Electrophoresis, Polyacrylamide Gel; D005982:Glutathione Transferase; D005779:Immunodiffusion; D007525:Isoelectric Focusing; D007527:Isoenzymes; D008099:Liver; D008168:Lung; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D007527:Isoenzymes; D005982:Glutathione Transferase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The metabolism of ICI 118,587, a partial agonist of beta 1-adrenoceptors, in mice, rats, rabbits, dogs, and humans.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '652-60',\n",
       "  'abstract': 'The absorption, metabolism, and excretion of 14C-labeled xamoterol (ICI 118,587) has been examined in mice, rats, rabbits, dogs, and humans. There was incomplete absorption by all species after oral administration, ranging from 9% by humans to 36% by dogs. Most of the absorbed radioactivity was eliminated within 24 hr of administration and the renal route predominated. Conjugates of the parent compound were the only observed metabolites in urine, the phenolic glucuronide being the principal animal metabolite and the phenol sulfate being the only human metabolite. There were marked interspecies variations in metabolite patterns and dogs were the only animal species in which the sulfate metabolite was detected. Comparison of the urinary metabolite patterns also showed higher output of the conjugates after oral administration than after intravenous administration, indicating that first pass metabolism was taking place. Little significant change in absorption or metabolism was seen over a range of oral doses; in rats, some saturation of the glucuronide-conjugating mechanism was observed but the sulfate-conjugating mechanism showed little, if any, diminished capacity at high dose levels in dogs. The use of fast atom bombardment mass spectroscopy for the determination of the molecular weight of conjugates is described.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Marten|T R|TR|;Bourne|G R|GR|;Miles|G S|GS|;Shuker|B|B|;Rankine|H D|HD|;Dutka|V N|VN|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149919',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000818:Animals; D001646:Bile; D002855:Chromatography, Thin Layer; D004285:Dogs; D005243:Feces; D005260:Female; D005965:Glucuronates; D006801:Humans; D006868:Hydrolysis; D007408:Intestinal Absorption; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D011412:Propanolamines; D011817:Rabbits; D011863:Radioimmunoassay; D051381:Rats; D013045:Species Specificity; D013056:Spectrophotometry, Ultraviolet; D013431:Sulfates; D017307:Xamoterol',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D005965:Glucuronates; D011412:Propanolamines; D013431:Sulfates; D017307:Xamoterol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Malignant arrhythmias in acute myocardial infarction. Relationship to serum potassium and effect of selective and non-selective beta-blockade.',\n",
       "  'issue': '28 Suppl 1()',\n",
       "  'pages': '77-85',\n",
       "  'abstract': 'The risk of malignant arrhythmias during myocardial infarction is greatly increased in patients with diuretic-induced hypokalaemia. In our study an increased risk was seen also in hypokalaemic patients not treated with diuretics. This indicates that hypokalaemia as such could trigger malignant arrhythmias. The frequency of hypokalaemia was much higher (22.5%) in diuretic-treated infarct patients than in those not treated with diuretics (12.9%). Thus, hypokalaemia should be avoided in diuretic-treated patients with increased risk of myocardial infarction. The incidence of malignant arrhythmias in hypokalaemic patients was 13.2% in those treated with non-selective beta-blockers on admission versus 26.1% in those treated with selective beta-blockers; corresponding figures in infarctions with serum potassium concentrations above 3.6 mmol/L were 9.4% and 10.4%, respectively. Non-selective beta-blockers reduced the frequency of malignant arrhythmias in hypokalaemic infarctions. This was in contrast to selective beta-blockers, which had no favourable effect on the frequency of malignant arrhythmias in hypokalaemic infarctions. Non-selective beta-blockers did not completely counteract the hypokalaemia. Still, the risk of malignant arrhythmias decreased. Thus, our study indicates that apart from hypokalaemia, some additional mechanism specifically linked to adrenaline stimulation in important for the development of malignant arrhythmias in acute myocardial infarction.',\n",
       "  'journal': 'Drugs',\n",
       "  'authors': 'Johansson|B W|BW|;Dziamski|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149923',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000368:Aged; D001145:Arrhythmias, Cardiac; D004232:Diuretics; D005260:Female; D006801:Humans; D007008:Hypokalemia; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D011188:Potassium',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D004232:Diuretics; D011188:Potassium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.2165/00003495-198400281-00008',\n",
       "  'references': '7026815;6861446;6799077;7083938;6142420;6358896;16994594;6134137;240481;6138927;6247002;7010157;7034473;6136900;6365408;5821045;6314140;6116950;6942634',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drugs',\n",
       "  'nlm_unique_id': '7600076',\n",
       "  'issn_linking': '0012-6667',\n",
       "  'country': 'New Zealand'},\n",
       " {'title': 'Complications of treatment of peripheral vertigo.',\n",
       "  'issue': '63(11)',\n",
       "  'pages': '561-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ear, nose, & throat journal',\n",
       "  'authors': 'Harris|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149924',\n",
       "  'mesh_terms': 'D000617:Aminoglycosides; D014151:Anti-Anxiety Agents; D000932:Antiemetics; D001621:Betahistine; D004232:Diuretics; D006801:Humans; D008575:Meniere Disease; D014717:Vertigo',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000617:Aminoglycosides; D014151:Anti-Anxiety Agents; D000932:Antiemetics; D004232:Diuretics; D001621:Betahistine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ear Nose Throat J',\n",
       "  'nlm_unique_id': '7701817',\n",
       "  'issn_linking': '0145-5613',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Ca2+, Mg2+-ATPase activity of the erythrocyte membrane in patients with lung cancer].',\n",
       "  'issue': '6(3)',\n",
       "  'pages': '72-3',\n",
       "  'abstract': 'The activity of erythrocyte membrane Ca2+, Mg2+-ATPase (EC 3.6.1.3) was studied in 22 patients suffering from lung cancer. The enzyme activity was found to increase. The observed changes indicate significant disturbances in the mechanisms of ion transport in organs and tissues during tumour growth.',\n",
       "  'journal': \"Eksperimental'naia onkologiia\",\n",
       "  'authors': 'Semenchuk|D D|DD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149925',\n",
       "  'mesh_terms': 'D000230:Adenocarcinoma; D000328:Adult; D000368:Aged; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D018288:Carcinoma, Small Cell; D002294:Carcinoma, Squamous Cell; D004910:Erythrocyte Membrane; D005260:Female; D006801:Humans; D008175:Lung Neoplasms; D008297:Male; D008875:Middle Aged',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eksp Onkol',\n",
       "  'nlm_unique_id': '8406659',\n",
       "  'issn_linking': '0204-3564',\n",
       "  'country': 'Ukraine'},\n",
       " {'title': 'Magnesium, electrolyte transport and coronary vascular tone.',\n",
       "  'issue': '28 Suppl 1()',\n",
       "  'pages': '120-42',\n",
       "  'abstract': \"Coronary heart diseases (CHD) have high indices of mortality and morbidity. A number of CHD and myocardial ischaemic syndromes such as unstable angina pectoris, sudden death ischaemic heart disease, acute myocardial infarction and ventricular arrhythmias have been associated with losses of myocardial magnesium and potassium. Mg++ ions are essential for regulation of Na+ and K+ transport across cell membranes, including those found in cardiac and vascular smooth muscle cells. Mg++ activates an Na+-K+-ATPase pump which in turn plays a major role in regulating Na+-K+ transport. Loss of cellular Mg++ results in loss of critically important phosphagens: MgATP and creatine phosphate. Thus, under conditions where cellular Mg++ is depleted (e.g. hypoxia, ischaemia, anoxia), the Na+-K+ pump and phosphagen stores will be compromised, leading to alterations in resting membrane potentials. Cellular Mg++ depletion has been found to result in concomitant depletion of K+ in a number of cells, including cardiac and vascular muscles. The consequences of these events are often production of cardiac arrhythmias. Myocardial and vascular injury lead to disturbances in electrolyte transport across cell membranes, whereby Na+ and Ca++ uptakes are enhanced and, just prior or concomitantly, Mg++ and K+ are lost. Such electrolyte disturbances often lead to necrotic foci. Considerable evidence has accumulated to indicate that the extracellular concentration of Mg++ is important in control of arterial tone and blood pressure via pressure via regulation of vascular membrane Mg++-Ca++ exchange sites. A reduction in the extracellular Mg++ concentration can produce hypertension, coronary vasospasm and potentiation of vasoconstrictor agents by allowing excess entry of Ca++; concomitantly, the potency of vasodilator agents is reduced. Alterations in vascular membrane Mg++ results in arterial and arteriolar membranes which are 'leaky', thus contributing to the cellular reduction in K+ and gain of Na+ and Ca+. Alterations in extracellular K+ or Na+ concentrations over physiological ranges, in the face of a Mg++ deficit, can exacerbate the coronary vasospasm noted with reduction in only extracellular Mg++. Since free Mg++ ions are necessary for maintaining Ca+ ions (both plasma membrane-bound and sarcoplasmic reticulum membrane-bound via Ca++ ATPases), intracellular free Mg++ would rise in conditions which result in cellular loss of Mg++, thereby exacerbating and contributing to elevation of blood pressure and coronary vasospasm.(ABSTRACT TRUNCATED AT 400 WORDS)\",\n",
       "  'journal': 'Drugs',\n",
       "  'authors': 'Altura|B M|BM|;Altura|B T|BT|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149922',\n",
       "  'mesh_terms': 'D000818:Animals; D001693:Biological Transport, Active; D002463:Cell Membrane Permeability; D002784:Cholesterol; D003327:Coronary Disease; D003331:Coronary Vessels; D000242:Cyclic AMP; D004032:Diet; D004573:Electrolytes; D006801:Humans; D008274:Magnesium; D008903:Minerals; D018377:Neurotransmitter Agents; D009994:Osmolar Concentration; D011188:Potassium; D000254:Sodium-Potassium-Exchanging ATPase; D014652:Vascular Diseases; D014881:Water Supply',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D004573:Electrolytes; D008903:Minerals; D018377:Neurotransmitter Agents; D002784:Cholesterol; D000242:Cyclic AMP; D000254:Sodium-Potassium-Exchanging ATPase; D008274:Magnesium; D011188:Potassium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.2165/00003495-198400281-00013',\n",
       "  'references': '4570425;7462924;1182944;206307;6680619;596244;7242415;6635865;7203;418838;6132092;6541279;1190780;7150872;4419576;83101;14133953;5039972;7305671;4363012;6867714;390330;6812785;5840376;6128451;4171329;6096640;7437017;13874651;793367;16694904;6116625;14434402;1016735;386807;13976753;6348202;6023566;729651;6407598;325421;6400430;5415554;6125727;13429856;13596362;6129380;4283444;87274;13313307;6869560;6118113;7297597;767020;224400;5596471;5771691;7185863;6110822;360793;13885999;7428148;5079145;7326233;6286068;433823;846497;7443079;5297313;7318362;661356;13772208;24541216;4718747;630136;687387;5410283;655086;7041309;5034598;5763574;74660;6966281;7037303;7368975;270670;324293;7361117;6942639;14894423;4743680;6168223;6701524;6461865;5124570;5540910;13438845;14337569;7239148;838837;4163142;4323905;4588182;396090;13965055;7026293;7020396;6620432;6353622;7185864;817294;5798629;665571;4124937;4124777;5043414;399240;7402146;1227505;562063;1139518;14153216;6059403;4455835',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drugs',\n",
       "  'nlm_unique_id': '7600076',\n",
       "  'issn_linking': '0012-6667',\n",
       "  'country': 'New Zealand'},\n",
       " {'title': '[Endocrine and metabolic disorders in anorexia nervosa. Their meaning].',\n",
       "  'issue': '10(3)',\n",
       "  'pages': '125-9',\n",
       "  'abstract': 'The authors distinguish among the hormonal and metabolic disturbances found in Anorexia nervosa those, numerous, which are the results of emaciation only, and others which could be signs of central neuro-chemical dysregulation. The disturbances of the gonadotropic function and of the control of the \"hunger-fattening\" phenomena are probably of the latter type; however the nature of those dysfunctions and of their corresponding neuro-mediators remain so far hypothetical.',\n",
       "  'journal': \"L'Encephale\",\n",
       "  'authors': 'Chupin|M|M|;Venisse|J L|JL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149926',\n",
       "  'mesh_terms': 'D000568:Amenorrhea; D000856:Anorexia Nervosa; D001835:Body Weight; D004700:Endocrine System Diseases; D005260:Female; D006065:Gonadotropins, Pituitary; D006728:Hormones; D006801:Humans; D007006:Hypogonadism; D007027:Hypothalamic Diseases; D007031:Hypothalamus; D007515:Islets of Langerhans; D008659:Metabolic Diseases; D018377:Neurotransmitter Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006065:Gonadotropins, Pituitary; D006728:Hormones; D018377:Neurotransmitter Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Encephale',\n",
       "  'nlm_unique_id': '7505643',\n",
       "  'issn_linking': '0013-7006',\n",
       "  'country': 'France'},\n",
       " {'title': '[Initial results of a pharmacokinetic study of pipothiazine and its palmitic ester (Piportil L4) in a schizophrenic population].',\n",
       "  'issue': '10(4)',\n",
       "  'pages': '171-6',\n",
       "  'abstract': 'Plasma kinetics of pipotiazine have been studied in ten schizophrenic patients after oral administration of single dose of pipotiazine at 7 a.m. (30 mg, drops). Peak plasma concentrations are reached one hour after administration (41.8 +/- 19,9 ng/ml) and then rapidly decline until 24 h (2.2 +/- 1.2 ng/ml). During the following days plasma concentrations remain stable at the same sampling times. After 3 days wash-out and first intramuscular injection of pipotiazine palmitate (100 mg) main pharmacokinetic data are found: plasma concentrations of pipotiazine are not detectable during at less 3 days after injection, maximal drug level is attained during second week after i.m. (1.7 +/- 0.9 ng/ml). A period of decline is then recorded. Furthermore the mean ratio between pipotiazine plasma concentration after oral and i.m. administration is about 20. When pipotiazine palmitate is given every fourth week, steady state seems to be reached as early as the second month.',\n",
       "  'journal': \"L'Encephale\",\n",
       "  'authors': 'Girard|M|M|;Granier|F|F|;Schmitt|L|L|;Cotonat|J|J|;Escande|M|M|;Blanc|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149927',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D014150:Antipsychotic Agents; D001711:Biotransformation; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007700:Kinetics; D008297:Male; D008875:Middle Aged; D010640:Phenothiazines; D012559:Schizophrenia; D013843:Thiazines',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010640:Phenothiazines; D013843:Thiazines',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Encephale',\n",
       "  'nlm_unique_id': '7505643',\n",
       "  'issn_linking': '0013-7006',\n",
       "  'country': 'France'},\n",
       " {'title': '[2 cases of amineptine dependence].',\n",
       "  'issue': '10(4)',\n",
       "  'pages': '189-91',\n",
       "  'abstract': 'We relate two cases of amineptine (Survector) overconsumption by patients cured for atypical depression with asthenia and activities deficit as the prevalent symptoms. Prescription of two tablets a day (0,200 g) was respected in one case during six months, and in the other case during two years, with therapeutic benefit on apragmatism. To no obvious reason, within few months both patients had gradually raised the doses to twenty tablets (2 g) and thirty tablets (3 g) respectively: we observed subexcitation, insomnia, sensorial hyperaesthesia, irritability, tachyphemia with dysarthria, anorexia with weight lost of more than 10 kg and amphetamine-like troubles without confusion or delusion, as a result of which both patients were treated for their addiction, in hospital. Treatment with clorazepate perfusions did not cause any physical dependence problems. However, psychological dependence was strong enough for one of the patients to go out, on the third day, against medical decision. As far as we know, in France, only one such case of addiction use at high doses and in single intakes is mentioned in the existing literature. However, our observations suggest that it might be necessary to re-assess the place of amineptine among new antidepressive molecules with psychostimulant abilities.',\n",
       "  'journal': \"L'Encephale\",\n",
       "  'authors': 'Ginestet|D|D|;Cazas|O|O|;Branciard|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149928',\n",
       "  'mesh_terms': 'D000328:Adult; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D001247:Asthenia; D000697:Central Nervous System Stimulants; D003866:Depressive Disorder; D003986:Dibenzocycloheptenes; D005260:Female; D006801:Humans; D019966:Substance-Related Disorders',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D000697:Central Nervous System Stimulants; D003986:Dibenzocycloheptenes; C011597:amineptin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Encephale',\n",
       "  'nlm_unique_id': '7505643',\n",
       "  'issn_linking': '0013-7006',\n",
       "  'country': 'France'},\n",
       " {'title': 'Immunoprecipitation of radiolabeled human thyroid cell proteins by serum from patients with autoimmune thyroid disease.',\n",
       "  'issue': '115(6)',\n",
       "  'pages': '2137-44',\n",
       "  'abstract': \"Characterization of the antigen to thyroid-stimulating immunoglobulin (TSI), presumably the TSH receptor, remains elusive. We, therefore, attempted immunoprecipitation of the TSI antigen using cultured human thyroid cells radiolabeled to high specific activity by [35S]methionine (all proteins labeled) or by 125I and lactoperoxidase (primarily cell surface proteins labeled). Both techniques produced similar results. Crude membrane preparations from the labeled cells were solubilized in buffer containing 1% Triton and then incubated with TSI-containing or control serum. Immunoglobulin was precipitated with goat antihuman immunoglobulin and subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis and autoradiography. About 30 proteins were immunoprecipitated by both normal and control sera. However, only 1 protein (mol wt, approximately 320,000) was preferentially selected by TSI-containing serum (6 of 6 tested). This protein was also immunoprecipitated by the majority of sera from patients with Hashimoto's thyroiditis. The 320,000 mol wt protein constituted only a minute amount of total radiolabeled membrane protein, because it was not apparent on electrophoresis of the membrane extract before immunoprecipitation. It corresponded (in migration) to a human thyroglobulin (Tg) standard. Tg also inhibited immunoprecipitation of the 320,000 mol wt band. The anti-Tg antibody titer correlated significantly with the degree of immunoprecipitation of the 320,000 mol wt band. No specific immunoprecipitation of any protein was observed when radiolabeled guinea pig membrane proteins were used. These data provide insight into the difficulties involved in the identification of the TSH receptor with serum containing TSI.\",\n",
       "  'journal': 'Endocrinology',\n",
       "  'authors': 'Rapoport|B|B|;Seto|P|P|;Magnusson|R P|RP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149929',\n",
       "  'mesh_terms': 'D000941:Antigens; D001327:Autoimmune Diseases; D011232:Chemical Precipitation; D006111:Graves Disease; D006801:Humans; D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D007158:Immunologic Techniques; D008565:Membrane Proteins; D013961:Thyroid Gland',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000941:Antigens; D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D008565:Membrane Proteins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1210/endo-115-6-2137',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Endocrinology',\n",
       "  'nlm_unique_id': '0375040',\n",
       "  'issn_linking': '0013-7227',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Role of the hypophysis in regulation of pancreatic and gastric somatostatin.',\n",
       "  'issue': '115(6)',\n",
       "  'pages': '2260-5',\n",
       "  'abstract': 'Since hypophysectomy and GH deficiency are associated with decreases in hypothalamic content and release of SRIF, it was of interest to determine whether these hormonal alterations also affect peripheral tissue levels of SRIF. Hypophysectomized (hypox) rats were studied at various times after surgery and compared with age-matched controls. Pancreatic, gastric, and hypothalamic SRIF levels were measured by RIA and expressed as nanograms per mg protein or nanograms per organ. Decreased levels of hypothalamic SRIF were observed in hypox animals at all time periods after surgery. In contrast, pancreatic SRIF concentrations increased within 1 week of hypophysectomy, and the tissue content increased as much as 3-fold after 20 weeks. Measurement of the SRIF content of isolated rat islets of Langerhans revealed a 67% increased content/islet in hypox rats compared with controls. The gastric SRIF concentration was not changed early, but subsequently, the total organ content was significantly decreased compared with that in controls. The changes in stomach and pancreas SRIF contents became more marked with duration of pituitary deficiency. Studies in genetically dwarfed Snell mice, lacking primarily GH but also other anterior pituitary hormones, were similar to the findings noted in hypox rats; the SRIF concentration was significantly increased in the pancreas and decreased in the stomach and hypothalamus. It is probable that deficiencies in other hormones as well as GH are involved in producing the changes in pancreatic SRIF in hypox and dwarfed animals. This contention was supported in that replacement of T3 (5 micrograms/kg . day) reduced pancreatic SRIF concentration by 30%, while GH plus T3 produced a significantly greater (60%) decrease in pancreatic SRIF in hypox rats.',\n",
       "  'journal': 'Endocrinology',\n",
       "  'authors': 'Recant|L|L|;Voyles|N R|NR|;Wilkins|S D|SD|;Fairtile|R D|RD|;King|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149930',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D004392:Dwarfism; D005753:Gastric Mucosa; D013006:Growth Hormone; D007016:Hypophysectomy; D007018:Hypopituitarism; D007515:Islets of Langerhans; D008297:Male; D010179:Pancreas; D010902:Pituitary Gland; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013004:Somatostatin; D013006:Growth Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1210/endo-115-6-2260',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Endocrinology',\n",
       "  'nlm_unique_id': '0375040',\n",
       "  'issn_linking': '0013-7227',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Somatostatin as a hormone regulating the function of the digestive system].',\n",
       "  'issue': '35(3)',\n",
       "  'pages': '125-38',\n",
       "  'abstract': '',\n",
       "  'journal': 'Endokrynologia Polska',\n",
       "  'authors': 'Szafran|H|H|;Sztefko|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149931',\n",
       "  'mesh_terms': 'D000818:Animals; D004063:Digestion; D004285:Dogs; D004435:Eating; D005215:Fasting; D005768:Gastrointestinal Hormones; D006168:Guinea Pigs; D006706:Homeostasis; D006801:Humans; D010189:Pancreatic Juice; D051381:Rats; D013004:Somatostatin',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D005768:Gastrointestinal Hormones; D013004:Somatostatin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Endokrynol Pol',\n",
       "  'nlm_unique_id': '0370674',\n",
       "  'issn_linking': '0423-104X',\n",
       "  'country': 'Poland'},\n",
       " {'title': 'Effect of Morris 7777 hepatoma on microsomal glucose-6-phosphatase latent activity.',\n",
       "  'issue': '32(2)',\n",
       "  'pages': '100-4',\n",
       "  'abstract': 'The change in the activity of several hepatic enzymes during hepatocarcinogenesis suggests a pattern of dedifferentiation. This category of enzymes includes glucose-6-phosphatase and gamma-glutamyltranspeptidase (GGT). A detailed kinetic analysis of microsomal glucose-6-phosphatase activity revealed that both the translocase and phosphohydrolase activities were markedly reduced in Morris 7777 hepatoma transplanted in male Buffalo rats. In addition, the activity of the translocase component increased 2.4-fold, while the phosphohydrolase activity decreased 1.6-fold in the liver of tumor-bearing animals. GGT activity in the host liver was not effected by the presence of the tumor. These results suggest differences in the effect of Morris 7777 hepatoma on: the phosphohydrolase and translocase activities of microsomal glucose-6-phosphatase and the sensitivity of glucose-6-phosphatase and GGT activities in the host liver.',\n",
       "  'journal': 'Enzyme',\n",
       "  'authors': 'Dobrosielski-Vergona|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149932',\n",
       "  'mesh_terms': 'D000818:Animals; D005952:Glucose-6-Phosphatase; D007700:Kinetics; D008114:Liver Neoplasms, Experimental; D008297:Male; D008862:Microsomes, Liver; D009115:Muridae; D009368:Neoplasm Transplantation; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005723:gamma-Glutamyltransferase; D005952:Glucose-6-Phosphatase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000469458',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Enzyme',\n",
       "  'nlm_unique_id': '1262265',\n",
       "  'issn_linking': '0013-9432',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Hepatic gamma-glutamyl transferase and hepatic fibrosis in patients with alcoholic liver disease.',\n",
       "  'issue': '32(2)',\n",
       "  'pages': '110-5',\n",
       "  'abstract': 'The activity of gamma-glutamyl transferase (GGT) in the liver of 22 patients with alcoholic liver disease, 24 with nonalcoholic liver disease and 12 normal controls was measured. The enhanced hepatic GGT activity was higher in alcoholic patients and nonalcoholic patients than in the normal controls. No statistical significance of difference could be found in hepatic GGT activity between alcoholic and nonalcoholic patients, while serum GGT activity was markedly elevated in alcoholic patients compared to nonalcoholic patients. There was better correlation between hepatic and serum GGT activity in alcoholic patients. Furthermore the enhanced hepatic GGT activity could contribute to the pathogenesis of liver fibrosis as a result of the investigation for hepatic GGT activity and histological liver fibrosis.',\n",
       "  'journal': 'Enzyme',\n",
       "  'authors': 'Yamauchi|M|M|;Kimura|K|K|;Kawase|H|H|;Watanabe|Y|Y|;Kitahara|T|T|;Ogura|K|K|;Fujisawa|K|K|;Kameda|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149933',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D006801:Humans; D008099:Liver; D008103:Liver Cirrhosis; D008104:Liver Cirrhosis, Alcoholic; D008107:Liver Diseases; D008108:Liver Diseases, Alcoholic; D008875:Middle Aged; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000469460',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Enzyme',\n",
       "  'nlm_unique_id': '1262265',\n",
       "  'issn_linking': '0013-9432',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Purification and characterization of aminopeptidase N from human plasma.',\n",
       "  'issue': '32(2)',\n",
       "  'pages': '65-75',\n",
       "  'abstract': 'Human plasma aminopeptidase N (EC 3.4.11.2) was homogeneously purified from outdated bank plasma. Purification procedures included ammonium sulfate fractionation, immunoaffinity chromatography, DEAE-cellulose column chromatography, hydroxyapatite column chromatography and Sephadex G-200 gel filtration. The final recovery of the enzyme was 18% and its specific activity was 71.6 mumol/min/mg protein. SDS-polyacrylamide gel disc electrophoresis and analytical ultracentrifugation showed the homogeneity of the enzyme. Equilibrium ultracentrifugation showed a molecular weight of 210,800. SDS-polyacrylamide gel disc electrophoresis indicated that the enzyme was a dimer consisting of two identical subunits. The isoelectric point of the enzyme was 3.9 at 4 degrees C. The amino acid composition of the enzyme was very similar to those of aminopeptidase N from human kidney, small intestine, and placenta which we have reported previously. Neutral sugar accounted for 11.6%. The Km, Vmax and Kcat values and hydrolytic coefficient (Kcat/Km) of the enzyme with L-alanyl-beta-naphthylamide as substrate were 8.7 X 10(-5) mol/l, 85.9 mumol/min/mg protein, 303/s and 3,483/mmol/l/s, respectively. The enzyme was activated by cobalt ions and markedly inhibited by amastatin. Plasma aminopeptidase N was immunologically indistinguishable from kidney aminopeptidase N.',\n",
       "  'journal': 'Enzyme',\n",
       "  'authors': 'Tokioka-Terao|M|M|;Hiwada|K|K|;Kokubu|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149934',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000626:Aminopeptidases; D018826:CD13 Antigens; D002241:Carbohydrates; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002845:Chromatography; D002846:Chromatography, Affinity; D002848:Chromatography, DEAE-Cellulose; D002850:Chromatography, Gel; D003035:Cobalt; D004355:Drug Stability; D006358:Hot Temperature; D006801:Humans; D007668:Kidney; D007700:Kinetics',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000596:Amino Acids; D002241:Carbohydrates; D003035:Cobalt; D000626:Aminopeptidases; D018826:CD13 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000469453',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Enzyme',\n",
       "  'nlm_unique_id': '1262265',\n",
       "  'issn_linking': '0013-9432',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': '[Crohn disease and ulcerative colitis. Frequency, familial occurrence and pregnancy course].',\n",
       "  'issue': '53()',\n",
       "  'pages': '103-32',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ergebnisse der inneren Medizin und Kinderheilkunde',\n",
       "  'authors': 'Küster|W|W|;Lenz|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149935',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D002648:Child; D002675:Child, Preschool; D002874:Chromosome Mapping; D003093:Colitis, Ulcerative; D003348:Cortisone; D003424:Crohn Disease; D003430:Cross-Sectional Studies; D004200:Diseases in Twins; D005260:Female; D006680:HLA Antigens; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications; D011379:Prognosis; D012737:Sex Factors; D013167:Spondylitis, Ankylosing; D012460:Sulfasalazine; D014424:Turner Syndrome',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D006680:HLA Antigens; D012460:Sulfasalazine; D003348:Cortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ergeb Inn Med Kinderheilkd',\n",
       "  'nlm_unique_id': '0370703',\n",
       "  'issn_linking': '0071-111X',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Oligo(methionyl) proteins. Enzymatic hydrolysis of the model isopeptides N epsilon-oligo(L-methionyl)-L-lysine.',\n",
       "  'issue': '145(2)',\n",
       "  'pages': '257-63',\n",
       "  'abstract': 'A number of model isopeptides containing oligo(methionine) chains varying in length (2-5 residues) covalently linked to the epsilon-amino group of lysine were synthesized by solid-phase procedures. Hydrolysis of these peptides by pepsin, chymotrypsin, cathepsin C (dipeptidyl peptidase IV) and intestinal aminopeptidase N was investigated using high-performance liquid chromatography to identify and quantify the hydrolysis products. Methionine oligomers grafted onto lysine were cleaved to tripeptides by pepsin. Chymotrypsin preferentially hydrolyzed the methionyl-methionine bond preceding the isopeptide bond. Cathepsin C released dimethionyl units from the covalently attached polymers. Intestinal aminopeptidase caused efficient hydrolysis of both peptides and isopeptide bonds although free methionine decreased the cleavage of the latter bond. Hydrophobic characteristics of oligo(methionine) chains promoted enzyme-catalyzed transpeptidations resulting probably from acyl-transfer-type reactions. Complementary hydrolysis of the isopeptides by these digestive enzymes suggests that covalent attachment of oligo(amino acid)s to food proteins may improve their nutritional value.',\n",
       "  'journal': 'European journal of biochemistry',\n",
       "  'authors': 'Gaertner|H|H|;Puigserver|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149936',\n",
       "  'mesh_terms': 'D000626:Aminopeptidases; D018826:CD13 Antigens; D002918:Chymotrypsin; D006868:Hydrolysis; D007700:Kinetics; D008239:Lysine; D008715:Methionine; D009842:Oligopeptides; D010196:Pancreatic Elastase; D010434:Pepsin A',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D009842:Oligopeptides; D008715:Methionine; D000626:Aminopeptidases; D018826:CD13 Antigens; D002918:Chymotrypsin; D010196:Pancreatic Elastase; D010434:Pepsin A; D008239:Lysine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1432-1033.1984.tb08546.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Biochem',\n",
       "  'nlm_unique_id': '0107600',\n",
       "  'issn_linking': '0014-2956',\n",
       "  'country': 'England'},\n",
       " {'title': 'Serum lipid distribution and mortality in Belgium.',\n",
       "  'issue': '5(10)',\n",
       "  'pages': '778-83',\n",
       "  'abstract': 'During the year 1982 serum cholesterol and apolipoprotein A1 and B levels were measured in 1319 male subjects (mean age 20 years) from different provinces of Belgium. The serum cholesterol level and the apolipoprotein B level were distinctly lower in Dutch-speaking than in French-speaking subjects. An increase of 1.1 mg% of total cholesterol was found per kg per consumer unit per year of butter consumed and a decrease of 1.1 mg% per kg per consumer unit per year of margarine consumed. The higher cholesterol value in French-speaking subjects correlated significantly with a high regional mortality from all causes and from ischaemic heart disease in male subjects of the 45-64-year age group. A 10 mg% difference in serum cholesterol at the age of 20 years corresponds with an increase in mortality from all causes of 20% and from ischaemic heart disease of 21%. A significant difference in log GGT (gamma glutamyl-transpeptidase)--possibly due to differences in alcohol consumption--was observed between the provinces of Belgium. The difference in cholesterol and apolipoprotein B level remained significant after adjustment for log GGT.',\n",
       "  'journal': 'European heart journal',\n",
       "  'authors': 'Kesteloot|H|H|;Bande|J|J|;Pille|J|J|;Geboers|J|J|;Vertenten|E|E|;de Hemptinne|J|J|;van Houte|O|O|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149937',\n",
       "  'mesh_terms': 'D000328:Adult; D001054:Apolipoproteins A; D001055:Apolipoproteins B; D001530:Belgium; D002784:Cholesterol; D008076:Cholesterol, HDL; D003327:Coronary Disease; D004041:Dietary Fats; D005247:Feeding Behavior; D006801:Humans; D008055:Lipids; D008297:Male; D008875:Middle Aged; D009026:Mortality; D012044:Regression Analysis; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001054:Apolipoproteins A; D001055:Apolipoproteins B; D008076:Cholesterol, HDL; D004041:Dietary Fats; D008055:Lipids; D002784:Cholesterol; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/oxfordjournals.eurheartj.a061566',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur Heart J',\n",
       "  'nlm_unique_id': '8006263',\n",
       "  'issn_linking': '0195-668X',\n",
       "  'country': 'England'},\n",
       " {'title': 'Dose-response relationship of the beta-adrenoceptor antagonist bisoprolol in patients with coronary heart disease and chronic obstructive bronchitis.',\n",
       "  'issue': '27(2)',\n",
       "  'pages': '135-9',\n",
       "  'abstract': 'The effects of single, consecutively increased, oral doses of the beta-adrenoceptor antagonist bisoprolol (5, 10, 15, 20, 30 and 40 mg) on blood pressure, heart rate and bronchomotor tone were investigated in an open acute trial with 16 patients suffering from angina pectoris due to coronary heart disease and reversible chronic obstructive bronchitis. Even the lowest dose of bisoprolol (5 mg) caused a marked, long-lasting reduction in blood pressure and heart rate. After doses exceeding 20 mg, the incidence of an exaggerated pharmacodynamic effect on heart rate (beta 1-blockade) increased with dose. At doses above 30 mg, bisoprolol showed incipient impairment of bronchomotor function (beta 2-blockade) in individual patients. It is concluded that bisoprolol exhibits high beta 1-selectivity, i.e. a wide beta 1/beta 2 split, since blockade of bronchial beta 2-receptors only occurred at doses well above the therapeutically relevant dose range. The results may not be applicable to chronic treatment.',\n",
       "  'journal': 'European journal of clinical pharmacology',\n",
       "  'authors': 'Dorow|P|P|;Tönnesmann|U|U|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149938',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D000368:Aged; D000403:Airway Resistance; D017298:Bisoprolol; D001794:Blood Pressure; D001991:Bronchitis; D002908:Chronic Disease; D003327:Coronary Disease; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D005996:Nitroglycerin; D011412:Propanolamines',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D005996:Nitroglycerin; D017298:Bisoprolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00544035',\n",
       "  'references': '25391;6113900;22216522;337270;239966',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Clin Pharmacol',\n",
       "  'nlm_unique_id': '1256165',\n",
       "  'issn_linking': '0031-6970',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Ventilatory effects of beta 1-receptor-selective blockade with bisoprolol and metoprolol in asthmatic patients.',\n",
       "  'issue': '27(2)',\n",
       "  'pages': '141-5',\n",
       "  'abstract': 'In a double blind, placebo-controlled study the ventilatory effects of the beta 1-selective receptor blockers bisoprolol (EMD 33512) and metoprolol and their interactions with the beta 2-adrenoceptor agonist terbutaline were investigated in 8 asthmatic patients. Both beta-blockers, in all the doses given, caused a significant decrease in peak expiratory flow rate (PEFR). Vital capacity (VC) and forced expiratory volume in one second (FEV1) were significantly decreased only after 10 mg bisoprolol. Terbutaline inhalation caused the same significant improvements in FEV1 and PEFR during placebo as during bisoprolol 10 mg, bisoprolol 20 mg and metoprolol 100 mg. Both beta-blockers caused equal changes in heart rate (HR) at rest. Systolic and diastolic blood pressure (BP) decreased significantly after bisoprolol 20 mg and metoprolol 100 mg, but not after bisoprolol 10 mg. Inhalation of terbutaline up to a dose of 3.5 mg had no influence on HR and BP. The results point to good beta 1-selectivity of bisoprolol 10 mg and 20 mg and metoprolol 100 mg in asthmatic patients. No correlation was found between the plasma levels of the beta-blockers and the changes in the ventilatory indices, HR or BP.',\n",
       "  'journal': 'European journal of clinical pharmacology',\n",
       "  'authors': 'Lammers|J W|JW|;Folgering|H T|HT|;van Herwaarden|C L|CL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149939',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D001249:Asthma; D017298:Bisoprolol; D001794:Blood Pressure; D005541:Forced Expiratory Volume; D006339:Heart Rate; D006801:Humans; D008297:Male; D008790:Metoprolol; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D011412:Propanolamines; D012129:Respiratory Function Tests; D014797:Vital Capacity',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D008790:Metoprolol; D017298:Bisoprolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00544036',\n",
       "  'references': '6756931;872491;1112122;1233216;6113900;339932;1094802;239966;576035',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Clin Pharmacol',\n",
       "  'nlm_unique_id': '1256165',\n",
       "  'issn_linking': '0031-6970',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Influence of triazolam on thermal heat balance in poor sleepers.',\n",
       "  'issue': '27(2)',\n",
       "  'pages': '173-9',\n",
       "  'abstract': 'The influence of a benzodiazepine (triazolam) on the body temperature of poor sleepers during nights disturbed by airplane noises has been examined. Subjects were divided into 3 groups each of 8 men. Following a double-blind design, Group A (controls) received a placebo for 6 consecutive nights, Group B received 0.25 mg triazolam, and Group C received 0.5 mg triazolam on nights N3, N4 and N5. On all other nights Group B and C subjects received placebo. For all 3 groups, nights N3 and N5 were disturbed by 32, semi-randomly distributed airplane noises. Air and wall temperatures (To = 20 degrees C), and air humidity (Tdp = 10 degrees C), were kept constant. Rectal temperature and 4 local skin temperatures were recorded from each subject. Urine samples were collected each morning for measurement of cortisol and catecholamine levels. Noise was found to cause an increase in body heat storage, but only in Group A. Both drug groups showed impairment of body heat balance. The hypothermic action of triazolam could be explained both by a central action of the drug on the thermoregulatory controller and by a peripheral action on blood vessels.',\n",
       "  'journal': 'European journal of clinical pharmacology',\n",
       "  'authors': 'Libert|J P|JP|;Weber|L D|LD|;Amoros|C|C|;Muzet|A|A|;Ehrhart|J|J|;Follenius|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149940',\n",
       "  'mesh_terms': 'D000328:Adult; D014151:Anti-Anxiety Agents; D001831:Body Temperature; D001833:Body Temperature Regulation; D002395:Catecholamines; D004298:Dopamine; D004311:Double-Blind Method; D004837:Epinephrine; D006801:Humans; D006854:Hydrocortisone; D009638:Norepinephrine; D012881:Skin Temperature; D007319:Sleep Initiation and Maintenance Disorders; D013997:Time Factors; D014229:Triazolam',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D002395:Catecholamines; D014229:Triazolam; D004298:Dopamine; D006854:Hydrocortisone; D009638:Norepinephrine; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00544042',\n",
       "  'references': '4784737;5921729;4349454;5912770;13953735;22814;4353036;14173555;6127778;5731785;904439;6250823;591083;1000625',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Clin Pharmacol',\n",
       "  'nlm_unique_id': '1256165',\n",
       "  'issn_linking': '0031-6970',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Serological and partial molecular characterization of a Thy-1 homolog in tunicates.',\n",
       "  'issue': '14(11)',\n",
       "  'pages': '1031-9',\n",
       "  'abstract': 'The occurrence of a Thy-1 homolog in the tissues of the advanced invertebrate group of tunicates has been investigated by using two monoclonal antibodies specific to rodent Thy-1.1 determinants and a heterologous anti-rat Thy-1 antiserum. In cellular and soluble-phase radioimmunoassays for Thy-1 using intact hemocytes, tissue extracts and hemolymph, membrane-bound and soluble Thy-1.1 cross-reacting determinants have been detected. Immunoprecipitation experiments with hemocyte deoxycholate extracts and hemolymph, labeled with 125I by lactoperoxidase/chloramine T and with NaB3H4 by galactose oxidase, established the association of the Thy-1.1 cross-reacting determinants with a single glycoprotein of apparent m.w. estimated at 27 000 in hemocytes and 22 500 in hemolymph by sodium dodecyl sulfate polyacrylamide gel electrophoresis. The significance of this finding is discussed in relation to the phylogenetic emergence of the Thy-1 molecule during evolution.',\n",
       "  'journal': 'European journal of immunology',\n",
       "  'authors': 'Mansour|M H|MH|;Cooper|E L|EL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149941',\n",
       "  'mesh_terms': 'D000818:Animals; D000954:Antigens, Surface; D001921:Brain; D002462:Cell Membrane; D004591:Electrophoresis, Polyacrylamide Gel; D005690:Galactose; D005692:Galactose Oxidase; D006458:Hemolymph; D051379:Mice; D008806:Mice, Inbred AKR; D008808:Mice, Inbred CBA; D008970:Molecular Weight; D011863:Radioimmunoassay; D051381:Rats; D011919:Rats, Inbred Strains; D018800:Thy-1 Antigens; D013950:Thymus Gland; D014561:Urochordata',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000954:Antigens, Surface; D018800:Thy-1 Antigens; D005692:Galactose Oxidase; D005690:Galactose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/eji.1830141113',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Immunol',\n",
       "  'nlm_unique_id': '1273201',\n",
       "  'issn_linking': '0014-2980',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Suriclone, a new anxiolytic of the cyclopyrrolone family: evidence for possible interference with GABAergic systems.',\n",
       "  'issue': '104(1-2)',\n",
       "  'pages': '139-44',\n",
       "  'abstract': 'The action of suriclone (R.P. 31,264), a new non-benzodiazepine compound of the cyclopyrrolone family with clinical anxiolytic activity was examined using biochemical and electrophysiological models supposed to be capable of revealing central GABAergic activity. Suriclone, which does not act directly on the gamma-aminobutyric acid (GABA) receptor (muscimol binding assay), markedly reduced the increase of striatal HVA level induced in the rat by a neuroleptic and decreased the cerebellar vermis cGMP content. Moreover, in the cat, suriclone was able to enhance dorsal root potential amplitude which reflects an increase of the presynaptic inhibition. In view of these results, a central GABAergic mechanism of action may be proposed for suriclone.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Boireau|A|A|;Stutzmann|J M|JM|;Garret|C|C|;Julou|L|L|;Blanchard|J C|JC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149942',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D001667:Binding, Competitive; D002415:Cats; D002531:Cerebellum; D002707:Chlordiazepoxide; D003342:Corpus Striatum; D006152:Cyclic GMP; D003975:Diazepam; D005071:Evoked Potentials; D006719:Homovanillic Acid; D066298:In Vitro Techniques; D009118:Muscimol; D009287:Naphthyridines; D009567:Nitrazepam; D010640:Phenothiazines; D010879:Piperazines; D051381:Rats; D013116:Spinal Cord; D013457:Sulfur Compounds; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D009287:Naphthyridines; D010640:Phenothiazines; D010879:Piperazines; D013457:Sulfur Compounds; D009118:Muscimol; D005680:gamma-Aminobutyric Acid; D002707:Chlordiazepoxide; D009567:Nitrazepam; D006152:Cyclic GMP; C037283:suriclone; D003975:Diazepam; D006719:Homovanillic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90380-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Adenosine decreases aspartate and glutamate release from rat hippocampal slices.',\n",
       "  'issue': '104(1-2)',\n",
       "  'pages': '19-26',\n",
       "  'abstract': 'The effect of adenosine and related compounds on the release of endogenous aspartate and glutamate from isolated, superfused rat hippocampal slices was studied at rest and during electrical stimulation of the stratum radiatum in the CA3/CA2 region, using a sensitive mass-spectrometric technique. Evoked extracellular potentials were recorded from the CA1 region. Adenosine, at 3 X 10(-4) M concentration, inhibited the stimulation-evoked potentials and prevented the stimulation-induced release of aspartate and glutamate. Similarly, 1-phenylisopropyladenosine (10(-6) M) and cyclohexyladenosine (10(-6) M) depressed both electrical and neurochemical responses to stimulation of the stratum radiatum. 8-Phenyltheophylline (5 X 10(-6) M) increased the release of aspartate and glutamate and antagonized the cyclohexyladenosine-induced inhibition of amino acid release. Our results support the hypothesis that adenosine modulates the electrophysiological responses to stimulation of stratum radiatum through a reduction of the release of the excitatory amino acids aspartate and glutamate.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Corradetti|R|R|;Lo Conte|G|G|;Moroni|F|F|;Passani|M B|MB|;Pepeu|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149943',\n",
       "  'mesh_terms': 'D000241:Adenosine; D000818:Animals; D001224:Aspartic Acid; D003342:Corpus Striatum; D004558:Electric Stimulation; D005071:Evoked Potentials; D005971:Glutamates; D018698:Glutamic Acid; D006624:Hippocampus; D066298:In Vitro Techniques; D008297:Male; D013058:Mass Spectrometry; D010660:Phenylisopropyladenosine; D051381:Rats; D011956:Receptors, Cell Surface; D011983:Receptors, Purinergic; D013806:Theophylline; D014970:Xanthines',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005971:Glutamates; D011956:Receptors, Cell Surface; D011983:Receptors, Purinergic; D014970:Xanthines; C008514:methylxanthine; D010660:Phenylisopropyladenosine; D001224:Aspartic Acid; D018698:Glutamic Acid; D013806:Theophylline; C028322:8-phenyltheophylline; D000241:Adenosine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90364-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Effect of cyanide on nitrovasodilator-induced relaxation, cyclic GMP accumulation and guanylate cyclase activation in rat aorta.',\n",
       "  'issue': '104(1-2)',\n",
       "  'pages': '61-70',\n",
       "  'abstract': \"The effects of sodium cyanide on relaxation, increases in cyclic GMP accumulation and guanylate cyclase activation induced by sodium nitroprusside and other nitrovasodilators were examined in rat thoracic aorta. Cyanide abolished nitroprusside-induced relaxation and the associated increase in cyclic GMP levels. Basal levels of cyclic GMP and cyclic AMP were also depressed. Reversal of nitroprusside-induced relaxation by cyanide was independent of the tissue level of cyclic GMP prior to addition of cyanide. Incubation of nitroprusside with cyanide prior to addition to aortic strips did not alter the relaxant effect of nitroprusside. Sodium azide-, hydroxylamine-, N-methyl-N'-nitro-N-nitrosoguanide-, nitroglycerin- and acetylcholine-induced relaxations and increased levels of cyclic GMP were also inhibited by cyanide. Relaxations induced by nitric oxide were also inhibited by cyanide, although the relaxation with the low concentration of nitric oxide employed was not accompanied by detectable increases in cyclic GMP. Relaxation to 8-bromo-cyclic GMP was essentially unaltered by cyanide; however, isoproterenol-induced relaxation was inhibited. Guanylate cyclase in soluble and particulate fractions of aorta homogenates was activated by nitroprusside and the activation was prevented by cyanide. The present results suggest that cyanide inhibits nitrovasodilator-induced relaxation through inhibition of guanylate cyclase activation; however, cyanide may also have nonspecific effects which inhibit relaxation.\",\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Rapoport|R M|RM|;Murad|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149944',\n",
       "  'mesh_terms': 'D000818:Animals; D001013:Aorta, Thoracic; D001464:Barium; D003486:Cyanides; D006152:Cyclic GMP; D004789:Enzyme Activation; D005292:Ferricyanides; D006162:Guanylate Cyclase; D066298:In Vitro Techniques; D008297:Male; D009126:Muscle Relaxation; D009131:Muscle, Smooth, Vascular; D009599:Nitroprusside; D009638:Norepinephrine; D011189:Potassium Chloride; D051381:Rats; D011919:Rats, Inbred Strains; D012966:Sodium Cyanide; D014665:Vasodilator Agents',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D003486:Cyanides; D005292:Ferricyanides; D014665:Vasodilator Agents; D009599:Nitroprusside; D001464:Barium; D011189:Potassium Chloride; D006162:Guanylate Cyclase; D006152:Cyclic GMP; D012966:Sodium Cyanide; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90369-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Effects of peripheral alpha 1- and alpha 2-adrenoceptor agonists on baroreceptor responsiveness in conscious dogs.',\n",
       "  'issue': '104(1-2)',\n",
       "  'pages': '71-8',\n",
       "  'abstract': 'Baroreceptor responsiveness was investigated in conscious dogs following increasing doses (i.v.) of the selective alpha-adrenoceptor agonists methoxamine (alpha 1) and oxymetazoline (alpha 2), in the presence and absence of beta-adrenoceptor blockade. The study was repeated in another group of dogs with background afferent baroreceptor nerve activity reduced by continuous infusion of sodium nitroprusside. Both agonists dose dependently increased mean arterial pressure and reflexly decreased heart rate. In dogs pretreated with a beta-adrenoceptor antagonist a correlation between increase in mean arterial pressure (increase up to 70 mmHg) and increase in heart period (baroreceptor responsiveness) indicated no difference in the regression lines between methoxamine and oxymetazoline for both the normotensive and the sodium nitroprusside groups. However, in the dogs not pretreated with a beta-adrenoceptor antagonist the slope of the regression line for oxymetazoline was steeper than that for methoxamine (P less than 0.01) in the normotensive group. In the sodium nitroprusside group the regression line for oxymetazoline was situated significantly to the left of the methoxamine line (P less than 0.05). It is suggested that this greater bradycardic response to the alpha 2-adrenoceptor agonist oxymetazoline was caused by suppression of the cardiac sympathetic component (presynaptic modulation of noradrenaline release) in addition to the vagal activation and the sympathetic withdrawal component of the reflex. This indicates that drugs with alpha 2-adrenoceptor agonistic activity can influence a reflex physiological situation under conditions of low sympathetic nerve activity.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Harron|D W|DW|;Kobinger|W|W|;Lillie|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149945',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D001794:Blood Pressure; D004285:Dogs; D005260:Female; D006339:Heart Rate; D008297:Male; D008729:Methoxamine; D009474:Neurons; D009599:Nitroprusside; D010109:Oxymetazoline; D011311:Pressoreceptors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000319:Adrenergic beta-Antagonists; D009599:Nitroprusside; D010109:Oxymetazoline; D008729:Methoxamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90370-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'The contractions induced in rat and guinea-pig aortic strips by the alpha 2-adrenoceptor selective agonists B-HT 920 and UK 14,304 are mediated by alpha 1-adrenoceptors.',\n",
       "  'issue': '104(3-4)',\n",
       "  'pages': '197-203',\n",
       "  'abstract': 'The alpha-adrenergic action of the selective alpha 2-adrenoceptor agonists B-HT 920 and UK 14,304 was investigated on helically cut preparations of rat and guinea-pig isolated aorta. The alpha 1-adrenoceptor selective stimulant (-)-phenylephrine was included for comparison. All agonists induced concentration-dependent contractions in both preparations. Calcium entry blockade by D 600 almost abolished the contractions evoked by B-HT 920 and UK 14,304 in rat aorta while those evoked in guinea-pig aorta were less strongly affected. Contractions elicited by (-)-phenylephrine were moderately impaired by D 600 in rat aorta whereas there was only a limited effect in guinea-pig aorta. Analysis of the prazosin and yohimbine antagonism of B-HT 920- and UK 14,304-evoked contractions showed the involvement of alpha 1-like adrenoceptors in rat and guinea-pig aorta, prazosin being approximately 1000 times more potent that yohimbine. The results show that B-HT 920 and UK 14,304 contract rat and guinea-pig aorta via alpha 1-like adrenoceptors which are not identical. It is submitted that rat and guinea-pig alpha 1-adrenoceptors activate different contractile processes.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Beckeringh|J J|JJ|;Thoolen|M J|MJ|;De Jonge|A|A|;Wilffert|B|B|;Timmermans|P B|PB|;Van Zwieten|P A|PA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149946',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000818:Animals; D001011:Aorta; D001381:Azepines; D000068438:Brimonidine Tartrate; D004305:Dose-Response Relationship, Drug; D005711:Gallopamil; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular; D011224:Prazosin; D011810:Quinoxalines; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha; D013045:Species Specificity; D015016:Yohimbine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D001381:Azepines; D011810:Quinoxalines; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D005711:Gallopamil; D000068438:Brimonidine Tartrate; C024763:talipexole; D011224:Prazosin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90394-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Effects of nipradilol (K-351) on the electrophysiological properties of canine cardiac tissues: comparison with propranolol and sotalol.',\n",
       "  'issue': '104(3-4)',\n",
       "  'pages': '335-44',\n",
       "  'abstract': 'The electrophysiological effects of K-351 (0.3-300 microM), a new beta-adrenoceptor blocking drug, on canine Purkinje and ventricular muscle fibers were examined and compared with those of propranolol (0.3-30 microM) and sotalol (3-300 microM) using standard microelectrode techniques. K-351 and propranolol dose dependently reduced the maximum upstroke velocity of phase 0 and action potential amplitude in both cardiac tissues. Action potential durations (APD) of Purkinje fibers were shortened by both propranolol and K-351 but prolonged by sotalol. However, in ventricular muscle fibers K-351 and sotalol significantly prolonged APD and effective refractory periods which contrasted with the unchanged APD after propranolol. These results suggest that K-351 is a beta-blocking drug possessing a membrane stabilizing action (class I antiarrhythmic properties) and in ventricular muscles it can also exert an APD-prolonging effect (class III antiarrhythmic properties).',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Nakaya|H|H|;Kimura|S|S|;Nakao|Y|Y|;Kanno|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149947',\n",
       "  'mesh_terms': 'D000200:Action Potentials; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D000889:Anti-Arrhythmia Agents; D004285:Dogs; D005260:Female; D006321:Heart; D066298:In Vitro Techniques; D008297:Male; D011412:Propanolamines; D011433:Propranolol; D011690:Purkinje Fibers; D012032:Refractory Period, Electrophysiological; D013015:Sotalol',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D011412:Propanolamines; D011433:Propranolol; D013015:Sotalol; C036089:nipradilol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90410-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Influence of blood pressure control on delivery in pregnant rats in a warm environment].',\n",
       "  'issue': '33(3)',\n",
       "  'pages': '283-9',\n",
       "  'abstract': 'The relation between blood pressure and delivery in pregnant rats was investigated when the blood pressure of pregnant rats was controlled by a pressor or antihypertensive drug in the middle or final stage of pregnancy. All of the pregnant rats studied delivered in a 23 degrees C environment in spite of blood pressure control by a pressor or antihypertensive drug. At 33 degrees C, the pregnant rats were divided into two groups whose blood pressure was increased severely (160-175 mm Hg) or moderately (145-155 mm Hg) at 10 days of pregnancy. Those in the former group delivered, but those in the latter died in the final stage of pregnancy. When the pregnant rats in the group with high blood pressure on day 10 were treated with a antihypertensive drug in the middle stage of pregnancy or with a pressor drug in the final stage, the mortality rate was 100 per cent in both cases. The delivery rate was 57 per cent when the pregnant rats were treated with a antihypertensive drug from the middle to the final stage of pregnancy. In the group with low blood pressure on day 10, all of the pregnant rats delivered when they were treated with a pressor drug in the middle stage of pregnancy. However, the delivery rate was 89 per cent when the pregnant rats were treated with antihypertensive drug in the final stage of pregnancy.',\n",
       "  'journal': 'Jikken dobutsu. Experimental animals',\n",
       "  'authors': 'Fujita|S|S|;Yamauchi|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149948',\n",
       "  'mesh_terms': 'D000818:Animals; D001794:Blood Pressure; D005039:Etilefrine; D005260:Female; D006358:Hot Temperature; D006830:Hydralazine; D007743:Labor, Obstetric; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D006830:Hydralazine; D005039:Etilefrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1538/expanim1978.33.3_283',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jikken Dobutsu',\n",
       "  'nlm_unique_id': '1256412',\n",
       "  'issn_linking': '0007-5124',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Evidence for glutamate as a neurotransmitter in the cat vestibular nerve: radioautographic and biochemical studies.',\n",
       "  'issue': '56(3)',\n",
       "  'pages': '523-31',\n",
       "  'abstract': 'Evidence that glutamate acts as a neurotransmitter in vestibular nerve fibers was sought (1) by electron microscope radioautographic identification of the uptake sites of [3H]-glutamic acid after incubation of slices of cat vestibular nuclei, and (2) by measuring changes in sodium-dependent high affinity glutamate uptake in nerve endings containing homogenates from normal and deafferented vestibular nuclei 8 to 11 days after unilateral vestibular nerve lesion. Electron microscopic radioautography revealed that glutamate had been taken up by numerous nerve endings projecting over the whole vestibular nuclear complex. The biochemical approach indicated that after section of the vestibular nerve, a significant decrease in high affinity glutamate uptake occurred in the vestibular nuclei, which lost their exclusively ipsilateral projection. This decrease varied from one area of the deafferented vestibular nuclei to another, reaching -58% in the lateral area of the central part corresponding to the ventral lateral vestibular nucleus and the rostral part of the descending vestibular nucleus. It is concluded that glutamate (or aspartate) is used by the vestibular nerve fibers as a neurotransmitter in the vestibular nuclei.',\n",
       "  'journal': 'Experimental brain research',\n",
       "  'authors': 'Raymond|J|J|;Nieoullon|A|A|;Demêmes|D|D|;Sans|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149949',\n",
       "  'mesh_terms': 'D000818:Animals; D001224:Aspartic Acid; D001345:Autoradiography; D002415:Cats; D005971:Glutamates; D018698:Glutamic Acid; D008854:Microscopy, Electron; D009411:Nerve Endings; D009435:Synaptic Transmission; D014725:Vestibular Nerve; D014726:Vestibular Nuclei',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005971:Glutamates; D001224:Aspartic Acid; D018698:Glutamic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00237993',\n",
       "  'references': '6103731;5441444;832132;4747772;871919;6133598;6947243;4346867;762285;6744038;5485402;6125;5687381;4365397;6120026;7363976;5808758;7155455;13664841;6114994;4313893;6884471;7284827;589462;6131111;200055;4914344;5297601;20487878;42117;6128;6267510;14907713;647379;6113562;5598823;5295930;492534;4404455;4340458;5075702',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '85051700',\n",
       "  'medline_ta': 'Exp Brain Res',\n",
       "  'nlm_unique_id': '0043312',\n",
       "  'issn_linking': '0014-4819',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Mitochondrial compartmentation of metabolic CO2 resulting from its site of origin in relation to urea synthesis.',\n",
       "  'issue': '177(1)',\n",
       "  'pages': '138-42',\n",
       "  'abstract': 'In isolated hepatocytes the entry into urea of metabolic 14CO2 derived from [14C] formate is modified by the addition of dichloroacetate and hydroxypyruvate. An explanation is that this results from changes in the cytoplasmic/mitochondrial pH gradient. 14CO2 derived from [1-14C] alanine enters into urea more readily than 14CO2 arising from [1-14C]glutamate. It is proposed that the difference, which is more than 4-fold, is indicative of a preferred pathway for metabolic CO2 in liver mitochondria from pyruvate dehydrogenase to carbamoylphosphate synthetase than form oxoglutarate dehydrogenase. Acetazolamide inhibition of carbonic anhydrase is without effect on this observed incorporation into urea.',\n",
       "  'journal': 'FEBS letters',\n",
       "  'authors': 'Hems|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149953',\n",
       "  'mesh_terms': 'D000086:Acetazolamide; D000409:Alanine; D000818:Animals; D002245:Carbon Dioxide; D002451:Cell Compartmentation; D003999:Dichloroacetic Acid; D005561:Formates; D005971:Glutamates; D018698:Glutamic Acid; D008099:Liver; D008930:Mitochondria, Liver; D011773:Pyruvates; D051381:Rats; D011919:Rats, Inbred Strains; D014508:Urea',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005561:Formates; D005971:Glutamates; D011773:Pyruvates; C030544:formic acid; D002245:Carbon Dioxide; D018698:Glutamic Acid; D014508:Urea; C012375:hydroxypyruvic acid; D003999:Dichloroacetic Acid; D000086:Acetazolamide; D000409:Alanine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-5793(84)80998-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'FEBS Lett',\n",
       "  'nlm_unique_id': '0155157',\n",
       "  'issn_linking': '0014-5793',\n",
       "  'country': 'England'},\n",
       " {'title': 'Human neuropeptide Y, somatostatin and vasopressin precursors identified in cell-free translations of hypothalamic mRNA.',\n",
       "  'issue': '177(2)',\n",
       "  'pages': '175-8',\n",
       "  'abstract': 'Messenger mRNA has been prepared from post mortem human hypothalami and translated in a cell-free system. Using specific antibodies, biosynthetic precursors have been identified to neuropeptide Y (12 kDa), somatostatin (15 kDa) and vasopressin/neurophysin (19 kDa).',\n",
       "  'journal': 'FEBS letters',\n",
       "  'authors': 'Ivell|R|R|;Emson|P|P|;Richter|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149954',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000818:Animals; D001127:Arginine Vasopressin; D006801:Humans; D007031:Hypothalamus; D008297:Male; D009419:Nerve Tissue Proteins; D009478:Neuropeptide Y; D009481:Neurophysins; D010121:Oxytocin; D014176:Protein Biosynthesis; D011498:Protein Precursors; D012333:RNA, Messenger; D011817:Rabbits; D013004:Somatostatin; D014667:Vasopressins',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D009419:Nerve Tissue Proteins; D009478:Neuropeptide Y; D009481:Neurophysins; D011498:Protein Precursors; D012333:RNA, Messenger; D014667:Vasopressins; D001127:Arginine Vasopressin; D010121:Oxytocin; D013004:Somatostatin; C042084:preproneuropeptide Y',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-5793(84)81278-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'FEBS Lett',\n",
       "  'nlm_unique_id': '0155157',\n",
       "  'issn_linking': '0014-5793',\n",
       "  'country': 'England'},\n",
       " {'title': 'Amino acid neurotransmitters in the CNS: effect of thiopental.',\n",
       "  'issue': '177(2)',\n",
       "  'pages': '249-54',\n",
       "  'abstract': 'Thiopental, a thiobarbiturate which partitions prefentially into the hydrophobic environment, inhibited transport of amino acid neurotransmitters, GABA, aspartate and glutamate, and of biogenic amine, dopamine, across the synaptosomal membrane. At a given protein and thiopental concentration GABA transport was more sensitive to the barbiturate than were the movements of aspartate and glutamate although the uptake of each amino acid was inhibited essentially to the same extent as was its K+-stimulated release. By contrast, inhibition of dopamine uptake was larger than that of its release. Thiopental also inhibited the release of amino acid neurotransmitters caused by anaerobiosis. It is suggested that the barbiturate modifies the properties of the synaptosomal lipids and/or hydrophobic segments of proteins and thereby, simultaneously and independently, affects various membrane functions. The equal inhibition of uptake and release of amino acid neurotransmitters is consistent with the postulate that their transport occurs through the reversible membrane carriers which function efficiently in both the inward and outward directions.',\n",
       "  'journal': 'FEBS letters',\n",
       "  'authors': 'Pastuszko|A|A|;Wilson|D F|DF|;Erecińska|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149955',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000693:Anaerobiosis; D000818:Animals; D001224:Aspartic Acid; D001692:Biological Transport; D001921:Brain; D004298:Dopamine; D005971:Glutamates; D018698:Glutamic Acid; D007700:Kinetics; D008297:Male; D018377:Neurotransmitter Agents; D011188:Potassium; D051381:Rats; D011919:Rats, Inbred Strains; D013574:Synaptosomes; D013874:Thiopental; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000596:Amino Acids; D005971:Glutamates; D018377:Neurotransmitter Agents; D001224:Aspartic Acid; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D013874:Thiopental; D011188:Potassium; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-5793(84)81293-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'FEBS Lett',\n",
       "  'nlm_unique_id': '0155157',\n",
       "  'issn_linking': '0014-5793',\n",
       "  'country': 'England'},\n",
       " {'title': 'Rat Thy-1 antigen has a hydrophobic segment at the carboxyl terminus.',\n",
       "  'issue': '178(1)',\n",
       "  'pages': '105-8',\n",
       "  'abstract': 'We have isolated a cDNA clone coding for rat Thy-1 antigen from a rat thymocyte cDNA library. The 549 base pairs insert includes the complete coding region of a mature Thy-1 polypeptide of 142 amino acids, 31 amino acids longer than the previously reported glycoprotein sequence. These 31 amino acids contain an extremely hydrophobic region of 26 uncharged amino acids which apparently represent the transmembrane segment that allows for integration within the membrane. The presence of this additional protein segment will solve most of the enigmas regarding the properties of the C-terminal region of Thy-1 antigen.',\n",
       "  'journal': 'FEBS letters',\n",
       "  'authors': 'Moriuchi|T|T|;Silver|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149956',\n",
       "  'mesh_terms': 'D000595:Amino Acid Sequence; D000818:Animals; D000954:Antigens, Surface; D001483:Base Sequence; D003001:Cloning, Molecular; D004247:DNA; D051381:Rats; D011920:Rats, Inbred WF; D018800:Thy-1 Antigens',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000954:Antigens, Surface; D018800:Thy-1 Antigens; D004247:DNA',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-5793(84)81250-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'FEBS Lett',\n",
       "  'nlm_unique_id': '0155157',\n",
       "  'issn_linking': '0014-5793',\n",
       "  'country': 'England'},\n",
       " {'title': '[Lithium valproate: its neuropharmacological spectrum and effect on transmitter amino acid content of the brain of rats].',\n",
       "  'issue': '47(5)',\n",
       "  'pages': '11-5',\n",
       "  'abstract': 'The authors studied lithium valproate synthesized at the Institute of Pharmacology, Academy of Medical Sciences of the USSR, and compared it with sodium valproate (depakin, France). It was discovered that like sodium valproate, lithium valproate has a marked anticonvulsant activity, being also effective in experimental seizures induced by bicucullin, exerts a moderate sedative action (potentiation of sodium thiopental and hexenal anesthesia), and a distinct tranquilizing effect in experimental outward inhibition of the conditioned active avoidance response. At the same time the presence in the molecule of lithium ions led to a change in the neurochemical profile of valproate, manifested by an increase in the rat brain content of GABA and glutamate.',\n",
       "  'journal': 'Farmakologiia i toksikologiia',\n",
       "  'authors': 'Kharlamov|A N|AN|;Shumkova|O V|OV|;Blinkova|N F|NF|;Tolmacheva|N S|NS|;Raevskiĭ|K S|KS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149951',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000818:Animals; D000927:Anticonvulsants; D001921:Brain; D003214:Conditioning, Classical; D004305:Dose-Response Relationship, Drug; D008094:Lithium; D016651:Lithium Carbonate; D051379:Mice; D009043:Motor Activity; D018377:Neurotransmitter Agents; D051381:Rats; D014635:Valproic Acid',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000596:Amino Acids; D000927:Anticonvulsants; D018377:Neurotransmitter Agents; D016651:Lithium Carbonate; D014635:Valproic Acid; D008094:Lithium',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Farmakol Toksikol',\n",
       "  'nlm_unique_id': '16920420R',\n",
       "  'issn_linking': '0014-8318',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Model of the defense reaction in rats to study the antifenamine effect of neuroleptics for demonstrating their specific action].',\n",
       "  'issue': '47(5)',\n",
       "  'pages': '110-3',\n",
       "  'abstract': \"The authors studied the ability of neuroleptics to eliminate the amphetamine-induced (5 mg/kg) disorders of the transformation of the defense response trajectory in rats kept in a U-shaped maze. Haloperidol (0.1 mg/kg) and clozapine (2 mg/kg) similarly normalized the animals' behavior but differently affected the motor automatisms typical for amphetamine stereotypy. Metoclopramide (1 mg/kg) reduced the external manifestations of amphetamint stereotypy but did not abolish the disorders in the defense response. It is likely that the ability of the neuroleptics to produce an antiamphetamine action in experimental defense response with multiple transformation of the responses might characterize specific properties of the drugs belonging to the class under discussion.\",\n",
       "  'journal': 'Farmakologiia i toksikologiia',\n",
       "  'authors': 'Baturin|V A|VA|;Iuntsev|S V|SV|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149952',\n",
       "  'mesh_terms': 'D000661:Amphetamine; D000818:Animals; D014150:Antipsychotic Agents; D004558:Electric Stimulation; D004924:Escape Reaction; D005260:Female; D006801:Humans; D008297:Male; D051381:Rats; D011930:Reaction Time; D013239:Stereotyped Behavior',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D000661:Amphetamine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Farmakol Toksikol',\n",
       "  'nlm_unique_id': '16920420R',\n",
       "  'issn_linking': '0014-8318',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Inhibitory effect of calmodulin inhibitors on palytoxin-induced K+ release from rabbit erythrocytes.',\n",
       "  'issue': '178(1)',\n",
       "  'pages': '44-6',\n",
       "  'abstract': 'Palytoxin (PTX) caused K+ release from rabbit erythrocytes at a concentration as low as 10(-11) M. The K+ release due to PTX at a concentration below 10(-9) M was dependent on Ca2+ in medium. The effect of Ca2+ was substituted fully by Sr2+ and partially by Ba2+. W-7 (2 X 10(-4) M), a known inhibitor of calmodulin, markedly inhibited the rate of K+ release due to PTX. W-5 (2 X 10(-4) M), an analog of W-7 with lower affinity to calmodulin than W-7, showed weaker inhibition. Other calmodulin antagonists, such as prenylamine, chlorpromazine and compound 48/80, also inhibited the PTX-induced K+ release. These results suggest that the K+ release induced by PTX involves the process(es) mediated by intracellular Ca2+ and calmodulin.',\n",
       "  'journal': 'FEBS letters',\n",
       "  'authors': 'Nagase|H|H|;Ozaki|H|H|;Urakawa|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149957',\n",
       "  'mesh_terms': 'D000178:Acrylamides; D000818:Animals; D002118:Calcium; D002147:Calmodulin; D003064:Cnidarian Venoms; D004912:Erythrocytes; D011188:Potassium; D011817:Rabbits; D013324:Strontium; D013449:Sulfonamides; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000178:Acrylamides; D002147:Calmodulin; D003064:Cnidarian Venoms; D013449:Sulfonamides; C017967:W 7; C034700:N-(6-aminohexyl)-1-naphthalenesulfonamide; C010272:palytoxin; D011188:Potassium; D002118:Calcium; D013324:Strontium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-5793(84)81236-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'FEBS Lett',\n",
       "  'nlm_unique_id': '0155157',\n",
       "  'issn_linking': '0014-5793',\n",
       "  'country': 'England'},\n",
       " {'title': '[The rat vas deferens as a test object for assessing the action of chemical compounds].',\n",
       "  'issue': '47(5)',\n",
       "  'pages': '104-10',\n",
       "  'abstract': 'The vas deferens is widely used for studies of the action of chemical compounds on adrenergic processes. The recent data indicate that the response of the vas deferens to transmural electric stimulation can be blocked by the substances possessing different properties and that to have a correct assessment of the action of new chemical compounds, of great importance is both the animal species and the characteristics of the strips used (epididymal and prostatic) and electric impulses. The epididymal strip of the rat vas deferens--transmural stimulation by serial electric impulses is a convenient model for screening new chemical compounds.',\n",
       "  'journal': 'Farmakologiia i toksikologiia',\n",
       "  'authors': 'Avakian|O M|OM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149950',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D004558:Electric Stimulation; D004822:Epididymis; D008297:Male; D051381:Rats; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D017981:Receptors, Neurotransmitter; D011957:Receptors, Opioid; D013566:Sympathomimetics; D014649:Vas Deferens',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D017981:Receptors, Neurotransmitter; D011957:Receptors, Opioid; D013566:Sympathomimetics',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Farmakol Toksikol',\n",
       "  'nlm_unique_id': '16920420R',\n",
       "  'issn_linking': '0014-8318',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Behavioral and electrophysiological studies of peptide-induced emesis in dogs.',\n",
       "  'issue': '43(15)',\n",
       "  'pages': '2952-4',\n",
       "  'abstract': 'The electrophysiological responses of neurons in the canine area postrema (AP) to ionophoretic application of neuropeptides and transmitters were studied and correlated with the presence or absence of an emetic response on systemic administration. Of 17 common neuropeptides 11 were emetic when applied systemically at doses of 0.03-0.35 mg/kg. The emesis was dose dependent and was no longer observed in animals with chronic ablation of the AP. The responses of 122 AP single units were recorded. Neurons were silent at rest, and most were excited by glutamate, apomorphine, and dopamine. Excitatory responses to each of eight emetic peptides were recorded in 22-65% of cells studied; no responses were found to two peptides that were not emetic. The response to glutamate was always a brief, high-frequency discharge; the responses to all 13 other excitatory substances were of long latency, low frequency, and long duration. With high ionophoretic current or multiple applications, units would frequently become spontaneously active for many minutes or longer. The similarity of response of so many substances on small neurons suggests a common ionic or metabolic mechanism underlying the response. The direct correlation between the occurrence of emesis on systemic administration and the presence of excitatory receptors on AP neurons provides strong support for the proposed role of the AP as the chemoreceptor trigger zone for emesis.',\n",
       "  'journal': 'Federation proceedings',\n",
       "  'authors': 'Carpenter|D O|DO|;Briggs|D B|DB|;Strominger|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149958',\n",
       "  'mesh_terms': 'D000200:Action Potentials; D000818:Animals; D002552:Cerebral Ventricles; D004285:Dogs; D004639:Emetics; D005755:Gastrins; D005971:Glutamates; D018698:Glutamic Acid; D008526:Medulla Oblongata; D009638:Norepinephrine; D013973:Thyrotropin-Releasing Hormone; D014839:Vomiting',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004639:Emetics; D005755:Gastrins; D005971:Glutamates; D018698:Glutamic Acid; D013973:Thyrotropin-Releasing Hormone; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fed Proc',\n",
       "  'nlm_unique_id': '0372771',\n",
       "  'issn_linking': '0014-9446',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Role of calmodulin in neurotransmitter synthesis.',\n",
       "  'issue': '43(15)',\n",
       "  'pages': '3011-4',\n",
       "  'abstract': 'Tyrosine 3-monooxygenase (EC 1.14.16.2) and tryptophan 5-monooxygenase (EC 1.14.16.4) are generally believed to be the rate-limiting enzymes in the biosynthesis of the neurotransmitters, catecholamines and serotonin, respectively, and therefore the regulation of their activities is of particular importance. At least three calmodulin-dependent protein kinases differed in their molecular weights and substrate specificities, designated I, II, and III in the order of decreasing molecular weight, in rat brain cytosol. Among them, calmodulin-dependent protein kinase II with a molecular weight of about 540,000 appeared to occur only in the nervous tissues. Kinase II was found, on the one hand, to phosphorylate tyrosine 3-monooxygenase and tryptophan 5-monooxygenase, leading to the activation of these monooxygenases in the presence of activator protein and, on the other hand, to phosphorylate tubulin and microtubule-associated protein 2, which results in disassembly of the microtubules that had been assembled. These results suggest the possibility that both the secretion and biosynthesis of monoamine neurotransmitters stimulated by Ca2+ influx in the nervous system may be regulated by calmodulin-dependent protein kinase II via the phosphorylation of microtubule proteins and the phosphorylation of the monooxygenases that are the rate-limiting enzymes in the biosynthesis of the neurotransmitters.',\n",
       "  'journal': 'Federation proceedings',\n",
       "  'authors': 'Fujisawa|H|H|;Yamauchi|T|T|;Nakata|H|H|;Okuno|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149959',\n",
       "  'mesh_terms': 'D000588:Amines; D000818:Animals; D001921:Brain; D002147:Calmodulin; D046911:Macromolecular Substances; D008970:Molecular Weight; D018377:Neurotransmitter Agents; D011487:Protein Conformation; D011494:Protein Kinases; D051381:Rats; D013379:Substrate Specificity; D014365:Tryptophan Hydroxylase; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000588:Amines; D002147:Calmodulin; D046911:Macromolecular Substances; D018377:Neurotransmitter Agents; D014446:Tyrosine 3-Monooxygenase; D014365:Tryptophan Hydroxylase; D011494:Protein Kinases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fed Proc',\n",
       "  'nlm_unique_id': '0372771',\n",
       "  'issn_linking': '0014-9446',\n",
       "  'country': 'United States'},\n",
       " {'title': 'New aspects of glutathione biochemistry and transport: selective alteration of glutathione metabolism.',\n",
       "  'issue': '43(15)',\n",
       "  'pages': '3031-42',\n",
       "  'abstract': '',\n",
       "  'journal': 'Federation proceedings',\n",
       "  'authors': 'Meister|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149960',\n",
       "  'mesh_terms': 'D000818:Animals; D001692:Biological Transport; D005978:Glutathione; D005981:Glutathione Synthase; D006801:Humans; D007668:Kidney; D008661:Metabolism, Inborn Errors; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D005723:gamma-Glutamyltransferase; D005981:Glutathione Synthase; D005978:Glutathione',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fed Proc',\n",
       "  'nlm_unique_id': '0372771',\n",
       "  'issn_linking': '0014-9446',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Testicular atrophy syndrome].',\n",
       "  'issue': '49(9)',\n",
       "  'pages': '13-7',\n",
       "  'abstract': '',\n",
       "  'journal': \"Fel'dsher i akusherka\",\n",
       "  'authors': \"Kondrat'eva|L V|LV|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149961',\n",
       "  'mesh_terms': 'D000293:Adolescent; D001284:Atrophy; D002648:Child; D003456:Cryptorchidism; D003937:Diagnosis, Differential; D006801:Humans; D008297:Male; D013577:Syndrome; D013737:Testis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Feldsher Akush',\n",
       "  'nlm_unique_id': '16930040R',\n",
       "  'issn_linking': '0014-9772',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Interneuronal relations in elementary neuronal assemblies].',\n",
       "  'issue': '70(8)',\n",
       "  'pages': '1125-31',\n",
       "  'abstract': 'Mechanisms of integrating cortical neurons into discrete modules--elementary ensembles--as functional units involved in formation of mosaic activity, in which input information is coded, were studied. Neurons primarily activated by specific afferent terminals and consistently responding with minimal latencies form the center of the ensemble while its periphery consists of secondary activated cells with variable long-latency reaction. Probabilistic participation of the latter in the ensemble structure underlies the cortical mechanism of plasticity. Neurons inhibited intracortically and, probably, by ascending inhibitory ways are situated in the periphery and at output ensemble elements.',\n",
       "  'journal': 'Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova',\n",
       "  'authors': 'Kogan|A B|AB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149962',\n",
       "  'mesh_terms': 'D000818:Animals; D002540:Cerebral Cortex; D005971:Glutamates; D018698:Glutamic Acid; D006168:Guinea Pigs; D009044:Motor Cortex; D009433:Neural Inhibition; D009473:Neuronal Plasticity; D051381:Rats; D013003:Somatosensory Cortex; D014110:Touch; D014793:Visual Cortex; D014796:Visual Perception',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D005971:Glutamates; D018698:Glutamic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fiziol Zh SSSR Im I M Sechenova',\n",
       "  'nlm_unique_id': '0427673',\n",
       "  'issn_linking': '0015-329X',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Neurochemical mechanisms of the involvement of sensorimotor cortex neurons in food and orienting-exploratory behavior].',\n",
       "  'issue': '70(9)',\n",
       "  'pages': '1311-5',\n",
       "  'abstract': \"Reactions of individual neurons to electrical stimulation of motivational areas of the lateral hypothalamus were studied in the somatosensory cortex of alert rabbits during micro. iontophoretic application of acetylcholine, norepinephrine or cycloheximide. The former two drugs altered equally the neuron reactions both on weak (inducing an orienting response) and strong stimulation (causing feeding behaviour). The latter drug also affected the neuron reactions. The feeding and orienting responses seem to be actualized through a specific peptide synthesis in the somatosensory cortex's neurons altering their sensitivity to neurotransmitters.\",\n",
       "  'journal': 'Fiziologicheskii zhurnal SSSR imeni I. M. Sechenova',\n",
       "  'authors': 'Sudakov|S K|SK|;Meshcheriakov|A F|AF|;Sterio|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149963',\n",
       "  'mesh_terms': 'D000109:Acetylcholine; D000818:Animals; D003513:Cycloheximide; D004558:Electric Stimulation; D005106:Exploratory Behavior; D005247:Feeding Behavior; D007026:Hypothalamic Area, Lateral; D008297:Male; D009044:Motor Cortex; D009474:Neurons; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D009949:Orientation; D011817:Rabbits; D013003:Somatosensory Cortex',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D003513:Cycloheximide; D000109:Acetylcholine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fiziol Zh SSSR Im I M Sechenova',\n",
       "  'nlm_unique_id': '0427673',\n",
       "  'issn_linking': '0015-329X',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Soldering precious metal alloys. Durability testing using the bending test].',\n",
       "  'issue': '32(9)',\n",
       "  'pages': '995-1000',\n",
       "  'abstract': '',\n",
       "  'journal': 'Das Dental-Labor. Le Laboratoire dentaire. The Dental laboratory',\n",
       "  'authors': 'Sperner|F|F|;Bramer|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149964',\n",
       "  'mesh_terms': 'D012994:Dental Soldering; D004548:Elasticity; D006047:Gold Alloys; D006358:Hot Temperature; D013314:Stress, Mechanical; D013499:Surface Properties',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006047:Gold Alloys',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dent Labor (Munch)',\n",
       "  'nlm_unique_id': '16520470R',\n",
       "  'issn_linking': '0011-8656',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'An assessment of the novel antihistamine BW 825C in the treatment of chronic idiopathic urticaria. A placebo-controlled study.',\n",
       "  'issue': '169(4)',\n",
       "  'pages': '179-83',\n",
       "  'abstract': '20 patients with a diagnosis of chronic idiopathic urticaria were entered into a double-blind placebo-controlled cross-over study. All patients completed the trial and during the assessment period they were treated with placebo, BW 825C (4 mg) and BW 825C (8 mg) according to a fully randomised and balanced treatment plan. Both doses of BW 825C were found to be highly effective and significantly better than placebo in controlling signs and symptoms of urticaria. Few adverse reactions were reported and in this small group of patients there was no significant difference from placebo in reports of drowsiness or any other side-effects.',\n",
       "  'journal': 'Dermatologica',\n",
       "  'authors': 'Gibson|J R|JR|;Harvey|S G|SG|;Barth|J H|JH|;Moss|M Y|MY|;Burke|C A|CA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149965',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D005260:Female; D006634:Histamine H1 Antagonists; D006801:Humans; D008297:Male; D008875:Middle Aged; D011725:Pyridines; D011897:Random Allocation; D012894:Sleep Stages; D014311:Triprolidine; D014581:Urticaria',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D006634:Histamine H1 Antagonists; D011725:Pyridines; D014311:Triprolidine; C043648:acrivastine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000249599',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dermatologica',\n",
       "  'nlm_unique_id': '0211607',\n",
       "  'issn_linking': '0011-9075',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Protein kinases and insulin action in fat cells.',\n",
       "  'issue': '12(5)',\n",
       "  'pages': '768-71',\n",
       "  'abstract': '',\n",
       "  'journal': 'Biochemical Society transactions',\n",
       "  'authors': 'Denton|R M|RM|;Brownsey|R W|RW|;Hopkirk|T J|TJ|;Belsham|G J|GJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149966',\n",
       "  'mesh_terms': 'D001275:ATP Citrate (pro-S)-Lyase; D000103:Acetyl-CoA Carboxylase; D000273:Adipose Tissue; D000818:Animals; D007328:Insulin; D008297:Male; D008970:Molecular Weight; D010766:Phosphorylation; D011494:Protein Kinases; D051381:Rats',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007328:Insulin; D001275:ATP Citrate (pro-S)-Lyase; D011494:Protein Kinases; D000103:Acetyl-CoA Carboxylase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1042/bst0120768',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Soc Trans',\n",
       "  'nlm_unique_id': '7506897',\n",
       "  'issn_linking': '0300-5127',\n",
       "  'country': 'England'},\n",
       " {'title': 'Inhibition of alpha 2-adrenergic agonists on AVP-induced cAMP accumulation in isolated collecting tubule of the rat kidney.',\n",
       "  'issue': '37(3)',\n",
       "  'pages': '263-75',\n",
       "  'abstract': 'A microradioimmunoassay for cAMP was developed in order to analyse the effects of alpha-adrenergic agonists on vasopressin (AVP)-induced cAMP cell accumulation in single pieces of microdissected medullary (MCT) and cortical (CCT) rat collecting tubules. Under the experimental conditions chosen (4 min of incubation in the presence of a phosphodiesterase inhibitor), no cAMP could be detected either in the bathing solution or in non-stimulating samples of tubule. In MCT, 10(-6) M AVP stimulated cAMP generation up to 128.3 +/- 9.0 (SEM) fmoles per mm of tubule per 4 min, N = 11. The response was dose-dependent with a KA value below 10(-10) M AVP. The addition of norepinephrine (NE) (10(-5) M in the presence of propranolol) suppressed the larger part of the response to AVP (from 92% with 2 X 10(-11) M AVP to 76% with 10(-6) M AVP); the addition of 10(-7) M NE still reduced by 59% the MCT response to 10(-10) M AVP (26.2 +/- 5.9 vs. 64.0 +/- 6.4 fmoles/mm, N = 3). In CCT, 10(-5) M NE reduced by 84% the cAMP generation induced by 10(-10) M AVP (8.8 +/- 2.0 vs. 54.2 +/- 3.5 fmoles/mm, N = 3). This inhibitory action of NE against the AVP effect in CCT was mimicked by 10(-7) M clonidine; in MCT it was suppressed by phentolamine and yohimbine, but not by prazosin, suggesting that alpha 2-adrenoreceptors are involved. On the other hand, the addition of the alpha-agonists to the incubation solution produced no inhibition of the cAMP cell accumulations induced by glucagon, calcitonin and isoproterenol in CCT, or glucagon in MCT, an observation demonstrating that alpha 2-adrenergic agonists selectively inhibit vasopressin-dependent cAMP generation by these nephron segments.',\n",
       "  'journal': 'Molecular and cellular endocrinology',\n",
       "  'authors': 'Chabardès|D|D|;Montégut|M|M|;Imbert-Teboul|M|M|;Morel|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149967',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000818:Animals; D001127:Arginine Vasopressin; D000242:Cyclic AMP; D007684:Kidney Tubules; D007685:Kidney Tubules, Collecting; D008297:Male; D009638:Norepinephrine; D010646:Phentolamine; D011224:Prazosin; D051381:Rats; D011919:Rats, Inbred Strains; D015016:Yohimbine',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D001127:Arginine Vasopressin; D015016:Yohimbine; D000242:Cyclic AMP; D009638:Norepinephrine; D011224:Prazosin; D010646:Phentolamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0303-7207(84)90096-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Mol Cell Endocrinol',\n",
       "  'nlm_unique_id': '7500844',\n",
       "  'issn_linking': '0303-7207',\n",
       "  'country': 'Ireland'},\n",
       " {'title': 'Actions of growth hormone-releasing factor and somatostatin on adenylate cyclase and growth hormone release in rat anterior pituitary.',\n",
       "  'issue': '37(3)',\n",
       "  'pages': '277-84',\n",
       "  'abstract': 'The interaction of growth hormone-releasing factor (GRF) and somatostatin (SRIF) on adenylate cyclase activity and growth hormone release was investigated in pituitary homogenates and 2-day cultured rat anterior pituitary cells. GRF stimulated growth hormone release by about 3-fold (ED50 1.6 X 10(-12) M) and caused a rapid 15-fold increase in cyclic AMP production (ED50 6.0 X 10(-12) M). The increase in cyclic AMP was due to direct stimulation of adenylate cyclase by GRF, which caused a 4-fold increase in the activity of the enzyme measured in anterior pituitary homogenates. GRF-induced cyclic AMP formation and GRF-stimulated adenylate cyclase activity were maximally inhibited to the extent of about 50% by 10(-8) M somatostatin. In contrast, GRF-stimulated growth hormone release was completely inhibited by somatostatin (ID50 3.2 X 10(-11) M), suggesting a second site of action of somatostatin. These studies demonstrate that GRF stimulates growth hormone release via activation of adenylate cyclase and a rise in intracellular cyclic AMP. In addition, these findings indicate that the inhibitory action of somatostatin on growth hormone release is exerted at two levels, one at the level of adenylate cyclase affecting the production of cyclic AMP, and the other beyond the formation of the nucleotide, at a site which modulates the release of growth hormone from the cell.',\n",
       "  'journal': 'Molecular and cellular endocrinology',\n",
       "  'authors': 'Harwood|J P|JP|;Grewe|C|C|;Aguilera|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149968',\n",
       "  'mesh_terms': 'D000262:Adenylyl Cyclases; D000818:Animals; D000242:Cyclic AMP; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D004789:Enzyme Activation; D005260:Female; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D010903:Pituitary Gland, Anterior; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013004:Somatostatin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D000242:Cyclic AMP; D000262:Adenylyl Cyclases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0303-7207(84)90097-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Mol Cell Endocrinol',\n",
       "  'nlm_unique_id': '7500844',\n",
       "  'issn_linking': '0303-7207',\n",
       "  'country': 'Ireland'},\n",
       " {'title': 'Regulation of enzymes responsible for neurotransmitter synthesis and degradation in cultured rat sympathetic neurons. III. Effects of sodium butyrate.',\n",
       "  'issue': '106(2)',\n",
       "  'pages': '282-8',\n",
       "  'abstract': \"The effects of Na butyrate on the differentiation of newborn rat sympathetic neurons in primary cultures have been studied. Butyrate did not affect the long-term survival of these neurons in the presence of optimal concentrations of nerve growth factor, but decreased in a dose-dependent manner their protein content. In the range, 0.5-20 mM, butyrate did not modify the specific activity of lactate dehydrogenase in these cultures. Choline acetyltransferase activity developed at a 4.5- to 12-fold higher rate in cultures grown with 1-5 mM butyrate than in its absence. Concomitantly, tyrosine hydroxylase, dopa decarboxylase, dopamine-beta-hydroxylase, and acetylcholinesterase were depressed in cultures grown with butyrate. The deficit in acetylcholinesterase total activity was accompanied by an inhibition of the development of the asymmetric 16 S form of the enzyme. The deficit in tyrosine hydroxylase activity did not result from either a modification of the app Km for the enzyme's cofactor or a modification of its state of cAMP-dependent phosphorylation, but from a decrease in the number of immunoprecipitable enzyme molecules. A similar result was obtained with acetylcholinesterase. Butyrate thus reproduced in a qualitative manner the effects of a macromolecular factor purified from muscle conditioned medium on these neurons (J. P. Swerts, A. LeVan Thaï, A. Vigny, and M. J. Weber (1983) Dev. Biol. 100, 1-11; J. P. Swerts, Le Van Thai, and M. J. Weber (1984) 103, 230-234), raising the hypothesis of a common pathway in the regulation of neurotransmitter phenotype by these two agents.\",\n",
       "  'journal': 'Developmental biology',\n",
       "  'authors': 'Swerts|J P|JP|;Weber|M J|MJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149969',\n",
       "  'mesh_terms': 'D000110:Acetylcholinesterase; D000818:Animals; D000831:Animals, Newborn; D002087:Butyrates; D020148:Butyric Acid; D002478:Cells, Cultured; D002795:Choline O-Acetyltransferase; D004296:Dopa Decarboxylase; D004299:Dopamine beta-Hydroxylase; D007527:Isoenzymes; D007700:Kinetics; D007770:L-Lactate Dehydrogenase; D009474:Neurons; D018377:Neurotransmitter Agents; D010766:Phosphorylation; D051381:Rats; D013564:Sympathetic Nervous System; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002087:Butyrates; D007527:Isoenzymes; D018377:Neurotransmitter Agents; D020148:Butyric Acid; D007770:L-Lactate Dehydrogenase; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D002795:Choline O-Acetyltransferase; D000110:Acetylcholinesterase; D004296:Dopa Decarboxylase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0012-1606(84)90226-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dev Biol',\n",
       "  'nlm_unique_id': '0372762',\n",
       "  'issn_linking': '0012-1606',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Histologic differentiation of human fetal pancreatic explants transplanted into nude mice.',\n",
       "  'issue': '33(12)',\n",
       "  'pages': '1180-7',\n",
       "  'abstract': 'The transplantation of human fetal pancreas has been suggested as a means of treatment of insulin-dependent diabetes in man. We have obtained human fetal pancreata during the second trimester of pregnancy and transplanted 1-mm3 explants subcutaneously (s.c.) into both diabetic and nondiabetic nude mice, some of the tissue being cultured in vitro before implantation. These implants coalesced and grew. They were removed at intervals up to 37 wk later and showed selective differentiation of endocrine tissue that normally occurs in the fetus and neonate, with formation of bipolar, mantle, and mature islets. There was growth of this endocrine tissue with significantly more islets than in the freshly stained fetal pancreas assuming an average dimension larger than 150 micron, which is the reported mean diameter of a neonatal islet. Duct and fibrous tissue remained viable, but there was no definitive acinar tissue seen. The pancreata uncultured before implantation reached a larger size than that attained by those implants cultured before being transplanted, the difference probably being the amount of ductular and mesenchymal tissue still present. Of those glands cultured before transplantation, the longer the period of culture, the smaller the size the implants reached. Culture beyond 3 wk in vitro made it difficult to macroscopically locate the implant. These data show that, in human fetal pancreas removed from its usual environment, both selective differentiation of the endocrine component and growth of the islets can occur.',\n",
       "  'journal': 'Diabetes',\n",
       "  'authors': 'Tuch|B E|BE|;Ng|A B|AB|;Jones|A|A|;Turtle|J R|JR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149970',\n",
       "  'mesh_terms': 'D000818:Animals; D005260:Female; D005934:Glucagon; D006801:Humans; D007124:Immunoenzyme Techniques; D007328:Insulin; D051379:Mice; D008819:Mice, Nude; D010179:Pancreas; D016035:Pancreas Transplantation; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D013004:Somatostatin; D013997:Time Factors; D014183:Transplantation, Heterologous',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007328:Insulin; D013004:Somatostatin; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '10.2337/diab.33.12.1180',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Diabetes',\n",
       "  'nlm_unique_id': '0372763',\n",
       "  'issn_linking': '0012-1797',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Insulin, glucagon, and somatostatin release from the prediabetic Chinese hamster.',\n",
       "  'issue': '27(3)',\n",
       "  'pages': '387-91',\n",
       "  'abstract': 'Diabetes mellitus in the adult Chinese hamster is characterized by subnormal pancreatic insulin release in vitro, decreased insulin content, and lack of obesity. The cause of the islet B-cell failure is not clear. We measured insulin, glucagon, and somatostatin release from in vitro perfused pancreases of young (mean age 10 and 20 weeks), genetically diabetic animals (subline AC, mean plasma glucose 8.0 and 16.6 mmol/l, respectively). Compared to age- and sex-matched normal hamsters (subline M, mean plasma glucose 5.3 mmol/l), the younger diabetic animals had a significantly elevated mean plasma glucose level, but net in vitro pancreatic release of insulin, glucagon, and somatostatin was normal. Pancreatic content of insulin and glucagon was also not significantly different from normal. At age 20 weeks, when the plasma glucose of the diabetic animals was even more elevated, pancreatic content and release of insulin were significantly subnormal, whereas glucagon and somatostatin release were normal, and pancreatic content of glucagon was normal. In a similar group of young (mean age 10 weeks) diabetic animals, non-fasting plasma insulin levels were within the normal range, but the corresponding glucose levels were excessive in most of the animals (13 out of 19). In conclusion, 10-week-old diabetic hamsters show mild hyperglycaemia which cannot be accounted for directly by decreased pancreatic release in response to a glucose plus arginine stimulus in vitro. Decreased ability of the B cell to respond in vivo to hyperglycaemia or peripheral resistance to insulin may contribute to later B-cell failure in the older diabetic hamster.',\n",
       "  'journal': 'Diabetologia',\n",
       "  'authors': 'Frankel|B J|BJ|;Heldt|A M|AM|;Gerritsen|G C|GC|;Grodsky|G M|GM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149971',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D001120:Arginine; D006224:Cricetinae; D003412:Cricetulus; D003921:Diabetes Mellitus, Experimental; D005934:Glucagon; D005947:Glucose; D007328:Insulin; D000078790:Insulin Secretion; D007515:Islets of Langerhans; D007700:Kinetics; D008297:Male; D009154:Mutation; D011236:Prediabetic State; D013004:Somatostatin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D007328:Insulin; D013004:Somatostatin; D005934:Glucagon; D001120:Arginine; D005947:Glucose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00304855',\n",
       "  'references': '4217291;210361;4830228;825367;446913;858819;7017743;1116650;5630193;343471;13741689;4217296;1261502;4907137;6761191;7047274;4217290;5450181;4557374;4430717',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Diabetologia',\n",
       "  'nlm_unique_id': '0006777',\n",
       "  'issn_linking': '0012-186X',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Studies on the mechanism of heterochromatic position effect at the rosy locus of Drosophila melanogaster.',\n",
       "  'issue': '108(3)',\n",
       "  'pages': '603-15',\n",
       "  'abstract': 'Experiments are described that extend the characterization of position effect variants of the rosy locus and test possible mechanisms of heterochromatic position effect. Rosy position effect variants exhibit a variegated phenotype with respect to xanthine dehydrogenase activity in malpighian tubules. The breakpoints of the position effect mutations are located on the DNA map of the rosy region outside of the rosy locus DNA; ryps11136 is located in the DNA of the l(3)S12 gene immediately proximal to rosy, whereas ryps1149 is located some 15 kb distal to rosy in the pic locus. Southern blot experiments are described that test and reject the notion that heterochromatic position effect results from underreplication of the position-affected gene. Rather, the results of Northern blots serve to direct attention to position effect as a defect in transcription. Histone region deletion heterozygosity and butyrate-feeding experiments failed to exhibit specific suppression of position effect at the rosy locus.',\n",
       "  'journal': 'Genetics',\n",
       "  'authors': 'Rushlow|C A|CA|;Bender|W|W|;Chovnick|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149972',\n",
       "  'mesh_terms': 'D000818:Animals; D002087:Butyrates; D003001:Cloning, Molecular; D004247:DNA; D004331:Drosophila melanogaster; D005260:Female; D005786:Gene Expression Regulation; D006570:Heterochromatin; D006657:Histones; D008297:Male; D009693:Nucleic Acid Hybridization; D011061:Poly A; D012333:RNA, Messenger; D014158:Transcription, Genetic; D014968:Xanthine Dehydrogenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002087:Butyrates; D006570:Heterochromatin; D006657:Histones; D012333:RNA, Messenger; D011061:Poly A; D004247:DNA; D014968:Xanthine Dehydrogenase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/genetics/108.3.603',\n",
       "  'references': '881736;17246163;1195397;6432334;6420075;6418389;6168446;116133',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Genetics',\n",
       "  'nlm_unique_id': '0374636',\n",
       "  'issn_linking': '0016-6731',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Inheritance of adrenal phenylethanolamine N-methyltransferase activity in the rat.',\n",
       "  'issue': '108(3)',\n",
       "  'pages': '633-49',\n",
       "  'abstract': 'Phenylethanolamine N-methyltransferase (PNMT) is the enzyme that catalyzes the S-adenosyl-L-methionine-dependent methylation of (-)norepinephrine to (-)epinephrine in the adrenal medulla. Adrenal PNMT activity is markedly different in two highly inbred rat strains; enzyme activity in the F344 strain is more than fivefold greater than that in the Buf strain. Initial characterization of the enzyme in the two inbred strains reveals evidence for catalytic and structural differences, as reflected in dissimilar Km values for the cosubstrate (S-adenosyl-L-methionine) and prominent differences in thermal inactivation curves. To assess adrenal PNMT activity in an F344 X Buf pedigree, we employed a statistical procedure to test for one- and two-locus hypotheses in the presence of within-class correlations due to cage or litter effects. The PNMT data in the pedigree are best accounted for by segregation at a simple major locus superimposed upon a polygenic background; data obtained from the biochemical studies suggest that the major locus is a structural gene locus.',\n",
       "  'journal': 'Genetics',\n",
       "  'authors': \"Stolk|J M|JM|;Vantini|G|G|;Guchhait|R B|RB|;Hurst|J H|JH|;Perry|B D|BD|;U'Prichard|D C|DC|;Elston|R C|RC|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149973',\n",
       "  'mesh_terms': 'D000313:Adrenal Medulla; D000818:Animals; D002395:Catecholamines; D003433:Crosses, Genetic; D004299:Dopamine beta-Hydroxylase; D005260:Female; D005796:Genes; D008297:Male; D010625:Phenylethanolamine N-Methyltransferase; D051381:Rats; D011915:Rats, Inbred BUF; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002395:Catecholamines; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/genetics/108.3.633',\n",
       "  'references': '4287854;4400965;4403563;4833273;623485;623486;623487;40158;6500262;13863458',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Genetics',\n",
       "  'nlm_unique_id': '0374636',\n",
       "  'issn_linking': '0016-6731',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Analysis of the relation of the frequency of new gene mutations for Mendelian diseases to parental age].',\n",
       "  'issue': '20(10)',\n",
       "  'pages': '1726-32',\n",
       "  'abstract': 'The effect of parental age on mutation rates of achondroplasia, neurophibromatosis, hereditary gastrointestinal adenomatosis and Duchenne muscular dystrophy loci was studied. A significant parental age effect on the occurrence of new mutations for achondroplasia and neurophybromatosis was shown. The paternal component of this parental age effect was the major factor in the occurrence of such mutations. The risk of the occurrence of new cases of achondroplasia and neurophybromatosis, as compared with their overall frequency, due to new mutations, are increased by a factor of 2 and 3, respectively, up to the paternal age of 50. The possibility of application of the data obtained in genetic counselling is discussed.',\n",
       "  'journal': 'Genetika',\n",
       "  'authors': \"Bazhenova|M D|MD|;Kozlova|S I|SI|;Al'tshuler|B A|BA|;Tatishvili|G G|GG|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149974',\n",
       "  'mesh_terms': 'D005260:Female; D005787:Gene Frequency; D030342:Genetic Diseases, Inborn; D006801:Humans; D008297:Male; D008423:Maternal Age; D009377:Multiple Endocrine Neoplasia; D009136:Muscular Dystrophies; D009154:Mutation; D009456:Neurofibromatosis 1; D010009:Osteochondrodysplasias; D010331:Paternal Age; D012306:Risk; D013577:Syndrome',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Genetika',\n",
       "  'nlm_unique_id': '0047354',\n",
       "  'issn_linking': '0016-6758',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Alcohol and the elderly. Psychotropics and the elderly: interactions to watch for.',\n",
       "  'issue': '39(12)',\n",
       "  'pages': '30-6, 39-42',\n",
       "  'abstract': 'Alcohol can increase blood levels of diazepam, and probably of other benzodiazepines. Alcohol also potentiates the CNS-depressant effects of these drugs. Before adding a psychotropic drug in older patients, discontinue as many drugs as possible. Prescribe smaller doses and follow cardiovascular status. Determine serum levels when in doubt, especially with tricyclic antidepressants.',\n",
       "  'journal': 'Geriatrics',\n",
       "  'authors': 'Richelson|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149975',\n",
       "  'mesh_terms': 'D000328:Adult; D000367:Age Factors; D000368:Aged; D000863:Antacids; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001463:Barbiturates; D001569:Benzodiazepines; D002927:Cimetidine; D004221:Disulfiram; D004347:Drug Interactions; D000431:Ethanol; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D009638:Norepinephrine; D011619:Psychotropic Drugs',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000863:Antacids; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001463:Barbiturates; D011619:Psychotropic Drugs; D001569:Benzodiazepines; D000431:Ethanol; D002927:Cimetidine; D004221:Disulfiram; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Geriatrics',\n",
       "  'nlm_unique_id': '2985102R',\n",
       "  'issn_linking': '0016-867X',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Lecithin and total phospholipid concentrations in lung homogenates of fetuses and newborn rabbits after beta-receptor stimulation].',\n",
       "  'issue': '55(4)',\n",
       "  'pages': '249-52',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ginekologia polska',\n",
       "  'authors': 'Dzienis|K|K|;Jaroszewicz|K|K|;Urban|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149976',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000818:Animals; D000831:Animals, Newborn; D005260:Female; D005325:Fetal Organ Maturity; D005865:Gestational Age; D008168:Lung; D010713:Phosphatidylcholines; D010743:Phospholipids; D011247:Pregnancy; D011817:Rabbits',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D010713:Phosphatidylcholines; D010743:Phospholipids',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ginekol Pol',\n",
       "  'nlm_unique_id': '0374641',\n",
       "  'issn_linking': '0017-0011',\n",
       "  'country': 'Poland'},\n",
       " {'title': 'Does gastric acid release plasma somatostatin in man?',\n",
       "  'issue': '25(11)',\n",
       "  'pages': '1217-20',\n",
       "  'abstract': 'Food and insulin hypoglycaemia raise plasma concentrations of somatostatin. Both also stimulate gastric acid secretion but it is not clear whether gastric acid itself has any effect on somatostatin secretion. We, therefore, studied the effect on plasma concentrations of somatostatin of infusion of 0.1 N HC1 into the stomach and duodenum of healthy subjects. Plasma somatostatin did not rise with a small dose of HC1 given intragastrically (15 mmol) or intraduodenally (4 mmol). After an intraduodenal infusion of 60 mmol HC1 over 30 minutes, sufficient to reduce intraluminal pH to 2, plasma somatostatin rose moderately in five subjects from a mean value (+/- SEM) of 32 +/- 3 pg/ml to a peak at 10 minutes of 54 +/- 11 pg/ml. It is concluded that: (a) intragastric acid infusions do not release circulating somatostatin in man; and (b) that intraduodenal acidification albeit at grossly supraphysiological doses is a moderate stimulus of plasma somatostatin release. Therefore, gastric acid is unlikely to be a major factor mediating postprandial plasma somatostatin release in man.',\n",
       "  'journal': 'Gut',\n",
       "  'authors': \"Lucey|M R|MR|;Wass|J A|JA|;Fairclough|P D|PD|;O'Hare|M|M|;Kwasowski|P|P|;Penman|E|E|;Webb|J|J|;Rees|L H|LH|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149977',\n",
       "  'mesh_terms': 'D000328:Adult; D004386:Duodenum; D005744:Gastric Acid; D006801:Humans; D006851:Hydrochloric Acid; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D008297:Male; D013004:Somatostatin; D013270:Stomach',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D013004:Somatostatin; D006851:Hydrochloric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.11.1217',\n",
       "  'references': '5460746;4685087;4139406;56779;58151;408145;677795;690183;420498;34554;36319;6104549;7390059;6105024;6112841;6114894;6118013;7337824;6313256;6139847',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': \"Effect of vasoactive intestinal polypeptide and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands.\",\n",
       "  'issue': '25(11)',\n",
       "  'pages': '1225-9',\n",
       "  'abstract': \"The effect of VIP and somatostatin on secretion of epidermal growth factor and bicarbonate from Brunner's glands was investigated in the rat. Vasoactive intestinal polypeptide infused in doses of 10 and 100 ng/kg/h significantly increased epidermal growth factor and bicarbonate output, but the concentrations did not change. Somatostatin infused at doses of 1, 10, 100 and 1000 ng/kg/h against a background of VIP 100 ng/kg/h inhibited in dose-dependent fashion the stimulated epidermal growth factor and bicarbonate outputs from rat Brunner's gland pouches. Also basal secretion was inhibited by somatostatin. Infusion of antisomatostatin serum stimulated Brunner's gland secretion. By immunohistochemical studies of rat duodena, it was found that epidermal growth factor, is almost exclusively present in the secretory cells of Brunner's glands. It is concluded that VIP stimulates secretion of epidermal growth factor and bicarbonate from Brunner's glands, an effect which is inhibited by somatostatin. A possible role for somatostatin in the control of Brunner's gland secretion is suggested.\",\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Kirkegaard|P|P|;Olsen|P S|PS|;Nexø|E|E|;Holst|J J|JJ|;Poulsen|S S|SS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149978',\n",
       "  'mesh_terms': 'D000818:Animals; D001639:Bicarbonates; D002011:Brunner Glands; D004305:Dose-Response Relationship, Drug; D004386:Duodenum; D004815:Epidermal Growth Factor; D007419:Intestinal Secretions; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012636:Secretory Rate; D013004:Somatostatin; D014660:Vasoactive Intestinal Peptide',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001639:Bicarbonates; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; D004815:Epidermal Growth Factor',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.11.1225',\n",
       "  'references': '5944054;342970;350728;467514;398091;6156425;7018988;6116642;6126917;6191365;6605273;6698442;6608137;13292870',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': 'Suppression of somatostatin release by duodenogastric reflux in dogs.',\n",
       "  'issue': '25(11)',\n",
       "  'pages': '1230-3',\n",
       "  'abstract': 'The effect of duodenogastric reflux on systemic and portal venous blood concentrations of somatostatin has been studied in the dog. Duodenogastric reflux suppressed somatostatin concentrations in both systemic and portal venous blood, but this did not occur when bile alone was diverted into the stomach. The suppression was also much less marked when truncal vagotomy accompanied the reflux. These findings suggest that altered somatostatin activity may play a part in the production of the pathophysiological changes occurring in clinical conditions such as peptic ulceration, in which there is an increase in duodenogastric reflux.',\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Thomas|W E|WE|;Ardill|J|J|;Buchanan|K D|KD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149979',\n",
       "  'mesh_terms': 'D000818:Animals; D001646:Bile; D004195:Disease Models, Animal; D004285:Dogs; D004383:Duodenogastric Reflux; D005755:Gastrins; D011169:Portal Vein; D013004:Somatostatin; D014628:Vagotomy',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005755:Gastrins; D013004:Somatostatin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.11.1230',\n",
       "  'references': '4161967;5808483;5473603;5313395;5033839;4682665;4700283;47535;325638;339322;682987;690183;7429304;6107772;6108902;6112778;7262129;7297577;6122629;7083998;7084804;45575',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': 'Adrenergic effects on exocrine secretion of rat submandibular epidermal growth factor.',\n",
       "  'issue': '25(11)',\n",
       "  'pages': '1234-40',\n",
       "  'abstract': 'The present study was undertaken to investigate the effect of alpha- and beta-adrenergic agonists on secretion of epidermal growth factor (EGF) from the rat submandibular glands and to test the possibility of intestinal absorption of EGF. Alpha-adrenergic agonists increased the concentration of salivary EGF by approximately a hundred times, while the serum concentration of EGF was unchanged. The contents of EGF in the submandibular glands decreased upon administration of the alpha-adrenergic agonist noradrenaline, and this was confirmed on immunohistochemical investigation of the glands. Beta-adrenergic agonists had no effect on secretion of EGF from the submandibular glands. Intestinal absorption of EGF could not be confirmed, as stimulation by noradrenaline with free passage of saliva to the gastrointestinal tract and intrajejunal infusion of EGF had no influence on the concentration of EGF in serum. This study shows that alpha-adrenergic agonists stimulate exocrine secretion of submandibular EGF and that EGF in physiological amounts are not absorbed in the gastrointestinal tract.',\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Olsen|P S|PS|;Kirkegaard|P|P|;Poulsen|S S|SS|;Nexø|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149980',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000818:Animals; D004815:Epidermal Growth Factor; D007408:Intestinal Absorption; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012463:Saliva; D013268:Stimulation, Chemical; D013363:Submandibular Gland',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D004815:Epidermal Growth Factor',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.11.1234',\n",
       "  'references': '315307;6257217;13880319;1059391;6605273;6602382;4726306;6337948;302030;267927;7003006;6180163;7009622;75067;4368688;186790;391019;14308;6969274;6965906;40842;4735904;7030877;6324875;972168;382984;6608137;776732;6292122',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effects of sulphasalazine and disodium azodisalicylate on colonic PGE2 concentrations determined by equilibrium in vivo dialysis of faeces in patients with ulcerative colitis and healthy controls.',\n",
       "  'issue': '25(11)',\n",
       "  'pages': '1271-8',\n",
       "  'abstract': 'The role of arachidonic acid metabolites and the mode of action of 5-aminosalicylic acid, the active moiety of sulphasalazine and disodium azodisalicylate, in ulcerative colitis remain obscure. Therefore, experiments were performed in which the effects of medication on immunoreactive prostaglandin (PG) E2 concentrations in free faecal water were assessed using the equilibrium in vivo dialysis of faeces. Colonic PGE2 concentrations in patients with active ulcerative colitis (n = 11) ranged from 2035-18,000 pg/ml to be compared with a range of 103-188 pg/ml in healthy volunteers (n = 10; p less than 0.001). In all healthy volunteers PGE2 concentrations decreased slightly (p less than 0.05) after disodium azodisalicylate intake 2 g/day, whereas low dose disodium azodisalicylate (0.25 g/day) caused no change. In patients with ulcerative colitis in complete clinical, sigmoidoscopic, and histologic remission withdrawal of sulphasalazine (2 g/day; n = 6) increased PGE2 concentrations to values above normal levels (p less than 0.05) which returned to pretrial values (p less than 0.05) on disodium azodisalicylate (2 g/day; n = 7). In conclusion, increased PGE2 in free faecal water indicates an abnormality in the colonic mucosa, even in the absence of conventional signs of inflammation. We could not confirm the hypothesis that sulphasalazine and 5-aminosalicylic acid exert their therapeutic effect through promotion of endogenous cytoprotective prostaglandins. In contrast, the observation that raised PGE2 concentrations were normalised by disodium azodisalicylate in patients with inactive ulcerative colitis suggests that subclinical disease activity was decreased by 5-aminosalicylic acid.',\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Lauritsen|K|K|;Hansen|J|J|;Bytzer|P|P|;Bukhave|K|K|;Rask-Madsen|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149981',\n",
       "  'mesh_terms': 'D000328:Adult; D000636:Aminosalicylic Acids; D003093:Colitis, Ulcerative; D003106:Colon; D003956:Dialysis; D015232:Dinoprostone; D005243:Feces; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011458:Prostaglandins E; D012460:Sulfasalazine; D014867:Water',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000636:Aminosalicylic Acids; D011458:Prostaglandins E; D014867:Water; D012460:Sulfasalazine; D015232:Dinoprostone; C032587:olsalazine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.11.1271',\n",
       "  'references': '236516;53480;4854;72239;30669;101423;82016;374175;7350030;6103724;6104551;6105118;7429322;6107263;6107853;6112777;6112788;6113614;6114012;6114307;6791938;6117846;6120182;6120459;6810465;6126420;7173720;6826100;6131017;6131674;6573927;6416934;6143704;14075156;14277301;13260656',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': 'Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.',\n",
       "  'issue': '25(11)',\n",
       "  'pages': '1291-5',\n",
       "  'abstract': 'The purpose of our study was to evaluate the effect of somatostatin (500 microgram/h intravenously) upon insulin, c-peptide, glucagon and plasma amino acids concentrations in patients with and without cirrhosis of the liver. The typical plasma amino acid pattern in cirrhosis is characterised by increased concentrations of the aromatic amino acids and decreased concentrations of the branched chain amino acids and of alanine and glycine. After administration of somatostatin insulin, c-peptide and glucagon concentrations decreased and those of the branched chain amino acids in both groups increased; in addition in patients with cirrhosis the plasma concentrations of threonine, serine, glycine, alanine, lysine, and arginine increased also. Infusion of somatostatin plus insulin in patients with cirrhosis succeeded in preventing the increase in the branched chain amino acid concentrations, while the infusion of somatostatin plus glucagon decreased threonine, serine, glycine, alinine, phenylalanine, tyrosine, lysine and arginine concentrations. It is therefore suggested that the effect of somatostatin on the plasma amino acids may be because of the reduction of insulin and glucagon concentrations; however, other effects of somatostatin cannot be excluded at present.',\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Limberg|B|B|;Kommerell|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149982',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000597:Amino Acids, Branched-Chain; D002096:C-Peptide; D005934:Glucagon; D006801:Humans; D007328:Insulin; D008104:Liver Cirrhosis, Alcoholic; D008297:Male; D010649:Phenylalanine; D013004:Somatostatin; D014443:Tyrosine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000596:Amino Acids; D000597:Amino Acids, Branched-Chain; D002096:C-Peptide; D007328:Insulin; D014443:Tyrosine; D010649:Phenylalanine; D013004:Somatostatin; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.11.1291',\n",
       "  'references': '5910856;4997492;4808927;4594711;4134714;47485;1165731;1202086;1239396;1263837;818729;62115;979641;63654;832796;631443;648812;207947;690190;421995;467210;90864;6990172;7026404;7031418;7076013;6123064;7043186',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': '[Changes in surface tension, electric potentials and acetylcholinesterase activity in the blood of children with schizophrenic psychoses treated with neuroleptics].',\n",
       "  'issue': '25(1-2)',\n",
       "  'pages': '73-86',\n",
       "  'abstract': '',\n",
       "  'journal': 'Folia medica Cracoviensia',\n",
       "  'authors': 'Bichoński|R|R|;Dabrowski|Z|Z|;Pawełek|J|J|;Gut|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149984',\n",
       "  'mesh_terms': 'D000110:Acetylcholinesterase; D000200:Action Potentials; D000293:Adolescent; D014150:Antipsychotic Agents; D002648:Child; D002675:Child, Preschool; D004910:Erythrocyte Membrane; D006801:Humans; D012561:Schizophrenia, Childhood; D013500:Surface Tension',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D000110:Acetylcholinesterase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Folia Med Cracov',\n",
       "  'nlm_unique_id': '0374617',\n",
       "  'issn_linking': '0015-5616',\n",
       "  'country': 'Poland'},\n",
       " {'title': '[Biological theory of alcoholism].',\n",
       "  'issue': '25(1-2)',\n",
       "  'pages': '97-118',\n",
       "  'abstract': '',\n",
       "  'journal': 'Folia medica Cracoviensia',\n",
       "  'authors': 'Słowik|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149985',\n",
       "  'mesh_terms': 'D000437:Alcoholism; D001921:Brain; D004198:Disease Susceptibility; D004361:Drug Tolerance; D006801:Humans; D009243:NAD; D018377:Neurotransmitter Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D009243:NAD',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Folia Med Cracov',\n",
       "  'nlm_unique_id': '0374617',\n",
       "  'issn_linking': '0015-5616',\n",
       "  'country': 'Poland'},\n",
       " {'title': '[Effects of N-696, a new beta-blocking agent, on canine experimental arrhythmias].',\n",
       "  'issue': '84(3)',\n",
       "  'pages': '259-66',\n",
       "  'abstract': 'We evaluated antiarrhythmic effects of N-696 using canine digitalis ventricular arrhythmia models and electrophysiological actions of N-696 using canine ventricular muscles and isolated blood perfused A-V node preparations and compared the effects with those of propranolol. 1) N-696 at 30 mg/kg, i.v. was not effective on digitalis arrhythmia, but reduced the total heart rate and atrial rate for 60 min and transiently decreased the blood pressure. Propranolol at 3 mg/kg, i.v. transiently suppressed digitalis ventricular arrhythmia and decreased the total heart rate, atrial rate and blood pressure. The minimum effective plasma concentration of propranolol was 1.7 +/- 0.4 microgram/ml. 2) Ten to 100 micrograms/ml N-696 and 3 to 10 micrograms/ml propranolol did not affect the resting potential and the action potential duration at 75% repolarization of the canine ventricular muscle, but decreased the maximum rate of rise of the action potential in a dose-dependent fashion, and 100 micrograms/ml N-696 decreased significantly the action potential amplitude. The minimum effective drug concentration of N-696 was 60 micrograms/ml, and that of propranolol was 6 micrograms/ml. 3) N-696 (30 micrograms-3mg) dose-dependently delayed the A-V conduction time of the isolated blood perfused A-V node preparation when it was administered into the posterior septal artery (PSA) and the anterior septal artery (ASA). Propranolol (10-600 micrograms) also had similar effects, but the doses of N-696 delaying the A-V conduction time by 15% was about 8 to 21 times higher than those of propranolol.',\n",
       "  'journal': 'Nihon yakurigaku zasshi. Folia pharmacologica Japonica',\n",
       "  'authors': 'Ishii|M|M|;Komori|S|S|;Satoh|H|H|;Ohta|T|T|;Motomura|S|S|;Hashimoto|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149986',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac; D001283:Atrioventricular Node; D001794:Blood Pressure; D004071:Digitalis Glycosides; D004285:Dogs; D005260:Female; D006339:Heart Rate; D007546:Isoquinolines; D008297:Male; D008564:Membrane Potentials; D011433:Propranolol',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D007546:Isoquinolines; D011433:Propranolol; C036593:tilisolol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nihon Yakurigaku Zasshi',\n",
       "  'nlm_unique_id': '0420550',\n",
       "  'issn_linking': '0015-5691',\n",
       "  'country': 'Japan'},\n",
       " {'title': '[Effects of some drugs on plasma uric acid in rats--actions of catecholamines and beta-blocking agents].',\n",
       "  'issue': '84(3)',\n",
       "  'pages': '293-301',\n",
       "  'abstract': 'Effects of catecholamines on plasma uric acid and allantoin levels were studied in oxonate-treated rats and non-treated rats. 1) In non-treated rats, epinephrine, isoproterenol and phenylephrine, which were injected intravenously, clearly increased plasma uric acid and allantoin, and norepinephrine had only a slight effect. The orders of potency to increase plasma uric acid and allantoin were epinephrine greater than isoproterenol greater than phenylephrine greater than norepinephrine. Beta-adrenoceptor agonists also increased plasma uric acid and allantoin in non-treated rats. The order of potency to increase plasma uric acid was isoproterenol salbutamol trimetoquinol greater than terbutaline, and that of potency to increase plasma allantoin was isoproterenol salbutamol greater than or equal to trimetoquinol greater than terbutaline. 2) In oxonate-treated rats, the four beta-adrenoceptor agonists (50 micrograms/kg, i.v.) markedly potentiated the hyperuricemic effect of oxonate. These effects of beta-adrenoceptor agonists were inhibited by propranolol (2.0 mg/kg. i.v.). In addition, the effect of isoproterenol was inhibited by butoxamine (1.0 mg/kg, i.v.), but not by atenolol (1.0 mg/kg, i.v.). These results suggest that hyperuricemia induced by catecholamines is closely related to beta 2-adrenoceptor action.',\n",
       "  'journal': 'Nihon yakurigaku zasshi. Folia pharmacologica Japonica',\n",
       "  'authors': 'Sugino|H|H|;Kagoshima|M|M|;Katagiri|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149987',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000481:Allantoin; D000818:Animals; D002395:Catecholamines; D004347:Drug Interactions; D004837:Epinephrine; D007545:Isoproterenol; D008297:Male; D009638:Norepinephrine; D010094:Oxonic Acid; D010656:Phenylephrine; D051381:Rats; D011919:Rats, Inbred Strains; D014527:Uric Acid',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D010656:Phenylephrine; D014527:Uric Acid; D000481:Allantoin; D010094:Oxonic Acid; D007545:Isoproterenol; D009638:Norepinephrine; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nihon Yakurigaku Zasshi',\n",
       "  'nlm_unique_id': '0420550',\n",
       "  'issn_linking': '0015-5691',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Peripheral B and T-cell subsets defined by monoclonal antibodies in patients treated with histamine type-2 receptor antagonists.',\n",
       "  'issue': '69(4)',\n",
       "  'pages': '503-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Haematologica',\n",
       "  'authors': 'Cavanna|L|L|;Fornari|F|F|;Groppi|F|F|;Tansini|P|P|;Rossi|S|S|;Prati|C|C|;Buscarini|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149983',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D001402:B-Lymphocytes; D005260:Female; D006635:Histamine H2 Antagonists; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D013601:T-Lymphocytes',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D006635:Histamine H2 Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Haematologica',\n",
       "  'nlm_unique_id': '0417435',\n",
       "  'issn_linking': '0390-6078',\n",
       "  'country': 'Italy'},\n",
       " {'title': '[Treatment of typical trigeminus neuralgias. Overview of the current state of drug and surgical therapy].',\n",
       "  'issue': '102(38)',\n",
       "  'pages': '935-9',\n",
       "  'abstract': 'Carbamazepine continues to be the most useful drug in the treatment of trigeminal neuralgia. Diphenylhydantoin may be given in addition to or instead of Carbamazepine. Refractory cases may benefit from combination with Baclofen or Chlorphenesin. In cases of persistent pain the concomitant use of tricyclic antidepressant drugs is recommended. If pain continues in spite of multiple medical therapies or if serious side effects develop, then surgical procedures such as percutaneous controlled thermocoagulation or microvascular decompression are indicated. Percutaneous thermocoagulation is associated with the lowest mortality and morbidity rate and can easily be repeated. Microvascular decompression should especially be offered to young patients, who want to avoid any sensory disturbance of the face, and recommended for other patients for whom all other forms of therapy including percutaneous thermocoagulation have failed.',\n",
       "  'journal': 'Fortschritte der Medizin',\n",
       "  'authors': 'Möbius|E|E|;Leopold|H C|HC|;Paulus|W M|WM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149988',\n",
       "  'mesh_terms': 'D000328:Adult; D014150:Antipsychotic Agents; D001418:Baclofen; D002220:Carbamazepine; D002743:Chlorphenesin; D004564:Electrocoagulation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009123:Muscle Hypotonia; D010292:Paresthesia; D010672:Phenytoin; D014277:Trigeminal Neuralgia',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D002220:Carbamazepine; D010672:Phenytoin; D001418:Baclofen; D002743:Chlorphenesin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fortschr Med',\n",
       "  'nlm_unique_id': '2984763R',\n",
       "  'issn_linking': '0015-8178',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Alternative therapy concept for the treatment of psychosomatic disorders. Controlled double-blind evaluation of fluspirilene versus bromazepam].',\n",
       "  'issue': '102(40)',\n",
       "  'pages': '1033-6',\n",
       "  'abstract': \"Today, Fluspirilene 1.5 mg i.m. (Imap 1,5 mg), is used to treat psychosomatic conditions, anxiety states and psychogenic disorders. The present article reports on clinical studies involving these indications. The efficacy of Fluspirilene 1.5 mg i.m. was demonstrated in patients with functional organic complaints, autonomic emotional symptom complexes, patients with anxiety, patients with functional heart complaints, and patients with functional gynaecological disorders. The results of a controlled study of 1.5 mg Fluspirilene i.m. and 6 mg Bromazepam are discussed. Forty-five patients from a neurologist's practice participated, all of whom had been classified as treatment-requiring patients with neurotic anxiety, on the basis of the physician's diagnosis and psychometric examination. Treatment lasted 42 days. The clinical assessment by the physician revealed that 1.5 mg Fluspirilene i.m. is significantly more effective than Bromazepam. The psychometric findings showed that patients with marked somatic anxiety treated with Fluspirilene showed greater improvement as expressed in a reduction in anxiety, lightening of mood, and increased activity, as compared with Bromazepam.\",\n",
       "  'journal': 'Fortschritte der Medizin',\n",
       "  'authors': 'Lehmann|E|E|;Hassel|P|P|;Thörner|G W|GW|;Karrass|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149989',\n",
       "  'mesh_terms': 'D000328:Adult; D014151:Anti-Anxiety Agents; D001960:Bromazepam; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D005484:Fluspirilene; D006801:Humans; D008297:Male; D011594:Psychometrics; D011602:Psychophysiologic Disorders; D013141:Spiro Compounds',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D013141:Spiro Compounds; D005484:Fluspirilene; D001960:Bromazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fortschr Med',\n",
       "  'nlm_unique_id': '2984763R',\n",
       "  'issn_linking': '0015-8178',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Effects of somatostatin, glucagon and insulin on glycogen synthesis in isolated rat hepatocytes.',\n",
       "  'issue': '16(10)',\n",
       "  'pages': '513-5',\n",
       "  'abstract': 'The effects of somatostatin on basal and hormone-mediated rates of glycogenesis were studied in isolated rat hepatocytes. Somatostatin (1.5 X 10(-11) - 1.5 X 10(-8) M) had no effect on glycogen synthesis in the presence of 30 mM glucose and did not overcome a glucagon (1.5 X 10(-10) M)-induced inhibition of glycogenesis.',\n",
       "  'journal': 'Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme',\n",
       "  'authors': 'Bone|A J|AJ|;Younan|S I|SI|;Conlon|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149990',\n",
       "  'mesh_terms': 'D000818:Animals; D005934:Glucagon; D006706:Homeostasis; D066298:In Vitro Techniques; D007328:Insulin; D008099:Liver; D008112:Liver Glycogen; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D007328:Insulin; D008112:Liver Glycogen; D013004:Somatostatin; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1055/s-2007-1014837',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Horm Metab Res',\n",
       "  'nlm_unique_id': '0177722',\n",
       "  'issn_linking': '0018-5043',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Analysis of pancreatic peptide hormones by reversed-phase high-performance liquid chromatography.',\n",
       "  'issue': '16(9)',\n",
       "  'pages': '487-91',\n",
       "  'abstract': 'Reversed-phase high-performance liquid chromatography (HPLC) is examined as a method for separating pancreatic peptides. The method was based on gradient elution with acetonitrile in an acid phosphate buffer (pH 3.10). Apart from human and porcine insulin all the other peptide standards tested (thyrotropin-releasing factor, vaso-active intestinal polypeptide, human C-peptide, porcine C-peptide, somatostatin, porcine glucagon, porcine proinsulin and porcine pancreatic polypeptide) could be separated simultaneously in 40 minutes with a binary gradient composed of five linear segments and increasing from 0 to 60% acetonitrile. Human and porcine insulin could be almost completely resolved by a minimal reduction in the steepness of the acetonitrile gradient. Repeated injections of human C-peptide and porcine insulin resulted in a coefficient of variation of less than 1.5% in the retention times. The use of 125I-labelled peptides gave recoveries exceeding 90%. HPLC of acid ethanol extracts of autopsy pancreases from three infants showed that the immunoreactivity of the peptides measured remained unaffected by the chromatography. Both immunoreactive C-peptide and immunoreactive insulin (IRI) were recovered in two peaks, the second common peak representing proinsulin and amounting to 6.5 to 8.4% of total IRI. Immunoreactive glucagon was eluted in a single peak. Chromatography of plasma extracts from two infants of diabetic mothers demonstrated that proinsulin accounted for 59-63% of total IRI, while insulin was separated into two peaks corresponding to the standards of human insulin and porcine insulin. These results indicate that reversed -phase HPLC is a method with a good reproducibility and a high recovery applicable to the rapid and effective separation of pancreatic peptides from biological extracts.',\n",
       "  'journal': 'Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme',\n",
       "  'authors': 'Knip|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149991',\n",
       "  'mesh_terms': 'D000818:Animals; D002096:C-Peptide; D002851:Chromatography, High Pressure Liquid; D005934:Glucagon; D006728:Hormones; D006801:Humans; D007223:Infant; D007328:Insulin; D010179:Pancreas; D010191:Pancreatic Polypeptide; D010455:Peptides; D011384:Proinsulin; D011863:Radioimmunoassay; D013004:Somatostatin; D013552:Swine; D013973:Thyrotropin-Releasing Hormone; D014660:Vasoactive Intestinal Peptide',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002096:C-Peptide; D006728:Hormones; D007328:Insulin; D010455:Peptides; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; D010191:Pancreatic Polypeptide; D013973:Thyrotropin-Releasing Hormone; D005934:Glucagon; D011384:Proinsulin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1055/s-2007-1014826',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Horm Metab Res',\n",
       "  'nlm_unique_id': '0177722',\n",
       "  'issn_linking': '0018-5043',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Perissodactyla: the primary structure of hemoglobins from the lowland tapir (Tapirus terrestris): glutamic acid in position 2 of the beta chains].',\n",
       "  'issue': '365(9)',\n",
       "  'pages': '1097-106',\n",
       "  'abstract': 'The hemoglobins from a lowland tapir (Tapirus terrestris) were analysed and the complete primary structure is described. The globin chains were separated on CM cellulose column in 8M urea and the amino-acid sequences were determined in the liquid phase sequenator. The results show that globin consists of two alpha chains (alpha I and alpha II) and beta major and beta minor components. The alpha chains differ only at one position: alpha I contains aspartic acid and alpha II glycine. The beta chains are heterogeneous: aspartic and glutamic acid were found at position beta 21 and beta 73 of the beta major components and asparagine and serine at position beta 139. In the beta minor components four positions were found with more than one amino acid, namely beta 2, beta 4, beta 6 and beta 56. The sequences are compared with those of man, horse and rhinoceros. Four residues of horse methemoglobin, which are involved in the alpha 1 beta 1 contacts are substituted in tapir hemoglobins. In the alpha chains: alpha 107(G14)Ser----Val, alpha 111-(G18) Val----Leu, alpha 115(GH3) Asn----Asp or Gly; in the beta chains: beta 116(G18) Arg----Gln. The amino acid at beta 2 of the major components is glutamic acid while glutamine and histidine are found in the minor components. Although glutamic acid, a binding site for ATP, does not interact with 2,3-bisphosphoglycerate, glutamine and histidine in the minor components are responsible for the slight effect of 2,3-bisphosphoglycerate on tapir hemoglobin.',\n",
       "  'journal': \"Hoppe-Seyler's Zeitschrift fur physiologische Chemie\",\n",
       "  'authors': 'Mazur|G|G|;Braunitzer|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149994',\n",
       "  'mesh_terms': 'D000595:Amino Acid Sequence; D000818:Animals; D001120:Arginine; D003488:Cyanogen Bromide; D005971:Glutamates; D018698:Glutamic Acid; D006454:Hemoglobins; D006868:Hydrolysis; D010455:Peptides; D010527:Perissodactyla; D014357:Trypsin',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D005971:Glutamates; D006454:Hemoglobins; D010455:Peptides; D018698:Glutamic Acid; D001120:Arginine; D014357:Trypsin; D003488:Cyanogen Bromide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hoppe Seylers Z Physiol Chem',\n",
       "  'nlm_unique_id': '2985060R',\n",
       "  'issn_linking': '0018-4888',\n",
       "  'country': 'Germany'},\n",
       " {'title': \"Elderly patient's confusion confounds diagnosis and treatment of depression.\",\n",
       "  'issue': '35(11)',\n",
       "  'pages': '1091-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Hospital & community psychiatry',\n",
       "  'authors': 'Frances|A|A|;Teusink|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149995',\n",
       "  'mesh_terms': 'D000275:Adjustment Disorders; D000368:Aged; D014150:Antipsychotic Agents; D003072:Cognition Disorders; D003221:Confusion; D003704:Dementia; D003866:Depressive Disorder; D003891:Desipramine; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D003891:Desipramine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hosp Community Psychiatry',\n",
       "  'nlm_unique_id': '0040250',\n",
       "  'issn_linking': '0022-1597',\n",
       "  'country': 'United States'},\n",
       " {'title': 'In vivo interactions between H2-receptor antagonists and ethanol metabolism in man and in rats.',\n",
       "  'issue': '4(6)',\n",
       "  'pages': '1231-4',\n",
       "  'abstract': 'The influence of a 7-day medication of either cimetidine (1,000 mg per day) or ranitidine (300 mg per day) on serum ethanol concentrations after a single oral dose of ethanol (0.8 gm per kg body weight) was investigated in a randomized placebo-controlled study in eight male volunteers. Compared with the placebo, cimetidine but not ranitidine produced a significant increase in both the peak serum ethanol concentration (85.9 +/- 3.5 vs. 73.0 +/- 3.2 mg dl-1, p less than 0.02) and in the area under the serum ethanol concentration time curve (350 +/- 19 vs. 304 +/- 25 mg dl-1 hr-1, p less than 0.05). However, the ethanol elimination rate was not affected by cimetidine. When ethanol (1.0 gm per kg body weight) was administered intravenously, cimetidine failed to induce a change in ethanol metabolism. Furthermore, the effect of H2-receptor antagonists was studied in animal experiments. Female Sprague-Dawley rats received a single dose of ethanol (7 or 3 gm per kg body weight) together with an intraperitoneal injection of either cimetidine (120 mg per kg body weight), ranitidine (120 mg per kg body weight) or isotonic saline. After alcohol absorption, ethanol elimination was significantly inhibited by both cimetidine (3.99 +/- 0.39 vs. 5.68 +/- 0.23 mmoles kg-1 hr-1, p less than 0.02) and ranitidine (4.21 +/- 0.14 vs. 5.68 +/- 0.23 mmoles kg-1 hr-1, p less than 0.02) at high ethanol concentrations (60 to 20 mM) but not at blood ethanol concentrations below 20 mM.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Hepatology (Baltimore, Md.)',\n",
       "  'authors': 'Seitz|H K|HK|;Veith|S|S|;Czygan|P|P|;Bösche|J|J|;Simon|B|B|;Gugler|R|R|;Kommerell|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149992',\n",
       "  'mesh_terms': 'D000328:Adult; D000818:Animals; D000983:Antipyrine; D002927:Cimetidine; D000431:Ethanol; D005260:Female; D006635:Histamine H2 Antagonists; D006801:Humans; D008297:Male; D011899:Ranitidine; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D006635:Histamine H2 Antagonists; D000431:Ethanol; D002927:Cimetidine; D011899:Ranitidine; D000983:Antipyrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/hep.1840040623',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hepatology',\n",
       "  'nlm_unique_id': '8302946',\n",
       "  'issn_linking': '0270-9139',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Nonphysician practitioners make slow headway on staff privileges.',\n",
       "  'issue': '58(24)',\n",
       "  'pages': '82-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Hospitals',\n",
       "  'authors': 'Richards|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149996',\n",
       "  'mesh_terms': 'D002684:Chiropractic; D006801:Humans; D007591:Joint Commission on Accreditation of Healthcare Organizations; D013677:Medical Laboratory Science; D008504:Medical Staff Privileges; D008505:Medical Staff, Hospital; D009719:Nurse Anesthetists; D009721:Nurse Midwives; D009722:Nurse Practitioners; D009907:Optometry; D026741:Physical Therapy Modalities; D010823:Physician Assistants; D011032:Podiatry; D011586:Psychology, Clinical; D014481:United States',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hospitals',\n",
       "  'nlm_unique_id': '0374657',\n",
       "  'issn_linking': '0018-5973',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Recognition specificities, development and possible biological function of natural killer cells in the mouse. II. Changes in NK recognition during ontogeny and ageing, and examination of role of environment in controlling the expressed recognition repertoire.',\n",
       "  'issue': '53(4)',\n",
       "  'pages': '731-43',\n",
       "  'abstract': 'We have used a spleen fragment assay to assess subpopulations of NK effector cells in individual mice and to analyse the patterns of inhibition of lytic activity seen in the presence of different sugars (mono-, di- and tri-saccharides). Our data suggest that during ontogeny the heterogeneity (diversity) of the NK effector population increases in a fashion which is somewhat characteristic of the individual strain under investigation. Furthermore, when a similar analysis was performed on NK cells in the spleen of lethally irradiated recipient mice receiving syngeneic or semi-allogeneic bone marrow stem cell precursors, we found that the phenotype of inhibition by different sugars was a characteristic of the bone marrow donor and not of the recipient. In so far as the assay described assesses target recognition by NK cells (and not subsequent parameters involved in the lytic event) these data can be interpreted in terms of a relative independence of the expressed recognition repertoire of NK cells from the environment in which their differentiation occurs.',\n",
       "  'journal': 'Immunology',\n",
       "  'authors': 'Gorczynski|R M|RM|;Harris|J F|JF|;Kennedy|M|M|;MacRae|S|S|;Chang|M P|MP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149997',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D002241:Carbohydrates; D003602:Cytotoxicity, Immunologic; D004187:Disaccharides; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D007694:Killer Cells, Natural; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008809:Mice, Inbred C3H; D011828:Radiation Chimera; D013154:Spleen; D014312:Trisaccharides',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002241:Carbohydrates; D004187:Disaccharides; D014312:Trisaccharides',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '242101;334169;305459;705260;722082;83702;108680;476826;479761;509522;6930673;6968872;7451961;7204975;6164514;6165896;6166701;6790607;6169452;7299137;6946516;7061852;7105064;7108226;6182045;6185241;6826257;6601135;6833762;6682730;6411358',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Immunology',\n",
       "  'nlm_unique_id': '0374672',\n",
       "  'issn_linking': '0019-2805',\n",
       "  'country': 'England'},\n",
       " {'title': 'Suppression of CTL responses in vitro by large granular T cells.',\n",
       "  'issue': '8(4)',\n",
       "  'pages': '201-6',\n",
       "  'abstract': 'The generation of large granular T cells (LGC) that display cytotoxicity similar to activated natural killer (NK) cells was described previously by the authors. To determine whether LGC can regulate the generation of allospecific CTL (C57BL/6, anti-DBA/2), we used primed responding T cells (Thy-1.2) and (Thy-1.1) to perform co-cultures. The cytolytic activities and the phenotype of the harvested T cells were examined after a co-culture period (3-6 days). We observed that the survival of fresh responding T cells was impaired in the co-cultures. Activated (4 days) responding T cells can survive in similar coculture conditions. This led to the conclusion that LGC can inactivate the CTL generation in fresh T-cell populations and that fresh and activated responding cells have different susceptibilities to LGC interactions.',\n",
       "  'journal': 'Immunology letters',\n",
       "  'authors': 'Schaaf-Lafontaine|N|N|;Boniver|J|J|;Huygen|K|K|;Degiovanni|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149998',\n",
       "  'mesh_terms': 'D000818:Animals; D000954:Antigens, Surface; D002455:Cell Division; D002478:Cells, Cultured; D003602:Cytotoxicity, Immunologic; D007165:Immunosuppression Therapy; D007370:Interferon Type I; D007376:Interleukin-2; D007694:Killer Cells, Natural; D007959:Lymphocyte Culture Test, Mixed; D051379:Mice; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D013602:T-Lymphocytes, Cytotoxic; D018800:Thy-1 Antigens',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000954:Antigens, Surface; D007370:Interferon Type I; D007376:Interleukin-2; D018800:Thy-1 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0165-2478(84)90078-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Immunol Lett',\n",
       "  'nlm_unique_id': '7910006',\n",
       "  'issn_linking': '0165-2478',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'The neurobiology of hepatic encephalopathy.',\n",
       "  'issue': '4(6)',\n",
       "  'pages': '1235-42',\n",
       "  'abstract': '',\n",
       "  'journal': 'Hepatology (Baltimore, Md.)',\n",
       "  'authors': 'Jones|E A|EA|;Schafer|D F|DF|;Ferenci|P|P|;Pappas|S C|SC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149993',\n",
       "  'mesh_terms': 'D000818:Animals; D005074:Evoked Potentials, Visual; D006501:Hepatic Encephalopathy; D006801:Humans; D018377:Neurotransmitter Agents; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D011963:Receptors, GABA-A; D005680:gamma-Aminobutyric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/hep.1840040624',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hepatology',\n",
       "  'nlm_unique_id': '8302946',\n",
       "  'issn_linking': '0270-9139',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Molecular biology of catecholamine neurons. Similar gene hypothesis.',\n",
       "  'issue': '6(5 Pt 2)',\n",
       "  'pages': 'II1-6',\n",
       "  'abstract': 'We have postulated that the catecholamine-synthesizing enzymes tyrosine hydroxylase (TH), dopamine beta-hydroxylase (DBH), and phenylethanolamine N-methyltransferase (PNMT) are coded for by similar genes. To analyze the structural relationship of genes coding for these enzymes, we have cloned DNAs complementary (cDNA) to DBH and PNMT messenger RNAs (mRNAs). Using hybrid selection analysis to identify the cDNA clones positively, we discovered cross-hybridization between DBH cDNA clones and PNMT mRNA and between PNMT cDNA clones and DBH mRNA. Further analysis by RNA blot hybridization revealed that the DBH cDNA probe hybridized predominantly to a 5500 nucleotide mRNA and less strongly to a 1100 nucleotide species, and the PNMT cDNA probe hybridized strongly to the 1100 nucleotide mRNA and weakly to the 5500 nucleotide message. DNA blot hybridization analysis demonstrated that DBH and PNMT cDNA probes hybridized to several common restriction fragments of total cellular DNA. The evidence presented here suggests the existence of homologous gene-coding regions in DBH and PNMT cDNAs. These homologies may be the result of duplication of a common ancestral gene. DNA blot analysis suggests that these enzymes are coded for by single genes, which may be located in close proximity to each other in the DNA, and points to the existence of either a single gene or linked genes coding for all catecholamine enzymes.',\n",
       "  'journal': 'Hypertension (Dallas, Tex. : 1979)',\n",
       "  'authors': 'Joh|T H|TH|;Baetge|E E|EE|;Reis|D J|DJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6149999',\n",
       "  'mesh_terms': 'D000313:Adrenal Medulla; D000818:Animals; D002417:Cattle; D004247:DNA; D004274:DNA, Recombinant; D004299:Dopamine beta-Hydroxylase; D007163:Immunosorbent Techniques; D009693:Nucleic Acid Hybridization; D010625:Phenylethanolamine N-Methyltransferase; D014176:Protein Biosynthesis; D012333:RNA, Messenger; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D004274:DNA, Recombinant; D012333:RNA, Messenger; D004247:DNA; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.hyp.6.5_pt_2.ii1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hypertension',\n",
       "  'nlm_unique_id': '7906255',\n",
       "  'issn_linking': '0194-911X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effect of centrally acting alpha-adrenergic agonists on sympathetic nervous system function in humans.',\n",
       "  'issue': '6(5 Pt 2)',\n",
       "  'pages': 'II57-62',\n",
       "  'abstract': 'Three studies were undertaken to reevaluate whether there is a peripheral component in the reduction of sympathetic activity caused by centrally acting drugs; and whether the antihypertensive effect of these drugs is due entirely to this reduction. Plasma growth hormone and norepinephrine concentrations were used as respective markers of central alpha-adrenoceptor stimulation and peripheral sympathetic activity. In six normal volunteers, intravenous infusion of 0.2 mg clonidine and 2 mg guanfacine was compared. The falls in systolic blood pressure and plasma norepinephrine concentration were slightly greater after clonidine (18 mm Hg and 0.22 ng/ml) than after guanfacine (12 mm Hg and 0.13 ng/ml) administration. These falls occurred earlier than the rise in growth hormone, which rose to a maximum of 23 and 20 IU/ml respectively at 45 minutes after dosing. In six patients with essential hypertension clonidine and alpha-methyldopa caused similar falls in blood pressure and plasma norepinephrine concentration although these changes occurred later with alpha-methyldopa. Plasma growth hormone levels remained undetectable in most patients. In Wistar rats the effect of central and peripheral alpha 2-blockade on clonidine-induced changes was compared. Two groups of six rats received intravenous RX 781094, 0.3 mg/kg, or vehicle 10 minutes before receiving clonidine, 5 micrograms/kg i.v. In the latter, control group, clonidine reduced mean blood pressure by 30.7 +/- 1.9 mm Hg and heart rate by 46 +/- 6.7 beats/min. Plasma norepinephrine fell from 0.22 +/- 0.023 ng/ml to 0.116 +/- 0.013 ng/ml. After pretreatment with RX 781094, blood pressure did not change and heart rate fell by 18 +/- 2.7 beats/min.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Hypertension (Dallas, Tex. : 1979)',\n",
       "  'authors': 'Brown|M J|MJ|;Harland|D|D|;Murphy|M B|MB|;Struthers|A D|AD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150000',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001794:Blood Pressure; D003000:Clonidine; D004146:Dioxanes; D013006:Growth Hormone; D016316:Guanfacine; D006146:Guanidines; D006801:Humans; D006973:Hypertension; D019329:Idazoxan; D008297:Male; D008750:Methyldopa; D009638:Norepinephrine; D010648:Phenylacetates; D051381:Rats; D011919:Rats, Inbred Strains; D013564:Sympathetic Nervous System',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D006146:Guanidines; D010648:Phenylacetates; D016316:Guanfacine; D008750:Methyldopa; D013006:Growth Hormone; D003000:Clonidine; D009638:Norepinephrine; D019329:Idazoxan',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.hyp.6.5_pt_2.ii57',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hypertension',\n",
       "  'nlm_unique_id': '7906255',\n",
       "  'issn_linking': '0194-911X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Withdrawal reactions following cessation of central alpha-adrenergic receptor agonists.',\n",
       "  'issue': '6(5 Pt 2)',\n",
       "  'pages': 'II71-5',\n",
       "  'abstract': 'Interruption of long-term treatment with alpha 2-adrenergic receptor agonists may be associated with reversal of their hemodynamic effects, clinical and biochemical evidence of increased peripheral sympathetic activity, and behavioral responses similar to those seen after narcotic or alcohol withdrawal. Reactions are most commonly observed after short-acting imidazoline drugs such as clonidine and tiamenidine. Reactions are less common after longer acting agents such as guanfacine. A new management approach to withdrawal has been evaluated, which uses a combination of alpha 1-blockade (prazosin) and cardioselective beta-blockade (atenolol) together with a benzodiazepine (chlordiazepoxide). Withdrawal reactions were not observed in eight patients in whom clonidine was withdrawn under cover of these agents. The mechanism of the withdrawal reaction may involve agonist-induced down regulation of alpha 2-adrenergic receptor affinity, number, or both. Experimental studies with the irreversible alpha-antagonist phenoxybenzamine on the turnover of alpha 2-receptors suggest that recovery of receptor number may be much slower in the brain than in the periphery.',\n",
       "  'journal': 'Hypertension (Dallas, Tex. : 1979)',\n",
       "  'authors': 'Reid|J L|JL|;Campbell|B C|BC|;Hamilton|C A|CA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150002',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000368:Aged; D000818:Animals; D000959:Antihypertensive Agents; D001569:Benzodiazepines; D001794:Blood Pressure; D001921:Brain; D002707:Chlordiazepoxide; D003000:Clonidine; D005260:Female; D016316:Guanfacine; D006146:Guanidines; D006339:Heart Rate; D006801:Humans; D006973:Hypertension; D008297:Male; D008750:Methyldopa; D008875:Middle Aged; D010643:Phenoxybenzamine; D010648:Phenylacetates; D011224:Prazosin; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha; D013375:Substance Withdrawal Syndrome; D013876:Thiophenes',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D006146:Guanidines; D010648:Phenylacetates; D011942:Receptors, Adrenergic, alpha; D013876:Thiophenes; D010643:Phenoxybenzamine; D001569:Benzodiazepines; C010354:tiamenidine; D016316:Guanfacine; D008750:Methyldopa; D002707:Chlordiazepoxide; D003000:Clonidine; D011224:Prazosin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.hyp.6.5_pt_2.ii71',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hypertension',\n",
       "  'nlm_unique_id': '7906255',\n",
       "  'issn_linking': '0194-911X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Ultrastructural localization of specific gonococcal macromolecules with antibody-gold sphere immunological probes.',\n",
       "  'issue': '46(2)',\n",
       "  'pages': '361-6',\n",
       "  'abstract': 'In an effort to determine the ultrastructural location of specific macromolecules on the surface of intact microorganisms and in experimentally infected tissues, a new method of rapidly conjugating antibodies to gold spheres via a staphylococcal protein A intermediary has been developed. This new technique provides the excellent density of marking and versatility of sphere size provided by existing gold methods, but decreases preparation time, decreases the chance of bacterial contamination of antibody reagents, and increases specificity of marking. Staphylococcal protein A-coated gold spheres were conjugated with antibodies from rabbits immunized with purified gonococcal pili. The resulting gold-antibody conjugates allowed demonstration of antibody binding to pilus structures of the same gonococcal strain whose pili were used to raise the antibody and demonstration of the lack of antibody recognition of pilus structures on two other gonococcal strains. The failure of gold spheres to attach to isogenic nonpiliated clones of the homologous gonococcus indicated the absence of pilus antigens on the surface of these organisms. The use of a double label--small gold spheres conjugated to anti-pilus antibody and larger gold spheres conjugated to anti-protein I antibody--allowed the simultaneous localization of two gonococcal antigens.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Robinson|E N|EN|;McGee|Z A|ZA|;Kaplan|J|J|;Hammond|M E|ME|;Larson|J K|JK|;Buchanan|T M|TM|;Schoolnik|G K|GK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150005',\n",
       "  'mesh_terms': 'D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D010861:Fimbriae, Bacterial; D006046:Gold; D008854:Microscopy, Electron; D009344:Neisseria gonorrhoeae; D013205:Staphylococcal Protein A',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D013205:Staphylococcal Protein A; D006046:Gold',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.2.361-366.1984',\n",
       "  'references': '4110101;820643;323352;30693;366014;224008;42969;392723;6999596;7430615;6166621;7026575;6976394;7034182;7086887;6807844;7051784;7129958;6752106;6828470;6187017;6187796;6189888;6143785',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Brain stem catecholamine mechanisms in tonic and reflex control of blood pressure.',\n",
       "  'issue': '6(5 Pt 2)',\n",
       "  'pages': 'II7-15',\n",
       "  'abstract': 'Neurons of the lower brain stem maintain resting levels of arterial pressure (AP), mediate reflex responses from cardiopulmonary receptors, and are an important site of the hypotensive actions of alpha 2-adrenergic agonists. Details of the pathways and transmitters that mediate tonic and reflex control of AP are emerging. Afferent fibers of cardiopulmonary receptors in the ninth and tenth nerves terminate bilaterally in the nucleus of the tractus solitarius (NTS). Although some neurons contain substance P, the primary neurotransmitter appears to be the excitatory amino acid L-glutamate (L-glu). Neurons in rostral ventrolateral medulla, which most probably comprise the C1 group of epinephrine neurons, are also critical in AP control. C1 neurons project to innervate cholinergic preganglionic sympathetic neurons in the spinal cord. Stimulation of the C1 area electrically or with L-glu increases AP, while lesions or local injection of the inhibitory amino acid gamma-aminobutyric acid (GABA) lowers AP to levels comparable to spinal cord transection. Lesions of C1 neurons or their pathways abolish vasodepressor reflexes from baroreceptors and vagal afferents. In contrast, noradrenergic neurons of the caudal ventrolateral medulla, the A1 group, project rostrally to innervate, in part, vasopressin neurons of the hypothalamus. Stimulation of A1 neurons lowers AP, while lesions or GABA elevates it. We propose that C1 neurons comprise the so-called tonic vasomotor center of the brain stem and also mediate, via a projection from the NTS, the vasodepressor limb of baroreflexes. The NTS-C1 projection may be GABAergic.',\n",
       "  'journal': 'Hypertension (Dallas, Tex. : 1979)',\n",
       "  'authors': 'Reis|D J|DJ|;Granata|A R|AR|;Joh|T H|TH|;Ross|C A|CA|;Ruggiero|D A|DA|;Park|D H|DH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150001',\n",
       "  'mesh_terms': 'D000818:Animals; D001794:Blood Pressure; D001933:Brain Stem; D002320:Cardiovascular Physiological Phenomena; D002319:Cardiovascular System; D002395:Catecholamines; D004299:Dopamine beta-Hydroxylase; D004558:Electric Stimulation; D006339:Heart Rate; D007608:Kainic Acid; D008526:Medulla Oblongata; D009434:Neural Pathways; D009474:Neurons; D010625:Phenylethanolamine N-Methyltransferase; D011311:Pressoreceptors; D013116:Spinal Cord; D014446:Tyrosine 3-Monooxygenase; D014630:Vagus Nerve; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D002395:Catecholamines; D005680:gamma-Aminobutyric Acid; D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase; D007608:Kainic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.hyp.6.5_pt_2.ii7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hypertension',\n",
       "  'nlm_unique_id': '7906255',\n",
       "  'issn_linking': '0194-911X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Fimbria-like hemagglutinin of Escherichia coli O75 strains.',\n",
       "  'issue': '46(2)',\n",
       "  'pages': '401-7',\n",
       "  'abstract': 'Fifteen strains of Escherichia coli O75 from human feces and patients with urinary tract infections were analyzed for their hemagglutinative properties, production of hemolysin and colicin, and plasmid contents. Fourteen strains produced type-1 fimbriae in broth culture. Nine of the strains agglutinated human P1 and p erythrocytes, i.e., possessed an X adhesin (X hemagglutinin). All but one of the X+ strains agglutinated human but not sheep or rabbit erythrocytes. Of the 15 strains, 4 had P fimbriae; one strain had both X hemagglutinin and P fimbriae. A coli-like structure was found by electron microscopy on the surface of the X+ strains. This structure was purified from two strains and characterized chemically and serologically. It was a protein consisting of subunits with an apparent molecular weight of 16,000. The amounts of hydrophobic amino acids in proteins purified from strains IH11033 and IH11128 were 35 and 39%, respectively. The amino acid content of the proteins was quite similar; only glutamine-glutamate and tyrosine contents were different. The radiolabeled protein bound to human erythrocytes, but it differed morphologically from typical E. coli fimbriae. Several methods showed the hemagglutinin, termed O75-X, to be serologically related in all the O75 X+ strains. The eight X+ O75:K5:H- strains had type-1 fimbriae and an identical outer membrane protein pattern, lacked P fimbriae and hemolytic activity, and are proposed to represent a clonal group.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Väisänen-Rhen|V|V|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150006',\n",
       "  'mesh_terms': 'D000268:Adhesiveness; D000596:Amino Acids; D003087:Colicins; D004926:Escherichia coli; D005243:Feces; D010861:Fimbriae, Bacterial; D006388:Hemagglutinins; D006460:Hemolysin Proteins; D006801:Humans; D008970:Molecular Weight; D010957:Plasmids; D014552:Urinary Tract Infections',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000596:Amino Acids; D003087:Colicins; D006388:Hemagglutinins; D006460:Hemolysin Proteins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.2.401-407.1984',\n",
       "  'references': '4956166;5432063;4929799;5014925;637870;346488;98070;215191;6103871;6103872;6771248;7425302;6111559;6269464;7026236;6125477;6126799;6218094;6140222;6372323;14434282',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Hemodynamic and cardiac effects of centrally acting antihypertensive drugs.',\n",
       "  'issue': '6(5 Pt 2)',\n",
       "  'pages': 'II76-81',\n",
       "  'abstract': 'The centrally acting alpha-adrenergic receptor agonist compounds have been available for treatment of hypertension for more than 25 years. Through studies of these compounds during this time, new knowledge has been made available not only on their mechanisms of antihypertensive action but also on the role of the adrenergic nervous system in essential hypertension. This discussion primarily reviews work from this laboratory on the cardiovascular actions of these compounds but reflects the general information from other quarters. In general, reduction of arterial pressure induced by these agents is associated with a cardiac output that remains relatively unchanged and with organ blood flows that are preserved. As a result of the reduced pressure, cardiac function is improved; and in recent studies, cardiac mass may be reduced. Associated with the reduced arterial pressure is an expanded plasma volume that is associated with a reduced blood viscosity, hematocrit, and plasma renin activity, but which may be at the expense of some return of arterial pressure toward pretreatment levels. The latter usually requires the addition of diuretic therapy. Current studies in our laboratory concern the performance of the heart following regression of ventricular hypertrophy both at reduced as well as increased ventricular afterloads.',\n",
       "  'journal': 'Hypertension (Dallas, Tex. : 1979)',\n",
       "  'authors': 'Frohlich|E D|ED|;Messerli|F H|FH|;Pegram|B L|BL|;Kardon|M B|MB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150003',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000368:Aged; D000375:Aging; D000818:Animals; D001794:Blood Pressure; D001809:Blood Viscosity; D002302:Cardiac Output; D002320:Cardiovascular Physiological Phenomena; D003000:Clonidine; D006321:Heart; D006339:Heart Rate; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension; D008750:Methyldopa; D008875:Middle Aged; D009929:Organ Size; D010953:Plasma Volume; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D012018:Reflex',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D008750:Methyldopa; D003000:Clonidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.hyp.6.5_pt_2.ii76',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hypertension',\n",
       "  'nlm_unique_id': '7906255',\n",
       "  'issn_linking': '0194-911X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Exclusive presence of lactose-sensitive fimbriae on a typical strain (WVU45) of Actinomyces naeslundii.',\n",
       "  'issue': '46(2)',\n",
       "  'pages': '453-8',\n",
       "  'abstract': 'Lactose-sensitive fimbriae were identified as the only fimbriae present on Actinomyces naeslundii WVU45 (ATCC 12104). A single antigen reactive with antiserum against WVU45 cells was detected by cross immunoelectrophoresis of isolated fimbriae, and a monospecific antiserum against this antigen reacted with all fimbriae observed on the bacterial surface by immunoelectron microscopy. Moreover, the loss of one cell surface antigen by a spontaneous mutant of A. naeslundii WVU45 (WVU45M), isolated by its failure to react with a monospecific antibody against the fimbriae, was associated with the loss of all fimbriae. The functional involvement of the fimbriae in lactose-sensitive bacterial adherence was demonstrated by the ability of WVU45, but not WVU45M, cells to agglutinate neuraminidase-treated erythrocytes and by the lactose-sensitive hemagglutinating activity of immune complexes formed with isolated fimbriae and monospecific antibody. Bacterial agglutination assays with different monospecific antibodies revealed an antigenic similarity between the fimbriae of A. naeslundii WVU45 and the lactose-sensitive fimbriae (type 2) of Actinomyces viscosus T14V. In contrast, cross-reactivity was not observed between the WVU45 fimbriae and type 1 fimbriae, the structures involved in lactose-resistant adherence of strain T14V to saliva-treated hydroxyapatite. Functional differences between the fimbriae of A. naeslundii and A. viscosus strains may be correlated with well-established differences in the in vivo distribution of these organisms: namely, the preference of typical A. naeslundii for epithelial surfaces and of A. viscosus for tooth surfaces.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Cisar|J O|JO|;David|V A|VA|;Curl|S H|SH|;Vatter|A E|AE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150007',\n",
       "  'mesh_terms': 'D000190:Actinomyces; D000942:Antigens, Bacterial; D010861:Fimbriae, Bacterial; D007785:Lactose',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000942:Antigens, Bacterial; D007785:Lactose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.2.453-458.1984',\n",
       "  'references': '659366;30701;282008;730385;468376;90074;6769798;7399676;7000708;7216448;7275934;6115881;6169645;7076303;6124506;6185429;6188696;6132880;6874075;6578231;6141143;6150008;14907713;13986422;5432796;4132890;977124;137307;138733;624593',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'In summary: satellite symposium on central alpha-adrenergic blood pressure regulating mechanisms.',\n",
       "  'issue': '6(5 Pt 2)',\n",
       "  'pages': 'II87-93',\n",
       "  'abstract': 'This symposium reviewed the fundamental principles, pharmacology, and clinical pharmacology of central alpha-adrenergic blood pressure regulating mechanisms. Fundamental principles Arterial baro- and chemoreceptor signals reach the nucleus of the tractus solitarius (NTS) via vagal and glossopharyngeal afferents. The NTS communicates with sympathetic preganglionic neurons in the spinal cord via centers and tracts in the medulla, pons, and hypothalamus that include an alpha-adrenergic inhibitory network. Descending tracts emphasized in this symposium originate in the C-1 epinephrine cells of the medulla, B-1 and B-3 serotonin cells of the medulla, and A-5 norepinephrine cells of the pons. Transmitters involved are norepinephrine, epinephrine, serotonin, glutamate, and gamma-aminobutyric acid (GABA). Catecholamine enzymes share protein domains in their primary structures and may be coded by linked or single genes. New methods of purifying and locating alpha- and beta-receptors have been developed. Pharmacology Methyldopa, clonidine, and clonidine-like drugs lower blood pressure by stimulating postsynaptic alpha 2-receptors in a brain stem inhibitory network, which down-regulates these receptors. Alpha 1-receptors were found to be higher in normotensive than in hypertensive rats and were increased in the latter by methyldopa administration. Alpha 2-receptors were found to differ in various tissues, which permits the development of highly selective agonists and antagonists. Although alpha-methylnorepinephrine is probably the principal metabolite of methyldopa, alpha-methylepinephrine and alpha-methyldopamine may also contribute. The site of action usually is identified as the NTS. Possible roles for the descending tracts were suggested. Clinical pharmacology Methyldopa, clonidine, guanfacine, and related drugs lower blood pressure principally by CNS mechanisms but peripheral actions may also contribute.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Hypertension (Dallas, Tex. : 1979)',\n",
       "  'authors': 'Abrams|W B|WB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150004',\n",
       "  'mesh_terms': 'D000344:Afferent Pathways; D000818:Animals; D000959:Antihypertensive Agents; D001794:Blood Pressure; D001921:Brain; D003000:Clonidine; D004837:Epinephrine; D005930:Glossopharyngeal Nerve; D005971:Glutamates; D018698:Glutamic Acid; D016316:Guanfacine; D006146:Guanidines; D006801:Humans; D007031:Hypothalamus; D008526:Medulla Oblongata; D008750:Methyldopa; D009638:Norepinephrine; D010648:Phenylacetates; D011149:Pons; D011311:Pressoreceptors; D011942:Receptors, Adrenergic, alpha; D012701:Serotonin; D013116:Spinal Cord; D013375:Substance Withdrawal Syndrome; D014630:Vagus Nerve; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000959:Antihypertensive Agents; D005971:Glutamates; D006146:Guanidines; D010648:Phenylacetates; D011942:Receptors, Adrenergic, alpha; D016316:Guanfacine; D012701:Serotonin; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D008750:Methyldopa; D003000:Clonidine; D009638:Norepinephrine; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1161/01.hyp.6.5_pt_2.ii87',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hypertension',\n",
       "  'nlm_unique_id': '7906255',\n",
       "  'issn_linking': '0194-911X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Lectin-dependent attachment of Actinomyces naeslundii to receptors on epithelial cells.',\n",
       "  'issue': '46(2)',\n",
       "  'pages': '459-64',\n",
       "  'abstract': 'The adherence of Actinomyces naeslundii WVU45 to monolayer cultures of human epithelial cell lines was mediated by the lactose-sensitive fimbriae (type 2) of strain WVU45. The attachment of Actinomyces viscosus T14V, which has both types 1 and 2 fimbriae, was approximately half that of A. naeslundii, and only minimal attachment of A. naeslundii and A. viscosus mutants lacking type 2 fimbriae was detected. The adherence of strain WVU45 was enhanced two- to threefold by neuraminidase treatment of the epithelial cells. The Fab fragments of antibodies which recognize the type 2 fimbriae inhibited the adherence of A. naeslundii WVU45 to the epithelial cells. The bacterial interaction with epithelial cells was inhibited by lactose, methyl-beta-D-galactoside, and N-acetyl-D-galactosamine, but not by methyl-alpha-D-galactoside, cellobiose, N-acetyl-D-glucosamine, L-fucose, or D-mannose. To further characterize the epithelial cell receptors for the bacterial lectin, we utilized several plant and invertebrate lectins as potential inhibitors of bacterial adherence. Lectins from Bauhinia purpurea and Arachis hypogaea which recognize N-acetyl-D-galactosamine, D-galactose, and D-galactose-beta-(1----3)-N-acetyl-D-galactosamine inhibited bacterial attachment, and binding of these lectins to epithelial cells was enhanced by the addition of neuraminidase. Lectins reacting with alpha-linked D-galactose, alpha-linked N-acetyl-D-galactosamine, D-mannose, or sialic acid were not inhibitory. Under similar assay conditions, adherence of a mannose-sensitive strain of Escherichia coli was inhibited by concanavalin A but not by the lectin from Bauhinia purpurea. These results indicate that certain plant lectins have specificities similar to that of the actinomyces fimbrial lectin and are, therefore, useful probes for identifying receptors on epithelial cells for certain bacteria.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Brennan|M J|MJ|;Cisar|J O|JO|;Vatter|A E|AE|;Sandberg|A L|AL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150008',\n",
       "  'mesh_terms': 'D000190:Actinomyces; D000268:Adhesiveness; D002240:Carbohydrate Sequence; D002478:Cells, Cultured; D004848:Epithelium; D010861:Fimbriae, Bacterial; D006801:Humans; D008871:Microvilli; D011975:Receptors, Mitogen',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D011975:Receptors, Mitogen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.2.459-464.1984',\n",
       "  'references': '811657;977124;1033785;323718;624593;659366;427833;571437;468376;232691;6769798;7399676;7000708;7447466;6115881;6124506;6287920;7138029;6132880;6578231;6141143;6150007;13986422',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Loss of pili and decreased attachment to human cells by Neisseria meningitidis and Neisseria gonorrhoeae exposed to subinhibitory concentrations of antibiotics.',\n",
       "  'issue': '46(2)',\n",
       "  'pages': '507-13',\n",
       "  'abstract': 'Recent evidence has suggested that surface structures of pathogenic bacteria, which are important in attachment to human mucosal surfaces, may be absent on bacteria grown in the presence of subinhibitory concentrations of antibiotics. We studied the effect of tetracycline and penicillin on meningococcal and gonococcal pili. Subinhibitory concentrations of tetracycline and penicillin were found to markedly reduce the number of pili per meningococcus or gonococcus and the percentage of meningococci or gonococci with pili, as determined by negative-staining electron microscopy. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of outer membrane preparations suggested that tetracycline decreased expression of pili by inhibiting synthesis of pilin subunits. In contrast, pilin subunit synthesis was unaltered by penicillin, suggesting a defect in assembly of pilin subunits or in anchoring of assembled pili. The decrease in the number of pili that occurred with subinhibitory concentrations of both tetracycline and penicillin was accompanied by a marked decrease in the ability of the organisms to attach to human cells. Gonococci or meningococci removed from the influence of subinhibitory concentrations of the antibiotics regained piliation, and attachment returned to levels near those of controls. The expression of meningococcal and gonococcal pili may be affected by factors that influence synthesis of pilin subunits or factors that interfere with the assembly and anchoring of pili in the outer membrane.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Stephens|D S|DS|;Krebs|J W|JW|;McGee|Z A|ZA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150009',\n",
       "  'mesh_terms': 'D000268:Adhesiveness; D001426:Bacterial Proteins; D004305:Dose-Response Relationship, Drug; D004848:Epithelium; D010861:Fimbriae, Bacterial; D006801:Humans; D009343:Neisseria; D009344:Neisseria gonorrhoeae; D009345:Neisseria meningitidis; D010406:Penicillins; D013752:Tetracycline',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001426:Bacterial Proteins; D010406:Penicillins; D013752:Tetracycline',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.2.507-513.1984',\n",
       "  'references': '4979098;4923921;4586413;4611195;803544;169728;942051;138485;14116;403140;376560;110692;6965441;6102108;6103875;6783539;6111540;7014632;6785363;6113259;6175245;6127165;6183218;6402552;6187017;6133608;6413594;6140896;15828194',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Solubilization and partial characterization of the intestinal receptor for Escherichia coli heat-stable enterotoxin.',\n",
       "  'issue': '46(2)',\n",
       "  'pages': '537-43',\n",
       "  'abstract': 'Binding of Escherichia coli strain 431 heat-stable enterotoxin (STa) and activation of intestinal particulate guanylate cyclase by E. coli STa were studied with rat intestinal epithelial cells and brush border membranes (BBMs). The rates of guanylate cyclase stimulation by 431 STa in cells and BBMs were rapid, with maximal levels of cyclic GMP observed within 5 min. Specific binding of 125I-labeled STa from E. coli 431 (431 125I-STa) and activation of guanylate cyclase by unlabeled 431 STa were observed with intestinal BBMs; however, neither was detected with membranes from nonintestinal tissues. The STa receptor was solubilized with 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, a nondenaturing dipolar ionic detergent, in yields of approximately 50%. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of the detergent-solubilized receptor-431 125I-STa complex, followed by autoradiography, showed that 431 125I-STa bound to a single BBM component with a molecular weight of about 100,000. Binding of 431 STa to its solubilized receptor was saturable, specific, and essentially irreversible. Pretreatment of the soluble receptor with trypsin and pronase but not chymotrypsin decreased binding of 431 125I-STa. The 431 STa-receptor complex was dissociated by boiling in the presence of 1% sodium dodecyl sulfate, incubation with 0.5 M acetic acid, or reduction with dithiothreitol. In contrast to the residual particulate guanylate cyclase activity of detergent-treated membranes, solubilized guanylate cyclase was not stimulated by STa. Membrane structure appears to play an important role in the coordination of STa binding and stimulation of guanylate cyclase activity.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Dreyfus|L A|LA|;Robertson|D C|DC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150010',\n",
       "  'mesh_terms': 'D000818:Animals; D001427:Bacterial Toxins; D004220:Disulfides; D004768:Enterotoxins; D004789:Enzyme Activation; D004926:Escherichia coli; D029968:Escherichia coli Proteins; D006162:Guanylate Cyclase; D007413:Intestinal Mucosa; D008970:Molecular Weight; D051381:Rats; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D011971:Receptors, Immunologic; D018000:Receptors, Peptide; D012995:Solubility',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001427:Bacterial Toxins; D004220:Disulfides; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D011971:Receptors, Immunologic; D018000:Receptors, Peptide; C034151:heat stable toxin (E coli); D006162:Guanylate Cyclase; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.2.537-543.1984',\n",
       "  'references': '5432063;4334491;4698230;4737496;4153733;237786;237789;1101807;177461;791862;332292;203862;346481;26412;26915;31794;215544;83301;33065;222120;6988518;6989817;6104864;6105969;6106030;6106508;6254034;6776986;6109723;7014566;6114709;6167519;6116386;7026442;6271254;6273167;6273411;6955781;6214556;6134677;6134728;6136535;6358024;6196292;6537947;6143730;14907713;14023808',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Isolation and structural characterization of the equine erythrocyte receptor for enterotoxigenic Escherichia coli K99 fimbrial adhesin.',\n",
       "  'issue': '46(2)',\n",
       "  'pages': '578-84',\n",
       "  'abstract': 'The erythrocyte receptor for Escherichia coli K99 fimbrial adhesin was isolated from equine erythrocytes and characterized as Neu5Gc-alpha(2----3)-Galp-beta(1----4)-GLcp-beta(1----1)-Ceramide. This glycolipid acted as the receptor for K99 by four different experimental approaches: inhibition of equine erythrocyte hemagglutination by preincubation of K99-positive bacteria or purified K99 fimbriae with the isolated glycolipid; inhibition of attachment of K99-positive bacteria to porcine intestinal epithelial cells in the presence of the isolated glycolipid; induction of binding of K99-positive bacteria or purified K99 fimbriae to normally unreactive guinea pig erythrocytes by coating these cells with the isolated glycolipid; and isolation of the receptor by affinity chromatography with K99 coupled to CNBr-activated Sepharose 4B, indicating a strong interaction between K99 and the isolated glycolipid.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Smit|H|H|;Gaastra|W|W|;Kamerling|J P|JP|;Vliegenthart|J F|JF|;de Graaf|F K|FK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150011',\n",
       "  'mesh_terms': 'D018830:Adhesins, Escherichia coli; D000268:Adhesiveness; D000818:Animals; D001426:Bacterial Proteins; D002240:Carbohydrate Sequence; D004910:Erythrocyte Membrane; D004926:Escherichia coli; D010861:Fimbriae, Bacterial; D006017:Glycolipids; D006162:Guanylate Cyclase; D006168:Guinea Pigs; D006384:Hemagglutination; D006736:Horses; D007413:Intestinal Mucosa; D009682:Magnetic Resonance Spectroscopy; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled; D011971:Receptors, Immunologic; D018000:Receptors, Peptide',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018830:Adhesins, Escherichia coli; D001426:Bacterial Proteins; D006017:Glycolipids; D011971:Receptors, Immunologic; D018000:Receptors, Peptide; D006162:Guanylate Cyclase; D000074261:Receptors, Enterotoxin; D050705:Receptors, Guanylate Cyclase-Coupled',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.2.578-584.1984',\n",
       "  'references': '4356060;4433715;1100837;1218089;773832;893369;22493;6103878;6159326;7459337;7026448;7053380;7037645;6801030;7083254;6123486;6125146;6126799;6822513;6340671;6307345;14135466',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Characterization of Haemophilus influenzae type b fimbriae.',\n",
       "  'issue': '46(3)',\n",
       "  'pages': '787-96',\n",
       "  'abstract': 'We confirmed that the fimbriae of Haemophilus influenzae type b conferred hemagglutinating activity (HA) towards human erythrocytes, and erythrocytes of certain other species. Most (17/25) cerebrospinal fluid isolates lacked detectable HA on direct testing, but selective enrichment for fimbriation (f+) indicated that 22 of 25 strains could produce these surface structures. HA was unchanged from pH 4.5 to 9.5 and was not inhibited by mannose or certain other simple sugars. The HA titer of a suspension of three f+ strains was slightly decreased at 50 degrees C; HA was lost by heating at 60 degrees C for 3 min. Growth on a variety of solid and liquid media and under differing degrees of oxygenation did not change the HA titer of a suspension of three f+ strains. Fimbriation was not lost on repeated subculture. Wild-type fimbriated strains, and those derived by transformation, did not contain detectable plasmid DNA. Transformation of a strain lacking fimbriae to f+ was associated with the appearance of an outer membrane protein of 24 kilodaltons. This protein was purified from one strain to homogeneity on sodium dodecyl sulfate-polyacrylamide gel electrophoresis by selective detergent solubilization and ammonium sulfate fractionation. Colonization capacity was equivalent with an isogenic untypable strain lacking or possessing fimbriae. Fimbriae of type b H. influenzae possess characteristics similar to those structures on other gram-negative bacteria; their role in cell physiology or pathogenesis of invasive disease is unknown.',\n",
       "  'journal': 'Infection and immunity',\n",
       "  'authors': 'Stull|T L|TL|;Mendelman|P M|PM|;Haas|J E|JE|;Schoenborn|M A|MA|;Mack|K D|KD|;Smith|A L|AL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150012',\n",
       "  'mesh_terms': 'D000268:Adhesiveness; D001425:Bacterial Outer Membrane Proteins; D003470:Culture Media; D004910:Erythrocyte Membrane; D010861:Fimbriae, Bacterial; D006192:Haemophilus Infections; D006193:Haemophilus influenzae; D006388:Hemagglutinins; D006801:Humans; D008854:Microscopy, Electron',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001425:Bacterial Outer Membrane Proteins; D003470:Culture Media; D006388:Hemagglutinins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/iai.46.3.787-796.1984',\n",
       "  'references': '5334095;5432063;4402481;4197389;4198720;4542033;4200266;809353;772168;821935;1085778;603028;348723;96134;110692;6103871;6106042;6109710;6116723;6976326;6977529;6286603;6286714;6126509;6127165;6127463;6128303;6138383;6138390;6139338',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Infect Immun',\n",
       "  'nlm_unique_id': '0246127',\n",
       "  'issn_linking': '0019-9567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Reversal of histamine-mediated immunosuppression by structurally diverse histamine type II (H2) receptor antagonists.',\n",
       "  'issue': '6(5)',\n",
       "  'pages': '467-73',\n",
       "  'abstract': 'The effect of a series of structurally-diverse histamine type II (H2)-receptor antagonists on histamine-mediated immunosuppression of human peripheral blood lymphocytes (HPBL) has been examined. This analysis of structure--activity relationships was undertaken to examine the validity of the recent proposal arising from clinical studies that H2-receptor antagonists containing a furan ring were devoid of the effects on lymphocyte function reported previously in studies using cimetidine and other H2-receptor antagonists containing an imidazole nucleus. Cimetidine and two furan-containing antagonists, ranitidine and SKF 93479, were found to be devoid of any effect on PHA-induced proliferation of human peripheral blood lymphocytes over a wide concentration range (10(-4) to 10(-10)M). At high drug concentrations (10(-3)M) significant suppression of mitogen stimulation was observed but this was accompanied by significant cytotoxicity. All three antagonists were effective in reversing the suppression of PHA-stimulation of HPBL induced by exogenous histamine. Reversal of histamine-induced immunosuppression was obtained at drug concentrations (2.0 X 10(-4) to 1.0 X 10(-6)M) which were non-toxic and did not affect PHA-induced proliferation in the absence of histamine. Ranitidine was the most potent antagonist in reversing histamine-mediated immunosuppression. The ability of structurally-diverse H2-receptor antagonists to modify the action of histamine on lymphocyte function lends support to the view that histamine exerts its effects via classical H2-receptors. The ability of ranitidine to alter lymphocyte responsiveness in analogous fashion to cimetidine indicates that the possibility of alterations in immune function should be considered in clinical studies using ranitidine and other furan-containing H2-receptor antagonists.',\n",
       "  'journal': 'International journal of immunopharmacology',\n",
       "  'authors': 'Badger|A M|AM|;Young|J|J|;Poste|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150013',\n",
       "  'mesh_terms': 'D000818:Animals; D002478:Cells, Cultured; D055598:Chemical Phenomena; D002621:Chemistry; D002927:Cimetidine; D006632:Histamine; D006635:Histamine H2 Antagonists; D007108:Immune Tolerance; D008214:Lymphocytes; D008934:Mitogens; D009000:Monocytes; D011744:Pyrimidinones; D011899:Ranitidine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006635:Histamine H2 Antagonists; D008934:Mitogens; D011744:Pyrimidinones; C033275:SK&F 93479; D002927:Cimetidine; D006632:Histamine; D011899:Ranitidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0192-0561(84)90085-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Int J Immunopharmacol',\n",
       "  'nlm_unique_id': '7904799',\n",
       "  'issn_linking': '0192-0561',\n",
       "  'country': 'England'},\n",
       " {'title': 'Exercise-induced urinary abnormalities in long-distance runners.',\n",
       "  'issue': '5(5)',\n",
       "  'pages': '237-40',\n",
       "  'abstract': 'The post-exercise urine samples from 122 long-distance runners showed evident abnormalities upon microscopic examination in 95% of all subjects. Proteinuria, alone or with microscopic hematuria, was frequently found. Macroscopic hematuria was a rare occurrence. The urine samples collected in 30 runners before, immediately after the race, and 6, 12, 24, 36, and 48 h later showed a significant post-race decrease in the osmolarity and a significant increase in gamma-glutamyl transferase and N-acetyl-beta-glucosaminidase enzyme activity. Plasma renin activity and plasma aldosterone, determined before and after the race in nine runners, showed a significant increase in the post-race samples. The abnormal urinary findings disappeared in all cases within 24-36 h. It can be concluded that urinary abnormalities are very common after exercise. These abnormalities are most often of a \"renal\" origin, probably due to a temporary hemodynamic impairment, partially of glomerular but principally of tubular function.',\n",
       "  'journal': 'International journal of sports medicine',\n",
       "  'authors': 'Gilli|P|P|;De Paoli Vitali|E|E|;Tataranni|G|G|;Farinelli|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150014',\n",
       "  'mesh_terms': 'D000118:Acetylglucosaminidase; D000293:Adolescent; D000328:Adult; D000450:Aldosterone; D004573:Electrolytes; D005260:Female; D006029:Glycosuria; D006417:Hematuria; D006801:Humans; D008875:Middle Aged; D010807:Physical Endurance; D011507:Proteinuria; D012083:Renin; D012420:Running; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004573:Electrolytes; D000450:Aldosterone; D005723:gamma-Glutamyltransferase; D000118:Acetylglucosaminidase; D012083:Renin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1055/s-2008-1025912',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Int J Sports Med',\n",
       "  'nlm_unique_id': '8008349',\n",
       "  'issn_linking': '0172-4622',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Supramolecular cytology of coated vesicles.',\n",
       "  'issue': '91()',\n",
       "  'pages': '1-43',\n",
       "  'abstract': '',\n",
       "  'journal': 'International review of cytology',\n",
       "  'authors': 'Fine|R E|RE|;Ockleford|C D|CD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150015',\n",
       "  'mesh_terms': 'D000818:Animals; D005075:Biological Evolution; D001693:Biological Transport, Active; D002458:Cell Fractionation; D002966:Clathrin; D003034:Coated Pits, Cell-Membrane; D004705:Endocytosis; D011992:Endosomes; D008247:Lysosomes; D008565:Membrane Proteins; D010587:Phagocytosis',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D002966:Clathrin; D008565:Membrane Proteins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0074-7696(08)61313-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Int Rev Cytol',\n",
       "  'nlm_unique_id': '2985180R',\n",
       "  'issn_linking': '0074-7696',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Pathology of polyneuropathies].',\n",
       "  'issue': '25(10)',\n",
       "  'pages': '589-98',\n",
       "  'abstract': '',\n",
       "  'journal': 'Der Internist',\n",
       "  'authors': 'Schröder|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150016',\n",
       "  'mesh_terms': 'D001369:Axons; D001706:Biopsy; D003711:Demyelinating Diseases; D006652:Histological Techniques; D006801:Humans; D009186:Myelin Sheath; D010525:Peripheral Nerves; D010488:Polyarteritis Nodosa; D011115:Polyneuropathies; D011843:Radiculopathy',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Internist (Berl)',\n",
       "  'nlm_unique_id': '0264620',\n",
       "  'issn_linking': '0020-9554',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Surgery performed by inexperienced physicians].',\n",
       "  'issue': '32(9)',\n",
       "  'pages': '400',\n",
       "  'abstract': '',\n",
       "  'journal': 'HNO',\n",
       "  'authors': 'Müller|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150017',\n",
       "  'mesh_terms': 'D005860:Germany, West; D006801:Humans; D008197:Lymph Node Excision; D008318:Malpractice; D059348:Peripheral Nerve Injuries; D010823:Physician Assistants',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'HNO',\n",
       "  'nlm_unique_id': '2985099R',\n",
       "  'issn_linking': '0017-6192',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Physician attitudes toward early cancer detection.',\n",
       "  'issue': '166(4)',\n",
       "  'pages': '285-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'IMJ. Illinois medical journal',\n",
       "  'authors': 'Havlicek|P L|PL|;Warnecke|R B|RB|;Manfredi|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150018',\n",
       "  'mesh_terms': 'D001291:Attitude of Health Personnel; D006801:Humans; D009369:Neoplasms; D010820:Physicians; D011364:Professional Practice; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'IMJ Ill Med J',\n",
       "  'nlm_unique_id': '7703940',\n",
       "  'issn_linking': '',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Perspectives in carotid body research.',\n",
       "  'issue': '57(4)',\n",
       "  'pages': '931-57',\n",
       "  'abstract': 'This review deals with some basic mechanisms that are operative in carotid body chemoreception. It describes the evolution of concepts and different hypotheses or theories developed to explain possible mechanisms responsible for the onset of sensory discharges in the carotid nerve. Unfortunately, no single hypothesis has been proved beyond doubt, and this may explain their variety. At present, we do not know why this task has been so difficult, although one may think of several possibilities. 1) Carotid body chemoreceptors are anatomically complex being formed by glomus (type I) and sustentacular (type II) cells. Branches of the carotid (sinus) nerve innervate the glomus cells forming sensory synapses oriented in either or both directions and the junction is enveloped by processes of the sustentacular cells. 2) Chemoreceptors are polymodal, since they respond to a variety of natural and chemical stimuli. 3) It is possible that various stimuli may act on different elements of the receptor complex. 4) It is also possible that stimuli may act using different mechanisms. In addition, the multitude of biochemical and biophysical processes (some of them still unknown) operating at different receptor levels has made it very difficult to propose a unified mechanism of action.',\n",
       "  'journal': 'Journal of applied physiology: respiratory, environmental and exercise physiology',\n",
       "  'authors': 'Eyzaguirre|C|C|;Zapata|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150019',\n",
       "  'mesh_terms': 'D000136:Acid-Base Equilibrium; D000818:Animals; D002245:Carbon Dioxide; D002344:Carotid Body; D002346:Carotid Sinus; D002628:Chemoreceptor Cells; D004525:Efferent Pathways; D005728:Ganglia, Sympathetic; D005930:Glossopharyngeal Nerve; D006801:Humans; D009433:Neural Inhibition; D018377:Neurotransmitter Agents; D010100:Oxygen; D012119:Respiration; D009435:Synaptic Transmission; D009626:Terminology as Topic; D014630:Vagus Nerve',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.; D016454:Review\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D002245:Carbon Dioxide; D010100:Oxygen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/jappl.1984.57.4.931',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Appl Physiol Respir Environ Exerc Physiol',\n",
       "  'nlm_unique_id': '7801242',\n",
       "  'issn_linking': '0161-7567',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Transganglionic transport of D-aspartate from cochlear nucleus to cochlea--a quantitative autoradiographic study.',\n",
       "  'issue': '15(3)',\n",
       "  'pages': '197-213',\n",
       "  'abstract': 'This study concerns the connections of the inner and outer hair cells and the different types of ganglion cells of the mammalian cochlea with the central nervous system by making use of their putative neurotransmitters. D-[3H]Aspartate (D-ASP), a putative marker for glutamatergic neurons, was injected into the cochlear nucleus of cats and guinea pigs and the cochleas prepared for light microscopic autoradiography after varying survival times. A quantitative, statistical autoradiographic method is described. Grain counts per unit area were made for each of 14 tissue compartments in the cochlea and normalized to permit comparisons between cases. An operationally defined background labeling level was computed for each case and a statistical test for significance applied to the neuron-containing tissue compartments. With increasing survival times, significant labeling appeared successively in the cochlear nerve root, in each type of spiral ganglion cell, and in the neuron-containing tissue compartments of the organ of Corti. The findings are consistent with uptake of D-ASP and retrograde transport by cochlear nerve axons from the cochlear nucleus to the perikarya and peripheral processes of the spiral ganglion. We conclude that axons of all spiral ganglion cells project to the cochlear nucleus and that this nucleus is directly connected with both the inner and outer hair cells. Transganglionic transport of D-ASP from the cochlear nucleus is consistent with the hypothesis that the cochlear nerve axons use glutamate or aspartate as a neurotransmitter.',\n",
       "  'journal': 'Hearing research',\n",
       "  'authors': 'Jones|D R|DR|;Morest|D K|DK|;Oliver|D L|DL|;Potashner|S J|SJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150020',\n",
       "  'mesh_terms': 'D000818:Animals; D001224:Aspartic Acid; D001345:Autoradiography; D001369:Axons; D001692:Biological Transport; D002415:Cats; D003051:Cochlea; D003712:Dendrites; D005971:Glutamates; D018698:Glutamic Acid; D006168:Guinea Pigs; D006198:Hair Cells, Auditory; D018377:Neurotransmitter Agents; D009925:Organ of Corti; D013136:Spiral Ganglion; D013237:Stereoisomerism; D013997:Time Factors; D014316:Tritium',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D005971:Glutamates; D018377:Neurotransmitter Agents; D014316:Tritium; D001224:Aspartic Acid; D018698:Glutamic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0378-5955(84)90029-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hear Res',\n",
       "  'nlm_unique_id': '7900445',\n",
       "  'issn_linking': '0378-5955',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Radiological features of polyarteritis nodosa.',\n",
       "  'issue': '32(7)',\n",
       "  'pages': '602-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Journal of the Association of Physicians of India',\n",
       "  'authors': 'Khan|A S|AS|;Siddiqui|M A|MA|;Ahmad|J|J|;Khan|E|E|;Islam|S F|SF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150021',\n",
       "  'mesh_terms': 'D000328:Adult; D000792:Angiography; D005260:Female; D006801:Humans; D010488:Polyarteritis Nodosa; D012077:Renal Artery; D014513:Ureter; D014567:Urography',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Assoc Physicians India',\n",
       "  'nlm_unique_id': '7505585',\n",
       "  'issn_linking': '0004-5772',\n",
       "  'country': 'India'},\n",
       " {'title': 'Regulation of phenylalanine biosynthesis in Rhodotorula glutinis.',\n",
       "  'issue': '160(2)',\n",
       "  'pages': '676-81',\n",
       "  'abstract': 'The phenylalanine biosynthetic pathway in the yeast Rhodotorula glutinis was examined, and the following results were obtained. (i) 3-Deoxy-D-arabinoheptulosonate-7-phosphate (DAHP) synthase in crude extracts was partially inhibited by tyrosine, tryptophan, or phenylalanine. In the presence of all three aromatic amino acids an additive pattern of enzyme inhibition was observed, suggesting the existence of three differentially regulated species of DAHP synthase. Two distinctly regulated isozymes inhibited by tyrosine or tryptophan and designated DAHP synthase-Tyr and DAHP synthase-Trp, respectively, were resolved by DEAE-Sephacel chromatography, along with a third labile activity inhibited by phenylalanine tentatively identified as DAHP synthase-Phe. The tyrosine and tryptophan isozymes were relatively stable and were inhibited 80 and 90% by 50 microM of the respective amino acids. DAHP synthase-Phe, however, proved to be an extremely labile activity, thereby preventing any detailed regulatory studies on the partially purified enzyme. (ii) Two species of chorismate mutase, designated CMI and CMII, were resolved in the same chromatographic step. The activity of CMI was inhibited by tyrosine and stimulated by tryptophan, whereas CMII appeared to be unregulated. (iii) Single species of prephenate dehydratase and phenylpyruvate aminotransferase were observed. Interestingly, the branch-point enzyme prephenate dehydratase was not inhibited by phenylalanine or affected by tyrosine, tryptophan, or both. (iv) The only site for control of phenylalanine biosynthesis appeared to be DAHP synthase-Phe. This is apparently sufficient since a spontaneous mutant, designated FP9, resistant to the growth-inhibitory phenylalanine analog p-fluorophenylalanine contained a feedback-resistant DAHP synthase-Phe and cross-fed a phenylalanine auxotroph of Bacillus subtilis.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Fiske|M J|MJ|;Kane|J F|JF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150022',\n",
       "  'mesh_terms': 'D010723:3-Deoxy-7-Phosphoheptulonate Synthase; D000446:Aldehyde-Lyases; D002826:Chorismate Mutase; D006836:Hydro-Lyases; D007535:Isomerases; D007700:Kinetics; D003904:Mitosporic Fungi; D010649:Phenylalanine; D011302:Prephenate Dehydratase; D012248:Rhodotorula',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D010649:Phenylalanine; D010723:3-Deoxy-7-Phosphoheptulonate Synthase; D000446:Aldehyde-Lyases; D006836:Hydro-Lyases; D011302:Prephenate Dehydratase; D007535:Isomerases; D002826:Chorismate Mutase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.2.676-681.1984',\n",
       "  'references': '16345879;6780530;7068528;4421507;4360539;4867215;6128337;16345763;6109712;6127340;407230;7049576;6119978;6210688;4631707;6060189;942051;5640158;7195398;7051977',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Immunofluorescence study of fimbrial phase variation in Escherichia coli KS71.',\n",
       "  'issue': '160(2)',\n",
       "  'pages': '691-5',\n",
       "  'abstract': 'An immunofluorescence assay was developed to study fimbrial phase variation in a pyelonephritogenic Escherichia coli strain, KS71. By using fluorochrome-labeled antibodies specific for either P, type-1C, or type-1 fimbriae of strain KS71, it was shown that in a broth culture of strain KS71 the fimbrial types mostly occurred on different cells. Only 9% of the cells carried more than one fimbrial type. The KS71 cell population was fractionated into subpopulations expressing only one of the fimbrial types or lacking fimbriae. Immunofluorescence assay of the subpopulations revealed a rapid phase variation in fimbrial synthesis. Kinetic analyses of a nonfimbriated cell population suggested that a change from one fimbrial phase to another was not totally random.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Nowicki|B|B|;Rhen|M|M|;Väisänen-Rhen|V|V|;Pere|A|A|;Korhonen|T K|TK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150023',\n",
       "  'mesh_terms': 'D004926:Escherichia coli; D010861:Fimbriae, Bacterial; D005455:Fluorescent Antibody Technique; D007106:Immune Sera; D007700:Kinetics',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007106:Immune Sera',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.2.691-695.1984',\n",
       "  'references': '5318403;1100526;323718;336832;40882;6103871;6103872;6251543;7014730;6116085;6116279;6171696;6122965;6123483;6125477;6126799;6127800;6131427;6340671;6132885;6138388;6140222;6146600',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Isolation and characterization of Bacteroides nodosus fimbriae: structural subunit and basal protein antigens.',\n",
       "  'issue': '160(2)',\n",
       "  'pages': '740-7',\n",
       "  'abstract': 'We examined the isolation of fimbriae from Bacteroides nodosus. It was found that the best preparations were obtained from the supernatant of washed cells cultured on solid medium, from which fimbriae could be recovered in high yield and purity by a simple one-step procedure. Analysis of such preparations by sodium dodecyl sulfate gel electrophoresis showed that greater than 98% of the protein consisted of fimbrial structural subunits whose molecular weight was ca. 17,000. These preparations also usually exhibited minor contamination with a polypeptide of ca. 80,000 molecular weight, as well as trace amounts of lipopolysaccharide. Attempts to release additional fimbriae by the traditional means of subjecting the bacterial cells to physical stress, such as shearing or heating, resulted primarily in an increase in the level of contamination, without significant gain in the yield of fimbriae. Removal of the 80,000-dalton component could not be achieved by any of a variety of techniques normally used in fimbriae purification, including isoelectric precipitation, MgCl2 precipitation, and CsCl gradient ultracentrifugation, implying a direct physical association with the fimbrial strand. Electron micrographs of fractions containing this protein show cap-shaped structures attached to the ends of what appeared to be fimbrial stubs. These observations suggest that the 80,000-dalton polypeptide may actually constitute the basal attachment site which anchors the fimbria to the outer membrane, analogous to a similar protein recently described in enterotoxigenic strains of Escherichia coli. In B. nodosus, this 80,000-dalton protein is a major surface antigen, and like the fimbrial subunit, exhibited variation in electrophoretic mobility between serotypically different isolates.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Mattick|J S|JS|;Anderson|B J|BJ|;Mott|M R|MR|;Egerton|J R|JR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150024',\n",
       "  'mesh_terms': 'D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D001439:Bacteroides; D004591:Electrophoresis, Polyacrylamide Gel; D010861:Fimbriae, Bacterial; D046911:Macromolecular Substances; D008854:Microscopy, Electron; D008970:Molecular Weight',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000942:Antigens, Bacterial; D001426:Bacterial Proteins; D046911:Macromolecular Substances',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.2.740-747.1984',\n",
       "  'references': '5486966;16030827;945799;6667210;7251146;780333;625599;327023;1180526;4707164;6113626;4707892;43354;4825998;262607;4731308;7448630;388439;6123145;6129239;79200;6126799;5813556;6156828;6154040;4960185;6135410;6995111;605298;4748954;1206378;1133574;5318403;6113142;6131880',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Cloning and expression in Escherichia coli of the gene encoding the structural subunit of Bacteroides nodosus fimbriae.',\n",
       "  'issue': '160(2)',\n",
       "  'pages': '748-54',\n",
       "  'abstract': 'Bacteroides nodosus is the primary causative agent of ovine foot rot. Virulent isolates of this bacterium contain fimbriae which appear to play a major role in both infectivity and protective immunity. This paper presents the cloning and expression in Escherichia coli of the gene encoding the structural subunit of the fimbriae of B. nodosus. Total DNA was isolated from B. nodosus VCS 1001 (serogroup A), digested with HindIII, and inserted into the positive-selection vector pTR262. Recombinant E. coli clones were screened directly with anti-fimbrial antiserum by using a colony immunoassay. Several positive colonies were identified, each of which contained the same 5.5-kilobase HindIII insert. The prototype has been designated pBA101. Some clones also contained additional flanking sequences from the B. nodosus genome. Western transfer analyses verified that the positive clones were producing the B. nodosus fimbrial structural subunit, molecular weight ca. 17,500. The level of expression of the antigen in E. coli was comparable to that in B. nodosus itself and was unaffected by the insertion site or orientation of the cloned fragment, indicating that synthesis was being directed from an internal promoter. Restriction mapping and deletion analyses localized the fimbrial subunit gene to the vicinity of a PvuII site near the central region of the original HindIII insert. The expressed antigen was located in the membrane-cell wall fraction and may be exposed on the surface of the recombinant E. coli cells.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Anderson|B J|BJ|;Bills|M M|MM|;Egerton|J R|JR|;Mattick|J S|JS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150025',\n",
       "  'mesh_terms': 'D001426:Bacterial Proteins; D001439:Bacteroides; D001483:Base Sequence; D002872:Chromosome Deletion; D003001:Cloning, Molecular; D004262:DNA Restriction Enzymes; D004274:DNA, Recombinant; D004926:Escherichia coli; D010861:Fimbriae, Bacterial; D005796:Genes; D005798:Genes, Bacterial; D014158:Transcription, Genetic',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001426:Bacterial Proteins; D004274:DNA, Recombinant; D004262:DNA Restriction Enzymes',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.2.748-754.1984',\n",
       "  'references': '6150024;16030827;945799;6667210;7251146;780333;6260582;6113626;6653780;4707892;43354;6304737;4825998;4731308;7448630;388439;6127165;6123145;79200;6132874;6126799;5813556;388356;4960185;169355;4748954;6137984;413571;6141144;5318403;6113142;6131880',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'gamma-Glutamyltranspeptidase from Proteus mirabilis: localization and activation by phospholipids.',\n",
       "  'issue': '160(3)',\n",
       "  'pages': '1031-6',\n",
       "  'abstract': 'Antiserum was prepared against the purified gamma-glutamyltranspeptidase (EC 2.3.2.2) of Proteus mirabilis. The antiserum inactivated the gamma-glutamyltranspeptidase activities of both purified enzyme and intact cells. Native cells were agglutinated with the antibody. Immunocytochemical studies with indirect immunofluorescence and electron microscopy analysis suggested that gamma-glutamyltranspeptidase is localized on the surface of the cell. Its distribution in the cell wall or periplasmic space or both was also confirmed by the treatment of cells with lysozyme-EDTA. The purified enzyme was activated by the addition of membrane phospholipids isolated from the same bacterium. The hydrolysis activity was stimulated more than the transpeptidation activity by several phospholipids.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Nakayama|R|R|;Kumagai|H|H|;Tochikura|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150026',\n",
       "  'mesh_terms': 'D004789:Enzyme Activation; D007106:Immune Sera; D005779:Immunodiffusion; D007700:Kinetics; D008854:Microscopy, Electron; D010743:Phospholipids; D011513:Proteus mirabilis; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D007106:Immune Sera; D010743:Phospholipids; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.3.1031-1036.1984',\n",
       "  'references': '5866128;4892500;5794484;5274454;4329866;1089432;1120776;238530;90;9027;18185;21085;28224;34615;458272;6105156;6108040;6113879;6115679;6124972;6833295;6137189;6144289;6148333;13194028;13578996;13641241;13671378;14253434;15625873',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Genetic analysis of autolysin-deficient and flagellaless mutants of Bacillus subtilis.',\n",
       "  'issue': '160(3)',\n",
       "  'pages': '1123-9',\n",
       "  'abstract': 'Three mutants with an autolysin-deficient and flagellaless phenotype (lyt) were genetically analyzed and compared with three thermosensitive flagellaless mutants. In view of the near indistinguishability of their phenotypes, all six mutations were assigned to fla loci. They were distributed into four linkage groups, designated flaA through flaD. flaA and flaB map between pyrD and thyA, flaD maps between aroD and lys, and, in agreement with a previous report, flaC maps near hisA. A locus associated with hypermotility, ifm-3, maps near the latter marker. Introduction of ifm-3 into lyt-1- and flaA4-containing strains led to partial suppression of the nonmotile phenotype. We discuss the possibility that the cellular concentration of autolysins is regulated by the expression of fla genes. Discrepancies with respect to previous mapping of flaA and flaB are accounted for.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Pooley|H M|HM|;Karamata|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150027',\n",
       "  'mesh_terms': 'D000581:Amidohydrolases; D001412:Bacillus subtilis; D002465:Cell Movement; D002874:Chromosome Mapping; D002876:Chromosomes, Bacterial; D003433:Crosses, Genetic; D005407:Flagella; D005796:Genes; D005798:Genes, Bacterial; D005838:Genotype; D009154:Mutation; D009238:N-Acetylmuramoyl-L-alanine Amidase; D010641:Phenotype; D013045:Species Specificity; D014161:Transduction, Genetic; D014169:Transformation, Bacterial',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000581:Amidohydrolases; D009238:N-Acetylmuramoyl-L-alanine Amidase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.3.1123-1129.1984',\n",
       "  'references': '4962145;4977981;4979438;4990908;4622900;4204911;809421;815238;821929;827683;405929;339815;418407;33966;6222032',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Analysis of initiation of sites of cell wall growth in Streptococcus faecium during a nutritional shift.',\n",
       "  'issue': '160(3)',\n",
       "  'pages': '935-42',\n",
       "  'abstract': 'Three-dimensional reconstruction methods were applied to electron micrographs of Streptococcus faecium to study the initiation of cell wall growth sites during a nutritional shift experiment. Upon lowering the mass doubling time from 76 to 33 min by the addition of excess glutamate, the formation of new cell wall growth sites accelerated above the old steady-state rate at about the same time (10 to 15 min) as did mass, RNA, protein, cell numbers, and autolytic capacity but considerably before DNA (30 min) and peptidoglycan (20 min) synthesis did. During the shift, the average range of cell volumes over which new wall growth sites were introduced did not change significantly. However, upon the shift there was an increase in the frequency of cells having new sites, which was due to the faster-growing cells initiating more new sites in peripheral locations before division. After a transition period, the number of new sites per milliliter of culture increased at a rate that paralleled that of the culture mass. These findings support a model in which new sites are introduced when cells grow to a relatively constant, growth rate-independent size, while the rate at which sites form and grow increases with the growth rate. In this model, chromosome synthesis does not regulate the formation of new sites of cell wall growth, but existing sites cannot be completed until rounds of chromosome synthesis are completed.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Gibson|C W|CW|;Daneo-Moore|L|L|;Higgins|M L|ML|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150028',\n",
       "  'mesh_terms': 'D001426:Bacterial Proteins; D002473:Cell Wall; D005971:Glutamates; D018698:Glutamic Acid; D007700:Kinetics; D008854:Microscopy, Electron; D013291:Streptococcus',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001426:Bacterial Proteins; D005971:Glutamates; D018698:Glutamic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.3.935-942.1984',\n",
       "  'references': '4866337;4892010;4988243;4994035;4257049;4116754;806582;794735;415050;96099;355233;361715;6772634;7012453;6262433;7320694;6173377;6841311;6408063;6429274;13385433;13611202;13611203;13921527;13293190',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Purification and characterization of a novel type of fimbriae from the oral anaerobe Bacteroides gingivalis.',\n",
       "  'issue': '160(3)',\n",
       "  'pages': '949-57',\n",
       "  'abstract': 'Fimbriae and their constituent protein (fimbrilin) were purified to homogeneity from the bacterial wash fluid and cell lysate fraction, respectively, of Bacteroides gingivalis 381. Fimbriae, observed by negative staining, were curly, single-stranded filaments with a diameter of ca. 5 nm. The apparent molecular weight of the fimbrilin was 43,000. Fimbriae were resistant to sodium dodecyl sulfate denaturation at 70 degrees C. Heating at 100 degrees C in sodium dodecyl sulfate was needed to completely dissociate them to monomers of fimbrilin. Different sets of antigenic determinants seemed to be exposed on the surfaces of fimbriae and sodium dodecyl sulfate-denatured fimbrilin. Purified fimbriae did not show either hemagglutinating activity or hemagglutination inhibitory activity, although it has been inferred on the basis of circumstantial evidence that fimbriae are correlated to hemagglutinating activity of the organism. Hemagglutinin activity, however, was detected in culture supernatant, and this observation suggests that fimbriae of a different type or a lectin-like protein may be acting as hemagglutinin in B. gingivalis.',\n",
       "  'journal': 'Journal of bacteriology',\n",
       "  'authors': 'Yoshimura|F|F|;Takahashi|K|K|;Nodasaka|Y|Y|;Suzuki|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150029',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000693:Anaerobiosis; D000936:Antigen-Antibody Complex; D001439:Bacteroides; D002458:Cell Fractionation; D010861:Fimbriae, Bacterial; D005881:Gingiva; D006801:Humans; D007106:Immune Sera; D005779:Immunodiffusion; D008565:Membrane Proteins; D008854:Microscopy, Electron; D008970:Molecular Weight',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000596:Amino Acids; D000936:Antigen-Antibody Complex; D007106:Immune Sera; D008565:Membrane Proteins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1128/jb.160.3.949-957.1984',\n",
       "  'references': '4527823;1180526;773686;320648;404282;24002;86590;573762;394591;7380540;6254013;7216426;7026236;7030174;6275009;6124420;6189825;6653780;6089721;14907713',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Bacteriol',\n",
       "  'nlm_unique_id': '2985120R',\n",
       "  'issn_linking': '0021-9193',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Withdrawal symptoms after long-term treatment with low-potency neuroleptics.',\n",
       "  'issue': '45(12)',\n",
       "  'pages': '500-2',\n",
       "  'abstract': 'Twenty-six chronic schizophrenic outpatients receiving low-potency anticholinergic neuroleptics were switched over periods of up to 2 years to an equivalent dose of high-potency neuroleptics. Of these patients, 85% experienced withdrawal symptoms, mainly insomnia, anxiety, and tensional restlessness. Complete withdrawal of low-potency medication was achieved during the study period in 9 patients only. The mean duration of treatment with low-potency neuroleptics was 15 years and the mean dose was 147 mg chlorpromazine equivalents/day. It is suggested that new symptoms associated with withdrawal of low-potency neuroleptics may lead to overcompliance by patients and difficulty in achieving the minimum therapeutic dosage. Thus, low-potency neuroleptics would not appear suitable for the long-term treatment of most schizophrenic patients.',\n",
       "  'journal': 'The Journal of clinical psychiatry',\n",
       "  'authors': 'Chouinard|G|G|;Bradwejn|J|J|;Annable|L|L|;Jones|B D|BD|;Ross-Chouinard|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150030',\n",
       "  'mesh_terms': 'D000328:Adult; D017109:Akathisia, Drug-Induced; D000553:Ambulatory Care; D014150:Antipsychotic Agents; D001008:Anxiety Disorders; D002746:Chlorpromazine; D002908:Chronic Disease; D004409:Dyskinesia, Drug-Induced; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D012559:Schizophrenia; D007319:Sleep Initiation and Maintenance Disorders; D013375:Substance Withdrawal Syndrome; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D002746:Chlorpromazine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Clin Psychiatry',\n",
       "  'nlm_unique_id': '7801243',\n",
       "  'issn_linking': '0160-6689',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Alprazolam and premenstrual syndrome.',\n",
       "  'issue': '45(12)',\n",
       "  'pages': '526',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Journal of clinical psychiatry',\n",
       "  'authors': 'Freinhar|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150031',\n",
       "  'mesh_terms': 'D000328:Adult; D000525:Alprazolam; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D005260:Female; D006801:Humans; D011293:Premenstrual Syndrome',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D000525:Alprazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Clin Psychiatry',\n",
       "  'nlm_unique_id': '7801243',\n",
       "  'issn_linking': '0160-6689',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Mechanism of biliary secretion of membranous enzymes: bile acids are important factors for biliary occurrence of gamma-glutamyltransferase and other hydrolases.',\n",
       "  'issue': '96(2)',\n",
       "  'pages': '289-97',\n",
       "  'abstract': 'To elucidate the mechanism of biliary occurrence of gamma-glutamyl transferase [EC 2.3.2.2] and alkaline phosphatase [EC 3.1.3.1], the effect of bile acids on the biliary level of these enzymes was studied in vivo and in vitro. Following intravenous administration of taurocholate, the activities of both enzymes in rat bile increased markedly with a concomitant increase in the excretion of the bile acid. The biliary levels of these enzymes increased to reach a maximum at 10-20 min after administration of the bile acid and decreased thereafter. Right-side-out oriented rat liver canalicular membrane vesicles which localize gamma-glutamyltransferase, aminopeptidase M and alkaline phosphatase on their outer surface (Inoue, M., Kinne, R., Tran, T., Biempica, L., & Arias, I.M. (1983) J. Biol. Chem. 258, 5183-5188) were prepared. Upon incubation of the vesicles with either intact or heat-treated bile samples, the membranous enzymes were released from the vesicles in a time-dependent manner. Incubation of these vesicles with physiological concentrations of taurocholate also solubilized these enzymes from the membranes. Affinity chromatographic analysis on concanavalin A-Sepharose revealed that the transferase thus solubilized retained the hydrophobic domain responsible for anchoring the enzyme to membrane/lipid bilayers. These results indicate that bile acid(s) excreted into the bile canalicular lumen solubilized these enzymes from the apical membrane surface of the biliary tract cells by their detergent action.',\n",
       "  'journal': 'Journal of biochemistry',\n",
       "  'authors': 'Hirata|E|E|;Inoue|M|M|;Morino|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150032',\n",
       "  'mesh_terms': 'D000469:Alkaline Phosphatase; D000626:Aminopeptidases; D000818:Animals; D001646:Bile; D001647:Bile Acids and Salts; D018826:CD13 Antigens; D006801:Humans; D006867:Hydrolases; D008297:Male; D010190:Pancreatic Neoplasms; D051381:Rats; D011919:Rats, Inbred Strains; D012995:Solubility; D013656:Taurocholic Acid; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001647:Bile Acids and Salts; D013656:Taurocholic Acid; D005723:gamma-Glutamyltransferase; D006867:Hydrolases; D000469:Alkaline Phosphatase; D000626:Aminopeptidases; D018826:CD13 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/oxfordjournals.jbchem.a134837',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biochem',\n",
       "  'nlm_unique_id': '0376600',\n",
       "  'issn_linking': '0021-924X',\n",
       "  'country': 'England'},\n",
       " {'title': 'Chemical crosslinking of myosin subfragment-1 to F-actin in the presence of nucleotide.',\n",
       "  'issue': '96(2)',\n",
       "  'pages': '337-47',\n",
       "  'abstract': \"F-Actin and myosin subfragment-1 (S-1) were covalently crosslinked in the absence and presence of nucleotides, adenyl-5'-yl imidodiphosphate (AMPPNP), ATP, and ADP, at various KCl concentrations (0-0.5 M), using a zero-length crosslinker, 1-ethyl-3-[3-(dimethylamino)propyl]carbodiimide (EDC). The rate of production of the covalent acto-S-1 complex was almost proportional to the amount of the acto-S-1(-nucleotide) complex existing in the reaction medium. However, the Mg-ATPase activity of the covalent acto-S-1 complex thus produced was affected by the presence of nucleotides. When S-1 was crosslinked to F-actin in the absence of nucleotide at 0-0.5 M KCl, the Mg-ATPase activity of S-1 was enhanced from 0.1-0.3 to 12-15 s-1. The Mg-ATPase activity of covalent complex produced in the presence of AMPPNP at 0 M KCl was 13 s-1 which was equal to that produced in the absence of nucleotide. The activity decreased with increasing KCl concentration of the crosslinking medium, reaching 6 s-1 at 0.5 M KCl. Covalent acto-S-1 complex was also produced when acto-S-1-ADP-P was formed during ATP hydrolysis. The Mg-ATPase activity of the covalent acto-S-1 complex crosslinked during ATP hydrolysis at 0 M KCl was about 5 s-1 which was about half of that obtained in the absence of nucleotide, and it decreased to about 2 s-1 at 0.15 M KCl of crosslinking medium. In contrast, the acto-S-1-ADP complex gave a covalent complex which was indistinguishable in its extent and Mg-ATPase activity from that obtained in the absence of nucleotide. These results suggest that the structures of acto-S-1-AMPPNP and acto-S-1-ADP-P complexes are different from those of acto-S-1 and acto-S-1-ADP complexes.\",\n",
       "  'journal': 'Journal of biochemistry',\n",
       "  'authors': 'Arata|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150033',\n",
       "  'mesh_terms': 'D000199:Actins; D000227:Adenine Nucleotides; D000244:Adenosine Diphosphate; D000251:Adenosine Triphosphatases; D000255:Adenosine Triphosphate; D000266:Adenylyl Imidodiphosphate; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002234:Carbodiimides; D005022:Ethyldimethylaminopropyl Carbodiimide; D007700:Kinetics; D009132:Muscles; D015879:Myosin Subfragments; D009218:Myosins; D009994:Osmolar Concentration; D010446:Peptide Fragments; D011189:Potassium Chloride; D011817:Rabbits',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000199:Actins; D000227:Adenine Nucleotides; D002234:Carbodiimides; D015879:Myosin Subfragments; D010446:Peptide Fragments; D000266:Adenylyl Imidodiphosphate; D000244:Adenosine Diphosphate; D011189:Potassium Chloride; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D009218:Myosins; D005022:Ethyldimethylaminopropyl Carbodiimide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/oxfordjournals.jbchem.a134843',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biochem',\n",
       "  'nlm_unique_id': '0376600',\n",
       "  'issn_linking': '0021-924X',\n",
       "  'country': 'England'},\n",
       " {'title': 'Interactions of muscle beta-connectin with myosin, actin, and actomyosin at low ionic strengths.',\n",
       "  'issue': '96(2)',\n",
       "  'pages': '499-506',\n",
       "  'abstract': 'The interaction of the muscle elastic protein connectin with myosin and actin filaments was investigated by turbidimetry, viscosity, flow birefringence measurements, and electron microscopic observations. In KCl concentrations lower than 0.15 M at pH 7.0 at 25 degrees C, both myosin and actin filaments were aggregated by connectin. Myosin filaments were entangled with each other in the presence of connectin. Actin filaments were assembled into bundles under the influence of connectin just as under that of alpha-actinin. The physiological significance of the interactions of connectin with myosin and actin filaments is discussed in relation to the localization of connectin in myofibrils. The Mg2+-activated ATPase activity of actomyosin was appreciably enhanced by connectin in the presence of KCl concentrations lower than 0.1 M. The extent of activation by connectin was smaller than by alpha-actinin. The enhancement of the ATPase activity may be due to acceleration of the onset of superprecipitation of actomyosin.',\n",
       "  'journal': 'Journal of biochemistry',\n",
       "  'authors': 'Kimura|S|S|;Maruyama|K|K|;Huang|Y P|YP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150034',\n",
       "  'mesh_terms': 'D000199:Actins; D000205:Actomyosin; D000251:Adenosine Triphosphatases; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D002645:Chickens; D064211:Connectin; D003599:Cytoskeleton; D007700:Kinetics; D008854:Microscopy, Electron; D009124:Muscle Proteins; D009132:Muscles; D009218:Myosins; D009994:Osmolar Concentration; D011494:Protein Kinases',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000199:Actins; D064211:Connectin; D009124:Muscle Proteins; D000205:Actomyosin; D011494:Protein Kinases; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D009218:Myosins; D000252:Calcium-Transporting ATPases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/oxfordjournals.jbchem.a134862',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biochem',\n",
       "  'nlm_unique_id': '0376600',\n",
       "  'issn_linking': '0021-924X',\n",
       "  'country': 'England'},\n",
       " {'title': 'A sensitive assay method for the measurement of S-adenosylmethionine in tissue.',\n",
       "  'issue': '96(3)',\n",
       "  'pages': '679-82',\n",
       "  'abstract': 'An assay method has been developed for the measurement of tissue levels of S-adenosylmethionine based upon the ability of this compound to activate tripolyphosphatase associated with S-adenosylmethionine synthetase beta prepared from rat liver. The method has been used to measure S-adenosylmethionine levels in rat liver after feeding rats on various concentrations of methionine in the diet. The results obtained by this method agree well with those measured by the spectrophotometric method. The limit of sensitivity of the assay was about 0.1 nmol of S-adenosylmethionine in an incubation volume of 0.1 ml (10(-6) M).',\n",
       "  'journal': 'Journal of biochemistry',\n",
       "  'authors': 'Suma|Y|Y|;Matsumoto|C|C|;Sawai|Y|Y|;Tsukada|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150035',\n",
       "  'mesh_terms': 'D017766:Acid Anhydride Hydrolases; D000818:Animals; D004032:Diet; D007700:Kinetics; D008099:Liver; D008715:Methionine; D008716:Methionine Adenosyltransferase; D010744:Phosphoric Monoester Hydrolases; D051381:Rats; D011919:Rats, Inbred Strains; D012436:S-Adenosylmethionine',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D012436:S-Adenosylmethionine; D008715:Methionine; D008716:Methionine Adenosyltransferase; D010744:Phosphoric Monoester Hydrolases; D017766:Acid Anhydride Hydrolases; C023193:tripolyphosphatase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/oxfordjournals.jbchem.a134885',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biochem',\n",
       "  'nlm_unique_id': '0376600',\n",
       "  'issn_linking': '0021-924X',\n",
       "  'country': 'England'},\n",
       " {'title': 'Inhibition of smooth muscle actin-activated myosin Mg2+-ATPase activity by caldesmon.',\n",
       "  'issue': '259(22)',\n",
       "  'pages': '13656-9',\n",
       "  'abstract': 'Caldesmon, a major calmodulin- and actin-binding protein of smooth muscle (Sobue, K., Muramoto, Y., Fujita, M., and Kakiuchi, S. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 5652-5655), has been obtained in highly purified form from chicken gizzard by a modification of a previously published procedure (Ngai, P. K., Carruthers, C. A., and Walsh, M. P. (1984) Biochem. J. 218, 863-870) and was found to cause a significant inhibition of both superprecipitation and actin-activated myosin Mg2+-ATPase activity in a system reconstituted from the purified contractile and regulatory proteins without influencing the phosphorylation state of myosin. This inhibitory effect was seen both in the presence and absence of tropomyosin. A Ca2+-and calmodulin-dependent kinase which catalyzed phosphorylation of caldesmon was identified in chicken gizzard; this kinase is distinct from myosin light-chain kinase. Caldesmon prepared by calmodulin-Sepharose affinity chromatography was contaminated with caldesmon kinase activity and was unable to inhibit actomyosin ATPase activity or superprecipitation. Phosphatase activity capable of dephosphorylating caldesmon was also identified in smooth muscle. These results indicate that caldesmon can inhibit smooth muscle actomyosin ATPase activity in vitro, and this function may itself be subject to regulation by reversible phosphorylation of caldesmon.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Ngai|P K|PK|;Walsh|M P|MP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150036',\n",
       "  'mesh_terms': 'D000199:Actins; D000205:Actomyosin; D000251:Adenosine Triphosphatases; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002118:Calcium; D002147:Calmodulin; D002148:Calmodulin-Binding Proteins; D011232:Chemical Precipitation; D002645:Chickens; D005895:Gizzard, Avian; D009130:Muscle, Smooth; D009218:Myosins; D010749:Phosphoprotein Phosphatases; D011494:Protein Kinases; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000199:Actins; D002147:Calmodulin; D002148:Calmodulin-Binding Proteins; D000205:Actomyosin; D011494:Protein Kinases; D010749:Phosphoprotein Phosphatases; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D009218:Myosins; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Phosphorylation of tyrosine hydroxylase by calmodulin-dependent multiprotein kinase.',\n",
       "  'issue': '259(22)',\n",
       "  'pages': '13680-3',\n",
       "  'abstract': 'Tyrosine hydroxylase purified from rat pheochromocytoma was phosphorylated stoichiometrically by either cyclic AMP-dependent protein kinase or calmodulin-dependent multiprotein kinase from skeletal muscle, but not by five other protein kinases tested. The activity of tyrosine hydroxylase was elevated 3-fold by cyclic AMP-dependent protein kinase, but no activation was observed after phosphorylation by calmodulin-dependent multiprotein kinase. Phosphorylation produced by cyclic AMP-dependent protein kinase and calmodulin-dependent multiprotein kinase was additive, suggesting different sites of phosphorylation. This was confirmed by high-performance liquid chromatography analysis of tryptic phosphopeptides which demonstrated that the major sites phosphorylated by each protein kinase were distinct. A calmodulin-dependent multiprotein kinase that had identical properties and substrate specificity to the skeletal muscle enzyme was partially purified from rat pheochromocytoma. The possibility that this protein kinase is involved in the regulation of tyrosine hydroxylase activity in adrenergic tissue in vivo is discussed.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Vulliet|P R|PR|;Woodgett|J R|JR|;Cohen|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150037',\n",
       "  'mesh_terms': 'D000310:Adrenal Gland Neoplasms; D000818:Animals; D002147:Calmodulin; D002851:Chromatography, High Pressure Liquid; D000242:Cyclic AMP; D004789:Enzyme Activation; D006006:Glycogen Synthase; D010673:Pheochromocytoma; D010766:Phosphorylation; D011494:Protein Kinases; D051381:Rats; D014357:Trypsin; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': 'D002147:Calmodulin; D000242:Cyclic AMP; D014446:Tyrosine 3-Monooxygenase; D006006:Glycogen Synthase; D011494:Protein Kinases; D014357:Trypsin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Characterization of a Ca2+-stimulated Mg2+-dependent adenosine triphosphatase in Friend murine erythroleukemia cell plasma membranes.',\n",
       "  'issue': '259(22)',\n",
       "  'pages': '13824-31',\n",
       "  'abstract': 'Since agents which affect Ca2+ fluxes have been shown to affect the commitment to terminal differentiation of murine erythroleukemia cells treated with an inducer of differentiation (Bridges, K., Levenson, R., Housman, D., and Cantley, L. (1981) J. Cell Biol. 90, 542-544), we investigated the presence of Ca2+-transport systems in plasma membranes isolated from these cells. Plasma membranes from murine erythroleukemia cells exhibited a high affinity (Ca2+-Mg2+)-ATPase activity with a Vmax of 29 +/- 4 nmol/mg/min and an apparent K0.5 for free Ca2+ of 0.13 microM. This activity was strongly inhibited in a dose-dependent fashion by low concentrations of trifluoperazine, compound 48/80, lanthanum, and vanadate with I50 of 29 microM, 1.75 micrograms/ml, 1.5 microM, and 0.4 microM, respectively. The inhibitory effect of compound 48/80 was specifically reversed by exogenously added calmodulin. Phosphorylation of plasma membranes with [gamma-32P] ATP followed by sodium dodecyl sulfate electrophoretic analysis at low pH revealed a Ca2+-dependent phosphoprotein with an apparent molecular mass of 138,000 daltons which co-migrated with the Ca2+-dependent phosphoprotein from human erythrocytes and was separable from sarcoplasmic reticulum (Ca2+-Mg2+)-ATPase. The 32P incorporated into the phosphoprotein could be chased with unlabeled ATP and the protein-phosphate bond was unstable at alkaline pH suggesting an acylphosphate ATPase intermediate like that previously characterized in other (Ca2+-Mg2+)-ATPases.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Debetto|P|P|;Cantley|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150038',\n",
       "  'mesh_terms': 'D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D002147:Calmodulin; D002460:Cell Line; D002462:Cell Membrane; D004533:Egtazic Acid; D007811:Lanthanum; D004915:Leukemia, Erythroblastic, Acute; D051379:Mice; D010750:Phosphoproteins; D014268:Trifluoperazine; D014638:Vanadates; D014639:Vanadium; D003189:p-Methoxy-N-methylphenethylamine',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002147:Calmodulin; D010750:Phosphoproteins; D014639:Vanadium; D014268:Trifluoperazine; D014638:Vanadates; D003189:p-Methoxy-N-methylphenethylamine; D004533:Egtazic Acid; D007811:Lanthanum; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Orientation of the glucose transporter in the human erythrocyte membrane. Investigation by in situ proteolytic dissection.',\n",
       "  'issue': '259(22)',\n",
       "  'pages': '13878-84',\n",
       "  'abstract': 'Glucose transporter proteins (zone 4.5) which had been photoaffinity labeled with [3H]cytochalasin B in human erythrocyte ghosts were subjected to enzymatic dissection in order to study the transmembrane disposition of the protein in situ. Proteolytic enzymes as well as glycosidases were used to treat unsealed and resealed ghosts in order to explore the various membrane domains of the transporter in a topographically defined manner. Limited digestion of sealed ghosts with trypsin had no effect on the apparent Mr of the transporter (55,000). Similar treatment in unsealed ghosts, however, resulted in the generation of a major fragment of 21.5 kDa, along with several minor fragments. Thermolysin also had no effect on sealed ghosts but caused a complete loss of radiolabel from the zone 4.5 region with no lower-molecular-weight fragments being retained on the gel. Chymotrypsin treatment resulted in the generation of a single peak, Mr = 18,400, in both sealed and unsealed ghosts indicating its action occurs at the outer surface. Digestion with carboxypeptidase and aminopeptidase indicate the C-terminal end of the transporter is located exterior to the membrane with the N terminus located at the cytoplasmic surface. Treatment with endoglycosidase resulted in a shift of mobility of the transporter to a lower Mr of 49,000. The results obtained indicate that the carbohydrate is located near the C-terminal end and that the cytochalasin B-binding site is located near the cytoplasmic N-terminal end.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': \"Shanahan|M F|MF|;D'Artel-Ellis|J|J|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150039',\n",
       "  'mesh_terms': 'D000626:Aminopeptidases; D001665:Binding Sites; D018826:CD13 Antigens; D002268:Carboxypeptidases; D002352:Carrier Proteins; D020789:Cathepsin C; D002918:Chymotrypsin; D003571:Cytochalasin B; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D004910:Erythrocyte Membrane; D006026:Glycoside Hydrolases; D006801:Humans; D008970:Molecular Weight; D009004:Monosaccharide Transport Proteins; D013820:Thermolysin; D014357:Trypsin; D001616:beta-Galactosidase',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002352:Carrier Proteins; D009004:Monosaccharide Transport Proteins; D003571:Cytochalasin B; D006026:Glycoside Hydrolases; C026093:keratan-sulfate endo-1,4-beta-galactosidase; D001616:beta-Galactosidase; D002268:Carboxypeptidases; D000626:Aminopeptidases; D018826:CD13 Antigens; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D020789:Cathepsin C; D002918:Chymotrypsin; D014357:Trypsin; D013820:Thermolysin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'DNA-dependent ATPase activity associated with phage P22 gene 12 protein.',\n",
       "  'issue': '259(22)',\n",
       "  'pages': '14038-43',\n",
       "  'abstract': 'The product of bacteriophage P22 gene 12 is known from genetic experiments to be essential for phage DNA replication. The P22 12 protein has been purified to near homogeneity from Escherichia coli lysogenic for lambda-P22 hybrid phage containing the replication genes of P22. The protein has a subunit molecular weight of 46,000. The purified protein contains ATPase activity that is stimulated by single-stranded DNA. The ATPase is poorly stimulated by double-stranded DNA. All four ribonucleoside triphosphates are hydrolyzed; none of the deoxynucleoside triphosphates are hydrolyzed. In addition, the P22 12 protein binds to single-stranded DNA in the presence of ATP. Studies of oligonucleotide synthesis by P22 12 protein in conjunction with E. coli dnaG primase are presented in the succeeding paper (Wickner, S. (1984) J. Biol. Chem. 259, 14044-14047).',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Wickner|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150040',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D001426:Bacterial Proteins; D010582:Bacteriophage lambda; D004265:DNA Helicases; D019915:DNA Primase; D004261:DNA Replication; D004926:Escherichia coli; D005033:Ethylmaleimide; D006868:Hydrolysis; D008970:Molecular Weight; D009711:Nucleotides; D012316:RNA Nucleotidyltransferases; D012483:Salmonella Phages; D014764:Viral Proteins',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001426:Bacterial Proteins; D009711:Nucleotides; D014764:Viral Proteins; D019915:DNA Primase; D012316:RNA Nucleotidyltransferases; D000251:Adenosine Triphosphatases; D004265:DNA Helicases; D005033:Ethylmaleimide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Purification and properties of the inhibitory guanine nucleotide regulatory unit of brain adenylate cyclase.',\n",
       "  'issue': '259(22)',\n",
       "  'pages': '14222-9',\n",
       "  'abstract': 'Hormonal inhibition of adenylate cyclase is mediated by a guanine nucleotide regulatory protein (Ni) which is different from the one which mediates hormonal stimulation. There is substantial evidence that the active component of Ni (termed alpha i can be ADP-ribosylated by a toxin from Bordetella pertussis. We have found that in bovine cerebral cortex there are three proteins of similar molecular weight (39,000-41,000) which are modified by pertussis toxin. We have purified these proteins and have resolved the 41,000-dalton protein from the 40,000/39,000-dalton doublet. All three forms of pertussis toxin substrate can be isolated in free form or together with a 36,000 beta component. We have also purified this beta component. ADP-ribosylation of the three pertussis toxin substrates is greatly enhanced by the addition of the purified beta component. This makes possible an assay of beta subunit activity based on its interaction with alpha i. The three forms of pertussis toxin substrate which we have purified differ in two functions: susceptibility to ADP-ribosylation and GTPase activity. The 41,000-dalton protein is more readily ADP-ribosylated by pertussis toxin than the smaller forms. The 39,000-dalton protein has GTPase activity with a low Km (0.3 microM) for GTP. The GTPase activity can be doubled by phospholipids. The GTPase activity of the 41,000-dalton protein is almost undetectable. It is not yet known what the relationship of the forms is to each other. The smaller forms may be derived from the larger by proteolysis or it may be intrinsically different. It remains to be shown whether one of the forms represents a different type of regulatory protein which transmits a hormonal signal to effectors other than adenylate cyclase.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Neer|E J|EJ|;Lok|J M|JM|;Wolf|L G|LG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150041',\n",
       "  'mesh_terms': 'D000246:Adenosine Diphosphate Ribose; D037361:Adenylate Cyclase Toxin; D000262:Adenylyl Cyclases; D000818:Animals; D001427:Bacterial Toxins; D001921:Brain; D002417:Cattle; D002499:Centrifugation, Density Gradient; D002846:Chromatography, Affinity; D002852:Chromatography, Ion Exchange; D020558:GTP Phosphohydrolases; D019204:GTP-Binding Proteins; D046911:Macromolecular Substances; D008970:Molecular Weight; D037342:Pertussis Toxin; D010566:Virulence Factors, Bordetella',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D037361:Adenylate Cyclase Toxin; D001427:Bacterial Toxins; D046911:Macromolecular Substances; D010566:Virulence Factors, Bordetella; D000246:Adenosine Diphosphate Ribose; D037342:Pertussis Toxin; D020558:GTP Phosphohydrolases; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Mutational analysis of primosome assembly sites. II. Role of secondary structure in the formation of active sites.',\n",
       "  'issue': '259(22)',\n",
       "  'pages': '14293-300',\n",
       "  'abstract': 'Based on their activity as effectors for the ATPase activity of Escherichia coli replication factor Y and as templates for primosome-directed DNA synthesis, single-point mutations in the L- and H-strand primosome assembly sites from pBR322 DNA have been grouped into four classes (Abarzúa, P., Soeller, W., and Marians, K. (1984) J. Biol. Chem. 259, 14286-14292). In this report, the effect of various ligands on the characteristic activities of primosome assembly site class II mutants has been examined. Both Mn2+ and spermidine can, at low levels, substitute for Mg2+ in the activation of wild-type sites as effectors for factor Y-catalyzed hydrolysis of ATP. Class II mutant sites characteristically require higher levels of these ligands for activation, suggesting that the specific higher order structure of an active primosome assembly site is maintained through base pairing within the single-stranded DNA sequence. This conclusion is supported by the following. 1) Excess levels of the E. coli single-stranded DNA-binding protein can inactivate wild-type sites at 1 mM Mg2+. Either the addition of NaCl to 80 mM or an increase in the Mg2+ concentration to 5 mM protects against this inactivation. Class II mutant sites, however, cannot be stabilized by 80 mM NaCl at 1 mM Mg2+, and only some class II mutants can be stabilized at 5 mM Mg2+. 2) Active second-site revertants, isolated in vivo and in vitro, of inactive primosome assembly sites containing multiple-base substitutions have mutated to restore lost base pairs in the proposed stem and loop structure of the sites.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Soeller|W|W|;Abarzúa|P|P|;Marians|K J|KJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150042',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D000255:Adenosine Triphosphate; D001426:Bacterial Proteins; D001483:Base Sequence; D001665:Binding Sites; D004265:DNA Helicases; D004269:DNA, Bacterial; D004268:DNA-Binding Proteins; D006868:Hydrolysis; D008274:Magnesium; D008345:Manganese; D009154:Mutation; D013095:Spermidine',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001426:Bacterial Proteins; D004269:DNA, Bacterial; D004268:DNA-Binding Proteins; D008345:Manganese; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; D004265:DNA Helicases; D008274:Magnesium; D013095:Spermidine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Atrial natriuretic factor selectively activates particulate guanylate cyclase and elevates cyclic GMP in rat tissues.',\n",
       "  'issue': '259(23)',\n",
       "  'pages': '14332-4',\n",
       "  'abstract': 'The effects on guanylate cyclase and cyclic GMP accumulation of a synthetic peptide containing the amino acid sequence and biological activity of atrial natriuretic factor (ANF) were studied. ANF activated particulate guanylate cyclase in a concentration- and time- dependent fashion in crude membranes obtained from homogenates of rat kidney. Activation of particulate guanylate cyclase by ANF was also observed in particulate fractions from homogenates of rat aorta, testes, intestine, lung, and liver, but not from heart or brain. Soluble guanylate cyclase obtained from these tissues was not activated by ANF. Trypsin treatment of ANF prevented the activation of guanylate cyclase, while heat treatment had no effect. Accumulation of cyclic GMP in kidney minces and aorta was stimulated by ANF activation of guanylate cyclase. These data suggest a role for particulate guanylate cyclase in the molecular mechanisms underlying the physiological effects of ANF such as vascular relaxation, natriuresis, and diuresis.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Waldman|S A|SA|;Rapoport|R M|RM|;Murad|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150043',\n",
       "  'mesh_terms': 'D000818:Animals; D009320:Atrial Natriuretic Factor; D006152:Cyclic GMP; D004789:Enzyme Activation; D005260:Female; D006162:Guanylate Cyclase; D007668:Kidney; D007700:Kinetics; D009124:Muscle Proteins; D009318:Natriuresis; D051381:Rats; D014018:Tissue Distribution; D014357:Trypsin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D009124:Muscle Proteins; C472610:atrial natriuretic peptide, rat; D009320:Atrial Natriuretic Factor; D014357:Trypsin; D006162:Guanylate Cyclase; D006152:Cyclic GMP',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Specific binding of blood coagulation factor XIIIa to thrombin-stimulated platelets.',\n",
       "  'issue': '259(23)',\n",
       "  'pages': '14721-7',\n",
       "  'abstract': \"We studied the binding of 125I-platelet and plasma Factor XIII (125I-Factor XIII) to human platelets. When 125I-Factor XIII was incubated with gel-filtered platelets, calcium chloride (5 mM) and thrombin (1 unit/ml) at 37 degrees C, saturable binding was observed. Half-maximal binding occurred at 1 min. Binding was inhibited 93% by a 100-fold molar excess of unlabeled ligand but not by other purified proteins. Greater than 87% of platelet-bound radioactivity migrated as thrombin-cleaved a-chains (a'-chains) in sodium dodecyl sulfate-polyacrylamide gels indicating that Factor XIIIa but not Factor XIII binds to platelets. 125I-Factor XIIIa does not bind to unstimulated platelets. When platelet secretion was blocked, binding was markedly inhibited. 125I-Factor XIIIa bound minimally to platelets stimulated with agonists other than thrombin. Thus, binding is dependent on platelet activation, as well as modification of platelets by thrombin. 125I-Factor XIIIa bound to gamma-thrombin-stimulated platelets, at concentrations which did not clot fibrinogen. Therefore, Factor XIIIa is not bound to fibrin associated with platelets. Binding was only partially reversible. Approximately 12,000 molecules of Factor XIIIa were bound per platelet. 125I-Factor XIIIa bound normally to platelets from patients with severe Glanzmann's thrombasthenia indicating that 125I-Factor XIIIa does not bind to platelet glycoproteins IIb or IIIa, or platelet-bound fibrinogen. Chymotrypsin treatment of platelets inhibited 125I-Factor XIIIa binding by 78% without inhibiting secretion. Methylamine and putrescine, Factor XIIIa substrates, and N-ethylmaleimide, an active site inhibitor, did not inhibit binding. Factor XIIIa bound to platelets was enzymatically active and catalyzed [3H]putrescine incorporation into platelet proteins. The specific binding of Factor XIIIa to platelets suggests it may play a role in physiologic reactions involving platelets.\",\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Greenberg|C S|CS|;Shuman|M A|MA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150044',\n",
       "  'mesh_terms': 'D001665:Binding Sites; D001667:Binding, Competitive; D001792:Blood Platelets; D002413:Cations, Divalent; D002918:Chymotrypsin; D005176:Factor XIII; D006801:Humans; D007457:Iodine Radioisotopes; D007700:Kinetics; D010974:Platelet Aggregation; D013917:Thrombin; D011503:Transglutaminases',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002413:Cations, Divalent; D007457:Iodine Radioisotopes; D005176:Factor XIII; D011503:Transglutaminases; D002918:Chymotrypsin; D013917:Thrombin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'A peptide associated with eggs causes a mobility shift in a major plasma membrane protein of spermatozoa.',\n",
       "  'issue': '259(23)',\n",
       "  'pages': '14874-9',\n",
       "  'abstract': 'A peptide (resact) associated with the eggs of the sea urchin, Arbacia punctulata, which stimulates sperm respiration rates by 5-10-fold, was purified and its amino acid sequence was determined. The sequence was found to be Cys-Val-Thr-Gly-Ala-Pro-Gly-Cys-Val-Gly-Gly-Gly-Arg-Leu-NH2. The peptide was subsequently synthesized by solid phase methods, amidated at the carboxyl-terminal Leu, and shown to be identical to the isolated, native material. The peptide half-maximally stimulated A. punctulata spermatozoan respiration at 0.5 nM and half-maximally elevated cyclic GMP concentrations at 25 nM at an extracellular pH of 6.6. The increase in oxygen consumption was coupled with a stimulation of motility. However, at elevated extracellular pH (pH 8.0), resact failed to appreciably stimulate respiration while the elevations of cyclic GMP continued to occur. Resact did not cross-react with sperm cells obtained from Lytechinus pictus or Strongylocentrotus purpuratus; a peptide (speract) obtained from S. purpuratus eggs (Gly-Phe-Asp-Leu-Asn-Gly-Gly-Gly-Val-Gly) which activates S. purpuratus sperm respiration did not stimulate A. punctulata spermatozoa. Resact caused a shift in the apparent molecular weight (160,000-150,000) of a major sperm plasma membrane protein; as with cyclic GMP elevations, this response was evident at extracellular pH values of both 6.6 and 8.0. The protein exists in the cell as a phosphoprotein and 32P is released coincident with the molecular weight change. Approximately 115 nM resact caused one-half-maximal conversion of the 160,000-dalton protein after 1 min of incubation. Resact caused the apparent molecular weight conversion of the protein within 5 s and appeared to do so in an irreversible manner. The molecular weight change of the protein was also observed after the addition of monensin A (25 microM) and NH4Cl (40 mM), two agents known to elevate intracellular pH and to increase sperm respiration rates. The membrane protein appears to be the enzyme guanylate cyclase, but since concentrations of resact causing one-half-maximal conversion of the Mr = 160,000 form of the enzyme are about 250 times higher than those causing one-half-maximal stimulation of respiration, the relationship of the apparent molecular weight conversion to a subsequent physiological event remains unclear.',\n",
       "  'journal': 'The Journal of biological chemistry',\n",
       "  'authors': 'Suzuki|N|N|;Shimomura|H|H|;Radany|E W|EW|;Ramarao|C S|CS|;Ward|G E|GE|;Bentley|J K|JK|;Garbers|D L|DL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150045',\n",
       "  'mesh_terms': 'D000595:Amino Acid Sequence; D000643:Ammonium Chloride; D000818:Animals; D002462:Cell Membrane; D006152:Cyclic GMP; D004591:Electrophoresis, Polyacrylamide Gel; D005260:Female; D006162:Guanylate Cyclase; D008297:Male; D008565:Membrane Proteins; D008970:Molecular Weight; D010101:Oxygen Consumption; D010455:Peptides; D012617:Sea Urchins; D013084:Sperm-Ovum Interactions; D013094:Spermatozoa',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D008565:Membrane Proteins; D010455:Peptides; D000643:Ammonium Chloride; C042019:resact; D006162:Guanylate Cyclase; D006152:Cyclic GMP',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Biol Chem',\n",
       "  'nlm_unique_id': '2985121R',\n",
       "  'issn_linking': '0021-9258',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Trace analysis of benzodiazepine drugs in blood using deactivated amberlite XAD-7 porous polymer beads and silica capillary column gas chromatography with electron-capture detection.',\n",
       "  'issue': '301(1)',\n",
       "  'pages': '137-54',\n",
       "  'abstract': 'A general method for the trace analysis of benzodiazepine drugs and their major metabolites at single dose therapeutic levels in 0.2 ml blood samples is described. The method involves solvent extraction of blood with toluene, isolation of the analytes using deactivated Amberlite XAD-7 porous polymer beads, and analysis of the cleaned-up extracts by capillary column gas chromatography with electron-capture detection. The clean-up technique eliminates lipids and other interfering material, enabling routine analysis of blood extracts to be carried out with no significant deterioration in column or detector performance over a period of many months. The use of fused-silica capillary columns coated with SE-52 and the correct choice of chromatographic conditions permits underivatised benzodiazepines of widely differing volatilities and polarites to be analysed. Data for 26 benzodiazepines and metabolites are presented.',\n",
       "  'journal': 'Journal of chromatography',\n",
       "  'authors': 'Douse|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150046',\n",
       "  'mesh_terms': 'D000180:Acrylic Resins; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D055598:Chemical Phenomena; D002621:Chemistry; D002849:Chromatography, Gas; D004563:Electrochemistry; D006801:Humans; D007202:Indicators and Reagents; D008863:Microspheres; D011137:Polystyrenes',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000180:Acrylic Resins; D014151:Anti-Anxiety Agents; D007202:Indicators and Reagents; D011137:Polystyrenes; D001569:Benzodiazepines; C015661:amberlite XAD 7',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0021-9673(01)89184-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Chromatogr',\n",
       "  'nlm_unique_id': '0427043',\n",
       "  'issn_linking': '',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Determination of bromazepam in plasma and of its main metabolites in urine by reversed-phase high-performance liquid chromatography.',\n",
       "  'issue': '310(1)',\n",
       "  'pages': '129-37',\n",
       "  'abstract': 'A high-performance liquid chromatographic method for the determination of bromazepam in plasma and of its main metabolites in urine is described. The unchanged drug is extracted from plasma with dichloromethane, using Extrelut 1 extraction tubes. The residue from this extract is subsequently analysed by reversed-phase high-performance liquid chromatography with ultraviolet detection (230 nm). The limit of detection is 6 ng/ml of plasma, using a 1-ml specimen. For the determination of the metabolites, the urine samples are incubated to effect enzymatic deconjugation and are then extracted with dichloromethane. Following two clean-up steps (back extractions), the final residue is analysed on the same reversed-phase system as the plasma samples. The limit of detection for the two metabolites is 200 ng/ml.',\n",
       "  'journal': 'Journal of chromatography',\n",
       "  'authors': 'Heizmann|P|P|;Geschke|R|R|;Zinapold|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150047',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D001960:Bromazepam; D002417:Cattle; D002851:Chromatography, High Pressure Liquid; D005966:Glucuronidase; D006207:Half-Life; D006801:Humans; D006900:Hydroxylation; D008099:Liver; D011725:Pyridines; D013056:Spectrophotometry, Ultraviolet',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D011725:Pyridines; C042089:3-hydroxybromazepam; C043575:2-(2-amino-5-bromobenzoyl)pyridine; C043574:N-methylbromazepam; D005966:Glucuronidase; D001960:Bromazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0378-4347(84)80074-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Chromatogr',\n",
       "  'nlm_unique_id': '0427043',\n",
       "  'issn_linking': '',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Histometric study of the localisation of lymphocyte subsets and accessory cells in human Mantoux reactions.',\n",
       "  'issue': '37(11)',\n",
       "  'pages': '1227-34',\n",
       "  'abstract': 'Intradermal injection of purified protein derivative produced typical delayed type hypersensitivity reactions in five healthy human subjects. The major subpopulations of lymphocytes and certain accessory cells were located in frozen sections of biopsies of the lesions with monoclonal antibodies and immunohistochemical staining. The densities (expressed as number/unit area for comparison) of the different types of cells were counted at various microanatomical locations in the tissue. The inflammatory cells were concentrated in narrow zones, initially (24 h) only surrounding small blood vessels but later (48-96 h) also around sweat ducts. Lymphocytes were the predominant cell type at these sites with T4 and T8 cells randomly intermixed at a ratio similar to that in the mononuclear cell fraction of the peripheral blood samples removed at the time of biopsy. There was also a scanty diffuse infiltrate in the intervening dermis, but here the T4:T8 ratio was significantly lower than that in the peripheral blood or perivascular cuffs. There was considerable intersubject variation in the relative preponderance of T8 cells in the diffuse infiltrate. The results suggest that there is no subset selection in the initial emigration of lymphocytes through vascular endothelium in the delayed hypersensitivity reaction, but that the subsets behave differently during the subsequent migration through the tissues. It remains to be determined whether the extent to which T8 cells migrate more rapidly than T4 cells through the tissues may influence the reaction at the site of entry of organisms or antigens into the body by altering the balance of the immunoregulatory lymphocyte subsets. This may underlie some of the differences in susceptibility to infection between subjects and determine the type of granuloma that develops in a particular patient.',\n",
       "  'journal': 'Journal of clinical pathology',\n",
       "  'authors': 'Gibbs|J H|JH|;Ferguson|J|J|;Brown|R A|RA|;Kenicer|K J|KJ|;Potts|R C|RC|;Coghill|G|G|;Swanson Beck|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150048',\n",
       "  'mesh_terms': 'D000328:Adult; D000911:Antibodies, Monoclonal; D000938:Antigen-Presenting Cells; D006801:Humans; D006968:Hypersensitivity, Delayed; D007124:Immunoenzyme Techniques; D007428:Intradermal Tests; D007958:Leukocyte Count; D008297:Male; D008875:Middle Aged; D012867:Skin; D013601:T-Lymphocytes; D014374:Tuberculin Test',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/jcp.37.11.1227',\n",
       "  'references': '4179068;4128124;142111;303147;307761;617802;6991122;6792756;7042840;7042841;6751631;6751638;6216407;6762253;6342880;6221839;6820737;6223731;6224743;6604784',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Clin Pathol',\n",
       "  'nlm_unique_id': '0376601',\n",
       "  'issn_linking': '0021-9746',\n",
       "  'country': 'England'},\n",
       " {'title': 'Glutamate- and GABA-containing neurons in the mouse and rat brain, as demonstrated with a new immunocytochemical technique.',\n",
       "  'issue': '229(3)',\n",
       "  'pages': '374-92',\n",
       "  'abstract': 'Antisera were raised against gamma-aminobutyric acid (GABA) or glutamate (Glu) conjugated to bovine serum albumin with glutaraldehyde. After purification, these antisera reacted strongly with fixed GABA or Glu, but not significantly with other amino acids fixed with glutaraldehyde to brain macromolecules. The antisera were used to demonstrate the distributions of Glu-like and GABA-like immunoreactivities (Glu-LI and GABA-LI) in parts of the perfusion-fixed mouse and rat brain, including the olfactory bulb, cerebral neocortex, thalamus, basal ganglia, lower brain stem, and cerebellum. The level of GABA-LI varied widely among brain regions, thus it was very high in the globus pallidus and substantia nigra and low in the bulk of the thalamus. The GABA antisera labeled nonpyramidal neurons of the neocortex, most cells of the reticular nucleus of the thalamus, medium-sized cells of the caudatoputamen, and stellate, basket, Golgi, and Purkinje cells of the cerebellum. The distribution of GABA-LI closely matched that of the GABA-synthesizing enzyme, glutamic acid decarboxylase (GAD), as revealed in immunocytochemical studies by others. However, the GABA antisera seem to be better suited than GAD antisera for demonstrating putative GABA-ergic axons. The results suggest that GABA-LI, as displayed by the present method, is a good marker of neurons thought to use GABA as a transmitter. Glutamate-like immunoreactivity was much more evenly distributed among regions than GABA-LI, but was particularly low in globus pallidus and substantia nigra and high in the cerebral cortex. Mitral cells of the olfactory bulb, pyramidal neocortical cells, and other cells assumed to use Glu or aspartate as transmitter were stained for Glu-LI, but so also were neurons that are thought to use other transmitters, such as cells in the substantia nigra pars compacta, in the dorsal raphe nucleus, and in the brain stem motor nuclei. The Glu antisera seem to reveal the \"transmitter pool\" as well as the \"metabolic pool\" of Glu in perfusion-fixed material. This report shows that it is possible by means of immunocytochemistry to display reliably the tissue contents of GABA and Glu in material that has been fixed by perfusion with glutaraldehyde.',\n",
       "  'journal': 'The Journal of comparative neurology',\n",
       "  'authors': 'Ottersen|O P|OP|;Storm-Mathisen|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150049',\n",
       "  'mesh_terms': 'D000818:Animals; D001921:Brain; D005968:Glutamate Decarboxylase; D005971:Glutamates; D018698:Glutamic Acid; D007106:Immune Sera; D007118:Immunoassay; D051379:Mice; D009474:Neurons; D051381:Rats; D012710:Serum Albumin, Bovine; D014018:Tissue Distribution; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005971:Glutamates; D007106:Immune Sera; D012710:Serum Albumin, Bovine; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/cne.902290308',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Comp Neurol',\n",
       "  'nlm_unique_id': '0406041',\n",
       "  'issn_linking': '0021-9967',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Human hypersensitivity to a sham vaccine prepared from mosquito-cell culture fluids.',\n",
       "  'issue': '74(6)',\n",
       "  'pages': '808-11',\n",
       "  'abstract': 'A sham vaccine, prepared with the C6/36 cell line derived from larval Aedes albopictus mosquitoes, was skin tested on 12 volunteers. Although no reactions were observed after prick tests, three immediate reactions did occur after intradermal tests. Subcutaneous administration of the C6/36 sham vaccine was initially performed on the nine subjects who did not demonstrate immediate reactions. Five of these subjects developed delayed reactions at the site of the intradermal test within 12 hr after inoculation. A Prausnitz-Küstner test was performed on the back of one unsensitized subject by use of both unheated and heated sera from three subjects who had immediate skin reactions, three who demonstrated a delayed reaction, and one who had a negative skin response. In the Prausnitz-Küstner test, immediate skin reactions were observed with all seven unheated sera but with none of the heated serum aliquots. The determination that skin reactivity was associated with a heat-labile serum factor suggested the mechanism was IgE-mediated. Under close surveillance, the C6/36 sham vaccine was administered subcutaneously to one volunteer who had previously demonstrated an immediate response. This subject developed an anaphylactic reaction characterized by hives at the site and more distantly from the site of the subcutaneous inoculation. Hypersensitivity to A. albopictus larval antigens is common and precludes the use of C6/36 cell culture as a substrate for viral vaccines.',\n",
       "  'journal': 'The Journal of allergy and clinical immunology',\n",
       "  'authors': 'Scott|R M|RM|;Shelton|A L|AL|;Eckels|K H|KH|;Bancroft|W H|WH|;Summers|R J|RJ|;Russell|P K|PK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150050',\n",
       "  'mesh_terms': 'D002478:Cells, Cultured; D009033:Culicidae; D005260:Female; D006801:Humans; D006967:Hypersensitivity; D006969:Hypersensitivity, Immediate; D008297:Male; D012882:Skin Tests; D014612:Vaccines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D014612:Vaccines',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0091-6749(84)90183-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Allergy Clin Immunol',\n",
       "  'nlm_unique_id': '1275002',\n",
       "  'issn_linking': '0091-6749',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Familial mucosal neuromatosis: a minor form of the MEN-2b syndrome].',\n",
       "  'issue': '7(6-7)',\n",
       "  'pages': '479-84',\n",
       "  'abstract': 'When the alert ophthalmologist found visible corneal nerves on a clear stroma, he must remind about the multiple endocrine neoplasia syndrome (M.E.N.-2b) and look for the medullary carcinoma of thyroid and the pheochromocytomas. Recognition of these ocular lesions as components of the syndrome is of the utmost importance because prompt identification of individuals affected by multiple endocrine neoplasia type 2 b facilitates early treatment of associated medullary thyroid carcinomas and pheochromocytomas. These endocrine neoplasias must be carefully searched by endocrine means. We present for the first time, in our knowledge, one family with M.E.N.-2b syndrome without endocrine neoplasias at this moment. We think it can be one minor presentation. We call this form \"familial multiple mucosal neuromas\".',\n",
       "  'journal': \"Journal francais d'ophtalmologie\",\n",
       "  'authors': 'Valentines|J|J|;Marigo|M|M|;Quintana|M|M|;Gomez|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150051',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000310:Adrenal Gland Neoplasms; D000328:Adult; D002277:Carcinoma; D002648:Child; D003315:Cornea; D003937:Diagnosis, Differential; D005142:Eyelid Neoplasms; D005260:Female; D006801:Humans; D006984:Hypertrophy; D008297:Male; D009377:Multiple Endocrine Neoplasia; D009456:Neurofibromatosis 1; D009463:Neuroma; D010641:Phenotype; D010673:Pheochromocytoma; D013964:Thyroid Neoplasms; D014062:Tongue Neoplasms',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Fr Ophtalmol',\n",
       "  'nlm_unique_id': '7804128',\n",
       "  'issn_linking': '0181-5512',\n",
       "  'country': 'France'},\n",
       " {'title': 'Suppression and stimulation of growth hormone release in sheep by somatostatin analogs.',\n",
       "  'issue': '7(4)',\n",
       "  'pages': '277-81',\n",
       "  'abstract': 'The inhibitory and stimulatory effects of somatostatin analogues on growth hormone secretion have been studied in the sheep. Plasma immunoreactive growth hormone (GH) was stimulated by the iv administration of the antilipolytic compound 3,5-dimethylpyrazole and was followed by infusion of somatostatin (SRIF) and analogues into the carotid artery. The analogues D-trp8-D-cys14-SRIF, des-AA1,2,4,5,12D-trp8-D-cys-14SRIF, and SRIF-Wy 40793 were shown to cause a dose-dependent suppression of plasma GH, followed by a significant rise (\"rebound\") on terminating the infusion. In general, the greater the suppression, the greater the rebound. A significant correlation between the rebound increase in plasma GH and dose of both SRIF and des-AA1,2,4,5,12D-trp8-cys14-SRIF was demonstrated (p less than 0.01 and p less than 0.001, respectively). This analogue and Wy-40793 showed a significantly greater rebound than did SRIF following 50% suppression of the GH response (p less than 0.01 and p less than 0.05, respectively). Although two analogues were shown to be significantly more potent than SRIF (p less than 0.01), in this sheep bioassay the duration of action did not appear to be longer than that of the native hormone for any of the three analogues.',\n",
       "  'journal': 'Journal of endocrinological investigation',\n",
       "  'authors': 'Redekopp|C|C|;Livesey|J|J|;Donald|R A|RA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150052',\n",
       "  'mesh_terms': 'D000818:Animals; D004305:Dose-Response Relationship, Drug; D005260:Female; D013006:Growth Hormone; D008433:Mathematics; D010446:Peptide Fragments; D011720:Pyrazoles; D012756:Sheep; D013004:Somatostatin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D010446:Peptide Fragments; D011720:Pyrazoles; C031459:somatostatin, nonapeptide-D-Trp(8)-; D013004:Somatostatin; C020948:somatostatin, Trp(8)-Cys(14)-; C043690:Wy 40793; D013006:Growth Hormone; C027635:3,5-dimethylpyrazole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF03351002',\n",
       "  'references': '90860;6112356;6105610;210361;174366;4132421;5320561;836315;4815179;395066;6111928;6113951;4125377;947121;700091;6987657;4742541;6104680;4808882;683009;4682131;6109991;683008;6153047;979656;4893149',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Endocrinol Invest',\n",
       "  'nlm_unique_id': '7806594',\n",
       "  'issn_linking': '0391-4097',\n",
       "  'country': 'Italy'},\n",
       " {'title': \"An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease.\",\n",
       "  'issue': '7(4)',\n",
       "  'pages': '335-9',\n",
       "  'abstract': \"An improved assay for detecting blocking or inhibitory activity on TSH-binding (TBBA) in neat serum of patients with Graves' disease is described. The assay is sensitive, reproducible, simple, and quick. Crude membranes prepared from guinea pig fat (FCM) were used as the source of TSH receptors. One major feature of the assay is the use of small amounts of FCM to increase assay sensitivity. The sensitivity of the assay was found to be inversely proportional to the amount of FCM used. Using a quantity of 10-20 micrograms crude FCM achieved a satisfactory balance between assay sensitivity and accuracy. The assay employs two sequential one-hour incubations at room temperature, first incubating the FCM with the serum sample, followed by removal of excess sample and washing, and then incubating the exposed FCM with 125I-TSH for quantitative determination of specific TSH binding. The assay is recommended as a standard method for measurement of blocking activity in serum of specific TSH binding. Seventy-four percent of the patients with Graves' disease showed positive blocking activity while all normal individuals and patients with Hashimoto's thyroiditis and with nonautoimmune thyroid disorders were negative.\",\n",
       "  'journal': 'Journal of endocrinological investigation',\n",
       "  'authors': 'Tao|T W|TW|;Kriss|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150053',\n",
       "  'mesh_terms': 'D000273:Adipose Tissue; D000818:Animals; D006111:Graves Disease; D006168:Guinea Pigs; D006801:Humans; D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D008297:Male; D011869:Radioligand Assay; D011956:Receptors, Cell Surface; D011989:Receptors, Thyrotropin; D013967:Thyroiditis, Autoimmune',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D011956:Receptors, Cell Surface; D011989:Receptors, Thyrotropin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF03351013',\n",
       "  'references': '6894892;5538559;45421;218990;233633;4137321;6156613;581876;6291808;77120;4349046;6120179;6126489;14907713;6265939;200488;4366120',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Endocrinol Invest',\n",
       "  'nlm_unique_id': '7806594',\n",
       "  'issn_linking': '0391-4097',\n",
       "  'country': 'Italy'},\n",
       " {'title': 'Methylamines and islet function: cationic aspects.',\n",
       "  'issue': '7(4)',\n",
       "  'pages': '347-55',\n",
       "  'abstract': 'Methylamine (2 to 10 mM) caused a dose-related inhibition of insulin release evoked in rat pancreatic islets by nutrient or non nutrient secretagogues. Trimethylamine exerted comparable effects upon insulin release. Methylamine (2 mM) inhibited insulin secretion but failed to affect 45Ca uptake and efflux in response to a rise in extracellular K+ concentration, suggesting that methylamine acts, to a certain extent at least, at a distal site in the secretory sequence. Methylamine, however, also exerted untoward ionic effects. First, methylamine (2 to 10 mM) apparently caused a dose-related increase in cellular pH. Second, methylamine (2mM) augmented 86Rb outflow from islets perifused either in the absence or presence of glucose or gliclazide, and inhibited Ca2+ inflow (as judged from the net uptake or efflux of 45Ca) in islets stimulated by D-glucose, L-leucine or 2-ketoisocaproate. This multiplicity of ionic and other effects may account for the fact that, in the presence of distinct secretagogues, the secretory process appeared more or less sensitive towards methylamine, depending on the relative importance of changes in cellular pH, K+ permeability and intracellular Ca2+ distribution as determinants of the secretory response.',\n",
       "  'journal': 'Journal of endocrinological investigation',\n",
       "  'authors': 'Lebrun|P|P|;Gomis|R|R|;Deleers|M|M|;Billaudel|B|B|;Mathias|P C|PC|;Herchuelz|A|A|;Malaisse-Lagae|F|F|;Sener|A|A|;Malaisse|W J|WJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150054',\n",
       "  'mesh_terms': 'D000217:Acyltransferases; D000818:Animals; D002118:Calcium; D004305:Dose-Response Relationship, Drug; D005021:Ethylamines; D005947:Glucose; D006863:Hydrogen-Ion Concentration; D007328:Insulin; D007515:Islets of Langerhans; D008744:Methylamines; D010539:Permeability; D011188:Potassium; D051381:Rats; D012413:Rubidium; D011503:Transglutaminases',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005021:Ethylamines; D007328:Insulin; D008744:Methylamines; C027451:methylamine; D000217:Acyltransferases; D011503:Transglutaminases; D005947:Glucose; D012413:Rubidium; D011188:Potassium; D002118:Calcium; C016162:triethylamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF03351015',\n",
       "  'references': '6995249;6988247;6147286;6760899;7031228;6409083;369389;7005451;6339276;4333019;7021285;6254641;6767412;4921884;364009;6126183;6138101;5333500;6993189;6997106;4922110;6342673;6289823;7011884;6285995;6153867;38117;6354699;6148157',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Endocrinol Invest',\n",
       "  'nlm_unique_id': '7806594',\n",
       "  'issn_linking': '0391-4097',\n",
       "  'country': 'Italy'},\n",
       " {'title': 'Bilateral pheochromocytomas.',\n",
       "  'issue': '7(4)',\n",
       "  'pages': '387-92',\n",
       "  'abstract': \"Bilateral pheochromocytomas most often occur as components of well-described syndromes: multiple endocrine neoplasia types 2a and 2b, von Hippel-Lindau disease and neurofibromatosis. We describe 4 patients with isolated bilateral pheochromocytomas; their tumors arose in the absence of stigmata and family history of the syndromes. The manifestations of these 4 individuals are compared with those of 14 other patients who developed pheochromocytomas in both adrenal glands as part of the syndromes. The 4 patients with the isolated pheochromocytomas manifest more rapidly progressing disease: they were 10-14 yrs of age, distinctly younger than those with the syndrome. Three of the 4 exhibited adrenal medullas that were composed entirely of tumor in contrast to the hyperplasia that usually accompanies other bilateral pheochromocytomas. However, malignant transformation of pheochromocytomas was seen both in a non-syndrome patient and in a patient with Lindau's disease.\",\n",
       "  'journal': 'Journal of endocrinological investigation',\n",
       "  'authors': 'Kalff|V|V|;Shapiro|B|B|;Lloyd|R|R|;Nakajo|M|M|;Sisson|J C|JC|;Beierwaltes|W H|WH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150055',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000310:Adrenal Gland Neoplasms; D000313:Adrenal Medulla; D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia; D009456:Neurofibromatosis 1; D010673:Pheochromocytoma; D013577:Syndrome; D006623:von Hippel-Lindau Disease',\n",
       "  'publication_types': \"D002363:Case Reports; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF03351022',\n",
       "  'references': '6814376;4621893;6103678;7235418;4632792;7231514;7469177;6956401;17659;449657;640643;949038;4340974;14215463;904439;4433191;7057475;1275056;945722;24537959;14486930;922654;7234871;679223',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Endocrinol Invest',\n",
       "  'nlm_unique_id': '7806594',\n",
       "  'issn_linking': '0391-4097',\n",
       "  'country': 'Italy'},\n",
       " {'title': 'Histochemical localization of gamma glutamyl transpeptidase in the paranodal region of peripheral nerve.',\n",
       "  'issue': '32(12)',\n",
       "  'pages': '1303-8',\n",
       "  'abstract': 'Gamma glutamyl transpeptidase (GGT), an amino acid transport enzyme, was investigated in normal and degenerated sciatic nerve of rat. The enzyme activity, which is considered to be a marker for cerebrovascular endothelium, was found to be absent in microvessels of normal and degenerated nerves. In the perineurium of normal nerve, GGT activity was faint, while in degenerated nerve, it increased. The most striking finding of this study was the observation of GGT activity at the paranode of each normal myelinated axon. It is interesting that after axotomy (8 weeks), no GGT activity was observed in the Schwann cells of degenerated nerve. Thus, Schwann cell plasmalemma contributed to GGT staining only when this cell was in contact with an axon mature enough to cause it to produce myelin. We conclude that, in peripheral nerve, transmembrane amino acid transport is apparently regional and associated with the paranodal region of myelinated nerve fibers.',\n",
       "  'journal': 'The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society',\n",
       "  'authors': 'Mrsulja|B J|BJ|;Gulati|A K|AK|;Zalewski|A A|AA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150056',\n",
       "  'mesh_terms': 'D000818:Animals; D006651:Histocytochemistry; D008297:Male; D008854:Microscopy, Electron; D009410:Nerve Degeneration; D009900:Optic Nerve; D051381:Rats; D011916:Rats, Inbred F344; D012584:Sciatic Nerve; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/32.12.6150056',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Histochem Cytochem',\n",
       "  'nlm_unique_id': '9815334',\n",
       "  'issn_linking': '0022-1554',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Catecholaminergic and GABAergic anatomical relationship in the rat substantia nigra, locus coeruleus, and hypothalamic median eminence: immunocytochemical visualization of biosynthetic enzymes on serial semithin plastic-embedded sections.',\n",
       "  'issue': '32(12)',\n",
       "  'pages': '1331-8',\n",
       "  'abstract': 'The visualization of protein antigens has been performed on semithin sections embedded in Araldite. After partial removal of the resin and a light proteolytic treatment of the tissue we were able to localize several biosynthetic enzymes: tyrosine hydroxylase (TH), phenylethanolamine N-methyltransferase (PNMT), and glutamic acid decarboxylase (GAD), which are, respectively, markers of catecholaminergic, adrenergic, gamma-aminobutyric acid (GABA)ergic systems. This technique afforded a high resolution of light microscopy details and immunostaining of TH, GAD, and PNMT on serial sections enabled us to compare with great precision GABAergic and adrenergic innervations in the rat locus coeruleus. In addition, it allows us to study the possible relationship between these terminals and the noradrenergic neurons. We also compared the general pattern of distribution of TH- and GAD-positive endings in the hypothalamic median eminence. The preliminary results obtained with this technique revealed some interesting facts previously unseen when preparations with lower histological resolution were used.',\n",
       "  'journal': 'The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society',\n",
       "  'authors': 'Berod|A|A|;Chat|M|M|;Paut|L|L|;Tappaz|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150057',\n",
       "  'mesh_terms': 'D000818:Animals; D001369:Axons; D002395:Catecholamines; D005968:Glutamate Decarboxylase; D006651:Histocytochemistry; D007106:Immune Sera; D007124:Immunoenzyme Techniques; D008125:Locus Coeruleus; D008297:Male; D008473:Median Eminence; D010625:Phenylethanolamine N-Methyltransferase; D051381:Rats; D013378:Substantia Nigra; D014446:Tyrosine 3-Monooxygenase; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002395:Catecholamines; D007106:Immune Sera; D005680:gamma-Aminobutyric Acid; D014446:Tyrosine 3-Monooxygenase; D010625:Phenylethanolamine N-Methyltransferase; D005968:Glutamate Decarboxylase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/32.12.6150057',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Histochem Cytochem',\n",
       "  'nlm_unique_id': '9815334',\n",
       "  'issn_linking': '0022-1554',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Histochemical localization of aspartate aminotransferase activity in the hippocampal formation and in peripheral ganglia of the rat with special reference to the glutamate transmitter metabolism.',\n",
       "  'issue': '25(5)',\n",
       "  'pages': '505-10',\n",
       "  'abstract': 'The regional distribution and cellular localization of aspartate aminotransferase (AspAT), an glutamate/aspartate metabolizing enzyme, was studied in the hippocampal formation, in dorsal root ganglia, and in superior cervical ganglia during the postnatal development of the rat. In the dendritic layers of the hippocampal formation the enzyme activity was found to be very low in newborns, increased markedly from the second week of life and reached adult levels during the postweaning period. These results coincide with parameters of the maturation of glutamatergic structures in this brain region. The staining intensity of AspAT in the peripheral ganglia, in which glutamate/aspartate inputs do not obviously occur, did not display any evident differences during the postnatal development. The increase of AspAT activity parallel to the maturation of glutamatergic/aspartatergic mechanisms suggest that the enzyme studied is involved in glutamate/aspartate neurotransmitter metabolism.',\n",
       "  'journal': 'Journal fur Hirnforschung',\n",
       "  'authors': 'Schmidt|W|W|;Wolf|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150058',\n",
       "  'mesh_terms': 'D000367:Age Factors; D000818:Animals; D001219:Aspartate Aminotransferases; D001224:Aspartic Acid; D005727:Ganglia, Spinal; D005728:Ganglia, Sympathetic; D005971:Glutamates; D018698:Glutamic Acid; D006624:Hippocampus; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D009435:Synaptic Transmission',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005971:Glutamates; D001224:Aspartic Acid; D018698:Glutamic Acid; D001219:Aspartate Aminotransferases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Hirnforsch',\n",
       "  'nlm_unique_id': '0421521',\n",
       "  'issn_linking': '0021-8359',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Production and detection of monoclonal anti-idiotype antibodies directed against a monoclonal anti-beta-adrenergic ligand antibody.',\n",
       "  'issue': '74(1)',\n",
       "  'pages': '163-71',\n",
       "  'abstract': 'A new method has been developed to raise monoclonal anti-idiotypic antibodies. Monoclonal anti-idiotypic antibodies were obtained by fusion of NS-1 myeloma cells with splenocytes of mice immunised by intravenous injections of fixed hybridoma cells bearing a monoclonal antibody specific for beta-adrenergic ligands. New screening tests were developed to analyse the resulting hybridoma supernatants for different anti-idiotypic properties. Among 23 hybridoma supernatants recognising the idiotype, 6 were found to inhibit hapten binding and 3 of these recognised beta-adrenergic receptors.',\n",
       "  'journal': 'Journal of immunological methods',\n",
       "  'authors': 'Guillet|J G|JG|;Chamat|S|S|;Hoebeke|J|J|;Strosberg|A D|AD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150059',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D000911:Antibodies, Monoclonal; D002294:Carcinoma, Squamous Cell; D002460:Cell Line; D006801:Humans; D006825:Hybridomas; D007130:Immunoglobulin Idiotypes; D008024:Ligands; D008214:Lymphocytes; D051379:Mice; D008807:Mice, Inbred BALB C; D010954:Plasmacytoma; D011943:Receptors, Adrenergic, beta',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000911:Antibodies, Monoclonal; D007130:Immunoglobulin Idiotypes; D008024:Ligands; D011943:Receptors, Adrenergic, beta',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0022-1759(84)90377-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Immunol Methods',\n",
       "  'nlm_unique_id': '1305440',\n",
       "  'issn_linking': '0022-1759',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Male infertility].',\n",
       "  'issue': '90(4)',\n",
       "  'pages': '239-322',\n",
       "  'abstract': '',\n",
       "  'journal': \"Journal d'urologie\",\n",
       "  'authors': 'Pontonnier|F|F|;Navratil|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150060',\n",
       "  'mesh_terms': 'D003456:Cryptorchidism; D005837:Genitalia, Male; D012739:Gonadal Steroid Hormones; D006801:Humans; D007248:Infertility, Male; D008297:Male; D013091:Spermatogenesis; D013094:Spermatozoa; D013736:Testicular Neoplasms; D013737:Testis; D014646:Varicocele',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D012739:Gonadal Steroid Hormones',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Urol (Paris)',\n",
       "  'nlm_unique_id': '8006503',\n",
       "  'issn_linking': '0248-0018',\n",
       "  'country': 'France'},\n",
       " {'title': 'Changes in hydroxy and carboxylic acid compositions in the supernatant fluids of mosquito cell cultures infected with dengue viruses.',\n",
       "  'issue': '44(3)',\n",
       "  'pages': '256-62',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of invertebrate pathology',\n",
       "  'authors': 'Kuno|G|G|;Brooks|J B|JB|;Wycoff|B J|BJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150061',\n",
       "  'mesh_terms': 'D000818:Animals; D002264:Carboxylic Acids; D002460:Cell Line; D009033:Culicidae; D003716:Dengue Virus; D006880:Hydroxy Acids; D012703:Serotyping; D013045:Species Specificity; D014779:Virus Replication',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D002264:Carboxylic Acids; D006880:Hydroxy Acids',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0022-2011(84)90022-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Invertebr Pathol',\n",
       "  'nlm_unique_id': '0014067',\n",
       "  'issn_linking': '0022-2011',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Antigenic difference between viral strains causing classical and mild types of epidemic hemorrhagic fever with renal syndrome in China.',\n",
       "  'issue': '150(6)',\n",
       "  'pages': '889-94',\n",
       "  'abstract': 'The antigenic relationship between viral isolates from Apodemus and Rattus that appear to cause the classical and mild types of epidemic hemorrhagic fever (EHF) in China was studied by cross-immunofluorescence, cross-neutralization, immunofluorescence blocking tests, and cross-enzyme-linked immunosorbent assay (ELISA). Obvious antigenic diversity between the isolates was demonstrated by cross-neutralization, immunofluorescence blocking tests, and cross-ELISA. Antisera from patients with classical EHF neutralized viruses of both types to a similar degree, but antisera from patients with mild EHF showed little neutralization of apodemus virus. Similarly, antisera from classical EHF blocked immunofluorescence by monoclonal antibody (25-1 McAb) derived from apodemus virus to both viral antigens, but antisera from mild EHF gave only low-grade blocking against apodemus viral antigen. Direct antigenic titrations of both viral strains by cross-ELISA yielded similar results. That distinct antigenic differences exist between viral strains causing these two types of EHF might be of great importance to the serological differentiation of the viruses and the study of EHF vaccine.',\n",
       "  'journal': 'The Journal of infectious diseases',\n",
       "  'authors': 'Song|G|G|;Hang|C S|CS|;Liao|H X|HX|;Fu|J L|JL|;Gao|G Z|GZ|;Qiu|H L|HL|;Zhang|Q F|QF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150062',\n",
       "  'mesh_terms': 'D000818:Animals; D000956:Antigens, Viral; D003429:Cross Reactions; D004797:Enzyme-Linked Immunosorbent Assay; D005455:Fluorescent Antibody Technique; D006476:Hantavirus; D006480:Hemorrhagic Fever with Renal Syndrome; D006801:Humans; D007674:Kidney Diseases; D012328:RNA Viruses; D051381:Rats; D012703:Serotyping; D013577:Syndrome',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000956:Antigens, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/infdis/150.6.889',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Infect Dis',\n",
       "  'nlm_unique_id': '0413675',\n",
       "  'issn_linking': '0022-1899',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Hemagglutination-inhibiting antibody in hemorrhagic fever with renal syndrome.',\n",
       "  'issue': '150(6)',\n",
       "  'pages': '895-8',\n",
       "  'abstract': 'Hemagglutination activity was demonstrated in a Hantaan virus antigen prepared from infected suckling mouse brain by sucrose-acetone extraction. Hemagglutination of goose erythrocytes was pH dependent and was optimal at pH 6.0-6.2. Immunofluorescent and hemagglutination-inhibiting antibodies were significantly correlated in 80 human and 13 animal sera. Hemagglutination-inhibiting antibody was present in some patients 20 years after the onset of hemorrhagic fever with renal syndrome. The hemagglutination inhibition test was useful for confirming that an insectivore, Suncus murinus, may be an animal reservoir host of a Hantaan-like virus.',\n",
       "  'journal': 'The Journal of infectious diseases',\n",
       "  'authors': 'Tsai|T F|TF|;Tang|Y W|YW|;Hu|S L|SL|;Ye|K L|KL|;Chen|G L|GL|;Xu|Z Y|ZY|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150063',\n",
       "  'mesh_terms': 'D000818:Animals; D000914:Antibodies, Viral; D000917:Antibody Formation; D006476:Hantavirus; D006385:Hemagglutination Inhibition Tests; D006480:Hemorrhagic Fever with Renal Syndrome; D007674:Kidney Diseases; D051379:Mice; D012328:RNA Viruses',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/infdis/150.6.895',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Infect Dis',\n",
       "  'nlm_unique_id': '0413675',\n",
       "  'issn_linking': '0022-1899',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Increased transglutaminase activity in elicited and activated macrophages: relationship to production of superoxide anion.',\n",
       "  'issue': '36(6)',\n",
       "  'pages': '719-27',\n",
       "  'abstract': 'To evaluate whether transglutaminase (TG) might be involved in production of oxygen metabolites, TG activity was measured in resident, in activated, and in elicited murine peritoneal macrophages. These various types of macrophages show a wide diversity in their ability to generate oxygen metabolites. Like other transglutaminases, the macrophage enzyme was found to be a calcium-dependent enzyme that was stabilized by dithiothreitol and inhibited by dansylcadaverine. The TG activity was approximately six-times higher in lysates of LPS-elicited macrophages compared with lysates of resident macrophages; this paralleled the six-fold increase in phorbol myristate acetate-stimulated release of superoxide anion (O2-). From mixing experiments, the difference in TG activity was not due to an endogenous cellular inhibitor in the resident cells. The apparent Km of TG for putrescine was similar in lysates of resident and LPS-elicited macrophages, but the Vmax was significantly greater in lysates of LPS-elicited cells. Macrophages obtained from mice injected with either viable bacillus Calmette-Guérin, muramyl dipeptide, or killed Corynebacterium parvum released three- to six-times more O2- than did resident macrophages. The TG activity in these macrophages was also two- to six- times higher than in resident cells. However, macrophages that were primed by exposure to LPS in vitro exhibited increased production of O2- but no increase in TG activity. We conclude that enhanced TG activity is not a prerequisite for the enhanced O2- production observed in activated macrophages.',\n",
       "  'journal': 'Journal of leukocyte biology',\n",
       "  'authors': 'Harris|L K|LK|;Pabst|M J|MJ|;Johnston|R B|RB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150064',\n",
       "  'mesh_terms': 'D000217:Acyltransferases; D000818:Animals; D004229:Dithiothreitol; D007700:Kinetics; D008070:Lipopolysaccharides; D008262:Macrophage Activation; D008264:Macrophages; D051379:Mice; D009163:Mycobacterium bovis; D013481:Superoxides; D011503:Transglutaminases',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D008070:Lipopolysaccharides; D013481:Superoxides; D000217:Acyltransferases; D011503:Transglutaminases; D004229:Dithiothreitol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/jlb.36.6.719',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Leukoc Biol',\n",
       "  'nlm_unique_id': '8405628',\n",
       "  'issn_linking': '0741-5400',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Somatostatin inhibits prolactin release from the lactotroph primed with oestrogen and cyproterone acetate in man.',\n",
       "  'issue': '103(3)',\n",
       "  'pages': '333-5',\n",
       "  'abstract': 'The present study investigated the effect of administration of somatostatin (SRIF) on the release of prolactin in men. No effect was observed when SRIF was administered to eugonadal men. Release of prolactin was inhibited, however, when SRIF was administered to oestrogen-treated agonadal subjects (male-to-female trans-sexuals) and to an even greater degree when subjects had been pretreated with a combination of oestrogen and cyproterone acetate. This is consistent with findings in the rat. Thus in man, as in the rat, SRIF can inhibit prolactin secretion, but only after treatment with oestrogen.',\n",
       "  'journal': 'The Journal of endocrinology',\n",
       "  'authors': 'Gooren|L J|LJ|;Harmsen-Louman|W|W|;van Kessel|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150065',\n",
       "  'mesh_terms': 'D000328:Adult; D002369:Castration; D003534:Cyproterone; D003864:Depression, Chemical; D004997:Ethinyl Estradiol; D006801:Humans; D008297:Male; D010903:Pituitary Gland, Anterior; D011388:Prolactin; D013004:Somatostatin; D014189:Transsexualism',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004997:Ethinyl Estradiol; D013004:Somatostatin; D011388:Prolactin; D003534:Cyproterone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1677/joe.0.1030333',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Endocrinol',\n",
       "  'nlm_unique_id': '0375363',\n",
       "  'issn_linking': '0022-0795',\n",
       "  'country': 'England'},\n",
       " {'title': 'Purification and properties of autolytic endo-beta-N-acetylglucosaminidase and the N-acetylmuramyl-L-alanine amidase from Bacillus subtilis strain 168.',\n",
       "  'issue': '130(9)',\n",
       "  'pages': '2395-402',\n",
       "  'abstract': 'beta-N-Acetylglucosaminidase has been purified from the walls of Bacillus subtilis 168 and compared with the other known autolysin, N-acetylmuramyl-L-alanine amidase (amidase). The beta-N-acetylglucosaminidase was a dimer in LiCl buffers with a sub-unit molecular weight of 90000 and a pH optimum of about 5.0. It was very sensitive to proteolytic enzymes and was critically activated by 0.1 to 0.2 M-LiCl. It was insoluble in concentrations of LiCl lower than 0.05 to 0.1 M. It was less strongly bound to walls than was the amidase, which was a monomer of molecular weight 30000 to 40000 in LiCl buffers. The beta-N-acetylglucosaminidase is an endo-enzyme and showed no exo-activity. Lysozyme-like enzyme (muramidase) activity was undetectable in the wall extracts examined.',\n",
       "  'journal': 'Journal of general microbiology',\n",
       "  'authors': 'Rogers|H J|HJ|;Taylor|C|C|;Rayter|S|S|;Ward|J B|JB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150066',\n",
       "  'mesh_terms': 'D000118:Acetylglucosaminidase; D000581:Amidohydrolases; D001412:Bacillus subtilis; D002473:Cell Wall; D006596:Hexosaminidases; D006863:Hydrogen-Ion Concentration; D005779:Immunodiffusion; D008070:Lipopolysaccharides; D008094:Lithium; D008274:Magnesium; D017038:Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; D008970:Molecular Weight; D009238:N-Acetylmuramoyl-L-alanine Amidase; D010712:Phosphatidic Acids; D013379:Substrate Specificity; D013682:Teichoic Acids',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D008070:Lipopolysaccharides; D010712:Phosphatidic Acids; D013682:Teichoic Acids; C009900:lipoteichoic acid; D008094:Lithium; D006596:Hexosaminidases; D000118:Acetylglucosaminidase; D017038:Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase; D000581:Amidohydrolases; D009238:N-Acetylmuramoyl-L-alanine Amidase; D008274:Magnesium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1099/00221287-130-9-2395',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Gen Microbiol',\n",
       "  'nlm_unique_id': '0375371',\n",
       "  'issn_linking': '0022-1287',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cholinergic receptors in the Aplysia gill.',\n",
       "  'issue': '15(5)',\n",
       "  'pages': '325-32',\n",
       "  'abstract': 'Acetylcholine has been suggested as a neurotransmitter released in the Aplysia gill by peripheral afferents of central neurons and by peripheral neurons within the gill. The perfused gill, isolated from the abdominal ganglion, was examined. At concentrations greater than 1 microM, acetylcholine elicited a slowly developing tonic contraction of the afferent vein that reversed upon washout. This effect was observed on both quiescent and active preparations. At concentrations less than 1 microM, acetylcholine perfusion resulted in a reduction of gill tone. The excitatory effect of acetylcholine was reduced 80 and 60% by the cholinergic antagonists atropine and hexamethonium, respectively. The acetylcholine-evoked contraction was potentiated 2.5-fold when curare was coinfused. Carbachol did not mimic the excitatory effects of acetylcholine. At all concentrations examined (1-100 microM), carbachol infusion reduced baseline tension, the amplitude of spontaneous contractions and contractions evoked by FMRFamide and dopamine. Contractions evoked by perfusion of p-chlorophenylthiocyclic AMP were greatly reduced when carbachol was added to the perfusate. Further addition of curare reversibly blocked carbachol inhibition of the cyclic AMP-evoked contractions. These findings suggest that excitatory and inhibitory cholinergic receptors are involved in the regulation of gill contractile behavior by acetylcholine.',\n",
       "  'journal': 'Journal of neurobiology',\n",
       "  'authors': 'Weiss|S|S|;Goldberg|J I|JI|;Edstrom|J P|JP|;Lukowiak|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150067',\n",
       "  'mesh_terms': 'D000109:Acetylcholine; D000818:Animals; D001048:Aplysia; D001285:Atropine; D002217:Carbachol; D000242:Cyclic AMP; D004298:Dopamine; D005880:Gills; D018738:Hexamethonium; D006584:Hexamethonium Compounds; D010830:Physostigmine; D011950:Receptors, Cholinergic; D013873:Thionucleotides; D014403:Tubocurarine',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': \"D006584:Hexamethonium Compounds; D011950:Receptors, Cholinergic; D013873:Thionucleotides; D018738:Hexamethonium; C015929:8-((4-chlorophenyl)thio)cyclic-3',5'-AMP; D001285:Atropine; D002217:Carbachol; D010830:Physostigmine; D000242:Cyclic AMP; D000109:Acetylcholine; D004298:Dopamine; D014403:Tubocurarine\",\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/neu.480150503',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Neurobiol',\n",
       "  'nlm_unique_id': '0213640',\n",
       "  'issn_linking': '0022-3034',\n",
       "  'country': 'United States'},\n",
       " {'title': \"The nature of the chick's magnesium-sensitive retinal spreading depression.\",\n",
       "  'issue': '15(5)',\n",
       "  'pages': '333-43',\n",
       "  'abstract': 'Spreading depression (SD) in the chick retina is completely suppressed by 10 mM MgCl2 in the bathing solution (Mg-sensitive SD). However, after increasing the KCl concentration in the Mg solution to values between 10 and 20 mM the retina can again exhibit SDs (Mg-insensitive SD). It has been postulated that the Mg-sensitive SD is a glutamatergic phenomenon. This is supported by the effect of four gl(utamate)-antagonists--L-proline, glutamic acid diethyl ester (GDEE), D-alpha-aminoadipate (D-AA), and 2-amino-4-phosphonobutyrate (APB)--which all suppressed this type of SD. It was suggested that this effect is due to competitive binding of glutamate involved in the Mg-sensitive SD and the gl-antagonist to glutamate receptors. The suppression of SD could be reversed by washing the preparation in a physiologic salt solution. The gl-antagonists in relatively high concentrations had a cytotoxic effect which, when severe, suppressed SD and prevented the recovery of this phenomenon by washing the compound out of the tissue. The compounds examined had, in addition to their gl-antagonistic properties, a gl-agonistic effect, which was postulated to enhance the Na+ permeability of neural membranes resulting in a release of K+ into the extracellular space. In preparations bathed in 10 mM MgCl2 (which suppresses Mg-sensitive SDs) the four compounds investigated promoted Mg-insensitive SDs supposedly when the extracellular K+ concentration reached values between 10 and 20 mequiv.',\n",
       "  'journal': 'Journal of neurobiology',\n",
       "  'authors': 'Van Harreveld|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150068',\n",
       "  'mesh_terms': 'D015074:2-Aminoadipic Acid; D000613:Aminobutyrates; D000818:Animals; D002645:Chickens; D004594:Electrophysiology; D005971:Glutamates; D018698:Glutamic Acid; D008274:Magnesium; D008297:Male; D011392:Proline; D012160:Retina; D009435:Synaptic Transmission',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': 'D000613:Aminobutyrates; D005971:Glutamates; C011829:glutamic acid diethyl ester; D015074:2-Aminoadipic Acid; D018698:Glutamic Acid; D011392:Proline; C012729:2-amino-4-phosphonobutyric acid; D008274:Magnesium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/neu.480150504',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Neurobiol',\n",
       "  'nlm_unique_id': '0213640',\n",
       "  'issn_linking': '0022-3034',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Improved tolerance of vincristine by glutamic acid. A preliminary report.',\n",
       "  'issue': '2(3)',\n",
       "  'pages': '219-22',\n",
       "  'abstract': 'In a murine model system, glutamic acid has demonstrated host protective properties during administration of vincristine (VCR). Subsequently, glutamic acid has been evaluated in patients receiving VCR during adjuvant chemotherapy for stage II carcinoma of the breast. The cumulative VCR dosage and toxicities incurred in 16 patients receiving glutamic acid have been compared to those observed in 88 patients who previously received VCR without glutamic acid in the same chemotherapy program. All patients received VCR 1.0 mg/m2 weekly for 6 weeks with dose modification for neurotoxicity. Treatment patients received glutamic acid 1.5 grams p.o. daily in three divided doses during the induction course. Of the 16 treatment patients, 9 (56%) received 100% ideal dosage of VCR during induction therapy whereas only 24 of 88 (27%) comparison patients attained this dosage level (p less than .025). Gastrointestinal and hematologic toxicities were similar in both groups. These preliminary results suggest the need for an expanded trial of this agent during administration of VCR.',\n",
       "  'journal': 'Journal of neuro-oncology',\n",
       "  'authors': 'Jackson|D V|DV|;Pope|E K|EK|;Case|L D|LD|;Wells|H B|HB|;White|D R|DR|;Cooper|M R|MR|;Caldwell|R D|RD|;Black|W R|WR|;Muss|H B|HB|;Cruz|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150069',\n",
       "  'mesh_terms': 'D000971:Antineoplastic Combined Chemotherapy Protocols; D001943:Breast Neoplasms; D004359:Drug Therapy, Combination; D005260:Female; D005971:Glutamates; D018698:Glutamic Acid; D006801:Humans; D009422:Nervous System Diseases; D014750:Vincristine',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D005971:Glutamates; D018698:Glutamic Acid; D014750:Vincristine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00253273',\n",
       "  'references': '1168475;4352365;13862376;14018556;5163089;6280320;7306914;6981342;6982752;6116478',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Neurooncol',\n",
       "  'nlm_unique_id': '8309335',\n",
       "  'issn_linking': '0167-594X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The control of firing pattern in nigral dopamine neurons: single spike firing.',\n",
       "  'issue': '4(11)',\n",
       "  'pages': '2866-76',\n",
       "  'abstract': 'Dopamine (DA) neurons have been recorded in vivo in four states of activity: hyperpolarized, nonfiring; single spike firing; burst firing; and depolarization inactivation. Nonfiring DA neurons can be made to fire by iontophoretic application of the excitatory substances glutamate and cholecystokinin, or by depolarizing current injection. Spontaneously active DA cells typically fire in a slow (3 to 8 Hz) irregular pattern. In vivo intracellular recordings revealed that this pattern is sustained by the alternation of two currents: a spontaneously occurring slow depolarization (13 +/- 3 mV amplitude, 78 +/- 40 msec duration) which brings the membrane potential of the DA cell to spike threshold (-42 mV), and an afterhyperpolarization mediated by a calcium-activated potassium conductance (IK(Ca)). The slow depolarization is a pacemaker-like conductance, with a rate of rise proportional to the membrane potential. The regular pacemaker pattern of the spontaneously occurring slow depolarization is interrupted by the IK(Ca) which appears to be triggered by calcium entry during the action potential. Thus, intracellular injection of the calcium chelator EGTA will cause DA cells to fire in a regular, pacemaker pattern. The IK(Ca) is observed after single spikes and trains of spikes with the amplitude of the afterhyperpolarization being proportional to the number of spikes in a train. Both the afterhyperpolarization and the firing accommodation observed during depolarizing current injection can be blocked by intracellular injection of the calcium chelator EGTA.',\n",
       "  'journal': 'The Journal of neuroscience : the official journal of the Society for Neuroscience',\n",
       "  'authors': 'Grace|A A|AA|;Bunney|B S|BS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150070',\n",
       "  'mesh_terms': 'D000200:Action Potentials; D000818:Animals; D004298:Dopamine; D004533:Egtazic Acid; D004558:Electric Stimulation; D005971:Glutamates; D018698:Glutamic Acid; D007478:Iontophoresis; D008297:Male; D009474:Neurons; D051381:Rats; D011919:Rats, Inbred Strains; D013378:Substantia Nigra',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D005971:Glutamates; D018698:Glutamic Acid; D004533:Egtazic Acid; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Neurosci',\n",
       "  'nlm_unique_id': '8102140',\n",
       "  'issn_linking': '0270-6474',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The control of firing pattern in nigral dopamine neurons: burst firing.',\n",
       "  'issue': '4(11)',\n",
       "  'pages': '2877-90',\n",
       "  'abstract': 'In addition to firing in a single spiking mode, dopamine (DA) cells have been observed to fire in a bursting pattern with consecutive spikes in a burst displaying progressively decreasing amplitude and increasing duration. In vivo intracellular recording demonstrated the bursts to typically ride on a depolarizing wave (5 to 15 mV amplitude). Although the burst-firing frequency of DA cells showed little correlation with the base line firing rate, increases in firing rate were usually associated with an increase in burst firing. Increases in burst firing could also be elicited by intracellular calcium injection and could be prevented by intracellular injection of EGTA, suggesting a calcium involvement in bursting. Blockade of potassium conductances with extracellular iontophoresis of barium or intracellular injection of tetraethylammonium bromide could also trigger an increased degree of burst firing in DA cells. These data suggest that the increased calcium influx accompanying an increased firing rate triggers burst firing, possibly by inactivating a potassium conductance. A switch from a single spiking mode to a burst-firing mode may be important in modulating striatal DA release, as shown for burst firing in other preparations.',\n",
       "  'journal': 'The Journal of neuroscience : the official journal of the Society for Neuroscience',\n",
       "  'authors': 'Grace|A A|AA|;Bunney|B S|BS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150071',\n",
       "  'mesh_terms': 'D000200:Action Potentials; D000818:Animals; D001464:Barium; D002118:Calcium; D004298:Dopamine; D004533:Egtazic Acid; D005971:Glutamates; D018698:Glutamic Acid; D007473:Ion Channels; D007478:Iontophoresis; D008274:Magnesium; D008297:Male; D009474:Neurons; D011188:Potassium; D051381:Rats; D011919:Rats, Inbred Strains; D013378:Substantia Nigra',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D005971:Glutamates; D007473:Ion Channels; D001464:Barium; D018698:Glutamic Acid; D004533:Egtazic Acid; D008274:Magnesium; D011188:Potassium; D002118:Calcium; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Neurosci',\n",
       "  'nlm_unique_id': '8102140',\n",
       "  'issn_linking': '0270-6474',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Inhibitors of metalloendoprotease activity prevent K+-stimulated neurotransmitter release from the retina of Xenopus laevis.',\n",
       "  'issue': '4(12)',\n",
       "  'pages': '3112-9',\n",
       "  'abstract': 'Metalloendoprotease activity was identified in retinal homogenates using a synthetic fluorogenic metalloendoprotease substrate and specific metalloendoprotease inhibitors. The requirement of metalloendoprotease activity in neurotransmitter release was examined during the depolarization-induced release of [3H]glycine from the retina of Xenopus laevis. Neurons with high affinity uptake and calcium-dependent, K+-stimulated release of glycine have been described previously in this retina. When isolated retinas preloaded with [3H]glycine are depolarized by 22 mM K+, the usual efflux of [3H]glycine is completely abolished by the metalloendoprotease inhibitor, 1,10-phenanthroline (100 micrograms/ml). The inhibition of [3H]glycine release by 1,10-phenanthroline is dose dependent; furthermore, 1,10-phenanthroline blocks release by chelating metal and not Ca2+, since addition of equimolar calcium does not alter the inhibition. The metalloendoprotease inhibitor, carbobenzoxy (CBZ)-L-phenylalanine, also prevents release, whereas the amino acid, L-phenylalanine, has no effect. Synthetic carbobenzoxy dipeptide amides which are metalloendoprotease substrates (e.g., CBZ-Gly-Leu-amide, CBZ-Ser-Leu-amide, and CBZ-Gly-Phe-amide) also prevent [3H]glycine release in a dose-dependent and reversible manner. The synthetic dipeptide CBZ-Gly-Gly-amide, however, is not a metalloendoprotease substrate and has no effect on release. The ability of synthetic dipeptides to inhibit neurotransmitter release is amino acid specific, dose dependent, reversible, and matches their ability to interact with characterized metalloendoproteases. Depolarization-stimulated transmitter release may therefore require the activity of a metalloendoprotease.',\n",
       "  'journal': 'The Journal of neuroscience : the official journal of the Society for Neuroscience',\n",
       "  'authors': 'Frederick|J M|JM|;Hollyfield|J G|JG|;Strittmatter|W J|WJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150072',\n",
       "  'mesh_terms': 'D000818:Animals; D005998:Glycine; D008561:Membrane Fusion; D009469:Neuromuscular Junction; D009474:Neurons; D018377:Neurotransmitter Agents; D010618:Phenanthrolines; D010649:Phenylalanine; D011188:Potassium; D011480:Protease Inhibitors; D012160:Retina; D013569:Synapses; D014316:Tritium; D014981:Xenopus',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D010618:Phenanthrolines; D011480:Protease Inhibitors; D014316:Tritium; D010649:Phenylalanine; D011188:Potassium; D005998:Glycine; C025205:1,10-phenanthroline',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Neurosci',\n",
       "  'nlm_unique_id': '8102140',\n",
       "  'issn_linking': '0270-6474',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effect of ethanol consumed in combination with high or low fat diets on the postinitiation phase of hepatocarcinogenesis in the rat.',\n",
       "  'issue': '114(12)',\n",
       "  'pages': '2311-23',\n",
       "  'abstract': 'In this study, the effect of chronic ethanol ingestion on the modification of the postinitiation phase of hepatocarcinogenesis was examined. Hepatic lesions were initiated in Sprague-Dawley rats by administration of 10 doses of aflatoxin B1 (AFB1) over a 2-week period. Following a week of acclimation rats were fed ethanol (35% of caloric intake) in low fat (11% of calories) or high fat (35% of calories) AIN-76-based liquid diets according to a unique feeding regime for 12 weeks. The effect of ethanol on the development of hepatic gamma-glutamyltransferase (GGT)-positive foci and on nutrient status was evaluated. Only those rats consuming ethanol with a high fat diet developed fatty livers, but all those consuming ethanol had low hepatic vitamin A and glutathione levels compared to pair-fed and ad libitum-fed controls. Despite these changes, no effect of ethanol consumption on the formation of GGT-positive foci was observed. Rats fed a high fat diet had an increased number and size of foci compared to rats on a low fat diet (P less than or equal to 0.01). It was concluded that despite these effects of ethanol on several physiological parameters, modification of the development of presumptive preneoplastic hepatic foci was not affected.',\n",
       "  'journal': 'The Journal of nutrition',\n",
       "  'authors': 'Misslbeck|N G|NG|;Campbell|T C|TC|;Roe|D A|DA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150073',\n",
       "  'mesh_terms': 'D016604:Aflatoxin B1; D000348:Aflatoxins; D000818:Animals; D001835:Body Weight; D004041:Dietary Fats; D004357:Drug Synergism; D000431:Ethanol; D008107:Liver Diseases; D008113:Liver Neoplasms; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D014801:Vitamin A; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000348:Aflatoxins; D004041:Dietary Fats; D014801:Vitamin A; D000431:Ethanol; D016604:Aflatoxin B1; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/jn/114.12.2311',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Nutr',\n",
       "  'nlm_unique_id': '0404243',\n",
       "  'issn_linking': '0022-3166',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Endocrine cells in intestinal metaplasia of the stomach.',\n",
       "  'issue': '144(3)',\n",
       "  'pages': '171-8',\n",
       "  'abstract': 'In this study we have investigated the mucin profile and the endocrine cell population in gastric endoscopic biopsies from 22 patients affected by chronic gastritis and intestinal metaplasia and in five surgical specimens of stomachs removed because of intestinal-type carcinoma (4) or peptic ulcer (1). High iron diamine-Alcian blue (HID-Ab) staining and peptide immunocytochemistry (peroxidase anti-peroxidase technique) were used. Forty-one foci of intestinal metaplasia were detected, 15 produced sulphomucins and 26 sialomucins. Of the endocrine cells investigated, gastrin and somatostatin cells were the most frequently observed, while cholecystokinin, glucose-dependent insulinotropic peptide-, secretin- and enteroglucagon-containing cells were also found in the metaplastic areas, but less frequently. No significant correlation was found between the type of mucin and the types of endocrine cells present, the latter usually resembling those normally found in the small intestine. On the basis of these results we conclude that intestinal metaplasia involves mucin- and peptide-producing cells of the stomach in a variable manner, with no correlation between the two.',\n",
       "  'journal': 'The Journal of pathology',\n",
       "  'authors': 'Mingazzini|P|P|;Carlei|F|F|;Malchiodi-Albedi|F|F|;Lezoche|E|E|;Covotta|A|A|;Speranza|V|V|;Polak|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150074',\n",
       "  'mesh_terms': 'D000328:Adult; D002766:Cholecystokinin; D005749:Gastric Inhibitory Polypeptide; D005753:Gastric Mucosa; D005755:Gastrins; D005756:Gastritis; D004763:Glucagon-Like Peptides; D006801:Humans; D007124:Immunoenzyme Techniques; D007422:Intestines; D008679:Metaplasia; D008875:Middle Aged; D009077:Mucins; D012633:Secretin; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005755:Gastrins; D009077:Mucins; D012633:Secretin; D013004:Somatostatin; D005749:Gastric Inhibitory Polypeptide; D004763:Glucagon-Like Peptides; D002766:Cholecystokinin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/path.1711440304',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pathol',\n",
       "  'nlm_unique_id': '0204634',\n",
       "  'issn_linking': '0022-3417',\n",
       "  'country': 'England'},\n",
       " {'title': 'Endocrine function of cryptorchid testes.',\n",
       "  'issue': '105(5)',\n",
       "  'pages': '853-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Journal of pediatrics',\n",
       "  'authors': 'Sack|J|J|;Theodor|R|R|;Davidson|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150075',\n",
       "  'mesh_terms': 'D002648:Child; D006063:Chorionic Gonadotropin; D003456:Cryptorchidism; D006801:Humans; D008297:Male; D013737:Testis; D013739:Testosterone',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D006063:Chorionic Gonadotropin; D013739:Testosterone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0022-3476(84)80336-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pediatr',\n",
       "  'nlm_unique_id': '0375410',\n",
       "  'issn_linking': '0022-3476',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Pyrimidine de novo synthesis during the life cycle of the intraerythrocytic stage of Plasmodium falciparum.',\n",
       "  'issue': '70(4)',\n",
       "  'pages': '536-41',\n",
       "  'abstract': \"The 6 enzymes involved in de novo synthesis of pyrimidines were measured in Plasmodium falciparum isolated by saponin lysis from RBC's nonsynchronized and synchronized in vitro cultures. The total activities were found to be dependent on the stage of the P. falciparum cycle. In parasites isolated from synchronized cultures, the highest activities for all enzymes were found at about 27 hr after synchronization in the late trophozoite stage, or just before schizont formation. Merozoites and ring forms contained little de novo activity. The first enzyme of the pathway, carbamyl phosphate synthetase (CPS-II) preferentially utilized glutamine. Ammonia was a poor substrate. CPS-II was unstable in the absence of the cryoprotectants, dimethylsulfoxide and glycerol. The apparent Km for MgATP--was 3.8 +/- 0.7 mM and the enzyme in all morphological forms of P. falciparum (ring, mature trophozoites and schizonts) was inhibited by UTP. The activity of the fourth enzyme of the pathway, dihydroorotate dehydrogenase, appeared to be linked to the cell's respiratory chain; inhibitors of mammalian electron transport such as cyanide, amytal, antimycin A, thenoyltrifluoroacetone and ubiquinone analogs also inhibited the P. falciparum enzyme. The demonstration of the variation of activity of the pyrimidine enzymes correlates with the increased synthesis of nucleic acids in the late trophozoite stage. These observations provide a basis for the testing of the effectiveness of pyrimidine analogs as potential antimetabolites against various forms of the parasite.\",\n",
       "  'journal': 'The Journal of parasitology',\n",
       "  'authors': \"Gero|A M|AM|;Brown|G V|GV|;O'Sullivan|W J|WJ|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150076',\n",
       "  'mesh_terms': \"D000255:Adenosine Triphosphate; D000818:Animals; D001221:Aspartate Carbamoyltransferase; D002223:Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); D004080:Dihydroorotase; D004081:Dihydroorotate Oxidase; D004579:Electron Transport; D004912:Erythrocytes; D007700:Kinetics; D009962:Orotate Phosphoribosyltransferase; D009964:Orotidine-5'-Phosphate Decarboxylase; D010963:Plasmodium falciparum; D014500:Uracil Nucleotides; D014542:Uridine Monophosphate\",\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': \"D014500:Uracil Nucleotides; D000255:Adenosine Triphosphate; D014542:Uridine Monophosphate; D004081:Dihydroorotate Oxidase; D001221:Aspartate Carbamoyltransferase; D009962:Orotate Phosphoribosyltransferase; D004080:Dihydroorotase; D009964:Orotidine-5'-Phosphate Decarboxylase; D002223:Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing)\",\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Parasitol',\n",
       "  'nlm_unique_id': '7803124',\n",
       "  'issn_linking': '0022-3395',\n",
       "  'country': 'United States'},\n",
       " {'title': 'A quantitative study of enteric endocrine cells in celiac sprue.',\n",
       "  'issue': '3(5)',\n",
       "  'pages': '665-71',\n",
       "  'abstract': 'A quantitative morphological investigation of eight endocrine cell types in mucosal biopsies from adults with untreated celiac sprue was undertaken. The quantitative data expressed as cells per millimeter of epithelium most accurately reflected the changes seen in celiac disease, as it takes into account changes in mucosal thickness due to the absence of villi in celiac biopsies. The results showed significant increases in the number of cholecystokinin and enterochromaffin cells, a significant decrease in somatostatin, gastric inhibitory polypeptide and secretin cells, and no change in the motilin, gastrin, and glicentin cells. Significant changes in cell size (cross-sectional area) were also demonstrated in the somatostatin and gastrin cells which were smaller in the celiac biopsies.',\n",
       "  'journal': 'Journal of pediatric gastroenterology and nutrition',\n",
       "  'authors': 'Buchan|A M|AM|;Grant|S|S|;Brown|J C|JC|;Freeman|H J|HJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150077',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D002446:Celiac Disease; D002452:Cell Count; D002766:Cholecystokinin; D004386:Duodenum; D004759:Enterochromaffin Cells; D005260:Female; D005749:Gastric Inhibitory Polypeptide; D005768:Gastrointestinal Hormones; D005934:Glucagon; D006801:Humans; D007413:Intestinal Mucosa; D008297:Male; D008875:Middle Aged; D009037:Motilin; D052336:Proglucagon; D011498:Protein Precursors; D012633:Secretin; D013004:Somatostatin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005768:Gastrointestinal Hormones; D011498:Protein Precursors; D012633:Secretin; D013004:Somatostatin; D009037:Motilin; D052336:Proglucagon; D005749:Gastric Inhibitory Polypeptide; D005934:Glucagon; D002766:Cholecystokinin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/00005176-198411000-00004',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pediatr Gastroenterol Nutr',\n",
       "  'nlm_unique_id': '8211545',\n",
       "  'issn_linking': '0277-2116',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Ca2+-transport and Mg2+- and Ca2+-ATPase activity in the exocrine pancreas.',\n",
       "  'issue': '3 Suppl 1()',\n",
       "  'pages': 'S11-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of pediatric gastroenterology and nutrition',\n",
       "  'authors': 'Katz|S|S|;Ansah|T A|TA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150078',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D000255:Adenosine Triphosphate; D000818:Animals; D001692:Biological Transport; D017301:Ca(2+) Mg(2+)-ATPase; D002118:Calcium; D000252:Calcium-Transporting ATPases; D002147:Calmodulin; D002462:Cell Membrane; D004305:Dose-Response Relationship, Drug; D007770:L-Lactate Dehydrogenase; D008274:Magnesium; D010179:Pancreas; D051381:Rats',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002147:Calmodulin; D000255:Adenosine Triphosphate; D007770:L-Lactate Dehydrogenase; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D008274:Magnesium; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/00005176-198400031-00005',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pediatr Gastroenterol Nutr',\n",
       "  'nlm_unique_id': '8211545',\n",
       "  'issn_linking': '0277-2116',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Theoretical estimation of punch velocities and displacements of single-punch and rotary tablet machines.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '645-51',\n",
       "  'abstract': \"The speed of travel of punches during compaction by a Manesty F3 single punch and D3B Rotary punch tablet machine has been derived from machine dimensions, normal operating speeds and by consideration of the consolidation of a theoretical compact. The analysis may also be used for machines with other dimensions, operating at different speeds with other materials, but would require modification if the punch head design on the rotary machine differed significantly. Punch speeds at the beginning of the compression cycle were similar for the two types of machines, namely 10.36 and 10.24 cm s-1 for the single and rotary machines. The time to reach maximum compression and the total time of contact between punches and powder for the single punch machine was 0.1 s for a compaction force of approximately 40 KN. For the rotary machine operating at approximately the same force, these two parameters were found to be 0.052 and 0.083 s respectively. The additional contact time is associated with a period during which there is no vertical movement of the punch, providing a 'dwell' time of 0.0314 s when the powder is held at a constant volume.\",\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Charlton|B|B|;Newton|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150079',\n",
       "  'mesh_terms': 'D004339:Drug Compounding; D008962:Models, Theoretical; D013607:Tablets; D013678:Technology, Pharmaceutical',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D013607:Tablets',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04836.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Amine oxidase activities in brown adipose tissue of the rat: identification of semicarbazide-sensitive (clorgyline-resistant) activity at the fat cell membrane.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '652-8',\n",
       "  'abstract': 'Amine oxidase activity, previously described in homogenates of brown adipose tissue of the rat, has now been investigated in preparations of isolated fat cells. It was found that the specific activities of both monoamine oxidase A (MAO) and of the semicarbazide-sensitive clorgyline-resistant amine oxidase (SSAO) were higher in isolated fat cells than in the original whole tissue. Brown adipocytes therefore represent a major source of both these enzymes. In plasma membranes prepared from these isolated brown fat cells by borate extraction there was a similar enrichment of activity of SSAO and of the plasma membrane marker enzyme, phosphodiesterase I. However in preparations of cell membranes made by binding the cells to polycation-coated beads, enrichment of phosphodiesterase I activity was much greater than that of SSAO. It is suggested that the disposition of the enzyme within the cell membrane may account for the discrepancy in these results, i.e. the sidedness of the membrane may be important. Histochemical visualization of enzyme activity in whole tissue at the ultrastructural level was undertaken. Positive staining of mitochondria was achieved in the presence of the MAO substrate, tryptamine. Staining around the edges of the brown fat cells was observed with the SSAO substrates, tyramine and benzylamine. Staining was largely absent when substrate was omitted or after pretreatment with the irreversible SSAO inhibitor, hydralazine and the slowly reversible inhibitor, semicarbazide. It is not definitely proven that this staining represents sites of enzyme activity but the results are consistent with evidence from other studies indicating that SSAO in brown adipose tissue of the rat may be found predominantly at the fat cell surface.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Barrand|M A|MA|;Fox|S A|SA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150080',\n",
       "  'mesh_terms': 'D002001:Adipose Tissue, Brown; D000818:Animals; D002462:Cell Membrane; D003010:Clorgyline; D005260:Female; D006651:Histocytochemistry; D008297:Male; D008863:Microspheres; D008928:Mitochondria; D008995:Monoamine Oxidase; D043264:Phosphodiesterase I; D010727:Phosphoric Diester Hydrolases; D011437:Propylamines; D051381:Rats; D011919:Rats, Inbred Strains; D012663:Semicarbazides; D014363:Tryptamines',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D011437:Propylamines; D012663:Semicarbazides; D014363:Tryptamines; D008995:Monoamine Oxidase; D010727:Phosphoric Diester Hydrolases; D043264:Phosphodiesterase I; D003010:Clorgyline',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04837.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Physiological disposition of oral piracetam in Sprague-Dawley rats.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '659-62',\n",
       "  'abstract': \"The distribution and fate of piracetam (2-oxo-1-pyrrolidine acetamide, Nootropil), the prototype 'nootropic drug', was examined in rats given 100-1000 mg kg-1 by gavage, with or without [3H]piracetam as a tracer. Peak serum concentrations were attained after 60 min. Its half-life of disappearance from serum was about 2 h during the initial 8 h after administration and then about 6.4 h for the next 16 h. Brain piracetam concentrations equilibrated with those of serum at about 4 h, after which they fell exponentially but remained about twice those of serum; piracetam concentrations in the brainstem were lower (by 30-40%) than those in the cortex, olfactory bulb, and colliculi. No evidence could be obtained for significant piracetam metabolism, either in-vivo or when incubated with liver homogenates. No specific binding of [3H]piracetam to any of various subcellular fractions was observed after its administration along with unlabelled carrier. Repeated daily doses of piracetam (7 days, 100 mg kg-1) failed to elevate serum or brain concentrations beyond those observed after a single dose.\",\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Tacconi|M T|MT|;Wurtman|R J|RJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150081',\n",
       "  'mesh_terms': 'D000818:Animals; D001711:Biotransformation; D001921:Brain; D006207:Half-Life; D008297:Male; D010889:Piracetam; D011760:Pyrrolidinones; D051381:Rats; D011919:Rats, Inbred Strains; D012436:S-Adenosylmethionine; D013347:Subcellular Fractions; D013997:Time Factors; D014018:Tissue Distribution',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D011760:Pyrrolidinones; D012436:S-Adenosylmethionine; D010889:Piracetam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04838.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Plasma protein binding of frusemide in renal failure rabbits: investigation of endogenous protein binding inhibitors.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '663-7',\n",
       "  'abstract': 'The reduction mechanism of frusemide-protein binding in the plasma of renal failure was investigated. The drug-albumin binding was inhibited by the low molecular-weight fraction obtained from acute renal failure rabbits, suggesting the presence of the inhibitors in the plasma. Further, this fraction was divided into six subfractions by Bio-Gel P-2. Fractions II and V2 showed significant inhibition of the protein binding of frusemide. Among uraemic toxins, four indole derivatives markedly inhibited the protein binding. Analysis by hplc confirmed that the concentration of indican was markedly increased in acute renal failure rabbit plasma. It is suggested that this compound could be one of the major inducers of the protein binding defect.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Ikeda|K|K|;Yoshitomi|H|H|;Nakayama|T|T|;Goto|S|S|;Kimura|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150082',\n",
       "  'mesh_terms': 'D058186:Acute Kidney Injury; D000818:Animals; D001798:Blood Proteins; D002850:Chromatography, Gel; D002851:Chromatography, High Pressure Liquid; D005665:Furosemide; D007200:Indican; D007210:Indoleacetic Acids; D007211:Indoles; D008297:Male; D008627:Mercuric Chloride; D008970:Molecular Weight; D011485:Protein Binding; D011817:Rabbits; D012710:Serum Albumin, Bovine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001798:Blood Proteins; D007210:Indoleacetic Acids; D007211:Indoles; C014612:indolebutyric acid; D012710:Serum Albumin, Bovine; D008627:Mercuric Chloride; C024139:indole-3-lactic acid; C030737:indoleacetic acid; D005665:Furosemide; D007200:Indican',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04839.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'The action and interaction of beta-phenethylamines and imidazolines on prejunctional alpha 2-adrenoceptors of guinea-pig ileum in the presence of the non-competitive antagonist benextramine.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '668-72',\n",
       "  'abstract': 'The effects of benextramine, a selective non-competitive, irreversible antagonist of alpha-adrenoceptors, against alpha 2-adrenoceptor agonists has been investigated in isolated field-stimulated guinea-pig ileum. Benextramine was equipotent against the imidazoline, clonidine and the thiazoloazepine B-HT920, however, higher concentrations of benextramine were required for an equivalent non-competitive antagonism of the beta-phenethylamine, alpha-methylnoradrenaline. Using benextramine to differentially block the agonist effects of clonidine but not alpha-methylnoradrenaline it was shown that clonidine can competitively antagonize the effects of alpha-methylnoradrenaline. From these and previous results on the differential effects of imidazoline-like and beta-phenethylamine-like drugs on alpha 2-adrenoceptors, it is proposed that two distinct populations of these receptors exist.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Mottram|D R|DR|;Thakar|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150083',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001381:Azepines; D003000:Clonidine; D003538:Cystamine; D004558:Electric Stimulation; D006168:Guinea Pigs; D007082:Ileum; D007093:Imidazoles; D066298:In Vitro Techniques; D009119:Muscle Contraction; D009130:Muscle, Smooth; D008771:Nordefrin; D010627:Phenethylamines; D011942:Receptors, Adrenergic, alpha',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D001381:Azepines; D007093:Imidazoles; D010627:Phenethylamines; D011942:Receptors, Adrenergic, alpha; C029998:benextramine; C024763:talipexole; D003000:Clonidine; D003538:Cystamine; D008771:Nordefrin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04840.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Differential effects of 5-hydroxytryptaminergic antagonists upon apomorphine- and lergotrile-induced hypothermia and stereotyped behaviour in rats.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '673-6',\n",
       "  'abstract': 'The dopaminergic stimulants apomorphine and lergotrile both evoked hypothermia and stereotyped behaviour in rats. These drug effects were sensitive to antagonism by haloperidol, a dopaminergic receptor blocker. In rats pretreated with 5-hydroxytryptaminergic receptor blockers, cinanserin reduced apomorphine-induced hypothermia but cyproheptadine did not. Both cinanserin and cyproheptadine significantly potentiated lergotrile-induced hypothermia. Similarly, the stereotypic effects of apomorphine were partly reduced by cyproheptadine, although higher doses of cyproheptadine did potentiate lergotrile-induced stereotyped behaviour. These findings of different influences of 5-HT antagonists upon the effects of apomorphine and lergotrile indicate that these two dopaminergic stimulants may not work in identical manner to produce outwardly similar drug effects.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Wade|R L|RL|;Quock|R M|RM|;Malone|M H|MH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150084',\n",
       "  'mesh_terms': 'D006916:5-Hydroxytryptophan; D000818:Animals; D001058:Apomorphine; D001831:Body Temperature; D002928:Cinanserin; D003533:Cyproheptadine; D004873:Ergolines; D006220:Haloperidol; D006801:Humans; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013239:Stereotyped Behavior',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D004873:Ergolines; D003533:Cyproheptadine; D006916:5-Hydroxytryptophan; D006220:Haloperidol; D002928:Cinanserin; D001058:Apomorphine; C031875:lergotrile',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04841.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'The effects of chronic inhalation of salbutamol on the acute airway responsiveness to salbutamol and ipratropium bromide in the conscious and the anaesthetized guinea-pig.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '677-82',\n",
       "  'abstract': 'The effects of chronic exposure to a nebulized mist of salbutamol on the capacity of systemic salbutamol to prolong the time taken for inhaled histamine to produce bronchospasm in guinea-pigs have been examined. Initially a reproducible cough time to inhalation of histamine acid phosphate (0.5 ml ml-1) in 100% O2 was established. Antagonism of this response by intraperitoneal salbutamol or ipratropium Br was assessed to establish submaximal responses to these drugs. A fresh group of animals was then exposed to a persistent mist of nebulized water for 16 days, before and during which each animal was tested by exposure to histamine mist either alone or shortly after salbutamol (10 micrograms kg-1 i.p.) or ipratropium Br (5 micrograms kg-1 i.p.). The nebulized water had no effect on the response to the drugs. The same animals were rested for 7 days and then exposed to nebulized salbutamol solution (5 mg ml-1) for 15 days, during which time tachyphylaxis developed to salbutamol (i.p.) but not to ipratropium Br. At the end of the 15 days the animals were anaesthetized and total lung resistance (RL) measured. At this time, the protective effect of intravenous salbutamol was also diminished by comparison with untreated guinea-pigs while the response to ipratropium Br was unaffected. A separate group exposed to 1 mg ml-1 of nebulized salbutamol for 20 days developed selective tachyphylaxis to intraperitoneal salbutamol. The animals were then allowed to breathe room air and the response to intraperitoneal salbutamol after 13 days returned to normal as did the effects of intravenous salbutamol on the RL response to histamine.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Woodsford|P V|PV|;Tomlinson|D R|DR|;Ward|M J|MJ|;Palmer|J P|JP|;Poole|T R|TR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150085',\n",
       "  'mesh_terms': 'D000336:Aerosols; D000403:Airway Resistance; D000420:Albuterol; D000758:Anesthesia; D000818:Animals; D001286:Atropine Derivatives; D001985:Bronchial Provocation Tests; D001986:Bronchial Spasm; D006168:Guinea Pigs; D006632:Histamine; D009241:Ipratropium; D008297:Male; D013618:Tachyphylaxis',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000336:Aerosols; D001286:Atropine Derivatives; D006632:Histamine; D009241:Ipratropium; D000420:Albuterol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04842.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'The role of opioid receptor sub-types in tifluadom-induced feeding.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '683-6',\n",
       "  'abstract': 'There is now considerable evidence that opioid agonists and benzodiazepines increase food and water intake in a variety of animal species. The appetitive effects of the novel opioid-benzodiazepine tifluadom have been investigated. (+/-)-Tifluadom significantly increased food intake in freely-feeding rats. This stimulation of appetite was attributable principally to the activity of the (+)-isomer. Furthermore tifluadom-induced feeding was blocked by the opioid antagonists naloxone, naltrexone, Mr 1452 and Mr 2266 but not by the delta-opioid receptor antagonist ICI 154, 129, or by the benzodiazepine antagonist Ro 15-1788. These results suggest that tifluadom exerts its effect on food intake by interaction with opioid as opposed to benzodiazepine receptors and that this activity is mediated by kappa and/or mu- rather than delta-opioid receptor sub-types.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Jackson|H C|HC|;Sewell|R D|RD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150086',\n",
       "  'mesh_terms': 'D000818:Animals; D001569:Benzodiazepines; D001570:Benzodiazepinones; D001575:Benzomorphans; D003292:Convulsants; D004435:Eating; D004743:Enkephalin, Leucine; D005442:Flumazenil; D008297:Male; D009270:Naloxone; D009271:Naltrexone; D009292:Narcotic Antagonists; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid; D013237:Stereoisomerism',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001570:Benzodiazepinones; D001575:Benzomorphans; D003292:Convulsants; D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D001569:Benzodiazepines; D009270:Naloxone; D005442:Flumazenil; C027247:MR 2266; D004743:Enkephalin, Leucine; D009271:Naltrexone; C029552:Mr 1452; C036405:ICI 154129; C035470:tifluadom',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04843.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'The determination of leachable chromium from chromicized catgut sutures.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '687-9',\n",
       "  'abstract': 'Application of the British Pharmacopoeia (BP) Analytical procedure for the determination of leachable chromium to samples of catgut sutures yielded fading coloured solutions and was considered to constitute a poor basis for an analytical method. The United States Pharmacopeia (USP) method and an adaptation of the American Public Health Association (APHA) method were explored and found to give linear responses over the concentration range of interest. Both these methods were applied to a series of samples and the results obtained were different as the APHA method measures total chromium while the USP procedure determines only chromium (VI).',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Smith|W J|WJ|;Johnston|M A|MA|;Lea|A R|AR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150087',\n",
       "  'mesh_terms': 'D000818:Animals; D002398:Catgut; D002415:Cats; D002857:Chromium; D003124:Colorimetry; D010084:Oxidation-Reduction; D013537:Sutures',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D002857:Chromium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04844.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Warfarin-sulfinpyrazone interaction on binding to human serum albumin.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '689-90',\n",
       "  'abstract': 'Sulfinpyrazone displacement of warfarin from human serum albumin was studied in-vitro. At low sulfinpyrazone concentrations one molecule of warfarin is displaced on binding by one molecule of sulfinpyrazone. Clinical plasma concentrations of sulfinpyrazone are, however, too low to cause significant displacement.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Larsen|F G|FG|;Larsen|C G|CG|;Brodersen|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150088',\n",
       "  'mesh_terms': 'D001667:Binding, Competitive; D006801:Humans; D066298:In Vitro Techniques; D011485:Protein Binding; D012709:Serum Albumin; D013442:Sulfinpyrazone; D014859:Warfarin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D012709:Serum Albumin; D014859:Warfarin; D013442:Sulfinpyrazone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04845.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'o- and M-iodohippurate binding to plasma proteins as a model drug transport mechanism.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '690-3',\n",
       "  'abstract': 'The pharmacokinetics of two isomers, o- and m-iodohippurate, were determined in rabbits and rats and the effect of protein binding on their elimination is demonstrated. Both isomers are rapidly eliminated by transport systems in the kidney and their clearance by the kidney approaches the renal plasma flow regardless of protein binding, m-Iodohippurate is more highly bound to plasma proteins than o-iodohippurate and its rate of elimination is enhanced in comparison with o-iodohippurate. In the case of these two isomers, the binding to plasma proteins should be considered as a transport mechanism and not as a storage depot.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Láznícek|M|M|;Kvĕtina|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150089',\n",
       "  'mesh_terms': 'D000818:Animals; D001692:Biological Transport; D001798:Blood Proteins; D006863:Hydrogen-Ion Concentration; D007457:Iodine Radioisotopes; D007465:Iodohippuric Acid; D007536:Isomerism; D007700:Kinetics; D008297:Male; D008954:Models, Biological; D011485:Protein Binding; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001798:Blood Proteins; D007457:Iodine Radioisotopes; D007465:Iodohippuric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04846.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Binding of busulfan to plasma proteins and blood cells.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '694-6',\n",
       "  'abstract': 'The reversible and non-reversible binding of busulfan to plasma proteins and to blood cells has been evaluated in man. The reversible binding to plasma proteins was insignificant in both healthy subjects and in patients with chronic myelocytic leukaemia. The percentage of busulfan irreversibly bound to plasma ligands was 32.4. Busulfan was distributed evenly between blood cells and plasma. The fraction of busulfan irreversibly bound to the blood cells was 46.9%. The major portion of busulfan that is degraded in whole blood reacts with the blood cells and the main part of that binds to macromolecular components in the cells.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Ehrsson|H|H|;Hassan|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150090',\n",
       "  'mesh_terms': 'D001711:Biotransformation; D001773:Blood Cells; D001798:Blood Proteins; D002066:Busulfan; D006400:Hematocrit; D006801:Humans; D066298:In Vitro Techniques; D011485:Protein Binding',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001798:Blood Proteins; D002066:Busulfan',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04847.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Inhibition by diethylcarbamazine of acetylcholine-induced endothelium-dependent relaxation of rabbit aorta: are leukotrienes involved?',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '696-7',\n",
       "  'abstract': 'Acetylcholine caused relaxations of preconstricted rabbit aortic strips if the endothelium was intact. These relaxations were reversed in a concentration-dependent manner by diethylcarbamazine, an inhibitor of slow-reacting substance and leukotriene formation. However, when exogenous leukotrienes (LTA4, LTB4, LTC4 and LTD4) were added to the precontracted arterial strips none of them caused relaxation, showing that they are unlikely to be involved as mediators in the acetylcholine-induced relaxation of rabbit aorta.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Förstermann|U|U|;Neufang|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150091',\n",
       "  'mesh_terms': 'D000109:Acetylcholine; D000818:Animals; D001013:Aorta, Thoracic; D001095:Arachidonic Acids; D004049:Diethylcarbamazine; D004727:Endothelium; D066298:In Vitro Techniques; D017572:Leukotriene A4; D007975:Leukotriene B4; D009126:Muscle Relaxation; D009131:Muscle, Smooth, Vascular; D011817:Rabbits; D013189:SRS-A',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001095:Arachidonic Acids; D017572:Leukotriene A4; D013189:SRS-A; D007975:Leukotriene B4; D000109:Acetylcholine; D004049:Diethylcarbamazine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04848.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'An homogeneous population of beta 1-adrenoceptors subserves inhibitory responses in guinea-pig ileal preparations.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '698-9',\n",
       "  'abstract': 'In transmurally stimulated guinea-pig ileal preparations, the pA2 values obtained with the selective beta 1- and beta 2-adrenoceptor antagonists atenolol and ICI 118,551 were independent of the beta-adrenoceptor agonist used [-)-isoprenaline or fenoterol) and were similar to values reported in isolated cardiac tissue. On the basis of these results, the relaxant responses to beta-adrenoceptor agonists in guinea-pig ileal preparations appear to be mediated by an homogeneous population of beta 1-adrenoceptors.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Mian|M A|MA|;Malta|E|E|;Raper|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150092',\n",
       "  'mesh_terms': 'D000818:Animals; D001262:Atenolol; D005280:Fenoterol; D006168:Guinea Pigs; D007082:Ileum; D066298:In Vitro Techniques; D007545:Isoproterenol; D009119:Muscle Contraction; D009130:Muscle, Smooth; D011412:Propanolamines; D011943:Receptors, Adrenergic, beta',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; D005280:Fenoterol; C026777:ICI 118551; D001262:Atenolol; D007545:Isoproterenol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04849.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Central and peripheral inhibition of gastrointestinal transit in rats: narcotics differ substantially by acting at either or both levels.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '699-701',\n",
       "  'abstract': 'The roles of local intestinal and centrally mediated opiate-specific mechanisms underlying gastrointestinal transit inhibiton by five typical narcotic analgesics were assessed by the rat charcoal meal test. The doses (mg kg-1 s.c.) reducing the progression of charcoal to 50% of drug-free controls in 5 min (ID50) were approximately 1 for morphine and methadone, 0.5 and 40 for diamorphine and pethidine (all given 25 min before charcoal) and 0.001 for etorphine (10 min before charcoal). The delay in test meal travel caused by these ID50 doses was completely prevented by i.p. naloxone. Intracerebroventricular (i.c.v.) naloxone fully antagonized pethidine and etorphine but had no effect on morphine. Morphine, but either pethidine nor etorphine, was antagonized by i.p. N-methyl naloxone (a peripheral antagonist). Diamorphine and methadone were partially antagonized by i.c.v. naloxone or i.p. N-methyl naloxone.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Peracchia|F|F|;Bianchi|G|G|;Fiocchi|R|R|;Petrillo|P|P|;Tavani|A|A|;Manara|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150093',\n",
       "  'mesh_terms': 'D000701:Analgesics, Opioid; D000818:Animals; D005048:Etorphine; D005769:Gastrointestinal Motility; D003932:Heroin; D007274:Injections, Intraperitoneal; D007276:Injections, Intraventricular; D008297:Male; D008614:Meperidine; D009020:Morphine; D009270:Naloxone; D051381:Rats',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000701:Analgesics, Opioid; D009270:Naloxone; D005048:Etorphine; D003932:Heroin; D009020:Morphine; D008614:Meperidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04850.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Role of vagus in the antagonism of ouabain induced arrhythmias in dogs by beta-adrenoceptor antagonists and related drugs.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '702-4',\n",
       "  'abstract': 'The effects of propranolol and related drugs were investigated on ouabain-induced ventricular tachycardia (VT) in dogs with intact and ablated vagi. Propranolol and UM-272 completely antagonized the ouabain VT in dogs with intact vagi, whereas timolol was ineffective. Bilateral vagotomy completely abolished the effect of UM-272 and reduced the effect of propranolol. Diphenylhydantoin, however, reversed ouabain VT in dogs with both intact and ablated vagi. It is inferred that the vagus plays a significant role in the arrhythmolytic effect of propranolol and UM-272.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Alkondon|M|M|;Ray|A|A|;Sen|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150094',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac; D001794:Blood Pressure; D004285:Dogs; D005260:Female; D006339:Heart Rate; D006352:Heart Ventricles; D008297:Male; D010042:Ouabain; D010672:Phenytoin; D011433:Propranolol; D013610:Tachycardia; D013999:Timolol; D014628:Vagotomy; D014630:Vagus Nerve',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D010042:Ouabain; D010672:Phenytoin; C002616:pranolium; D013999:Timolol; D011433:Propranolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04851.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'The effects of phenylpropanolamine and other sympathomimetics on food consumption and motor activity in mice.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '704-6',\n",
       "  'abstract': \"The effects of phenylpropanolamine on motor activity and on food intake were compared with those of S-amphetamine, ephedrine, 2-aminoindane and fenfluramine in groups of mice. Motor activity was additionally measured in mice pretreated with levodopa and benserazide, and food intake in mice pretreated with alpha-methyl-p-tyrosine. Amphetamine (2.5 mg kg-1) increased motor activity, phenylpropanolamine (10-40 mg kg-1) and 2-aminoindane (2.5-10 mg kg-1) decreased activity whilst ephedrine (2.5-40 mg kg-1) had a biphasic effect. Fenfluramine (10-40 mg kg-1) had negligible effect on activity. In mice pretreated with levodopa and benserazide both phenylpropanolamine and 2-aminoindane caused a massive increase in motor activity whilst fenfluramine's action was not affected in the same way. Whilst the anorectic action of fenfluramine was considerably potentiated in mice pretreated with alpha-methyl-p-tyrosine, that of amphetamine, ephedrine, 2-aminoindane and phenylpropanolamine was either unaffected or initially antagonized. It is concluded that the mechanisms of motor and anorectic actions of phenylpropanolamine are similar to those of amphetamine.\",\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Cairns|M J|MJ|;Foldys|J E|JE|;Rees|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150095',\n",
       "  'mesh_terms': 'D000818:Animals; D001545:Benserazide; D004435:Eating; D005260:Female; D007980:Levodopa; D008297:Male; D008781:Methyltyrosines; D051379:Mice; D009043:Motor Activity; D010665:Phenylpropanolamine; D013566:Sympathomimetics; D013997:Time Factors; D019805:alpha-Methyltyrosine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D008781:Methyltyrosines; D013566:Sympathomimetics; D010665:Phenylpropanolamine; D007980:Levodopa; D019805:alpha-Methyltyrosine; D001545:Benserazide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04852.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Human angiotensin I competes with two non-thiol converting enzyme inhibitors (CGS 13934 & MK-422) to inhibit the angiotensin-converting enzyme activity of human plasma.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '707-8',\n",
       "  'abstract': 'A simple in-vitro enzyme system has been used to demonstrate that human angiotensin I interacts competitively with the two non-thiol converting enzyme inhibitors CGS 13934 and MK-422 to inhibit the hydrolysis of a synthetic substrate by human plasma ACE.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Chen|D S|DS|;Nussberger|J|J|;Brunner|H R|HR|;Waeber|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150096',\n",
       "  'mesh_terms': 'D000803:Angiotensin I; D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D004151:Dipeptides; D015773:Enalaprilat; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D007211:Indoles; D007700:Kinetics; D008297:Male; D007703:Peptidyl-Dipeptidase A',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000806:Angiotensin-Converting Enzyme Inhibitors; D000809:Angiotensins; D004151:Dipeptides; D007211:Indoles; C041886:pentoprilat; D000803:Angiotensin I; D007703:Peptidyl-Dipeptidase A; D015773:Enalaprilat',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04853.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'The effect of therapeutic agents on cartilage degradation in-vivo.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '709-10',\n",
       "  'abstract': 'Implantation of minced autologous cartilage into inflamed air pouches in mice allows the study of therapeutic agents on both the inflammatory process and cartilage degradation. Non-steroidal anti-inflammatory agents were found to reduce cell accumulation in response to carrageenan, but were unable to prevent proteoglycan loss from cartilage. In contrast, D-penicillamine had no effect on the inflammatory process but significantly reduced proteoglycan loss. Our findings suggest that the autologous cartilage transplantation model in the mouse may be useful for studying novel anti-arthritic agents.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Sedgwick|A D|AD|;Moore|A R|AR|;Sin|Y M|YM|;Al-Duaij|A Y|AY|;Landon|B|B|;Willoughby|D A|DA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150097',\n",
       "  'mesh_terms': 'D000818:Animals; D000893:Anti-Inflammatory Agents; D002351:Carrageenan; D002356:Cartilage; D005260:Female; D007249:Inflammation; D051379:Mice; D011509:Proteoglycans',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000893:Anti-Inflammatory Agents; D011509:Proteoglycans; D002351:Carrageenan',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04854.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'A possible cytochrome P-450-mediated N-oxidation of diethylcarbamazine.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '711-2',\n",
       "  'abstract': 'There was a marked sex difference in the N-oxidation of diethylcarbamazine (DEC) in the rat. In 72 h, 41 and 20% of the administered DEC was excreted in urine as the N-oxide in male and female rats respectively. Safrole, metyrapone and ethanol inhibited this N-oxide formation in male rats by 71, 37 and 44% whereas in female rats the values were 20, 25 and 0% respectively. Phenobarbitone and anthracene enhanced N-oxide formation in male rats by 17 and 20% and in female rats by 50 and 90% respectively, but the amount of the N-oxide formed was more in the males. The result suggests a possible involvement of a sub-population of cytochrome P-450 isozyme (which is more in male rats) in the N-oxidation of DEC.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Joseph|C A|CA|;Dixon|P A|PA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150098',\n",
       "  'mesh_terms': 'D000818:Animals; D003577:Cytochrome P-450 Enzyme System; D004049:Diethylcarbamazine; D005260:Female; D007527:Isoenzymes; D008297:Male; D010084:Oxidation-Reduction; D051381:Rats; D011919:Rats, Inbred Strains; D012737:Sex Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D007527:Isoenzymes; D003577:Cytochrome P-450 Enzyme System; D004049:Diethylcarbamazine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04855.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Correlation between gastric irritancy and anti-inflammatory activity of non-steroidal anti-inflammatory drugs.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '713-5',\n",
       "  'abstract': 'Gastric irritancies and anti-inflammatory potencies of 25 commercially available non-steroidal anti-inflammatory drugs (NSAIDs) have been measured in the rat. When irritancy is measured as the dose required to produce a specified level of gastric mucosal damage, it is found that irritancy increases with anti-inflammatory potency. However, when irritancy is measured as the level of gastric mucosal damage at the anti-inflammatory ED50 (which is a clinically realistic measure) then irritancy decreases as anti-inflammatory potency increases. Hence it should be possible to design high-potency, low-irritancy NSAIDs.',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Dearden|J C|JC|;Nicholson|R M|RM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150099',\n",
       "  'mesh_terms': 'D000818:Animals; D000893:Anti-Inflammatory Agents; D002351:Carrageenan; D005753:Gastric Mucosa; D007509:Irritants; D007928:Lethal Dose 50; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013329:Structure-Activity Relationship',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000893:Anti-Inflammatory Agents; D007509:Irritants; D002351:Carrageenan',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04856.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Distribution coefficients of atenolol and sotalol: a critique.',\n",
       "  'issue': '36(10)',\n",
       "  'pages': '716',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': 'Day|N H|NH|;Parr|G D|GD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150100',\n",
       "  'mesh_terms': 'D001262:Atenolol; D006801:Humans; D007700:Kinetics; D013015:Sotalol',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001262:Atenolol; D013015:Sotalol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.2042-7158.1984.tb04857.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': 'Amine oxidases: a Cambridge workshop, August 4-6, 1984. An informal look at the biochemistry, pharmacology and clinical importance of amine oxidases.',\n",
       "  'issue': '36 Suppl()',\n",
       "  'pages': '1W-70W',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Journal of pharmacy and pharmacology',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150101',\n",
       "  'mesh_terms': 'D000818:Animals; D006801:Humans; D008995:Monoamine Oxidase; D008996:Monoamine Oxidase Inhibitors; D000587:Oxidoreductases Acting on CH-NH Group Donors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D008996:Monoamine Oxidase Inhibitors; D008995:Monoamine Oxidase; D000587:Oxidoreductases Acting on CH-NH Group Donors',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Pharmacol',\n",
       "  'nlm_unique_id': '0376363',\n",
       "  'issn_linking': '0022-3573',\n",
       "  'country': 'England'},\n",
       " {'title': '[The behavior of 1,4-benzodiazepine drugs in the acidic media. I. Proton and carbon 13 nuclear magnetic resonance spectra of oxazolam, cloxazolam and haloxazolam in the acidic media].',\n",
       "  'issue': '104(6)',\n",
       "  'pages': '607-13',\n",
       "  'abstract': '',\n",
       "  'journal': 'Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan',\n",
       "  'authors': 'Kuwayama|T|T|;Yashiro|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150102',\n",
       "  'mesh_terms': 'D000143:Acids; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D001570:Benzodiazepinones; D002247:Carbon Isotopes; D009682:Magnetic Resonance Spectroscopy; D011522:Protons',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000143:Acids; D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D002247:Carbon Isotopes; D011522:Protons; D001569:Benzodiazepines; C000425:oxazolam; C005522:cloxazolam; C018779:haloxazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1248/yakushi1947.104.6_607',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Yakugaku Zasshi',\n",
       "  'nlm_unique_id': '0413613',\n",
       "  'issn_linking': '0031-6903',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Quantitative relationships between structure and pharmacokinetics of beta-adrenoceptor blocking agents in man.',\n",
       "  'issue': '12(3)',\n",
       "  'pages': '263-87',\n",
       "  'abstract': 'The structure and pharmacokinetics relationship of 14-beta-adrenoceptor antagonists was investigated in humans. Statistically significant linear and parabolic correlations were found to exist between standard and derived mean pharmacokinetic parameters and the apparent octanol/buffer (pH 7.4) partition coefficient of the compounds. The lipophilic/hydrophilic properties were the primary determinants for the pharmacokinetic behavior of the compounds. Most of the pharmacokinetic parameters were also significantly correlated with the plasma protein/plasma water partition coefficient for the compounds. When the values of the pharmacokinetic parameters of the individual compounds were predicted from the regressions on the apparent partition coefficients in octanol/buffer (pH 7.4) and in plasma protein/plasma water, the error was on average 60%.',\n",
       "  'journal': 'Journal of pharmacokinetics and biopharmaceutics',\n",
       "  'authors': 'Hinderling|P H|PH|;Schmidlin|O|O|;Seydel|J K|JK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150103',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007668:Kidney; D007700:Kinetics; D008657:Metabolic Clearance Rate; D012044:Regression Analysis; D012995:Solubility; D013329:Structure-Activity Relationship',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF01061721',\n",
       "  'references': '10124;913016;6115665;881641;4399660;641844;6993682;4145013;22728;428185;738350;656265;6114740;600309;6102500;7333348;4153285;786354;6116760;6788057;639436;4155762;4147199;6491907;988964;913023;582753;7378256;16040;710025;16695059;13747253;6130139;891097;6167716;7252794;20259;6125395;6114166;668796;829788;237402;14623;4479578;6122452;4764375;7295488',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharmacokinet Biopharm',\n",
       "  'nlm_unique_id': '0357115',\n",
       "  'issn_linking': '0090-466X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Influence of alpha- and beta-adrenergic antagonists on dopamine-induced responses in the isolated heart of Mercenaria mercenaria.',\n",
       "  'issue': '73(10)',\n",
       "  'pages': '1491-3',\n",
       "  'abstract': \"Agents with predominantly adrenergic antagonistic properties (the alpha-blockers, phentolamine and tolazoline, and the beta-blocker propranolol), and those with suspected alpha-blocking capabilities [hydralazine and 3,3'-(4,4'-biphenylene)bis(2,5-diphenyl-2H-tetrazolium chloride) (neotetrazolium chloride); I] were added individually to a bath containing an isolated Mercenaria mercenaria heart. Two and one-half minutes later, dopamine was added to the bath as the second drug and cardiac responses were noted. Pretreatment with saline controls, followed by dopamine 2.5 min later, produced results that were identical with those which occurred after the administration of dopamine alone, i.e., marked stimulation and cardiac arrest. Pretreatment with phentolamine and I were the only procedures that prevented dopamine-induced cardiac arrest. Phentolamine, tolazoline, and hydralazine generally produced positive inotropic responses when initially added to the bath, whereas propranolol mimicked the effects caused by the addition of dopamine alone or after saline pretreatment. The M. mercenaria heart appears to possess an adrenergic receptor of an alpha-configuration.\",\n",
       "  'journal': 'Journal of pharmaceutical sciences',\n",
       "  'authors': 'Mann|D E|DE|;Gautieri|R F|RF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150104',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D049872:Bivalvia; D004298:Dopamine; D018492:Dopamine Antagonists; D006321:Heart; D066298:In Vitro Techniques; D009200:Myocardial Contraction',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D018492:Dopamine Antagonists; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/jps.2600731045',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharm Sci',\n",
       "  'nlm_unique_id': '2985195R',\n",
       "  'issn_linking': '0022-3549',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Characteristics of palytoxin-induced depolarization in squid axons.',\n",
       "  'issue': '231(3)',\n",
       "  'pages': '488-94',\n",
       "  'abstract': 'The effects of palytoxin on squid axon membranes have been studied by means of internal perfusion and voltage clamp techniques. When applied externally at a concentration ranging from 1 X 10(-8) to 1 X 10(-6) M, palytoxin caused a large depolarization of the membrane that was reversed slowly after washing with toxin-free solution. The toxin-induced depolarization disappeared quickly upon decreasing the external sodium concentration from 445 to 1 mM and the membrane was hyperpolarized beyond the original level. Palytoxin did not cause depolarization if both external and internal solutions were devoid of sodium. The toxin-induced depolarization was only reversed partially by external application of 1 X 10(-6) M tetrodotoxin. Palytoxin had no effect on the resting potential when perfused internally. These results indicate that palytoxin acts from outside of the nerve membrane to increase sodium permeability, thereby causing a depolarization. The palytoxin-poisoned membrane was also permeable to other cations with a permeability ratio of Na/Li/Cs/NH4 = 1:0.62:0.75:1.45. Under voltage clamp conditions, palytoxin shifted the voltage dependence of peak sodium current and steady-state potassium current in the direction of hyperpolarization and reduced markedly the maximum amplitude of peak sodium current. However, the kinetics of sodium current underwent little or no change except a shift of voltage dependence toward hyperpolarization. Leakage current increased markedly after application of palytoxin. In view of these observations and data from the literature, it was suggested that palytoxin creates a new channel in the membrane, thereby causing an increase in cation permeability, depolarization, and other effects such as muscle contraction.',\n",
       "  'journal': 'The Journal of pharmacology and experimental therapeutics',\n",
       "  'authors': 'Muramatsu|I|I|;Uemura|D|D|;Fujiwara|M|M|;Narahashi|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150105',\n",
       "  'mesh_terms': 'D000178:Acrylamides; D000818:Animals; D001369:Axons; D002412:Cations; D002463:Cell Membrane Permeability; D003064:Cnidarian Venoms; D049832:Decapodiformes; D004305:Dose-Response Relationship, Drug; D066298:In Vitro Techniques; D007473:Ion Channels; D008564:Membrane Potentials; D012964:Sodium',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000178:Acrylamides; D002412:Cations; D003064:Cnidarian Venoms; D007473:Ion Channels; D012964:Sodium; C010272:palytoxin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharmacol Exp Ther',\n",
       "  'nlm_unique_id': '0376362',\n",
       "  'issn_linking': '0022-3565',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effect of alpha adrenergic agonists and blockers on Purkinje fiber transmembrane potentials and automaticity in the dog.',\n",
       "  'issue': '231(3)',\n",
       "  'pages': '566-71',\n",
       "  'abstract': 'Previous studies have shown that alpha adrenergic stimulation can reduce the automaticity of canine Purkinje fibers. In the present study, our interest was to determine whether this is an alpha-1 or alpha-2 adrenergic action. We used standard microelectrode techniques to study the effects of the alpha agonists, phenylephrine and clonidine, and the alpha antagonists, prazosin and yohimbine, on phenylephrine-induced decreases in automaticity. Prazosin and yohimbine, 1 X 10(-5) M, alone, significantly reduced the amplitude and upstroke velocity (Vmax) of stimulated action potentials. In addition, yohimbine, 1 X 10(-5) M, accelerated and prazosin, 1 X 10(-5) M, attenuated repolarization. Prazosin, 1 X 10(-5) M, and yohimbine greater than or equal to 1 X 10(-7) M, alone, decreased automaticity. Phenylephrine, 5 X 10(-8) M, alone, significantly increased the cycle length of automatic Purkinje fibers. The effects of phenylephrine on automaticity were blocked by prazosin but not by yohimbine. Clonidine, alone, 1 X 10(-6) and 1 X 10(-5) M, significantly reduced automaticity, an effect that was not blocked by yohimbine or prazosin. Clonidine, 1 X 10(-6) and 1 X 10(-5) M, also significantly reduced Vmax and prolonged action potential duration of driven Purkinje fibers, an action consistent with direct membrane effects. These experiments suggest that the negative chronotropic effects of phenylephrine on Purkinje fiber automaticity are mediated by alpha-1 adrenergic receptors.',\n",
       "  'journal': 'The Journal of pharmacology and experimental therapeutics',\n",
       "  'authors': 'Rosen|M R|MR|;Weiss|R M|RM|;Danilo|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150106',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000818:Animals; D003000:Clonidine; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006329:Heart Conduction System; D066298:In Vitro Techniques; D008564:Membrane Potentials; D010656:Phenylephrine; D011224:Prazosin; D011690:Purkinje Fibers; D015016:Yohimbine',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D010656:Phenylephrine; D015016:Yohimbine; D003000:Clonidine; D011224:Prazosin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharmacol Exp Ther',\n",
       "  'nlm_unique_id': '0376362',\n",
       "  'issn_linking': '0022-3565',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Is there a functional linkage between neurotransmitter uptake mechanisms and presynaptic receptors?',\n",
       "  'issue': '231(3)',\n",
       "  'pages': '671-7',\n",
       "  'abstract': 'The possibility of interaction between neurotransmitter uptake mechanisms and presynaptic receptors regulating transmitter release was investigated using rat brain synaptosomes in superfusion. Various conditions were considered including: absence of substrate for the uptake with uptake potentially operative; absence of substrate and presence of uptake inhibitors; and uptake activated by added substrate, with or without uptake inhibitors. The release of [3H]-5-hydroxytryptamine ([3H]-5-HT) evoked by 15 mM KCl from cerebral cortex synaptosomes was inhibited by lysergic acid diethylamide. The 5-HT uptake inhibitors citalopram and chlorimipramine did not affect the inhibitory action of lysergic acid diethylamide. Clonidine decreased both the K+-evoked release of [3H]norepinephrine and that of [3H]-5-HT in cortical synaptosomes through the activation of presynaptic alpha-2 adrenoceptors. In superfusion conditions, the action of clonidine on [3H]norepinephrine release was not antagonized by the norepinephrine uptake inhibitors desipramine or cocaine; similarly, the inhibition of [3H]-5-HT release was unaffected when 5-HT uptake was blocked. The K+-evoked release of [3H]dopamine from striatal nerve terminals was potentiated by acetylcholine (ACh) through the activation of muscarinic presynaptic receptors. The action of ACh was not modified by the presence of nomifensine, a dopamine uptake inhibitor. Finally, in superfused cortical synaptosomes, the block of the high-affinity uptake of choline by hemicholinium-3 had no effect on the muscarinic autoreceptor-mediated inhibition of [3H]ACh release by ACh. Altogether the present results do not support the previously proposed idea that in nerve terminals a functional coupling may exist between uptake mechanisms and presynaptic receptors.',\n",
       "  'journal': 'The Journal of pharmacology and experimental therapeutics',\n",
       "  'authors': 'Raiteri|M|M|;Bonanno|G|G|;Marchi|M|M|;Maura|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150107',\n",
       "  'mesh_terms': 'D000109:Acetylcholine; D000818:Animals; D002997:Clomipramine; D003000:Clonidine; D003042:Cocaine; D003891:Desipramine; D004298:Dopamine; D006426:Hemicholinium 3; D066298:In Vitro Techniques; D008238:Lysergic Acid Diethylamide; D008297:Male; D018377:Neurotransmitter Agents; D014179:Neurotransmitter Uptake Inhibitors; D009627:Nomifensine; D009638:Norepinephrine; D011189:Potassium Chloride; D051381:Rats; D011919:Rats, Inbred Strains; D017981:Receptors, Neurotransmitter; D012701:Serotonin; D013574:Synaptosomes',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D014179:Neurotransmitter Uptake Inhibitors; D017981:Receptors, Neurotransmitter; D009627:Nomifensine; D006426:Hemicholinium 3; D012701:Serotonin; D011189:Potassium Chloride; D008238:Lysergic Acid Diethylamide; D003042:Cocaine; D003000:Clonidine; D000109:Acetylcholine; D002997:Clomipramine; D003891:Desipramine; D004298:Dopamine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharmacol Exp Ther',\n",
       "  'nlm_unique_id': '0376362',\n",
       "  'issn_linking': '0022-3565',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Development of tolerance to alpha-2 adrenergic agonists in the vascular system of the rat after chronic treatment with clonidine.',\n",
       "  'issue': '231(3)',\n",
       "  'pages': '685-91',\n",
       "  'abstract': 'The possibility of development of tolerance after chronic treatment with clonidine (CLN) was investigated in the vascular system of the rat. Rats were treated with CLN for 3 to 10 days by dissolving the drug in the drinking water at concentrations of 0.1 to 10 micrograms/ml. Pressor responses to several vasoconstrictors were examined after pithing. Rats given CLN-containing water at a concentration of 10 micrograms/ml were considered as receiving CLN at about 1 mg/kg/day and were found to be subsensitive to l-norepinephrine. Decrease in the sensitivity varied with the length of CLN treatment and the maximum decrease was attained within 5 days of the treatment. Recovery from the subsensitivity required a long deprivation time of CLN; after 10 days of treatment, 14 days of deprivation did not cause any recovery in the sensitivity. The subsensitivity also was observed in the alpha-2 adrenergic agonists, CLN and azepexole, whereas it was not detected in alpha-1 adrenergic agents, phenylephrine and methoxamine, and the nonadrenergic vasoconstrictors, angiotensin-II and Lys-vasopressin. Pressor responses to stimulation of the complete sympathetic outflow also decreased in the CLN-treated rats. These results show clearly that chronic treatment with CLN makes rat vasculature subsensitive to l-norepinephrine and suggest that this phenomenon involves specific desensitization developed in the contractile mechanisms of vascular smooth muscles mediated by alpha-2 adrenergic receptors.',\n",
       "  'journal': 'The Journal of pharmacology and experimental therapeutics',\n",
       "  'authors': 'Ishii|K|K|;Kato|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150108',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000818:Animals; D001794:Blood Pressure; D003000:Clonidine; D003655:Decerebrate State; D004361:Drug Tolerance; D008297:Male; D009131:Muscle, Smooth, Vascular; D009638:Norepinephrine; D051381:Rats; D011919:Rats, Inbred Strains; D013564:Sympathetic Nervous System',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D003000:Clonidine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Pharmacol Exp Ther',\n",
       "  'nlm_unique_id': '0376362',\n",
       "  'issn_linking': '0022-3565',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Day treatment transition groups. Helping outpatients stay out.',\n",
       "  'issue': '22(10)',\n",
       "  'pages': '11-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of psychosocial nursing and mental health services',\n",
       "  'authors': 'Echternacht|M R|MR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150109',\n",
       "  'mesh_terms': 'D000553:Ambulatory Care; D014150:Antipsychotic Agents; D003120:Colorado; D003631:Day Care, Medical; D006126:Group Processes; D006127:Group Structure; D006801:Humans; D001523:Mental Disorders; D011615:Psychotherapy, Group; D012917:Social Adjustment',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Psychosoc Nurs Ment Health Serv',\n",
       "  'nlm_unique_id': '8200911',\n",
       "  'issn_linking': '0279-3695',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Military cold injury during the war in the Falkland Islands 1982: an evaluation of possible risk factors.',\n",
       "  'issue': '130(2)',\n",
       "  'pages': '89-96',\n",
       "  'abstract': 'Throughout the history of war, there have been many instances when the cold has ravaged armies more effectively than their enemies. Delineated risk factors are restricted to negro origins, previous cod injury, moderate but not heavy cigarette smoking and the possession of blood group O. No attention has been directed to the possibility that abnormal blood constituents could feasibly predispose to the development of local cold injury. This study considers this possibility and investigates the potential contribution of certain components of the circulating blood which might do so. Three groups of soldiers from two of the battalions who served during the war in the Falkland Islands in 1982 were investigated. The risk factors which were sought included the presence or absence of asymptomatic cryoglobulinaemia, abnormal total protein, albumin, individual gamma globulin or complement C3 or C4 levels, plasma hyperviscosity or evidence of chronic alcoholism manifesting as high haemoglobin, PCV, RBC, MCV or gamma glutamyl transpeptidase (GGT). No cases of cryoglobulinaemia were isolated and there was no haematological evidence to suggest that any of those men who had developed cold injury, one year before this study was performed, had abnormal circulating proteins, plasma hyperviscosity or indicators of alcohol abuse. Individual blood groups were not incriminated as a predisposing factor although the small numbers of negroes in this series fared badly. Although this investigation has excluded a range of potential risk factors which could contribute to the development of cold injury, the problem persists.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Journal of the Royal Army Medical Corps',\n",
       "  'authors': 'Craig|R P|RP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150110',\n",
       "  'mesh_terms': 'D000328:Adult; D000437:Alcoholism; D001789:Blood Group Antigens; D001798:Blood Proteins; D001809:Blood Viscosity; D003080:Cold Temperature; D004911:Erythrocyte Volume; D006452:Hemoglobinometry; D049671:History, 18th Century; D049673:History, 20th Century; D006801:Humans; D008297:Male; D008887:Military Medicine; D012306:Risk; D006113:United Kingdom; D014857:Warfare; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016456:Historical Article; D016428:Journal Article',\n",
       "  'chemical_list': 'D001789:Blood Group Antigens; D001798:Blood Proteins; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/jramc-130-02-05',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J R Army Med Corps',\n",
       "  'nlm_unique_id': '7505627',\n",
       "  'issn_linking': '0035-8665',\n",
       "  'country': 'England'},\n",
       " {'title': '2-[[[2-(2,6-Dimethoxyphenoxy)ethyl]amino]-methyl] -1,4-benzoxathian: a new antagonist with high potency and selectivity toward alpha 1-adrenoreceptors.',\n",
       "  'issue': '27(12)',\n",
       "  'pages': '1535-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of medicinal chemistry',\n",
       "  'authors': 'Melchiorre|C|C|;Brasili|L|L|;Giardinà|D|D|;Pigini|M|M|;Strappaghetti|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150111',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D004146:Dioxanes; D004147:Dioxins; D007202:Indicators and Reagents; D008297:Male; D051381:Rats; D011942:Receptors, Adrenergic, alpha; D014649:Vas Deferens',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': \"D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D004147:Dioxins; D007202:Indicators and Reagents; D011942:Receptors, Adrenergic, alpha; C010654:(2-(2',6'-dimethoxy)phenoxyethylamino)methylbenzo-1,4-dioxane\",\n",
       "  'keywords': '',\n",
       "  'doi': '10.1021/jm00378a001',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Chem',\n",
       "  'nlm_unique_id': '9716531',\n",
       "  'issn_linking': '0022-2623',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Probes for narcotic receptor mediated phenomena. 7. Synthesis and pharmacological properties of irreversible ligands specific for mu or delta opiate receptors.',\n",
       "  'issue': '27(12)',\n",
       "  'pages': '1570-4',\n",
       "  'abstract': 'Syntheses of affinity reagents for opiate receptors based on the fentanyl, endo-ethenotetrahydrooripavine, and etonitazene carbon-nitrogen skeletons are described. The isothiocyanate, bromoacetamido, and methylfumaramido alkylating functions were employed in these compounds, some of which had previously been shown to be mu specific (12, BIT) and delta specific (8, FIT and 19, FAO) in vitro. Antinociceptive activity of the title compounds was determined in the mouse hot-plate test, which revealed that certain compounds in each class showed morphine-like activity. The binding EC50 values against [3H]Dalamid for opiate receptors in NG108-15 (delta receptors) and rat brain membranes (mu + delta receptors) are also reported. With this type of experiment, it was possible to independently measure the apparent affinity of the etonitazene congeners 12-14 for the mu and delta receptors.',\n",
       "  'journal': 'Journal of medicinal chemistry',\n",
       "  'authors': 'Burke|T R|TR|;Bajwa|B S|BS|;Jacobson|A E|AE|;Rice|K C|KC|;Streaty|R A|RA|;Klee|W A|WA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150112',\n",
       "  'mesh_terms': 'D000818:Animals; D001562:Benzimidazoles; D002460:Cell Line; D002462:Cell Membrane; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D005283:Fentanyl; D005910:Glioma; D006822:Hybrid Cells; D007202:Indicators and Reagents; D008024:Ligands; D009682:Magnetic Resonance Spectroscopy; D013058:Mass Spectrometry; D051379:Mice; D009292:Narcotic Antagonists; D009447:Neuroblastoma; D051381:Rats; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D013329:Structure-Activity Relationship; D013797:Thebaine',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D001562:Benzimidazoles; D007202:Indicators and Reagents; D008024:Ligands; D009292:Narcotic Antagonists; D011957:Receptors, Opioid; D017465:Receptors, Opioid, delta; D017450:Receptors, Opioid, mu; D013797:Thebaine; C037669:endo-ethenotetrahydrooripavine; D005283:Fentanyl',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1021/jm00378a008',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Chem',\n",
       "  'nlm_unique_id': '9716531',\n",
       "  'issn_linking': '0022-2623',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Acidic furo[3,2-b]indoles. A new series of potent antiallergy agents.',\n",
       "  'issue': '27(12)',\n",
       "  'pages': '1629-33',\n",
       "  'abstract': \"A series of furo[3,2-b]indole carboxylic acids, tetrazoles, and carbamoyltetrazoles was prepared and tested in vitro with use of a model of active pulmonary anaphylaxis, the modified Schultz-Dale Test (SDT). In this model, isolated guinea pig lung strips are repeatedly challenged with antigen in the presence of an antihistamine (H1). Most of the acidic furo[3,2-b]indoles tested inhibited the leukotriene-mediated lung contraction in a dose-related manner. Compounds with an N-phenyl substituent were more potent (IC50 less than or equal to 5.0 microM) inhibitors of SDT than the N-methyl analogues (IC50 greater than or equal to 22.0 microM). Most of the N-phenyl analogues were more potent in SDT than Fisons' mediator-release inhibitor proxicromil (FPL-57,787; IC50 = 6.3 microM). The most potent furo[3,2-b]indoles were those unsubstituted at C-7 and with N-phenyl, 2-carbamoyltetrazole, and 3-alkoxy substituents. All of the carboxylic acid ester analogues tested were weak or inactive at concentrations of 10-30 microM.\",\n",
       "  'journal': 'Journal of medicinal chemistry',\n",
       "  'authors': 'Unangst|P C|PC|;Carethers|M E|ME|;Webster|K|K|;Janik|G M|GM|;Robichaud|L J|LJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150113',\n",
       "  'mesh_terms': 'D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D005663:Furans; D006168:Guinea Pigs; D006634:Histamine H1 Antagonists; D066298:In Vitro Techniques; D007202:Indicators and Reagents; D007211:Indoles; D008168:Lung; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D010047:Ovalbumin; D011738:Pyrilamine; D013329:Structure-Activity Relationship',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D005663:Furans; D006634:Histamine H1 Antagonists; D007202:Indicators and Reagents; D007211:Indoles; D010047:Ovalbumin; D011738:Pyrilamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1021/jm00378a017',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Chem',\n",
       "  'nlm_unique_id': '9716531',\n",
       "  'issn_linking': '0022-2623',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Pyrido[3',2':4,5]thieno[3,2-d]-N-triazines: a new series of orally active antiallergic agents.\",\n",
       "  'issue': '27(12)',\n",
       "  'pages': '1639-43',\n",
       "  'abstract': \"A new series of orally active mediator release inhibitors, pyrido[3',2':4,5]thieno[3,2-d]-N-triazines, was synthesized and evaluated for antiallergic activity. Several products showed high activity as inhibitors or wheal information in the rat passive cutaneous anaphylaxis screen and as inhibitors of histamine release from passively sensitized rat mast cells. Many compounds were orally active in the PCA test. The most potent compound, 7-phenylpyrido-[3',2':4,5]thieno[3,2-d]-1,2,3-triazin-4(3H)- one (10) with an I50 value of 0.05 microM, was 60 times more potent than disodium cromoglycate (DSCG) in the RMC assay.\",\n",
       "  'journal': 'Journal of medicinal chemistry',\n",
       "  'authors': 'Youssefyeh|R D|RD|;Brown|R E|RE|;Wilson|J|J|;Shah|U|U|;Jones|H|H|;Loev|B|B|;Khandwala|A|A|;Leibowitz|M J|MJ|;Sonnino-Goldman|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150114',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000818:Animals; D001886:Bordetella pertussis; D055598:Chemical Phenomena; D002621:Chemistry; D004353:Drug Evaluation, Preclinical; D006634:Histamine H1 Antagonists; D007202:Indicators and Reagents; D009682:Magnetic Resonance Spectroscopy; D008407:Mast Cells; D010047:Ovalbumin; D010323:Passive Cutaneous Anaphylaxis; D051381:Rats; D011919:Rats, Inbred Strains; D013329:Structure-Activity Relationship; D014227:Triazines',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D006634:Histamine H1 Antagonists; D007202:Indicators and Reagents; D014227:Triazines; D010047:Ovalbumin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1021/jm00378a019',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Chem',\n",
       "  'nlm_unique_id': '9716531',\n",
       "  'issn_linking': '0022-2623',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Computer-generated maps as an aid to mosquito control (Diptera: Culicidae).',\n",
       "  'issue': '21(5)',\n",
       "  'pages': '489-500',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of medical entomology',\n",
       "  'authors': 'Hunt|G J|GJ|;Hacker|C S|CS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150115',\n",
       "  'mesh_terms': 'D000818:Animals; D003201:Computers; D003465:Culex; D009033:Culicidae; D005260:Female; D008377:Maps as Topic; D009032:Mosquito Control; D011157:Population Dynamics; D012621:Seasons; D013045:Species Specificity; D013781:Texas',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/jmedent/21.5.489',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Entomol',\n",
       "  'nlm_unique_id': '0375400',\n",
       "  'issn_linking': '0022-2585',\n",
       "  'country': 'England'},\n",
       " {'title': 'Culiseta melanura (Diptera: Culicidae): population structure and nectar feeding in a freshwater swamp and surrounding areas in southeastern Massachusetts, USA.',\n",
       "  'issue': '21(5)',\n",
       "  'pages': '567-72',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of medical entomology',\n",
       "  'authors': 'Nasci|R S|RS|;Edman|J D|JD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150116',\n",
       "  'mesh_terms': 'D000818:Animals; D009033:Culicidae; D004777:Environment; D005247:Feeding Behavior; D005260:Female; D005618:Fresh Water; D007303:Insect Vectors; D008136:Longevity; D008404:Massachusetts; D010058:Oviposition; D011153:Population; D012621:Seasons; D013045:Species Specificity',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/jmedent/21.5.567',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Entomol',\n",
       "  'nlm_unique_id': '0375400',\n",
       "  'issn_linking': '0022-2585',\n",
       "  'country': 'England'},\n",
       " {'title': 'A case of 2-methylacetoacetyl CoA thiolase deficiency with coincidental chromosome abnormalities.',\n",
       "  'issue': '21(5)',\n",
       "  'pages': '397',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of medical genetics',\n",
       "  'authors': 'Gray|R G|RG|;Lowther|G W|GW|;Littlewood|J M|JM|;Middleton|B|B|;Bennett|M J|MJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150117',\n",
       "  'mesh_terms': 'D000101:Acetyl-CoA C-Acetyltransferase; D000123:Acetyltransferases; D005260:Female; D006801:Humans; D007223:Infant; D009030:Mosaicism; D012729:Sex Chromosome Aberrations; D014424:Turner Syndrome; D014960:X Chromosome',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D000123:Acetyltransferases; D000101:Acetyl-CoA C-Acetyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/jmg.21.5.397',\n",
       "  'references': '6930361;7173255',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Genet',\n",
       "  'nlm_unique_id': '2985087R',\n",
       "  'issn_linking': '0022-2593',\n",
       "  'country': 'England'},\n",
       " {'title': \"A Delphi study to identify future roles for physician's assistants.\",\n",
       "  'issue': '59(12)',\n",
       "  'pages': '962-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Journal of medical education',\n",
       "  'authors': 'Shelton|S R|SR|;Lyons|B A|BA|;Allen|R M|RM|;Allensworth|D C|DC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150118',\n",
       "  'mesh_terms': 'D003697:Delphi Technique; D006801:Humans; D010823:Physician Assistants',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/00001888-198412000-00008',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Med Educ',\n",
       "  'nlm_unique_id': '0375377',\n",
       "  'issn_linking': '0022-2577',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The functional recovery of damaged brain: the effect of GM1 monosialoganglioside.',\n",
       "  'issue': '12(2-3)',\n",
       "  'pages': '397-408',\n",
       "  'abstract': 'In the present study the topology and the biochemical mechanisms underlying the functional recovery of the dopaminergic nigrostriatal system is further analyzed. Rats with unilateral hemitransection were treated with 30 mg/kg GM1 monosialoganglioside or with its internal ester derivative for different periods of time. GM1 enhances 3H-dopamine uptake in striatal synaptosomes of the lesioned side, and the enhancement of dopamine uptake precedes that of striatal tyrosine hydroxylase activity. The above biochemical effects are accompanied by changes in behavioral- and electrophysiological-related parameters. The effect of GM1 on striatal tyrosine hydroxylase of the lesioned side disappears when the ascending dopaminergic fibers are extensively lesioned. This suggests that the source of regrowing dopaminergic nerve terminals in the striatum of partially lesioned rats resides mainly in the intact axons remaining in the ipsilateral side. When GM1 is injected into partially lesioned rats kept in darkness, no effect on tyrosine hydroxylase activity is observed. This indicates that the mechanism through which GM1 acts involves a normal light-dark cycle.',\n",
       "  'journal': 'Journal of neuroscience research',\n",
       "  'authors': 'Toffano|G|G|;Savoini|G|G|;Aporti|F|F|;Calzolari|S|S|;Consolazione|A|A|;Maura|G|G|;Marchi|M|M|;Raiteri|M|M|;Agnati|L F|LF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150119',\n",
       "  'mesh_terms': 'D000818:Animals; D001927:Brain Diseases; D003342:Corpus Striatum; D004298:Dopamine; D004594:Electrophysiology; D005677:G(M1) Ganglioside; D005732:Gangliosides; D051381:Rats; D011919:Rats, Inbred Strains; D013378:Substantia Nigra; D013574:Synaptosomes; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005732:Gangliosides; D005677:G(M1) Ganglioside; D014446:Tyrosine 3-Monooxygenase; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/jnr.490120224',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Neurosci Res',\n",
       "  'nlm_unique_id': '7600111',\n",
       "  'issn_linking': '0360-4012',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Granule formation in large granular lymphocytes (LGL). Ultrastructural and cytochemical studies on cells from patients with abnormally expanded lgl populations.',\n",
       "  'issue': '16(4)',\n",
       "  'pages': '759-71',\n",
       "  'abstract': 'The peripheral blood mononuclear cells from five patients with abnormally expanded populations of large granular lymphocytes (LGL) of possible malignant origin have been studied by electron microscopy. These cells had fewer granules than normal circulating LGL but displayed a variety of organelles possibly involved in the process of granule formation. This process apparently originated from the fusion of vesicles that had a characteristic cup-shape (and appeared to be derived from the Golgi apparatus) with smaller vesicles, mostly of the coated type. This fusion resulted in the formation of multivesicular bodies (MVB) whose limiting membrane was constituted by that of the cup-shaped vesicle. MVB gradually matured into electron-dense granules. A number of cup-shaped vesicles were found positive for the cytochemical localization of thiamine pyrophosphatase (TPP) activity that is a specific marker of the trans aspect of the Golgi apparatus, a finding which confirmed that they were Golgi-derived. The smaller, mostly coated, vesicles were positive for acid phosphatase (AP) and evidence was obtained indicating that they subserved the function of transporting acid hydrolases from the rough endoplasmic reticulum to the cup-shaped vesicles or to the MVB. The plasma membrane did not appear to contribute to MVB or granule formation since endocytic vacuoles induced by reacting the cell surface with the appropriate monoclonal antibodies (followed by peroxidase labelled anti-immunoglobulin) were never seen while fusing with granules or MVB. Rather, these vesicles formed secondary lysosomes after having encountered smooth or, more rarely, coated vesicles. Granulogenesis in LGL, therefore, resembles the process of granule formation observed in secretory cells. The active process of granulogenesis detected in the patient cells and a number of other findings indicate that they were LGL at early stages of maturation. The surface phenotype consistently found in these cells (OKT3+, Leu 1+, OKT8+, Leu 2a+, OKT11+, Leu 5+ and OKM1) is different from that of the majority of the normal LGL and may correspond to that of immature LGL.',\n",
       "  'journal': 'Journal of submicroscopic cytology',\n",
       "  'authors': 'Grossi|C E|CE|;Zicca|A|A|;Leprini|A|A|;Cadoni|A|A|;Pandolfi|F|F|;Burgio|V L|VL|;Romagnani|S|S|;Guglielmi|C|C|;Ferrarini|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150120',\n",
       "  'mesh_terms': 'D000135:Acid Phosphatase; D000328:Adult; D000368:Aged; D003594:Cytoplasmic Granules; D005260:Female; D006801:Humans; D007945:Leukemia, Lymphoid; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D013834:Thiamine Pyrophosphatase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000135:Acid Phosphatase; D013834:Thiamine Pyrophosphatase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Submicrosc Cytol',\n",
       "  'nlm_unique_id': '0235232',\n",
       "  'issn_linking': '0022-4782',\n",
       "  'country': 'Italy'},\n",
       " {'title': 'Activated charcoal and syrup of ipecac in prevention of cimetidine and pindolol absorption in man after administration of metoclopramide as an antiemetic agent.',\n",
       "  'issue': '22(2)',\n",
       "  'pages': '103-14',\n",
       "  'abstract': 'The effects of activated charcoal and ipecac syrup by mouth on cimetidine and pindolol absorption were studied in seven subjects, who had ingested 20 mg metoclopramide 1 h earlier, and compared with the adsorption capacity of charcoal in vitro. Activated charcoal, 50 g, given 5 min after 400 mg cimetidine + 10 mg pindolol, reduced their absorption by 99% or more, based on AUC0-48h and the 48-h urinary excretion of the drugs. Syrup of ipecac caused emesis on each occasion. On the average, ipecac reduced the absorption of cimetidine and pindolol by 75% and 60%, respectively. Based on studies in vitro it seems probable that the adsorbing capacity of charcoal for cimetidine but not for pindolol will be saturated if 50 g charcoal is given after an overdose of about 100 fold the therapeutic dose. Because the use of ipecac allowed an absorption of the drugs at least 30 fold that allowed by charcoal, the immediate administration of activated charcoal, without preceding lavage or emesis, should be considered in such poisonings where the adsorption capacity of high charcoal doses will not be saturated.',\n",
       "  'journal': 'Journal of toxicology. Clinical toxicology',\n",
       "  'authors': 'Neuvonen|P J|PJ|;Olkkola|K T|KT|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150121',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000327:Adsorption; D000328:Adult; D000704:Analysis of Variance; D002606:Charcoal; D002927:Cimetidine; D004341:Drug Evaluation; D004347:Drug Interactions; D005260:Female; D005766:Gastrointestinal Contents; D006801:Humans; D007408:Intestinal Absorption; D007486:Ipecac; D008297:Male; D008787:Metoclopramide; D010869:Pindolol; D011897:Random Allocation',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D002606:Charcoal; D002927:Cimetidine; D007486:Ipecac; D010869:Pindolol; D008787:Metoclopramide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/15563658408992547',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Toxicol Clin Toxicol',\n",
       "  'nlm_unique_id': '8213460',\n",
       "  'issn_linking': '0731-3810',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Glutamate dehydrogenase and a proposed glutamate-aspartate pathway for citrate synthesis in rat ventral prostate.',\n",
       "  'issue': '132(6)',\n",
       "  'pages': '1239-43',\n",
       "  'abstract': 'Glutamate dehydrogenase activity was determined in mitochondrial preparations from rat ventral prostate and rat kidney. Kinetic parameters of the ventral prostate enzyme were comparable to those for the kidney enzyme. Glutamate dehydrogenase activity in the direction of glutamate oxidative deamination was inhibited by alpha-ketoglutarate. However, the characteristics of alpha-ketoglutarate inhibition indicated that glutamate oxidation via glutamate dehydrogenase can occur at in vivo prostatic alpha-ketoglutarate levels. These results suggest that glutamate dehydrogenase activity in prostate may provide a continuous source of alpha-ketoglutarate for aspartate transamination to oxalacetate and ultimate citrate synthesis. In addition prostate mitochondria are able to couple the glutamic dehydrogenase reaction to aspartate aminotransferase. Under these conditions aspartate in the presence of glutamate and acetyl coenzyme A will result in a net synthesis of citrate. Consequently we propose an aspartate-glutamate pathway for citrate synthesis in prostate.',\n",
       "  'journal': 'The Journal of urology',\n",
       "  'authors': 'Franklin|R B|RB|;Costello|L C|LC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150122',\n",
       "  'mesh_terms': 'D000105:Acetyl Coenzyme A; D000818:Animals; D001224:Aspartic Acid; D002951:Citrates; D019343:Citric Acid; D003641:Deamination; D005969:Glutamate Dehydrogenase; D005971:Glutamates; D018698:Glutamic Acid; D007656:Ketoglutaric Acids; D007668:Kidney; D008297:Male; D008928:Mitochondria; D011467:Prostate; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002951:Citrates; D005971:Glutamates; D007656:Ketoglutaric Acids; D019343:Citric Acid; D001224:Aspartic Acid; D018698:Glutamic Acid; D000105:Acetyl Coenzyme A; D005969:Glutamate Dehydrogenase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0022-5347(17)50113-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Urol',\n",
       "  'nlm_unique_id': '0376374',\n",
       "  'issn_linking': '0022-5347',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Doctors--barefoot and otherwise. The World Health Organization, the United States, and global primary medical care.',\n",
       "  'issue': '252(22)',\n",
       "  'pages': '3146-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'JAMA',\n",
       "  'authors': 'Mullan|F|F|;Bryant|J H|JH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150123',\n",
       "  'mesh_terms': 'D003150:Community Health Workers; D003226:Congresses as Topic; D003906:Developing Countries; D004501:Education, Medical; D014943:Global Health; D006291:Health Policy; D010820:Physicians; D011320:Primary Health Care; D014481:United States; D000078329:Workforce; D014944:World Health Organization',\n",
       "  'publication_types': 'D016423:Congress',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1001/jama.252.22.3146',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'JAMA',\n",
       "  'nlm_unique_id': '7501160',\n",
       "  'issn_linking': '0098-7484',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Neurotransmitter release and vascular reactivity in spontaneously hypertensive rats.',\n",
       "  'issue': '48(11)',\n",
       "  'pages': '1263-9',\n",
       "  'abstract': 'This study was designed to investigate neurotransmitter release during the sympathetic nerve stimulation of perfused mesenteric arterial beds of spontaneously hypertensive rats (SHR) and normotensive Wistar-Kyoto rats (WKY) at young and adult ages. The role of Ca in neurotransmitter release and vascular responsiveness was also examined by using a Ca-antagonist (verapamil). Pressor responses to electrical nerve stimulation and exogenous noradrenaline were greater in SHR than in WKY. Noradrenaline overflow by electrical nerve stimulation from mesenteric arterial beds was also significantly greater in young SHR than age-matched WKY. However, in adult SHR, the noradrenaline overflow was reduced compared with WKY. After verapamil infusion (5.0 X 10(-7)M approximately 2.5 X 10(-6)M), suppression of the pressor responses and noradrenaline overflow evoked by electrical nerve stimulation was greater in SHR than in WKY at both ages. The pressor responses to exogenous noradrenaline were also inhibited by verapamil more in young SHR than in young WKY. In adult SHR, the inhibition was similar to age-matched WKY. These results suggest that noradrenaline release from sympathetic nerve endings in SHR increase at a young age and decreases in adults, and depends at least partly on Ca-influx at both ages as dose vasoconstrictor reactivity. Therefore, Ca-dependency in SHR at both pre- and post-synaptic sites of neurotransmission may contribute to the pathogenesis of hypertension.',\n",
       "  'journal': 'Japanese circulation journal',\n",
       "  'authors': 'Tsuda|K|K|;Kuchii|M|M|;Kusuyama|Y|Y|;Hano|T|T|;Nishio|I|I|;Masuyama|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150124',\n",
       "  'mesh_terms': 'D000818:Animals; D001794:Blood Pressure; D002118:Calcium; D002395:Catecholamines; D004558:Electric Stimulation; D006145:Guanethidine; D006973:Hypertension; D008297:Male; D008638:Mesenteric Arteries; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D011224:Prazosin; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D013564:Sympathetic Nervous System; D014661:Vasoconstriction; D014700:Verapamil',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D002395:Catecholamines; D018377:Neurotransmitter Agents; D014700:Verapamil; D002118:Calcium; D009638:Norepinephrine; D011224:Prazosin; D006145:Guanethidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1253/jcj.48.1263',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jpn Circ J',\n",
       "  'nlm_unique_id': '7806868',\n",
       "  'issn_linking': '0047-1828',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Rapid progression of an aortic lesion in a patient with aortitis syndrome.',\n",
       "  'issue': '25(4)',\n",
       "  'pages': '633-7',\n",
       "  'abstract': 'In a 28-year-old woman with aortitis syndrome, repeated aortography revealed the development of a coarctation of the abdominal aorta occurring over a period of 1 year. Clinical and surgical examinations showed evidence of inflammation and ruled out other diseases during that time. This suggests that in cases of aortitis syndrome arterial lesions may show rapid progression over short time periods and in the absence of untoward events.',\n",
       "  'journal': 'Japanese heart journal',\n",
       "  'authors': 'Morooka|S|S|;Murakami|T|T|;Serizawa|T|T|;Uchida|Y|Y|;Iizuka|M|M|;Koide|T|T|;Takabatake|Y|Y|;Sugimoto|T|T|;Rhee|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150125',\n",
       "  'mesh_terms': 'D000328:Adult; D001012:Aorta, Abdominal; D001015:Aortic Arch Syndromes; D001017:Aortic Coarctation; D001772:Blood Cell Count; D005260:Female; D006801:Humans; D011859:Radiography; D013625:Takayasu Arteritis',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1536/ihj.25.633',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jpn Heart J',\n",
       "  'nlm_unique_id': '0401175',\n",
       "  'issn_linking': '0021-4868',\n",
       "  'country': 'Japan'},\n",
       " {'title': '[Bacterial diarrhoea: diarrhoea caused by enterotoxins].',\n",
       "  'issue': '32(7)',\n",
       "  'pages': '701-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Rinsho byori. The Japanese journal of clinical pathology',\n",
       "  'authors': 'Takeda|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150126',\n",
       "  'mesh_terms': 'D000262:Adenylyl Cyclases; D000818:Animals; D002771:Cholera; D000242:Cyclic AMP; D006152:Cyclic GMP; D003967:Diarrhea; D004768:Enterotoxins; D004926:Escherichia coli; D004927:Escherichia coli Infections; D006162:Guanylate Cyclase; D006801:Humans; D051379:Mice; D014734:Vibrio cholerae',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D004768:Enterotoxins; D000242:Cyclic AMP; D000262:Adenylyl Cyclases; D006162:Guanylate Cyclase; D006152:Cyclic GMP',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rinsho Byori',\n",
       "  'nlm_unique_id': '2984781R',\n",
       "  'issn_linking': '0047-1860',\n",
       "  'country': 'Japan'},\n",
       " {'title': '[Effects of visual and mental strain on VDT (visual display terminal) performance].',\n",
       "  'issue': '26(2)',\n",
       "  'pages': '105-11',\n",
       "  'abstract': \"The progression of visual and mental strain in VDT work was investigated through an experimentally-designed VDT task providing a number of stressors including pacing, repetition, judgment and output decisions. We measured the effects of CFF (critical fusion frequency), TAF (the ability to maintain concentration), EEG (electroencephalogram) and near-point accommodation of various changes in the duration of the testing period. The subjects were seven male university students who performed single multiplication problems at a rate of 60 per minute. The problems were presented to them on a CRT screen and on paper for periods of 90 min each. The results obtained were as follows; CFF values and near-point accommodation of VDT performance were significantly decreased compared to Non-VDT's as a control. The TAF test showed that the mental strain in a VDT task is greater than that in a Non-VDT task. CFF values of VDT performance showed a tendency to decline in the 30th min after commencement, but in the 60th min and thereafter a significant lowering was noticed. In TAF and near-point accommodation of VDT performance, the greatest decline was in the 60th min, and this was significantly reduced only immediately after the work period. CFF values and near-point accommodation were not recovered after 60 min from the end of a 90 min VDT task. However, TAF X L values recovered in the 30th min after VDT performance. The peak level of alpha waves from the parietal region moved toward the slow alpha band with the elapse of VDT task time, but returned [or reverted] to the initial state 30 min after the test period ended.\",\n",
       "  'journal': 'Sangyo igaku. Japanese journal of industrial health',\n",
       "  'authors': 'Kumashiro|M|M|;Mikami|K|K|;Hasegawa|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150127',\n",
       "  'mesh_terms': 'D000065:Accommodation, Ocular; D000328:Adult; D001248:Asthenopia; D003626:Data Display; D004569:Electroencephalography; D005425:Flicker Fusion; D006801:Humans; D008297:Male; D005222:Mental Fatigue; D009784:Occupational Diseases; D013647:Task Performance and Analysis',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Sangyo Igaku',\n",
       "  'nlm_unique_id': '0150531',\n",
       "  'issn_linking': '0047-1879',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Actions of nipradilol (K-351), a new alpha- and beta-adrenoceptor blocker, on the rabbit portal vein.',\n",
       "  'issue': '35(4)',\n",
       "  'pages': '359-69',\n",
       "  'abstract': 'Nipradilol but not desnitro nipradilol [N-) nipradilol) inhibited the norepinephrine (NE)-induced depolarization and contraction of the rabbit portal vein. The NE-induced contraction and depolarization were also blocked by prazosin, but not blocked by yohimbine. Therefore, nipradilol possesses an alpha 1-blocking action. The order of potency was prazosin greater than nipradilol greater than yohimbine greater than (N-)-nipradilol = 0. With applications of field stimulations to muscle tissues, the smooth muscle membrane was depolarized with a latency of several seconds, and the action potential was generated. These phenomena were blocked by tetrodotoxin (TTX), prazosin or nipradilol, but not by yohimbine. Isoproterenol (Isop) inhibited the 30 mM K-induced contraction, and this inhibitory action was blocked by (N-), nipradilol, nipradilol or propranolol, dose-dependently. The potency of beta-blocking actions of nipradilol was much the same as that observed by propranolol and (N-) nipradilol. When nipradilol (10(-5) M) was applied to the tissue, the amplitude of the 30 mM K contraction was slightly reduced. Such inhibitory action was not observed by application of (N-) nipradilol. The Ki values of nipradilol for blocking actions on the NE-induced contraction and Isop-induced relaxation were of the same order of 10(-7) M. Therefore, the potencies of alpha 1-blocking and beta-blocking actions of nipradilol may be the same in the rabbit portal vein. These findings suggest that the vasodilating action of nipradilol on the rabbit portal vein is mainly due to the alpha 1-blocking action and that the nitrate action of this agent may be weak.',\n",
       "  'journal': 'Japanese journal of pharmacology',\n",
       "  'authors': 'Nanjo|T|T|;Kitamura|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150128',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D004558:Electric Stimulation; D066298:In Vitro Techniques; D008564:Membrane Potentials; D008839:Microelectrodes; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular; D009638:Norepinephrine; D011169:Portal Vein; D011224:Prazosin; D011412:Propanolamines; D011817:Rabbits; D015016:Yohimbine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D015016:Yohimbine; C036089:nipradilol; D009638:Norepinephrine; D011224:Prazosin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1254/jjp.35.359',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jpn J Pharmacol',\n",
       "  'nlm_unique_id': '2983305R',\n",
       "  'issn_linking': '0021-5198',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Cardiovascular effects of a new positive inotropic agent, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]-ethanol (TA-064) in the anesthetized dog and isolated guinea pig heart.',\n",
       "  'issue': '35(4)',\n",
       "  'pages': '415-23',\n",
       "  'abstract': 'The positive inotropic effect of TA-064, (-)-(R)-1-(p-hydroxyphenyl)-2-[(3,4-dimethoxyphenethyl)amino]ethanol, was studied in the anesthetized dog and isolated guinea pig heart. An intravenous administration of TA-064 dose-dependently increased the cardiac contractile force with little effect on blood pressure in dogs. The positive inotropic activity of TA-064 was 1/100 that of isoproterenol and similar to that of dobutamine. This effect of TA-064 was stereospecific, and it was blocked by practolol. Thus TA-064 has beta 1-adrenoceptor agonistic action. The positive inotropic effect of TA-064 was more pronounced than the positive chronotropic effect, compared with those of isoproterenol. Similar effect of TA-064 was observed in the reserpinized dog and in the isolated perfused heart of the guinea pig as well. TA-064 administered intraduodenally at a dose of 0.1 mg/kg increased contractile force by 120% of the control, and the effect lasted for more than 150 min. TA-064 given in the femoral artery demonstrated a very weak vasodilating effect on the artery. TA-064 is an orally active, positive inotropic agent. The selective positive inotropic action of TA-064 may result from its beta 1-adrenoceptor agonistic property.',\n",
       "  'journal': 'Japanese journal of pharmacology',\n",
       "  'authors': 'Nagao|T|T|;Ikeo|T|T|;Murata|S|S|;Sato|M|M|;Nakajima|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150129',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000758:Anesthesia; D000818:Animals; D001794:Blood Pressure; D002316:Cardiotonic Agents; D004280:Dobutamine; D004285:Dogs; D004983:Ethanolamines; D005269:Femur; D006168:Guinea Pigs; D006321:Heart; D066298:In Vitro Techniques; D008297:Male; D009200:Myocardial Contraction; D010477:Perfusion; D010656:Phenylephrine; D012039:Regional Blood Flow; D012110:Reserpine; D013237:Stereoisomerism',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D004983:Ethanolamines; D010656:Phenylephrine; D004280:Dobutamine; D012110:Reserpine; C037293:denopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1254/jjp.35.415',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jpn J Pharmacol',\n",
       "  'nlm_unique_id': '2983305R',\n",
       "  'issn_linking': '0021-5198',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Parallelism between avoidance-suppressing and prolactin-increasing effects of antipsychotic drugs in rats.',\n",
       "  'issue': '35(4)',\n",
       "  'pages': '451-6',\n",
       "  'abstract': 'Temporal changes in the avoidance responses and serum prolactin levels were investigated for a 360 min period after s.c. administration of antipsychotic drugs such as chlorpromazine (2 mg/kg), prochlorperazine (2 mg/kg), haloperidol (0.035 mg/kg), droperidol (0.03 mg/kg), YM-09151-2 (0.005 mg/kg) and sulpiride (80 mg/kg) in rats. Male adult rats of the Wistar strain were trained under a continuous lever-press avoidance schedule (Sidman type) to observe avoidance-suppressing effects of the drugs. The avoidance response was suppressed after administration of chlorpromazine, prochlorperazine, haloperidol, droperidol and YM-09151-2, showing significant decrease in response rate and significant increase in shock rate when compared with those after saline administration, while it was scarcely suppressed within 150 min after sulpiride. On the other hand, serum prolactin levels were increased after administration of all the drugs used. Furthermore, parallelism between temporal changes in the avoidance responses and those in serum prolactin levels was observed after administration of the antipsychotic drugs, except for sulpiride. These results suggest that the prolactin-increasing effects of antipsychotic drugs are applicable for predicting antipsychotic efficacies in humans, excluding sulpiride therapy.',\n",
       "  'journal': 'Japanese journal of pharmacology',\n",
       "  'authors': 'Hayashi|T|T|;Tadokoro|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150130',\n",
       "  'mesh_terms': 'D000818:Animals; D014150:Antipsychotic Agents; D001362:Avoidance Learning; D001549:Benzamides; D002090:Butyrophenones; D008297:Male; D010640:Phenothiazines; D011388:Prolactin; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D001549:Benzamides; D002090:Butyrophenones; D010640:Phenothiazines; D011388:Prolactin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1254/jjp.35.451',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jpn J Pharmacol',\n",
       "  'nlm_unique_id': '2983305R',\n",
       "  'issn_linking': '0021-5198',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Reduced alpha 2-adrenoceptor binding in lower brainstem of stroke-prone spontaneously hypertensive rats.',\n",
       "  'issue': '35(4)',\n",
       "  'pages': '468-70',\n",
       "  'abstract': '',\n",
       "  'journal': 'Japanese journal of pharmacology',\n",
       "  'authors': 'Yamada|S|S|;Ishima|T|T|;Hayashi|M|M|;Tomita|T|T|;Hayashi|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150131',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000818:Animals; D001794:Blood Pressure; D001933:Brain Stem; D002561:Cerebrovascular Disorders; D003000:Clonidine; D011224:Prazosin; D051381:Rats; D011918:Rats, Inbred SHR; D011921:Rats, Inbred WKY; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D003000:Clonidine; D011224:Prazosin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1254/jjp.35.468',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jpn J Pharmacol',\n",
       "  'nlm_unique_id': '2983305R',\n",
       "  'issn_linking': '0021-5198',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Effect of alpha 1- and alpha 2-adrenoceptor agonists and antagonists on ACTH secretion in intact and in hypothalamic deafferentated rats.',\n",
       "  'issue': '36(1)',\n",
       "  'pages': '23-33',\n",
       "  'abstract': 'The effect of systemically injected alpha 1- and alpha 2-adrenoceptor agonists and antagonists on ACTH secretion was studied in rats. Epinephrine, norepinephrine, phenylephrine, clonidine, B-HT933, and B-HT920 caused a significant and dose-related increase of the ACTH concentration in the serum. The order of median effective dose (ED50) of these drugs on ACTH secretion was as follows: epinephrine not equal to norepinephrine less than B-HT920 less than clonidine less than phenylephrine much less than B-HT933. Isoproterenol, a beta-adrenoceptor agonist, had no effect on ACTH secretion. ACTH secretion induced by epinephrine or phenylephrine was significantly inhibited by alpha-adrenoceptor antagonists, phentolamine and phenoxybenzamine. However, propranolol, a beta-adrenoceptor antagonist, had no effect on ACTH secretion induced by epinephrine. Prazosin, an alpha 1-antagonist, and yohimbine, an alpha 2-antagonist, significantly blocked ACTH secretion induced by phenylephrine, an alpha 1-agonist, and B-HT933, an alpha 2-agonist, respectively. ACTH secretion induced by norepinephrine or a low dose of clonidine was inhibited by both prazosin and yohimbine. However, ACTH secretion induced by a high dose of clonidine was blocked only by prazosin. In rats with complete deafferentation of the medial basal hypothalamus (MBH), ACTH secretion induced by epinephrine, norepinephrine, and clonidine was significantly blocked, as compared with intact rats. These results suggest that both peripheral alpha 1- and alpha 2-adrenoceptors are involved in ACTH secretion induced by systemically injected adrenergic drugs in rats, and intact neural pathways entering the MBH are necessary for this ACTH releasing action.',\n",
       "  'journal': 'Japanese journal of pharmacology',\n",
       "  'authors': 'Shimizu|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150132',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000324:Adrenocorticotropic Hormone; D000344:Afferent Pathways; D000818:Animals; D001794:Blood Pressure; D001810:Blood Volume; D007031:Hypothalamus; D066298:In Vitro Techniques; D008297:Male; D008473:Median Eminence; D010902:Pituitary Gland; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000324:Adrenocorticotropic Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1254/jjp.36.23',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Jpn J Pharmacol',\n",
       "  'nlm_unique_id': '2983305R',\n",
       "  'issn_linking': '0021-5198',\n",
       "  'country': 'Japan'},\n",
       " {'title': '[The significance of bacterial pili in urinary tract infection. I. Pathogenicity of E. coli pili in urinary tract infection].',\n",
       "  'issue': '75(7)',\n",
       "  'pages': '1074-83',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nihon Hinyokika Gakkai zasshi. The japanese journal of urology',\n",
       "  'authors': 'Hirose|T|T|;Kumamoto|Y|Y|;Nishio|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150133',\n",
       "  'mesh_terms': 'D000327:Adsorption; D000818:Animals; D004926:Escherichia coli; D005260:Female; D010861:Fimbriae, Bacterial; D051379:Mice; D014551:Urinary Tract; D014552:Urinary Tract Infections',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.5980/jpnjurol1928.75.7_1074',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nihon Hinyokika Gakkai Zasshi',\n",
       "  'nlm_unique_id': '2984841R',\n",
       "  'issn_linking': '0021-5287',\n",
       "  'country': 'Japan'},\n",
       " {'title': '[Selected aspects of neural transmission in the retina].',\n",
       "  'issue': '86(6)',\n",
       "  'pages': '275-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Klinika oczna',\n",
       "  'authors': 'Stankiewicz|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150134',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D006801:Humans; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D011950:Receptors, Cholinergic; D012160:Retina; D009435:Synaptic Transmission',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000596:Amino Acids; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D011950:Receptors, Cholinergic',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Klin Oczna',\n",
       "  'nlm_unique_id': '0376614',\n",
       "  'issn_linking': '0023-2157',\n",
       "  'country': 'Poland'},\n",
       " {'title': '[Physiological response to stress].',\n",
       "  'issue': '23(4)',\n",
       "  'pages': '38-48',\n",
       "  'abstract': '',\n",
       "  'journal': 'Taehan kanho. The Korean nurse',\n",
       "  'authors': 'Hwang|A R|AR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150135',\n",
       "  'mesh_terms': 'D004702:Endocrine Glands; D006706:Homeostasis; D006801:Humans; D007031:Hypothalamus; D018377:Neurotransmitter Agents; D013312:Stress, Physiological',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Taehan Kanho',\n",
       "  'nlm_unique_id': '1264143',\n",
       "  'issn_linking': '0047-3618',\n",
       "  'country': 'Korea (South)'},\n",
       " {'title': 'Biochemical investigations on a patient with a defect in cytosolic acetoacetyl-CoA thiolase, associated with mental retardation.',\n",
       "  'issue': '7(3)',\n",
       "  'pages': '125-8',\n",
       "  'abstract': 'A severely mentally retarded boy with two normal siblings was persistently found to excrete elevated amounts of 3-hydroxybutyrate and acetoacetate. Enzyme analysis in cultured fibroblasts revealed a probable deficiency in cytosolic acetoacetyl-CoA thiolase which was about half the control activity with normal mitochondrial thiolase activities. Treatment with reduced dietary fat was initiated and a rapid reduction of the ketosis to biochemical normality was demonstrated. Shortly after initiating dietary treatment he presented with severe gastrointestinal problems and the histological features of colitis cystica superficialis. This appeared to respond to intravenous hydrocortisone therapy with an apparent complete recovery.',\n",
       "  'journal': 'Journal of inherited metabolic disease',\n",
       "  'authors': 'Bennett|M J|MJ|;Hosking|G P|GP|;Smith|M F|MF|;Gray|R G|RG|;Middleton|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150136',\n",
       "  'mesh_terms': 'D000101:Acetyl-CoA C-Acetyltransferase; D000123:Acetyltransferases; D002478:Cells, Cultured; D002784:Cholesterol; D003600:Cytosol; D005227:Fatty Acids; D005347:Fibroblasts; D006801:Humans; D007223:Infant; D008607:Intellectual Disability; D007657:Ketone Bodies; D008052:Lipid Metabolism, Inborn Errors; D008297:Male; D012016:Reference Values',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D005227:Fatty Acids; D007657:Ketone Bodies; D002784:Cholesterol; D000123:Acetyltransferases; D000101:Acetyl-CoA C-Acetyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF01801770',\n",
       "  'references': '4258782;4721608;6777599;6133656;7173255;4724596;36452;20597;68686;5567963;7138583;6712135;5165621;5116556',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'J Inherit Metab Dis',\n",
       "  'nlm_unique_id': '7910918',\n",
       "  'issn_linking': '0141-8955',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Elastin: relation of protein and gene structure to disease.',\n",
       "  'issue': '51(6)',\n",
       "  'pages': '605-23',\n",
       "  'abstract': 'The elastic properties of many tissues such as the lung, dermis, and large blood vessels are due to the presence of elastic fibers in the extracellular space. These fibers have been shown by biochemical and ultrastructural analysis to be comprised of two distinct components, a more abundant amorphous component and the microfibrillar component. The microfibrillar component is found in 10- to 12-nm fibrils which are located primarily around the periphery of the amorphous component but, to some extent, interspersed within it. The protein, elastin, makes up the highly insoluble amorphous component and is responsible for the elastic properties. Elastin is found throughout the vertebrate kingdom except for very primitive fish and possesses an unusual chemical composition consonant with its characteristic physical properties. Elastin is composed largely of glycine, proline, and other hydrophobic residues and contains multiple lysine-derived cross-links, such as the desmosines, which link the individual polypeptide chains into a rubber-like network. The intervening, hydrophobic regions of the polypeptide chains between the cross-links are highly mobile, and the elastic properties of the fibers can be described in terms of the theory of rubber elasticity. Recent application of recombinant DNA techniques has led to further understanding of the structure of elastin. Analyses of the bovine and human elastin genes have demonstrated that the hydrophobic and cross-linking domains are encoded in separate exons. These exons tend to be small, varying from 27 to 114 base pairs, and are separated by large intervening sequences. Furthermore, DNA sequence analysis has demonstrated that the elastin molecule contains two cysteine residues which were not previously identified near the carboxy terminus and which may be important in the interaction of elastin with other extracellular matrix proteins. Further DNA sequencing should determine the complete amino acid sequence of elastin. Biosynthetic studies and in vitro translation of elastin mRNA have demonstrated that a 72,000-dalton polypeptide, designated tropoelastin, is the initial translation product. Analysis of several developing systems has demonstrated that elastin synthesis is controlled by the level of elastin mRNA. After packaging into membrane-bound vesicles in the Golgi apparatus, tropoelastin is secreted by exocytosis into the extracellular space where it is cross-linked by a copper-requiring extracellular enzyme, lysyl oxidase. Elastin can be solubilized only by proteases that have consequently been designated elastases, although these are general, powerful proteases that can hydrolyze numerous proteins.(ABSTRACT TRUNCATED AT 400 WORDS)',\n",
       "  'journal': 'Laboratory investigation; a journal of technical methods and pathology',\n",
       "  'authors': 'Rosenbloom|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150137',\n",
       "  'mesh_terms': 'D000595:Amino Acid Sequence; D000596:Amino Acids; D000818:Animals; D001011:Aorta; D001483:Base Sequence; D005075:Biological Evolution; D001847:Bone Diseases; D055598:Chemical Phenomena; D002621:Chemistry; D003483:Cutis Laxa; D004247:DNA; D004549:Elastin; D005796:Genes; D030342:Genetic Diseases, Inborn; D006801:Humans; D008173:Lung Diseases, Obstructive; D046911:Macromolecular Substances; D008382:Marfan Syndrome; D008854:Microscopy, Electron; D008249:Protein-Lysine 6-Oxidase; D011561:Pseudoxanthoma Elasticum; D012333:RNA, Messenger; D013045:Species Specificity; D013577:Syndrome; D014333:Tropoelastin; D014652:Vascular Diseases',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.; D016454:Review\",\n",
       "  'chemical_list': 'D000596:Amino Acids; D046911:Macromolecular Substances; D012333:RNA, Messenger; D014333:Tropoelastin; D004247:DNA; D004549:Elastin; D008249:Protein-Lysine 6-Oxidase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lab Invest',\n",
       "  'nlm_unique_id': '0376617',\n",
       "  'issn_linking': '0023-6837',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Use of vasodilator agents in the treatment of cardiac insufficiency].',\n",
       "  'issue': '83(11)',\n",
       "  'pages': '460-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Medicina clinica',\n",
       "  'authors': 'Ruano Calvo|F J|FJ|;Larman Tellechea|M|M|;Pajarón López|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150138',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D002121:Calcium Channel Blockers; D006333:Heart Failure; D006801:Humans; D009638:Norepinephrine; D012084:Renin-Angiotensin System; D013564:Sympathetic Nervous System; D014665:Vasodilator Agents; D014667:Vasopressins',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D002121:Calcium Channel Blockers; D014665:Vasodilator Agents; D014667:Vasopressins; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Med Clin (Barc)',\n",
       "  'nlm_unique_id': '0376377',\n",
       "  'issn_linking': '0025-7753',\n",
       "  'country': 'Spain'},\n",
       " {'title': 'An infantile autistic syndrome characterised by the presence of succinylpurines in body fluids.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1058-61',\n",
       "  'abstract': 'Succinyladenosine and succinylaminoimidazole carboxamide riboside were found in body fluids from 3 children, including a brother and sister, with severe psychomotor delay and autism. Both succinylpurines were identified by acid hydrolysis, anion-exchange chromatography, and ultraviolet spectrophotometry. Concentrations of both compounds were around 100 mumol/l in cerebrospinal fluid, between 5 and 10 mumol/l in plasma, and in the mmol/l range in urine. Succinylpurines were undetectable in cerebrospinal fluid and plasma from controls but there might be trace amounts in normal urine. The compounds are dephosphorylated derivatives of the intracellular metabolites adenylosuccinate and succinylaminoimidazole carboxamide ribotide, the two substrates of adenylosuccinase (adenylosuccinate lyase, EC 4.3.2.2). Their presence indicates a deficiency of this enzyme, which is involved in both de novo synthesis of purines and the formation of adenosine monophosphate from inosine monophosphate. Assays in one patient revealed markedly decreased adenylosuccinase activity in the liver and absence of activity in the kidney. The accumulation of both succinylpurines in the cerebrospinal fluid suggests that there is also a deficiency of this enzyme in the brain and that it may be the basic defect in a subgroup of children with genetically determined autism.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Jaeken|J|J|;Van den Berghe|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150139',\n",
       "  'mesh_terms': 'D000241:Adenosine; D000620:Aminoimidazole Carboxamide; D001321:Autistic Disorder; D001826:Body Fluids; D002675:Child, Preschool; D002852:Chromatography, Ion Exchange; D005260:Female; D006801:Humans; D006868:Hydrolysis; D007223:Infant; D008297:Male; D011596:Psychomotor Disorders; D011687:Purines; D012263:Ribonucleosides; D013056:Spectrophotometry, Ultraviolet; D013386:Succinates',\n",
       "  'publication_types': \"D002363:Case Reports; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D011687:Purines; D012263:Ribonucleosides; D013386:Succinates; C043566:succinylaminoimidazole carboxamide riboside; D000620:Aminoimidazole Carboxamide; C043565:succinyladenosine; D000241:Adenosine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Non-A, non-B hepatitis occurring in agammaglobulinaemic patients after intravenous immunoglobulin.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1062-4',\n",
       "  'abstract': 'Acute non-A, non-B hepatitis developed in twelve patients with primary hypogammaglobulinaemia during treatment with intravenous gammaglobulin prepared by Cohn fractionation of pooled plasma. The illness was clinically and histologically identical to the short-incubation non-A, non-B, hepatitis observed in haemophilic patients receiving factor VIII concentrates. Most of the patients were symptomless, but 10 months after onset ten of the twelve still had abnormal liver function. The occurrence of non-A, non-B hepatitis in agammaglobulinaemics indicates that humoral mechanisms are not essential for production of hepatocyte necrosis in this infection. This outbreak emphasises the need for a screening test to identify the agent in blood products, and shows that Cohn fractionation of plasma does not always inactivate the agent. Furthermore, the finding that the virus can be transmitted in IgG concentrates suggests either that the general population has a very low level of antibodies to the putative virus or that such antibodies are not virus-neutralising.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Lever|A M|AM|;Webster|A D|AD|;Brown|D|D|;Thomas|H C|HC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150140',\n",
       "  'mesh_terms': 'D000361:Agammaglobulinemia; D001219:Aspartate Aminotransferases; D002986:Clinical Trials as Topic; D003208:Concanavalin A; D005260:Female; D006526:Hepatitis C; D006525:Hepatitis, Viral, Human; D006801:Humans; D007136:Immunoglobulins; D007273:Injections, Intramuscular; D007275:Injections, Intravenous; D010641:Phenotype; D013601:T-Lymphocytes',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D007136:Immunoglobulins; D003208:Concanavalin A; D001219:Aspartate Aminotransferases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91506-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Influence of propranolol on weight and salt and water homoeostasis in chronic liver disease.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1064-8',\n",
       "  'abstract': 'Sixteen patients with chronic liver disease were treated with propranolol or placebo in a double-blind study. Skinfold thickness, total body water and exchangeable sodium, and urinary sodium were measured every 6 months for a year; body weight was measured every 2 (later every 3) months for 15 months. Propranolol treatment was associated with a significant rise in body weight after 9 months and significant rises in skinfold thickness and body fat after 12 months. Propranolol-treated patients showed a fall in total body water at 6 months and a rise in urinary sodium concentration at 12 months. They did not show the rise in total body exchangeable sodium that occurred in placebo-treated patients. Propranolol seems to affect salt and water homoeostasis favourably in patients with chronic liver disease.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Hayes|P C|PC|;Stewart|W W|WW|;Bouchier|I A|IA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150141',\n",
       "  'mesh_terms': 'D000273:Adipose Tissue; D001835:Body Weight; D002908:Chronic Disease; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008107:Liver Diseases; D008297:Male; D011433:Propranolol; D012885:Skinfold Thickness; D012964:Sodium; D013997:Time Factors; D014882:Water-Electrolyte Balance',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D012964:Sodium; D011433:Propranolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91507-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Transplantation of unpurged autologous bone-marrow in acute myeloid leukaemia in first remission.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1068-70',\n",
       "  'abstract': 'Twelve consecutive patients aged 18-53 were given autologous remission bonemarrow and cyclophosphamide and total-body irradiation to maintain first remission of acute myeloid leukaemia. Follow-up lasted at least 6 months. Seven patients remain in complete unmaintained remission 26-140 weeks post-autograft with overall remissions of 42-202 weeks. The prediction of leukaemia-free survival based on these results is 58% at 3 years. The procedure was well tolerated and resulted in little morbidity and no mortality.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Burnett|A K|AK|;Tansey|P|P|;Watkins|R|R|;Alcorn|M|M|;Maharaj|D|D|;Singer|C R|CR|;McKinnon|S|S|;McDonald|G A|GA|;Robertson|A G|AG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150142',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003520:Cyclophosphamide; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D008297:Male; D008875:Middle Aged; D014182:Transplantation, Autologous; D014916:Whole-Body Irradiation',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D003520:Cyclophosphamide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91508-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Isolation of a virus from chimpanzee liver cell cultures inoculated with sera containing the agent of non-A, non-B hepatitis.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1071-5',\n",
       "  'abstract': 'A membrane-coated virus having a diameter of 85-90 nm and containing a 40-45 nm core was found to replicate in cell cultures derived from chimpanzee liver after inoculation of serum containing infective non-A, non-B (NANB) hepatitis viruses from two independent sources. Replication of this agent was not observed when the same cells were inoculated with a chloroform-extracted inoculum or were left uninoculated. Replication involves assembly of virus cores on tubular structures similar to those seen in liver cells of chimpanzees infected with most isolates of NANB virus.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Prince|A M|AM|;Huima|T|T|;Williams|B A|BA|;Bardina|L|L|;Brotman|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150143',\n",
       "  'mesh_terms': 'D000818:Animals; D002478:Cells, Cultured; D006526:Hepatitis C; D006518:Hepatitis Viruses; D006525:Hepatitis, Viral, Human; D006801:Humans; D008099:Liver; D002679:Pan troglodytes; D013997:Time Factors; D014779:Virus Replication',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91509-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Non-A, non-B hepatitis.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1077-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150144',\n",
       "  'mesh_terms': 'D000818:Animals; D006526:Hepatitis C; D006518:Hepatitis Viruses; D006525:Hepatitis, Viral, Human; D006801:Humans; D065227:Transfusion Reaction',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Haemolytic uraemic syndrome.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1078-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150145',\n",
       "  'mesh_terms': 'D006463:Hemolytic-Uremic Syndrome; D006801:Humans; D014810:Vitamin E',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D014810:Vitamin E',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Are postoperative pulmonary complications preventable?',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1079-80',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150146',\n",
       "  'mesh_terms': 'D006801:Humans; D008171:Lung Diseases; D011183:Postoperative Complications',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91513-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'CT scans in psychiatry.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1080-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150147',\n",
       "  'mesh_terms': 'D000368:Aged; D001921:Brain; D003937:Diagnosis, Differential; D006801:Humans; D001523:Mental Disorders; D014057:Tomography, X-Ray Computed',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Kidney brokerage: a glimpse of the future?',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1081',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150148',\n",
       "  'mesh_terms': 'D004992:Ethics, Medical; D006801:Humans; D016030:Kidney Transplantation; D018570:Risk Assessment; D009927:Tissue and Organ Procurement; D014184:Transplantation, Homologous; D035761:Wedge Argument',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Health Care and Public Health',\n",
       "  'doi': '10.1016/s0140-6736(84)91515-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18930',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Drug-induced parkinsonism in the elderly.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1082-3',\n",
       "  'abstract': 'Of 95 new cases of parkinsonism referred to a department of geriatric medicine, 48 (51%) were associated with prescribed drugs. Clinical features in drug-induced and idiopathic cases were very similar, including the proportion with typical tremor. 25% of patients with drug-induced parkinsonism (DIP) could not walk when first seen and 45% required hospital admission (for a median stay of 23 days, range 5-101). The clinical features of DIP resolved permanently in two-thirds of cases in a mean of 7 weeks but with a range of 1 to 36 weeks. 5 cases of DIP initially resolved but idiopathic parkinsonism developed after an interval of 3 to 18 months. Perhaps some old people have low striatal dopamine levels and a small neuroleptic effect tips them into overt parkinsonism or unmasks latent idiopathic disease. The commonest offending drug was prochlorperazine (21 cases). In no case did this drug seem to be indicated.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Stephen|P J|PJ|;Williamson|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150149',\n",
       "  'mesh_terms': 'D000368:Aged; D014150:Antipsychotic Agents; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D010300:Parkinson Disease; D010302:Parkinson Disease, Secondary; D011346:Prochlorperazine; D011446:Prospective Studies; D013881:Thioridazine; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D013881:Thioridazine; D011346:Prochlorperazine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91516-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Relation between breast-feeding and incidence rates of insulin-dependent diabetes mellitus. A hypothesis.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1083-6',\n",
       "  'abstract': 'The variations in incidence rates of insulin-dependent diabetes mellitus (IDDM) in childhood within and between genetically very similar Scandinavian populations and the variations in incidence rates with time are difficult to explain. Epidemiological data show that the incidence of childhood IDDM may now be declining and suggest an inverse correlation between breast-feeding frequency and IDDM in childhood. Case-control data show that diabetic children were breast-fed for shorter periods of time than their healthy siblings and the population at large and that a smaller proportion of diabetic children were ever breast-fed. It is postulated that insufficient breast-feeding of genetically susceptible newborn infants may lead to beta-cell infection and IDDM later in life.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Borch-Johnsen|K|K|;Joner|G|G|;Mandrup-Poulsen|T|T|;Christy|M|M|;Zachau-Christiansen|B|B|;Kastrup|K|K|;Nerup|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150150',\n",
       "  'mesh_terms': 'D000293:Adolescent; D001942:Breast Feeding; D002648:Child; D002675:Child, Preschool; D003718:Denmark; D003922:Diabetes Mellitus, Type 1; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011795:Surveys and Questionnaires; D013548:Sweden; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91517-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'DNA juggling in the immune system.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1086-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Rabbitts|T H|TH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150151',\n",
       "  'mesh_terms': 'D000917:Antibody Formation; D001402:B-Lymphocytes; D002875:Chromosomes; D004247:DNA; D004274:DNA, Recombinant; D005802:Genes, MHC Class II; D006801:Humans; D009857:Oncogenes; D014176:Protein Biosynthesis; D011947:Receptors, Antigen, B-Cell; D011948:Receptors, Antigen, T-Cell; D013601:T-Lymphocytes',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004274:DNA, Recombinant; D011947:Receptors, Antigen, B-Cell; D011948:Receptors, Antigen, T-Cell; D004247:DNA',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91518-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Forty years on when afar and asunder.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1088',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Pond|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150152',\n",
       "  'mesh_terms': 'D004501:Education, Medical; D004739:England; D049673:History, 20th Century; D007393:International Educational Exchange; D009656:North America; D014857:Warfare',\n",
       "  'publication_types': 'D016456:Historical Article; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91519-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Referrals to hospital.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1089',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Todd|J W|JW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150153',\n",
       "  'mesh_terms': 'D000368:Aged; D005194:Family Practice; D006761:Hospitals; D006801:Humans; D012017:Referral and Consultation; D006113:United Kingdom',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91520-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Combined treatment with LHRH agonist and pure antiandrogen in advanced carcinoma of prostate.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1090',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Labrie|F|F|;Belanger|A|A|;Dupont|A|A|;Emond|J|J|;Lacoursiere|Y|Y|;Monfette|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150154',\n",
       "  'mesh_terms': 'D000726:Androgen Antagonists; D004359:Drug Therapy, Combination; D007987:Gonadotropin-Releasing Hormone; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000726:Androgen Antagonists; D007987:Gonadotropin-Releasing Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91521-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"Bell's phenomenon in diagnosis of myasthenia gravis.\",\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1090-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Furukawa|T|T|;Tsukagoshi|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150155',\n",
       "  'mesh_terms': 'D000328:Adult; D005133:Eye Movements; D005260:Female; D006801:Humans; D009157:Myasthenia Gravis',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91522-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Campylobacter-like organisms unusual in type A (pernicious anaemia) gastritis.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1091',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': \"O'Connor|H J|HJ|;Axon|A T|AT|;Dixon|M F|MF|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150156',\n",
       "  'mesh_terms': 'D000752:Anemia, Pernicious; D002167:Campylobacter; D005756:Gastritis; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91523-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Immunogenicity of low dose (1.25 and 0.31 micrograms) hepatitis B vaccine.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1091-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Goudeau|A|A|;Dubois|F|F|;Dubois|M C|MC|;Louq|C|C|;Mazert|M C|MC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150157',\n",
       "  'mesh_terms': 'D000328:Adult; D005260:Female; D006510:Hepatitis B Antibodies; D006801:Humans; D014761:Viral Hepatitis Vaccines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D018848:Controlled Clinical Trial; D016422:Letter',\n",
       "  'chemical_list': 'D006510:Hepatitis B Antibodies; D014761:Viral Hepatitis Vaccines',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91524-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Do cholecystectomy rates correlate with geographic variations in prevalence of gallstones?',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1092-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'McPherson|K|K|;Strong|P M|PM|;Jones|L|L|;Britton|B J|BJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150158',\n",
       "  'mesh_terms': 'D002763:Cholecystectomy; D002769:Cholelithiasis; D006801:Humans; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91525-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Impaired renal function and hypercalcaemia associated with etretinate.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1093',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Horber|F F|FF|;Zimmermann|A|A|;Frey|F J|FJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150159',\n",
       "  'mesh_terms': 'D005050:Etretinate; D006801:Humans; D006934:Hypercalcemia; D007668:Kidney; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D001749:Urinary Bladder Neoplasms',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D005050:Etretinate',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91526-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Antibodies to HTLV-III in patients with acquired immunodeficiency or lymphadenopathy syndrome in West Germany.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1094',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Hehlmann|R|R|;Kreeb|G|G|;Erfle|V|V|;Piechowiak|H|H|;Krüger|G|G|;Goebel|F D|FD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150160',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D000914:Antibodies, Viral; D000917:Antibody Formation; D017977:Deltaretrovirus; D005860:Germany, West; D006716:Homosexuality; D006801:Humans; D008206:Lymphatic Diseases',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91528-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Reference range for lymphocyte counts in health.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1094',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Robbins|G|G|;Henthorn|J|J|;Brozović|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150161',\n",
       "  'mesh_terms': 'D005260:Female; D006801:Humans; D007958:Leukocyte Count; D008214:Lymphocytes; D008297:Male; D012016:Reference Values',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91527-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"Infantile autism and Rett's syndrome: common chromosomal denominator.\",\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1094-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gillberg|C|C|;Wahlström|J|J|;Hagberg|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150162',\n",
       "  'mesh_terms': 'D001259:Ataxia; D001321:Autistic Disorder; D002648:Child; D002873:Chromosome Fragility; D003704:Dementia; D005260:Female; D006225:Hand; D006801:Humans; D008297:Male; D013577:Syndrome',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91529-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Free radicals, lipid peroxidation, and cell damage.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1095',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Halliwell|B|B|;Gutteridge|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150163',\n",
       "  'mesh_terms': 'D000975:Antioxidants; D005609:Free Radicals; D006801:Humans; D008054:Lipid Peroxides; D008099:Liver',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000975:Antioxidants; D005609:Free Radicals; D008054:Lipid Peroxides',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91530-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Interpretation of clofibrate trial.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1095-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Green|K G|KG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150164',\n",
       "  'mesh_terms': 'D002986:Clinical Trials as Topic; D002994:Clofibrate; D003327:Coronary Disease; D004311:Double-Blind Method; D006801:Humans; D008297:Male; D011897:Random Allocation; D012107:Research Design',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016422:Letter; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D002994:Clofibrate',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91531-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Recruitment to breast cancer trials.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1096-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Stewart|H J|HJ|;Robinson|S M|SM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150165',\n",
       "  'mesh_terms': 'D001943:Breast Neoplasms; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008408:Mastectomy; D010342:Patient Acceptance of Health Care; D011897:Random Allocation; D012606:Scotland',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91532-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Assessing quality of obstetric care.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1097',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Golding|J|J|;Peters|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150166',\n",
       "  'mesh_terms': 'D002986:Clinical Trials as Topic; D005260:Female; D005315:Fetal Diseases; D006801:Humans; D008433:Mathematics; D011247:Pregnancy; D011295:Prenatal Care; D011787:Quality of Health Care',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91533-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Misleading advertisements: sanctions and corrections.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1097-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Collier|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150167',\n",
       "  'mesh_terms': 'D000329:Advertising; D003906:Developing Countries; D004345:Drug Industry; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91534-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Is better feedback a major stimulus to spontaneous adverse reaction monitoring?',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1098',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Griffin|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150168',\n",
       "  'mesh_terms': 'D003142:Communication; D004346:Drug Information Services; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91535-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Drug safety.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1098-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Taggart|A J|AJ|;Taggart|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150169',\n",
       "  'mesh_terms': 'D064420:Drug-Related Side Effects and Adverse Reactions; D005069:Evaluation Studies as Topic; D006801:Humans; D011358:Product Surveillance, Postmarketing; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91536-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Anticardiolipin antibodies and lupus anticoagulant.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1099',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Harris|E N|EN|;Loizou|S|S|;Englert|H|H|;Derue|G|G|;Chan|J K|JK|;Gharavi|A E|AE|;Hughes|G R|GR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150170',\n",
       "  'mesh_terms': 'D000906:Antibodies; D001779:Blood Coagulation Factors; D002308:Cardiolipins; D006801:Humans; D016682:Lupus Coagulation Inhibitor',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000906:Antibodies; D001779:Blood Coagulation Factors; D002308:Cardiolipins; D016682:Lupus Coagulation Inhibitor',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91537-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Papanicolaou smears and risk of cervical neoplasia.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1099-100',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150171',\n",
       "  'mesh_terms': 'D005260:Female; D006801:Humans; D065006:Papanicolaou Test; D012306:Risk; D002583:Uterine Cervical Neoplasms; D014626:Vaginal Smears',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cervical cancer screening for younger women.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1100',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Last|P|P|;Ritchie|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150172',\n",
       "  'mesh_terms': 'D000328:Adult; D000367:Age Factors; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91539-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Carbon monoxide and cot death.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1101',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Emery|J L|JL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150173',\n",
       "  'mesh_terms': 'D002249:Carbon Monoxide Poisoning; D006801:Humans; D007223:Infant; D013398:Sudden Infant Death',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91540-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"Deterioration of severe Graves' ophthalmopathy during cyclosporin treatment.\",\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1101',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Howlett|T A|TA|;Lawton|N F|NF|;Fells|P|P|;Besser|G M|GM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150174',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D003524:Cyclosporins; D005260:Female; D006111:Graves Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D009886:Ophthalmoplegia; D014792:Visual Acuity',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D003524:Cyclosporins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91541-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Markets in kidneys.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1102',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bach|D L|DL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150175',\n",
       "  'mesh_terms': 'D028663:Ethical Theory; D004992:Ethics, Medical; D006801:Humans; D016030:Kidney Transplantation; D018570:Risk Assessment; D009927:Tissue and Organ Procurement; D014184:Transplantation, Homologous',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Health Care and Public Health',\n",
       "  'doi': '10.1016/s0140-6736(84)91542-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18903',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'In-utero platelet transfusion in alloimmune thrombocytopenia.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1103-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Naiman|J L|JL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150176',\n",
       "  'mesh_terms': 'D001805:Blood Transfusion, Intrauterine; D002585:Cesarean Section; D005260:Female; D005315:Fetal Diseases; D006801:Humans; D017713:Platelet Transfusion; D011247:Pregnancy; D013921:Thrombocytopenia',\n",
       "  'publication_types': 'D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91546-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Fibrionectin, a marker for malignant ascites.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1104',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Deverbizier|G|G|;Beauchant|M|M|;Chapron|A|A|;Touchard|G|G|;Reiss|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150177',\n",
       "  'mesh_terms': 'D001201:Ascites; D005353:Fibronectins; D006801:Humans; D008103:Liver Cirrhosis; D009369:Neoplasms',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D005353:Fibronectins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91547-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Serious professional misconduct. Points from report of GMC working party.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1105-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150178',\n",
       "  'mesh_terms': 'D002983:Clinical Competence; D003406:Credentialing; D004739:England; D006801:Humans; D008318:Malpractice; D010820:Physicians',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Definition of insanity.',\n",
       "  'issue': '2(8411)',\n",
       "  'pages': '1108',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Brahams|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150179',\n",
       "  'mesh_terms': 'D004739:England; D005555:Forensic Psychiatry; D007298:Insanity Defense',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91551-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Randomised controlled trial of effect of raw and holder pasteurised human milk and of formula supplements on incidence of neonatal infection.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1111-3',\n",
       "  'abstract': 'Supplementary formula feeds inhibited the protective effect of expressed raw and pasteurised human milk in 226 high-risk neonates in a randomised controlled trial. The infection rate in the group given pasteurised human milk and formula (33%) was significantly higher than the rates in the groups given raw human milk (10.5%), pasteurised human milk (14.3%), and raw human milk and formula (16%). This accords with the impressions that some of the association of infection with artificial feeding is partly attributable to the lack of the protective effect of human milk. Heating expressed human milk to 62.5 degrees C for 30 min significantly reduces its protective effect.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Narayanan|I|I|;Prakash|K|K|;Murthy|N S|NS|;Gujral|V V|VV|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150180',\n",
       "  'mesh_terms': 'D000818:Animals; D001419:Bacteria; D001424:Bacterial Infections; D001903:Bottle Feeding; D001942:Breast Feeding; D002417:Cattle; D002986:Clinical Trials as Topic; D005260:Female; D006361:Heating; D006801:Humans; D007194:India; D007225:Infant Food; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D008892:Milk; D008895:Milk, Human; D011897:Random Allocation; D012306:Risk; D013242:Sterilization',\n",
       "  'publication_types': \"D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91554-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Syncope in aortic valvular stenosis.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1113-6',\n",
       "  'abstract': 'Simultaneous, continuous ambulatory recordings of systemic and pulmonary arterial pressure and heart rate were made in four patients with aortic valvular stenosis (AS) to explore the mechanisms of syncope in the disorder. When compared with six normal volunteers, patients with AS showed a subnormal systemic arterial pressure response to graded submaximal exercise. Three near-syncopal episodes, occurring during abrupt symptom-limited exercise, were associated with simultaneous acute falls in systemic and pulmonary arterial pressure in the absence of cardiac arrhythmia. Acute reflex peripheral arterial and venous vasodilatation, which may be mediated by the effects of sudden changes in left-ventricular pressure on ventricular baroreceptor activity, plays a central role in the exertion-induced syncope of aortic stenosis.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Richards|A M|AM|;Nicholls|M G|MG|;Ikram|H|H|;Hamilton|E J|EJ|;Richards|R D|RD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150181',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000368:Aged; D001024:Aortic Valve Stenosis; D001794:Blood Pressure; D005080:Exercise Test; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D011669:Pulmonary Wedge Pressure; D013575:Syncope; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91555-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Association between cyclosporin neurotoxicity and hypomagnesaemia.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1116-20',\n",
       "  'abstract': 'The serum magnesium levels of all 12 allogeneic bone-marrow transplant recipients who experienced the neurotoxic effects of cyclosporin (CyA) were more than two standard deviations below the normal range. The neurological events seemed to segregate into three separate syndromes. 7 patients had grand-mal seizures, which occurred within the first several weeks of CyA therapy (median onset 12 days). At the time of their first seizure all 7 patients had hypomagnesaemia, which had developed rapidly over the preceding 1-3 weeks. 3 patients had four episodes of cerebellar ataxia, tremor, and depression. These subacute episodes developed after prolonged CyA therapy (median onset 67 days). Each episode was associated with hypomagnesaemia. 2 patients had a transient episode of expressive aphasia following a long period of hypomagnesaemia. In all cases symptoms resolved or did not recur with adequate magnesium replacement. These data suggest that CyA neurotoxicity is associated with hypomagnesaemia and may be treated or prevented with magnesium replacement.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Thompson|C B|CB|;June|C H|CH|;Sullivan|K M|KM|;Thomas|E D|ED|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150182',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D001037:Aphasia; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003524:Cyclosporins; D004830:Epilepsy, Tonic-Clonic; D006801:Humans; D008274:Magnesium; D009422:Nervous System Diseases; D012189:Retrospective Studies; D012306:Risk; D013997:Time Factors',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D003524:Cyclosporins; D008274:Magnesium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91556-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effects of captopril on abnormalities of the peripheral circulation and respiratory function in patients with severe heart failure.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1120-4',\n",
       "  'abstract': 'Limb blood flow and respiratory function were compared in ten patients with severe heart failure inadequately controlled by diuretics and normal control subjects matched for age and sex. Both forearm and calf blood flow, at rest and after exercise, were lower in the patients than in the control subjects. Oxygen consumption during submaximal exercise was also lower in the patients and minute ventilation was higher. Captopril, administered in a single-blind controlled study to the patients, resulted in an improvement in these abnormalities, with the exception of oxygen consumption. It also improved exercise tolerance and reduced perceived exertion during exercise. Captopril is effective treatment for severe heart failure and improves some of the peripheral haemodynamic and respiratory abnormalities.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Cowley|A J|AJ|;Rowley|J M|JM|;Stainer|K|K|;Hampton|J R|JR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150183',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D001775:Blood Circulation; D002216:Captopril; D002986:Clinical Trials as Topic; D005542:Forearm; D006333:Heart Failure; D006801:Humans; D007866:Leg; D008297:Male; D008875:Middle Aged; D010101:Oxygen Consumption; D005082:Physical Exertion; D011392:Proline; D012119:Respiration; D013997:Time Factors',\n",
       "  'publication_types': \"D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D011392:Proline; D002216:Captopril',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91557-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '85059809',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Human lymphoid cells express epithelial membrane antigen. Implications for diagnosis of human neoplasms.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1124-9',\n",
       "  'abstract': 'Epithelial membrane antigen (EMA) is generally assumed to be expressed only on epithelial cells. However, EMA was also found on reactive and neoplastic plasma cells, on some non-Hodgkin\\'s lymphomas (particularly cases of T-cell lymphoma and \"malignant histiocytosis\"), and on Reed-Sternberg cells in cases of lymphocyte-predominant Hodgkin\\'s disease. EMA was also induced on normal blood lymphocytes by exposure to human T-lymphotropic virus type II or phytohaemagglutinin. The specificity of these aberrant reactions was confirmed by the use of three different monoclonal anti-EMA antibodies (E29, HMFG2, and LICR.LON/M8), and by showing that EMA in lymphoid tissue is similar in molecular weight to EMA in human milk. These results indicate that additional anti-epithelial antibodies (eg, anti-cytokeratins) should be used in conjunction with anti-EMA for tumour diagnosis.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Delsol|G|G|;Gatter|K C|KC|;Stein|H|H|;Erber|W N|WN|;Pulford|K A|KA|;Zinne|K|K|;Mason|D Y|DY|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150184',\n",
       "  'mesh_terms': 'D000911:Antibodies, Monoclonal; D001943:Breast Neoplasms; D006646:Histiocytosis, Langerhans-Cell; D006689:Hodgkin Disease; D006801:Humans; D007124:Immunoenzyme Techniques; D008214:Lymphocytes; D008223:Lymphoma; D008565:Membrane Proteins; D008970:Molecular Weight; D018396:Mucin-1; D009369:Neoplasms; D013601:T-Lymphocytes',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D008565:Membrane Proteins; D018396:Mucin-1',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91558-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Inhibition of dithranol inflammation by free-radical scavengers.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1129-30',\n",
       "  'abstract': 'Dithranol (anthralin) inflammation of forearm skin was completely inhibited by various scavengers of free radicals of the oxygen species. It is concluded that dithranol inflammation is initiated by formation of free radicals; these may act through lipid peroxidation and production of inflammatory endoperoxides or by a more direct mechanism.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Finnen|M J|MJ|;Lawrence|C M|CM|;Shuster|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150185',\n",
       "  'mesh_terms': 'D000287:Administration, Topical; D000328:Adult; D000368:Aged; D000873:Anthracenes; D000875:Anthralin; D002083:Butylated Hydroxyanisole; D004224:Diterpenes; D003875:Drug Eruptions; D004890:Erythema; D005260:Female; D005609:Free Radicals; D006801:Humans; D008297:Male; D008875:Middle Aged; D000084562:Retinyl Esters; D014801:Vitamin A; D014810:Vitamin E',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D000873:Anthracenes; D004224:Diterpenes; D005609:Free Radicals; D000084562:Retinyl Esters; D014801:Vitamin A; D014810:Vitamin E; C014794:retinol palmitate; D002083:Butylated Hydroxyanisole; C009166:retinol acetate; D000875:Anthralin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91559-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Aflatoxins and kwashiorkor.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1133-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150186',\n",
       "  'mesh_terms': 'D000348:Aflatoxins; D002648:Child; D006801:Humans; D007732:Kwashiorkor',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D000348:Aflatoxins',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Tick-borne Borrelia.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1134-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150187',\n",
       "  'mesh_terms': 'D000818:Animals; D001096:Arachnid Vectors; D001899:Borrelia Infections; D006801:Humans; D008193:Lyme Disease; D013987:Ticks',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'True antithesis or mere misunderstanding?',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1135-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150188',\n",
       "  'mesh_terms': 'D003153:Community Health Services; D004739:England; D006760:Hospitalization',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91563-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Curtailment of prescribing in the National Health Service.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1136-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150189',\n",
       "  'mesh_terms': 'D001569:Benzodiazepines; D003365:Costs and Cost Analysis; D011307:Drug Prescriptions; D007885:Legislation, Pharmacy; D013810:Therapeutic Equivalency; D006113:United Kingdom',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D001569:Benzodiazepines',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cot death: the unfounded lurking suspicion.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1137',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150190',\n",
       "  'mesh_terms': 'D001237:Asphyxia; D003644:Death Certificates; D004739:England; D005260:Female; D006801:Humans; D007223:Infant; D013398:Sudden Infant Death',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'DNA in medicine. Oncogenes.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1138-42',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Weiss|R A|RA|;Marshall|C J|CJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150191',\n",
       "  'mesh_terms': 'D002874:Chromosome Mapping; D003001:Cloning, Molecular; D004273:DNA, Neoplasm; D004274:DNA, Recombinant; D004279:DNA, Viral; D005815:Genetic Code; D006801:Humans; D007951:Leukemia, Myeloid; D009154:Mutation; D009369:Neoplasms; D009857:Oncogenes; D010641:Phenotype; D012190:Retroviridae; D014178:Translocation, Genetic',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004273:DNA, Neoplasm; D004274:DNA, Recombinant; D004279:DNA, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91566-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'The platelet in asthma.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1142-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Morley|J|J|;Sanjar|S|S|;Page|C P|CP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150192',\n",
       "  'mesh_terms': 'D000403:Airway Resistance; D001249:Asthma; D001792:Blood Platelets; D001986:Bronchial Spasm; D004205:Cromolyn Sodium; D006801:Humans; D008168:Lung; D009130:Muscle, Smooth; D010972:Platelet Activating Factor; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D010972:Platelet Activating Factor; D004205:Cromolyn Sodium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91567-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Two-class medicine returns to the United States: impact of Medi-Cal reform.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1144-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Waitzkin|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150193',\n",
       "  'mesh_terms': 'D000328:Adult; D002140:California; D005260:Female; D006291:Health Policy; D006801:Humans; D008297:Male; D008484:Medicaid; D008489:Medical Indigency; D008875:Middle Aged; D014481:United States',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Health Care and Public Health; Medi-Cal',\n",
       "  'doi': '10.1016/s0140-6736(84)91568-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18495',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Wasted resources. Investigations.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1146-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Todd|J W|JW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150194',\n",
       "  'mesh_terms': 'D003955:Diagnostic Tests, Routine; D005260:Female; D006801:Humans; D008297:Male; D009110:Munchausen Syndrome',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91569-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Expression of donor allergic response patterns by bone marrow transplant recipients.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1148',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Desai|S|S|;Walker|S A|SA|;Shaw|P J|PJ|;Riches|P G|PG|;Hobbs|J R|JR|;Wild|G|G|;Harper|J I|JI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150195',\n",
       "  'mesh_terms': 'D016026:Bone Marrow Transplantation; D005260:Female; D006801:Humans; D006967:Hypersensitivity; D007223:Infant; D008297:Male; D011183:Postoperative Complications; D014019:Tissue Donors',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91571-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Adjuvant hormonal chemotherapy in early breast cancer: early results from a controlled trial.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1148-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Senanayake|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150196',\n",
       "  'mesh_terms': 'D001943:Breast Neoplasms; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D011897:Random Allocation; D013629:Tamoxifen',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016422:Letter; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D013629:Tamoxifen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91572-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Glucagon-(1-21)-peptide to prevent biliary colic pain.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1149',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Jacobson|G|G|;Nilsonn|B|B|;Nordgren|C E|CE|;Selking|O|O|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150197',\n",
       "  'mesh_terms': 'D001660:Biliary Tract Diseases; D002986:Clinical Trials as Topic; D003085:Colic; D005934:Glucagon; D006801:Humans; D010446:Peptide Fragments; D011897:Random Allocation',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016422:Letter; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D010446:Peptide Fragments; C043386:glucagon (1-21); D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91573-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Artificial HDL as an anti-atherosclerotic drug.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1149-50',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Orekhov|A N|AN|;Misharin AYu|||;Tertov|V V|VV|;Khashimov|Kh A|KhA|;Pokrovsky|S N|SN|;Repin|V S|VS|;Smirnov|V N|VN|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150198',\n",
       "  'mesh_terms': 'D001161:Arteriosclerosis; D002478:Cells, Cultured; D006801:Humans; D050356:Lipid Metabolism; D008075:Lipoproteins, HDL; D009131:Muscle, Smooth, Vascular',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D008075:Lipoproteins, HDL',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91574-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Changing trends of cervical neoplasia in Israeli Jews.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1150',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Schachter|A|A|;Avraham|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150199',\n",
       "  'mesh_terms': 'D000328:Adult; D002278:Carcinoma in Situ; D005260:Female; D006801:Humans; D007557:Israel; D007585:Jews; D008403:Mass Screening; D008875:Middle Aged; D002583:Uterine Cervical Neoplasms',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91575-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Selection of infertile men for in-vitro fertilisation.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1150-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Rowland|G|G|;Hewitt|J|J|;Cohen|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150200',\n",
       "  'mesh_terms': 'D005307:Fertilization in Vitro; D006801:Humans; D007248:Infertility, Male; D008297:Male; D013076:Sperm Count; D013081:Sperm Motility',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91576-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Early prognosis for IVF pregnancies through plasma oestrogens.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1151',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Emperaire|J C|JC|;Ruffie|A|A|;Audebert|A J|AJ|;Verdaguer|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150201',\n",
       "  'mesh_terms': 'D004624:Embryo Transfer; D004967:Estrogens; D005260:Female; D005307:Fertilization in Vitro; D006801:Humans; D011247:Pregnancy; D011379:Prognosis; D013997:Time Factors',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D004967:Estrogens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91577-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'DNA probes in Duchenne muscular dystrophy.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1151-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Clayton|J|J|;Emery|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150202',\n",
       "  'mesh_terms': 'D003402:Creatine Kinase; D004274:DNA, Recombinant; D005260:Female; D006580:Genetic Carrier Screening; D006801:Humans; D008297:Male; D009136:Muscular Dystrophies; D012306:Risk',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D004274:DNA, Recombinant; D003402:Creatine Kinase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91578-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Co-trimoxazole toxicity.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1152',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Lennon|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150203',\n",
       "  'mesh_terms': 'D000328:Adult; D004338:Drug Combinations; D004342:Drug Hypersensitivity; D006801:Humans; D013420:Sulfamethoxazole; D014295:Trimethoprim; D015662:Trimethoprim, Sulfamethoxazole Drug Combination',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D004338:Drug Combinations; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim; D013420:Sulfamethoxazole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91579-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Diagnosis of deep-vein thrombosis.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1152-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150204',\n",
       "  'mesh_terms': 'D006801:Humans; D010690:Phlebography; D010992:Plethysmography, Impedance; D013924:Thrombophlebitis',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Captopril during pregnancy.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1153',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Fiocchi|R|R|;Lijnen|P|P|;Fagard|R|R|;Staessen|J|J|;Amery|A|A|;Van Assche|F|F|;Spitz|B|B|;Rademaker|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150205',\n",
       "  'mesh_terms': 'D002216:Captopril; D005260:Female; D005315:Fetal Diseases; D006801:Humans; D006973:Hypertension; D008875:Middle Aged; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D011392:Proline',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D011392:Proline; D002216:Captopril',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91581-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Trophoblast cells in peripheral blood.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1153-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Rushton|D I|DI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150206',\n",
       "  'mesh_terms': 'D004617:Embolism; D005260:Female; D006801:Humans; D008938:Mitosis; D011247:Pregnancy; D011296:Prenatal Diagnosis; D014328:Trophoblastic Neoplasms; D014327:Trophoblasts; D014594:Uterine Neoplasms',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91582-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Alopecia areata: a heterogeneous disease.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1154',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Zauli|D|D|;Veronesi|S|S|;Lama|L|L|;Miserocchi|F|F|;Bianchi|F B|FB|;De Padova|M P|MP|;Tosti|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150207',\n",
       "  'mesh_terms': 'D000506:Alopecia Areata; D001323:Autoantibodies; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D001323:Autoantibodies',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91584-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Consequences for subsequent pregnancies of bacteriuria in schoolgirls.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1154',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Selkon|J B|JB|;Davison|J M|JM|;Sprott|M S|MS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150208',\n",
       "  'mesh_terms': 'D001437:Bacteriuria; D005260:Female; D005947:Glucose; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D005947:Glucose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91583-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'AIDS in an Italian drug addict.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1155',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Lazzarin|A|A|;Parravicini|C L|CL|;Meola|G|G|;Moroni|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150209',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D000328:Adult; D000914:Antibodies, Viral; D017977:Deltaretrovirus; D005260:Female; D006801:Humans; D007558:Italy; D019966:Substance-Related Disorders',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91586-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Sickle-cell-anaemia patients from Martinique have an increased prevalence of HTLV-I antibodies.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1155-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gessain|A|A|;Gazzolo|L|L|;Yoyo|M|M|;Fortier|L|L|;Robert-Guroff|M|M|;de-Thé|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150210',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell; D000914:Antibodies, Viral; D002648:Child; D002675:Child, Preschool; D017977:Deltaretrovirus; D006801:Humans; D008297:Male; D008395:Martinique; D065227:Transfusion Reaction',\n",
       "  'publication_types': \"D016422:Letter; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91587-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Hypersensitivity to intradermal hepatitis B vaccine.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1156',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Goldwater|P N|PN|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150211',\n",
       "  'mesh_terms': 'D000328:Adult; D017325:Hepatitis B Vaccines; D006801:Humans; D006967:Hypersensitivity; D007271:Injections, Intradermal; D008297:Male; D014761:Viral Hepatitis Vaccines',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91588-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': '51Cr-EDTA test for coeliac disease.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1156',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Stevens|F M|FM|;Bourke|M A|MA|;McCarthy|C F|CF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150212',\n",
       "  'mesh_terms': 'D002446:Celiac Disease; D002860:Chromium Radioisotopes; D004492:Edetic Acid; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D002860:Chromium Radioisotopes; D004492:Edetic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91589-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Absence of seasonality in emergency hospital admissions for inflammatory bowel disease.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1156-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Don|B A|BA|;Goldacre|M J|MJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150213',\n",
       "  'mesh_terms': 'D003093:Colitis, Ulcerative; D003424:Crohn Disease; D004630:Emergencies; D004739:England; D006801:Humans; D010343:Patient Admission; D012621:Seasons',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91590-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Seasonal prophylactic treatment with pirenzepine to prevent duodenal ulcer recurrence.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1157',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Morelli|A|A|;Narducci|F|F|;Pelli|M A|MA|;Farroni|F|F|;Daniotti|S|S|;Del Soldato|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150214',\n",
       "  'mesh_terms': 'D001570:Benzodiazepinones; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004381:Duodenal Ulcer; D006801:Humans; D010890:Pirenzepine; D011897:Random Allocation; D012008:Recurrence; D012621:Seasons',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016422:Letter; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D001570:Benzodiazepinones; D010890:Pirenzepine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91592-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Water-ski spill and ulcerative colitis.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1157',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bundgaard|A|A|;Jarnum|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150215',\n",
       "  'mesh_terms': 'D000328:Adult; D001265:Athletic Injuries; D003093:Colitis, Ulcerative; D006801:Humans; D008297:Male',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91591-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Health and disease in apartheid South Africa.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1158',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Walker|A R|AR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150216',\n",
       "  'mesh_terms': 'D009017:Morbidity; D011057:Politics; D011634:Public Health; D013019:South Africa',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91594-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'The Biko case: an appeal.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1158',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Hoffenberg|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150217',\n",
       "  'mesh_terms': 'D004992:Ethics, Medical; D049673:History, 20th Century; D006801:Humans; D011329:Prisoners; D028743:Professional Misconduct; D013019:South Africa',\n",
       "  'publication_types': 'D019215:Biography; D016456:Historical Article; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Health Care and Public Health; Legal Approach; South African Medical and Dental Council',\n",
       "  'doi': '10.1016/s0140-6736(84)91593-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18926',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Chloroquine-resistant malaria in India.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1159',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Mahoney|M P|MP|;Wright|P A|PA|;Bhattacharjee|K D|KD|;Brown|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150218',\n",
       "  'mesh_terms': 'D002738:Chloroquine; D004352:Drug Resistance, Microbial; D006801:Humans; D007194:India; D008288:Malaria; D008297:Male; D008875:Middle Aged; D010963:Plasmodium falciparum',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D002738:Chloroquine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91598-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Malaria control in Tanzania.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1159-60',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Msengi|A E|AE|;Yohani|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150219',\n",
       "  'mesh_terms': 'D001927:Brain Diseases; D002648:Child; D006801:Humans; D008288:Malaria; D010963:Plasmodium falciparum; D013636:Tanzania',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91599-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"Epidemic of dysentery in West Bengal: clinicians' enigma.\",\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1160',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bose|R|R|;Nashipuri|J N|JN|;Sen|P K|PK|;Datta|P|P|;Bhattacharya|S K|SK|;Datta|D|D|;Sen|D|D|;Bhattacharya|M K|MK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150220',\n",
       "  'mesh_terms': 'D004196:Disease Outbreaks; D004403:Dysentery; D006801:Humans; D007194:India; D012762:Shigella dysenteriae',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91600-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Hydatid disease and albendazole.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1160-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Braithwaite|P A|PA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150221',\n",
       "  'mesh_terms': 'D015766:Albendazole; D001562:Benzimidazoles; D004443:Echinococcosis; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D001562:Benzimidazoles; D015766:Albendazole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91601-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Sellafield, Seascale, and stem cells.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1161',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Cutler|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150222',\n",
       "  'mesh_terms': 'D002648:Child; D004739:England; D006801:Humans; D007953:Leukemia, Radiation-Induced; D011832:Radiation Injuries',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91602-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Is the TRH test usually unnecessary?',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1161-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kerr|D J|DJ|;Alexander|W D|WD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150223',\n",
       "  'mesh_terms': 'D006801:Humans; D006980:Hyperthyroidism; D011863:Radioimmunoassay; D013972:Thyrotropin; D013973:Thyrotropin-Releasing Hormone',\n",
       "  'publication_types': 'D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': 'D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91603-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'First-line test of thyroid function.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1162',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Caldwell|G|G|;Toft|A D|AD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150224',\n",
       "  'mesh_terms': 'D006801:Humans; D006980:Hyperthyroidism; D013960:Thyroid Function Tests; D013972:Thyrotropin',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D013972:Thyrotropin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91604-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Anorexia, depression, and zinc deficiency.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1162-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150225',\n",
       "  'mesh_terms': 'D000856:Anorexia Nervosa; D003866:Depressive Disorder; D006801:Humans; D015032:Zinc',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D015032:Zinc',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Progestagens and high-density lipoproteins.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1163',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kuusi|T|T|;Tikkanen|M J|MJ|;Nikkilä|E A|EA|;Sipinen|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150226',\n",
       "  'mesh_terms': 'D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D017135:Desogestrel; D005260:Female; D006801:Humans; D016912:Levonorgestrel; D008075:Lipoproteins, HDL; D009644:Norgestrel; D009652:Norpregnenes',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016422:Letter',\n",
       "  'chemical_list': 'D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D008075:Lipoproteins, HDL; D009652:Norpregnenes; D009644:Norgestrel; D016912:Levonorgestrel; D017135:Desogestrel',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91607-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Sore eyes due to accidental exposure to ultraviolet B.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1163',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Asbury|J F|JF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150227',\n",
       "  'mesh_terms': 'D005123:Eye; D006801:Humans; D008029:Lighting; D008297:Male; D014466:Ultraviolet Rays',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91606-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Reliability of drug history in analgesic users.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1163-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Schwarz|A|A|;Faber|U|U|;Borner|K|K|;Keller|F|F|;Offermann|G|G|;Molzahn|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150228',\n",
       "  'mesh_terms': 'D000328:Adult; D000700:Analgesics; D005260:Female; D006801:Humans; D008487:Medical History Taking; D008875:Middle Aged; D012650:Self Disclosure; D019966:Substance-Related Disorders',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000700:Analgesics',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91608-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'No increase in allergic reactions with intracavitary administration of cisplatin.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1164',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Markman|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150229',\n",
       "  'mesh_terms': 'D002945:Cisplatin; D004342:Drug Hypersensitivity; D006801:Humans; D007267:Injections',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D002945:Cisplatin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91609-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Carbamazepine for uncontrolled rage outbursts.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1164-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Mattes|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150230',\n",
       "  'mesh_terms': 'D000328:Adult; D000786:Anger; D002220:Carbamazepine; D006801:Humans; D008297:Male; D011889:Rage; D012920:Social Behavior Disorders',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D002220:Carbamazepine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91610-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Errors in blood glucose determination.',\n",
       "  'issue': '2(8412)',\n",
       "  'pages': '1165',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'de Pasqua|A|A|;Mattock|M B|MB|;Phillips|R|R|;Keen|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150231',\n",
       "  'mesh_terms': 'D001786:Blood Glucose; D001800:Blood Specimen Collection; D003951:Diagnostic Errors; D006801:Humans; D013997:Time Factors',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D001786:Blood Glucose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)91611-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Intestinal permeability and inflammation in rheumatoid arthritis: effects of non-steroidal anti-inflammatory drugs.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1171-4',\n",
       "  'abstract': 'The suggestion that the intestinal mucosa may be abnormally permeable and a site of absorption of antigens in rheumatoid arthritis was tested by the use of a 51Cr-EDTA (edetic acid) absorption test. 24 patients with rheumatoid arthritis excreted significantly more 51Cr-EDTA than did 34 controls. Intestinal permeability was normal in untreated patients but almost invariably abnormal in patients treated with non-steroidal anti-inflammatory drugs. Studies in patients with osteoarthritis showed that the permeability abnormalities were due to an effect of NSAIDs on both the proximal and the distal intestine and that the effect was systemically mediated. Indium-111-labelled leucocyte scans showed ileocaecal inflammation in 6 of 9 patients on or recently on NSAIDs. Although increased intestinal permeability does not seem to be important in the pathogenesis of rheumatoid arthritis, the administration of NSAIDs may lead to loss of intestinal integrity, thus facilitating antigenic absorption and perhaps contributing to persistence of the disease.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bjarnason|I|I|;Williams|P|P|;So|A|A|;Zanelli|G D|GD|;Levi|A J|AJ|;Gumpel|J M|JM|;Peters|T J|TJ|;Ansell|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150232',\n",
       "  'mesh_terms': 'D000893:Anti-Inflammatory Agents; D001172:Arthritis, Rheumatoid; D002860:Chromium Radioisotopes; D004492:Edetic Acid; D006801:Humans; D007204:Indium; D007249:Inflammation; D007413:Intestinal Mucosa; D007962:Leukocytes; D010003:Osteoarthritis; D010539:Permeability; D011868:Radioisotopes; D011877:Radionuclide Imaging',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000893:Anti-Inflammatory Agents; D002860:Chromium Radioisotopes; D011868:Radioisotopes; D007204:Indium; D004492:Edetic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92739-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Clinical evaluation of a recombinant hepatitis B vaccine.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1174-5',\n",
       "  'abstract': 'Recombinant hepatitis B vaccine prepared from antigen expressed in yeast was given to 30 healthy young volunteers. Seroconversion rates and anti-HBs levels were compared with those in a control group matched for age and sex who had received plasma-derived hepatitis B vaccine. 4 weeks after the third immunisation results were similar in the two groups. In the recombinant vaccine group the immune response developed more slowly during the early phase and seroconversion rates and mean anti-HBs levels were slightly lower in males; this probably reflects use of a lower dose of recombinant vaccine (10 micrograms compared with 20 micrograms of the plasma vaccine). Side-effects were slight and antibody titres against Candida albicans were not increased in recipients of the recombinant vaccine.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Jilg|W|W|;Lorbeer|B|B|;Schmidt|M|M|;Wilske|B|B|;Zoulek|G|G|;Deinhardt|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150233',\n",
       "  'mesh_terms': 'D000328:Adult; D002986:Clinical Trials as Topic; D004274:DNA, Recombinant; D005260:Female; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D006801:Humans; D007114:Immunization; D008297:Male; D012441:Saccharomyces cerevisiae; D012737:Sex Factors; D013997:Time Factors; D014761:Viral Hepatitis Vaccines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D004274:DNA, Recombinant; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D017325:Hepatitis B Vaccines; D014761:Viral Hepatitis Vaccines',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92740-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'HLA C associations with acute leukaemia.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1176-8',\n",
       "  'abstract': 'Frequencies of HLA A, B, C, and DR antigens were calculated in 1009 leukaemia patients, all of whom had been treated with bone-marrow transplantation and reported to the International Bone Marrow Transplant Registry. Cw3 (relative risk = 2 X 26, p = 0 X 00002) and Cw4 (relative risk = 2 X 18, p = 0 X 00003) were significantly associated with acute leukaemia (p values adjusted for multiple comparisons). Cw3 (relative risk = 2 X 97, p = 0 X 00002) and Cw4 (relative risk = 2 X 10, p = 0 X 004) were also significantly associated with acute lymphoblastic leukaemia and Cw4 was significantly associated with acute myelogenous leukaemia (relative risk = 2 X 39, p = 0 X 0003). The data suggest that Cw3 and Cw4 may be markers for leukaemia susceptibility genes, genes that code for low immune responsiveness to putative leukaemia viruses, or genes that regulate the response to chemotherapy and, therefore, the attainment of remission, since most of these patients underwent transplantation during remission.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': \"D'Amaro|J|J|;Bach|F H|FH|;Van Rood|J J|JJ|;Rimm|A A|AA|;Bortin|M M|MM|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150234',\n",
       "  'mesh_terms': 'D005060:Europe; D005819:Genetic Markers; D006680:HLA Antigens; D015236:HLA-C Antigens; D006801:Humans; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D015470:Leukemia, Myeloid, Acute; D009656:North America',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D005819:Genetic Markers; D006680:HLA Antigens; D015236:HLA-C Antigens; C038653:HLA-C*03 antigen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92741-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Genetic markers in narcolepsy.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1178-80',\n",
       "  'abstract': 'Narcolepsy has long been known to have a hereditary familial basis. All of 37 patients with narcolepsy expressed the major histocompatibility complex antigen HLA DR2 compared with 21.5% of 200 normal controls. This finding confirms the genetic basis for the disease, and furthermore links it with the short arm of chromosome 6. If the sleep disturbance in narcolepsy is due to a gene-determined defect in a neurotransmitter or receptor factor, the responsible agent may be DR2 itself or an enzyme determinant linked to DR2. This is the strongest HLA-disease association so far discovered.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Langdon|N|N|;Welsh|K I|KI|;van Dam|M|M|;Vaughan|R W|RW|;Parkes|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150235',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D002906:Chromosomes, Human, 6-12 and X; D005260:Female; D005819:Genetic Markers; D006680:HLA Antigens; D015791:HLA-A3 Antigen; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II; D006801:Humans; D008297:Male; D008875:Middle Aged; D009290:Narcolepsy',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005819:Genetic Markers; D006680:HLA Antigens; D015791:HLA-A3 Antigen; D015235:HLA-B Antigens; D015236:HLA-C Antigens; D006684:HLA-DR Antigens; D000949:Histocompatibility Antigens Class II',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92742-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'First-trimester diagnosis of Lesch-Nyhan syndrome.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1180-3',\n",
       "  'abstract': \"Chorionic villi were sampled at 8-9 weeks' gestation in four women whose fetuses were at risk for Lesch-Nyhan syndrome. Radiochemical assay of hypoxanthine phosphoribosyl transferase activity and fetal sexing (in two fetuses by means of a Y chromosome specific cDNA probe) showed that three fetuses were affected. The biochemical findings were confirmed after therapeutic abortion in two cases and spontaneous abortion in the third. Chorion biopsy and ultramicroscale enzymology may be a suitable alternative to recombinant-DNA-based methods for first-trimester diagnosis in selected diseases where the abnormal gene product is an enzyme expressed in the chorion by the 8th week of pregnancy.\",\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gibbs|D A|DA|;McFadyen|I R|IR|;Crawfurd|M D|MD|;De Muinck Keizer|E E|EE|;Headhouse-Benson|C M|CM|;Wilson|T M|TM|;Farrant|P H|PH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150236',\n",
       "  'mesh_terms': 'D002824:Chorionic Villi; D005260:Female; D006579:Heterozygote; D006801:Humans; D007041:Hypoxanthine Phosphoribosyltransferase; D007621:Karyotyping; D007926:Lesch-Nyhan Syndrome; D008297:Male; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis; D012732:Sex Determination Analysis',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D007041:Hypoxanthine Phosphoribosyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92743-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Polymyositis associated with monoclonal gammopathy.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1183-6',\n",
       "  'abstract': 'Three patients presented with gradual onset of proximal muscle weakness. Electromyography and muscle biopsy were abnormal in each patient and typical of myositis. All three had an IgG kappa monoclonal paraprotein in the serum. Examination of muscle biopsy specimens by direct immunofluorescence revealed linear deposits of IgG kappa along the sarcolemmal basement membrane of individual fibres. Stains for lambda light chains, other immunoglobulins, and complement components were negative. Plasmapheresis and immunosuppressive drugs produced clinical improvement in all three patients. Muscle biopsies were taken from two of the patients after plasma exchange and drug therapy and showed no immune deposits. These observations suggest a possible cause-and-effect relation between the serum paraprotein and the inflammatory myopathy in these patients.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kiprov|D D|DD|;Miller|R G|RG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150237',\n",
       "  'mesh_terms': 'D000368:Aged; D000911:Antibodies, Monoclonal; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D006942:Hypergammaglobulinemia; D007147:Immunoglobulin Light Chains; D007145:Immunoglobulin kappa-Chains; D007166:Immunosuppressive Agents; D008297:Male; D008875:Middle Aged; D009220:Myositis; D010956:Plasmapheresis',\n",
       "  'publication_types': \"D002363:Case Reports; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D007147:Immunoglobulin Light Chains; D007145:Immunoglobulin kappa-Chains; D007166:Immunosuppressive Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92744-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'A fibrinolytic defect in chronic back pain syndromes.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1186-7',\n",
       "  'abstract': 'Blood fibrinolytic activity was measured in 18 subjects with severe chronic back pain and 18 age and sex matched controls. The patients showed evidence of defective fibrinolysis--namely, significant prolongation of the euglobulin clot-lysis time, reduction in fibrin-plate lysis-area and plasminogen levels, and increase in levels of the fibrinolytic inhibitors, alpha 2 antiplasmin and alpha 2 macroglobulin. This defect could be associated with fibrin deposition and scar formation and be responsible for the development and/or perpetuation of chronic inflammation and scarring at sites of damage in the spine. Enhancement of fibrinolytic activity may offer a new approach to the management of these back problems, and a double-blind controlled trial is in progress.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Jayson|M I|MI|;Keegan|A|A|;Million|R|R|;Tomlinson|I|I|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150238',\n",
       "  'mesh_terms': 'D000328:Adult; D001416:Back Pain; D002908:Chronic Disease; D005260:Female; D005340:Fibrinogen; D005342:Fibrinolysis; D006801:Humans; D008259:Macroglobulins; D008297:Male; D008875:Middle Aged; D010958:Plasminogen; D013577:Syndrome; D000979:alpha-2-Antiplasmin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D008259:Macroglobulins; D000979:alpha-2-Antiplasmin; D005340:Fibrinogen; D010958:Plasminogen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92745-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Who needs growth hormone?',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1189-90',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150239',\n",
       "  'mesh_terms': 'D002648:Child; D006130:Growth Disorders; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D006801:Humans',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Medical student selection in the UK.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1190-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150240',\n",
       "  'mesh_terms': 'D004521:Educational Measurement; D006801:Humans; D007407:Interviews as Topic; D012570:School Admission Criteria; D013337:Students, Medical; D006113:United Kingdom',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Allergy to aminophylline.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1192',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150241',\n",
       "  'mesh_terms': 'D000628:Aminophylline; D003877:Dermatitis, Contact; D004342:Drug Hypersensitivity; D006801:Humans',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D000628:Aminophylline',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Spasmodic dysphonia.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1192-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150242',\n",
       "  'mesh_terms': 'D006801:Humans; D007818:Laryngeal Diseases; D013035:Spasm; D014832:Voice Disorders',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Treatment of early breast cancer.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1193',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150243',\n",
       "  'mesh_terms': 'D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D013997:Time Factors',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016421:Editorial',\n",
       "  'chemical_list': 'D000970:Antineoplastic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Sudden infant death. Overheating and cot death.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1199-201',\n",
       "  'abstract': 'Four risk factors for overheating were sought in the histories of 34 cot-death victims in Oxford and Scarborough. 19 babies were unusually hot or sweating when found dead; 14 died in an unusually warm environment; 17 had evidence of a terminal infective illness; and 24 were excessively clothed or overwrapped. 3 babies had all four risk factors, 8 had three, 17 had two, and 4 had one risk factor. Only 2 had no risk factor; both had had very low birthweights. In 6 of 15 babies (40%) whose rectal temperature was recorded after death the temperature was above 37 degrees C, the highest being 42 degrees C. If parents could be educated to anticipate the dangerous situations preceding febrile apnoea, many cot deaths could probably be avoided.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Stanton|A N|AN|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150244',\n",
       "  'mesh_terms': 'D001831:Body Temperature; D003020:Clothing; D005260:Female; D005334:Fever; D006358:Hot Temperature; D006801:Humans; D007223:Infant; D007230:Infant, Low Birth Weight; D007231:Infant, Newborn; D008297:Male; D012306:Risk; D013398:Sudden Infant Death; D013546:Sweating; D014777:Virus Diseases',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92753-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Hard world outside: some pitfalls to avoid in the community care of the mentally handicapped.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1202-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kinnell|H G|HG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150245',\n",
       "  'mesh_terms': 'D000293:Adolescent; D003156:Community Mental Health Services; D003365:Costs and Cost Analysis; D003688:Deinstitutionalization; D004739:England; D005260:Female; D006801:Humans; D008607:Intellectual Disability; D008297:Male; D008875:Middle Aged; D012947:Social Work',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92754-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Review of mortality results in randomised trials in early breast cancer.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1205',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150246',\n",
       "  'mesh_terms': 'D000367:Age Factors; D000970:Antineoplastic Agents; D001943:Breast Neoplasms; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D011897:Random Allocation; D012107:Research Design; D013629:Tamoxifen; D013997:Time Factors',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000970:Antineoplastic Agents; D013629:Tamoxifen',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Breast cancer, cervical cancer, and depot medroxyprogesterone acetate. WHO Collaborative Study of Neoplasia and Steroid Contraceptives.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1207-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150247',\n",
       "  'mesh_terms': 'D000328:Adult; D001943:Breast Neoplasms; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone; D017258:Medroxyprogesterone Acetate; D012306:Risk; D002583:Uterine Cervical Neoplasms',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016422:Letter',\n",
       "  'chemical_list': 'D017258:Medroxyprogesterone Acetate; D008525:Medroxyprogesterone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Reversal of opioid-associated late-onset respiratory depression by nalbuphine hydrochloride.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1208',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Hammond|J E|JE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150248',\n",
       "  'mesh_terms': 'D000368:Aged; D005260:Female; D003932:Heroin; D006801:Humans; D009019:Morphinans; D009266:Nalbuphine; D011183:Postoperative Complications; D012131:Respiratory Insufficiency; D013997:Time Factors',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D009019:Morphinans; D003932:Heroin; D009266:Nalbuphine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92760-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Somatostatin, a potent analgesic.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1208-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Chrubasik|J|J|;Meynadier|J|J|;Blond|S|S|;Scherpereel|P|P|;Ackerman|E|E|;Weinstock|M|M|;Bonath|K|K|;Cramer|H|H|;Wünsch|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150249',\n",
       "  'mesh_terms': 'D000328:Adult; D000700:Analgesics; D000818:Animals; D004285:Dogs; D005260:Female; D006801:Humans; D007267:Injections; D007276:Injections, Intraventricular; D007278:Injections, Spinal; D008297:Male; D008875:Middle Aged; D010148:Pain, Intractable; D051381:Rats; D013004:Somatostatin',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000700:Analgesics; D013004:Somatostatin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92761-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Opportunistic AIDS.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1209-10',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Cohen|J|J|;Winearls|C|C|;Oliveira|D|D|;Williams|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150250',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged; D011183:Postoperative Complications; D065227:Transfusion Reaction',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92762-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Circulating immune complexes in dermatitis herpetiformis and coeliac disease.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1210',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Husby|S|S|;Svehag|S E|SE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150251',\n",
       "  'mesh_terms': 'D000936:Antigen-Antibody Complex; D002446:Celiac Disease; D003874:Dermatitis Herpetiformis; D006801:Humans; D010587:Phagocytosis',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000936:Antigen-Antibody Complex',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92763-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Anti-idiotypic suppression of antibodies to factor VIIIc.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1210-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Frommel|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150252',\n",
       "  'mesh_terms': 'D000917:Antibody Formation; D000941:Antigens; D001323:Autoantibodies; D005169:Factor VIII; D006467:Hemophilia A; D006801:Humans; D007108:Immune Tolerance; D007130:Immunoglobulin Idiotypes; D008297:Male',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000941:Antigens; D001323:Autoantibodies; D007130:Immunoglobulin Idiotypes; D005169:Factor VIII',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92764-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Non-infectious epididymitis associated with amiodarone therapy.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1211-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gasparich|J P|JP|;Mason|J T|JT|;Greene|H L|HL|;Berger|R E|RE|;Krieger|J N|JN|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150253',\n",
       "  'mesh_terms': 'D000328:Adult; D000638:Amiodarone; D001572:Benzofurans; D004823:Epididymitis; D006801:Humans; D008297:Male; D008875:Middle Aged; D013610:Tachycardia',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D001572:Benzofurans; D000638:Amiodarone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92765-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effect of epoprostenol on platelet deposition on synthetic artery grafts.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1212',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': \"Sinzinger|H|H|;O'Grady|J|J|;Fitscha|P|P|;Kaliman|J|J|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150254',\n",
       "  'mesh_terms': 'D000368:Aged; D001792:Blood Platelets; D001807:Blood Vessel Prosthesis; D011464:Epoprostenol; D005260:Female; D006083:Graft Occlusion, Vascular; D006801:Humans; D008297:Male; D008875:Middle Aged',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D011464:Epoprostenol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92766-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Ketanserin in intermittent claudication.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1212-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Fonseca|V|V|;Ramage|A G|AG|;Mikhailidis|D P|DP|;Barradas|M A|MA|;Jeremy|J Y|JY|;Dandona|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150255',\n",
       "  'mesh_terms': 'D001066:Appetite; D001794:Blood Pressure; D001835:Body Weight; D006801:Humans; D007383:Intermittent Claudication; D007650:Ketanserin; D010880:Piperidines',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D010880:Piperidines; D007650:Ketanserin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92767-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Spontaneous platelet aggregation in whole blood: dependence on age and haematocrit.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1213',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Burgess-Wilson|M E|ME|;Green|S|S|;Heptinstall|S|S|;Mitchell|J R|JR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150256',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D006400:Hematocrit; D006801:Humans; D066298:In Vitro Techniques; D008875:Middle Aged; D010974:Platelet Aggregation',\n",
       "  'publication_types': \"D016422:Letter; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92768-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Breast self-examination.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1214',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Harris|W G|WG|;Flaherty|C|C|;Philip|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150257',\n",
       "  'mesh_terms': 'D001943:Breast Neoplasms; D005260:Female; D006266:Health Education; D006801:Humans; D008875:Middle Aged; D010173:Palpation; D012648:Self Care',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92769-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Hospital stay for fractured neck of femur.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1214',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Boyce|W J|WJ|;Shakespeare|D T|DT|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150258',\n",
       "  'mesh_terms': 'D005265:Femoral Neck Fractures; D006801:Humans; D007902:Length of Stay',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92770-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Primary health care in Gambian villages.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1215',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150260',\n",
       "  'mesh_terms': 'D005714:Gambia; D011320:Primary Health Care',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Wasteful referrals.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1214-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150259',\n",
       "  'mesh_terms': 'D005194:Family Practice; D006760:Hospitalization; D012017:Referral and Consultation; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Immunisation misinformation.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1215-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Hull|D|D|;Nicoll|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150261',\n",
       "  'mesh_terms': 'D002648:Child; D004739:England; D006801:Humans; D007114:Immunization; D008458:Measles Vaccine; D010567:Pertussis Vaccine',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D008458:Measles Vaccine; D010567:Pertussis Vaccine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92773-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Anaerobic curved rods in breast abscess.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1216',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Sturm|A W|AW|;Sikkenk|P J|PJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150262',\n",
       "  'mesh_terms': 'D000038:Abscess; D000328:Adult; D001421:Bacteria, Anaerobic; D001424:Bacterial Infections; D001941:Breast Diseases; D005260:Female; D006801:Humans',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92774-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Confirmation of need for rabies immunoglobulin as well as post-exposure vaccine.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1216-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Glück|R|R|;Wegmann|A|A|;Germanier|R|R|;Keller|H|H|;Dettwiler|H U|HU|;Wandeler|A I|AI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150263',\n",
       "  'mesh_terms': 'D006801:Humans; D007116:Immunization, Passive; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D011819:Rabies Vaccines',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007136:Immunoglobulins; D011819:Rabies Vaccines',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92775-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Campylobacter-like organisms in gastritis.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1217',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Thomas|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150264',\n",
       "  'mesh_terms': 'D002167:Campylobacter; D005756:Gastritis; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92776-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cytotoxin production by members of genus Vibrio.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1217-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Madden|J M|JM|;McCardell|B A|BA|;Shah|D B|DB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150265',\n",
       "  'mesh_terms': 'D003603:Cytotoxins; D006801:Humans; D014734:Vibrio cholerae',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D003603:Cytotoxins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92777-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Diarrhoea and simultaneous excretion of Clostridium difficile cytotoxin and C perfringens enterotoxin.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1218',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Borriello|S P|SP|;Welch|A R|AR|;Larson|H E|HE|;Barclay|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150266',\n",
       "  'mesh_terms': 'D000900:Anti-Bacterial Agents; D003013:Clostridium; D003016:Clostridium perfringens; D003603:Cytotoxins; D003967:Diarrhea; D004768:Enterotoxins; D005243:Feces; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000900:Anti-Bacterial Agents; D003603:Cytotoxins; D004768:Enterotoxins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92778-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Planar lattices in faeces of babies.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1218-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Moura Nunes|J F|JF|;Canas Ferreira|M W|MW|;Pinto da Silva|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150267',\n",
       "  'mesh_terms': 'D005243:Feces; D006801:Humans; D007231:Infant, Newborn; D012401:Rotavirus; D012400:Rotavirus Infections',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92779-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cimetidine and primary hyperparathyroidism.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1219',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Sherwood|J K|JK|;Ackroyd|F W|FW|;Garcia|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150268',\n",
       "  'mesh_terms': 'D002927:Cimetidine; D006801:Humans; D006961:Hyperparathyroidism',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D002927:Cimetidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92780-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Imaging of T-cell lymphoma by radiolabelled monoclonal antibody.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1219-21',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bunn|P A|PA|;Carrasquillo|J A|JA|;Keenan|A M|AM|;Schroff|R W|RW|;Foon|K A|KA|;Hsu|S M|SM|;Gazdar|A F|AF|;Reynolds|J C|JC|;Perentesis|P|P|;Larson|S M|SM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150269',\n",
       "  'mesh_terms': 'D000328:Adult; D000911:Antibodies, Monoclonal; D006801:Humans; D007204:Indium; D008223:Lymphoma; D008297:Male; D011868:Radioisotopes; D011877:Radionuclide Imaging; D012751:Sezary Syndrome; D013601:T-Lymphocytes',\n",
       "  'publication_types': \"D002363:Case Reports; D016422:Letter; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D011868:Radioisotopes; D007204:Indium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92781-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Rapid screening of metabolic diseases by proton NMR.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1221-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Iles|R A|RA|;Snodgrass|G J|GJ|;Chalmers|R A|RA|;Stacey|T E|TE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150270',\n",
       "  'mesh_terms': 'D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008661:Metabolism, Inborn Errors; D011522:Protons',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D011522:Protons',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92783-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'A new statistical approach to the prognostic significance of plasma paraquat concentrations.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1222-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Hart|T B|TB|;Nevitt|A|A|;Whitehead|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150271',\n",
       "  'mesh_terms': 'D000328:Adult; D006801:Humans; D010269:Paraquat; D011379:Prognosis; D013223:Statistics as Topic; D013997:Time Factors',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D010269:Paraquat',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92784-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Intravenous propranolol in acute myocardial infarction.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1223',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150272',\n",
       "  'mesh_terms': 'D006801:Humans; D007275:Injections, Intravenous; D009203:Myocardial Infarction; D011433:Propranolol',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D011433:Propranolol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Enforcing a duty to care for patients in the NHS.',\n",
       "  'issue': '2(8413)',\n",
       "  'pages': '1224-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Brahams|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150273',\n",
       "  'mesh_terms': 'D000368:Aged; D004739:England; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D008297:Male; D010344:Patient Advocacy; D040841:Resource Allocation; D013222:State Medicine; D014850:Waiting Lists',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Health Care and Public Health; Legal Approach; National Health Service; R. v. Secretary of State for Social Services',\n",
       "  'doi': '10.1016/s0140-6736(84)92787-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18491',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Rapid diagnosis of tuberculous meningitis by latex particle agglutination.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1229-31',\n",
       "  'abstract': 'A simple latex particle agglutination test for the rapid detection of Mycobacterium tuberculosis plasma membrane antigen in cerebrospinal fluid was evaluated in 18 children with tuberculous meningitis and 134 control children with other disorders. The antigen was detected in all 18 patients with tuberculous meningitis, although an initial sample from 1 patient did not contain detectable antigen before it was concentrated. 133 of 134 control samples gave negative results.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Krambovitis|E|E|;McIllmurray|M B|MB|;Lock|P E|PE|;Hendrickse|W|W|;Holzel|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150274',\n",
       "  'mesh_terms': 'D000942:Antigens, Bacterial; D002648:Child; D002675:Child, Preschool; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007223:Infant; D007841:Latex Fixation Tests; D008297:Male; D009169:Mycobacterium tuberculosis; D014390:Tuberculosis, Meningeal',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000942:Antigens, Bacterial',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92792-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Controlled trial of hypnotherapy in the treatment of severe refractory irritable-bowel syndrome.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1232-4',\n",
       "  'abstract': '30 patients with severe refractory irritable-bowel syndrome were randomly allocated to treatment with either hypnotherapy or psychotherapy and placebo. The psychotherapy patients showed a small but significant improvement in abdominal pain, abdominal distension, and general well-being but not in bowel habit. The hypnotherapy patients showed a dramatic improvement in all features, the difference between the two groups being highly significant. In the hypnotherapy group no relapses were recorded during the 3-month follow-up period, and no substitution symptoms were observed.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Whorwell|P J|PJ|;Prior|A|A|;Faragher|E B|EB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150275',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000328:Adult; D002986:Clinical Trials as Topic; D003109:Colonic Diseases, Functional; D005260:Female; D005500:Follow-Up Studies; D005769:Gastrointestinal Motility; D006801:Humans; D006990:Hypnosis; D008297:Male; D008875:Middle Aged; D011613:Psychotherapy; D011897:Random Allocation; D013997:Time Factors',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92793-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Single-dose kanamycin therapy of gonococcal ophthalmia neonatorum.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1234-7',\n",
       "  'abstract': '117 infants with gonococcal ophthalmia neonatorum, including 27 with infections due to penicillinase-producing Neisseria gonorrhoeae, were treated as outpatients with five different regimens of single-dose intramuscular kanamycin (75 mg or 150 mg) with saline eye washes, gentamicin eye ointment, or chloramphenicol eye drops. There were no treatment failures among 68 patients treated with 75 mg or 150 mg kanamycin and gentamicin eye ointment (for 3 days). However, the minimum and maximum cumulative probabilities of cure of single-dose kanamycin with saline eye washes (for 3 days) were only 60% and 89%. 1 patient of 15 treated with 150 mg kanamycin plus chloramphenicol eye drops did not respond to treatment. Postgonococcal conjunctivitis developed in 14 (12%) infants, of whom 13 had positive cultures for Chlamydia trachomatis. Nasopharyngeal infection with N gonorrhoeae was eradicated in 9 of 11 infants colonised.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': \"Fransen|L|L|;Nsanze|H|H|;D'Costa|L|L|;Brunham|R C|RC|;Ronald|A R|AR|;Piot|P|P|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150276',\n",
       "  'mesh_terms': 'D000287:Administration, Topical; D002701:Chloramphenicol; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D005500:Follow-Up Studies; D005839:Gentamicins; D006801:Humans; D007231:Infant, Newborn; D007273:Injections, Intramuscular; D007612:Kanamycin; D009344:Neisseria gonorrhoeae; D009824:Ointments; D009878:Ophthalmia Neonatorum; D010403:Penicillin Resistance; D011897:Random Allocation',\n",
       "  'publication_types': \"D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005839:Gentamicins; D009824:Ointments; D007612:Kanamycin; D002701:Chloramphenicol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92794-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': '4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1237-9',\n",
       "  'abstract': '4-hydroxyandrostenedione, a potent inhibitor of the aromatase (oestrogen synthetase) system, was given to 11 patients with metastatic breast cancer. After a single 500 mg intramuscular injection a sustained reduction of serum oestradiol was observed for at least 1 week in all patients in whom the steroid was measured. 4 patients responded to treatment for periods of up to 4 months, and healing of bone metastases and reduction in size of soft-tissue metastases was evident. The only side-effects were pain at the injection site and hot flushes. 4-hydroxyandrostenedione is a new and specific aromatase inhibitor which shows promise in the treatment of patients with metastatic breast cancer.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Coombes|R C|RC|;Goss|P|P|;Dowsett|M|M|;Gazet|J C|JC|;Brodie|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150277',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000735:Androstenedione; D000818:Animals; D001859:Bone Neoplasms; D001943:Breast Neoplasms; D002369:Castration; D004958:Estradiol; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008593:Menopause; D051379:Mice; D008875:Middle Aged',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000735:Androstenedione; D004958:Estradiol; C014594:formestane',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92795-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Immunity against tetanus and effect of revaccination 25-30 years after primary vaccination.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1240-2',\n",
       "  'abstract': 'Fall off in tetanus immunity and the effect of late revaccination were investigated in a randomly selected group of Danes aged 25-30. Routine reinforcing doses of tetanus toxoid are not customary in Denmark except at injury and when there are certain occupational risks. 11% of the total group of 418 had antitoxin titres below that required for protection (ie, less than 0.01 IU/ml, determined by neutralisation technique). In those who had received only primary vaccination an exponential fall off in immunity was seen, and 25-30 years after primary vaccination, 28% had serum antitoxin concentrations below the level of protection. Up to 30 years after primary vaccination, one reinforcing dose of tetanus toxoid adsorbed by aluminium hydroxide was sufficient to induce protective titres of antitoxin. There were no serious side-effects and it was concluded that routine reinforcing doses of tetanus toxoid should be given before the age of 20 in Denmark and other countries where primary vaccination is given in the first years of life.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Simonsen|O|O|;Kjeldsen|K|K|;Heron|I|I|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150278',\n",
       "  'mesh_terms': 'D000328:Adult; D002986:Clinical Trials as Topic; D003718:Denmark; D005260:Female; D006801:Humans; D007110:Immunity, Active; D007117:Immunization, Secondary; D007223:Infant; D008297:Male; D011897:Random Allocation; D013742:Tetanus; D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid; D013997:Time Factors',\n",
       "  'publication_types': \"D002363:Case Reports; D016430:Clinical Trial; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D013743:Tetanus Antitoxin; D013745:Tetanus Toxoid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92796-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Rapid diagnosis of cytomegalovirus infection in immunocompromised patients by detection of early antigen fluorescent foci.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1242-5',\n",
       "  'abstract': \"Cell-cultures of cytomegalovirus (CMV) were fixed after 24 hours' incubation and examined by a monoclonal antibody based immunofluorescence method for the detection of CMV-specific early antigens. 385 urine, saliva, or blood samples from 63 immunocompromised patients were inoculated onto cell-cultures. Comparison with the results of conventional cell-cultures in patients who remained uninfected showed that the new technique had a specificity of 100%. The sensitivity was 80%. This immunofluorescence method gave positive results 27h after inoculation of the specimens instead of the mean of 17 X 5 days with the conventional method based on detection of cytopathic effect. 3 saliva samples, from patients who had previously excreted CMV, reacted in the immunofluorescence method but CMV, reacted in the cell-cultures-perhaps because the assay identified defective, interfering particles in these samples. The monoclonal antibodies were also used successfully in another immunofluorescence system to diagnose cytomegalovirus pneumonitis in 3 patients by testing material obtained by bronchoalveolar lavage.\",\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Griffiths|P D|PD|;Panjwani|D D|DD|;Stirk|P R|PR|;Ball|M G|MG|;Ganczakowski|M|M|;Blacklock|H A|HA|;Prentice|H G|HG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150279',\n",
       "  'mesh_terms': 'D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D000956:Antigens, Viral; D016026:Bone Marrow Transplantation; D003586:Cytomegalovirus Infections; D005455:Fluorescent Antibody Technique; D006801:Humans; D007108:Immune Tolerance; D016030:Kidney Transplantation; D008722:Methods; D011014:Pneumonia; D011650:Pulmonary Alveoli; D007507:Therapeutic Irrigation',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral; D000956:Antigens, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92797-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Immunoscintigraphy for detection of lymph node metastases from breast cancer.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1245-7',\n",
       "  'abstract': 'A radiolabelled monoclonal antibody that reacts with human breast cancer was injected into the web space of each hand in eight women with breast cancer, and the axillae were scanned 16-24 h later. Scans were positive in seven axillae with palpable lymph nodes and in two axillae with impalpable lymph nodes (metastases later confirmed by needle aspiration). The scan was negative in one axilla with a palpable mass, and here no tumour cells were obtained on needle aspiration. In a man with axillary lymphoma, no specific binding of antibody was observed. This technique could lead to earlier and more precise diagnosis of lymph node metastasis in patients with breast cancer.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Thompson|C H|CH|;Lichtenstein|M|M|;Stacker|S A|SA|;Leyden|M J|MJ|;Salehi|N|N|;Andrews|J T|JT|;McKenzie|I F|IF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150280',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal; D001365:Axilla; D001943:Breast Neoplasms; D005260:Female; D006801:Humans; D007279:Injections, Subcutaneous; D007457:Iodine Radioisotopes; D008207:Lymphatic Metastasis; D008223:Lymphoma; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D007457:Iodine Radioisotopes',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92798-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'An irritable mind or an irritable bowel?',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1249-50',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150281',\n",
       "  'mesh_terms': 'D003109:Colonic Diseases, Functional; D005769:Gastrointestinal Motility; D006801:Humans; D006990:Hypnosis',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Management of toxic epidermal necrolysis.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1250-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150282',\n",
       "  'mesh_terms': 'D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D003646:Debridement; D006801:Humans; D013262:Stevens-Johnson Syndrome',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Apartheid and psychiatry.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1252-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150283',\n",
       "  'mesh_terms': 'D006801:Humans; D028642:Mentally Ill Persons; D011057:Politics; D011287:Prejudice; D028743:Professional Misconduct; D011570:Psychiatry; D012955:Societies, Medical; D013019:South Africa',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Health Care and Public Health; Mental Health Therapies',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18901',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Coronary bypass with the internal mammary.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1253-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150284',\n",
       "  'mesh_terms': 'D000787:Angina Pectoris; D000818:Animals; D001807:Blood Vessel Prosthesis; D001026:Coronary Artery Bypass; D006801:Humans; D008323:Mammary Arteries; D008875:Middle Aged; D013895:Thoracic Arteries',\n",
       "  'publication_types': 'D003160:Comparative Study; D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'A new test for tuberculous meningitis.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1254',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150285',\n",
       "  'mesh_terms': 'D006801:Humans; D007841:Latex Fixation Tests; D014390:Tuberculosis, Meningeal',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Changes in the reported prevalence of childhood eczema since the 1939-45 war.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1255-7',\n",
       "  'abstract': 'Rates of reported eczema during early childhood were studied in 3 national cohorts of children born in 1946, 1958, and 1970. Overall rates rose from 5.1% in children born in 1946, to 7.3% in those born in 1958, to 12.2% in the 1970 cohort. In the 1958 and 1970 cohorts there was a positive association between eczema and breastfeeding. This relationship remained significant after allowing for parental history of allergy and socioeconomic status. Social classes I and II children born in 1946 were less likely to be reported as having eczema, compared with children from lower social classes, whereas children born into higher social classes in 1958 and 1970 had higher rates. These findings may reflect secular changes in the diagnosis of eczema or may represent a real increase in the disorder. The positive association with breastfeeding in the more recent cohorts suggests a new environmental agent may be crossing in breast-milk. The agent(s) may well be in other infant foods, since the rate of reported eczema in non-breastfed children rose from 5.7% in the 1946 and 1958 cohorts to 11.1% of children born in 1970.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Taylor|B|B|;Wadsworth|J|J|;Wadsworth|M|M|;Peckham|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150286',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D001942:Breast Feeding; D002648:Child; D002675:Child, Preschool; D004485:Eczema; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006967:Hypersensitivity; D007223:Infant; D007231:Infant, Newborn; D012923:Social Class; D011795:Surveys and Questionnaires; D006113:United Kingdom',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92805-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'DNA in medicine. Human genetics.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1257-62',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'White|R L|RL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150287',\n",
       "  'mesh_terms': 'D000328:Adult; D000483:Alleles; D001483:Base Sequence; D002648:Child; D002874:Chromosome Mapping; D003001:Cloning, Molecular; D004247:DNA; D005260:Female; D006580:Genetic Carrier Screening; D030342:Genetic Diseases, Inborn; D008040:Genetic Linkage; D005819:Genetic Markers; D005838:Genotype; D006801:Humans; D008297:Male; D009154:Mutation; D009693:Nucleic Acid Hybridization; D010641:Phenotype; D011247:Pregnancy; D011296:Prenatal Diagnosis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005819:Genetic Markers; D004247:DNA',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92806-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"How common is dementia in Parkinson's disease?\",\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1262-5',\n",
       "  'abstract': \"Current estimates suggest that about one in three patients with Parkinson's disease will become demented. Critical review of the studies on which this conclusion is based indicate that this figure is inflated. Errors in separating idiopathic Parkinson's disease from other causes of the akinetic-rigid syndrome, in differentiating dementia from confusional states, depression, and even normal ageing, and in defining and assessing dementia itself may have led to overestimation of the prevalence. A more conservative estimate is that one in five patients with Parkinson's disease is demented, but this assertion needs to be put to rigorous examination.\",\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Brown|R G|RG|;Marsden|C D|CD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150288',\n",
       "  'mesh_terms': 'D000368:Aged; D000544:Alzheimer Disease; D003704:Dementia; D003937:Diagnosis, Differential; D006801:Humans; D010300:Parkinson Disease; D010302:Parkinson Disease, Secondary',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92807-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Hospital treatment.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1266',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Todd|J W|JW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150289',\n",
       "  'mesh_terms': 'D004739:England; D006295:Health Resources; D006296:Health Services; D006300:Health Services Misuse; D006760:Hospitalization; D006801:Humans',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92808-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cross-cultural and anthropobiological reflections on African uvulectomy.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1267-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Wind|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150290',\n",
       "  'mesh_terms': 'D000349:Africa; D000884:Anthropology, Cultural; D002648:Child; D003431:Cross-Cultural Comparison; D003906:Developing Countries; D005260:Female; D006801:Humans; D009426:Netherlands; D014609:Uvula',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Manic depressive illness.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1268',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150291',\n",
       "  'mesh_terms': 'D001714:Bipolar Disorder; D006801:Humans; D008513:Medicine in Literature; D011037:Poetry as Topic',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Veno-arterial bypass in orthotopic liver grafting.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1269',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Calne|R Y|RY|;Rolles|K|K|;Farman|J V|JV|;Kneeshaw|J D|JD|;Smith|D P|DP|;Wheeldon|D R|DR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150292',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D007083:Iliac Artery; D016031:Liver Transplantation; D008297:Male; D008722:Methods; D008875:Middle Aged; D012501:Saphenous Vein',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92811-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'X-chromosome-specific probe DX13 for carrier detection and first trimester prenatal diagnosis in haemophilia A.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1269-70',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Tønnesen|T|T|;Søndergaard|F|F|;Mikkelsen|M|M|;Davies|K E|KE|;Old|J|J|;Winter|R M|RM|;Hauge|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150293',\n",
       "  'mesh_terms': 'D004247:DNA; D005260:Female; D006580:Genetic Carrier Screening; D008040:Genetic Linkage; D005819:Genetic Markers; D006467:Hemophilia A; D006801:Humans; D008297:Male; D010375:Pedigree; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis; D014960:X Chromosome',\n",
       "  'publication_types': \"D002363:Case Reports; D016422:Letter; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005819:Genetic Markers; D004247:DNA',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92812-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Lymphoid and haemopoietic malignancy case occurrence in UK, 1984.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1270-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Cartwright|R A|RA|;Miller|J G|JG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150294',\n",
       "  'mesh_terms': 'D006801:Humans; D007938:Leukemia; D008223:Lymphoma; D011446:Prospective Studies; D013029:Space-Time Clustering; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92813-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Ketoconazole and cholesterol synthesis.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1271',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Miettinen|T A|TA|;Valtonen|V V|VV|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150295',\n",
       "  'mesh_terms': 'D000924:Anticholesteremic Agents; D002784:Cholesterol; D006801:Humans; D007654:Ketoconazole',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000924:Anticholesteremic Agents; D002784:Cholesterol; D007654:Ketoconazole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92814-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Treatment of seborrhoeic dermatitis with topical ketoconazole.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1271-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Farr|P M|PM|;Shuster|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150296',\n",
       "  'mesh_terms': 'D000287:Administration, Topical; D012628:Dermatitis, Seborrheic; D006801:Humans; D007654:Ketoconazole; D008297:Male',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D007654:Ketoconazole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92815-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Danazol raises antithrombin III levels in cases of familial deficiency.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1272-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Fairfax|A J|AJ|;Ibbotson|R M|RM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150297',\n",
       "  'mesh_terms': 'D000328:Adult; D000990:Antithrombin III; D020152:Antithrombin III Deficiency; D003613:Danazol; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011245:Pregnadienes; D013924:Thrombophlebitis; D014648:Varicose Veins',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D011245:Pregnadienes; D000990:Antithrombin III; D003613:Danazol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92816-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cholecystokinin and cystic fibrosis.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1273',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gosden|C M|CM|;Gosden|J R|JR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150298',\n",
       "  'mesh_terms': 'D002766:Cholecystokinin; D003550:Cystic Fibrosis; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D002766:Cholecystokinin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92817-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Gallstones and cholecystectomy rates.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1273',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bateson|M C|MC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150299',\n",
       "  'mesh_terms': 'D002763:Cholecystectomy; D002769:Cholelithiasis; D006801:Humans; D012606:Scotland',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92818-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': '131I-MIBG and medullary carcinoma of the thyroid.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1273-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Connell|J M|JM|;Hilditch|T E|TE|;Elliott|A|A|;Semple|P F|PF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150300',\n",
       "  'mesh_terms': 'D019797:3-Iodobenzylguanidine; D002277:Carcinoma; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D008875:Middle Aged; D011877:Radionuclide Imaging; D013964:Thyroid Neoplasms',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D007457:Iodine Radioisotopes; D007462:Iodobenzenes; D019797:3-Iodobenzylguanidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92819-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Apologia for older techniques for localising phaeochromocytoma.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1274',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Brown|M J|MJ|;Allison|D J|DJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150301',\n",
       "  'mesh_terms': 'D000310:Adrenal Gland Neoplasms; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008722:Methods; D010673:Pheochromocytoma; D011247:Pregnancy; D011252:Pregnancy Complications, Neoplastic',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92820-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Diagnostic radioimmunoassay for familial amyloidotic polyneuropathy.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1274-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Nakazato|M|M|;Kurihara|T|T|;Kangawa|K|K|;Matsuo|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150302',\n",
       "  'mesh_terms': 'D000328:Adult; D000682:Amyloid; D000686:Amyloidosis; D009477:Hereditary Sensory and Autonomic Neuropathies; D006801:Humans; D011228:Prealbumin; D011863:Radioimmunoassay; D000685:Serum Amyloid A Protein',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000682:Amyloid; D011228:Prealbumin; D000685:Serum Amyloid A Protein',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92821-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Vitamin C and plasma cholesterol.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1275',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Livesley|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150303',\n",
       "  'mesh_terms': 'D000328:Adult; D000367:Age Factors; D000368:Aged; D001205:Ascorbic Acid; D008076:Cholesterol, HDL; D002908:Chronic Disease; D003327:Coronary Disease; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D008076:Cholesterol, HDL; D001205:Ascorbic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92822-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Increase in prevalence of anti-HTLV-III in haemophiliacs.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1275-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gürtler|L G|LG|;Wernicke|D|D|;Eberle|J|J|;Zoulek|G|G|;Deinhardt|F|F|;Schramm|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150304',\n",
       "  'mesh_terms': 'D000914:Antibodies, Viral; D017977:Deltaretrovirus; D006467:Hemophilia A; D006801:Humans',\n",
       "  'publication_types': 'D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92823-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Infection of chimpanzees with lymphadenopathy-associated virus.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1276-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Francis|D P|DP|;Feorino|P M|PM|;Broderson|J R|JR|;McClure|H M|HM|;Getchell|J P|JP|;McGrath|C R|CR|;Swenson|B|B|;McDougal|J S|JS|;Palmer|E L|EL|;Harrison|A K|AK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150305',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D000818:Animals; D000914:Antibodies, Viral; D017977:Deltaretrovirus; D004195:Disease Models, Animal; D008297:Male; D002679:Pan troglodytes; D012192:Retroviridae Infections',\n",
       "  'publication_types': \"D016422:Letter; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92824-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cyclosporin in ulcerative colitis.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1277-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gupta|S|S|;Keshavarzian|A|A|;Hodgson|H J|HJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150306',\n",
       "  'mesh_terms': 'D000368:Aged; D003093:Colitis, Ulcerative; D003524:Cyclosporins; D005260:Female; D006801:Humans; D012008:Recurrence',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D003524:Cyclosporins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92826-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cassava pancreatitis in western Europe.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1278',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Assan|R|R|;Boukersi|H|H|;Clauser|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150307',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000437:Alcoholism; D002114:Calcinosis; D048909:Diabetes Complications; D005060:Europe; D005260:Female; D006801:Humans; D008297:Male; D002365:Manihot; D008875:Middle Aged; D009748:Nutrition Disorders; D010195:Pancreatitis; D010939:Plant Poisoning',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92827-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Importance of preoperative antibiotic prophylaxis for patients undergoing acute appendicectomy.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1279',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Arnbjörnsson|E|E|;Mikaelsson|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150308',\n",
       "  'mesh_terms': 'D000900:Anti-Bacterial Agents; D001062:Appendectomy; D002648:Child; D002675:Child, Preschool; D004630:Emergencies; D006801:Humans; D011183:Postoperative Complications; D011292:Premedication',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000900:Anti-Bacterial Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92829-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Viruses and oral \"hairy\" leucoplakia.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1279',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Madeley|C R|CR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150309',\n",
       "  'mesh_terms': 'D002213:Capsid; D006801:Humans; D007972:Leukoplakia, Oral; D018139:Simplexvirus',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92828-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Unconvincing reassurance from the ABPI.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1280',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Collier|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150310',\n",
       "  'mesh_terms': 'D000329:Advertising; D004739:England; D007880:Legislation, Drug',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92831-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'The disabled medical student.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1280-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150311',\n",
       "  'mesh_terms': 'D006233:Disabled Persons; D004739:England; D006801:Humans; D013337:Students, Medical',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Nebulisers in domiciliary practice.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1281-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150312',\n",
       "  'mesh_terms': 'D000336:Aerosols; D000368:Aged; D000402:Airway Obstruction; D001993:Bronchodilator Agents; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006699:Home Care Services; D006801:Humans; D008875:Middle Aged; D011897:Random Allocation',\n",
       "  'publication_types': 'D002363:Case Reports; D016430:Clinical Trial; D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': 'D000336:Aerosols; D001993:Bronchodilator Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Lacticacidosis and thiamine deficiency.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1282',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Campbell|C H|CH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150313',\n",
       "  'mesh_terms': 'D000138:Acidosis; D000208:Acute Disease; D006801:Humans; D007773:Lactates; D013832:Thiamine Deficiency',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D007773:Lactates',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92835-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Once-daily antibiotic treatment of CAPD peritonitis.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1282-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gruer|L D|LD|;Kiddy|K|K|;Adu|D|D|;Michael|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150314',\n",
       "  'mesh_terms': 'D004359:Drug Therapy, Combination; D005839:Gentamicins; D006801:Humans; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D010538:Peritonitis; D014640:Vancomycin',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D005839:Gentamicins; D014640:Vancomycin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92836-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Breast-feeding and diabetes.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1283',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150315',\n",
       "  'mesh_terms': 'D001942:Breast Feeding; D003922:Diabetes Mellitus, Type 1; D005260:Female; D006801:Humans; D013548:Sweden',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Pregnancy outcome in women with diabetes and other autoimmune diseases.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1283-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Saad|E|E|;Wales|J K|JK|;Scott|J S|JS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150316',\n",
       "  'mesh_terms': 'D000022:Abortion, Spontaneous; D000328:Adult; D001327:Autoimmune Diseases; D003922:Diabetes Mellitus, Type 1; D005260:Female; D005313:Fetal Death; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011248:Pregnancy Complications; D011254:Pregnancy in Diabetics',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92838-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Early assessment of gestation in diabetics.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1284',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Pedersen|J F|JF|;Mølsted-Pedersen|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150317',\n",
       "  'mesh_terms': 'D005260:Female; D005317:Fetal Growth Retardation; D005865:Gestational Age; D006801:Humans; D011247:Pregnancy; D011254:Pregnancy in Diabetics',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92839-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins.',\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1284-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Porter|R N|RN|;Smith|W|W|;Craft|I L|IL|;Abdulwahid|N A|NA|;Jacobs|H S|HS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150318',\n",
       "  'mesh_terms': 'D002064:Buserelin; D002986:Clinical Trials as Topic; D005260:Female; D005307:Fertilization in Vitro; D006062:Gonadotropins; D006801:Humans; D010062:Ovulation Induction; D011247:Pregnancy; D011897:Random Allocation',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016422:Letter; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D006062:Gonadotropins; D002064:Buserelin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92840-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"Doctor's libel action proceeds before judge without a jury.\",\n",
       "  'issue': '2(8414)',\n",
       "  'pages': '1287',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Brahams|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150319',\n",
       "  'mesh_terms': 'D004739:England; D008318:Malpractice',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92844-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Prospective randomised trial of early dietary protein restriction in chronic renal failure.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1291-6',\n",
       "  'abstract': 'In a prospective randomised study of 228 patients with various renal diseases, early moderate dietary protein restriction retarded the development of end-stage renal failure. 149 patients were followed up for at least 18 months; the protein-restricted patients showed falls in serum urea and phosphate concentrations and in the 24 h excretion of urea, phosphate, and protein. Regression analysis of the reciprocals of serum creatinine against time showed that the average rate of decrease in reciprocal creatinine was three to five times lower in the protein-restricted groups than in the control groups. These results confirm that moderate dietary protein restriction is an acceptable and effective way of delaying functional renal deterioration. The finding has implications for the management of chronic renal insufficiency.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Rosman|J B|JB|;ter Wee|P M|PM|;Meijer|S|S|;Piers-Becht|T P|TP|;Sluiter|W J|WJ|;Donker|A J|AJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150320',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D003404:Creatinine; D004044:Dietary Proteins; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007676:Kidney Failure, Chronic; D008297:Male; D010349:Patient Compliance; D010710:Phosphates; D011446:Prospective Studies; D011897:Random Allocation; D013997:Time Factors; D014508:Urea',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D004044:Dietary Proteins; D010710:Phosphates; D014508:Urea; D003404:Creatinine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90818-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Beneficial effects of plasma exchange in acute inflammatory polyradiculoneuropathy.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1296-9',\n",
       "  'abstract': 'The results of a controlled trial in which 38 patients with severe acute inflammatory polyradiculoneuropathy took part indicate that plasma exchange favourably influenced the course of the disease. Significant benefits were seen in time until onset of improvement, course of muscular weakness, improvement in disability grades over the first 2 months, and working capacity after 1 month. Cost-benefit analysis showed that the exchange treatment resulted in net financial savings. The results suggest that plasma exchange may have a role in the treatment of severe acute inflammatory polyradiculoneuropathy.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Osterman|P O|PO|;Fagius|J|J|;Lundemo|G|G|;Pihlstedt|P|P|;Pirskanen|R|R|;Sidén|A|A|;Säfwenberg|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150321',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003362:Cost-Benefit Analysis; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D010951:Plasma Exchange; D011129:Polyradiculoneuropathy; D013997:Time Factors',\n",
       "  'publication_types': \"D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90819-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'A new DNA polymorphism for prenatal diagnosis of beta-thalassaemia in Mediterranean populations.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1299-301',\n",
       "  'abstract': 'The prevalence of a new polymorphism for the restriction enzyme Ava II in the psi beta-gene of the beta-globin gene cluster was determined in Mediterranean families with at least one beta-thalassaemia homozygote. The polymorphic site was absent in 54/115 beta-thalassaemic chromosomes but only in 4/120 normal chromosomes. The difference in frequencies of this polymorphism between normal and thalassaemic chromosomes greatly increases the feasibility of prenatal diagnosis of beta-thalassaemia by DNA analysis in this population.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Wainscoat|J S|JS|;Old|J M|JM|;Thein|S L|SL|;Weatherall|D J|DJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150322',\n",
       "  'mesh_terms': 'D001211:Asia, Western; D002875:Chromosomes; D003535:Cyprus; D004247:DNA; D005260:Female; D006115:Greece; D006720:Homozygote; D006801:Humans; D007558:Italy; D008521:Mediterranean Islands; D011110:Polymorphism, Genetic; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013789:Thalassemia',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D004247:DNA',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90820-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Phenoxy and picolinic acid herbicides and small-intestinal adenocarcinoma in sheep.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1301-5',\n",
       "  'abstract': 'A study of age and sex matched groups of adult female sheep from 88 flat, hill, and high-country farms was conducted in the South Island of New Zealand to investigate the influence of breed and certain environmental factors on the prevalence rate of small-intestinal adenocarcinoma (SIA). 20 678 female sheep aged 5.5-7.5 years were examined at slaughter, 125 cases of SIA were found (6 per thousand) in animals from 61 farms (69%) and the prevalence rate for individual farm groups varied from 0 to 38 per thousand. Differences in tumour rate between breed groups were significant but differences between farm type were not. Exposure to phenoxy (Ph), picolinic acid (Pi) herbicides, or both (PhPi) was associated with significant increases in tumour rate. The increase in rate was significant for exposure to each of the 3 herbicide groups. Exposure to recently sprayed feed stuffs was associated with a significantly larger increase in tumour rate than exposure to less recently sprayed food. There was no difference between tumour rates of sheep exposed to Ph herbicides with or without 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Rates rose significantly with the total number of Ph, Pi, PhPi sprays used on the farm. The variation in rates associated with herbicides is sufficient to explain the breed differences recorded.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Newell|K W|KW|;Ross|A D|AD|;Renner|R M|RM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150323',\n",
       "  'mesh_terms': 'D000230:Adenocarcinoma; D000336:Aerosols; D000821:Animal Feed; D000818:Animals; D004781:Environmental Exposure; D005260:Female; D006016:Glycolates; D006540:Herbicides; D007414:Intestinal Neoplasms; D007421:Intestine, Small; D009520:New Zealand; D010642:Phenoxyacetates; D010848:Picolinic Acids; D012756:Sheep; D012757:Sheep Diseases; D013997:Time Factors',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000336:Aerosols; D006016:Glycolates; D006540:Herbicides; D010642:Phenoxyacetates; D010848:Picolinic Acids',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90821-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Suppressor-cell activity in coeliac disease induced by alpha-gliadin, a dietary antigen.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1305-7',\n",
       "  'abstract': \"The wheat protein antigen alpha-gliadin, a fraction derived from gluten of molecular weight 60 000, activated suppressor cells from patients with coeliac disease but not from normal subjects or patients with Crohn's disease. Two other dietary antigens, casein and beta-lactoglobulin, failed to produce suppressor-cell activation. Since this phenomenon appears to be specific to coeliac disease, it may be of pathogenetic significance.\",\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': \"O'Farrelly|C|C|;Whelan|C A|CA|;Feighery|C F|CF|;Weir|D G|DG|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150324',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000941:Antigens; D002446:Celiac Disease; D004044:Dietary Proteins; D005260:Female; D005903:Gliadin; D005983:Glutens; D006801:Humans; D008213:Lymphocyte Activation; D008297:Male; D008875:Middle Aged; D008938:Mitosis; D010940:Plant Proteins; D050378:T-Lymphocytes, Regulatory',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000941:Antigens; D004044:Dietary Proteins; D010940:Plant Proteins; D005983:Glutens; D005903:Gliadin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90822-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Polio reconsidered.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1309-10',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150325',\n",
       "  'mesh_terms': 'D004196:Disease Outbreaks; D006801:Humans; D007223:Infant; D011051:Poliomyelitis; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D014481:United States',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Plasma exchange in the Guillain-Barré syndrome.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1312-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150327',\n",
       "  'mesh_terms': 'D006801:Humans; D010951:Plasma Exchange; D011129:Polyradiculoneuropathy',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Vascular disease, senility, and dementia.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1310-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150326',\n",
       "  'mesh_terms': 'D000368:Aged; D000544:Alzheimer Disease; D002561:Cerebrovascular Disorders; D003704:Dementia; D003937:Diagnosis, Differential; D006801:Humans; D009460:Neurologic Examination',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Ergot for dementia?',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1313-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150328',\n",
       "  'mesh_terms': 'D003704:Dementia; D004088:Dihydroergotoxine; D006801:Humans',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D004088:Dihydroergotoxine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Veterinary epidemiology and human disease.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1314',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150329',\n",
       "  'mesh_terms': 'D000820:Animal Diseases; D000818:Animals; D000829:Animals, Domestic; D004781:Environmental Exposure; D006801:Humans; D009017:Morbidity',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Poliomyelitis in the USA: virtual elimination of disease caused by wild virus.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1315-7',\n",
       "  'abstract': 'The average number of paralytic poliomyelitis cases per year in the United States has fallen from 16 000 just before vaccine was introduced in the 1950s to only 12 in 1978-83. 18 of the 69 cases (26%) reported in this 6-year period were not vaccine associated according to the epidemiological classification of paralytic poliomyelitis cases, established in 1975. The van Wezel antigenic differentiation test and oligonucleotide fingerprinting provide a laboratory basis for definitive characterisation of wild and vaccine-like poliovirus strains. Of the 69 cases, isolates from 42 have been analysed; 31 were vaccine-like poliovirus and 11 wild poliovirus. 7 of the wild poliovirus isolates are from cases in a 1979 outbreak caused by poliovirus imported from the Netherlands through Canada; 1 is from a single importation; and 3 are from isolated cases with no identified source. No indigenous wild strain has been isolated from any reported poliomyelitis case since 1981, when a wild strain was isolated from an immunodeficient individual.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kim-Farley|R J|RJ|;Bart|K J|KJ|;Schonberger|L B|LB|;Orenstein|W A|WA|;Nkowane|B M|BM|;Hinman|A R|AR|;Kew|O M|OM|;Hatch|M H|MH|;Kaplan|J E|JE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150330',\n",
       "  'mesh_terms': 'D006801:Humans; D009841:Oligonucleotides; D011051:Poliomyelitis; D017955:Poliovirus; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral; D014481:United States',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D009841:Oligonucleotides; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90829-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Induction of long-term immunity to paralytic poliomyelitis by use of non-infectious vaccine.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1317-21',\n",
       "  'abstract': 'Naturally acquired immunity to paralytic poliomyelitis, which is of long duration, is associated with serum antibody, immunological memory, or both. Persistence of circulating antibody is reassuring but not essential for long-term protection. Immunological memory induced by killed poliovirus vaccine is similar to that induced by infection, which is not a prerequisite for the induction of long-term immunity. Animal studies of experimental vaccines indicate that some antigenic components of poliovirus induce immunological memory without producing detectable antibody; killed poliovirus vaccine has the same effect in man. Killed vaccine containing 40, 8, and 32 D-antigen units of poliovirus types 1, 2, and 3, respectively, protects all recipients in both one-dose and two-dose schedules. This means that either schedule can be chosen to fit in with local immunisation programmes and thus reduce costs and increase population coverage.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Salk|D|D|;van Wezel|A L|AL|;Salk|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150331',\n",
       "  'mesh_terms': 'D000914:Antibodies, Viral; D000917:Antibody Formation; D006801:Humans; D007110:Immunity, Active; D007114:Immunization; D007115:Immunization Schedule; D007117:Immunization, Secondary; D007156:Immunologic Memory; D007223:Infant; D011051:Poliomyelitis; D011054:Poliovirus Vaccine, Inactivated; D013997:Time Factors',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000914:Antibodies, Viral; D011054:Poliovirus Vaccine, Inactivated',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90830-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Outbreak of paralytic poliomyelitis, Taiwan.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1322-4',\n",
       "  'abstract': 'Taiwan had been free of major poliomyelitis outbreaks since 1975, but from May 29 to Oct 26, 1982, 1031 cases of type 1 paralytic poliomyelitis were reported to the Taiwan health authorities. Before the outbreak approximately 80% of infants had received at least 2 doses of trivalent oral poliovaccine (OPV) by their first birthday. Of the 86% of poliomyelitis patients whose vaccination status was known 65% had not had poliovaccine, 19% had received one dose, 8% had received two doses, and 8% had received three or more doses. Vaccine efficacy was calculated to be 82% after one dose, 96% after two doses, and 98% after three or more doses. Failure to vaccinate rather than vaccine failure was the most important risk factor in this outbreak. A child who had not had any vaccine was 80 times more likely to become a case than one who had received three or more doses of poliovaccine, independent of sanitation facilities at home. A child was 5 times more likely to become a case if he received water from non-municipal rather than municipal sources. Furthermore, for children who received municipal water, the risk was doubled if the family shared a toilet with at least one other family. This outbreak shows that major epidemics can occur in areas that have high overall community vaccination levels. Identification and vaccination of subpopulations with low coverage is essential for the control of poliomyelitis.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kim-Farley|R J|RJ|;Rutherford|G|G|;Lichfield|P|P|;Hsu|S T|ST|;Orenstein|W A|WA|;Schonberger|L B|LB|;Bart|K J|KJ|;Lui|K J|KJ|;Lin|C C|CC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150332',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D004196:Disease Outbreaks; D006801:Humans; D007115:Immunization Schedule; D007223:Infant; D007231:Infant, Newborn; D011051:Poliomyelitis; D011055:Poliovirus Vaccine, Oral; D012424:Rural Population; D013624:Taiwan; D013997:Time Factors; D014611:Vaccination',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D011055:Poliovirus Vaccine, Oral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90831-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Unemployment and mortality in the OPCS Longitudinal Study.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1324-9',\n",
       "  'abstract': 'The mortality of men aged 15-64 who were seeking work in the week before the 1971 census was investigated by means of the OPCS Longitudinal Study, which follows up a 1% sample of the population of England and Wales. In contrast to the current position, only 4% of men of working age in 1971 fell into this category. The mortality of these unemployed men in the period 1971-81 was higher (standardised mortality ratio 136) than would be expected from death rates in all men in the Longitudinal Study. The socioeconomic distribution of the unemployed accounts for some of the raised mortality, but, after allowance for this, a 20-30% excess remains; this excess was apparent both in 1971-75 and in 1976-81. The data offer only limited support for the suggestion that some of this excess resulted from men becoming unemployed because of their ill-health; the trend in overall mortality over time and the pattern by cause of death were not those usually associated with ill-health selection. Previous studies have suggested that stress accompanying unemployment could be associated with raised suicide rates, as were again found here. Moreover, the mortality of women whose husbands were unemployed was higher than that of all married women (standardised mortality ratio 120), and this excess also persisted after allowance for their socioeconomic distribution. The results support findings by others that unemployment is associated with adverse effects on health.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Moser|K A|KA|;Fox|A J|AJ|;Jones|D R|DR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150333',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D004739:England; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009026:Mortality; D011446:Prospective Studies; D012923:Social Class; D012959:Socioeconomic Factors; D014478:Unemployment; D014852:Wales',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90832-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'DNA in medicine. Agricultural production.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1329-32',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Swaminathan|M S|MS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150334',\n",
       "  'mesh_terms': 'D000383:Agriculture; D003001:Cloning, Molecular; D004247:DNA; D004274:DNA, Recombinant; D002523:Edible Grain; D005523:Food Supply; D005786:Gene Expression Regulation; D005815:Genetic Code; D005818:Genetic Engineering; D006823:Hybrid Vigor; D009591:Nitrogenase; D010788:Photosynthesis; D010935:Plant Diseases; D010942:Plant Viruses',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D004274:DNA, Recombinant; D004247:DNA; D009591:Nitrogenase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90833-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Salt and hypertension.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1333-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Brown|J J|JJ|;Lever|A F|AF|;Robertson|J I|JI|;Semple|P F|PF|;Bing|R F|RF|;Heagerty|A M|AM|;Swales|J D|JD|;Thurston|H|H|;Ledingham|J G|JG|;Laragh|J H|JH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150335',\n",
       "  'mesh_terms': 'D000818:Animals; D004039:Diet, Sodium-Restricted; D006801:Humans; D006973:Hypertension; D051381:Rats; D012107:Research Design; D012965:Sodium Chloride',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D012965:Sodium Chloride',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90834-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Diet and hypertension.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1334',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Rosenberg|E|E|;Coleman|B R|BR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150336',\n",
       "  'mesh_terms': 'D004032:Diet; D006801:Humans; D006973:Hypertension; D012965:Sodium Chloride',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D012965:Sodium Chloride',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90835-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'NMR in multiple sclerosis and cerebral vascular disease.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1334-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Ormerod|I E|IE|;Roberts|R C|RC|;du Boulay|E P|EP|;McDonald|W I|WI|;Callanan|M M|MM|;Halliday|A M|AM|;Johnson|G|G|;Kendall|B E|BE|;Logsdail|S J|SJ|;Macmanus|D G|DG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150337',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D002561:Cerebrovascular Disorders; D003937:Diagnosis, Differential; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D008875:Middle Aged; D009103:Multiple Sclerosis',\n",
       "  'publication_types': 'D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90836-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Eye damage from Christmas trees.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1335',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Brazier|D J|DJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150338',\n",
       "  'mesh_terms': 'D005131:Eye Injuries; D006693:Holidays; D006801:Humans; D014197:Trees',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90838-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Papanicolaou smears and risk of cervical neoplasia.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1335',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'La Vecchia|C|C|;Franceschi|S|S|;Decarli|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150339',\n",
       "  'mesh_terms': 'D005260:Female; D006801:Humans; D065006:Papanicolaou Test; D012306:Risk; D002583:Uterine Cervical Neoplasms; D014626:Vaginal Smears',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90837-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Enterotoxigenic Campylobacter jejuni among children in South India.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1336',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Albert|M J|MJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150340',\n",
       "  'mesh_terms': 'D000328:Adult; D002169:Campylobacter Infections; D002168:Campylobacter fetus; D002675:Child, Preschool; D003967:Diarrhea; D004768:Enterotoxins; D006801:Humans; D007194:India',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D004768:Enterotoxins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90839-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Side-effects of benoxaprofen.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1336',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Inman|W H|WH|;Rawson|N S|NS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150341',\n",
       "  'mesh_terms': 'D000368:Aged; D056486:Chemical and Drug Induced Liver Injury; D006801:Humans; D007674:Kidney Diseases; D011422:Propionates',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D011422:Propionates; C011677:benoxaprofen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90840-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Two sudden deaths during prophylactic antiemetic treatment with high doses of domperidone and methylprednisolone.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1336-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Giaccone|G|G|;Bertetto|O|O|;Calciati|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150342',\n",
       "  'mesh_terms': 'D002945:Cisplatin; D003645:Death, Sudden; D004294:Domperidone; D004359:Drug Therapy, Combination; D006801:Humans; D008775:Methylprednisolone; D008875:Middle Aged; D014839:Vomiting',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D004294:Domperidone; D002945:Cisplatin; D008775:Methylprednisolone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90841-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1337',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bonser|R S|RS|;Adu|D|D|;Franklin|I|I|;McMaster|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150343',\n",
       "  'mesh_terms': 'D000328:Adult; D003524:Cyclosporins; D006463:Hemolytic-Uremic Syndrome; D006801:Humans; D016031:Liver Transplantation; D008297:Male; D014184:Transplantation, Homologous',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D003524:Cyclosporins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90842-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Acute renal failure due to diltiazem.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1337-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'ter Wee|P M|PM|;Rosman|J B|JB|;van der Geest|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150344',\n",
       "  'mesh_terms': 'D058186:Acute Kidney Injury; D000368:Aged; D001552:Benzazepines; D004110:Diltiazem; D006801:Humans; D008297:Male',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D001552:Benzazepines; D004110:Diltiazem',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90843-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Methyltetrazolethiol and the Antabuse reaction.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1338',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kitson|T M|TM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150345',\n",
       "  'mesh_terms': 'D001393:Azoles; D004221:Disulfiram; D066298:In Vitro Techniques; D013777:Tetrazoles',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D001393:Azoles; D013777:Tetrazoles; C038625:1-N-methyl-5-thiotetrazole; D004221:Disulfiram',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90844-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Once-daily verapamil.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1338-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Dunn|J M|JM|;Groth|P E|PE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150346',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D003327:Coronary Disease; D006801:Humans; D014700:Verapamil',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D014700:Verapamil',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90845-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Birth defects and video display terminals.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1339',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kurppa|K|K|;Holmberg|P C|PC|;Rantala|K|K|;Nurminen|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150347',\n",
       "  'mesh_terms': 'D000013:Congenital Abnormalities; D003626:Data Display; D004781:Environmental Exposure; D005260:Female; D006801:Humans; D011247:Pregnancy',\n",
       "  'publication_types': \"D016422:Letter; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90846-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Prenatal detection of Zellweger syndrome.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1339-40',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Schutgens|R B|RB|;Heymans|H S|HS|;Wanders|R J|RJ|;vd Bosch|H|H|;Schrakamp|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150348',\n",
       "  'mesh_terms': 'D019880:Aldehyde-Ketone Transferases; D000653:Amniotic Fluid; D001927:Brain Diseases; D005260:Female; D005347:Fibroblasts; D006801:Humans; D007674:Kidney Diseases; D008107:Liver Diseases; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013577:Syndrome; D014166:Transferases',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D014166:Transferases; D019880:Aldehyde-Ketone Transferases; C031222:formaldehyde transketolase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90847-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'First-trimester (chorion biopsy) diagnosis of citrullinaemia and methylmalonicaciduria.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1340',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kleijer|W J|WJ|;Thoomes|R|R|;Galjaard|H|H|;Wendel|U|U|;Fowler|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150349',\n",
       "  'mesh_terms': 'D000592:Amino Acid Metabolism, Inborn Errors; D002824:Chorionic Villi; D002956:Citrulline; D005260:Female; D006801:Humans; D008314:Malonates; D008764:Methylmalonic Acid; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011296:Prenatal Diagnosis; D011868:Radioisotopes',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D008314:Malonates; D011868:Radioisotopes; D002956:Citrulline; D008764:Methylmalonic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90848-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Impaired platelet prostacyclin binding in acute myocardial infarction.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1341-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150350',\n",
       "  'mesh_terms': 'D000328:Adult; D001792:Blood Platelets; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D011956:Receptors, Cell Surface; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D011956:Receptors, Cell Surface; D044006:Receptors, Epoprostenol; D011982:Receptors, Prostaglandin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': '51Cr-EDTA in studies of intestinal permeability.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1342-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Jenkins|R T|RT|;Lock|C J|CJ|;Rooney|P J|PJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150351',\n",
       "  'mesh_terms': 'D002860:Chromium Radioisotopes; D004492:Edetic Acid; D006801:Humans; D007413:Intestinal Mucosa; D007700:Kinetics; D008970:Molecular Weight; D010539:Permeability',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D002860:Chromium Radioisotopes; D004492:Edetic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90853-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Complex clinical workloads in a nutshell.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1343',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Dibble|J B|JB|;Will|E J|EJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150352',\n",
       "  'mesh_terms': 'D000368:Aged; D006801:Humans; D007676:Kidney Failure, Chronic; D008962:Models, Theoretical',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90855-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Pylons, their fields, and man.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1343',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bonnell|J A|JA|;Norris|W T|WT|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150353',\n",
       "  'mesh_terms': 'D004574:Electromagnetic Fields; D055590:Electromagnetic Phenomena; D006801:Humans',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90854-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Markets in kidneys.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1344',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150354',\n",
       "  'mesh_terms': 'D004467:Economics; D028663:Ethical Theory; D004992:Ethics, Medical; D006801:Humans; D016030:Kidney Transplantation; D018570:Risk Assessment; D009927:Tissue and Organ Procurement; D014481:United States',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Health Care and Public Health',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18915',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Unemployment and health.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1344-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Shaper|A G|AG|;Cook|D G|DG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150355',\n",
       "  'mesh_terms': 'D006262:Health; D006304:Health Status; D006801:Humans; D008137:Longitudinal Studies; D008297:Male; D014478:Unemployment; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90857-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Stabilising effect of aminoacids on factor VIII in lyophilised cryoprecipitate.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1345',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Margolis|J|J|;Eisen|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150356',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D004573:Electrolytes; D005079:Excipients; D005169:Factor VIII; D005340:Fibrinogen; D005612:Freeze Drying; D005947:Glucose; D057947:Parenteral Nutrition Solutions; D012996:Solutions',\n",
       "  'publication_types': 'D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': 'D000596:Amino Acids; D004573:Electrolytes; D005079:Excipients; D057947:Parenteral Nutrition Solutions; D012996:Solutions; C545824:amino-acid, glucose, and electrolyte solution; C026912:cryoprecipitate coagulum; D005169:Factor VIII; D005340:Fibrinogen; D005947:Glucose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90858-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Blood brotherhood: a risk factor for AIDS?',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1346',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Morfeldt-Månson|L|L|;Lindquist|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150357',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D001769:Blood; D003469:Culture; D005260:Female; D006801:Humans; D008297:Male; D012306:Risk; D013636:Tanzania',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90860-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Transfusion-induced AIDS in four premature babies.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1346',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': \"O'Duffy|J F|JF|;Isles|A F|AF|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150358',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D008297:Male; D065227:Transfusion Reaction',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90859-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Heterosexual partners: a large risk group for AIDS.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1346-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Des Jarlais|D C|DC|;Chamberland|M E|ME|;Yancovitz|S R|SR|;Weinberg|P|P|;Friedman|S R|SR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150359',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D005260:Female; D006801:Humans; D008297:Male; D009519:New York City; D012306:Risk; D012725:Sexual Behavior; D019966:Substance-Related Disorders',\n",
       "  'publication_types': \"D016422:Letter; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90861-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'HTLV-III antibody frequency and severity of lymphadenopathy.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1347',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bayer|H|H|;Bienzle|U|U|;Schneider|J|J|;Hunsmann|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150360',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D000293:Adolescent; D000328:Adult; D000368:Aged; D000914:Antibodies, Viral; D017977:Deltaretrovirus; D006716:Homosexuality; D006801:Humans; D008206:Lymphatic Diseases; D008297:Male; D008875:Middle Aged',\n",
       "  'publication_types': \"D016422:Letter; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90862-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"Single photon emission tomography with 123I-isopropylamphetamine in Alzheimer's disease and multi-infarct dementia.\",\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1348',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gemmell|H G|HG|;Sharp|P F|PF|;Evans|N T|NT|;Besson|J A|JA|;Lyall|D|D|;Smith|F W|FW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150361',\n",
       "  'mesh_terms': 'D000368:Aged; D000544:Alzheimer Disease; D000662:Amphetamines; D002544:Cerebral Infarction; D002552:Cerebral Ventricles; D003704:Dementia; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007457:Iodine Radioisotopes; D020367:Iofetamine; D008297:Male; D008875:Middle Aged; D014055:Tomography, Emission-Computed',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000662:Amphetamines; D007457:Iodine Radioisotopes; D020367:Iofetamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90864-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Treatment of priapism.',\n",
       "  'issue': '2(8415)',\n",
       "  'pages': '1348',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Lindoro|J|J|;Castro|J C|JC|;Cruz|F|F|;Marques|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150362',\n",
       "  'mesh_terms': 'D006801:Humans; D008297:Male; D008722:Methods; D011317:Priapism',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)90865-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Role of heart rate in pathophysiology of chronic stable angina.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1353-7',\n",
       "  'abstract': '11 patients with chronic, stable, effort angina, off medication apart from glyceryl trinitrate, were monitored continuously by electrocardiogram (ECG) during normal, unrestricted daily activity. Computerised ECG analysis demonstrated during 33 twenty-four hour periods of monitoring, 278 episodes of transient ischaemic ST segment depression of which 52 were associated with angina. In the 15 minutes preceding the onset of ischaemia, heart rate did not increase in 164 episodes, increased slightly (greater than or equal to 5 beats/min) in 61, and increased moderately or markedly (greater than or equal to 10 beats/min) in 53. Findings were similar when episodes with or without angina or episodes of different severity were analysed separately. In all patients, periods of sinus tachycardia exceeding the control rate by more than 30 beats/min and lasting more than 10 minutes, often occurred in the absence of angina and/or ST segment depression. Also, in 65% of the ischaemic episodes, heart rate at the beginning of the ST change was either below or less than 10 beats/min above the modal value of the twenty-four hour heart rate. This suggests that increased myocardial demand is not necessarily the only or the most common cause of acute ischaemia in patients with chronic effort angina during unrestricted daily activity. Factors which only transiently interfere with myocardial oxygen supply are probably important in this syndrome.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Chierchia|S|S|;Gallino|A|A|;Smith|G|G|;Deanfield|J|J|;Morgan|M|M|;Croom|M|M|;Maseri|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150363',\n",
       "  'mesh_terms': 'D000368:Aged; D000787:Angina Pectoris; D003201:Computers; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D010146:Pain; D013610:Tachycardia',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92055-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Testicular exocrine malfunction after torsion.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1357-60',\n",
       "  'abstract': 'The exocrine and endocrine functions of the testis were assessed in 67 patients a median of 4.0 years after unilateral torsion (range 3 months-12 years). Of 54 patients who underwent orchidopexy, some atrophy of the affected testis developed in 46; the degree of atrophy was significantly correlated with the duration of torsion (r = -0.56, p less than 0.001). The remaining 13 patients had undergone orchidectomy after a mean duration of torsion of 71 h. Seminal analysis was abnormal in 44 of 51 patients tested (86%), and the low total motile sperm count correlated with the duration of torsion (r = -0.53, p less than 0.001). Sperm counts were much lower in men with torsion for longer than 8 h than those with a shorter period of torsion (median 7.2 X 10(6) v 83.5 X 10(6); p less than 0.00003). Serum levels of luteinising hormone, prolactin, testosterone, and follicle-stimulating hormone were generally within normal limits. An acute ischaemic episode affecting only one testis causes bilateral loss of exocrine function in most patients, while endocrine function is preserved.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Thomas|W E|WE|;Cooper|M J|MJ|;Crane|G A|GA|;Lee|G|G|;Williamson|R C|RC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150364',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D001284:Atrophy; D002648:Child; D006065:Gonadotropins, Pituitary; D006801:Humans; D008297:Male; D012039:Regional Blood Flow; D013076:Sperm Count; D013081:Sperm Motility; D013086:Spermatic Cord Torsion; D013091:Spermatogenesis; D013737:Testis; D013739:Testosterone; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006065:Gonadotropins, Pituitary; D013739:Testosterone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92056-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Randomised comparative study of mefloquine, qinghaosu, and pyrimethamine-sulfadoxine in patients with falciparum malaria.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1360-1',\n",
       "  'abstract': \"A prospective trial in 80 patients randomly allocated to four antimalarial treatment regimens--mefloquine plus pyrimethamine-sulfadoxine ('Fansidar'); mefloquine plus qinghaosu; mefloquine, fansidar, and qinghaosu; and qinghaosu alone--was carried out on Hainan Island, China, in patients with chloroquine-resistant falciparum malaria. A radical cure with slight side-effects was obtained with mefloquine plus fansidar; the addition of qinghaosu greatly increased the rate of parasite clearance with no additional side-effects. Qinghaosu alone had a rapid rate of parasite clearance, no side-effects, but a high recrudescence rate. These antimalarial drugs seem to act at different stages of the asexual parasite cycle and their most efficient use may depend on when in the course of the disease they are given. Because of the continuing appearance of drug-resistant strains of Plasmodium falciparum combination drug therapy is now indicated, but which drugs and how best they should be used remains to be decided.\",\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Li|G Q|GQ|;Arnold|K|K|;Guo|X B|XB|;Jian|H X|HX|;Fu|L C|LC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150365',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000962:Antimalarials; D037621:Artemisinins; D002648:Child; D002681:China; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008288:Malaria; D008297:Male; D015767:Mefloquine; D008875:Middle Aged; D010963:Plasmodium falciparum; D011446:Prospective Studies; D011739:Pyrimethamine; D011804:Quinolines; D011897:Random Allocation; D012717:Sesquiterpenes; D013413:Sulfadoxine; D013424:Sulfanilamides',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D000962:Antimalarials; D037621:Artemisinins; D004338:Drug Combinations; D011804:Quinolines; D012717:Sesquiterpenes; D013424:Sulfanilamides; C001205:fanasil, pyrimethamine drug combination; D013413:Sulfadoxine; C031327:artemisinin; D015767:Mefloquine; D011739:Pyrimethamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92057-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Genomic alterations involving the c-myc proto-oncogene locus during the evolution of a case of chronic granulocytic leukaemia.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1362-5',\n",
       "  'abstract': 'In a patient with Ph-positive chronic granulocytic leukaemia who had 3 separate episodes of promyelocytic transformation associated with new cytogenetic and genetic changes DNA from the peripheral-blood leucocytes obtained during the second episode of transformation showed an 8-fold to 16-fold amplification of cellular myc proto-oncogene (c-myc) sequences, and rearrangement of these sequences. There was no amplification or rearrangement of c-myc sequences in DNA from leucocytes collected during the chronic phase, nor were these sequences amplified in DNA from leucocytes collected during the third episode of transformation. These observations show that new clones of cells that proliferate during the evolution of a myeloid leukaemia can carry genetic changes in addition to any recognisable karyotypic changes. Such genetic changes might underlie the progression of the disease.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'McCarthy|D M|DM|;Rassool|F V|FV|;Goldman|J M|JM|;Graham|S V|SV|;Birnie|G D|GD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150366',\n",
       "  'mesh_terms': 'D000328:Adult; D001483:Base Sequence; D002904:Chromosomes, Human, 21-22 and Y; D004273:DNA, Neoplasm; D005260:Female; D005784:Gene Amplification; D006098:Granulocytes; D006801:Humans; D007951:Leukemia, Myeloid; D009857:Oncogenes; D000090063:Proto-Oncogene Mas',\n",
       "  'publication_types': \"D002363:Case Reports; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D004273:DNA, Neoplasm; C000715470:MAS1 protein, human; D000090063:Proto-Oncogene Mas',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92058-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Detection of aneurysms by gamma-camera imaging after injection of autologous labelled platelets.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1365-7',\n",
       "  'abstract': 'Autologous platelet labelling was used to calculate platelet half-life in 860 patients with symptoms of coronary heart disease and/or peripheral vascular disease. Abnormal platelet deposition indicating an abdominal aortic aneurysm was found in 21 by gamma-camera imaging after reinjection of autologous indium-111 labelled platelets. Aneurysms detected by imaging were confirmed by angiography, computer tomography, and at subsequent surgery.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': \"Sinzinger|H|H|;O'Grady|J|J|;Fitscha|P|P|;Silberbauer|K|K|;Höfer|R|R|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150367',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D001012:Aorta, Abdominal; D001014:Aortic Aneurysm; D001792:Blood Platelets; D005260:Female; D006207:Half-Life; D006801:Humans; D007204:Indium; D008297:Male; D008875:Middle Aged; D011868:Radioisotopes; D011877:Radionuclide Imaging',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D011868:Radioisotopes; D007204:Indium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92059-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Ribavirin suppresses replication of lymphadenopathy-associated virus in cultures of human adult T lymphocytes.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1367-9',\n",
       "  'abstract': 'The in-vitro effect of ribavirin on the replication of lymphadenopathy-associated virus (LAV), one of the prototype viruses aetiologically associated with lymphadenopathy syndrome and acquired immunodeficiency syndrome, was tested. Ribavirin, a nucleoside, suppressed the replication of LAV in cultures of human adult T lymphocytes. Suppression occurred at ribavirin concentrations of 50 micrograms/ml or higher.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'McCormick|J B|JB|;Getchell|J P|JP|;Mitchell|S W|SW|;Hicks|D R|DR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150368',\n",
       "  'mesh_terms': 'D000328:Adult; D000956:Antigens, Viral; D002478:Cells, Cultured; D017977:Deltaretrovirus; D004305:Dose-Response Relationship, Drug; D005455:Fluorescent Antibody Technique; D006801:Humans; D012254:Ribavirin; D012263:Ribonucleosides; D013601:T-Lymphocytes; D014779:Virus Replication',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000956:Antigens, Viral; D012263:Ribonucleosides; D012254:Ribavirin',\n",
       "  'keywords': 'Acquired Immunodeficiency Syndrome--prevention and control; Clinical Research; Diseases; Drugs; Hiv Infections; In Vitro; Research Methodology; Treatment; Viral Diseases',\n",
       "  'doi': '10.1016/s0140-6736(84)92060-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '040185; 00177535',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cellular basis of immune response to antigens of ABO blood-group system. Capacity to provide help during response to T-cell-dependent ABO-system antigens is restricted to individuals of blood group O.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1369-71',\n",
       "  'abstract': 'It is postulated that the near-identity of the A and B antigens in man makes it impossible for individuals of groups A, A2, or B to provide T-cell help during a response to T-dependent non-self antigens by B2 lymphocytes. Thus, people of these groups are unable to produce immune IgG antibody. The presence of naturally occurring IgM antibody to non-self antigen from the age of 6 months is due to a separate system of T-cell-independent B1 cells which have arisen during evolution to protect the host against polysaccharide-encapsulated bacterial pathogens.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kay|L A|LA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150369',\n",
       "  'mesh_terms': 'D000017:ABO Blood-Group System; D000328:Adult; D000955:Antigens, T-Independent; D003429:Cross Reactions; D005260:Female; D006801:Humans; D007074:Immunoglobulin G; D007075:Immunoglobulin M; D007223:Infant; D008297:Male; D013601:T-Lymphocytes; D006377:T-Lymphocytes, Helper-Inducer',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000017:ABO Blood-Group System; D000955:Antigens, T-Independent; D007074:Immunoglobulin G; D007075:Immunoglobulin M',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92061-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Inspiration-phased oxygen delivery.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1371-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Winter|R J|RJ|;George|R J|RJ|;Moore-Gillon|J C|JC|;Geddes|D M|DM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150370',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D001991:Bronchitis; D002245:Carbon Dioxide; D003365:Costs and Cost Analysis; D006801:Humans; D008875:Middle Aged; D010100:Oxygen; D010102:Oxygen Inhalation Therapy; D011656:Pulmonary Emphysema',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D002245:Carbon Dioxide; D010100:Oxygen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92062-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Ophthalmia neonatorum today.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1375-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150371',\n",
       "  'mesh_terms': 'D006069:Gonorrhea; D006801:Humans; D007231:Infant, Newborn; D009878:Ophthalmia Neonatorum; D014141:Trachoma; D014944:World Health Organization',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Needlestick transmission of HTLV-III from a patient infected in Africa.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1376-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150372',\n",
       "  'mesh_terms': 'D000163:Acquired Immunodeficiency Syndrome; D000350:Africa, Central; D005260:Female; D006801:Humans; D009339:Needles; D009741:Nursing Staff, Hospital; D009784:Occupational Diseases; D014195:Travel; D006113:United Kingdom',\n",
       "  'publication_types': 'D002363:Case Reports; D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': 'Acquired Immunodeficiency Syndrome; Case Studies; Delivery Of Health Care; Developed Countries; Diseases; Europe; Health; Health Personnel; Hiv Infections; Hospital Personnel; Northern Europe; United Kingdom; Viral Diseases',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '036999; 00157845',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'New methods for stone extraction in urology.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1377-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150373',\n",
       "  'mesh_terms': 'D006801:Humans; D007669:Kidney Calculi; D008722:Methods; D014514:Ureteral Calculi',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Calamity at Bhopal.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1378-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150374',\n",
       "  'mesh_terms': 'D000062:Accidents, Occupational; D003485:Cyanates; D006540:Herbicides; D006801:Humans; D007194:India; D017953:Isocyanates',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D003485:Cyanates; D006540:Herbicides; D017953:Isocyanates; C008461:methyl isocyanate',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Unrecognised myocardial infarction.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1379',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150375',\n",
       "  'mesh_terms': 'D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'DNA in medicine. Human perfectibility.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1380-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Rose|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150376',\n",
       "  'mesh_terms': 'D000818:Animals; D005075:Biological Evolution; D001695:Biology; D004247:DNA; D004777:Environment; D005544:Forecasting; D005796:Genes; D030342:Genetic Diseases, Inborn; D005818:Genetic Engineering; D005838:Genotype; D040821:Human Characteristics; D006801:Humans; D009154:Mutation; D010641:Phenotype; D010661:Phenylketonurias; D012641:Selection, Genetic; D012931:Social Environment; D035503:Sociobiology',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004247:DNA',\n",
       "  'keywords': 'Genetics and Reproduction',\n",
       "  'doi': '10.1016/s0140-6736(84)92069-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '18778',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effect of fetal diagnostic testing on birth-rate of thalassaemia major in Britain.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1383-6',\n",
       "  'abstract': 'A programme of prospective heterozygote detection and counselling, fetal diagnostic testing, and abortion of fetuses affected by thalassaemia major introduced in Britain in 1977 has proved highly acceptable to at-risk couples of Cypriot and East African Asian origin, but less so to couples of Pakistani origin. However, many at-risk couples are still not detected prospectively, the proportion of thalassaemia-major births prevented was only 32% by the end of 1981, and there is little evidence of a further fall since then. The thalassaemia-major birth-rate had fallen by 60% in Cypriots and by 20% in East African Asians, but it had not fallen at all in Pakistanis. Improved approaches to fetal diagnosis of thalassaemia major are becoming available, so a concerted effort is needed to inform all the at-risk ethnic groups of the existence of the problem and the possibility of detection of affected fetuses.',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Modell|B|B|;Petrou|M|M|;Ward|R H|RH|;Fairweather|D V|DV|;Rodeck|C|C|;Varnavides|L A|LA|;White|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150377',\n",
       "  'mesh_terms': 'D000351:Africa, Eastern; D003535:Cyprus; D005260:Female; D006580:Genetic Carrier Screening; D005817:Genetic Counseling; D006801:Humans; D007194:India; D008297:Male; D010154:Pakistan; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012306:Risk; D013789:Thalassemia; D006113:United Kingdom',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92070-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'The ageing process is a key problem in biomedical research.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1386-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Holliday|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150378',\n",
       "  'mesh_terms': 'D000375:Aging; D006801:Humans; D012106:Research',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92071-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Promoting health through public policy.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1387-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Draper|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150379',\n",
       "  'mesh_terms': 'D002170:Canada; D003226:Congresses as Topic; D006291:Health Policy; D006293:Health Promotion; D006801:Humans; D011640:Public Policy',\n",
       "  'publication_types': 'D016423:Congress',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92072-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"Withdrawal symptoms after six weeks' treatment with diazepam.\",\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1389',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Murphy|S M|SM|;Owen|R T|RT|;Tyrer|P J|PJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150380',\n",
       "  'mesh_terms': 'D014151:Anti-Anxiety Agents; D002065:Buspirone; D002986:Clinical Trials as Topic; D003975:Diazepam; D004311:Double-Blind Method; D006801:Humans; D011743:Pyrimidines; D011897:Random Allocation; D013375:Substance Withdrawal Syndrome',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016422:Letter; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D011743:Pyrimidines; D003975:Diazepam; D002065:Buspirone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92075-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Successful treatment of persistent neonatal interstitial emphysema by flexible bronchoscopy.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1389-90',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'de Blic|J|J|;Scheinmann|P|P|;Paupe|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150381',\n",
       "  'mesh_terms': 'D001999:Bronchoscopy; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases; D011656:Pulmonary Emphysema; D011859:Radiography; D007507:Therapeutic Irrigation',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92076-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Vaccine-associated poliomyelitis.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1390-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150382',\n",
       "  'mesh_terms': 'D000328:Adult; D002648:Child; D006801:Humans; D007223:Infant; D008297:Male; D011051:Poliomyelitis; D011055:Poliovirus Vaccine, Oral',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D011055:Poliovirus Vaccine, Oral',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Immunisation \"misinformation\".',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1391-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150383',\n",
       "  'mesh_terms': 'D004348:Drug Labeling; D006801:Humans; D007114:Immunization; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Valproate and spina bifida.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1392',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Robert|E|E|;Löfkvist|E|E|;Mauguiere|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150384',\n",
       "  'mesh_terms': 'D000014:Abnormalities, Drug-Induced; D000293:Adolescent; D000328:Adult; D004827:Epilepsy; D005260:Female; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011248:Pregnancy Complications; D016136:Spina Bifida Occulta; D014635:Valproic Acid',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D014635:Valproic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92079-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Neutrophils and adult respiratory distress syndrome.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1392-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Crawford|S M|SM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150385',\n",
       "  'mesh_terms': 'D000328:Adult; D006801:Humans; D008297:Male; D009503:Neutropenia; D009504:Neutrophils; D012128:Respiratory Distress Syndrome',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92080-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Methoxyphenamine and dextromethorphan as safe probes for debrisoquine hydroxylation polymorphism.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1393',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Roy|S D|SD|;Hawes|E M|EM|;Hubbard|J W|JW|;McKay|G|G|;Midha|K K|KK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150386',\n",
       "  'mesh_terms': 'D003647:Debrisoquin; D003915:Dextromethorphan; D006801:Humans; D006900:Hydroxylation; D007546:Isoquinolines; D007981:Levorphanol; D008694:Methamphetamine; D010641:Phenotype; D011110:Polymorphism, Genetic',\n",
       "  'publication_types': \"D016422:Letter; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007546:Isoquinolines; D007981:Levorphanol; D008694:Methamphetamine; D003915:Dextromethorphan; C005157:methoxyphenamine; D003647:Debrisoquin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92081-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Aflatoxin, hepatocellular carcinoma, and schistosomiasis.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1393-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Daneshmend|T K|TK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150387',\n",
       "  'mesh_terms': 'D000348:Aflatoxins; D006528:Carcinoma, Hepatocellular; D002471:Cell Transformation, Neoplastic; D006801:Humans; D008113:Liver Neoplasms; D012552:Schistosomiasis',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000348:Aflatoxins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92082-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cell markers in lymphoproliferative disease.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1394',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Geisler|C|C|;Plesner|T|T|;Ralfkiaer|E|E|;Larsen|J K|JK|;Hansen|M M|MM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150388',\n",
       "  'mesh_terms': 'D000368:Aged; D000954:Antigens, Surface; D006801:Humans; D007945:Leukemia, Lymphoid; D008214:Lymphocytes; D008297:Male',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D000954:Antigens, Surface',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92083-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': \"South Africa's children.\",\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1395',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150389',\n",
       "  'mesh_terms': 'D001741:African Americans; D044383:Blacks; D002648:Child; D002662:Child Health Services; D006806:Human Rights; D006801:Humans; D007223:Infant; D007226:Infant Mortality; D013019:South Africa',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Primary health care in the Gambia.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1396',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gowers|P R|PR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150390',\n",
       "  'mesh_terms': 'D003365:Costs and Cost Analysis; D005260:Female; D005714:Gambia; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D011320:Primary Health Care',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92085-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Legibility of advertisements.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1396-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150391',\n",
       "  'mesh_terms': 'D000329:Advertising; D004345:Drug Industry; D006113:United Kingdom',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Fra(X)(p22) not associated with infantile autism.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1397',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150392',\n",
       "  'mesh_terms': 'D001321:Autistic Disorder; D002873:Chromosome Fragility; D002904:Chromosomes, Human, 21-22 and Y; D005260:Female; D005600:Fragile X Syndrome; D006801:Humans; D007223:Infant; D008297:Male; D012729:Sex Chromosome Aberrations',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'High incidence of adult acute leukaemia in north-west Lancashire.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1397-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gorst|D W|DW|;Atkinson|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150393',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000328:Adult; D000368:Aged; D004739:England; D006801:Humans; D007938:Leukemia; D008875:Middle Aged',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92089-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Are postoperative pulmonary complications preventable?',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1398',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150394',\n",
       "  'mesh_terms': 'D005260:Female; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D011183:Postoperative Complications; D012140:Respiratory Tract Diseases',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92091-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Adenosine deaminase activity in Diamond-Blackfan syndrome.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1398-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Whitehouse|D B|DB|;Hopkinson|D A|DA|;Evans|D I|DI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150395',\n",
       "  'mesh_terms': 'D000243:Adenosine Deaminase; D000741:Anemia, Aplastic; D005260:Female; D006801:Humans; D008297:Male; D009700:Nucleoside Deaminases; D010641:Phenotype; D013577:Syndrome',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D009700:Nucleoside Deaminases; D000243:Adenosine Deaminase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92092-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Diagnosis of deep-vein thrombosis.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1399-400',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Gram|J|J|;Jespersen|J|J|;Astrup|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150396',\n",
       "  'mesh_terms': 'D006801:Humans; D010690:Phlebography; D011877:Radionuclide Imaging; D013924:Thrombophlebitis; D014680:Veins',\n",
       "  'publication_types': 'D003160:Comparative Study; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92093-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Bone marrow transplantation strategies in acute leukaemia.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1400-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150397',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute; D008297:Male; D008875:Middle Aged; D014182:Transplantation, Autologous',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Severe hypotension due to epoprostenol.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1401-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Davies|S|S|;McKenna|F|F|;Turney|J|J|;Wright|V|V|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150398',\n",
       "  'mesh_terms': 'D000328:Adult; D011464:Epoprostenol; D005260:Female; D006801:Humans; D007022:Hypotension',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D011464:Epoprostenol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92095-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Sudden-infant-death syndrome in South-East Scotland.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1402',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Bain|A B|AB|;Bartholomew|S E|SE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150399',\n",
       "  'mesh_terms': 'D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D012606:Scotland; D013398:Sudden Infant Death',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92096-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Asphyxia in cot deaths.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1402-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Powell|D E|DE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150400',\n",
       "  'mesh_terms': 'D001237:Asphyxia; D006801:Humans; D007223:Infant; D013398:Sudden Infant Death',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92097-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Carbon monoxide and cot death.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1403',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Cleary|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150401',\n",
       "  'mesh_terms': 'D002249:Carbon Monoxide Poisoning; D006801:Humans; D000860:Hypoxia; D007223:Infant; D013398:Sudden Infant Death',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92098-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Overheating and cot death.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1403',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Cohen|B L|BL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150402',\n",
       "  'mesh_terms': 'D006360:Heat-Shock Proteins; D006361:Heating; D006801:Humans; D007223:Infant; D013398:Sudden Infant Death',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D006360:Heat-Shock Proteins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92099-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Age-specific cot-death rates.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1404',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Burch|P R|PR|;Chesters|M S|MS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150403',\n",
       "  'mesh_terms': 'D000367:Age Factors; D004739:England; D006801:Humans; D007223:Infant; D013223:Statistics as Topic; D013398:Sudden Infant Death; D014852:Wales',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92100-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Human astrovirus serotypes.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1405',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Kurtz|J B|JB|;Lee|T W|TW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150404',\n",
       "  'mesh_terms': 'D004739:England; D005759:Gastroenteritis; D006801:Humans; D001257:Mamastrovirus; D012703:Serotyping; D014713:Viruses, Unclassified',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92101-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Serum thiocyanate levels as indicator of passive smoking in children.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1405-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Poulton|J|J|;Rylance|G W|GW|;Taylor|A W|AW|;Edwards|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150405',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D013861:Thiocyanates; D014028:Tobacco Smoke Pollution',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D013861:Thiocyanates; D014028:Tobacco Smoke Pollution',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92102-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': 'Progestagens and high-density lipoproteins.',\n",
       "  'issue': '2(8416)',\n",
       "  'pages': '1406',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lancet (London, England)',\n",
       "  'authors': 'Godsland|I F|IF|;Wynn|V|V|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150406',\n",
       "  'mesh_terms': 'D017135:Desogestrel; D005260:Female; D006801:Humans; D008075:Lipoproteins, HDL; D008593:Menopause; D009652:Norpregnenes',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D008075:Lipoproteins, HDL; D009652:Norpregnenes; D017135:Desogestrel',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0140-6736(84)92103-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lancet',\n",
       "  'nlm_unique_id': '2985213R',\n",
       "  'issn_linking': '0140-6736',\n",
       "  'country': 'England'},\n",
       " {'title': '[Crohn disease: I. Possibilities and limits of conservative therapy].',\n",
       "  'issue': '364()',\n",
       "  'pages': '413-7',\n",
       "  'abstract': \"As the etiology of Crohn's disease is still unknown, medical as well as surgical treatment has to be symptomatic. Medical therapy is performed by use of prednisolone, salazosulfapyridine, metronidazole and elementary diet depending on the localisation and extension of the disease. Surgical treatment means therapy of complications like stenoses, fistulae and abscess formation. Neither after medical nor after surgical treatment the source of the disease is predictable.\",\n",
       "  'journal': 'Langenbecks Archiv fur Chirurgie',\n",
       "  'authors': 'Domschke|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150407',\n",
       "  'mesh_terms': 'D000636:Aminosalicylic Acids; D003131:Combined Modality Therapy; D003424:Crohn Disease; D004359:Drug Therapy, Combination; D005526:Food, Formulated; D006801:Humans; D008775:Methylprednisolone; D008795:Metronidazole; D012460:Sulfasalazine',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000636:Aminosalicylic Acids; D008795:Metronidazole; D012460:Sulfasalazine; D008775:Methylprednisolone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF01823248',\n",
       "  'references': '6354827;6140209;28219;6114023;6824395;1248701;38176;6111717;6140202;4854277;7399243;7084615;6192606;7429289;6124474',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Langenbecks Arch Chir',\n",
       "  'nlm_unique_id': '0204167',\n",
       "  'issn_linking': '0023-8236',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Radical operation and recurrence prevention with azulfidine in Crohn disease: a prospective multicenter study--initial results].',\n",
       "  'issue': '364()',\n",
       "  'pages': '427-30',\n",
       "  'abstract': \"The influence of radical versus more restricted operation and Azulfidine prophylaxis was studied in a controlled, partially randomized double blind multicenter trial (16 centres) in 177 patients over 3 years. Early relapse occurred more frequently in the radically operated group (49 vs. 31%) and less frequently under Azulfidine prophylaxis (34 vs. 46%). The radical operation had no advantage over the more restricted procedure and should be abandoned in Crohn's disease.\",\n",
       "  'journal': 'Langenbecks Archiv fur Chirurgie',\n",
       "  'authors': 'Ewe|K|K|;Malchow|H|H|;Herfarth|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150408',\n",
       "  'mesh_terms': 'D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D003424:Crohn Disease; D006801:Humans; D011183:Postoperative Complications; D012008:Recurrence; D012460:Sulfasalazine',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D012460:Sulfasalazine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF01823251',\n",
       "  'references': '24891;467942;374299;1248701;6365698;18856',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Langenbecks Arch Chir',\n",
       "  'nlm_unique_id': '0204167',\n",
       "  'issn_linking': '0023-8236',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Medical ethics from the viewpoint of the lawyer].',\n",
       "  'issue': '36(8)',\n",
       "  'pages': '169-70',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lebensversicherungs Medizin',\n",
       "  'authors': 'Laufs|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150410',\n",
       "  'mesh_terms': 'D002983:Clinical Competence; D004992:Ethics, Medical; D005860:Germany, West; D006801:Humans; D008318:Malpractice',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lebensversicher Med',\n",
       "  'nlm_unique_id': '2985219R',\n",
       "  'issn_linking': '0024-0044',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Prevention of cardiovascular diseases].',\n",
       "  'issue': '36(8)',\n",
       "  'pages': '170-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lebensversicherungs Medizin',\n",
       "  'authors': 'Schettler|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150411',\n",
       "  'mesh_terms': 'D002318:Cardiovascular Diseases; D003327:Coronary Disease; D005860:Germany, West; D006801:Humans; D008055:Lipids; D012306:Risk',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D008055:Lipids',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lebensversicher Med',\n",
       "  'nlm_unique_id': '2985219R',\n",
       "  'issn_linking': '0024-0044',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Stress--a risk factor?].',\n",
       "  'issue': '36(8)',\n",
       "  'pages': '173-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lebensversicherungs Medizin',\n",
       "  'authors': 'Tobiasch|V|V|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150412',\n",
       "  'mesh_terms': 'D003327:Coronary Disease; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D012306:Risk; D013315:Stress, Psychological',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lebensversicher Med',\n",
       "  'nlm_unique_id': '2985219R',\n",
       "  'issn_linking': '0024-0044',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Prognosis of withdrawal treatment of nicotine-dependent patients].',\n",
       "  'issue': '36(8)',\n",
       "  'pages': '178-81',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lebensversicherungs Medizin',\n",
       "  'authors': 'Prokop|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150413',\n",
       "  'mesh_terms': 'D006801:Humans; D011379:Prognosis; D011613:Psychotherapy; D012907:Smoking; D013375:Substance Withdrawal Syndrome',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lebensversicher Med',\n",
       "  'nlm_unique_id': '2985219R',\n",
       "  'issn_linking': '0024-0044',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Disability following survival of heart infarct].',\n",
       "  'issue': '36(8)',\n",
       "  'pages': '181-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lebensversicherungs Medizin',\n",
       "  'authors': 'Donat|K|K|;Weiss|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150414',\n",
       "  'mesh_terms': 'D000368:Aged; D004185:Disability Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D011379:Prognosis; D012050:Rehabilitation, Vocational',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lebensversicher Med',\n",
       "  'nlm_unique_id': '2985219R',\n",
       "  'issn_linking': '0024-0044',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Prognostic significance of heart arrhythmias].',\n",
       "  'issue': '36(8)',\n",
       "  'pages': '186-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lebensversicherungs Medizin',\n",
       "  'authors': 'Dietz|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150415',\n",
       "  'mesh_terms': 'D001145:Arrhythmias, Cardiac; D001919:Bradycardia; D003645:Death, Sudden; D006801:Humans; D011379:Prognosis; D013610:Tachycardia',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lebensversicher Med',\n",
       "  'nlm_unique_id': '2985219R',\n",
       "  'issn_linking': '0024-0044',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Churg-Strauss allergic granulomatous angiitis. Apropos of a case with favorable development].',\n",
       "  'issue': '4(7)',\n",
       "  'pages': '411-2, 415-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'LARC medical',\n",
       "  'authors': 'Martin|F|F|;Lepilliez|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150409',\n",
       "  'mesh_terms': 'D000328:Adult; D005260:Female; D006099:Granuloma; D006801:Humans; D010488:Polyarteritis Nodosa; D013997:Time Factors; D014657:Vasculitis',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'LARC Med',\n",
       "  'nlm_unique_id': '8203246',\n",
       "  'issn_linking': '0242-9462',\n",
       "  'country': 'France'},\n",
       " {'title': '[Complications of pacemaker therapy].',\n",
       "  'issue': '36(8)',\n",
       "  'pages': '189-97',\n",
       "  'abstract': '',\n",
       "  'journal': 'Lebensversicherungs Medizin',\n",
       "  'authors': 'Thormann|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150416',\n",
       "  'mesh_terms': 'D004562:Electrocardiography; D004567:Electrodes, Implanted; D006801:Humans; D010138:Pacemaker, Artificial; D012306:Risk',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Lebensversicher Med',\n",
       "  'nlm_unique_id': '2985219R',\n",
       "  'issn_linking': '0024-0044',\n",
       "  'country': 'Germany'},\n",
       " {'title': \"5'-Nucleotidyl-O-tyrosine bond in glutamine synthetase.\",\n",
       "  'issue': '107()',\n",
       "  'pages': '183-200',\n",
       "  'abstract': '',\n",
       "  'journal': 'Methods in enzymology',\n",
       "  'authors': 'Rhee|S G|SG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150418',\n",
       "  'mesh_terms': 'D000249:Adenosine Monophosphate; D002846:Chromatography, Affinity; D004926:Escherichia coli; D005974:Glutamate-Ammonia Ligase; D006863:Hydrogen-Ion Concentration; D007202:Indicators and Reagents; D007700:Kinetics; D011499:Protein Processing, Post-Translational; D013053:Spectrophotometry; D014443:Tyrosine; D014500:Uracil Nucleotides; D014542:Uridine Monophosphate',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': \"D007202:Indicators and Reagents; D014500:Uracil Nucleotides; C043542:tyrosinyl-5'-UMP; D000249:Adenosine Monophosphate; D014443:Tyrosine; C019586:tyrosinyl-5'-AMP; D014542:Uridine Monophosphate; D005974:Glutamate-Ammonia Ligase\",\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0076-6879(84)07012-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Methods Enzymol',\n",
       "  'nlm_unique_id': '0212271',\n",
       "  'issn_linking': '0076-6879',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Characterization of selenomethionine in proteins.',\n",
       "  'issue': '107()',\n",
       "  'pages': '620-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Methods in enzymology',\n",
       "  'authors': 'Sliwkowski|M X|MX|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150419',\n",
       "  'mesh_terms': 'D000101:Acetyl-CoA C-Acetyltransferase; D000596:Amino Acids; D003013:Clostridium; D011506:Proteins; D011868:Radioisotopes; D012643:Selenium; D012645:Selenomethionine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000596:Amino Acids; D011506:Proteins; D011868:Radioisotopes; D012645:Selenomethionine; D000101:Acetyl-CoA C-Acetyltransferase; D012643:Selenium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0076-6879(84)07045-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Methods Enzymol',\n",
       "  'nlm_unique_id': '0212271',\n",
       "  'issn_linking': '0076-6879',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The effects of alpha- or beta-adrenergic receptor agonists and antagonists and calcium entry blockers on the spontaneous vasomotion.',\n",
       "  'issue': '28(2)',\n",
       "  'pages': '143-58',\n",
       "  'abstract': 'The effects of systemic injections of vasoactive substances were studied in the micro-circulation of the hamster skin fold window preparation, which can be observed without anesthesia, exposure, and acute surgical procedures. The effects were characterized by the continuous measurement of the diameter of the arterial microvessels ranging from 100 to 8 micron. Power spectrum analysis was utilized to determine the frequency and the amplitude of the fundamental component of spontaneous diameter changes. Epinephrine and norepinephrine increased the frequency of vasomotion and reduced mean diameter at low dosages. Phentolamine reduced the frequency of vasomotion and increased mean diameter. Propranolol increased the frequency of vasomotion and did not significantly change mean diameter. Adenosine and verapamil suppressed vasomotion and increased mean diameter. These results are explained by postulating that low-dosage alpha-adrenergic receptor stimulation facilitates the spontaneous discharge of smooth muscle cells; beta-adrenergic receptor stimulation has the opposite effect, whereas beta-adrenergic receptor inhibition also enhances the vasomotor effect. Calcium entry blockers abolish the rhythmic discharge. This explanation of the activity of the various substances supports the hypothesis that the spontaneous vasomotion of the arterial microvessels is related to the intrinsic property of smooth muscle cells.',\n",
       "  'journal': 'Microvascular research',\n",
       "  'authors': 'Colantuoni|A|A|;Bertuglia|S|S|;Intaglietta|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150420',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000818:Animals; D002121:Calcium Channel Blockers; D003201:Computers; D006224:Cricetinae; D004305:Dose-Response Relationship, Drug; D008297:Male; D008647:Mesocricetus; D009131:Muscle, Smooth, Vascular; D012884:Skin Window Technique; D014666:Vasomotor System',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0026-2862(84)90014-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Microvasc Res',\n",
       "  'nlm_unique_id': '0165035',\n",
       "  'issn_linking': '0026-2862',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Hemorrhagic rectocolitis or ulcerative colitis in the black Senegalese. Apropos of 14 cases].',\n",
       "  'issue': '44(3)',\n",
       "  'pages': '269-78',\n",
       "  'abstract': 'Ulcerative colitis is exceptional in Africa South of the Sahara. The first case was described in 1964: up to 1982, 46 cases were reported. We report on 14 cases (6 females and 8 males) observed in black Senegalese for three years and a half. The medium age of patients was 30 years. All of them had a high social standard of living. Four patients showed intestinal amebiasis in their previous medical history. Clinical and evolutive patterns of ulcerative colitis in Africa present few differences in comparison with the classical ones. The diagnosis is established by endoscopy (rectosigmoidoscopy and/or colonoscopy) and histopathology. Cryptic abscesses were found in only 2 out of 14 cases. Rectal dysplasia was noted in 2 cases. The course of the disease developed on a fulminating acute mode in one case, on a continuous chronic mode in another case and on a chronic mode with relapses in 11 cases. Irrespective to the clinical form observed, intestinal amebiasis represents the most pressing differential diagnosis. Treatment appears to be difficult in severe acute forms out of an intensive care department, as well as in advanced extensive chronic forms. For the later in black Africa endoscopic and histopathological surveillance appears to be preferable to a total colectomy, made necessary by the important rectal lesions, because the functional sequelae of an ileostomy.',\n",
       "  'journal': 'Medecine tropicale : revue du Corps de sante colonial',\n",
       "  'authors': 'Aubry|P|P|;Klotz|F|F|;Oddes|B|B|;Seurat|P L|PL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150417',\n",
       "  'mesh_terms': 'D000305:Adrenal Cortex Hormones; D000328:Adult; D001741:African Americans; D044383:Blacks; D003093:Colitis, Ulcerative; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007411:Intestinal Diseases, Parasitic; D008019:Life Style; D008297:Male; D010288:Parenteral Nutrition; D012675:Senegal; D012460:Sulfasalazine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000305:Adrenal Cortex Hormones; D012460:Sulfasalazine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Med Trop (Mars)',\n",
       "  'nlm_unique_id': '8710146',\n",
       "  'issn_linking': '0025-682X',\n",
       "  'country': 'France'},\n",
       " {'title': 'Sufentanil--a new opioid anesthetic.',\n",
       "  'issue': '26(675)',\n",
       "  'pages': '106',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Medical letter on drugs and therapeutics',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150423',\n",
       "  'mesh_terms': 'D000701:Analgesics, Opioid; D000777:Anesthetics; D005283:Fentanyl; D006801:Humans; D017409:Sufentanil',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000701:Analgesics, Opioid; D000777:Anesthetics; D017409:Sufentanil; D005283:Fentanyl',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Med Lett Drugs Ther',\n",
       "  'nlm_unique_id': '2985240R',\n",
       "  'issn_linking': '0025-732X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Drugs for hypertension.',\n",
       "  'issue': '26(676)',\n",
       "  'pages': '107-12',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Medical letter on drugs and therapeutics',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150424',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001160:Arterioles; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D002216:Captopril; D004232:Diuretics; D004338:Drug Combinations; D004347:Drug Interactions; D006801:Humans; D006973:Hypertension; D010293:Pargyline; D049993:Sodium Chloride Symporter Inhibitors; D013565:Sympatholytics; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D001581:Benzothiadiazines; D002121:Calcium Channel Blockers; D004232:Diuretics; D004338:Drug Combinations; D049993:Sodium Chloride Symporter Inhibitors; D013565:Sympatholytics; D014665:Vasodilator Agents; D002216:Captopril; D010293:Pargyline',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Med Lett Drugs Ther',\n",
       "  'nlm_unique_id': '2985240R',\n",
       "  'issn_linking': '0025-732X',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Spleno-gonadal fusion. Presentation of a case and review of the literature].',\n",
       "  'issue': '36(13-14)',\n",
       "  'pages': '699-705',\n",
       "  'abstract': '',\n",
       "  'journal': 'Minerva pediatrica',\n",
       "  'authors': 'Parigi|G B|GB|;Ceffa|F|F|;Cassani|F|F|;Verga|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150425',\n",
       "  'mesh_terms': 'D002648:Child; D002828:Choristoma; D003456:Cryptorchidism; D003937:Diagnosis, Differential; D005834:Genital Neoplasms, Male; D006801:Humans; D008297:Male; D012611:Scrotum; D013154:Spleen; D013736:Testicular Neoplasms',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Minerva Pediatr',\n",
       "  'nlm_unique_id': '0400740',\n",
       "  'issn_linking': '0026-4946',\n",
       "  'country': 'Italy'},\n",
       " {'title': '[Additional anomalies in 2 children with the VACTERL association].',\n",
       "  'issue': '36(13-14)',\n",
       "  'pages': '713-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Minerva pediatrica',\n",
       "  'authors': 'Arrigo|T|T|;Pandullo|E|E|;Tedeschi|A|A|;Sindoni|A|A|;Manganaro|R|R|;De Luca|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150426',\n",
       "  'mesh_terms': 'D000015:Abnormalities, Multiple; D001003:Anal Canal; D001842:Bone and Bones; D002648:Child; D003456:Cryptorchidism; D005837:Genitalia, Male; D006801:Humans; D007223:Infant; D007668:Kidney; D007866:Leg; D008297:Male; D012007:Rectum; D012272:Ribs; D012611:Scrotum; D013577:Syndrome',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Minerva Pediatr',\n",
       "  'nlm_unique_id': '0400740',\n",
       "  'issn_linking': '0026-4946',\n",
       "  'country': 'Italy'},\n",
       " {'title': 'Acute management of serious envenomation by box-jellyfish (Chironex fleckeri).',\n",
       "  'issue': '141(12-13)',\n",
       "  'pages': '851-3',\n",
       "  'abstract': 'Two cases of serious envenomation by the northern Australian box-jellyfish (Chironex fleckeri) are reported. The first-aid measures and the subsequent management and follow-up of patients are discussed. In addition to its known life-saving effects, the early administration of the specific antivenom appears to be the best treatment for the savage pain of the sting, and may also result in a reduction of subsequent skin scarring.',\n",
       "  'journal': 'The Medical journal of Australia',\n",
       "  'authors': 'Williamson|J A|JA|;Le Ray|L E|LE|;Wohlfahrt|M|M|;Fenner|P J|PJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150421',\n",
       "  'mesh_terms': 'D000328:Adult; D000818:Animals; D000997:Antivenins; D001733:Bites and Stings; D002675:Child, Preschool; D003064:Cnidarian Venoms; D004359:Drug Therapy, Combination; D005260:Female; D005392:First Aid; D006801:Humans; D006854:Hydrocortisone; D008297:Male',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D000997:Antivenins; D003064:Cnidarian Venoms; D006854:Hydrocortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.5694/j.1326-5377.1984.tb132969.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Med J Aust',\n",
       "  'nlm_unique_id': '0400714',\n",
       "  'issn_linking': '0025-729X',\n",
       "  'country': 'Australia'},\n",
       " {'title': 'Wound necrosis caused by the venom of stingrays. Pathological findings and surgical management.',\n",
       "  'issue': '141(12-13)',\n",
       "  'pages': '854-5',\n",
       "  'abstract': 'Two cases of stingray injury which caused extensive tissue necrosis are reported. In one patient, the wound was allegedly inflicted by Dasyatis kuhlii, the blue-spotted stingray; in the other, by D. sephen, the cowtail ray. After excision of necrotic tissue, the wounds healed rapidly and without complications. Wound exploration and debridement of dead tissue are indicated in at least some stingray injuries, particularly when first-aid measures, such as early immersion in hot water or irrigation of the wound have not been carried out.',\n",
       "  'journal': 'The Medical journal of Australia',\n",
       "  'authors': 'Barss|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150422',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D001733:Bites and Stings; D003646:Debridement; D005397:Fish Venoms; D005528:Foot; D018409:Foot Injuries; D006801:Humans; D008297:Male; D009336:Necrosis; D013898:Thoracic Injuries',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D005397:Fish Venoms',\n",
       "  'keywords': '',\n",
       "  'doi': '10.5694/j.1326-5377.1984.tb132970.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Med J Aust',\n",
       "  'nlm_unique_id': '0400714',\n",
       "  'issn_linking': '0025-729X',\n",
       "  'country': 'Australia'},\n",
       " {'title': 'Psychogeriatrics.',\n",
       "  'issue': '2(1)',\n",
       "  'pages': '155-72',\n",
       "  'abstract': 'Many elderly manifest \"functional\" psychiatric symptoms that are not necessarily associated with a dementing process. The vast majority of these psychiatric syndromes are amenable to treatment if it is instituted early. Early treatment may prevent institutionalization. Of all age groups, the elderly have the highest suicide rate. The possibility of suicide must be evaluated and openly discussed. Drug abuse and alcoholism should also be considered. The elderly respond to much smaller doses of psychopharmacologic agents and are very sensitive to the side effects of these drugs. Polypharmacy, decreased compliance, and drug-drug interactions are common occurrences in the elderly. Not all psychiatric reactions of the elderly require pharmacologic intervention. Many respond to psychotherapy, which should be used more frequently than has been the practice in the past.',\n",
       "  'journal': 'Neurologic clinics',\n",
       "  'authors': 'Shamoian|C A|CA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150428',\n",
       "  'mesh_terms': 'D000341:Affective Disorders, Psychotic; D000368:Aged; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001007:Anxiety; D003693:Delirium; D003704:Dementia; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008297:Male; D001523:Mental Disorders; D011613:Psychotherapy; D012559:Schizophrenia; D013577:Syndrome',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neurol Clin',\n",
       "  'nlm_unique_id': '8219232',\n",
       "  'issn_linking': '0733-8619',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Psychologic and neuropsychologic aspects of Tourette's syndrome.\",\n",
       "  'issue': '2(1)',\n",
       "  'pages': '91-102',\n",
       "  'abstract': \"Behavioral, psychologic, and neuropsychologic aspects of Tourette's syndrome are reviewed. A hypothesis that unifies the behavioral and organic components is developed, along with recommendations for treatment.\",\n",
       "  'journal': 'Neurologic clinics',\n",
       "  'authors': 'Golden|G S|GS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150429',\n",
       "  'mesh_terms': 'D000124:Achievement; D000293:Adolescent; D000328:Adult; D001288:Attention; D000697:Central Nervous System Stimulants; D002648:Child; D003000:Clonidine; D006220:Haloperidol; D006801:Humans; D007360:Intelligence; D007802:Language; D007858:Learning; D008568:Memory; D010868:Pimozide; D011597:Psychomotor Performance; D005879:Tourette Syndrome',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000697:Central Nervous System Stimulants; D010868:Pimozide; D006220:Haloperidol; D003000:Clonidine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neurol Clin',\n",
       "  'nlm_unique_id': '8219232',\n",
       "  'issn_linking': '0733-8619',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Postinfectious and postvaccinial encephalomyelitis.',\n",
       "  'issue': '2(2)',\n",
       "  'pages': '341-53',\n",
       "  'abstract': 'Addressed are the features of postviral and postvaccinial syndromes affecting the CNS. The relationships among acute disseminated encephalomyelitis, EAE, and MS are discussed. Among the postvaccination syndromes covered are the neurologic sequelae of pertussis immunizations, with a description of a mouse model of this encephalopathy.',\n",
       "  'journal': 'Neurologic clinics',\n",
       "  'authors': 'Sriram|S|S|;Steinman|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150430',\n",
       "  'mesh_terms': 'D001921:Brain; D002543:Cerebral Hemorrhage; D002644:Chickenpox; D004679:Encephalomyelitis; D004673:Encephalomyelitis, Acute Disseminated; D006801:Humans; D007251:Influenza, Human; D008457:Measles; D009107:Mumps; D012409:Rubella; D014777:Virus Diseases',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neurol Clin',\n",
       "  'nlm_unique_id': '8219232',\n",
       "  'issn_linking': '0733-8619',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Antiasthmatic drugs.',\n",
       "  'issue': '81(11)',\n",
       "  'pages': '715-20',\n",
       "  'abstract': '',\n",
       "  'journal': 'Missouri medicine',\n",
       "  'authors': 'Cuddy|P G|PG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150431',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D000328:Adult; D000367:Age Factors; D000628:Aminophylline; D001249:Asthma; D001993:Bronchodilator Agents; D002648:Child; D002675:Child, Preschool; D004205:Cromolyn Sodium; D004359:Drug Therapy, Combination; D004837:Epinephrine; D006801:Humans; D007223:Infant; D010276:Parasympatholytics; D013566:Sympathomimetics; D013806:Theophylline; D014970:Xanthines',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000305:Adrenal Cortex Hormones; D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D010276:Parasympatholytics; D013566:Sympathomimetics; D014970:Xanthines; D000628:Aminophylline; C008514:methylxanthine; D013806:Theophylline; D004205:Cromolyn Sodium; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Mo Med',\n",
       "  'nlm_unique_id': '0400744',\n",
       "  'issn_linking': '0026-6620',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Gastrinoma: diagnosis and management of Zollinger-Ellison syndrome].',\n",
       "  'issue': '85(9)',\n",
       "  'pages': '1044-8',\n",
       "  'abstract': \"Diagnosis and management of Zollinger-Ellison syndrome (ZES) do not appear to be established even today. In the present study, 143 cases of ZES (including 12 of author's experience) were collected from Japanese literature and analyzed, and diagnosis and management were discussed. (1) Although 43% of patients showed high gastrin level (greater than or equal to 500pg/ml), it is worth to be stressed that gastrin level was below 300pg/ml in 29% of patients. (2) Secretin provocation test was essential for diagnosis and particularly useful for detecting ZES with low gastrin level. (3) Angiography and/or blood samplings of PTPC were widely used for localizing gastrinoma but the informations thus obtained were not always of help for complete removal of tumors since malignant or multiple gastrinomas were frequent. (4) An aim of management for ZES consists of complete removal of tumor but it is not always feasible. Therefore, removal of target organ (total gastrectomy) should be routinely added for long-term cure. (5) Value of chemical gastrectomy (H2-receptor antagonist) is still a matter of pros and cons but substantial value of this drug should be considered adjunct to surgery.\",\n",
       "  'journal': 'Nihon Geka Gakkai zasshi',\n",
       "  'authors': 'Sugihara|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150432',\n",
       "  'mesh_terms': 'D005743:Gastrectomy; D005755:Gastrins; D006635:Histamine H2 Antagonists; D006801:Humans; D012633:Secretin; D015043:Zollinger-Ellison Syndrome',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D005755:Gastrins; D006635:Histamine H2 Antagonists; D012633:Secretin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nihon Geka Gakkai Zasshi',\n",
       "  'nlm_unique_id': '0405405',\n",
       "  'issn_linking': '0301-4894',\n",
       "  'country': 'Japan'},\n",
       " {'title': '[Changes in GH, somatostatin, blood glucose and lactic acid levels in healthy subjects during tests using MC and HM insulin].',\n",
       "  'issue': '9(2)',\n",
       "  'pages': '159-62',\n",
       "  'abstract': '',\n",
       "  'journal': 'Minerva endocrinologica',\n",
       "  'authors': \"Sgambato|S|S|;Passariello|N|N|;Varano|R|R|;Paolisso|G|G|;D'Onofrio|F|F|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150427',\n",
       "  'mesh_terms': 'D000328:Adult; D001786:Blood Glucose; D013006:Growth Hormone; D006801:Humans; D007328:Insulin; D007773:Lactates; D019344:Lactic Acid; D013004:Somatostatin',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D007328:Insulin; D007773:Lactates; D019344:Lactic Acid; D013004:Somatostatin; D013006:Growth Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Minerva Endocrinol',\n",
       "  'nlm_unique_id': '8406505',\n",
       "  'issn_linking': '0391-1977',\n",
       "  'country': 'Italy'},\n",
       " {'title': '[The Pediatric Urology Conference].',\n",
       "  'issue': '85(9)',\n",
       "  'pages': '1206-9',\n",
       "  'abstract': 'This meeting was first established in 1972 for the purpose to make free discussion between the urologists and pediatric surgeons on pediatric urology. Several themes, such as undescended testis, hydronephrosis, intersex and stone disease, have been talked over. Ano-rectal malformation was one of the main themes, and many different opinions from both urological and surgical sides have been presented for the prevention of the complications of pelvic surgery. Pediatric urology has undergone a remarkable progress in the past 30 years. The main contribution has been brought about through the better understanding of the diseases in this field. Newer diagnostic methods and operative techniques have also influenced the development. What is left for the future in pediatric urology is how to preserve the renal function. It is not rare that the diseased child goes on to the end-stage renal failure, in spite of the successful intervention of urinary tracts. Hypodysplasia of the kidney is still incurable in the modern medicine. The best alternative may be renal transplantation. Pediatric urology is one member of a team of specialists to whom cases are referred by pediatricians and obstetricians. Earlier diagnosis, for example by the echogram of the fetus, and higher operative techniques are the themes in the future.',\n",
       "  'journal': 'Nihon Geka Gakkai zasshi',\n",
       "  'authors': 'Shimada|K|K|;Ikoma|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150433',\n",
       "  'mesh_terms': 'D003226:Congresses as Topic; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D010372:Pediatrics; D014570:Urologic Diseases; D014572:Urology',\n",
       "  'publication_types': 'D016423:Congress',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nihon Geka Gakkai Zasshi',\n",
       "  'nlm_unique_id': '0405405',\n",
       "  'issn_linking': '0301-4894',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'A sensitive procedure for determination of cathepsin D: activity in alveolar and peritoneal macrophages.',\n",
       "  'issue': '64(2)',\n",
       "  'pages': '155-62',\n",
       "  'abstract': 'Several new synthetic substrates fulfilling the specificity requirements of cathepsin D were synthesized. One of these D-Phe-Ser(O-CH2-C6H5)-Phe-Phe-Ala-Ala-pAB(pAB = p-aminobenzoate) proved to be highly sensitive and convenient for measuring activity. Enzyme determination was carried out in a two-step reaction. In the first step the enzyme hydrolyzes the Phe-Phe bond of the substrate at pH 3.4. In the second step aminopeptidase M (EC 3.4.11.2) degrades one of the products Phe-Ala-Ala-pAB at pH 7 to 8 with the release of free pAB, which is then determined by a diazotization procedure. Activity can be measured in as little as 1 to 5 micrograms of macrophage protein. The activity of cathepsin D in rat alveolar macrophages was almost ten times higher than in resident peritoneal macrophages, and more than 25 times higher than in blood monocytes. The data indicate that transformation of blood monocytes into macrophages is associated with a much greater increase of cathepsin D activity in alveolar than peritoneal macrophages.',\n",
       "  'journal': 'Molecular and cellular biochemistry',\n",
       "  'authors': 'Orlowski|M|M|;Orlowski|R|R|;Chang|J C|JC|;Wilk|E|E|;Lesser|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150434',\n",
       "  'mesh_terms': 'D000626:Aminopeptidases; D000818:Animals; D001202:Ascitic Fluid; D018826:CD13 Antigens; D002402:Cathepsin D; D007700:Kinetics; D008168:Lung; D008264:Macrophages; D009000:Monocytes; D009842:Oligopeptides; D011817:Rabbits; D013379:Substrate Specificity',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D009842:Oligopeptides; D000626:Aminopeptidases; D018826:CD13 Antigens; D002402:Cathepsin D',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00224772',\n",
       "  'references': '7560;6035483;5482633;4583261;5016644;6447249;6346052;14434765;4673185;6337226;6340719;14907713;6869796;7009773;4873246;7028098;5129683;6349998',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Mol Cell Biochem',\n",
       "  'nlm_unique_id': '0364456',\n",
       "  'issn_linking': '0300-8177',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Bone-marrow transplantation in the Maroteaux-Lamy syndrome (mucopolysaccharidosis type VI). Biochemical and clinical status 24 months after transplantation.',\n",
       "  'issue': '311(25)',\n",
       "  'pages': '1606-11',\n",
       "  'abstract': 'A 13-year-old girl with the severe form of the Maroteaux-Lamy syndrome (mucopolysaccharidosis Type VI, arylsulfatase B deficiency) has had successful reconstitution with bone marrow from her HLA-MLC-matched sister who had normal arylsulfatase B activity. Full engraftment has been present for 24 months. The following biochemical and clinical changes have occurred: arylsulfatase B activity in peripheral lymphocytes and granulocytes increased to normal levels, and the activity in serial liver-biopsy specimens increased from about 3 per cent of the mean normal level 43 days after transplantation to about 16 per cent at 600 days. Urinary excretion of acid mucopolysaccharide decreased. Ultrastructural evidence of accumulated dermatan sulfate was no longer detectable in bone-marrow cells; in peripheral-blood lymphocytes, granulocytes, or platelets; or in Ito cells of liver. Twenty-four months after engraftment, hepatosplenomegaly was substantially decreased and cardiopulmonary function was normal. Visual acuity and joint mobility were also improved. The patient returned to school and continued to perform well in academic studies. Thus, bone-marrow transplantation provided a source of enzymatically normal cells, which have altered the metabolic and clinical course of the disease.',\n",
       "  'journal': 'The New England journal of medicine',\n",
       "  'authors': 'Krivit|W|W|;Pierpont|M E|ME|;Ayaz|K|K|;Tsai|M|M|;Ramsay|N K|NK|;Kersey|J H|JH|;Weisdorf|S|S|;Sibley|R|R|;Snover|D|D|;McGovern|M M|MM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150438',\n",
       "  'mesh_terms': 'D000293:Adolescent; D016026:Bone Marrow Transplantation; D006328:Cardiac Catheterization; D002553:Cerebroside-Sulfatase; D002803:Chondro-4-Sulfatase; D005260:Female; D006025:Glycosaminoglycans; D006651:Histocytochemistry; D006801:Humans; D007962:Leukocytes; D008099:Liver; D009083:Mucopolysaccharidoses; D009087:Mucopolysaccharidosis VI; D012129:Respiratory Function Tests; D014792:Visual Acuity',\n",
       "  'publication_types': \"D002363:Case Reports; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D006025:Glycosaminoglycans; D002553:Cerebroside-Sulfatase; D002803:Chondro-4-Sulfatase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1056/NEJM198412203112504',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'N Engl J Med',\n",
       "  'nlm_unique_id': '0255562',\n",
       "  'issn_linking': '0028-4793',\n",
       "  'country': 'United States'},\n",
       " {'title': '[20 years of cooperation in the study of structure and function of tRNA and aminoacyl-tRNA-synthetases].',\n",
       "  'issue': '18(5)',\n",
       "  'pages': '1157-62',\n",
       "  'abstract': 'The article reviews the results of joint projects initiated 20 years ago in the field of tRNA and aminoacyl-tRNA synthetases. Laboratories located at Novosibirsk, Moscow, Kiev and other places remoted geographically effectively cooperated with each other. More than 30 common publications emerged and the data obtained were communicated at several international meetings. The effectiveness of cooperation was achieved by two important factors: (i) mutual scientific and methodological complementarity of the cooperating units, and (ii) absence of administrative pressure. The cooperation was strongly supported by the Scientific Council of Molecular Biology and 10 workshops were sponsored by the Council to facilitate personal contacts and to create an atmosphere of intensive and informal exchange of data and ideas. It is stressed that the experience worked out in this particular field is applicable to other fields of molecular biology.',\n",
       "  'journal': 'Molekuliarnaia biologiia',\n",
       "  'authors': 'Knorre|D G|DG|;Kiselev|L L|LL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150435',\n",
       "  'mesh_terms': 'D000604:Amino Acyl-tRNA Synthetases; D003226:Congresses as Topic; D009096:Multi-Institutional Systems; D012343:RNA, Transfer; D014586:USSR',\n",
       "  'publication_types': 'D016423:Congress',\n",
       "  'chemical_list': 'D012343:RNA, Transfer; D000604:Amino Acyl-tRNA Synthetases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Mol Biol (Mosk)',\n",
       "  'nlm_unique_id': '0105454',\n",
       "  'issn_linking': '0026-8984',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Aminoacyl-tRNA-synthetases and their high molecular weight complexes in experimental myocardial ischemia].',\n",
       "  'issue': '18(5)',\n",
       "  'pages': '1326-9',\n",
       "  'abstract': 'A number of aminoacyl-tRNA synthetases from rabbit liver during experimental myocardial infarction and from pig myocardium upon 15-min of autolysis were found to increase their activity in aminoacylation. Direct correlations between the activities of high molecular weight complexes and of the total extracts were not observed. It was shown that the specific activity of endogenous inorganic pyrophosphatase increased markedly during the ischemia of myocardium both in total myocardium extracts and in high molecular weight complexes.',\n",
       "  'journal': 'Molekuliarnaia biologiia',\n",
       "  'authors': 'Ivanov|L L|LL|;Tamuliavichius|A A|AA|;Lukoshiavichius|L Iu|LIu|;Kovalenko|M I|MI|;Rodovichius|G A|GA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150436',\n",
       "  'mesh_terms': 'D000604:Amino Acyl-tRNA Synthetases; D000818:Animals; D001329:Autolysis; D003327:Coronary Disease; D066298:In Vitro Techniques; D008099:Liver; D008970:Molecular Weight; D009203:Myocardial Infarction; D009206:Myocardium; D011755:Pyrophosphatases; D011817:Rabbits; D013552:Swine',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D011755:Pyrophosphatases; D000604:Amino Acyl-tRNA Synthetases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Mol Biol (Mosk)',\n",
       "  'nlm_unique_id': '0105454',\n",
       "  'issn_linking': '0026-8984',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Excessive incidence of orchidopexy; study and measures on the island of Walcheren].',\n",
       "  'issue': '128(44)',\n",
       "  'pages': '2077-81',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nederlands tijdschrift voor geneeskunde',\n",
       "  'authors': 'Snick|H K|HK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150443',\n",
       "  'mesh_terms': 'D003456:Cryptorchidism; D003951:Diagnostic Errors; D006266:Health Education; D006300:Health Services Misuse; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D009426:Netherlands',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ned Tijdschr Geneeskd',\n",
       "  'nlm_unique_id': '0400770',\n",
       "  'issn_linking': '0028-2162',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Phenotypic drift and clonal variation in differentiation antigen expression on AKR T-cell lymphoma lines grown in vitro.',\n",
       "  'issue': '3(3)',\n",
       "  'pages': '143-54',\n",
       "  'abstract': 'AKR T-cell lymphomas were adapted to tissue culture and analyzed for reactivity with monoclonal antibodies against Thy-1, Ly-1, Ly-2, Ly-5, and H-2K differentiation antigens to determine whether the original phenotype was maintained after adaptation to in vitro culture. Ly-1 and Ly-2 antigens were lost on the majority of lymphomas early in culture and the expression of other lymphocyte differentiation antigens fluctuated when the cell lines were reanalyzed at various time intervals. In addition, the T-lymphoma lines were cloned and the clonal progeny compared with each other and the parent cell lines for differentiation antigen expression. The results demonstrated marked intratumor heterogeneity with respect to antigenic profile. In vivo passage of the cell lines revealed that expression of various antigens was modified after transplantation suggesting that these lymphomas may be susceptible to microenvironmental influences effecting phenotypic alterations. Potential mechanisms contributing to the observed variations in antigenic phenotype on the cultured AKR T-lymphoma lines are discussed.',\n",
       "  'journal': 'Natural immunity and cell growth regulation',\n",
       "  'authors': 'Howell|A L|AL|;Richie|E R|ER|',\n",
       "  'pubdate': '1983',\n",
       "  'pmid': '6150437',\n",
       "  'mesh_terms': 'D000818:Animals; D000945:Antigens, Differentiation, T-Lymphocyte; D000950:Antigens, Ly; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D002453:Cell Cycle; D002460:Cell Line; D002471:Cell Transformation, Neoplastic; D002999:Clone Cells; D005787:Gene Frequency; D006183:H-2 Antigens; D064532:Histocompatibility Antigen H-2D; D008223:Lymphoma; D051379:Mice; D008806:Mice, Inbred AKR; D010641:Phenotype; D013601:T-Lymphocytes; D018800:Thy-1 Antigens',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000945:Antigens, Differentiation, T-Lymphocyte; D000950:Antigens, Ly; D000951:Antigens, Neoplasm; D000954:Antigens, Surface; D006183:H-2 Antigens; D064532:Histocompatibility Antigen H-2D; D018800:Thy-1 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nat Immun Cell Growth Regul',\n",
       "  'nlm_unique_id': '8407979',\n",
       "  'issn_linking': '0254-7600',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': '[Treatment of undescended testicles with gonadorelin (LH-RH) via nose spray; initial experiences and results].',\n",
       "  'issue': '128(44)',\n",
       "  'pages': '2081-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nederlands tijdschrift voor geneeskunde',\n",
       "  'authors': 'de Muinck Keizer-Schrama|S M|SM|;Hazebroek|F W|FW|;Drop|S L|SL|;Visser|H K|HK|;Molenaar|J C|JC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150444',\n",
       "  'mesh_terms': 'D000281:Administration, Intranasal; D000293:Adolescent; D000336:Aerosols; D002648:Child; D002675:Child, Preschool; D003456:Cryptorchidism; D004311:Double-Blind Method; D007987:Gonadotropin-Releasing Hormone; D006728:Hormones; D006801:Humans; D008297:Male; D010865:Pilot Projects',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000336:Aerosols; D006728:Hormones; D007987:Gonadotropin-Releasing Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ned Tijdschr Geneeskd',\n",
       "  'nlm_unique_id': '0400770',\n",
       "  'issn_linking': '0028-2162',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Transformation by the p21ras protein.',\n",
       "  'issue': '312(5992)',\n",
       "  'pages': '314',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nature',\n",
       "  'authors': 'Newbold|R F|RF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150439',\n",
       "  'mesh_terms': 'D000818:Animals; D002472:Cell Transformation, Viral; D020558:GTP Phosphohydrolases; D008322:Mammals; D009857:Oncogenes',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D020558:GTP Phosphohydrolases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1038/312314a0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nature',\n",
       "  'nlm_unique_id': '0410462',\n",
       "  'issn_linking': '0028-0836',\n",
       "  'country': 'England'},\n",
       " {'title': '[Hormonal treatment of undescended testicles with gonadorelin (LH-RH)].',\n",
       "  'issue': '128(44)',\n",
       "  'pages': '2100-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nederlands tijdschrift voor geneeskunde',\n",
       "  'authors': 'Scholtmeijer|R J|RJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150445',\n",
       "  'mesh_terms': 'D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003456:Cryptorchidism; D007987:Gonadotropin-Releasing Hormone; D006728:Hormones; D006801:Humans; D008297:Male',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006728:Hormones; D007987:Gonadotropin-Releasing Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ned Tijdschr Geneeskd',\n",
       "  'nlm_unique_id': '0400770',\n",
       "  'issn_linking': '0028-2162',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo.',\n",
       "  'issue': '312(5994)',\n",
       "  'pages': '548-51',\n",
       "  'abstract': 'A major aim in immunology has been to understand how the immune system evokes characteristic responses to infection, foreign tissue grafts and tumours. The current view of immunoregulation is based mainly on studies of lymphocyte subsets, either in vitro or by adoptive transfer to irradiated recipients. Many reagents are available for defining T-cell subsets, but only recently have there been helper T-cell-specific antibodies against the mouse equivalent of the Leu3/T4 (man) and W3/25 (rat) antigens. It is clear that monoclonal antibodies will eventually replace antilymphocyte globulin for immunosuppression in organ grafting, but although there has been some clinical success, most monoclonal reagents cause only transient reductions in their target cells in vivo. This uncertainty in the potency of monoclonal antibodies has led some workers to consider them as targeting agents for such highly cytotoxic drugs as ricin A (ref. 21). We show here that unmodified monoclonal antibodies can be extremely effective at depleting cells in vivo and can be used for the selective manipulation of different aspects of the immune response.',\n",
       "  'journal': 'Nature',\n",
       "  'authors': 'Cobbold|S P|SP|;Jayasuriya|A|A|;Nash|A|A|;Prospero|T D|TD|;Waldmann|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150440',\n",
       "  'mesh_terms': 'D000818:Animals; D000911:Antibodies, Monoclonal; D000917:Antibody Formation; D000950:Antigens, Ly; D000954:Antigens, Surface; D002460:Cell Line; D003602:Cytotoxicity, Immunologic; D006968:Hypersensitivity, Delayed; D007108:Immune Tolerance; D007111:Immunity, Cellular; D008213:Lymphocyte Activation; D008211:Lymphocyte Cooperation; D008297:Male; D051379:Mice; D013601:T-Lymphocytes; D018800:Thy-1 Antigens',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D000950:Antigens, Ly; D000954:Antigens, Surface; D018800:Thy-1 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1038/312548a0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nature',\n",
       "  'nlm_unique_id': '0410462',\n",
       "  'issn_linking': '0028-0836',\n",
       "  'country': 'England'},\n",
       " {'title': '[Cooperation between dentist and psychotherapist in the treatment of a patient with an extreme retching response].',\n",
       "  'issue': '91(9)',\n",
       "  'pages': '323-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nederlands tijdschrift voor tandheelkunde',\n",
       "  'authors': 'Bleijenberg|G|G|;Visser|R S|RS|;Deckers|M F|MF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150446',\n",
       "  'mesh_terms': 'D000328:Adult; D001521:Behavior Therapy; D003729:Dental Care; D003815:Dentists; D003887:Desensitization, Psychologic; D006801:Humans; D007400:Interprofessional Relations; D008297:Male; D011613:Psychotherapy; D014839:Vomiting',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ned Tijdschr Tandheelkd',\n",
       "  'nlm_unique_id': '0400771',\n",
       "  'issn_linking': '0028-2200',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Dynorphin(1-13) improves survival in cats with focal cerebral ischaemia.',\n",
       "  'issue': '312(5994)',\n",
       "  'pages': '551-2',\n",
       "  'abstract': 'Since the discovery of opiate receptors in the central nervous system (CNS), it has become apparent that endogenous opiate ligands are involved in CNS function. Most attention has focused on their role in modulating pain, but they have also been implicated in various physiological functions and in disease states. We are concerned with evidence that endogenous opioid peptides may also contribute to the neurological deficits arising from cerebral ischaemia. Dynorphin, which is widely distributed in the brain and pituitary, has been reported to produce unusual motor and behavioural effects and may act as a regulatory neuropeptide, not as a classical opiate agonist or antagonist. We have therefore administered to cats in which the right middle cerebral artery had been occluded both dynorphin (1-13) and analogue and control materials. We find that dynorphin (1-13) prolongs survival.',\n",
       "  'journal': 'Nature',\n",
       "  'authors': 'Baskin|D S|DS|;Hosobuchi|Y|Y|;Loh|H H|HH|;Lee|N M|NM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150441',\n",
       "  'mesh_terms': 'D000818:Animals; D002545:Brain Ischemia; D002415:Cats; D004399:Dynorphins; D004743:Enkephalin, Leucine; D006439:Hemodynamics; D008297:Male; D010446:Peptide Fragments',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D010446:Peptide Fragments; D004743:Enkephalin, Leucine; C026843:dynorphin (1-13); D004399:Dynorphins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1038/312551a0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nature',\n",
       "  'nlm_unique_id': '0410462',\n",
       "  'issn_linking': '0028-0836',\n",
       "  'country': 'England'},\n",
       " {'title': '[Modern sleep research].',\n",
       "  'issue': '55(9)',\n",
       "  'pages': '461-70',\n",
       "  'abstract': '',\n",
       "  'journal': 'Der Nervenarzt',\n",
       "  'authors': 'Steinberg|R|R|;Hippius|H|H|;Nedopil|N|N|;Rüther|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150447',\n",
       "  'mesh_terms': 'D002540:Cerebral Cortex; D002908:Chronic Disease; D002940:Circadian Rhythm; D006970:Disorders of Excessive Somnolence; D004569:Electroencephalography; D004576:Electromyography; D004585:Electrooculography; D005071:Evoked Potentials; D006801:Humans; D009290:Narcolepsy; D018377:Neurotransmitter Agents; D012891:Sleep Apnea Syndromes; D007319:Sleep Initiation and Maintenance Disorders; D012894:Sleep Stages; D012893:Sleep Wake Disorders; D014851:Wakefulness',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nervenarzt',\n",
       "  'nlm_unique_id': '0400773',\n",
       "  'issn_linking': '0028-2804',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells.',\n",
       "  'issue': '312(5995)',\n",
       "  'pages': '661-3',\n",
       "  'abstract': 'Neuroendocrine cells release a portion of their stored secretory hormone content when exposed to tissue-specific secretagogues. In the case of the adrenal medulla, catecholamines and enkephalin peptides, as well as other secretory proteins, are secreted in response to acetylcholine, which is released onto cholinergic receptors on chromaffin cells upon splanchnic nerve stimulation in vivo. Secretagogue stimulation thus depletes intracellular stores of exportable hormone. We were interested to know whether the signal for exportable hormone release might also function as a signal for compensatory hormone repletion by enhancing the biosynthesis of the released hormone(s). Accordingly, we have investigated the effect of nicotinic receptor stimulation on Met-enkephalin peptide biosynthesis and expression of proenkephalin messenger RNA in primary cultures of bovine chromaffin cells. Our results, reported here, suggest a model for stimulus-secretion-synthesis coupling in which nicotinic receptor occupancy activates two pathways. One pathway, dependent on calcium and not mimicked by increased intracellular cyclic AMP, leads to exocytotic hormone release; the other, probably via a calcium-dependent increase in intracellular cyclic AMP, leads to a compensatory increase in intracellular enkephalin through activation of transcription of the proenkephalin structural gene.',\n",
       "  'journal': 'Nature',\n",
       "  'authors': 'Eiden|L E|LE|;Giraud|P|P|;Dave|J R|JR|;Hotchkiss|A J|AJ|;Affolter|H U|HU|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150442',\n",
       "  'mesh_terms': 'D000313:Adrenal Medulla; D000818:Animals; D002417:Cattle; D002478:Cells, Cultured; D002837:Chromaffin Granules; D000242:Cyclic AMP; D004744:Enkephalin, Methionine; D004745:Enkephalins; D018738:Hexamethonium; D006584:Hexamethonium Compounds; D007700:Kinetics; D009538:Nicotine; D012333:RNA, Messenger; D011978:Receptors, Nicotinic',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004745:Enkephalins; D006584:Hexamethonium Compounds; D012333:RNA, Messenger; D011978:Receptors, Nicotinic; D018738:Hexamethonium; D004744:Enkephalin, Methionine; D009538:Nicotine; D000242:Cyclic AMP',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1038/312661a0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nature',\n",
       "  'nlm_unique_id': '0410462',\n",
       "  'issn_linking': '0028-0836',\n",
       "  'country': 'England'},\n",
       " {'title': '[Computer tomographic studies of patients with neuroleptic-induced disorders of extrapyramidal motor activity].',\n",
       "  'issue': '55(9)',\n",
       "  'pages': '483-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Der Nervenarzt',\n",
       "  'authors': 'Stuckstedte|H|H|;Bartels|M|M|;Naumann|D|D|;Schied|H W|HW|;Schroth|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150448',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents; D001284:Atrophy; D001921:Brain; D001925:Brain Damage, Chronic; D002421:Caudate Nucleus; D004409:Dyskinesia, Drug-Induced; D005116:Extrapyramidal Tracts; D005260:Female; D006801:Humans; D008134:Long-Term Care; D008297:Male; D008875:Middle Aged; D014057:Tomography, X-Ray Computed',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nervenarzt',\n",
       "  'nlm_unique_id': '0400773',\n",
       "  'issn_linking': '0028-2804',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Studies of gamma-glutamyltransferase activity in the brain tissue post mortem.',\n",
       "  'issue': '9(7)',\n",
       "  'pages': '917-25',\n",
       "  'abstract': 'Our experiments showed that the activity of gamma-glutamyltransferase (gamma-GT) did not remarkably change in homogenates of mouse, rat, and bovine brains during the first four days post mortem. In the course of that period, the brain microvessels also retained their gamma-GT activity. gamma-GT of microvessels from bovine brain cortex, solubilized with sodium deoxycholate, was eluted in the void volume Vo when chromatographed on a Sephadex G-200 column with the detergent Triton X-100. In human post mortem brains, the specific activity of gamma-GT in choroid plexi was found to be about five times higher than that in the cerebral cortex, white matter, basal ganglia, pons, and cerebellum but about four times lower than that in the microvessels obtained from the studied brain regions. Our findings suggest that it is possible to study the components of the blood-brain barrier on material from deceased subjects.',\n",
       "  'journal': 'Neurochemical research',\n",
       "  'authors': 'Veselý|J|J|;Cernoch|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150449',\n",
       "  'mesh_terms': 'D000818:Animals; D001812:Blood-Brain Barrier; D001921:Brain; D002417:Cattle; D003840:Deoxycholic Acid; D008297:Male; D051379:Mice; D008833:Microcirculation; D011180:Postmortem Changes; D051381:Rats; D011919:Rats, Inbred Strains; D013045:Species Specificity; D013997:Time Factors; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D003840:Deoxycholic Acid; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00964523',\n",
       "  'references': '229368;5274454;6068;12182;279933;6115328;4145786;4152876;42531;13061480;4968036;4469673;4150025;6108352;4774116;44543;6102743;14907713',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neurochem Res',\n",
       "  'nlm_unique_id': '7613461',\n",
       "  'issn_linking': '0364-3190',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Solubilization and some properties of gamma-glutamyltransferase from human brain microvessels.',\n",
       "  'issue': '9(7)',\n",
       "  'pages': '927-34',\n",
       "  'abstract': 'Detergents Triton X-100, sodium deoxycholate, and octyl-beta-D-glucopyranoside, and proteinase papain proved to be excellent agents solubilizing the gamma-glutamyltransferase (gamma-GT) from human brain cortex microvessels. Ficin also solubilized gamma-GT but to a lesser extent than papain. The relative molecular mass of the detergent-solubilized enzyme form was greater than 200,000 (in the presence of Triton X-100). The relative molecular mass of the proteinase-solubilized form was slightly greater than that of albumine. gamma-GTs of microvessels from five human brain regions and from the choroid plexus were tested for their specificity toward acceptors. The best acceptors were found to be (in decreasing order of activity) L-cystine, glycylglycine, L-glutamine, L-methionine, and L-alanine. The findings suggest that the main features of gamma-GT of the human blood-brain barrier are very similar to those of gamma-GTs from other human tissues.',\n",
       "  'journal': 'Neurochemical research',\n",
       "  'authors': 'Veselý|J|J|;Cernoch|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150450',\n",
       "  'mesh_terms': 'D001812:Blood-Brain Barrier; D002540:Cerebral Cortex; D003902:Detergents; D006801:Humans; D007527:Isoenzymes; D008566:Membranes; D008833:Microcirculation; D010447:Peptide Hydrolases; D012995:Solubility; D013379:Substrate Specificity; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D003902:Detergents; D007527:Isoenzymes; D005723:gamma-Glutamyltransferase; D010447:Peptide Hydrolases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00964524',\n",
       "  'references': '6068;12182;237905;27580;23264;6150449;4145786;14211324;4152876;42531;6105151;9027;14253434;4968036;4469673;4150025;25678;28224;44543;6102743;4992041;14907713;6133290;6113879;1275;1470',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neurochem Res',\n",
       "  'nlm_unique_id': '7613461',\n",
       "  'issn_linking': '0364-3190',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Amino acid changes in regions of the CNS in relation to function in experimental portal-systemic encephalopathy.',\n",
       "  'issue': '9(9)',\n",
       "  'pages': '1309-21',\n",
       "  'abstract': 'Sustained hyperammonemia resulting from portocaval anastomosis (PCA) in the rat, is accompanied by neurological symptoms and reversible morphological changes in brain, the nature and distribution of which suggest selective vulnerability of certain brain structures. The present study was initiated to investigate the effects of increasing CNS ammonia on the distribution of amino acids in regions of the rat brain in relation to the degree of neurological impairment in PCA rats. Four weeks following PCA, rats were administered ammonium acetate (5.2 mmol/kg, i.p.) to precipitate neurological symptoms of encephalopathy which included diminished locomotor activity, loss of hindlimb extension and righting reflexes and ultimately coma. At various stages during the development of encephalopathy, rats were sacrificed and the amino acids glutamine, glutamate and aspartate measured simultaneously, using a sensitive double-isotope dansyl microassay. Homogenates of the following regions of the CNS were assayed: cerebral cortex, hippocampus, striatum, midbrain, hypothalamus, cerebellum, medulla-pons, spinal cord (gray matter) and spinal cord (white matter). Sustained hyperammonemia associated with PCA alone resulted in a non-uniform 2-4 fold increase of glutamine in all regions of the CNS. Glutamate, on the other hand, was selectively increased in striatum and cerebellum, two regions of brain shown to exhibit early morphologically-characterised astrocytic abnormalities in rats with PCA. Onset of severe neurological dysfunction was accompanied by significantly decreased glutamine and glutamate in striatum and cerebellum. Thus, sustained hyperammonemia in association with portocaval shunting results in region-selective effects with respect to glutamine-glutamate metabolism in the CNS.',\n",
       "  'journal': 'Neurochemical research',\n",
       "  'authors': 'Giguère|J F|JF|;Butterworth|R F|RF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150451',\n",
       "  'mesh_terms': 'D000085:Acetates; D000596:Amino Acids; D000818:Animals; D001224:Aspartic Acid; D002490:Central Nervous System; D005971:Glutamates; D018698:Glutamic Acid; D005973:Glutamine; D006501:Hepatic Encephalopathy; D008297:Male; D011170:Portasystemic Shunt, Surgical; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000085:Acetates; D000596:Amino Acids; D005971:Glutamates; D005973:Glutamine; D001224:Aspartic Acid; D018698:Glutamic Acid; C018824:ammonium acetate',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00973042',\n",
       "  'references': '6817155;538643;6126834;14463560;6619844;890024;4601705;4364342;7463080;7381478;39099;487313;6154020;469965;559221;6121012;4690637;6131108;5950056;838855;5061800;290746',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neurochem Res',\n",
       "  'nlm_unique_id': '7613461',\n",
       "  'issn_linking': '0364-3190',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Bromazepam. Clinical trial in child-adolescent psychiatry].',\n",
       "  'issue': '32(9)',\n",
       "  'pages': '465-70',\n",
       "  'abstract': '',\n",
       "  'journal': \"Neuropsychiatrie de l'enfance et de l'adolescence\",\n",
       "  'authors': 'Jarrige|A|A|;Moron|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150452',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000296:Adolescent Psychiatry; D014151:Anti-Anxiety Agents; D001008:Anxiety Disorders; D001960:Bromazepam; D002648:Child; D002665:Child Psychiatry; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001960:Bromazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neuropsychiatr Enfance Adolesc',\n",
       "  'nlm_unique_id': '7905300',\n",
       "  'issn_linking': '0222-9617',\n",
       "  'country': 'France'},\n",
       " {'title': '[A case of multiple endocrine adenomatosis with atypical mesenteric localization of 2 gastrinomas].',\n",
       "  'issue': '39(17)',\n",
       "  'pages': '1165-70',\n",
       "  'abstract': '',\n",
       "  'journal': 'Minerva chirurgica',\n",
       "  'authors': 'Fontana|D|D|;Aloesio|R|R|;Della Beffa|V|V|;Rollino|R|R|;Bertero|D|D|;Bronda|M|M|;Oliaro|A|A|;Gaetini|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150453',\n",
       "  'mesh_terms': 'D000328:Adult; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008643:Mesentery; D009377:Multiple Endocrine Neoplasia; D010282:Parathyroid Neoplasms; D010534:Peritoneal Neoplasms; D015043:Zollinger-Ellison Syndrome',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Minerva Chir',\n",
       "  'nlm_unique_id': '0400726',\n",
       "  'issn_linking': '0026-4733',\n",
       "  'country': 'Italy'},\n",
       " {'title': 'Central neurotransmitter effects of organotin compounds: trials, tribulations and observations.',\n",
       "  'issue': '5(2)',\n",
       "  'pages': '267-77',\n",
       "  'abstract': 'Administration of trimethyltin (TMT) or triethyltin (TET) compounds to rats during postnatal development has known behavioral and neuropathological consequences. By measuring the concentrations of dopamine, norepinephrine, homovanillic acid, dihydroxyphenylacetic acid, gamma-aminobutyric acid, acetylcholine, and choline in different brain areas of TMT and TET-treated animals, an attempt was made to correlate these functional deficits with changes in CNS neurotransmitter alterations in vivo. TET had no effect on any of the substances measured whereas TMT significantly decreased gamma-aminobutyric acid and dopamine levels, but only in hippocampus and striatum, respectively. All other neurotransmitter substances measured were not affected. These findings illustrate the complexity inherent in attempting to use neurochemical techniques alone as an index of toxicity in the absence of specific defined hypotheses.',\n",
       "  'journal': 'Neurotoxicology',\n",
       "  'authors': 'Hanin|I|I|;Krigman|M R|MR|;Mailman|R B|RB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150454',\n",
       "  'mesh_terms': 'D015102:3,4-Dihydroxyphenylacetic Acid; D000109:Acetylcholine; D000818:Animals; D001923:Brain Chemistry; D002794:Choline; D004298:Dopamine; D006719:Homovanillic Acid; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D009947:Organotin Compounds; D051381:Rats; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D009947:Organotin Compounds; D015102:3,4-Dihydroxyphenylacetic Acid; D005680:gamma-Aminobutyric Acid; D002794:Choline; D000109:Acetylcholine; D004298:Dopamine; D009638:Norepinephrine; D006719:Homovanillic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Neurotoxicology',\n",
       "  'nlm_unique_id': '7905589',\n",
       "  'issn_linking': '0161-813X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': \"Continuous narcotic infusion: it's not just for cancer patients.\",\n",
       "  'issue': '14(12)',\n",
       "  'pages': '50-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nursing',\n",
       "  'authors': 'McGuire|L|L|;Wright|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150455',\n",
       "  'mesh_terms': 'D000328:Adult; D000701:Analgesics, Opioid; D004509:Education, Nursing, Continuing; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D009020:Morphine; D010146:Pain',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D000701:Analgesics, Opioid; D009020:Morphine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/00152193-198412000-00024',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nursing',\n",
       "  'nlm_unique_id': '7600137',\n",
       "  'issn_linking': '0360-4039',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Cardiovascular consequences of beta-agonist tocolysis: an echocardiographic study.',\n",
       "  'issue': '64(6)',\n",
       "  'pages': '787-91',\n",
       "  'abstract': 'M-mode echocardiography was performed before and during intravenous beta-adrenergic agonist tocolysis in 13 patients with preterm labor. There was a significant increase in heart rate, fractional shortening, and calculated cardiac output. There was also a significant decrease in both end-systolic and end-diastolic left ventricular dimensions, which resolved in 24 to 36 hours. There were, however, no changes in left atrial dimensions. The data derived from this study suggest that the pulmonary edema occasionally complicating beta-adrenergic agonist tocolysis is not the result of systolic cardiac dysfunction.',\n",
       "  'journal': 'Obstetrics and gynecology',\n",
       "  'authors': 'Finley|J|J|;Katz|M|M|;Rojas-Perez|M|M|;Roberts|J M|JM|;Creasy|R K|RK|;Schiller|N B|NB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150456',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000328:Adult; D001794:Blood Pressure; D002302:Cardiac Output; D004452:Echocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D007752:Obstetric Labor, Premature; D011247:Pregnancy; D011654:Pulmonary Edema; D012312:Ritodrine; D013726:Terbutaline; D014882:Water-Electrolyte Balance',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D012312:Ritodrine; D013726:Terbutaline',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Obstet Gynecol',\n",
       "  'nlm_unique_id': '0401101',\n",
       "  'issn_linking': '0029-7844',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Medical management of coronary heart disease: cardiovascular drug therapy.',\n",
       "  'issue': '32(11)',\n",
       "  'pages': '570-6, 608-10',\n",
       "  'abstract': '',\n",
       "  'journal': 'Occupational health nursing',\n",
       "  'authors': 'Taplin|N E|NE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150457',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000787:Angina Pectoris; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D003327:Coronary Disease; D006801:Humans; D009566:Nitrates',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D009566:Nitrates',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/216507998403201101',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Occup Health Nurs',\n",
       "  'nlm_unique_id': '0200443',\n",
       "  'issn_linking': '0029-7933',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Prosthetic care of for accident victims. An economically priced and esthetically acceptable solution].',\n",
       "  'issue': '29(3)',\n",
       "  'pages': '10-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Osterreichische Zahnprothetik',\n",
       "  'authors': 'Pilla|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150458',\n",
       "  'mesh_terms': 'D003779:Denture Design; D003830:Denture, Partial, Fixed; D006801:Humans; D018677:Tooth Injuries',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Osterr Zahnprothet',\n",
       "  'nlm_unique_id': '7901350',\n",
       "  'issn_linking': '0250-4839',\n",
       "  'country': 'Austria'},\n",
       " {'title': 'Surgical pathology of the pituitary: the adenomas. Part II.',\n",
       "  'issue': '19 Pt 2()',\n",
       "  'pages': '269-329',\n",
       "  'abstract': '',\n",
       "  'journal': 'Pathology annual',\n",
       "  'authors': 'Scheithauer|B W|BW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150459',\n",
       "  'mesh_terms': 'D000236:Adenoma; D000293:Adolescent; D000302:Adrenal Cortex; D000324:Adrenocorticotropic Hormone; D000328:Adult; D000368:Aged; D000682:Amyloid; D001932:Brain Neoplasms; D002277:Carcinoma; D002648:Child; D003480:Cushing Syndrome; D003937:Diagnosis, Differential; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone; D006470:Hemorrhage; D006801:Humans; D006965:Hyperplasia; D007986:Luteinizing Hormone; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia; D009347:Nelson Syndrome; D010902:Pituitary Gland; D010911:Pituitary Neoplasms; D011388:Prolactin; D013120:Spinal Cord Neoplasms; D013972:Thyrotropin',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000682:Amyloid; D000324:Adrenocorticotropic Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013972:Thyrotropin; D013006:Growth Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pathol Annu',\n",
       "  'nlm_unique_id': '0050610',\n",
       "  'issn_linking': '0079-0184',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Biopterin synthesis defects: problems in diagnosis.',\n",
       "  'issue': '74(6)',\n",
       "  'pages': '1004-11',\n",
       "  'abstract': \"Hyperphenylalaninemia due to a biopterin synthesis defect was detected in an infant with decreased biopterin and increased neopterin levels in plasma and urine. Tetrahydrobiopterin (BH4) administration normalized plasma phenylalanine levels. CSF biopterin and neurotransmitter metabolite levels were normal and with the infant's normal growth and development suggest that the defect in biopterin synthesis did not affect CNS biopterin metabolism. Comparison of plasma and urine pterin levels from this patient with levels reported in patients who have neurologic complications fails to reveal differences that would distinguish patients at risk for neurologic problems. CSF pterin and neurotransmitter levels may correlate with neurologic function in these patients. CSF pterin and neurotransmitter determinations should be performed prior to initiation of neurotransmitter precursor and BH4 replacement therapies in patients who were determined to have biopterin synthesis defect(s).\",\n",
       "  'journal': 'Pediatrics',\n",
       "  'authors': 'Hoganson|G|G|;Berlow|S|S|;Kaufman|S|S|;Milstien|S|S|;Schuett|V|V|;Matalon|R|R|;Naylor|E|E|;Seifert|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150460',\n",
       "  'mesh_terms': 'D001708:Biopterin; D004032:Diet; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008661:Metabolism, Inborn Errors; D019798:Neopterin; D018377:Neurotransmitter Agents; D010649:Phenylalanine; D011621:Pteridines',\n",
       "  'publication_types': \"D002363:Case Reports; D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D011621:Pteridines; D001708:Biopterin; D010649:Phenylalanine; D019798:Neopterin; C003402:sapropterin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pediatrics',\n",
       "  'nlm_unique_id': '0376422',\n",
       "  'issn_linking': '0031-4005',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Voltage-dependent effect of a scorpion toxin on sodium current inactivation.',\n",
       "  'issue': '402(1)',\n",
       "  'pages': '24-33',\n",
       "  'abstract': 'In voltage clamped nodes of Ranvier inactivation of the sodium permeability is slowed by toxin V from the scorpion Centruroides sculpturatus, by sea anemone toxin ATX II or by internally applied KIO3. The slow decay of the Na inward current is markedly accelerated if the test pulse is preceded by a depolarizing conditioning pulse followed by a 10-500 ms pause. This phenomenon was studied in detail, using conditioning pulses of varying amplitude and up to 15 s duration. In nodes treated with toxin V a 20 ms conditioning pulse to positive potentials was sufficient to produce a clear acceleration of the decay of the Na current and a reduction of the inward current remaining at the end of a 50 ms test pulse, i.e. a weakening of the toxin effect. In nodes treated with ATX II or internal KIO3 longer conditioning pulses were required. A similar effect of conditioning pulses on the decaying phase of the Na current was also observed in untreated fibres. To study the phenomenon quantitatively we fitted the decaying phase of the inward Na current with the equation INa = A exp(-t/tau 1) + B exp(-t/tau 2) + C. The effect of depolarizing conditioning pulses could be described as an increase of A, a decrease of B and C and a reduction of the time constants tau 1 and tau 2. I50/Ipeak, the normalised inward current remaining at the end of a 50 ms test pulse, decreased exponentially with increasing duration of the conditioning pulse to a steady-state value. The time constant tau and the steady-state value depended on the potential during the conditioning pulse. For nodes treated with toxin V, tau was 0.24 s at 0 mV and 12 degrees C and half inhibition occurred at -42 mV. The time constant tau was larger for nodes treated with ATX II or internal KIO3. At positive potentials, I50 was reduced to 20% of the control value in toxin V-treated nodes, but only to 70% in KIO3-treated nodes. Recovery from the effect of the conditioning pulse was studied by varying the pause between conditioning pulse and test pulse; recovery was 66-100% complete after 500 ms. The results are interpreted by assuming that a depolarizing conditioning pulse (a) accelerates inactivation of the sodium permeability and (b) causes dissociation of the toxin-receptor complex or transition into an inactive state. The latter effect occurs in toxin V-treated fibres but not in those treated with ATX II or KIO3.',\n",
       "  'journal': 'Pflugers Archiv : European journal of physiology',\n",
       "  'authors': 'Meves|H|H|;Rubly|N|N|;Watt|D D|DD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150461',\n",
       "  'mesh_terms': \"D000818:Animals; D002316:Cardiotonic Agents; D002463:Cell Membrane Permeability; D003064:Cnidarian Venoms; D007452:Iodates; D007473:Ion Channels; D008564:Membrane Potentials; D009498:Neurotoxins; D011188:Potassium; D017680:Potassium Compounds; D011893:Rana esculenta; D011901:Ranvier's Nodes; D012604:Scorpion Venoms; D012615:Sea Anemones; D012964:Sodium; D013779:Tetrodotoxin\",\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002316:Cardiotonic Agents; D003064:Cnidarian Venoms; D007452:Iodates; D007473:Ion Channels; D009498:Neurotoxins; D017680:Potassium Compounds; D012604:Scorpion Venoms; C033843:toxin V; D013779:Tetrodotoxin; C028800:toxin II (Anemonia sulcata); D012964:Sodium; C039693:potassium iodate; D011188:Potassium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00584827',\n",
       "  'references': '6125592;6103536;6306554;4545558;1086682;6118851;6283468;479827;6246941;6132957;6324910;6120781;5815327;439022;6105881;72754;5501056;14079681;304888;300786;1013286;731202;6604901;6247484',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pflugers Arch',\n",
       "  'nlm_unique_id': '0154720',\n",
       "  'issn_linking': '0031-6768',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Relationship between adrenal steroids and renal Na-K-ATPase. Effect of short-term hormone administration on the rat cortical collecting tubule.',\n",
       "  'issue': '402(1)',\n",
       "  'pages': '48-51',\n",
       "  'abstract': 'Mineralo- and glucocorticoids stimulate renal Na-K-ATPase activity if given over a few days, but their immediate effect on the enzyme (i.e. within the time period required to alter electrolyte transport) remains controversial. We evaluated the short-term (3 h) in vivo effect of physiologic and pharmacologic doses of the natural glucocorticoid (corticosterone) and mineralocorticoid (aldosterone), and of a semisynthetic glucocorticoid (dexamethasone) on Na-K-ATPase activity in cortical collecting tubules microdissected from adrenalectomized rats. This nephron segment was chosen because it is a major target site for both classes of corticoids. Neither corticosterone (0.006, 0.6, and 5 mg/100 g body wt, IM), nor dexamethasone (5 mg/100 g body wt, IM) or aldosterone (10 micrograms and 50 micrograms, IV) altered significantly Na-K-ATPase activity in the cortical collecting tubule of these animals 3 h after administration. These results confirm our previous observations in the mouse, and suggest that the enhancing effect of corticosteroids on the renal enzyme seen after longer intervals represents a secondary phenomenon, possibly related to augmentation of the sodium load presented to the pump.',\n",
       "  'journal': 'Pflugers Archiv : European journal of physiology',\n",
       "  'authors': 'Mujais|S K|SK|;Chekal|M A|MA|;Lee|S M|SM|;Katz|A I|AI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150462',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D000315:Adrenalectomy; D000450:Aldosterone; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D003345:Corticosterone; D003907:Dexamethasone; D007473:Ion Channels; D007684:Kidney Tubules; D007685:Kidney Tubules, Collecting; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium; D000254:Sodium-Potassium-Exchanging ATPase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D007473:Ion Channels; D000450:Aldosterone; D003907:Dexamethasone; D012964:Sodium; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D000254:Sodium-Potassium-Exchanging ATPase; D003345:Corticosterone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00584831',\n",
       "  'references': '4244236;6286651;6269438;6846539;6139788;6317714;6288247;4260019;6139787;223456;6274911;4277648;223455;4224513;6267947;6251422;6275714;6264796;6460449;4224455;4279600;123253;4264631',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pflugers Arch',\n",
       "  'nlm_unique_id': '0154720',\n",
       "  'issn_linking': '0031-6768',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Isolation and sequence analysis of cDNAs for the major potato tuber protein, patatin.',\n",
       "  'issue': '12(21)',\n",
       "  'pages': '7987-8000',\n",
       "  'abstract': 'A cDNA library from membrane-bound poly(A)+ mRNA of developing potato tubers was constructed and two classes of essentially full-length cDNA clones for a precursor to the major tuber glycoprotein, patatin were isolated. Sequence analysis shows that the two classes are approximately 99% homologous and correspond to the two major species of patatin identified previously by NH2-terminal amino acid sequence analysis. Sequence analysis also predicts that patatin is synthesized with a 23 amino acid signal sequence. Northern blot analysis shows that patatin mRNAs are 1550 +/- 50 nucleotides in length and are normally not present in polyribosomal or total RNA from stems or leaves.',\n",
       "  'journal': 'Nucleic acids research',\n",
       "  'authors': 'Mignery|G A|GA|;Pikaard|C S|CS|;Hannapel|D J|DJ|;Park|W D|WD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150463',\n",
       "  'mesh_terms': 'D000595:Amino Acid Sequence; D000818:Animals; D001483:Base Sequence; D002265:Carboxylic Ester Hydrolases; D004247:DNA; D004262:DNA Restriction Enzymes; D005796:Genes; D009693:Nucleic Acid Hybridization; D010940:Plant Proteins; D010944:Plants; D010957:Plasmids; D011061:Poly A; D011132:Polyribosomes; D014176:Protein Biosynthesis; D012333:RNA, Messenger; D011817:Rabbits; D012156:Reticulocytes',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': 'D010940:Plant Proteins; D012333:RNA, Messenger; C043222:patatin protein, Solanum tuberosum; D011061:Poly A; D004247:DNA; D002265:Carboxylic Ester Hydrolases; D004262:DNA Restriction Enzymes',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/nar/12.21.7987',\n",
       "  'references': '6159641;16662778;6269464;6310323;6295879;16661153;271968;16662777;1105573;782287;6997135',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nucleic Acids Res',\n",
       "  'nlm_unique_id': '0411011',\n",
       "  'issn_linking': '0305-1048',\n",
       "  'country': 'England'},\n",
       " {'title': 'All at sea.',\n",
       "  'issue': '80(40)',\n",
       "  'pages': '40-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nursing times',\n",
       "  'authors': 'Holmes|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150464',\n",
       "  'mesh_terms': 'D006801:Humans; D010823:Physician Assistants; D013366:Submarine Medicine; D006113:United Kingdom',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '85062875',\n",
       "  'medline_ta': 'Nurs Times',\n",
       "  'nlm_unique_id': '0423236',\n",
       "  'issn_linking': '0954-7762',\n",
       "  'country': 'England'},\n",
       " {'title': '[Treatment of arrhythmia in pregnancy].',\n",
       "  'issue': '39(35)',\n",
       "  'pages': '1175-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Polski tygodnik lekarski (Warsaw, Poland : 1960)',\n",
       "  'authors': 'Halawa|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150470',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac; D004071:Digitalis Glycosides; D004341:Drug Evaluation; D004554:Electric Countershock; D005260:Female; D006801:Humans; D007799:Lanatosides; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D004071:Digitalis Glycosides; D007799:Lanatosides; C018548:lanatoside C',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pol Tyg Lek',\n",
       "  'nlm_unique_id': '9705468',\n",
       "  'issn_linking': '0032-3756',\n",
       "  'country': 'Poland'},\n",
       " {'title': 'Vecuronium: a new nondepolarizing neuromuscular-blocking agent. Clinical pharmacology, pharmacokinetics, cardiovascular effects and use in special clinical situations.',\n",
       "  'issue': '4(5)',\n",
       "  'pages': '238-47',\n",
       "  'abstract': 'Vecuronium provides additional flexibility to the clinician using neuromuscular-blocking drugs. Its shorter duration of action, lack of significant cardiovascular effects and lack of dependence on the kidney for elimination provide clinical advantages over, or alternatives to, currently available, nondepolarizing neuromuscular-blocking drugs.',\n",
       "  'journal': 'Pharmacotherapy',\n",
       "  'authors': 'Miller|R D|RD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150465',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000758:Anesthesia; D000773:Anesthesia, Obstetrical; D006348:Cardiac Surgical Procedures; D002315:Cardiopulmonary Bypass; D002319:Cardiovascular System; D055598:Chemical Phenomena; D002621:Chemistry; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007700:Kinetics; D008875:Middle Aged; D003473:Neuromuscular Nondepolarizing Agents; D010197:Pancuronium; D011247:Pregnancy; D013390:Succinylcholine; D013997:Time Factors; D014673:Vecuronium Bromide',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D003473:Neuromuscular Nondepolarizing Agents; D014673:Vecuronium Bromide; D013390:Succinylcholine; D010197:Pancuronium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/j.1875-9114.1984.tb03368.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacotherapy',\n",
       "  'nlm_unique_id': '8111305',\n",
       "  'issn_linking': '0277-0008',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Toxicity, immunosuppressive effects and carcinogenic potential of volatile nitrites: possible relationship to Kaposi's sarcoma.\",\n",
       "  'issue': '4(5)',\n",
       "  'pages': '284-91',\n",
       "  'abstract': \"Volatile nitrite in the form of amyl nitrite was used for 100 years for the treatment of angina pectoris. In spite of recognized toxicity, its use in this form was considered safe. During the 1960s prescriptions were not required for purchase of amyl nitrite (called poppers) and its use for recreational purposes became popular. With reinstatement of the prescription requirement in 1969, non-medicinal, street-variety volatile nitrites were made commercially available in the form of mixtures of impure butyl and isobutyl nitrite; some of these preparations also included amyl nitrite. These products have been found to be profoundly immunosuppressive for human lymphocytes in vitro, and their by-products when metabolized into N-nitroso compounds have been known to be highly carcinogenic in many animal species. Recreational use of inhaled volatile nitrites is prevalent among male homosexuals and the compounds have been suspected as possible cofactors in Kaposi's sarcoma associated with the Acquired Immune Deficiency Syndrome (AIDS). This association could be explained by nitrite-induced vasodilation of rectal mucosal vessels providing a port of entry for a transmissible agent, by direct immunosuppression of the host allowing expression of a potentially oncogenic virus by co-carcinogenic effects of by-products by themselves or in conjunction with other putative cofactors such as cytomegalovirus. Nitrites should continue to be considered as a possible cofactor in the etiology of Kaposi's Sarcoma among male homosexuals and possibly those with other manifestations of AIDS.\",\n",
       "  'journal': 'Pharmacotherapy',\n",
       "  'authors': 'Newell|G R|GR|;Adams|S C|SC|;Mansell|P W|PW|;Hersh|E M|EM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150466',\n",
       "  'mesh_terms': 'D000680:Amyl Nitrite; D000818:Animals; D006716:Homosexuality; D006801:Humans; D007166:Immunosuppressive Agents; D008297:Male; D009369:Neoplasms; D009573:Nitrites; D005996:Nitroglycerin; D009603:Nitroso Compounds; D012514:Sarcoma, Kaposi; D019966:Substance-Related Disorders; D014835:Volatilization',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007166:Immunosuppressive Agents; D009573:Nitrites; D009603:Nitroso Compounds; C024225:n-butyl nitrite; D000680:Amyl Nitrite; D005996:Nitroglycerin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/j.1875-9114.1984.tb03376.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacotherapy',\n",
       "  'nlm_unique_id': '8111305',\n",
       "  'issn_linking': '0277-0008',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Clinical consequences of acetylation polymorphism].',\n",
       "  'issue': '39(37)',\n",
       "  'pages': '1249-52',\n",
       "  'abstract': '',\n",
       "  'journal': 'Polski tygodnik lekarski (Warsaw, Poland : 1960)',\n",
       "  'authors': 'Jendryczko|A|A|;Gmiński|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150471',\n",
       "  'mesh_terms': 'D000105:Acetyl Coenzyme A; D000101:Acetyl-CoA C-Acetyltransferase; D000107:Acetylation; D006801:Humans; D008099:Liver; D004364:Pharmaceutical Preparations; D010641:Phenotype; D011110:Polymorphism, Genetic; D044469:Racial Groups',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D004364:Pharmaceutical Preparations; D000105:Acetyl Coenzyme A; D000101:Acetyl-CoA C-Acetyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pol Tyg Lek',\n",
       "  'nlm_unique_id': '9705468',\n",
       "  'issn_linking': '0032-3756',\n",
       "  'country': 'Poland'},\n",
       " {'title': 'Drugs for hypertension. Seven classes to choose from.',\n",
       "  'issue': '76(7)',\n",
       "  'pages': '84-90',\n",
       "  'abstract': 'A wide variety of drugs are available for treatment of hypertension. Diuretics, long the sole therapy, can control blood pressure in more than 40% of patients. If a diuretic alone proves inadequate, a beta-adrenergic blocking agent, vasodilator, and central-acting sympathetic inhibitor may be added, as needed, in the familiar four-step program. A calcium channel blocker, with its vasodilating effects, or an angiotensin-converting enzyme inhibitor may be considered in appropriate situations. Selection among these agents should be based on knowledge of their pharmacologic action, duration of action, and side effects. With careful selection, blood pressure can be better controlled, side effects minimized, and patient compliance improved.',\n",
       "  'journal': 'Postgraduate medicine',\n",
       "  'authors': 'Orme|B M|BM|;Hegstrom|R H|RH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150472',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D006801:Humans; D006973:Hypertension; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D000959:Antihypertensive Agents; D002121:Calcium Channel Blockers; D004232:Diuretics; D014665:Vasodilator Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1080/00325481.1984.11698800',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Postgrad Med',\n",
       "  'nlm_unique_id': '0401147',\n",
       "  'issn_linking': '0032-5481',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cyclic hexa- and pentapeptide somatostatin analogues with reduced gastric inhibitory activity.',\n",
       "  'issue': '5(5)',\n",
       "  'pages': '857-60',\n",
       "  'abstract': 'The gastric inhibitory activity of cyclic hexa- and pentapeptide analogues of somatostatin was investigated in conscious cats with gastric fistulae. Gastric acid and pepsin secretions were stimulated by pentagastrin. Cyclo(Phe-Phe-D-Trp-Lys-Thr-Phe) showed no inhibition of acid secretion at molar doses up to 50-times the ID50 for somatostatin. This peptide inhibited pepsin secretion at the highest dose (50 micrograms kg-1 hr-1), and its potency is approximately 0.005 compared with somatostatin (1.0). Cyclo(Pro-Phe-D-Trp-Lys-Thr-Phe) inhibited acid (approximately 50%) and pepsin (approximately 85%) secretions, but the inhibition was not dose-related being similar with doses of 10 to 50 micrograms kg-1 hr-1. The cyclic pentapeptide, cyclo(7-aminoheptanoyl-Phe-D-Trp-Lys-Thr), was inactive in the dose range studied, with a potency less than 0.01. Cyclo[7-aminoheptanoyl-Phe-D-Trp-Lys-Thr(Bzl)] has been described as a somatostatin antagonist with respect to inhibition of growth hormone, insulin and glucagon release in rats [2]. Up to 60-fold molar excesses of this peptide failed to antagonise the inhibitory activity of somatostatin in the stomach. The results demonstrate that residues outside the central 6-11 region of somatostatin are very important for its gastric activity. The lack of gastric antagonistic activity of the pentapeptide antagonist indicates that these residues are likely to be involved in receptor recognition/binding.',\n",
       "  'journal': 'Peptides',\n",
       "  'authors': 'Hirst|B H|BH|;Arilla|E|E|;Coy|D H|DH|;Shaw|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150467',\n",
       "  'mesh_terms': 'D000818:Animals; D002415:Cats; D004305:Dose-Response Relationship, Drug; D005744:Gastric Acid; D010418:Pentagastrin; D010434:Pepsin A; D010446:Peptide Fragments; D013004:Somatostatin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D010446:Peptide Fragments; C036876:cyclo(7-aminoheptanoyl-phenylalanyl-tryptophyl-lysyl-threonyl); C040704:cyclo(Pro-Phe-Trp-Lys-Thr-Phe); D013004:Somatostatin; C043819:somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-; C043820:cyclo(7-aminoheptanoylphenylalanyl-tryptophyl-lysyl-benzylthreonyl); D010434:Pepsin A; D010418:Pentagastrin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0196-9781(84)90106-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Peptides',\n",
       "  'nlm_unique_id': '8008690',\n",
       "  'issn_linking': '0196-9781',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Pro-Leu-Gly-NH2 and pareptide inhibit development of tolerance to haloperidol catalepsy in the mouse.',\n",
       "  'issue': '5(5)',\n",
       "  'pages': '883-7',\n",
       "  'abstract': 'Single doses of MIF-1 (0.03-2.0 mg/kg, SC) and chronic pretreatments with MIF-1 (0.03-2.0 mg/kg, SC, BID, 3 1/2 days) or pareptide (0.25 mg/kg, SC, BID, 3 1/2 days) did not affect the acute cataleptic response to haloperidol in the mouse. Chronic pretreatment with haloperidol (8.0 mg/kg, IP, BID, 3 days) decreased the duration of catalepsy in mice given smaller challenge dose of haloperidol (2.0 or 3.0 mg/kg, IP) 15 hours after the last pretreatment injections. Administration of either MIF-1 or pareptide to mice also chronically pretreated with haloperidol antagonized the development of tolerance.',\n",
       "  'journal': 'Peptides',\n",
       "  'authors': 'Mycroft|F J|FJ|;Wei|E T|ET|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150468',\n",
       "  'mesh_terms': 'D000818:Animals; D002375:Catalepsy; D004361:Drug Tolerance; D006220:Haloperidol; D006801:Humans; D009075:MSH Release-Inhibiting Hormone; D008297:Male; D009074:Melanocyte-Stimulating Hormones; D051379:Mice',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'C024569:pareptide; D009074:Melanocyte-Stimulating Hormones; D009075:MSH Release-Inhibiting Hormone; D006220:Haloperidol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0196-9781(84)90111-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Peptides',\n",
       "  'nlm_unique_id': '8008690',\n",
       "  'issn_linking': '0196-9781',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Economics of antihypertensive therapy.',\n",
       "  'issue': '76(7)',\n",
       "  'pages': '97-105',\n",
       "  'abstract': 'Antihypertensive therapy has come a long way in the past 40 years. With the wide range of drugs now available, cost has become an additional consideration in selection of therapy. However, precise figures for comparison of drugs within and between classes can be difficult and time-consuming to gather. The unit-cost tables in this article are presented with the hope that they will simplify the selection process. Of course, unit cost is not the sole criterion to be considered; potency and frequency of administration also influence the overall cost of therapy.',\n",
       "  'journal': 'Postgraduate medicine',\n",
       "  'authors': 'Orme|B M|BM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150473',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D003365:Costs and Cost Analysis; D004232:Diuretics; D006801:Humans; D006973:Hypertension; D007008:Hypokalemia; D011189:Potassium Chloride; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D014665:Vasodilator Agents; D011189:Potassium Chloride',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1080/00325481.1984.11698802',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Postgrad Med',\n",
       "  'nlm_unique_id': '0401147',\n",
       "  'issn_linking': '0032-5481',\n",
       "  'country': 'England'},\n",
       " {'title': 'Gastrointestinal bleeding.',\n",
       "  'issue': '60(709)',\n",
       "  'pages': '760-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Postgraduate medical journal',\n",
       "  'authors': 'Read|A E|AE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150474',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D002927:Cimetidine; D004381:Duodenal Ulcer; D005260:Female; D006471:Gastrointestinal Hemorrhage; D005773:Gastroscopy; D006801:Humans; D008297:Male; D008875:Middle Aged; D010438:Peptic Ulcer Hemorrhage; D013004:Somatostatin; D013276:Stomach Ulcer',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013004:Somatostatin; D002927:Cimetidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/pgmj.60.709.760',\n",
       "  'references': '5305194;4542663;1087420;6971943;6971453;20266987;4544547;979485;306920;13589048;307312;20764384;4195545;7320966;301766;313579;305806;299743;20782569;14448730;391657;66425;14814824;478183;4122561;302111;13115299;20263267;5440587;47536;6103209;20782565;788030;4542662;310750;6390402;68272;369006;373855',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Postgrad Med J',\n",
       "  'nlm_unique_id': '0234135',\n",
       "  'issn_linking': '0032-5473',\n",
       "  'country': 'England'},\n",
       " {'title': 'Insulin receptors in rat brain cortex. Kinetic evidence for a receptor subtype in the central nervous system.',\n",
       "  'issue': '5(5)',\n",
       "  'pages': '937-44',\n",
       "  'abstract': 'Binding kinetics of porcine 125I-insulin were studied in synaptosomal and microsomal fractions of rat brain cortex. Receptor binding was temperature- and pH-dependent with optimum at 4 degrees C and pH 8.0-8.3. At 15 degrees C, steady state binding was heterogenous, and Scatchard analysis revealed two classes of receptors with Kd of 2 nmol/l and 40 nmol/l in amounts of 50 pmol/g and 200 pmol/g of membrane protein. Dissociation kinetics were biexponential with T1/2 of about 5 min and 180 min, and in contrast to other cell-types, not influenced by negative cooperativity. No receptor-mediated insulin degradation was detectable at 37 degrees C in the presence of bacitracin. Insulin analogues inhibited 125I-insulin binding with potencies relative to porcine insulin (%): human insulin 100, rat insulin (I + II) 71, coypu insulin 47, rat multiplication stimulating activity 8, porcine proinsulin 5, among which the three last values were significantly higher than in rat liver and fat cells. No competition was observed with porcine relaxin and mouse nerve growth factor up to about 1 mumol/l. Receptors were present in all regions of central nervous system with highest concentrations in the cerebral cortex, cerebellum and olfactory bulb, and lowest in the pons, medulla oblongata and spinal cord. In conclusion, insulin receptors in rat brain cortex are functionally different from other tissues regarding the insulin specificity and the absence of negative cooperativity. It is suggested that an insulin receptor subtype in rat brain mediates the growth activity of insulin on nerve cells.',\n",
       "  'journal': 'Peptides',\n",
       "  'authors': 'Gammeltoft|S|S|;Staun-Olsen|P|P|;Ottesen|B|B|;Fahrenkrug|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150469',\n",
       "  'mesh_terms': 'D000818:Animals; D002540:Cerebral Cortex; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007328:Insulin; D007700:Kinetics; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains; D011972:Receptor, Insulin; D012065:Relaxin; D013347:Subcellular Fractions; D013552:Swine; D013696:Temperature; D014018:Tissue Distribution; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007328:Insulin; D012065:Relaxin; D005723:gamma-Glutamyltransferase; D011972:Receptor, Insulin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0196-9781(84)90120-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Peptides',\n",
       "  'nlm_unique_id': '8008690',\n",
       "  'issn_linking': '0196-9781',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Medical treatment of ulcerative colitis.',\n",
       "  'issue': '60(709)',\n",
       "  'pages': '797-802',\n",
       "  'abstract': '',\n",
       "  'journal': 'Postgraduate medical journal',\n",
       "  'authors': 'Lennard-Jones|J E|JE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150475',\n",
       "  'mesh_terms': \"D000284:Administration, Oral; D000287:Administration, Topical; D000324:Adrenocorticotropic Hormone; D000636:Aminosalicylic Acids; D001379:Azathioprine; D003093:Colitis, Ulcerative; D004032:Diet; D006801:Humans; D007275:Injections, Intravenous; D019804:Mesalamine; D010819:Physician's Role; D011239:Prednisolone; D012460:Sulfasalazine\",\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000636:Aminosalicylic Acids; D012460:Sulfasalazine; D019804:Mesalamine; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D001379:Azathioprine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/pgmj.60.709.797',\n",
       "  'references': '4150435;4417491;4441827;168121;1097295;1103271;330354;72239;588990;203998;77426;26448;82099;364626;466209;509112;7399322;6105118;6777233;7002739;6109553;6780414;6113021;6114321;6114897;6117846;7030837;6120459;6121181;6803944;7117789;6127137;7129207;6336616;7173720;6826100;6134565;6345112;6305758;6873510;6615691;6414618;6416527;6438619;13182220;13618646;13760840;13865152;13994348;14218553;14238045;14238065;13260656',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Postgrad Med J',\n",
       "  'nlm_unique_id': '0234135',\n",
       "  'issn_linking': '0032-5473',\n",
       "  'country': 'England'},\n",
       " {'title': 'Modern management of atopic eczema.',\n",
       "  'issue': '228(1397)',\n",
       "  'pages': '1013-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'The Practitioner',\n",
       "  'authors': 'Verbov|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150476',\n",
       "  'mesh_terms': 'D000287:Administration, Topical; D000893:Anti-Inflammatory Agents; D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D006801:Humans; D007223:Infant',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Practitioner',\n",
       "  'nlm_unique_id': '0404245',\n",
       "  'issn_linking': '0032-6518',\n",
       "  'country': 'England'},\n",
       " {'title': '[Necrotizing angiitis with or without asthma. Clinical, biological and etiological differences. Role of hepatitis B virus].',\n",
       "  'issue': '13(37)',\n",
       "  'pages': '2245-8',\n",
       "  'abstract': 'Sixty-five cases of necrotizing angiitis, including 20 with asthma (group A) and 45 without asthma (group B) were studied retrospectively. All patients were investigated for markers of hepatitis B, at least the HBs antigen. Skin lesions and arthralgias were more common in group B patients. Eosinophilia during angiitis was almost constant in group A and was observed in only 6% of group B patients. Renal involvement, hepatic lesions and arterial hypertension seemed to be more frequent in group B but the difference was not significant. The HBs antigen was present in 1/20 patients of group A and in 17/45 patients of group B (p less than 0.01). The anti-HBs antibody was found with equal frequency in both groups. The clinical and biological differences observed between these two groups of patients strongly suggest that necrotizing vasculitis with and without asthma are two separate nosological entities and in particular, that they have different causes.',\n",
       "  'journal': 'Presse medicale (Paris, France : 1983)',\n",
       "  'authors': 'Bletry|O|O|;Guillevin|L|L|;Dubernet|T|T|;Lescourgues|B|B|;Courouce|A M|AM|;Cabane|J|J|;Herreman|G|G|;Godeau|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150479',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D001249:Asthma; D002648:Child; D005260:Female; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D006515:Hepatitis B virus; D006801:Humans; D008297:Male; D008875:Middle Aged; D009336:Necrosis; D010488:Polyarteritis Nodosa; D012189:Retrospective Studies; D014657:Vasculitis',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Presse Med',\n",
       "  'nlm_unique_id': '8302490',\n",
       "  'issn_linking': '0755-4982',\n",
       "  'country': 'France'},\n",
       " {'title': '[Cutaneous immunofluorescence in B virus diseases. 100 cases].',\n",
       "  'issue': '13(39)',\n",
       "  'pages': '2363-6',\n",
       "  'abstract': 'Immunofluorescence tests in healthy skin were performed in 75 patients with hepatitis B virus diseases (group I), in 25 HBs-antigen negative patients with the same diseases (group II) and in 90 controls (group III). HB virus diseases included acute, prolonged hepatitis; chronic, persistent and active hepatitis; cirrhosis and periarteritis nodosa. The immunofluorescence test was positive (micro- or macrogranular deposits in the walls of dermal vessels of HBs-antigen associated or not with immunoglobulins and complement) in 8 patients of group I (prolonged hepatitis 1; chronic persistent hepatitis 2; chronic active hepatitis 3; periarteritis nodosa 2), 3 of whom had no clinical manifestations, and in 3 patients of group II (chronic active hepatitis 2, periarteritis nodosa 1). Although not all patients with extrahepatic HB virus disease have a skin test positive for HBs-antigen and, conversely, a positive skin test does not necessarily imply clinical manifestations, it seems that skin immunofluorescence should be systematically performed as part of immunological investigations in all diseases where the HB virus might be involved.',\n",
       "  'journal': 'Presse medicale (Paris, France : 1983)',\n",
       "  'authors': 'Beylot|J|J|;Doutre|M S|MS|;Beylot|C|C|;Lacoste|D|D|;Boyer|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150480',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000936:Antigen-Antibody Complex; D002908:Chronic Disease; D003165:Complement System Proteins; D003450:Cryoglobulins; D005455:Fluorescent Antibody Technique; D006509:Hepatitis B; D006514:Hepatitis B Surface Antigens; D006801:Humans; D008104:Liver Cirrhosis, Alcoholic; D010488:Polyarteritis Nodosa; D012867:Skin',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000936:Antigen-Antibody Complex; D003450:Cryoglobulins; D006514:Hepatitis B Surface Antigens; D003165:Complement System Proteins',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Presse Med',\n",
       "  'nlm_unique_id': '8302490',\n",
       "  'issn_linking': '0755-4982',\n",
       "  'country': 'France'},\n",
       " {'title': '[Diagnosis, etiology and treatment of the hyperkinetic syndrome].',\n",
       "  'issue': '33(6)',\n",
       "  'pages': '222-33',\n",
       "  'abstract': '',\n",
       "  'journal': 'Praxis der Kinderpsychologie und Kinderpsychiatrie',\n",
       "  'authors': 'Brocke|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150477',\n",
       "  'mesh_terms': 'D001143:Arousal; D001289:Attention Deficit Disorder with Hyperactivity; D001521:Behavior Therapy; D000697:Central Nervous System Stimulants; D002540:Cerebral Cortex; D002648:Child; D002675:Child, Preschool; D003937:Diagnosis, Differential; D004569:Electroencephalography; D005512:Food Hypersensitivity; D006801:Humans; D008032:Limbic System; D009460:Neurologic Examination; D011575:Psychoanalytic Therapy; D011581:Psychological Tests; D009626:Terminology as Topic',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000697:Central Nervous System Stimulants',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Prax Kinderpsychol Kinderpsychiatr',\n",
       "  'nlm_unique_id': '0404246',\n",
       "  'issn_linking': '0032-7034',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Characterization of a somatostatin-28 containing the (Tyr-7, Gly-10) derivative of somatostatin-14: a terminal active product of prosomatostatin II processing in anglerfish pancreatic islets.',\n",
       "  'issue': '81(22)',\n",
       "  'pages': '7003-6',\n",
       "  'abstract': 'Anglerfish (Lophius piscatorius) Brockmann organs contain a form of somatostatin-14, identical to the hypothalamic tetradecapeptide, and two distinct forms of somatostatin-28, which can be separated by reversed-phase high-pressure liquid chromatography (HPLC). Analysis of the NH2-terminal amino acid sequence and comparison of the ability to incorporate 125I indicate that one of these forms corresponds to an octacosapeptide including in its sequence the (Tyr-7, Gly-10) derivative of somatostatin-14 (somatostatin II). Exposure of this somatostatin-28 species to an endopeptidase activity from the rat brain cortex generates a peptide immunologically related to somatostatin and undistinguishable from synthetic (Tyr-7, Gly-10) somatostatin-14 II by HPLC. This somatostatin-28 II exhibits a potent inhibitory effect on growth hormone release by rat anterior pituitary cells, comparable to the other somatostatin-28 form. Since (Tyr-7, Gly-10) somatostatin-14 II cannot be detected in anglerfish pancreatic islets, these results indicate that somatostatin-28 II represents the terminal active product of prosomatostatin II processing, whose structure was predicted from the cDNA nucleotide sequence corresponding to the second mRNA cloned from anglerfish Brockmann organs [Hobart, P., Crawford, R., Shen, L. P., Pictet, R. & Rutter, W. J. (1980) Nature (London) 288, 137-141].',\n",
       "  'journal': 'Proceedings of the National Academy of Sciences of the United States of America',\n",
       "  'authors': 'Morel|A|A|;Gluschankof|P|P|;Gomez|S|S|;Fafeur|V|V|;Cohen|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150481',\n",
       "  'mesh_terms': 'D000595:Amino Acid Sequence; D000818:Animals; D005399:Fishes; D011498:Protein Precursors; D011499:Protein Processing, Post-Translational; D013004:Somatostatin; D053561:Somatostatin-28',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D011498:Protein Precursors; D013004:Somatostatin; D053561:Somatostatin-28',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1073/pnas.81.22.7003',\n",
       "  'references': '4185494;4682131;4630101;387385;42908;7353633;6107860;6108563;6109284;7225368;6112138;6112710;6116704;6120101;6124973;6130085;6132607;6134727;6148264;6149550',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Proc Natl Acad Sci U S A',\n",
       "  'nlm_unique_id': '7505876',\n",
       "  'issn_linking': '0027-8424',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Lens transglutaminase selects specific beta-crystallin sequences as substrate.',\n",
       "  'issue': '81(22)',\n",
       "  'pages': '7017-20',\n",
       "  'abstract': 'A Ca2+-dependent transglutaminase (EC 2.3.2.13) has been demonstrated in the eye lenses of several mammalian species [Lorand, L., Hsu, L. K. M., Siefring, G. E., Jr., & Rafferty, N. S. (1981) Proc. Natl. Acad. Sci. USA 78, 1356-1360]. Using [3H]methylamine as a convenient probe for transglutaminase activity, we have explored the action of this enzyme in the bovine eye lens. We could characterize the glutamine residues acting as acyl-donor sites in three beta-crystallin chains, which are the only substrates for lens transglutaminase among the various lens-specific structural proteins, the crystallins. A single glutamine was found to bind [3H]methylamine in each of these three chains: glutamine -9 in beta Bp (beta B2), glutamine -21 in beta B3, and glutamine -23 or -24 in beta A3. The four glutamines are all located in the NH2-terminal regions, which presumably extend from the compact two-domain structure of the beta-crystallin chains. It was, moreover, established that several components of the lens cytoskeleton are substrates for transglutaminase.',\n",
       "  'journal': 'Proceedings of the National Academy of Sciences of the United States of America',\n",
       "  'authors': 'Berbers|G A|GA|;Feenstra|R W|RW|;van den Bos|R|R|;Hoekman|W A|WA|;Bloemendal|H|H|;de Jong|W W|WW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150482',\n",
       "  'mesh_terms': 'D000217:Acyltransferases; D000595:Amino Acid Sequence; D000818:Animals; D002417:Cattle; D003459:Crystallins; D005973:Glutamine; D007526:Isoelectric Point; D007908:Lens, Crystalline; D008744:Methylamines; D008970:Molecular Weight; D013379:Substrate Specificity; D011503:Transglutaminases',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D003459:Crystallins; D008744:Methylamines; D005973:Glutamine; C027451:methylamine; D000217:Acyltransferases; D011503:Transglutaminases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1073/pnas.81.22.7017',\n",
       "  'references': '5085985;4770792;236308;890737;927201;28146;6153122;7189714;7464942;6110191;6112745;6117852;7035168;6281623;6124971;6299583;6403545;6339521;6835368;6133417;6136410;6136967;6617875;6626553;6698025;6143256;6927387',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Proc Natl Acad Sci U S A',\n",
       "  'nlm_unique_id': '7505876',\n",
       "  'issn_linking': '0027-8424',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Gene transfer in lymphoid cells: expression of the Thy-1.2 antigen by Thy-1.1 BW5147 lymphoma cells transfected with unfractionated cellular DNA.',\n",
       "  'issue': '81(22)',\n",
       "  'pages': '7176-9',\n",
       "  'abstract': 'We have transferred the gene coding for the Thy-1.2 alloantigen into a Thy-1.1-bearing T-cell lymphoma. BALB/c thymocyte DNA, precipitated with calcium phosphate, was used to effect the transfer. We report the stable transformation of lymphoid cells by total cellular DNA. To our knowledge, this has not been previously reported. Transient expression of the transfected gene could be detected by flow cytofluorometry, and 5% (range, 1.5%-11%) of the recipient cells had Thy-1.2 antigen detectable on their surface 48 hr after transfer. \"Stable\" transformants were isolated by repeatedly selecting for cells expressing the Thy-1.2 antigen, by use of fluorescence-activated cell sorting or \"panning.\" No metabolic selection was required. The transferred gene, detected by Southern blotting, encoded a product that is indistinguishable from the normal antigen by immunoprecipitation and NaDod-SO4/PAGE.',\n",
       "  'journal': 'Proceedings of the National Academy of Sciences of the United States of America',\n",
       "  'authors': 'Berman|J W|JW|;Basch|R S|RS|;Pellicer|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150483',\n",
       "  'mesh_terms': 'D000818:Animals; D000954:Antigens, Surface; D002478:Cells, Cultured; D005786:Gene Expression Regulation; D005796:Genes; D005818:Genetic Engineering; D008223:Lymphoma; D051379:Mice; D013601:T-Lymphocytes; D018800:Thy-1 Antigens; D014162:Transfection; D014170:Transformation, Genetic',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000954:Antigens, Surface; D018800:Thy-1 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1073/pnas.81.22.7176',\n",
       "  'references': '4103301;4569167;4705382;4544550;1195397;15036;301614;302193;637870;351618;208776;210957;215191;286319;6246445;7414320;7460013;7292261;6275384;6818555;6297746;6572107;6188154;6308476;6582476;6199676;6324184',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Proc Natl Acad Sci U S A',\n",
       "  'nlm_unique_id': '7505876',\n",
       "  'issn_linking': '0027-8424',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Acetoacetate utilization by human placental mitochondria.',\n",
       "  'issue': '5(3)',\n",
       "  'pages': '271-6',\n",
       "  'abstract': 'It has been shown that mitochondria from human placenta incubated in the presence of 2-oxoglutarate or its precursors utilize acetoacetate at the rate about I nmol/min/mg protein. Utilization of acetoacetate is completely inhibited by arsenite. Mitochondria from human placental tissue show activity of 3-oxoacid-CoA transferase and acetoacetyl-CoA thiolase. It is proposed that acetoacetate utilization by placental mitochondria proceeds via the conversion to acetoacetyl-CoA catalysed by 3-oxoacid-CoA transferase, and then to acetyl-CoA, catalysed by acetoacetyl-CoA thiolase.',\n",
       "  'journal': 'Placenta',\n",
       "  'authors': 'Zołnierowicz|S|S|;Scisłowski|P W|PW|;Swierczyński|J|J|;Zelewski|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150478',\n",
       "  'mesh_terms': 'D000090:Acetoacetates; D000101:Acetyl-CoA C-Acetyltransferase; D015256:Coenzyme A-Transferases; D005260:Female; D006801:Humans; D007656:Ketoglutaric Acids; D008928:Mitochondria; D010920:Placenta; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011263:Pregnancy Trimester, Third; D013466:Sulfurtransferases',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000090:Acetoacetates; D007656:Ketoglutaric Acids; C016635:acetoacetic acid; D000101:Acetyl-CoA C-Acetyltransferase; D013466:Sulfurtransferases; D015256:Coenzyme A-Transferases; C021460:3-ketoacid CoA-transferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0143-4004(84)80037-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Placenta',\n",
       "  'nlm_unique_id': '8006349',\n",
       "  'issn_linking': '0143-4004',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Identification and characterization of the glucose transporter of the blood-brain barrier by cytochalasin B binding and immunological reactivity.',\n",
       "  'issue': '81(22)',\n",
       "  'pages': '7233-7',\n",
       "  'abstract': '[3H]Cytochalasin B was used as a ligand to identify and characterize the glucose transporter in cerebral microvessels of the rat and the pig. Specific cytochalasin B binding, defined as that fraction of the total binding that is stereospecifically displaced by excess (500 mM) D-glucose, is saturable. Kinetic studies of this specific binding to cerebral microvessel preparations showed a dissociation constant (Kd) of 0.65-0.88 microM and a maximal binding (Bmax) of 60-80 pmol/mg of protein. In comparison, the Bmax of particulate fractions of the cerebral cortex was about one-tenth that of cerebral microvessels. The ability of various hexoses to displace specific cytochalasin B binding to cerebral microvessels in vitro correlated well with the capability of these hexoses to cross the blood-brain barrier in vivo. Irreversible photoaffinity labeling of the glucose transporter of cerebral microvessels with cytochalasin B followed by solubilization and polyacrylamide gel electrophoresis labeled a polypeptide(s) with a molecular weight of about 53,000. Antibodies prepared against the glucose transporter of human erythrocytes also reacted with a polypeptide(s) with a molecular weight of about 53,000 on electrophoresed preparations of cerebral microvessels. These results indicate that cerebral microvessels are richly endowed with a glucose transporter moiety of similar molecular weight and antigenic characteristics as the glucose transporter of human erythrocytes and other mammalian tissues.',\n",
       "  'journal': 'Proceedings of the National Academy of Sciences of the United States of America',\n",
       "  'authors': 'Dick|A P|AP|;Harik|S I|SI|;Klip|A|A|;Walker|D M|DM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150484',\n",
       "  'mesh_terms': 'D000818:Animals; D001812:Blood-Brain Barrier; D002352:Carrier Proteins; D002540:Cerebral Cortex; D002560:Cerebrovascular Circulation; D003571:Cytochalasin B; D003847:Deoxyglucose; D005947:Glucose; D008297:Male; D008970:Molecular Weight; D009004:Monosaccharide Transport Proteins; D051381:Rats; D011919:Rats, Inbred Strains; D013347:Subcellular Fractions; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002352:Carrier Proteins; D009004:Monosaccharide Transport Proteins; D003571:Cytochalasin B; D003847:Deoxyglucose; D005723:gamma-Glutamyltransferase; D005947:Glucose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1073/pnas.81.22.7233',\n",
       "  'references': '5866278;6033532;4968036;4580109;1125240;1151383;921993;73470;711732;434144;375257;469532;6998256;6108994;7014557;7196262;7295669;7328147;6280190;7200980;7046746;7046752;6954540;6289825;6891216;6681949;6338925;6301198;6311978;6619870;6685458;6361813;6539126;14907713;14253434',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Proc Natl Acad Sci U S A',\n",
       "  'nlm_unique_id': '7505876',\n",
       "  'issn_linking': '0027-8424',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Electrical stimulation increases phosphorylation of tyrosine hydroxylase in superior cervical ganglion of rat.',\n",
       "  'issue': '81(22)',\n",
       "  'pages': '7243-7',\n",
       "  'abstract': 'Electrical stimulation of the superior cervical ganglion of the rat increased the phosphorylation of tyrosine hydroxylase (tyrosine 3-monooxygenase, EC 1.14.16.2) in this tissue. Ganglia were incubated with [32P]Pi for 90 min and were then electrically stimulated via the preganglionic nerve. Tyrosine hydroxylase was isolated from homogenates of the ganglia by immunoprecipitation followed by polyacrylamide gel electrophoresis. 32P-labeled tyrosine hydroxylase was visualized by radioautography, and the incorporation of 32P into the enzyme was quantitated by densitometry of the radioautograms. Stimulation of ganglia at 20 Hz for 5 min increased the incorporation of 32P into tyrosine hydroxylase to a level 5-fold that found in unstimulated control ganglia. The increase in phosphorylation of tyrosine hydroxylase was dependent on the duration and frequency of stimulation. Preganglionic stimulation did not increase the phosphorylation of tyrosine hydroxylase in a medium that contained low Ca2+ and high Mg2+. Increases in phosphorylation were reversible; within 30 min after the cessation of stimulation, the incorporation of 32P into tyrosine hydroxylase decreased to the level found in unstimulated ganglia. The nicotinic antagonist hexamethonium reduced the increase in 32P incorporation into tyrosine hydroxylase by about 50%, while the muscarinic antagonist atropine had no effect. Thus, preganglionic stimulation appeared to increase the phosphorylation of tyrosine hydroxylase in part by a nicotinic mechanism and in part by a noncholinergic mechanism. Antidromic stimulation of ganglia also increased the phosphorylation of tyrosine hydroxylase. Two-dimensional gel electrophoresis revealed that electrical stimulation also increased the incorporation of 32P into at least six other phosphoproteins in the ganglion.',\n",
       "  'journal': 'Proceedings of the National Academy of Sciences of the United States of America',\n",
       "  'authors': 'Cahill|A L|AL|;Perlman|R L|RL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150485',\n",
       "  'mesh_terms': 'D000818:Animals; D004558:Electric Stimulation; D005728:Ganglia, Sympathetic; D007526:Isoelectric Point; D008297:Male; D008970:Molecular Weight; D010766:Phosphorylation; D051381:Rats; D011919:Rats, Inbred Strains; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D014446:Tyrosine 3-Monooxygenase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1073/pnas.81.22.7243',\n",
       "  'references': '4382063;4315686;5432063;4153688;4155067;236308;240133;1202365;14638;23427;26830;33170;33381;36394;44856;6112040;6264032;45430;6278329;6288862;6127338;6127339;6127363;6127400;6130526;6132384;6132385;6141219',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Proc Natl Acad Sci U S A',\n",
       "  'nlm_unique_id': '7505876',\n",
       "  'issn_linking': '0027-8424',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Directed regrowth of axons from a misrouted nerve to their correct muscles in the limb of the adult newt.',\n",
       "  'issue': '222(1229)',\n",
       "  'pages': '477-89',\n",
       "  'abstract': 'When the forearm flexor nerve (f.f.n.) of the newt forelimb is surgically rerouted to the ventral body wall, regrowth of axons occurs and these axons reinnervate the muscle targets of the f.f.n. This process of nerve regeneration has been studied in detail over a 12 week period by using light and electron microscopy, electrophysiology and nerve fibre tracking after filling with cobalt chloride. The regrowing axons were analysed by electron microscopy and it is shown that they derive from the rerouted nerve at the position at which the f.f.n. leaves its normal ventral limb pathway. Axons in the pathway do not originate from the cut end of the f.f.n. on the ventral body wall. The regrowing axons are identified within the body of the rerouted nerve and they leave the f.f.n. by growing through the perineurium. Schwann cells are invariably associated with the regrowing axons and the pathway through which the growth cones and neurites grow consists predominantly of extracellular matrix fibrils. The stages of maturation of the regenerated f.f.n. including fasiculation of neurites, myelination and reformation of a perineurium are also described. The results of the study are discussed in terms of current ideas as to how specific regeneration of a correct and functional peripheral nervous system is achieved in urodele amphibians.',\n",
       "  'journal': 'Proceedings of the Royal Society of London. Series B, Biological sciences',\n",
       "  'authors': 'Holder|N|N|;Tonge|D A|DA|;Jesani|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150487',\n",
       "  'mesh_terms': 'D000818:Animals; D001369:Axons; D005121:Extremities; D008854:Microscopy, Electron; D009132:Muscles; D009416:Nerve Regeneration; D012455:Salamandridae',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1098/rspb.1984.0078',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Proc R Soc Lond B Biol Sci',\n",
       "  'nlm_unique_id': '7505889',\n",
       "  'issn_linking': '0950-1193',\n",
       "  'country': 'England'},\n",
       " {'title': 'Atrial natriuretic factor elicits an endothelium-independent relaxation and activates particulate guanylate cyclase in vascular smooth muscle.',\n",
       "  'issue': '81(23)',\n",
       "  'pages': '7661-4',\n",
       "  'abstract': 'A 26 amino acid synthetic peptide fragment of atrial natriuretic factor (ANF) relaxed isolated rabbit aortic segments in which the endothelium was either intact or functionally destroyed. The relaxations were temporally associated with increases in levels of cGMP with no change in the levels of cAMP. The ANF-induced increases in cGMP were also observed in aortic segments pretreated with calcium-free buffer or the cGMP phosphodiesterase inhibitor M&B 22,948. Qualitatively similar results were obtained for sodium nitroprusside. ANF selectively activated particulate guanylate cyclase, having no effect on the soluble form of the enzyme. Thus, the direct (endothelium-independent) vasodilator effect of ANF may be mediated via increased tissue levels of cGMP. ANF appears to increase vascular cGMP levels by activation of particulate guanylate cyclase.',\n",
       "  'journal': 'Proceedings of the National Academy of Sciences of the United States of America',\n",
       "  'authors': 'Winquist|R J|RJ|;Faison|E P|EP|;Waldman|S A|SA|;Schwartz|K|K|;Murad|F|F|;Rapoport|R M|RM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150486',\n",
       "  'mesh_terms': 'D000818:Animals; D001013:Aorta, Thoracic; D009320:Atrial Natriuretic Factor; D000242:Cyclic AMP; D006152:Cyclic GMP; D006162:Guanylate Cyclase; D007700:Kinetics; D009119:Muscle Contraction; D009124:Muscle Proteins; D009126:Muscle Relaxation; D009131:Muscle, Smooth, Vascular; D009599:Nitroprusside; D011817:Rabbits',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D009124:Muscle Proteins; D009599:Nitroprusside; D009320:Atrial Natriuretic Factor; D000242:Cyclic AMP; D006162:Guanylate Cyclase; D006152:Cyclic GMP',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1073/pnas.81.23.7661',\n",
       "  'references': '4334491;4375524;240848;177461;14978;16208;193029;203862;26915;231208;6106030;7219045;6297832;6857267;6136535;6313250;6314456;6140625;6419347;6141207;6230081;6232612;6539595;6147363;6541140;6149646',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '85063852',\n",
       "  'medline_ta': 'Proc Natl Acad Sci U S A',\n",
       "  'nlm_unique_id': '7505876',\n",
       "  'issn_linking': '0027-8424',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Silent intracellular calcium in sickle cell anemia red cells.',\n",
       "  'issue': '165()',\n",
       "  'pages': '17-28',\n",
       "  'abstract': '',\n",
       "  'journal': 'Progress in clinical and biological research',\n",
       "  'authors': 'Bookchin|R M|RM|;Ortiz|O E|OE|;Lew|V L|VL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150488',\n",
       "  'mesh_terms': 'D000755:Anemia, Sickle Cell; D017301:Ca(2+) Mg(2+)-ATPase; D002118:Calcium; D000252:Calcium-Transporting ATPases; D002463:Cell Membrane Permeability; D004910:Erythrocyte Membrane; D004913:Erythrocytes, Abnormal; D006801:Humans; D007473:Ion Channels; D008274:Magnesium; D011188:Potassium',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D007473:Ion Channels; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D008274:Magnesium; D011188:Potassium; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Prog Clin Biol Res',\n",
       "  'nlm_unique_id': '7605701',\n",
       "  'issn_linking': '0361-7742',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Serenics: the pharmacology of fluprazine and DU 28412.',\n",
       "  'issue': '167()',\n",
       "  'pages': '191-207',\n",
       "  'abstract': '',\n",
       "  'journal': 'Progress in clinical and biological research',\n",
       "  'authors': 'Bradford|L D|LD|;Olivier|B|B|;van Dalen|D|D|;Schipper|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150489',\n",
       "  'mesh_terms': 'D000374:Aggression; D000818:Animals; D004558:Electric Stimulation; D004597:Electroshock; D005260:Female; D006801:Humans; D007031:Hypothalamus; D051379:Mice; D018377:Neurotransmitter Agents; D010879:Piperazines; D011247:Pregnancy; D051381:Rats; D011941:Receptors, Adrenergic; D011957:Receptors, Opioid; D011985:Receptors, Serotonin; D013731:Territoriality',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D010879:Piperazines; D011941:Receptors, Adrenergic; D011957:Receptors, Opioid; D011985:Receptors, Serotonin; C035521:fluprazine; C043233:DU 28412',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Prog Clin Biol Res',\n",
       "  'nlm_unique_id': '7605701',\n",
       "  'issn_linking': '0361-7742',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Can social and agonistic interactions be used to detect anxiolytic activity of drugs?',\n",
       "  'issue': '167()',\n",
       "  'pages': '93-114',\n",
       "  'abstract': \"Majority of adult male albino random-bred mice housed singly or in small groups show agonistic behavior on interaction with a strange male mouse: some of them are predominantly aggressive ('aggressive' mice) while others show defenses or escapes even though their partners are not aggressive ('timid' mice). The remaining males not exhibiting agonistic behavior ('sociable' mice) show more social investigation then aggressive or timid mice and more locomotion then timid mice. Active defensive-escape behavior ('timidity') and inhibition of social investigation and of locomotion is much stronger in an unfamiliar cage with a strange male than in a home cage or on interaction with a female. Effects of 50 drugs on behavior of aggressive and timid male mice on agonistic interactions with non-aggressive male mice in neutral cages were tested. Most of the drugs possessing anxiolytic activity in man reduced active escapes or defenses at doses lower than those inhibiting attacks or locomotion and increased social investigation while most drugs without anxiolytic activity did not show these effects. Some anxiolytic drugs reduced tail-rattling (an ambivalent activity presumably reflecting both attack and escape tendency) at doses lower than those reducing attacks and increased locomotion. Only some benzodiazepines (nitrazepam, oxazepam and diazepam) produced the whole spectrum of these effects indicating a reduced defensive-escape tendency. The present results suggest that a selective inhibition of defensive-escape tendency on agonistic interactions can be a good predictor of anxiolytic activity of drugs. Profiles of effects of seven benzodiazepines in the present model of agonistic interaction to some extent differed: triazolam, clonazepam and flunitrazepam were more sedating (reduced timidity only at doses inhibiting locomotion) while nitrazepam, oxazepam, diazepam and chlordiazepoxide were less sedating (reduced timidity at non-sedative doses, stimulated social investigation and locomotion). Only drugs stimulating GABA-receptor complex (benzodiazepines, barbiturates and GABAergic drugs) inhibited active escapes and defenses at doses lower than those reducing attacks. This suggests that the GABA-receptor complex is involved in regulation of defensive-escape tendency in intraspecies conflict.\",\n",
       "  'journal': 'Progress in clinical and biological research',\n",
       "  'authors': 'Krsiak|M|M|;Sulcova|A|A|;Donat|P|P|;Tomasikova|Z|Z|;Dlohozkova|N|N|;Kosar|E|E|;Masek|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150490',\n",
       "  'mesh_terms': 'D000374:Aggression; D000378:Agonistic Behavior; D000818:Animals; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D004924:Escape Reaction; D006801:Humans; D008297:Male; D051379:Mice; D009043:Motor Activity; D011963:Receptors, GABA-A; D012919:Social Behavior',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D011963:Receptors, GABA-A; D001569:Benzodiazepines',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Prog Clin Biol Res',\n",
       "  'nlm_unique_id': '7605701',\n",
       "  'issn_linking': '0361-7742',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Bromazepam ('Lexotanil') compared with placebo: a double-blind, crossover study.\",\n",
       "  'issue': '4(1)',\n",
       "  'pages': '13-20',\n",
       "  'abstract': 'A double-blind, crossover study was carried out in 126 out-patients, most of them neurotics, to compare the efficacy and tolerance of bromazepam and placebo. Patients received either 6 mg bromazepam or placebo daily for 3 weeks and were then crossed over to the alternative treatment for a further 3 weeks. Treatment sequence was randomized. Clinical ratings of the severity of individual symptoms and the Hamilton Anxiety Rating Scale were used to measure response to treatment at the end of each period. During the first period, both bromazepam and placebo produced improvement and there was no statistically significant difference between the two groups. During the second period after crossover, however, significantly better results were achieved in patients on bromazepam than those on placebo. The incidence of side-effects, mainly drowsiness, was similar with bromazepam and placebo.',\n",
       "  'journal': 'Pharmatherapeutica',\n",
       "  'authors': 'Rey|A|A|;Bovet|J|J|;Schneider|P B|PB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150491',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D014151:Anti-Anxiety Agents; D001960:Bromazepam; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009497:Neurotic Disorders; D011569:Psychiatric Status Rating Scales; D011897:Random Allocation; D013997:Time Factors',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001960:Bromazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmatherapeutica',\n",
       "  'nlm_unique_id': '7606274',\n",
       "  'issn_linking': '0308-051X',\n",
       "  'country': 'England'},\n",
       " {'title': 'Long-term treatment of chronic schizophrenics with clopenthixol decanoate.',\n",
       "  'issue': '4(1)',\n",
       "  'pages': '53-6',\n",
       "  'abstract': 'A study was carried out in 68 chronic schizophrenic out-patients to assess the therapeutic effectiveness and tolerance of long-term maintenance treatment with a depot preparation of clopenthixol decanoate. Patients received 200 mg to 600 mg doses by intramuscular injection every 2 to 3 weeks for a mean treatment period of 20.3 months. Clinical symptomatology was assessed at regular intervals using the Brief Psychiatric Rating Scale (BPRS) and any adverse effects were recorded against a standard check-list. The results showed that there was a significant reduction in total and factor composition BPRS scores after treatment in all patients, the improvement becoming generally evident by the sixth month of treatment. Few autonomic and neurological side-effects were reported.',\n",
       "  'journal': 'Pharmatherapeutica',\n",
       "  'authors': 'Borsetti|G|G|;Rocco|P|P|;Spilimbergo|P G|PG|;Giavedoni|A|A|;Frangiamone|L|L|;Beccaceci|A|A|;Judice|A|A|;Cisternino|M|M|;Volterra|V|V|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150492',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents; D002908:Chronic Disease; D003006:Clopenthixol; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia; D013892:Thioxanthenes; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D013892:Thioxanthenes; C029674:clopenthixol decanoate; D003006:Clopenthixol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmatherapeutica',\n",
       "  'nlm_unique_id': '7606274',\n",
       "  'issn_linking': '0308-051X',\n",
       "  'country': 'England'},\n",
       " {'title': 'A 5-year follow-up study of chronic schizophrenics treated with clopenthixol decanoate.',\n",
       "  'issue': '4(1)',\n",
       "  'pages': '57-63',\n",
       "  'abstract': \"Twenty-three chronic schizophrenic patients were followed-up over periods up to 5 years (1978-1983) while receiving treatment with depot injections of clopenthixol decanoate in doses ranging from 100 to 600 mg every 2 to 4 weeks. The highest single dose given was 1600 mg. Improvement in psychotic symptoms occurred progressively over the 5 years, with reduction in mean overall symptom score for schizophrenia from 7.43 to 0.88. Mean side-effects scores decreased over the same period from 2.0 to 0.5. After 5 years, 10 patients were still maintained on clopenthixol decanoate. Although during the first 2 months there was little improvement in 'negative' or 'loss' symptoms, improvement was similar in 'positive' and 'negative' symptoms after 5 years. Clopenthixol decanoate appeared to have a better calming effect than that encountered with flupenthixol decanoate. At higher doses, it caused drowsiness and subdued hostility and aggression.\",\n",
       "  'journal': 'Pharmatherapeutica',\n",
       "  'authors': 'Carney|M W|MW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150493',\n",
       "  'mesh_terms': 'D000328:Adult; D014150:Antipsychotic Agents; D001480:Basal Ganglia Diseases; D002908:Chronic Disease; D003006:Clopenthixol; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D012559:Schizophrenia; D013892:Thioxanthenes',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D013892:Thioxanthenes; C029674:clopenthixol decanoate; D003006:Clopenthixol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmatherapeutica',\n",
       "  'nlm_unique_id': '7606274',\n",
       "  'issn_linking': '0308-051X',\n",
       "  'country': 'England'},\n",
       " {'title': 'The effects of GABA and benzodiazepine receptor antagonists on the anti-conflict actions of diazepam or ethanol.',\n",
       "  'issue': '21(4)',\n",
       "  'pages': '521-5',\n",
       "  'abstract': \"The effects of picrotoxin, bicuculline or RO 15-1788 on the anti-conflict action(s) of diazepam or ethanol were studied in rats using a modified Vogel's conflict test procedure. RO 15-1788 antagonized the anti-punishment effects of diazepam (2.5 mg/kg, IP), whereas various doses of bicuculline or picrotoxin did not interfere with diazepam's anti-conflict effect in this test situation. The anti-conflict action of ethanol (2 g/kg, IP) was antagonized by picrotoxin (1.0 mg/kg, IP), whereas both bicuculline and RO 15-1788 were without effect on the increased punishment response produced by ethanol. These data suggest that the anti-conflict properties of ethanol are at least partially mediated through an enhancement of central GABAergic activity.\",\n",
       "  'journal': 'Pharmacology, biochemistry, and behavior',\n",
       "  'authors': 'Liljequist|S|S|;Engel|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150494',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001640:Bicuculline; D003220:Conflict, Psychological; D003975:Diazepam; D004305:Dose-Response Relationship, Drug; D000431:Ethanol; D005442:Flumazenil; D008297:Male; D010852:Picrotoxin; D011678:Punishment; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D011963:Receptors, GABA-A; D010852:Picrotoxin; D000431:Ethanol; D005442:Flumazenil; D003975:Diazepam; D001640:Bicuculline',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0091-3057(84)80033-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Biochem Behav',\n",
       "  'nlm_unique_id': '0367050',\n",
       "  'issn_linking': '0091-3057',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Analgesic effect of opiates in offspring of opiate-treated female rats.',\n",
       "  'issue': '21(4)',\n",
       "  'pages': '555-9',\n",
       "  'abstract': 'The purpose of this study was to determine the effect that chronic maternal exposure to narcotics has on the effectiveness of analgesic drugs in the offspring. No exposure related differences were observed in the base level response to the noxious stimuli used. However, offspring of methadone and morphine-treated mothers tended to show decreased response latencies compared to control offspring, in both the hotplate and tail flick test, following the subcutaneous administration of narcotic analgesic drugs. In all groups studied, methadone offspring had significantly reduced latencies while morphine offspring had latencies that were intermediate between the control and methadone-treated groups (in general, control latencies greater than morphine latencies greater than methadone latencies). Morphine offspring were significantly different from the controls only in the 120-day-old female group. Treatment-related decreases in the effectiveness of the analgesics in both 25- and 120-day-old offspring suggest that exposure of developing rat pups to narcotics during gestation and early postnatal development is associated with long-lasting alterations in those processes involved with pain perception and/or interpretation.',\n",
       "  'journal': 'Pharmacology, biochemistry, and behavior',\n",
       "  'authors': 'Hovious|J R|JR|;Peters|M A|MA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150495',\n",
       "  'mesh_terms': 'D000701:Analgesics, Opioid; D000818:Animals; D005260:Female; D008297:Male; D008691:Methadone; D009020:Morphine; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D011919:Rats, Inbred Strains; D011930:Reaction Time; D012737:Sex Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000701:Analgesics, Opioid; D009020:Morphine; D008691:Methadone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0091-3057(84)80039-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Biochem Behav',\n",
       "  'nlm_unique_id': '0367050',\n",
       "  'issn_linking': '0091-3057',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Some effects of pimozide on nondeprived rats licking sucrose solutions in an anhedonia paradigm.',\n",
       "  'issue': '21(4)',\n",
       "  'pages': '617-24',\n",
       "  'abstract': \"The present work examines the generalizability of the anhedonia phenomenon (extinction-like responding with repeated neuroleptic treatment) by examining rats' licking behavior, a response heretofore untested, in the anhedonia paradigm. Nondeprived rats learned to lick a sucrose solution (32%) and were then tested for eight consecutive days in either a no-reward condition (N = 8) or two pimozide (PIM) with reward conditions (N = 8 at each of these two doses: 0.5 and 1.0 mg/kg). PIM treated animals did not exhibit rates or patterns of responding equivalent to animals in the extinction condition. Instead of an across session decline in rate, PIM treated animals showed a trend towards recovery on the rate measure. Within session patterns of responding of PIM treated animals more closely resembled animals in a normally rewarded condition responding at a generally lower rate, than animals in an extinction condition. The experimental procedure included the the use of home cage control animals, replication of the intermittent dosing procedure, and tests for transfer effects; all of these failed to produce patterns of responding typically obtained in the anhedonia paradigm when the response is lever pressing. Median lick duration and median interlick interval (ILI) were both lengthened with PIM treatment relative to injection control and extinction conditions, suggesting that pimozide treatment creates a motoric deficit. Taken together these results emphasize the importance of neuroleptics' motor vis a vis anhedonic effects.\",\n",
       "  'journal': 'Pharmacology, biochemistry, and behavior',\n",
       "  'authors': 'Gramling|S E|SE|;Fowler|S C|SC|;Collins|K R|KR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150496',\n",
       "  'mesh_terms': 'D000818:Animals; D014150:Antipsychotic Agents; D003216:Conditioning, Operant; D005108:Extinction, Psychological; D005247:Feeding Behavior; D008297:Male; D010868:Pimozide; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D010868:Pimozide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0091-3057(84)80047-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Biochem Behav',\n",
       "  'nlm_unique_id': '0367050',\n",
       "  'issn_linking': '0091-3057',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Comparative effects of tetrahydrocannabinol on psychostimulant-induced behaviors.',\n",
       "  'issue': '21(4)',\n",
       "  'pages': '641-4',\n",
       "  'abstract': 'The behavioral effects of delta-9-tetrahydrocannabinol (THC), one of the major psychoactive cannabinoids in marijuana, were tested in two models of psychostimulant-induced behaviors in rats (locomotor behavior and stereotyped gnawing) induced by amphetamine (AMPH) and methylphenidate (MEPH). Pretreatment with THC (10 mg/kg gavage) almost doubled the amount of AMPH-induced gnawing but produced no effect on AMPH-induced locomotor behavior. In contrast to AMPH, THC produced no direct effect on MEPH-induced gnawing but caused a strong suppression of MEPH-induced locomotor activity. In addition, there was no additional interaction between THC and reserpine as measured by suppression of MEPH-induced gnawing. This result was unexpected in view of the powerful interaction between THC and reserpine reported previously. Because of the clear THC-induced dissociation of the behavioral effects of these two psychostimulants (AMPH and MEPH), our working hypothesis is that THC affects motor behaviors by some non-dopaminergic mechanism.',\n",
       "  'journal': 'Pharmacology, biochemistry, and behavior',\n",
       "  'authors': 'Moss|D E|DE|;Koob|G F|GF|;McMaster|S B|SB|;Janowsky|D S|DS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150497',\n",
       "  'mesh_terms': 'D000661:Amphetamine; D000818:Animals; D001522:Behavior, Animal; D000697:Central Nervous System Stimulants; D013759:Dronabinol; D005260:Female; D006801:Humans; D008297:Male; D008774:Methylphenidate; D009043:Motor Activity; D051381:Rats; D011919:Rats, Inbred Strains; D012110:Reserpine; D013239:Stereotyped Behavior',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000697:Central Nervous System Stimulants; D008774:Methylphenidate; D013759:Dronabinol; D012110:Reserpine; D000661:Amphetamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0091-3057(84)80050-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Biochem Behav',\n",
       "  'nlm_unique_id': '0367050',\n",
       "  'issn_linking': '0091-3057',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effects of antipsychotic drugs on brain-stimulation detection: preliminary observations.',\n",
       "  'issue': '21(4)',\n",
       "  'pages': '645-9',\n",
       "  'abstract': 'The effects of two antipsychotic drugs, haloperidol and clozapine, on the detection of electrical brain stimulation were investigated. Rats were trained to make an instrumental response to a brain stimulation cue delivered via an electrode implanted in one of several forebrain or midbrain loci. A response to this stimulation was reinforced by the delivery of a rewarding electrical stimulus via a second electrode implanted in the hypothalamus. By varying the current intensity of the cue stimulus, a detection threshold was determined in each subject both prior to and after administration of various doses of haloperidol or clozapine. Compared to changes on vehicle control days, both drugs produced a dose-related elevation of the detection thresholds. Although haloperidol was more potent than clozapine in most subjects, the minimal effective doses of haloperidol for affecting detection from forebrain loci were lower than for affecting detection from midbrain loci. A reverse differential sensitivity was observed after clozapine administration. Concurrent effects of these two drugs on latency to respond, as well as on both task defined strength of responding and ability to inhibit responding not only indicated the specificity of threshold elevations, but provided additional behavioral information concerning the actions of the two antipsychotic agents. It is proposed that the method employed in this experiment is suitable for measuring the effects of drugs on the discriminative or perceptual properties of electrical brain stimulation and may indicate central sites of drug action.',\n",
       "  'journal': 'Pharmacology, biochemistry, and behavior',\n",
       "  'authors': 'Wheeling|H S|HS|;Kornetsky|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150498',\n",
       "  'mesh_terms': 'D000818:Animals; D014150:Antipsychotic Agents; D001921:Brain; D001931:Brain Mapping; D003024:Clozapine; D004558:Electric Stimulation; D006220:Haloperidol; D007031:Hypothalamus; D008297:Male; D008636:Mesencephalon; D051381:Rats; D013687:Telencephalon',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D003024:Clozapine; D006220:Haloperidol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0091-3057(84)80051-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Biochem Behav',\n",
       "  'nlm_unique_id': '0367050',\n",
       "  'issn_linking': '0091-3057',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Protection by SK&F 93479 against the haemodynamic effects of coronary artery ligation in dogs.',\n",
       "  'issue': '16(10)',\n",
       "  'pages': '987-98',\n",
       "  'abstract': 'The effects of SK&F 93479, a potent histamine H2-receptor antagonist, on the changes in haemodynamics induced by coronary artery ligation were investigated in anaesthetized dogs. Intravenous bolus injection of SK&F 93479 1 mg/kg followed by 1 mg/kg/h infusion caused transient decreases in systemic blood pressure, left ventricular pressure, and dLVP/dtmax, but did not significantly alter heart rate. Coronary artery ligation produced haemodynamic depression, and this was significantly prevented by pretreatment of the animals with SK&F 93479. These findings suggest that histamine may contribute to the haemodynamic changes arising from acute myocardial ischaemia.',\n",
       "  'journal': 'Pharmacological research communications',\n",
       "  'authors': 'Dai|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150499',\n",
       "  'mesh_terms': 'D000818:Animals; D001794:Blood Pressure; D003331:Coronary Vessels; D004285:Dogs; D006439:Hemodynamics; D006635:Histamine H2 Antagonists; D008026:Ligation; D008297:Male; D011744:Pyrimidinones',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006635:Histamine H2 Antagonists; D011744:Pyrimidinones; C033275:SK&F 93479',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0031-6989(84)80063-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Res Commun',\n",
       "  'nlm_unique_id': '0236354',\n",
       "  'issn_linking': '0031-6989',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Prolactin-releasing effect of zetidoline, a new neuroleptic agent, in the rat.',\n",
       "  'issue': '16(2)',\n",
       "  'pages': '117-27',\n",
       "  'abstract': 'The effect of a new neuroleptic agent, zetidoline, 1-(3-chlorophenyl)-3-[2-(3,3-dimethyl-l-azetidinyl)ethyl]imidaz olidin-2-one (ZET), on prolactin release was studied in both male and female rats and compared to that of the classic antipsychotic drugs chlorpromazine and haloperidol. Time-course and dose-effect studies showed that ZET induces a rapid and short lasting increase in plasma prolactin levels, with a significant increase after a dose as low as 0.33 mg/kg, i.p.. The overall patterns of prolactin release appeared to be similar in both sexes but the response was markedly greater in females than in males. The prolactin-releasing effect of ZET was counteracted by apomorphine and L-dopa, which indicates that blockade of dopamine receptors is the basis of its neuroendocrine action. As a prolactin-releaser, ZET was found to be about 5 times as potent as chlorpromazine and about one-ninth as potent as haloperidol.',\n",
       "  'journal': 'Pharmacological research communications',\n",
       "  'authors': 'Galliani|G|G|;Restelli|A|A|;Rosina|R|R|;Glässer|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150500',\n",
       "  'mesh_terms': 'D000818:Animals; D014150:Antipsychotic Agents; D001058:Apomorphine; D002746:Chlorpromazine; D004971:Estrus; D005260:Female; D006220:Haloperidol; D007093:Imidazoles; D007980:Levodopa; D008297:Male; D011247:Pregnancy; D011388:Prolactin; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D007093:Imidazoles; C027277:zetidoline; D007980:Levodopa; D011388:Prolactin; D006220:Haloperidol; D001058:Apomorphine; D002746:Chlorpromazine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0031-6989(84)80086-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Res Commun',\n",
       "  'nlm_unique_id': '0236354',\n",
       "  'issn_linking': '0031-6989',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Action of oxmetidine on the rabbit aorta: comparison with some calcium entry blockers and nitroglycerin.',\n",
       "  'issue': '16(2)',\n",
       "  'pages': '161-70',\n",
       "  'abstract': 'The novel histamine H2 receptor antagonist, oxmetidine, was tested on isolated rabbit aorta for its activity on calcium ion transport and/or utilization suggested from previous experiments. Its effect was compared with that of some \"classical\" calcium entry blockers (verapamil, D-600 and nifedipine) and of nitroglycerin which acts predominantly on the intracellular calcium. The effect of all these compounds was evaluated against the contraction elicited by KCl, angiotensin and noradrenaline acting by different spasmogenic mechanisms. Oxmetidine was found to antagonize to approximately the same extent the effect of the three stimulatory substances: however concentrations required for this effect were from 10 to 100 times as high as those required to inhibit histamine H2 receptors. Nitroglycerin behaved quite similarly but was approximately 10.000 times more potent than oxmetidine. Verapamil and D-600 (which were virtually identical) were always more potent (about 10 times) than oxmetidine but less efficacious on the angiotensin-induced contraction. Finally nifedipine was the most active compound on the KCl induced contraction but was almost ineffective against angiotensin. It is concluded that oxmetidine, though with a still unclear mechanism, possesses a weak but definite inhibitory effect on the availability of the intracellular calcium resembling the effect of nitroglycerin. Whether or not an action on the influx of calcium is also present cannot be surely established as long as calcium fluxes are not measured. Differences in the behaviour of the \"classical\" calcium entry blockers suggest that each of them possesses, together with the main well recognized effect, additional effects responsible for apparently surprising results obtained against different spasmogenic compounds.',\n",
       "  'journal': 'Pharmacological research communications',\n",
       "  'authors': 'Bertaccini|G|G|;Poli|E|E|;Raddino|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150501',\n",
       "  'mesh_terms': 'D000818:Animals; D001013:Aorta, Thoracic; D002121:Calcium Channel Blockers; D005260:Female; D005711:Gallopamil; D006635:Histamine H2 Antagonists; D007093:Imidazoles; D066298:In Vitro Techniques; D008297:Male; D009543:Nifedipine; D005996:Nitroglycerin; D011817:Rabbits; D014661:Vasoconstriction; D014700:Verapamil',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002121:Calcium Channel Blockers; D006635:Histamine H2 Antagonists; D007093:Imidazoles; D005711:Gallopamil; D014700:Verapamil; D005996:Nitroglycerin; D009543:Nifedipine; C027703:oxmetidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0031-6989(84)80091-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Res Commun',\n",
       "  'nlm_unique_id': '0236354',\n",
       "  'issn_linking': '0031-6989',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effect of sucralfate on the bioavailability of indenolol.',\n",
       "  'issue': '16(9)',\n",
       "  'pages': '845-50',\n",
       "  'abstract': 'Effect of concurrent administration of sucralfate on the bioavailability of indenolol in rats has been investigated. Albino rats were administered with lg/kg body weight of sucralfate just before the oral administration of indenolol solution (10 mg/kg), blood samples were collected at 0,15,30,45,60,120,240 and 360 minutes after the administration of drugs. Indenolol concentration was determined spectrofluorometrically, 2,4, and 6-hour Area Under the Curve (AUC) was calculated. The peak indenolol blood concentration was observed at 45th minute of drug administration. The level in rats treated with indenolol alone (2.46 +/- 0.07 microgram/ml) and indenolol along with sucralfate (1.21 +/- 0.06 microgram/ml) suggested more than a 50% decrease. There were 36.4%, 27.2% and 20.4% decrease in 2-hour AUC, 4-hour AUC and 6-hour AUC respectively. The data suggest that sucralfate significantly decreased the absorption of indenolol, especially in the early phase after administration and clinically significant interaction may occur due to concurrent administration of indenolol with sucralfate.',\n",
       "  'journal': 'Pharmacological research communications',\n",
       "  'authors': 'Babhair|S A|SA|;Tariq|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150502',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000535:Aluminum; D000818:Animals; D001682:Biological Availability; D004347:Drug Interactions; D007192:Indenes; D011412:Propanolamines; D051381:Rats; D013392:Sucralfate',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D007192:Indenes; D011412:Propanolamines; D013392:Sucralfate; C002989:indenolol; D000535:Aluminum',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0031-6989(84)80021-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Res Commun',\n",
       "  'nlm_unique_id': '0236354',\n",
       "  'issn_linking': '0031-6989',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Pipradrol-induced hyperthermia in the rabbit.',\n",
       "  'issue': '16(9)',\n",
       "  'pages': '923-31',\n",
       "  'abstract': 'Intravenous administration of the stimulant drug pipradrol evoked a dose-dependent hyperthermic response in rabbits. This drug effect was significantly reduced by pretreatment with chlorpromazine, phenoxybenzamine, intravenous BE-2254 or intracerebroventricular BE-2254. In animals pretreated with cyproheptadine or atropine, the hyperthermic effect was significantly potentiated. However, haloperidol, pimozide, diphenhydramine and pentobarbital failed to appreciably influence the drug response. These findings suggest that pipradrol-induced hyperthermia in the rabbit involves activation of central alpha-adrenergic receptors and is apparently enhanced by blockade of serotonergic or cholinergic receptors.',\n",
       "  'journal': 'Pharmacological research communications',\n",
       "  'authors': 'Small|S F|SF|;Quock|R M|RM|;Malone|M H|MH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150503',\n",
       "  'mesh_terms': 'D000818:Animals; D001831:Body Temperature; D004347:Drug Interactions; D007276:Injections, Intraventricular; D008297:Male; D010880:Piperidines; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha; D011950:Receptors, Cholinergic; D011985:Receptors, Serotonin; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D010880:Piperidines; D011942:Receptors, Adrenergic, alpha; D011950:Receptors, Cholinergic; D011985:Receptors, Serotonin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0031-6989(84)80029-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacol Res Commun',\n",
       "  'nlm_unique_id': '0236354',\n",
       "  'issn_linking': '0031-6989',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Comparative study of pA2 values of pirenzepine and atropine for guinea-pig gastric fundus and gastric smooth muscle.',\n",
       "  'issue': '29(6)',\n",
       "  'pages': '329-35',\n",
       "  'abstract': 'Concentration-response curves of bethanechol were obtained from isolated guinea pig gastric fundus and gastric circular smooth muscle strips before and after exposure to pirenzepine or atropine. In the presence of pirenzepine and atropine these curves were shifted parallel to the right with no change in maximum response. Against bethanechol, mean pA2 values were 7.06 for pirenzepine and 8.16 for atropine on gastric fundus, with slopes of Schild plots close to unity for both antagonists, whereas in the case of gastric smooth muscle pA2 values were 6.52 for pirenzepine and 8.52 for atropine, with the slope of the Schild plot significantly less than -1 in the case of pirenzepine. The values of the Schild slope seem to indicate that pirenzepine interacts with a single, apparently homogeneous population of muscarinic receptors on gastric mucosa, at variance with the behaviour of pirenzepine on receptors of gastric smooth muscle.',\n",
       "  'journal': 'Pharmacology',\n",
       "  'authors': 'Del Tacca|M|M|;Soldani|G|G|;Bernardini|C|C|;Martinotti|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150504',\n",
       "  'mesh_terms': 'D000818:Animals; D001285:Atropine; D001570:Benzodiazepinones; D018723:Bethanechol; D001626:Bethanechol Compounds; D005260:Female; D005748:Gastric Fundus; D005753:Gastric Mucosa; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction; D009130:Muscle, Smooth; D010890:Pirenzepine; D011976:Receptors, Muscarinic; D013270:Stomach',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D001570:Benzodiazepinones; D001626:Bethanechol Compounds; D011976:Receptors, Muscarinic; D018723:Bethanechol; D010890:Pirenzepine; D001285:Atropine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000138032',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Pharmacology',\n",
       "  'nlm_unique_id': '0152016',\n",
       "  'issn_linking': '0031-7012',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'The effect of ovariectomy, estradiol and progesterone on opioid modulation of feeding.',\n",
       "  'issue': '33(2)',\n",
       "  'pages': '237-41',\n",
       "  'abstract': \"A number of lines of evidence have suggested that alterations in gonadal steroids may modulate opioid function. We report here the effects of manipulation of female gonadal steroids on the opioid feeding system. Naloxone produced a depression of feeding in all groups. Although the group X dosage interaction was not significant, an internally consistent tendency effect of naloxone among the different treatment groups was observed. Estradiol treated rats were 20 times less sensitive to naloxone's suppressive effects of feeding than ovariectomized animals. Sham operated controls and animals treated with estradiol and progesterone had sensitivities to naloxone which were intermediate to those seen in estradiol treated and ovariectomized animals. A significant drug X dosage interaction was present for the ketocyclazocine effects at 4 hours. Overall, ovariectomized animals were resistant to feeding induced by ketocyclazocine compared to the other groups. Ovariectomy significantly decreased ir-dynorphin levels in the cortex and these values were restored towards normal by a combination of estrogen and progesterone treatment. These studies add to the growing literature suggesting a role for the peripheral endocrine system in the modulation of opioid feeding system.\",\n",
       "  'journal': 'Physiology & behavior',\n",
       "  'authors': 'Morley|J E|JE|;Levine|A S|AS|;Grace|M|M|;Kneip|J|J|;Gosnell|B A|BA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150505',\n",
       "  'mesh_terms': 'D000818:Animals; D001069:Appetite Regulation; D001921:Brain; D002369:Castration; D003496:Cyclazocine; D004399:Dynorphins; D004435:Eating; D004958:Estradiol; D016314:Ethylketocyclazocine; D005260:Female; D009270:Naloxone; D011374:Progesterone; D051381:Rats; D011919:Rats, Inbred Strains; D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D011957:Receptors, Opioid; D017473:Receptors, Opioid, kappa; D009270:Naloxone; D011374:Progesterone; D004958:Estradiol; D016314:Ethylketocyclazocine; C012395:ketazocine; D004399:Dynorphins; D003496:Cyclazocine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0031-9384(84)90105-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Physiol Behav',\n",
       "  'nlm_unique_id': '0151504',\n",
       "  'issn_linking': '0031-9384',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Self-injection of diazepam in naive rats: effects of dose, schedule and blockade of different receptors.',\n",
       "  'issue': '84(2)',\n",
       "  'pages': '174-7',\n",
       "  'abstract': 'The present series of experiments had two main objectives: The first was to determine the conditions under which self-injection of the benzodiazepine diazepam would be optimal; the second was to identify neurochemical substrates which underlie the maintenance of diazepam self-administration. Data from the first experiment indicated that rats maintained on an FI-1 (Fixed Interval of 1 min) schedule of food delivery self-injected significantly more diazepam than rats not maintained on this schedule. Results from the second experiment demonstrated that the benzodiazepine antagonist Ro 15-1788, and the GABA antagonist bicuculline, significantly reduced diazepam self-administration, but the opiate antagonist naloxone was without effect. Data from the third experiment showed that the dopamine antagonist haloperidol also significantly reduced the rate of diazepam self-injection. Thus, these findings indicate that the acquisition of diazepam self-injection occurs under an FI-1 schedule of food delivery, which has been shown to be middly stressful, while its maintenance depends upon the functional integrity of benzodiazepine and GABA receptors and upon the activity of dopaminergic pathways.',\n",
       "  'journal': 'Psychopharmacology',\n",
       "  'authors': 'Pilotto|R|R|;Singer|G|G|;Overstreet|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150506',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001640:Bicuculline; D003975:Diazepam; D004305:Dose-Response Relationship, Drug; D005108:Extinction, Psychological; D005442:Flumazenil; D006220:Haloperidol; D008297:Male; D009270:Naloxone; D051381:Rats; D011955:Receptors, Drug; D012055:Reinforcement Schedule; D012646:Self Administration',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D011955:Receptors, Drug; D009270:Naloxone; D005442:Flumazenil; D006220:Haloperidol; D003975:Diazepam; D001640:Bicuculline',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00427442',\n",
       "  'references': '460407;239165;574971;354753;6261143;43554;7146054;6265597;6986133;231789;7291219;746058;6813616;6292984;493291;7291250;7195030;6161385;747590;7422702;608135;7070212',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Psychopharmacology (Berl)',\n",
       "  'nlm_unique_id': '7608025',\n",
       "  'issn_linking': '0033-3158',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'An early phase II clinical trial of BW234U in the treatment of acute schizophrenia in newly admitted patients.',\n",
       "  'issue': '84(2)',\n",
       "  'pages': '282-4',\n",
       "  'abstract': 'Sixteen schizophrenic patients, who were newly admitted to hospital from the emergency room, underwent a 3-6-day washout before being treated for 4 weeks with BW234U, a dimethylpiperazinyl-propylcarbazole derivative. Eight patients showed moderate to marked improvement in schizophrenic symptoms and there was a statistically significant (P less than 0.001) reduction in the mean score for Clinical Global Impressions in all patients. Four patients did not complete the trial; two because of poor therapeutic effect, one because of a grand-mal seizure and one because of an episode of loss of consciousness of unknown origin. BW234U showed no evidence of neuroleptic plasma activity (as measured by radioreceptor assay), did not induce plasma prolactin elevation and did not appear to cause parkinsonism.',\n",
       "  'journal': 'Psychopharmacology',\n",
       "  'authors': 'Chouinard|G|G|;Annable|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150507',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000328:Adult; D014150:Antipsychotic Agents; D002227:Carbazoles; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011388:Prolactin; D011569:Psychiatric Status Rating Scales; D012559:Schizophrenia; D012565:Schizophrenic Psychology',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D002227:Carbazoles; D011388:Prolactin; C034931:rimcazole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00427460',\n",
       "  'references': '33969;927531;6112242;4631065;5169029;6121550',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Psychopharmacology (Berl)',\n",
       "  'nlm_unique_id': '7608025',\n",
       "  'issn_linking': '0033-3158',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Neurotransmitters and anxiety: overview.',\n",
       "  'issue': '17 Suppl 3()',\n",
       "  'pages': '3-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Psychopathology',\n",
       "  'authors': 'Lader|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150508',\n",
       "  'mesh_terms': 'D000437:Alcoholism; D001007:Anxiety; D001348:Aversive Therapy; D001696:Biomechanical Phenomena; D006801:Humans; D018377:Neurotransmitter Agents; D009626:Terminology as Topic',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000284126',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Psychopathology',\n",
       "  'nlm_unique_id': '8401537',\n",
       "  'issn_linking': '0254-4962',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Clinical studies of buspirone.',\n",
       "  'issue': '17 Suppl 3()',\n",
       "  'pages': '61-8',\n",
       "  'abstract': 'This literature review addresses two related questions: Is buspirone as clinically effective an antianxiety agent as the benzodiazepines? And does buspirone offer any safety advantages? Data from over 1,000 anxious outpatients reveal that an average dose of 20 mg of buspirone/day appears to be as effective an antianxiety agent as comparable doses of diazepam or clorazepate in both acute and more chronic administration studies. Buspirone appears to cause less clinically significant impairment in cognition or motor performance, is less likely to potentiate the effects of brain depressants like alcohol, has little if any abuse liability, and produces no clinically identifiable physical abstinence syndrome when discontinued after long-term administration. While the final answer on the clinical usefulness and side effect profile of this interesting drug awaits the results of its use in divergent clinical settings, this new antianxiety agent appears to be equally effective in treating anxiety but is safer than the benzodiazepines.',\n",
       "  'journal': 'Psychopathology',\n",
       "  'authors': 'Schuckit|M A|MA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150509',\n",
       "  'mesh_terms': 'D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D002065:Buspirone; D055598:Chemical Phenomena; D002621:Chemistry; D004341:Drug Evaluation; D006801:Humans; D011743:Pyrimidines',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D011743:Pyrimidines; D001569:Benzodiazepines; D002065:Buspirone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000284132',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Psychopathology',\n",
       "  'nlm_unique_id': '8401537',\n",
       "  'issn_linking': '0254-4962',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Neuropharmacology of buspirone.',\n",
       "  'issue': '17 Suppl 3()',\n",
       "  'pages': '69-78',\n",
       "  'abstract': \"Buspirone is a clinically effective anxiolytic with a unique structure and pharmacology which distinguishes it from the benzodiazepines. It has been termed anxioselective because it lacks anticonvulsant, sedative, or muscle-relaxant properties. Preclinical evidence suggests it lacks potential for abuse or physical dependence and interacts minimally with CNS depressants such as alcohol. Rather than working through traditional benzodiazepine mechanisms, buspirone affects diverse aspects of the brain's neurochemical circuitry. For example, it exerts potent influences on the nigrostriatal and mesolimbic dopamine systems, the dorsal raphe serotonergic system, and the locus coeruleus noradrenergic system. Although without direct receptor interaction, potentiation of cholinergically mediated behavior and involvement with GABAergic neurotransmission have also been demonstrated.\",\n",
       "  'journal': 'Psychopathology',\n",
       "  'authors': 'Riblet|L A|LA|;Eison|A S|AS|;Eison|M S|MS|;Taylor|D P|DP|;Temple|D L|DL|;VanderMaelen|C P|CP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150510',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001569:Benzodiazepines; D001696:Biomechanical Phenomena; D002065:Buspirone; D055598:Chemical Phenomena; D002621:Chemistry; D004298:Dopamine; D006801:Humans; D006993:Hypnotics and Sedatives; D008253:Macaca mulatta; D009126:Muscle Relaxation; D009132:Muscles; D009420:Nervous System; D009448:Neurochemistry; D011743:Pyrimidines; D051381:Rats; D019966:Substance-Related Disorders; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D011743:Pyrimidines; D001569:Benzodiazepines; D005680:gamma-Aminobutyric Acid; D002065:Buspirone; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000284133',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Psychopathology',\n",
       "  'nlm_unique_id': '8401537',\n",
       "  'issn_linking': '0254-4962',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Tardive dyskinesia: a two-year follow-up study.',\n",
       "  'issue': '25(11)',\n",
       "  'pages': '852-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Psychosomatics',\n",
       "  'authors': 'Yassa|R|R|;Nair|V|V|;Schwartz|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150511',\n",
       "  'mesh_terms': 'D000328:Adult; D000341:Affective Disorders, Psychotic; D000368:Aged; D014150:Antipsychotic Agents; D004409:Dyskinesia, Drug-Induced; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D019965:Neurocognitive Disorders; D012559:Schizophrenia',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/S0033-3182(84)72946-X',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Psychosomatics',\n",
       "  'nlm_unique_id': '0376506',\n",
       "  'issn_linking': '0033-3182',\n",
       "  'country': 'England'},\n",
       " {'title': 'Cause of impaired carbohydrate metabolism in hyperthyroidism.',\n",
       "  'issue': '25(5)',\n",
       "  'pages': '709-15',\n",
       "  'abstract': '',\n",
       "  'journal': 'Radiobiologia, radiotherapia',\n",
       "  'authors': 'Földes|J|J|;Megyesi|K|K|;Korányi|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150512',\n",
       "  'mesh_terms': 'D000328:Adult; D001786:Blood Glucose; D004912:Erythrocytes; D005260:Female; D005934:Glucagon; D006801:Humans; D006980:Hyperthyroidism; D007328:Insulin; D007457:Iodine Radioisotopes; D008875:Middle Aged; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D007328:Insulin; D007457:Iodine Radioisotopes; D013004:Somatostatin; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Radiobiol Radiother (Berl)',\n",
       "  'nlm_unique_id': '0401247',\n",
       "  'issn_linking': '0033-8184',\n",
       "  'country': 'Germany'},\n",
       " {'title': \"The common incidence of Basedow's-Graves' disease and chronic lymphocytic thyroiditis.\",\n",
       "  'issue': '25(5)',\n",
       "  'pages': '769-74',\n",
       "  'abstract': '',\n",
       "  'journal': 'Radiobiologia, radiotherapia',\n",
       "  'authors': 'Leövey|A|A|;Bakó|G|G|;Sztojka|I|I|;Szabó|J|J|;Kálmán|K|K|;Szabó|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150513',\n",
       "  'mesh_terms': 'D000906:Antibodies; D005260:Female; D006111:Graves Disease; D006801:Humans; D018828:Immunoglobulins, Thyroid-Stimulating; D008297:Male; D013967:Thyroiditis, Autoimmune',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000906:Antibodies; D018828:Immunoglobulins, Thyroid-Stimulating',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Radiobiol Radiother (Berl)',\n",
       "  'nlm_unique_id': '0401247',\n",
       "  'issn_linking': '0033-8184',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Short half-life benzodiazepines.',\n",
       "  'issue': '18(4)',\n",
       "  'pages': '1-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Rational drug therapy',\n",
       "  'authors': 'Greenblatt|D J|DJ|;Shader|R I|RI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150514',\n",
       "  'mesh_terms': 'D014151:Anti-Anxiety Agents; D001381:Azepines; D001569:Benzodiazepines; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008874:Midazolam; D014229:Triazolam',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001381:Azepines; D001569:Benzodiazepines; D014229:Triazolam; C020960:brotizolam; D008874:Midazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ration Drug Ther',\n",
       "  'nlm_unique_id': '1247445',\n",
       "  'issn_linking': '0031-7020',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Serotoninergic control of somatostatin and gastrin release from the isolated rat stomach.',\n",
       "  'issue': '9(1-2)',\n",
       "  'pages': '101-8',\n",
       "  'abstract': 'The influence of exogenous serotonin on the secretion of gastric somatostatin and gastrin was investigated under in vitro conditions using an isolated, vascularly perfused rat stomach preparation. Serotonin stimulated gastrin release, maximal effects were observed at 10(-6) M which increased gastrin levels by 78%; on the contrary, somatostatin secretion was inhibited (maximal inhibition of 56% at 10(-6) M). Changes in hormone secretion in response to serotonin were reversed by combined blockade of 5-HT1 and 5-HT2 receptors by methysergide and blockade of 5-HT2 receptors by ketanserin (10(-5) and 10(-6) M, respectively), and of cholinoreceptors by atropine (10(-5) M). It is concluded that in rats in vitro serotonin inhibits release of gastric somatostatin and stimulates gastrin secretion via specific serotonin receptors but muscarinic cholinergic receptors are also involved.',\n",
       "  'journal': 'Regulatory peptides',\n",
       "  'authors': 'Koop|H|H|;Arnold|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150515',\n",
       "  'mesh_terms': 'D000818:Animals; D005753:Gastric Mucosa; D005755:Gastrins; D066298:In Vitro Techniques; D007650:Ketanserin; D008297:Male; D008784:Methysergide; D010477:Perfusion; D010880:Piperidines; D051381:Rats; D011919:Rats, Inbred Strains; D011976:Receptors, Muscarinic; D011985:Receptors, Serotonin; D012701:Serotonin; D013004:Somatostatin',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005755:Gastrins; D010880:Piperidines; D011976:Receptors, Muscarinic; D011985:Receptors, Serotonin; D012701:Serotonin; D013004:Somatostatin; D007650:Ketanserin; D008784:Methysergide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0167-0115(84)90012-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Regul Pept',\n",
       "  'nlm_unique_id': '8100479',\n",
       "  'issn_linking': '0167-0115',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Somatostatin inhibits bombesin-induced effects on migrating myoelectric complexes in the small intestine of the rat.',\n",
       "  'issue': '9(1-2)',\n",
       "  'pages': '11-9',\n",
       "  'abstract': 'The effect of i.v. infusions of bombesin and somatostatin, administered either separately or in combination, on migrating myoelectric complexes (MMCs) in the small intestine were studied in conscious, fasted rats. The myoelectrical activity was recorded by means of three bipolar electrodes chronically implanted into the duodenum and jejunum. Infusion of bombesin (0.5, 0.9 and 3 pmol . kg-1 . min-1) interrupted the MMC and induced irregular spiking activity similar to that observed on feeding. Only after the highest dose a consistent inhibition of the MMCs and a significant increase (P less than 0.05) of the spiking activity were achieved at all recording levels. Somatostatin (90 pmol . kg-1 . min-1) did not interrupt the MMC, but reduced significantly the incidence of the activity fronts and spiking activity of the MMCs (P less than 0.05). The effects of bombesin (3 pmol . kg-1 . min-1) on the MMC pattern were inhibited by simultaneous infusion of somatostatin (P less than 0.05). In a second series of experiments, using anesthetized rats, infusion of bombesin (0.5 and 3 pmol . kg-1 . min-1) increased the plasma concentration of neurotensin- gastrin-like immunoreactivities in a dose-dependent manner. The results show that bombesin alters the myoelectrical activity of the small intestine from a fasting to a fed pattern. Since the effect of bombesin was inhibited by the hormone release inhibitor somatostatin, it is suggested that the effect of bombesin on MMC may be secondary to the release of gastrointestinal peptides, such as neurotensin or gastrin.',\n",
       "  'journal': 'Regulatory peptides',\n",
       "  'authors': 'Al-Saffar|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150516',\n",
       "  'mesh_terms': 'D000818:Animals; D001839:Bombesin; D004576:Electromyography; D004594:Electrophysiology; D005755:Gastrins; D007421:Intestine, Small; D009496:Neurotensin; D010455:Peptides; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005755:Gastrins; D010455:Peptides; D009496:Neurotensin; D013004:Somatostatin; D001839:Bombesin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0167-0115(84)90003-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Regul Pept',\n",
       "  'nlm_unique_id': '8100479',\n",
       "  'issn_linking': '0167-0115',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Subcellular distribution of somatostatin-14, somatostatin-28 and somatostatin-28 (1-12) in rat brain cortex and comparisons of their respective binding sites in brain and pituitary.',\n",
       "  'issue': '9(1-2)',\n",
       "  'pages': '129-37',\n",
       "  'abstract': 'Subcellular distribution and binding characteristics of the three endogenous peptides somatostatin-14 (SRIF-14), somatostatin-28 (SRIF-28) and somatostatin-28(1-12) (SRIF-28(1-12] derived from preprosomatostatin were investigated in the rat brain cortex. The three peptides are predominantly recovered from a crude mitochondrial pellet (P2), containing the pinched off nerve endings. Specific high affinity binding sites for 125I-N-Tyr-SRIF-14 and 125I-N-Tyr-SRIF-28 are present on pituitary and brain membranes. Under the same conditions, 125I-N-Tyr-SRIF-28(1-12) binding is undetectable. Moreover, SRIF-28(1-12) does not displace 125I-N-Tyr-SRIF-14 or 125I-N-Tyr-SRIF-28 binding. SRIF-28 is more potent than SRIF-14 to displace 125I-N-Tyr-SRIF-28 binding to brain and pituitary membranes, while both peptides are equipotent to displace 125I-N-Tyr-SRIF-14 binding. Finally, the regional distribution of 125I-N-Tyr-SRIF-14 and 125I-N-Tyr-SRIF-28 binding sites in the brain is identical. In conclusion, the present results are consistent with a neurotransmitter and neurohormonal role for SRIF-14 and SRIF-28. The function of SRIF-28(1-12) in brain remains to be elucidated. Additionally, a differential role for SRIF-14 and SRIF-28 both in adenohypophysis and brain cannot be ascertained at the present time.',\n",
       "  'journal': 'Regulatory peptides',\n",
       "  'authors': 'Moyse|E|E|;Benoit|R|R|;Enjalbert|A|A|;Gautron|J P|JP|;Kordon|C|C|;Ling|N|N|;Epelbaum|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150517',\n",
       "  'mesh_terms': 'D000818:Animals; D001665:Binding Sites; D001667:Binding, Competitive; D002540:Cerebral Cortex; D008297:Male; D010446:Peptide Fragments; D010902:Pituitary Gland; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin; D053561:Somatostatin-28; D013347:Subcellular Fractions; D014018:Tissue Distribution',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D010446:Peptide Fragments; D013004:Somatostatin; D053561:Somatostatin-28; C037197:somatostatin 28-(1-12)',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0167-0115(84)90015-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Regul Pept',\n",
       "  'nlm_unique_id': '8100479',\n",
       "  'issn_linking': '0167-0115',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Neuropeptides as central integrators of autonomic nerve activity: effects of TRH, SRIF, VIP and bombesin on gastric and adrenal nerves.',\n",
       "  'issue': '9(1-2)',\n",
       "  'pages': '47-52',\n",
       "  'abstract': 'The nerve activity of the gastric ramus of the splanchnic (sympathetic) nerve, gastric ramus of the vagus, adrenal ramus of the splanchnic nerve and the superior laryngeal nerve (laryngeal ramus of vagus) were assessed before and after i.c.v. injection of neuropeptides in the rat. TRH stimulated the vagal branch but attenuated the sympathetic outflow to the stomach. In contrast, the sympathetic outflow to the adrenal was enhanced by TRH. SRIF suppressed the activity of all the nerves studied. VIP did not affect the sympathetic outflow to the stomach while suppressing the gastric branch of the vagus. The adrenal sympathetic branch as well as the superior laryngeal nerve was stimulated by VIP. Bombesin suppressed both vagal and sympathetic outflow to the stomach but markedly stimulated the laryngeal branch of the vagus. The adrenal sympathetic nerve was either stimulated or attenuated slightly by bombesin. These results indicate that centrally administered neuropeptides produce reactions specific for each nerve.',\n",
       "  'journal': 'Regulatory peptides',\n",
       "  'authors': 'Somiya|H|H|;Tonoue|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150518',\n",
       "  'mesh_terms': 'D000311:Adrenal Glands; D000818:Animals; D001341:Autonomic Nervous System; D001839:Bombesin; D008297:Male; D009419:Nerve Tissue Proteins; D051381:Rats; D011919:Rats, Inbred Strains; D013004:Somatostatin; D013270:Stomach; D013973:Thyrotropin-Releasing Hormone; D014660:Vasoactive Intestinal Peptide',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D009419:Nerve Tissue Proteins; D014660:Vasoactive Intestinal Peptide; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D001839:Bombesin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0167-0115(84)90006-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Regul Pept',\n",
       "  'nlm_unique_id': '8100479',\n",
       "  'issn_linking': '0167-0115',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Synchronizing, sedative and anticonvulsive effects of centrally administered somatostatin in the conscious rabbit.',\n",
       "  'issue': '9(1-2)',\n",
       "  'pages': '77-86',\n",
       "  'abstract': 'The effects of intracerebroventricular injection of somatostatin-14 on the cortical and deep structure electrical activity, somatic behavior and rectal temperature, were studied in 45 unanesthetized rabbits. In addition the antiepileptic action of the peptide was tested in these models: pentamethylenetetrazole-induced cortical spikes and waves, epileptic focus by topical application of strychnine and voltage-threshold for amygdala after-discharge. The results indicate that somatostatin exerts synchronizing, sedative and weak antiepileptic effects when centrally administered to rabbits.',\n",
       "  'journal': 'Regulatory peptides',\n",
       "  'authors': 'Tartara|A|A|;Maurelli|M|M|;Savoldi|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150519',\n",
       "  'mesh_terms': 'D000818:Animals; D000927:Anticonvulsants; D001831:Body Temperature; D002490:Central Nervous System; D004569:Electroencephalography; D004594:Electrophysiology; D006993:Hypnotics and Sedatives; D007276:Injections, Intraventricular; D009043:Motor Activity; D009270:Naloxone; D011817:Rabbits; D013004:Somatostatin',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000927:Anticonvulsants; D006993:Hypnotics and Sedatives; D009270:Naloxone; D013004:Somatostatin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0167-0115(84)90010-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Regul Pept',\n",
       "  'nlm_unique_id': '8100479',\n",
       "  'issn_linking': '0167-0115',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Nephrotoxicity of contrast media. Comparison of iopamidol and diatrizoate by measurement of urinary enzymes after urography].',\n",
       "  'issue': '70(4)',\n",
       "  'pages': '176-9',\n",
       "  'abstract': 'An ionic (diatrizoate) and a non ionic (iopamidole) radiocontrast medium were compared as to their nephrotoxicity in a cohort of 21 patients with renal disease, 18 of which with normal renal function. The elevation of the urinary excretion of enzymes from renal tubular cells has been considered as a good index for renal tubular damage. We measured two lysosomal enzymes (NAG and beta glucuronidase) and a brush-border enzyme (gamma GT). In all patients we demonstrated an elevation of urinary excretion of the three enzymes already 12 hours after contrast medium administration. However, the elevation was statistically significant only after employment of the ionic contrast medium and concerned gamma GT and beta-glucuronidase; the urinary excretion of NAG did not vary significantly. Urinary enzymes levels returned to basal values 36 hours after intravenous pyelography. In conclusion, iopamidole showed a lower nephrotoxicity with respect to diatrizoate, as demonstrated by the lower levels of urinary enzymes excretion reached after its use.',\n",
       "  'journal': 'La Radiologia medica',\n",
       "  'authors': \"Schiavina|G|G|;Arrigo|G|G|;Vergnaghi|D|D|;Cavaliere|G|G|;Scarduelli|B|B|;Luzzatti|G|G|;D'Amico|G|G|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150520',\n",
       "  'mesh_terms': 'D000118:Acetylglucosaminidase; D003287:Contrast Media; D005966:Glucuronidase; D006801:Humans; D007668:Kidney; D014567:Urography; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D003287:Contrast Media; D005723:gamma-Glutamyltransferase; D005966:Glucuronidase; D000118:Acetylglucosaminidase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Radiol Med',\n",
       "  'nlm_unique_id': '0177625',\n",
       "  'issn_linking': '0033-8362',\n",
       "  'country': 'Italy'},\n",
       " {'title': 'Behavioral treatment methods for alcoholism.',\n",
       "  'issue': '1()',\n",
       "  'pages': '139-65',\n",
       "  'abstract': 'This chapter offers a review of the behavioral methodology directed to the treatment of alcoholism. Beginning with an outline of the theoretical bases of behavior therapy and assessment, a review with some historical perspective is undertaken of the chemical, electrical, and covert aversion treatments of alcoholism. Thereafter, the procedures of the social skills-training strategies (including marital skills and assertiveness training) are presented, followed by a discussion of the relaxation and desensitization techniques. The operant methodologies are illustrated by contingency contracting and the community-reinforcement approaches. Within the broad-spectrum procedures, a description of self-control training and an example of a broad-spectrum treatment study are offered. It is noted that although the merits of these various techniques are becoming widely recognized in the alcoholism treatment literature, the behavior therapeutic approaches to alcoholism have yet to receive widespread public acceptance. It is anticipated that future studies of treatment effectiveness will contribute to an increasing appreciation of the advantages of behavioral therapies to the management of alcohol abuse and dependence.',\n",
       "  'journal': 'Recent developments in alcoholism : an official publication of the American Medical Society on Alcoholism, the Research Society on Alcoholism, and the National Council on Alcoholism',\n",
       "  'authors': 'Caddy|G R|GR|;Block|T|T|',\n",
       "  'pubdate': '1983',\n",
       "  'pmid': '6150521',\n",
       "  'mesh_terms': 'D000437:Alcoholism; D001242:Assertiveness; D001348:Aversive Therapy; D001521:Behavior Therapy; D003216:Conditioning, Operant; D003887:Desensitization, Psychologic; D006801:Humans; D007398:Interpersonal Relations; D012064:Relaxation Therapy',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/978-1-4613-3617-4_8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Recent Dev Alcohol',\n",
       "  'nlm_unique_id': '8301996',\n",
       "  'issn_linking': '0738-422X',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Beta blockers in ischemic cardiopathy].',\n",
       "  'issue': '37 Suppl 1()',\n",
       "  'pages': '2-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista espanola de cardiologia',\n",
       "  'authors': 'Cía Gómez|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150526',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000787:Angina Pectoris; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005500:Follow-Up Studies; D006439:Hemodynamics; D006801:Humans; D009200:Myocardial Contraction; D009203:Myocardial Infarction; D009206:Myocardium; D009573:Nitrites; D010101:Oxygen Consumption',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D009573:Nitrites',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Esp Cardiol',\n",
       "  'nlm_unique_id': '0404277',\n",
       "  'issn_linking': '0300-8932',\n",
       "  'country': 'Spain'},\n",
       " {'title': '[Evaluation of the results obtained in thromboembolic vascular lesions with 2 platelet aggregation inhibitors].',\n",
       "  'issue': '32(4)',\n",
       "  'pages': '293-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de chirurgie, oncologie, radiologie, o.r.l., oftalmologie, stomatologie. Chirurgie',\n",
       "  'authors': 'Parisi|F R|FR|;Raso|A M|AM|;Fiorio|C|C|;Salvetti|M|M|',\n",
       "  'pubdate': '1983',\n",
       "  'pmid': '6150522',\n",
       "  'mesh_terms': 'D000328:Adult; D001241:Aspirin; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010080:Oxazoles; D010974:Platelet Aggregation; D012306:Risk; D013923:Thromboembolism',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D010080:Oxazoles; D001241:Aspirin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Chir Oncol Radiol O R L Oftalmol Stomatol Chir',\n",
       "  'nlm_unique_id': '7508736',\n",
       "  'issn_linking': '0377-5003',\n",
       "  'country': 'Romania'},\n",
       " {'title': 'Selective inhibition of sleep related growth hormone release by Phe-4-somatostatin.',\n",
       "  'issue': '45(3)',\n",
       "  'pages': '421-31',\n",
       "  'abstract': 'We have compared the effects of somatostatin (SS) and the somatostatin analog Phe-4-SS on nocturnal GH secretion in three normal male volunteers, 20 to 23 years of age. Subjects were studied in our sleep laboratory on 5 consecutive nights. Nights 1 and 2 were used for adaptation. On the third night (control night), all patients exhibited a typical GH peak accompanying slow-wave sleep, with maximum GH levels from 9.2 to 27 ng/ml. Insulin, glucagon and glucose levels were episodic and sleep-independent. On night 4, subjects received SS infusion at a rate of 3 micrograms/min, which inhibited GH levels consistently below 2.4 ng/ml. In two cases a post-infusion rebound of GH levels was observed. During SS infusion all three subjects showed a significant decrease in insulin levels (p less than 0.0005), followed by an immediate rebound after infusion was stopped. Glucagon levels fell significantly during infusion (p less than 0.001, p less than 0.025 and p less than 0.00025 respectively). Glucose was significantly higher than on control night in subject No. 3 (p less than 0.0005) and similar to control night in subjects 1 and 2. On the fifth night, Phe-4-SS was infused at a rate of 0.75 microgram/min. GH levels decreased significantly as compared to control night in all three subjects and remained virtually constant throughout the night. Insulin levels were diminished in subject No. 1 (p less than 0.0005), but were comparable to control values in subjects 2 and 3. Cessation of analog infusion was followed by a rebound in insulin levels in all three subjects. Glucagon values were not significantly lowered and the rebound effect was not apparent. Glucose levels were higher in response to Phe-4-SS than on control night, and fell below infusion values (p less than 0.001) after administration was discontinued. It was concluded that Phe-4-SS inhibits nocturnal secretion of GH more selectively than SS, but its effect is not more prolonged than that of SS.',\n",
       "  'journal': 'Research communications in chemical pathology and pharmacology',\n",
       "  'authors': 'Cabranes|J A|JA|;Vela|A|A|;Timoneda|F|F|;Meyers|C A|CA|;Coy|D H|DH|;Schally|A V|AV|;Charro|A L|AL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150528',\n",
       "  'mesh_terms': 'D000328:Adult; D001786:Blood Glucose; D002940:Circadian Rhythm; D005934:Glucagon; D013006:Growth Hormone; D006801:Humans; D007328:Insulin; D000078790:Insulin Secretion; D008297:Male; D012890:Sleep; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; C043613:somatostatin, Phe(4)-; D013006:Growth Hormone; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Res Commun Chem Pathol Pharmacol',\n",
       "  'nlm_unique_id': '0244734',\n",
       "  'issn_linking': '0034-5164',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Culicide collection in Country Basic Secondary Schools (ESBECS) for foreigners on the Isla de la Juventud. Preliminary study].',\n",
       "  'issue': '36(1)',\n",
       "  'pages': '59-62',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista cubana de medicina tropical',\n",
       "  'authors': 'Fuentes González|O|O|;Lugo Mendoza|J|J|;Castex Rodríguez|M|M|;Miqueli Negrín|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150523',\n",
       "  'mesh_terms': 'D003462:Cuba; D009033:Culicidae; D007303:Insect Vectors; D012574:Schools; D013045:Species Specificity',\n",
       "  'publication_types': \"D004740:English Abstract; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Cubana Med Trop',\n",
       "  'nlm_unique_id': '0074364',\n",
       "  'issn_linking': '0375-0760',\n",
       "  'country': 'Cuba'},\n",
       " {'title': 'Inhibition of growth hormone and glucagon release by Phe-4-somatostatin in patients with acromegaly.',\n",
       "  'issue': '45(3)',\n",
       "  'pages': '432-44',\n",
       "  'abstract': 'We have studied growth hormone (GH), insulin (I), glucagon (Gl) and glucose in basal conditions, after somatostatin (SS) (3 micrograms/ml) and Phe-4-SS (0.75 microgram/ml) infusion and IV bolus of the latter in 3 acromegalic patients. In two patients, Phe-4-SS inhibited glucagon and growth hormone secretion in a similar way as SS, without modifying insulin secretion. These effects were short-lived and ceased after the infusion was stopped. From these results it appears that Phe-4-SS is both more potent and more specific than SS with respect to inhibition of GH and glucagon release, but it does not have prolonged biological action. Lack of suppression of GH by SS or Phe-4-SS in the acromegalic patient with post-surgical recurrence of the disease could be due to the existence of receptor abnormalities, and suggests a diversity in the physiopathology of the disease.',\n",
       "  'journal': 'Research communications in chemical pathology and pharmacology',\n",
       "  'authors': 'Charro|A L|AL|;Cabranes|J A|JA|;Lafuente|A|A|;Diaz-Salgado|C|C|;Cordero|M|M|;Almoguera|I|I|;Comaru-Schally|A M|AM|;Meyers|C A|CA|;Coy|D H|DH|;Schally|A V|AV|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150529',\n",
       "  'mesh_terms': 'D000172:Acromegaly; D001786:Blood Glucose; D002940:Circadian Rhythm; D005260:Female; D005934:Glucagon; D013006:Growth Hormone; D006801:Humans; D007328:Insulin; D000078790:Insulin Secretion; D008297:Male; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; C043613:somatostatin, Phe(4)-; D013006:Growth Hormone; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Res Commun Chem Pathol Pharmacol',\n",
       "  'nlm_unique_id': '0244734',\n",
       "  'issn_linking': '0034-5164',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Serum gamma glutamyl transpeptidase activity in cattle with induced fascioliasis.',\n",
       "  'issue': '37(2)',\n",
       "  'pages': '167-71',\n",
       "  'abstract': 'Six-month-old calves were inoculated with 200 metacercariae of Fasciola hepatica over a 72 day period. Their aspartic transaminase, alkaline phosphatase, arginase and gamma glutamyl transpeptidase (GGT) values were measured at two-week intervals. Infections with a final fluke count of 19 to 87 flukes did not result in an increase of serum alkaline phosphatase or arginase compared with those in control calves. Serum aspartic transaminase values were increased significantly (P less than 0.025) above those of controls but were not increased over reference values. Seemingly, measurement of these enzymes would not be useful in assessing the degree of fluke infestation. In contrast, serum values of GGT increased 56 days after preliminary inoculation and remained high for at least 83 days after infection. The initial rise coincided with the penetration of bile ducts by migrating flukes. This relationship may be useful in further studies of fluke-induced biliary damage.',\n",
       "  'journal': 'Research in veterinary science',\n",
       "  'authors': 'Bulgin|M S|MS|;Anderson|B C|BC|;Hall|R F|RF|;Lang|B Z|BZ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150530',\n",
       "  'mesh_terms': 'D000469:Alkaline Phosphatase; D000818:Animals; D001119:Arginase; D001219:Aspartate Aminotransferases; D002417:Cattle; D002418:Cattle Diseases; D005211:Fascioliasis; D005260:Female; D008099:Liver; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D001119:Arginase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Res Vet Sci',\n",
       "  'nlm_unique_id': '0401300',\n",
       "  'issn_linking': '0034-5288',\n",
       "  'country': 'England'},\n",
       " {'title': '[Vecuronium: disadvantages and solutions].',\n",
       "  'issue': '31(5)',\n",
       "  'pages': '213',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista espanola de anestesiologia y reanimacion',\n",
       "  'authors': 'Miralles|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150524',\n",
       "  'mesh_terms': 'D004576:Electromyography; D006801:Humans; D008991:Monitoring, Physiologic; D009466:Neuromuscular Blocking Agents; D010197:Pancuronium; D014673:Vecuronium Bromide',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D009466:Neuromuscular Blocking Agents; D014673:Vecuronium Bromide; D010197:Pancuronium',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Esp Anestesiol Reanim',\n",
       "  'nlm_unique_id': '0134516',\n",
       "  'issn_linking': '0034-9356',\n",
       "  'country': 'Spain'},\n",
       " {'title': \"[Association of familial hyperparathyroidism and Cushing's disease].\",\n",
       "  'issue': '5(3)',\n",
       "  'pages': '201-4',\n",
       "  'abstract': \"Five members of one family had been operated on for primary hyperparathyroidism. One of them also had Cushing's disease (i.e. pituitary tumor). An association between familial hyperparathyroidism and Cushing's disease is quite unusual. Such a combination of rare diseases is not fortuitous though; it probably is but a special type of multiple endocrine neoplasia.\",\n",
       "  'journal': 'La Revue de medecine interne',\n",
       "  'authors': 'Gancel|A|A|;Courtois|H|H|;Dubois|D|D|;Meyer|M|M|;Dero|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150531',\n",
       "  'mesh_terms': 'D000328:Adult; D003480:Cushing Syndrome; D005260:Female; D006801:Humans; D006961:Hyperparathyroidism; D008297:Male; D008875:Middle Aged; D009377:Multiple Endocrine Neoplasia; D010375:Pedigree',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0248-8663(84)80054-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interne',\n",
       "  'nlm_unique_id': '8101383',\n",
       "  'issn_linking': '0248-8663',\n",
       "  'country': 'France'},\n",
       " {'title': '[Use of inotropic agents in the treatment of cardiac insufficiency].',\n",
       "  'issue': '37(3)',\n",
       "  'pages': '186-95',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista espanola de cardiologia',\n",
       "  'authors': 'Coma Canella|I|I|;López-Sendón|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150525',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D002395:Catecholamines; D002908:Chronic Disease; D003327:Coronary Disease; D004071:Digitalis Glycosides; D006333:Heart Failure; D006801:Humans; D007476:Ionophores; D010726:Phosphodiesterase Inhibitors',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D002395:Catecholamines; D004071:Digitalis Glycosides; D007476:Ionophores; D010726:Phosphodiesterase Inhibitors',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Esp Cardiol',\n",
       "  'nlm_unique_id': '0404277',\n",
       "  'issn_linking': '0300-8932',\n",
       "  'country': 'Spain'},\n",
       " {'title': 'Pharmacological modification of immunoregulatory activity of lymphocytes: facts and potential.',\n",
       "  'issue': '3(4)',\n",
       "  'pages': '274-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Survey of immunologic research',\n",
       "  'authors': 'Polmar|S H|SH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150532',\n",
       "  'mesh_terms': 'D000241:Adenosine; D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D002454:Cell Differentiation; D000242:Cyclic AMP; D005231:Fatty Acids, Unsaturated; D006632:Histamine; D007154:Immune System Diseases; D007165:Immunosuppression Therapy; D007249:Inflammation; D008211:Lymphocyte Cooperation; D008222:Lymphokines; D008264:Macrophages; D013491:Suppressor Factors, Immunologic; D013601:T-Lymphocytes',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.; D016454:Review\",\n",
       "  'chemical_list': 'D000945:Antigens, Differentiation, T-Lymphocyte; D000954:Antigens, Surface; D005231:Fatty Acids, Unsaturated; D008222:Lymphokines; D013491:Suppressor Factors, Immunologic; D006632:Histamine; D000242:Cyclic AMP; D000241:Adenosine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF02919043',\n",
       "  'references': '6601516;6446683;6460060;6190908;6966296;6296838;6605385;6966400;6987016;59738;6444561;6213308;6220065;6211316;350418;6216286;271970;6641949;6459376;6177462;6295385',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Surv Immunol Res',\n",
       "  'nlm_unique_id': '8215669',\n",
       "  'issn_linking': '0252-9564',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': '[Takayasu-Onishi arteritis. Clinical contribution].',\n",
       "  'issue': '75(7-8)',\n",
       "  'pages': '716-39',\n",
       "  'abstract': '',\n",
       "  'journal': 'Recenti progressi in medicina',\n",
       "  'authors': 'Biarese|V|V|;Marchi|L|L|;Di Marco|M|M|;Bouvet|M|M|;Lovisetto|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150527',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000925:Anticoagulants; D001015:Aortic Arch Syndromes; D001027:Aortography; D001158:Arteries; D002648:Child; D002675:Child, Preschool; D003095:Collagen Diseases; D003348:Cortisone; D003937:Diagnosis, Differential; D004691:Endarterectomy; D005260:Female; D006801:Humans; D007564:Japan; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013625:Takayasu Arteritis',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000925:Anticoagulants; D003348:Cortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Recenti Prog Med',\n",
       "  'nlm_unique_id': '0401271',\n",
       "  'issn_linking': '0034-1193',\n",
       "  'country': 'Italy'},\n",
       " {'title': '[Vasodilators in the treatment of arterial hypertension].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '289-302',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Gherasim|L|L|;Dorobanţu|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150533',\n",
       "  'mesh_terms': 'D002319:Cardiovascular System; D004359:Drug Therapy, Combination; D004630:Emergencies; D006801:Humans; D006973:Hypertension; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular; D012084:Renin-Angiotensin System; D013564:Sympathetic Nervous System; D014655:Vascular Resistance; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D014665:Vasodilator Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': '[Radionuclide angiography in assessing the heart function of myocardial infarct patients].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '317-23',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Carp|C|C|;Jovin|G|G|;Ginghină|C|C|;Murgoci|P|P|;Mihai|G|G|;Vintilă|P|P|;Rogozea|D|D|;Drăghici|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150536',\n",
       "  'mesh_terms': 'D006328:Cardiac Catheterization; D002932:Cineangiography; D004562:Electrocardiography; D005260:Female; D006321:Heart; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D011877:Radionuclide Imaging; D013670:Sodium Pertechnetate Tc 99m; D013318:Stroke Volume',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013670:Sodium Pertechnetate Tc 99m',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': '[Heart failure in acute myocardial infarct].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '309-16',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Mihail|A|A|;Crângulescu|N|N|;Bruckner|I I|II|;Durgheu|A|A|;Isacoff|D|D|;Căruntu|M|M|;Paraschiv|A|A|;Cinteză|M|M|;Vrejoiu|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150535',\n",
       "  'mesh_terms': 'D000328:Adult; D000367:Age Factors; D000368:Aged; D004562:Electrocardiography; D005260:Female; D006333:Heart Failure; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D011379:Prognosis; D012383:Romania; D012737:Sex Factors',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': '[Acute hemodynamic effects of nifedipine in hypertensive patients].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '303-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Koválszki|P|P|;Benedek|G|G|;Cotoi|S|S|;Albert|I|I|;Brassai|Z|Z|;Rapolski|M|M|;Hintea|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150534',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D004341:Drug Evaluation; D005260:Female; D006439:Hemodynamics; D006801:Humans; D006973:Hypertension; D008297:Male; D008875:Middle Aged; D009543:Nifedipine; D011187:Posture; D013997:Time Factors',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D009543:Nifedipine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': '[Relationship between the level of plasma renin activity and heart function in acute myocardial infarct].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '339-48',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Nicolaescu|V|V|;Câmpeanu|A|A|;Pleşea|O|O|;Rădoi|M|M|;Degeratu|T|T|;Băjenaru|C|C|;Georgescu|G|G|;Zaharescu|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150538',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D005260:Female; D006321:Heart; D006333:Heart Failure; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction; D012083:Renin; D012084:Renin-Angiotensin System; D013318:Stroke Volume',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D012083:Renin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': '[Usefulness of myocardial scintigrams with technetium in the diagnosis of acute myocardial necrosis].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '325-37',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Gherasim|L|L|;Cinteză|M|M|;Albu|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150537',\n",
       "  'mesh_terms': 'D000368:Aged; D004796:Clinical Enzyme Tests; D003937:Diagnosis, Differential; D011756:Diphosphates; D004562:Electrocardiography; D006321:Heart; D006801:Humans; D008875:Middle Aged; D009203:Myocardial Infarction; D009206:Myocardium; D009336:Necrosis; D011877:Radionuclide Imaging; D013667:Technetium; D016698:Technetium Tc 99m Pyrophosphate',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D011756:Diphosphates; D016698:Technetium Tc 99m Pyrophosphate; D013667:Technetium',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': '[Chronic treatment with vasodilators of heart failure. I. Hydralazine treatment].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '349-63',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Dumitriu|M|M|;Costică|I I|II|;Cinteză|M|M|;Dăescu|L|L|;Bălan|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150539',\n",
       "  'mesh_terms': 'D000368:Aged; D002908:Chronic Disease; D004341:Drug Evaluation; D005260:Female; D006333:Heart Failure; D006439:Hemodynamics; D006801:Humans; D006830:Hydralazine; D008297:Male; D008875:Middle Aged; D013318:Stroke Volume; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014665:Vasodilator Agents; D006830:Hydralazine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': 'Common pathways of invasion of mucosal barriers by Neisseria gonorrhoeae and Neisseria meningitidis.',\n",
       "  'issue': '3(1)',\n",
       "  'pages': '1-10',\n",
       "  'abstract': '',\n",
       "  'journal': 'Survey and synthesis of pathology research',\n",
       "  'authors': 'McGee|Z A|ZA|;Stephens|D S|DS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150544',\n",
       "  'mesh_terms': 'D016667:Bacterial Capsules; D001425:Bacterial Outer Membrane Proteins; D002448:Cell Adhesion; D005187:Fallopian Tubes; D005260:Female; D010861:Fimbriae, Bacterial; D006801:Humans; D008070:Lipopolysaccharides; D008854:Microscopy, Electron; D009092:Mucous Membrane; D009305:Nasopharynx; D009344:Neisseria gonorrhoeae; D009345:Neisseria meningitidis; D010447:Peptide Hydrolases; D010457:Peptidoglycan; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial; D012697:Serine Endopeptidases',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.; D016454:Review\",\n",
       "  'chemical_list': 'D001425:Bacterial Outer Membrane Proteins; D008070:Lipopolysaccharides; D010457:Peptidoglycan; D011135:Polysaccharides, Bacterial; C039455:capsular polysaccharide, meningococcal group B; D010447:Peptide Hydrolases; D012697:Serine Endopeptidases; C021433:IgA-specific serine endopeptidase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Surv Synth Pathol Res',\n",
       "  'nlm_unique_id': '8303576',\n",
       "  'issn_linking': '0253-438X',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': '[Special aspects in the treatment of heart failure in patients with the sick sinus syndrome].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '365-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Vintilă|P|P|;Făgărăşanu|R|R|;Rogozea|D|D|;Drăghici|D|D|;Ginghină|C|C|;Vintilă|M|M|;Carp|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150540',\n",
       "  'mesh_terms': 'D004070:Digitalis; D004232:Diuretics; D004359:Drug Therapy, Combination; D006333:Heart Failure; D006801:Humans; D010138:Pacemaker, Artificial; D010946:Plants, Medicinal; D010947:Plants, Toxic; D012804:Sick Sinus Syndrome; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004232:Diuretics; D014665:Vasodilator Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': \"[Neurotransmitter anomalies in Alzheimer's disease].\",\n",
       "  'issue': '140(10)',\n",
       "  'pages': '539-52',\n",
       "  'abstract': \"Neurochemical and histochemical techniques for characterization of neurotransmitters and their receptors in normal and pathological human brain have modified our understanding of Alzheimer's disease. From a hopeless clinico-pathological entity, it has become one of the models of possible physiopathological relations between neurotransmitter anomalies and dementia processes. Three types of neuromediator (or neuro-modulator): cholinergic, aminergic and peptidergic, appear to be affected to different degrees in 5 electively involved anatomical systems: cholinergic innominocorticoamygdalian and septohippocampic systems, noradrenergic ceruleocortical system, serotoninergic pontocortical system and cortical somatostatin and substance P systems. Critical analysis of neurochemical data shows that the biochemical nosology of Alzheimer's disease is confronted by the difficulty of constituting homogeneous series of both normal and pathological cases. Difficulties are increased when an attempt is made to establish correlations between neurotransmitter deficits and lesions or the demential process. This is the result of several factors: individual variability, difficulty in selecting valid controls, time elapsed before post-mortem sampling, imperfect understanding of the progressive topographical course of both cortical and subcortical lesions, which only now are being studied systematically and in a quantifiable manner, and finally the frequent absence of distinction between early and late forms of the disease. Truly senile forms should probably be distinguished, some authors believing them to be a particular type of aging process, from the presenile forms with more extensive biochemical changes. The constant presence of cholinergic symptoms show these to be fundamental features of the dementia but lesions of noradrenergic and serotoninergic systems also probably play an important role, and this triad is found in other dementia processes: trisomy 21, Parkinson's disease with dementia. Numerous questions concerning the neurotransmitter disorders in Alzheimer's disease remain unanswered: to what extent are the lesions due to neurone destruction? What occurs to the receptors? What factors condition severity of the disease? May the latter be directly correlated with the severity of the global dementia process or rather with the constitutive elements of the syndrome such as memory or attention disorders? What are the consequences of the peptidergic lesions? What is the sequential relation between lesions of corticopetal and intracortical afferent systems and what are their respective physiopathological significance?(ABSTRACT TRUNCATED AT 400 WORDS)\",\n",
       "  'journal': 'Revue neurologique',\n",
       "  'authors': 'Berger|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150545',\n",
       "  'mesh_terms': 'D000544:Alzheimer Disease; D000596:Amino Acids; D000818:Animals; D002540:Cerebral Cortex; D006801:Humans; D008125:Locus Coeruleus; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D010275:Parasympathetic Nervous System; D011950:Receptors, Cholinergic; D013564:Sympathetic Nervous System',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000596:Amino Acids; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D011950:Receptors, Cholinergic; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Neurol (Paris)',\n",
       "  'nlm_unique_id': '2984779R',\n",
       "  'issn_linking': '0035-3787',\n",
       "  'country': 'France'},\n",
       " {'title': '[Heart failure in patients wearing permanent pacemakers].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '369-72',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Drăghici|D|D|;Făgărăşanu|R|R|;Iliescu|M|M|;Vintilă|P|P|;Rogozea|D|D|;Ginghină|C|C|;Căpraru|N|N|;Carp|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150541',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D005260:Female; D006333:Heart Failure; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': 'The effect of monoclonal antibodies against Escherichia coli type 1 pili and capsular polysaccharides on the interaction between bacteria and human granulocytes.',\n",
       "  'issue': '20(4)',\n",
       "  'pages': '299-305',\n",
       "  'abstract': 'Monoclonal antibodies against Escherichia coli type 1 pili and the K13 capsular polysaccharide strongly influenced the interaction between human polymorphonuclear leucocytes (PMNL) and E. coli 06:K13:H1. Bacteria with type 1 pili, associated with the neutrophils, caused a metabolic activation but were not ingested. Addition of monoclonal antibodies to type 1 pili resulted in increased association, but also phagocytosis and metabolic activation of the granulocytes. Monoclonal antibodies against the K13 polysaccharide strongly stimulated phagocytosis, especially of the type 1 piliated bacteria, suggesting a synergistic effect between binding of type 1 pili and the Fc part of the capsular antibodies to the PMNL. Addition of D-mannose inhibited the opsonization of type 1 piliated E. coli 06:K13:H1 in the presence of both type 1 pilus antibodies and capsular antibodies. Monoclonal anti-idiotypic (anti-anti-capsular) antibodies reduced the association with the PMNL of the bacteria preopsonized with anti-capsular antibodies. The bacterial ingestion and the metabolic activation of the PMNL were also reduced, suggesting a role for anti-idiotypic antibodies in specific modulation of inflammation.',\n",
       "  'journal': 'Scandinavian journal of immunology',\n",
       "  'authors': 'Söderström|T|T|;Ohman|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150547',\n",
       "  'mesh_terms': 'D000888:Antibodies, Anti-Idiotypic; D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial; D016667:Bacterial Capsules; D004926:Escherichia coli; D010861:Fimbriae, Bacterial; D006801:Humans; D007130:Immunoglobulin Idiotypes; D009504:Neutrophils; D010587:Phagocytosis; D011135:Polysaccharides, Bacterial',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000888:Antibodies, Anti-Idiotypic; D000907:Antibodies, Bacterial; D000911:Antibodies, Monoclonal; D000942:Antigens, Bacterial; D007130:Immunoglobulin Idiotypes; D011135:Polysaccharides, Bacterial; C036962:capsular polysaccharide K1',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-3083.1984.tb01006.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Scand J Immunol',\n",
       "  'nlm_unique_id': '0323767',\n",
       "  'issn_linking': '0300-9475',\n",
       "  'country': 'England'},\n",
       " {'title': '[Echocardiographic evaluation (M system) of hypertrophy and wall stress of the left ventricle under volume and pressure loading].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '373-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Streian|C|C|;Brânzan|L|L|;Drăgulescu|S|S|;Cristodorescu|R|R|;Roşu|D|D|;Petrescu|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150542',\n",
       "  'mesh_terms': 'D000328:Adult; D002306:Cardiac Volume; D006332:Cardiomegaly; D004452:Echocardiography; D006321:Heart; D006801:Humans; D006973:Hypertension; D013599:Systole',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': 'Seminoma after orchiopexy. A case report.',\n",
       "  'issue': '18(4)',\n",
       "  'pages': '357-9',\n",
       "  'abstract': 'A 29-year-old man had been operated on for bilateral cryptorchism at the age of 11. The right testis was not found and was considered to be aplastic. The left testis was placed surgically in the scrotum. When he entered a follow-up study for early detection of testicular cancer, the right testis was found intraperitoneally and was removed. A left testicular biopsy showed carcinoma in situ and orchiectomy was performed. This testis contained an invasive seminoma.',\n",
       "  'journal': 'Scandinavian journal of urology and nephrology',\n",
       "  'authors': 'Thore|J|J|;Zetterlund|C G|CG|;Boiesen|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150548',\n",
       "  'mesh_terms': 'D000328:Adult; D002278:Carcinoma in Situ; D003456:Cryptorchidism; D004407:Dysgerminoma; D006801:Humans; D008297:Male; D009361:Neoplasm Invasiveness; D013736:Testicular Neoplasms',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/00365598409180211',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Scand J Urol Nephrol',\n",
       "  'nlm_unique_id': '0114501',\n",
       "  'issn_linking': '0036-5599',\n",
       "  'country': 'England'},\n",
       " {'title': '[Obturator neuralgia (Howship-Romberg phenomenon)].',\n",
       "  'issue': '114(42)',\n",
       "  'pages': '1462-4',\n",
       "  'abstract': \"A 73-year-old patient with obturator neuropathy presenting as disabling thigh pain is described. The clinical diagnosis was verified by electromyography. No indication for surgery could be found. The patient's discomfort was not influenced by common pain-killers, but was relieved by the antipsychotic drug Melleril.\",\n",
       "  'journal': 'Schweizerische medizinische Wochenschrift',\n",
       "  'authors': 'Saurenmann|P|P|;Brand|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150549',\n",
       "  'mesh_terms': 'D000368:Aged; D014150:Antipsychotic Agents; D005260:Female; D006801:Humans; D008297:Male; D009408:Nerve Compression Syndromes; D009437:Neuralgia; D009776:Obturator Nerve; D013881:Thioridazine',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D013881:Thioridazine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Schweiz Med Wochenschr',\n",
       "  'nlm_unique_id': '0404401',\n",
       "  'issn_linking': '0036-7672',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': '[Correlation between the concentration of free fatty acid, ECG aspects and left ventricular function in patients with primary dyslipemia].',\n",
       "  'issue': '36(4)',\n",
       "  'pages': '379-84',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de medicina interna, neurologe, psihiatrie, neurochirurgie, dermato-venerologie. Medicina interna',\n",
       "  'authors': 'Popescu|P|P|;Rusănescu|M|M|;Nanea|T|T|;Oprişan|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150543',\n",
       "  'mesh_terms': 'D000328:Adult; D003920:Diabetes Mellitus; D004562:Electrocardiography; D005230:Fatty Acids, Nonesterified; D006321:Heart; D006352:Heart Ventricles; D006801:Humans; D006949:Hyperlipidemias; D008875:Middle Aged; D009765:Obesity',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005230:Fatty Acids, Nonesterified',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna',\n",
       "  'nlm_unique_id': '7501915',\n",
       "  'issn_linking': '1220-0905',\n",
       "  'country': 'Romania'},\n",
       " {'title': 'Platelet-activating factor-induced aggregation of human platelets specifically inhibited by triazolobenzodiazepines.',\n",
       "  'issue': '226(4681)',\n",
       "  'pages': '1454-6',\n",
       "  'abstract': 'Platelet-activating factor (PAF), a naturally occurring phospholipid, is a potent activator of various biological processes, including platelet aggregation. The mechanisms by which PAF acts are largely unknown, partly because of the lack of specific inhibitors for PAF-elicited responses. It was found that in washed human platelets the psychotropic triazolobenzodiazepine drugs alprazolam and triazolam potently inhibited PAF-induced changes in shape, aggregation, and secretion. The effects were specific for PAF activation, since the responses of human platelets to adenosine diphosphate, thrombin, epinephrine, collagen, arachidonate, and the calcium ionophore A23187 were not inhibited by the triazolobenzodiazepines. These psychotropic drugs should be useful in investigating the possibility that PAF or PAF-like phospholipids play a role in neuronal function and in elucidating biochemical mechanisms activated specifically by PAF in a variety of cells.',\n",
       "  'journal': 'Science (New York, N.Y.)',\n",
       "  'authors': 'Kornecki|E|E|;Ehrlich|Y H|YH|;Lenox|R H|RH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150550',\n",
       "  'mesh_terms': 'D000244:Adenosine Diphosphate; D000525:Alprazolam; D014151:Anti-Anxiety Agents; D016718:Arachidonic Acid; D001095:Arachidonic Acids; D001569:Benzodiazepines; D001792:Blood Platelets; D000001:Calcimycin; D002850:Chromatography, Gel; D003094:Collagen; D004837:Epinephrine; D006801:Humans; D010972:Platelet Activating Factor; D010974:Platelet Aggregation; D013917:Thrombin; D014229:Triazolam',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001095:Arachidonic Acids; D010972:Platelet Activating Factor; D001569:Benzodiazepines; D014229:Triazolam; D016718:Arachidonic Acid; D000001:Calcimycin; D000244:Adenosine Diphosphate; D003094:Collagen; D013917:Thrombin; D004837:Epinephrine; D000525:Alprazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1126/science.6150550',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Science',\n",
       "  'nlm_unique_id': '0404511',\n",
       "  'issn_linking': '0036-8075',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Filariasis in Bengkoka Peninsula, Sabah, Malaysia: vector studies in relation to the transmission of filariasis.',\n",
       "  'issue': '15(2)',\n",
       "  'pages': '179-89',\n",
       "  'abstract': 'Using seven methods of surveillance, 58 species of mosquitoes from nine genera were in Pantai and the two neighbouring villages during two visits in 1982. Ma. bonneae was the most prevalent species attracted to man. In the forest shade Ma. bonneae and Ma. dives showed activity throughout the 24 hours with peak biting during 1900-2100 hours. An. balabacensis exhibited peak activity shortly after midnight. Inside and outside house, Ma. bonneae showed similar activity except that it ceased during the day. Mansonia was only mildly zoophilic. CDC light traps gave poor yields of mosquitoes. Pyrethrum spray catch inside houses early morning did not include any Mansonia. Outdoor day resting catch included Ma. bonneae fed on man. Transmission of Brugia, probably human filariasis, by Ma. bonneae occurred in Pantai and in the two neighbouring villages. One infection in Ma. dives was found in Pantai. The monthly infective biting rate and monthly transmission potential for Ma. bonneae were estimated at the forest shade and outside the house in Pantai.',\n",
       "  'journal': 'The Southeast Asian journal of tropical medicine and public health',\n",
       "  'authors': 'Chiang|G L|GL|;Cheong|W H|WH|;Samarawickrema|W A|WA|;Mak|J W|JW|;Kan|S K|SK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150551',\n",
       "  'mesh_terms': 'D000818:Animals; D001522:Behavior, Animal; D002020:Buffaloes; D009033:Culicidae; D005247:Feeding Behavior; D005368:Filariasis; D006801:Humans; D007303:Insect Vectors; D008296:Malaysia; D009032:Mosquito Control; D012621:Seasons; D013045:Species Specificity',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Southeast Asian J Trop Med Public Health',\n",
       "  'nlm_unique_id': '0266303',\n",
       "  'issn_linking': '0125-1562',\n",
       "  'country': 'Thailand'},\n",
       " {'title': '[Treatment of toxico-infectious shock].',\n",
       "  'issue': '',\n",
       "  'pages': '51-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Sovetskaia meditsina',\n",
       "  'authors': 'Ivanov|N R|NR|;Shenkman|B Z|BZ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150552',\n",
       "  'mesh_terms': 'D000818:Animals; D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D004359:Drug Therapy, Combination; D006493:Heparin; D006634:Histamine H1 Antagonists; D006801:Humans; D006854:Hydrocortisone; D006982:Hypertonic Solutions; D011817:Rabbits; D012772:Shock, Septic; D017693:Sodium Bicarbonate; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000900:Anti-Bacterial Agents; D001639:Bicarbonates; D006634:Histamine H1 Antagonists; D006982:Hypertonic Solutions; D014665:Vasodilator Agents; D017693:Sodium Bicarbonate; D006493:Heparin; D006854:Hydrocortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Sov Med',\n",
       "  'nlm_unique_id': '0404525',\n",
       "  'issn_linking': '0038-5077',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Cellular cooperation and the mechanisms regulating the immune response. I. Cells and the types of intercellular cooperation].',\n",
       "  'issue': '29(3)',\n",
       "  'pages': '193-208',\n",
       "  'abstract': '',\n",
       "  'journal': 'Revista de igiena, bacteriologie, virusologie, parazitologie, epidemiologie, pneumoftiziologie. Bacteriologia, virusologia, parazitologia, epidemiologia',\n",
       "  'authors': 'Olinescu|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150546',\n",
       "  'mesh_terms': 'D000818:Animals; D000937:Antigen-Antibody Reactions; D000950:Antigens, Ly; D001402:B-Lymphocytes; D000949:Histocompatibility Antigens Class II; D006801:Humans; D007111:Immunity, Cellular; D008211:Lymphocyte Cooperation; D008264:Macrophages; D008954:Models, Biological; D010587:Phagocytosis; D013601:T-Lymphocytes',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000950:Antigens, Ly; D000949:Histocompatibility Antigens Class II',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Bacteriol Virusol Parazitol Epidemiol',\n",
       "  'nlm_unique_id': '7508738',\n",
       "  'issn_linking': '0376-4494',\n",
       "  'country': 'Romania'},\n",
       " {'title': 'Absence of high-affinity binding sites for beta-adrenergic blockers and lack of adenyl cyclase stimulation to beta-adrenergic stimulators in most normal and adenomatous human thyroid tissues.',\n",
       "  'issue': '96(6)',\n",
       "  'pages': '1001-8',\n",
       "  'abstract': 'To determine whether the beta-blocking drug propranolol had any physiologic effect on normal (n = 14) and adenomatous (n = 15) human thyroid tissues, experiments were performed to study the binding of the beta-blockers 125I-iodocyanopindolol (125I-ICYP) and 125I-iodohydroxybenzylpindolol (125I-IHYP) and the stimulation of adenyl cyclase (AC) by isoproterenol. 125I-ICYP and 125I-IHYP failed to show high-affinity binding in 27 of 29 specimens, whereas two (one normal and one adenomatous) thyroid tissues demonstrated high-affinity binding (Kd 5.5 +/- 1 X 10(-9) M) for 125I-ICYP. Thyroid-stimulating hormone (0.3 IU/ml), guanosine triphosphate (10(-4) M), and Gpp (NH)p(10(-4) M) stimulated AC in all thyroid tissues, although in two tissues (normal) Gpp (NH)p failed to cause a significant increase. Isoproterenol (10(-4) M), in contrast, had no effect on basal AC activity or on guanosine triphosphate, and Gpp (NH) p stimulated AC activity in 26 of the 29 thyroid tissues. In one of the two tissues that increased AC in response to isoproterenol, the beta-blocking drugs propranolol hydrochloride, bunitrolol hydrochloride, and tolilprolol hydrochloride decreased AC stimulation to isoproterenol at concentrations of 10(-6) M (p less than 0.05). Higher concentrations of propranolol (10(-4) - 10(-2) M) decreased AC stimulation to thyroid-stimulating hormone (p less than 0.01), not only in this responsive tissue but also in tissues that failed to demonstrate high-affinity binding for 125I-ICYP and AC stimulation to isoproterenol (p less than 0.01). Thus most normal and adenomatous human thyroid tissues lack beta-receptors and a functioning beta-receptor AC system. High concentrations of propranolol in vitro decreased AC response by thyroid-stimulating hormone, but this is probably a nonreceptor-mediated effect.',\n",
       "  'journal': 'Surgery',\n",
       "  'authors': 'Goretzki|P E|PE|;Wahl|R A|RA|;Branscheid|D|D|;Roeher|H D|HD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150553',\n",
       "  'mesh_terms': 'D000236:Adenoma; D000262:Adenylyl Cyclases; D006160:Guanosine Triphosphate; D006165:Guanylyl Imidodiphosphate; D006801:Humans; D066298:In Vitro Techniques; D020120:Iodocyanopindolol; D007545:Isoproterenol; D010869:Pindolol; D011412:Propanolamines; D011433:Propranolol; D011943:Receptors, Adrenergic, beta; D013961:Thyroid Gland; D013964:Thyroid Neoplasms; D013972:Thyrotropin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; D006165:Guanylyl Imidodiphosphate; C011878:iodohydroxybenzylpindolol; D020120:Iodocyanopindolol; D006160:Guanosine Triphosphate; D013972:Thyrotropin; D011433:Propranolol; D010869:Pindolol; D000262:Adenylyl Cyclases; D007545:Isoproterenol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Surgery',\n",
       "  'nlm_unique_id': '0417347',\n",
       "  'issn_linking': '0039-6060',\n",
       "  'country': 'United States'},\n",
       " {'title': 'American Association of Endocrine Surgeons. Presidential address: Coming of age.',\n",
       "  'issue': '96(6)',\n",
       "  'pages': '949-56',\n",
       "  'abstract': '',\n",
       "  'journal': 'Surgery',\n",
       "  'authors': 'Friesen|S R|SR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150554',\n",
       "  'mesh_terms': 'D001921:Brain; D004064:Digestive System; D004068:Digestive System Physiological Phenomena; D004702:Endocrine Glands; D004704:Endocrinology; D005060:Europe; D005755:Gastrins; D049672:History, 19th Century; D049673:History, 20th Century; D006801:Humans; D009419:Nerve Tissue Proteins; D009490:Neurosecretory Systems; D018377:Neurotransmitter Agents; D010146:Pain; D010179:Pancreas; D010280:Parathyroid Glands; D010455:Peptides',\n",
       "  'publication_types': 'D016456:Historical Article; D016428:Journal Article',\n",
       "  'chemical_list': 'D005755:Gastrins; D009419:Nerve Tissue Proteins; D018377:Neurotransmitter Agents; D010455:Peptides',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Surgery',\n",
       "  'nlm_unique_id': '0417347',\n",
       "  'issn_linking': '0039-6060',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Clinical value of tumor doubling estimations in multiple endocrine neoplasia type II.',\n",
       "  'issue': '96(6)',\n",
       "  'pages': '981-7',\n",
       "  'abstract': \"Experience with children with multiple endocrine neoplasia (MEN) type IIb has emphasized that medullary thyroid cancer (MTC) in MEN IIb is more aggressive than in MEN IIa. Earlier ages of onset and apparently more rapid growth of MTC in MEN IIb suggest that these tumors have earlier ages of conversion to malignant states and/or shorter doubling times. The age at which a hyperplastic C cell becomes a malignant cell and the true doubling time cannot be estimated presently. Maximum volume-doubling times of 35 and 75 days (21 to 26 doublings) were calculated from tumor size and age at operation in five patients with MEN IIb aged 2 to 5 years. Calculations in 20 patients with MEN IIa revealed maximum doubling times of 110 to 440 days, with ages ranging from 7 to 29 years and number of doubling ranging from 18 to 38. Positive provocative calcitonin tests in two adult patients with MEN IIa after 10 to 11 years of repeated negative tests suggest a minimum doubling time of 190 to 210 days. Such experience emphasizes that negative stimulated calcitonin tests less than 11 years after operation do not provide assurance of cures for MTC in MEN IIa although negative tests after more than 5 years for MEN IIb are encouraging. Calculations of volume doublings accounting for various-sized tumors are compatible with Knudson's two-mutational-event theory on the initiation of neoplasia.\",\n",
       "  'journal': 'Surgery',\n",
       "  'authors': 'Jackson|C E|CE|;Talpos|G B|GB|;Block|M A|MA|;Norum|R A|RA|;Lloyd|R V|RV|;Tashjian|A H|AH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150555',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006965:Hyperplasia; D009377:Multiple Endocrine Neoplasia; D010673:Pheochromocytoma; D013577:Syndrome; D013964:Thyroid Neoplasms; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Surgery',\n",
       "  'nlm_unique_id': '0417347',\n",
       "  'issn_linking': '0039-6060',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Glucuronide conjugation reduces the cytotoxicity but not the mutagenicity of benzo(a)pyrene in the CHO/HGPRT assay.',\n",
       "  'issue': '4(5)',\n",
       "  'pages': '391-402',\n",
       "  'abstract': 'Benzo(a)pyrene (B[a]P) is biotransformed by the mixed-function oxidase (MFO) system to numerous metabolites some of which are cytotoxic and/or mutagenic to mammalian cells. However, conjugation of B(a)P metabolites with glucuronic acid in vivo is a major pathway of detoxication and elimination. The effects of glucuronide conjugation on B(a)P-induced cytotoxicity and mutagenicity were studied using the CHO/HGPRT assay with a rat liver homogenate preparation containing MFO system cofactors (S9 mix) and uridine diphosphate alpha-D-glucuronic acid (UDPGA). B(a)P metabolites proximate to the biologically active B(a)P quinones (B[a]P 6-OH) and to the B(a)P 7,8-diol-9,10 epoxide isomers (B[a]P 7,8-diol), were also assayed with S9 mix in the absence and presence of UDPGA. The addition of UDPGA to S9 mix reduced B(a)P-induced cytotoxicity but did not affect mutagenicity. B(a)P 6-OH-mediated cytotoxicity was also reduced in the presence of UDPGA. UDPGA had no effect on B(a)P 7,8-diol-induced cytotoxicity or mutagenicity. B(a)P phenols have been shown to be the preferred B(a)P-metabolite substrates for UDP-glucuronyltransferase enzymes. Thus, the reduction of B(a)P and B(a)P 6-OH-induced cytotoxicity by glucuronide conjugation is likely due to the elimination of cytotoxic phenols and quinones. Since B(a)P 7,8-diol is a poor substrate for UDP-glucuronyltransferase enzymes, no effects on B(a)P-induced mutagenicity or B(a)P 7,8-diol-induced cytotoxicity and mutagenicity were observed.',\n",
       "  'journal': 'Teratogenesis, carcinogenesis, and mutagenesis',\n",
       "  'authors': 'Recio|L|L|;Hsie|A W|AW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150556',\n",
       "  'mesh_terms': 'D000818:Animals; D001564:Benzo(a)pyrene; D001711:Biotransformation; D002470:Cell Survival; D002478:Cells, Cultured; D006224:Cricetinae; D003412:Cricetulus; D005260:Female; D005965:Glucuronates; D020723:Glucuronic Acid; D008862:Microsomes, Liver; D006899:Mixed Function Oxygenases; D009154:Mutation; D010053:Ovary; D013329:Structure-Activity Relationship',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': 'D005965:Glucuronates; D001564:Benzo(a)pyrene; D020723:Glucuronic Acid; D006899:Mixed Function Oxygenases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/tcm.1770040503',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Teratog Carcinog Mutagen',\n",
       "  'nlm_unique_id': '8100917',\n",
       "  'issn_linking': '0270-3211',\n",
       "  'country': 'United States'},\n",
       " {'title': 'An extended evaluation of an in vivo teratology screen utilizing postnatal growth and viability in the mouse.',\n",
       "  'issue': '4(5)',\n",
       "  'pages': '403-26',\n",
       "  'abstract': \"A teratology test system proposed by Chernoff and Kavlock utilizes growth and viability for 3 days after birth to prioritize chemicals for standard teratology testing. The present study is an extended observation of the growth and viability of Chernoff and Kavlock's animals from 41 treatments for 250 days to determine if neonatal weight reductions persisted throughout life, if mortality occurred later in life or, if other serious abnormalities developed that could not be anticipated from the neonatal data. One chemical which was positive in the present study would be a false negative in the standard teratology test and the Chernoff/Kavlock Assay (CKA). Congo red did not cause frank malformations or mortality but it specifically altered reproductive function in the offspring. Two chemicals produced a variety of unusual abnormalities that were not apparent in the neonates, indicating that postnatal testing is necessary to determine the full teratogenic potential of some compounds. Mice exposed prenatally to cytosine arabinoside became hydrocephalic and 30% of them lacked lower incisors. Nitrofen caused hydrocephaly, the age of eye-opening was delayed, a few of the mice had no eyes, and most of the mice lacked Harderian glands. Eighteen of the 41 treatments caused mortality of 15%, or greater, by day 3, and four of these treatments resulted in additional mortality past the neonatal period. No compound caused a decrease in viability after the neonatal period without also reducing days 1 or 3 litter sizes, validating the use of this measurement in the CKA. Cytosine arabinoside was administered later in gestation than the CKA dosing regime and caused a marginally significant increase in mortality near birth but killed over 50% of the pups after weaning. Altering the duration or period of exposure in the CKA may necessitate a longer postnatal evaluation than presently recommended. Neonatal weight, the second parameter used in the CKA to prioritize chemicals for additional testing, appears to be less useful than viability. It was a poor predictor of subsequent growth, some early weight effects persisted, while most of those concurrent with maternal weight reductions were transient. A correlation analysis of the parameters measured in the CKA and in the present study, excluding the compounds that produce frank malformations, indicated that compounds that reduced maternal weight gain during dosing had fewer live pups and growth was transiently retarded.(ABSTRACT TRUNCATED AT 400 WORDS)\",\n",
       "  'journal': 'Teratogenesis, carcinogenesis, and mutagenesis',\n",
       "  'authors': 'Gray|L E|LE|;Kavlock|R J|RJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150557',\n",
       "  'mesh_terms': 'D000818:Animals; D000831:Animals, Newborn; D005260:Female; D008297:Male; D051379:Mice; D009929:Organ Size; D011247:Pregnancy; D011270:Pregnancy, Animal; D012741:Sexual Maturation; D013723:Teratogens',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013723:Teratogens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/tcm.1770040504',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Teratog Carcinog Mutagen',\n",
       "  'nlm_unique_id': '8100917',\n",
       "  'issn_linking': '0270-3211',\n",
       "  'country': 'United States'},\n",
       " {'title': '2,3,7,8-Tetrachlorodibenzo-p-dioxin-induced cleft palate in the mouse: evidence for alterations in palatal shelf fusion.',\n",
       "  'issue': '4(5)',\n",
       "  'pages': '427-36',\n",
       "  'abstract': '2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) causes a high percentage of cleft palate in fetuses when administered during organogenesis in certain strains of mice including the C57BL/6J, but not in certain other strains (AKR/J). The purpose of the present study was to examine various biochemical and morphological aspects of TCDD-induced changes in the developing palatal shelves. Our results indicate that when TCDD (100 micrograms/kg) was given on individual days between days 8 and 10 of gestation, a high percentage of cleft palate was observed. Receptors specific for TCDD were detected in the C57BL/6J but not AKR/J palatal shelves. The amount of TCDD receptors is highest in the palatal shelves on day 13 as compared to other embryonic tissues including the liver. Examination of cryostat sections taken from embryos during the time of palatal elevation and fusion demonstrated that TCDD does not interfere with growth, elevation, or initial contact of the palatal shelves, but does interfere with firm adhesion and/or degeneration of the medial epithelial cells. Our results suggest that TCDD exerts a direct effect on the embryonic palatal shelves which results in formation of cleft palate.',\n",
       "  'journal': 'Teratogenesis, carcinogenesis, and mutagenesis',\n",
       "  'authors': 'Pratt|R M|RM|;Dencker|L|L|;Diewert|V M|VM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150558',\n",
       "  'mesh_terms': 'D000818:Animals; D002972:Cleft Palate; D003600:Cytosol; D004147:Dioxins; D005865:Gestational Age; D051379:Mice; D008806:Mice, Inbred AKR; D008810:Mice, Inbred C57BL; D010159:Palate; D000072317:Polychlorinated Dibenzodioxins; D018336:Receptors, Aryl Hydrocarbon; D011955:Receptors, Drug',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004147:Dioxins; D000072317:Polychlorinated Dibenzodioxins; D018336:Receptors, Aryl Hydrocarbon; D011955:Receptors, Drug',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/tcm.1770040505',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Teratog Carcinog Mutagen',\n",
       "  'nlm_unique_id': '8100917',\n",
       "  'issn_linking': '0270-3211',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Genetic activity of the carcinogen N-nitrosodiethanolamine (NDELA) on unstable mutant alleles of the white locus in Drosophila melanogaster.',\n",
       "  'issue': '4(5)',\n",
       "  'pages': '437-47',\n",
       "  'abstract': 'The genetic activities of the carcinogen N-nitrosodiethanolamine (NDELA) were assayed somatically and germinally on two stocks carrying unstable alleles of the white (w+) eye colour gene: one incorporating a TE (z TE w+; coded UZ), the other with a tandem duplication of part of the encoding w+ sequence (wi16). Treatment was applied topically on late embryonic and early larval stages over a wide dose range (0.01-2.0 M) and the general mutagenic levels actually achieved were measured in terms of the X-recessive mutations (lethals and visibles) recovered in Muller-5 tests on samples of the males scored for somatic sectoring. The carcinogen was germinally ineffective on the z TE w+ and wi16 loci even at the maximal tested dose (2.0 M), and was only weakly mutagenic with respect to the X-recessives (lethals + visibles) at massive doses (1.0-2.0 M). In contrast, it proved to be genetically effective somatically, inducing red eye sectors through regulatory effects involving the TE in the UZ stock and complete reversion to w+ in the case of wi16 at comparatively moderate doses (less than or equal to 0.26 M). The possible implications of the demonstration of the genetic activity of NDELA in the soma to the carcinogenic process, and to the wider problem of screening for environmental genotoxic compounds, are discussed.',\n",
       "  'journal': 'Teratogenesis, carcinogenesis, and mutagenesis',\n",
       "  'authors': 'Fahmy|M J|MJ|;Fahmy|O G|OG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150559',\n",
       "  'mesh_terms': 'D000483:Alleles; D000818:Animals; D004052:Diethylnitrosamine; D004331:Drosophila melanogaster; D005260:Female; D005854:Germ Cells; D009154:Mutation; D009602:Nitrosamines; D014960:X Chromosome',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D009602:Nitrosamines; C014129:N-nitrosodiethanolamine; D004052:Diethylnitrosamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/tcm.1770040506',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Teratog Carcinog Mutagen',\n",
       "  'nlm_unique_id': '8100917',\n",
       "  'issn_linking': '0270-3211',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Transplacental genetic and cytogenetic effects of alkylating agents in the mouse. I: Induction of somatic coat color mutations.',\n",
       "  'issue': '4(5)',\n",
       "  'pages': '449-57',\n",
       "  'abstract': 'Induction of somatic coat color mutations by the alkylating agents ENU, MNU, EMS, MMS, DES, DMS, and trenimon and by the tuberculostatic drug INH was investigated in the mammalian spot test. Positive results were obtained with EMS (100 mg/kg), ENU (20-60 mg/kg), and INH (100 mg/kg), while trenimon (100 micrograms/kg), DES (225 mg/kg), and MNU (2 mg/kg) yielded inconclusive data. No mutagenic activity was found for MMS (125 mg/kg) and DMS (50 mg/kg). The mutagenic potency of monofunctional alkylating agents at subtoxic doses decreases as follows ENU greater than EMS greater than DES greater than MMS = DMS. The hypothesis that somatic coat color mutations in the mouse are predominantly due to intragenic changes is discussed. Differences in the RS frequency between offspring of the crosses NMRI X DBA and C57 X T are due to differences in loci available for mutation induction. Mutations that uncover the recessive allele p contribute to a significant extent to the total RS frequency observed in the mammalian spot test.',\n",
       "  'journal': 'Teratogenesis, carcinogenesis, and mutagenesis',\n",
       "  'authors': 'Braun|R|R|;Hüttner|E|E|;Schöneich|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150560',\n",
       "  'mesh_terms': 'D000477:Alkylating Agents; D000818:Animals; D005260:Female; D006200:Hair Color; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009152:Mutagenicity Tests; D009154:Mutation; D011247:Pregnancy; D011270:Pregnancy, Animal; D012880:Skin Pigmentation',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000477:Alkylating Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/tcm.1770040507',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Teratog Carcinog Mutagen',\n",
       "  'nlm_unique_id': '8100917',\n",
       "  'issn_linking': '0270-3211',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Agoraphobia and panic disorder: treatment with alprazolam.',\n",
       "  'issue': '80(10)',\n",
       "  'pages': '50-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Texas medicine',\n",
       "  'authors': 'Mark|S L|SL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150561',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D000379:Agoraphobia; D000525:Alprazolam; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D005239:Fear; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010200:Panic; D010698:Phobic Disorders',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D000525:Alprazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Tex Med',\n",
       "  'nlm_unique_id': '0051012',\n",
       "  'issn_linking': '0040-4470',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The effect of bricanyl on placental circulation in late toxaemia of pregnancy.',\n",
       "  'issue': '30(3)',\n",
       "  'pages': '138-40',\n",
       "  'abstract': '',\n",
       "  'journal': 'Therapia Hungarica (English edition)',\n",
       "  'authors': 'Csákány|M G|MG|;Bagdány|S|S|;Vittay|P|P|;Birtalan|I|I|;Török|M|M|;Gati|I|I|',\n",
       "  'pubdate': '1982',\n",
       "  'pmid': '6150562',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D005260:Female; D006801:Humans; D009215:Myometrium; D010920:Placenta; D011225:Pre-Eclampsia; D011247:Pregnancy; D011263:Pregnancy Trimester, Third; D012039:Regional Blood Flow; D013726:Terbutaline',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D013726:Terbutaline',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ther Hung',\n",
       "  'nlm_unique_id': '8706535',\n",
       "  'issn_linking': '0133-3909',\n",
       "  'country': 'Hungary'},\n",
       " {'title': 'Nedocromil sodium: a new drug for the management of bronchial asthma.',\n",
       "  'issue': '39(11)',\n",
       "  'pages': '809-12',\n",
       "  'abstract': \"Nedocromil sodium (FPL 59002) is a pyranoquinoline dicarboxylic acid that has been developed for the management of bronchial asthma. We report the results of a double blind group comparative trial in which the disodium salt of nedocromil delivered by pressurised aerosol and a placebo were compared in the management of patients with a diagnosis of bronchial asthma who entered the double blind period on a minimum dose of beclomethasone dipropionate. In almost all the assessments of clinical activity nedocromil sodium was shown to be more effective than placebo. These include improvements in diary card symptom scores, reduction in concomitant use of a bronchodilator aerosol, and patients' and investigators' assessments of efficacy. Unwanted effects were few and mild. No patients were withdrawn from the trial.\",\n",
       "  'journal': 'Thorax',\n",
       "  'authors': 'Lal|S|S|;Malhotra|S|S|;Gribben|D|D|;Hodder|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150563',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000328:Adult; D000336:Aerosols; D000368:Aged; D001249:Asthma; D001507:Beclomethasone; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017835:Nedocromil; D011804:Quinolines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D000336:Aerosols; D011804:Quinolines; D017835:Nedocromil; D001507:Beclomethasone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/thx.39.11.809',\n",
       "  'references': '6187031;6409313',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Thorax',\n",
       "  'nlm_unique_id': '0417353',\n",
       "  'issn_linking': '0040-6376',\n",
       "  'country': 'England'},\n",
       " {'title': '[Xylometazoline (Otrivin) in acute rhinitis. A comparative study between pipette- and metered-dose aerosol applications].',\n",
       "  'issue': '104(29)',\n",
       "  'pages': '2024-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke',\n",
       "  'authors': 'Myklebust|G|G|;Sandvik|L|L|;Frostad|A B|AB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150564',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000281:Administration, Intranasal; D000293:Adolescent; D000316:Adrenergic alpha-Agonists; D000328:Adult; D000336:Aerosols; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D007093:Imidazoles; D008297:Male; D008875:Middle Aged; D010366:Peak Expiratory Flow Rate; D012220:Rhinitis',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D018848:Controlled Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000336:Aerosols; D007093:Imidazoles; C009695:xylometazoline',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Tidsskr Nor Laegeforen',\n",
       "  'nlm_unique_id': '0413423',\n",
       "  'issn_linking': '0029-2001',\n",
       "  'country': 'Norway'},\n",
       " {'title': 'Influence of triethyl lead on the activity of enzymes of the ascites tumor cell plasma membrane and its microviscosity.',\n",
       "  'issue': '23(2)',\n",
       "  'pages': '183-8',\n",
       "  'abstract': 'The influence of triethyl lead (TriEL) on the activity of plasma membrane-bound enzymes of Ehrlich ascites tumor cells and on membrane fluidity has been investigated. TriEL completely inhibits the (Na+-K+)-ATPase in its membrane-bound and even more pronounced in its solubilized form between 5 and about 20 microM. It also alters the microviscosity of the isolated plasma membrane up to a temperature of about 30 degrees C, but it does not have any influence on the fluidity of the membrane-derived liposomes. From these data it is concluded that the inhibitor may interact directly with the catalytic subunit of the (Na+ + K+)-ATPase, and may not exert its influence by interfering with the membrane lipids.',\n",
       "  'journal': 'Toxicology letters',\n",
       "  'authors': 'Haeffner|E W|EW|;Zimmermann|H P|HP|;Hoffmann|C J|CJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150565',\n",
       "  'mesh_terms': \"D015720:5'-Nucleotidase; D000251:Adenosine Triphosphatases; D000469:Alkaline Phosphatase; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002286:Carcinoma, Ehrlich Tumor; D002462:Cell Membrane; D005454:Fluorescence Polarization; D007700:Kinetics; D007854:Lead; D008560:Membrane Fluidity; D051379:Mice; D009708:Nucleotidases; D009942:Organometallic Compounds; D000254:Sodium-Potassium-Exchanging ATPase; D014783:Viscosity\",\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': \"D009942:Organometallic Compounds; D007854:Lead; C010360:triethyllead; D009708:Nucleotidases; D000469:Alkaline Phosphatase; D015720:5'-Nucleotidase; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D000254:Sodium-Potassium-Exchanging ATPase\",\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0378-4274(84)90124-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Toxicol Lett',\n",
       "  'nlm_unique_id': '7709027',\n",
       "  'issn_linking': '0378-4274',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Chronic inflammatory intestinal disease and pregnancy].',\n",
       "  'issue': '146(23)',\n",
       "  'pages': '1701-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ugeskrift for laeger',\n",
       "  'authors': 'Damgaard|B|B|;Orholm|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150567',\n",
       "  'mesh_terms': 'D003093:Colitis, Ulcerative; D003424:Crohn Disease; D005260:Female; D005938:Glucocorticoids; D006801:Humans; D011247:Pregnancy; D011248:Pregnancy Complications; D012306:Risk; D012460:Sulfasalazine',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D005938:Glucocorticoids; D012460:Sulfasalazine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ugeskr Laeger',\n",
       "  'nlm_unique_id': '0141730',\n",
       "  'issn_linking': '0041-5782',\n",
       "  'country': 'Denmark'},\n",
       " {'title': '[Poisoning with beta-adrenergic blocking agents. Symptoms and treatment].',\n",
       "  'issue': '146(26)',\n",
       "  'pages': '1947-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ugeskrift for laeger',\n",
       "  'authors': 'Rask|H|H|;Svendsen|T L|TL|;Kampmann|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150568',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000931:Antidotes; D001919:Bradycardia; D006801:Humans; D007022:Hypotension',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000931:Antidotes',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ugeskr Laeger',\n",
       "  'nlm_unique_id': '0141730',\n",
       "  'issn_linking': '0041-5782',\n",
       "  'country': 'Denmark'},\n",
       " {'title': 'Clinical and urodynamic effects of norfenefrine in women with stress incontinence.',\n",
       "  'issue': '39(5)',\n",
       "  'pages': '298-302',\n",
       "  'abstract': \"20 women with stress incontinence were treated with an alpha-adrenoceptor stimulating agent norfenefrine (Nevadral Retard) for 3 months. The mean dose administered was 60 mg given in slow-release tablets. Significant beneficial effect on the symptom and the 'sign' of stress incontinence was found as well as a significant increase in the maximum urethral closure pressure. 7 patients (35%) became subjectively and objectively continent. Only minor side effects were observed during treatment.\",\n",
       "  'journal': 'Urologia internationalis',\n",
       "  'authors': 'Lose|G|G|;Lindholm|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150569',\n",
       "  'mesh_terms': 'D015078:2-Hydroxyphenethylamine; D000316:Adrenergic alpha-Agonists; D000328:Adult; D000368:Aged; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009655:Octopamine; D010627:Phenethylamines; D014521:Urethra; D014550:Urinary Incontinence, Stress; D014563:Urodynamics',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D003692:Delayed-Action Preparations; D010627:Phenethylamines; D009655:Octopamine; D015078:2-Hydroxyphenethylamine; C005310:norfenefrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000280997',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Urol Int',\n",
       "  'nlm_unique_id': '0417373',\n",
       "  'issn_linking': '0042-1138',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': '[Microsurgery in urology].',\n",
       "  'issue': '23(5)',\n",
       "  'pages': '244-50',\n",
       "  'abstract': 'The use of microsurgical techniques offers operative perspectives also in urology. Microsurgery is indicated for reconstructive vascular surgery in the kidneys, in cases of erectile impotence, and in high maldescended testicles, for recanalisation of the vas deferens and in early childhood for plasty surgery of malformations of the upper urinary tract and such of the male genitals. Certain indications are presented under reference to own clinical experiences.',\n",
       "  'journal': 'Der Urologe. Ausg. A',\n",
       "  'authors': 'Konrad|G|G|;Mast|G J|GJ|;Schwaiger|R|R|;Ziegler|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150570',\n",
       "  'mesh_terms': 'D000328:Adult; D000783:Aneurysm; D001158:Arteries; D002648:Child; D002675:Child, Preschool; D003456:Cryptorchidism; D006801:Humans; D007021:Hypospadias; D007223:Infant; D007231:Infant, Newborn; D007680:Kidney Neoplasms; D016030:Kidney Transplantation; D008297:Male; D008866:Microsurgery; D012077:Renal Artery; D012078:Renal Artery Obstruction; D013536:Suture Techniques; D013737:Testis; D014513:Ureter; D014517:Ureteral Obstruction; D014570:Urologic Diseases; D014649:Vas Deferens',\n",
       "  'publication_types': \"D004740:English Abstract; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Urologe A',\n",
       "  'nlm_unique_id': '1304110',\n",
       "  'issn_linking': '0340-2592',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Attachment of E. coli-bearing K88 antigen to equine brush-border membranes.',\n",
       "  'issue': '9(6)',\n",
       "  'pages': '561-70',\n",
       "  'abstract': 'Equine small intestinal brush-border membranes, from 40 adult horses were tested in vitro for the presence of receptors for the Escherichia coli adhesive antigens K88ab, K88ac and K99. Only K88-positive strains of E. coli adhered strongly to horse brush-border membranes. In contrast, a K88-negative mutant strain J2, 2 K99-positive strains and 3 E. coli strains isolated from foals failed to adhere to horse brush-border membranes. Purified K88ac pili when reacted with equine brush-border membranes inhibited to a great extent the adhesion of K88-positive E. coli. Similarly, K88-positive E. coli previously reacted with K88 antibody, did not attach to equine brush-border membranes. Oral inoculation of 4 newborn foals with strains of K88-positive enterotoxigenic E. coli, producing either heat-stable or heat-labile enterotoxin, caused diarrhoea in 1 animal.',\n",
       "  'journal': 'Veterinary microbiology',\n",
       "  'authors': 'Tzipori|S|S|;Withers|M|M|;Hayes|J|J|;Robins-Browne|R|R|;Ward|K L|KL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150571',\n",
       "  'mesh_terms': 'D000268:Adhesiveness; D000818:Animals; D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001427:Bacterial Toxins; D003967:Diarrhea; D004768:Enterotoxins; D004926:Escherichia coli; D004927:Escherichia coli Infections; D029968:Escherichia coli Proteins; D036781:Fimbriae Proteins; D006162:Guanylate Cyclase; D006734:Horse Diseases; D006736:Horses; D007082:Ileum; D007413:Intestinal Mucosa; D007421:Intestine, Small; D008871:Microvilli; D011946:Receptors, Antigen',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; C026888:K88 antigen, E coli; C031429:K99 antigen; D011946:Receptors, Antigen; C034151:heat stable toxin (E coli); D036781:Fimbriae Proteins; D006162:Guanylate Cyclase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0378-1135(84)90018-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Vet Microbiol',\n",
       "  'nlm_unique_id': '7705469',\n",
       "  'issn_linking': '0378-1135',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Growth requirements for Moraxella bovis.',\n",
       "  'issue': '9(6)',\n",
       "  'pages': '593-8',\n",
       "  'abstract': 'Moraxella bovis isolates do not necessarily require complex growth media. Minimal growth requirements were approached by selecting mutants that grew on progressively simpler solid media. Isolate 137T was selected until it could be cultured on a medium containing sodium L-glutamate, with thiamine, nicotinamide, pyridoxine and inorganic salts. All 5 field strains isolated in 1983 showed the same requirements and no prior selection was needed. One of these 5 field strains (H388) was selected to require nicotinamide as the only added vitamin, and culture 137H was selected to grow without added vitamins. In contrast, type strains NCTC 8561 and NCTC 9426 could not be cultured on glutamate medium supplemented with a mixture of 8 growth factors. However, 35 out of 38 M. bovis cultures collected in this laboratory grew on that medium. A more complex medium (TG) contained 8 g glutamate and 2 g tryptone per litre of basal salts. Medium TG supported growth by both type strains and all 38 laboratory cultures. Growth on TG medium was promoted by adding 0.1 mg l-1 of pyridoxine, nicotinamide and thiamine. M. bovis strains from type-culture collections or those that have been subcultured on complex media only, may not have retained their native nutritional requirements.',\n",
       "  'journal': 'Veterinary microbiology',\n",
       "  'authors': 'Riley|W T|WT|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150572',\n",
       "  'mesh_terms': 'D003470:Culture Media; D005971:Glutamates; D018698:Glutamic Acid; D009016:Moraxella; D009154:Mutation; D009536:Niacinamide; D010461:Peptones; D011736:Pyridoxine; D013831:Thiamine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D003470:Culture Media; D005971:Glutamates; D010461:Peptones; D009536:Niacinamide; D018698:Glutamic Acid; C001830:tryptones; D011736:Pyridoxine; D013831:Thiamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0378-1135(84)90022-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Vet Microbiol',\n",
       "  'nlm_unique_id': '7705469',\n",
       "  'issn_linking': '0378-1135',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[The role of Bacteroides melaninogenicus in periodontitis].',\n",
       "  'issue': '40(3)',\n",
       "  'pages': '133-41',\n",
       "  'abstract': '',\n",
       "  'journal': 'Stomatologia',\n",
       "  'authors': 'Andronikaki|A G|AG|;Ioannidou|E|E|;Diamanti-Kipioti|A|A|;Mitsis|F I|FI|',\n",
       "  'pubdate': '1983',\n",
       "  'pmid': '6150566',\n",
       "  'mesh_terms': 'D000328:Adult; D001439:Bacteroides; D003773:Dental Plaque; D005260:Female; D005891:Gingivitis; D006801:Humans; D008297:Male; D008875:Middle Aged; D010510:Periodontal Diseases; D001443:Prevotella melaninogenica',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Stomatologia (Athenai)',\n",
       "  'nlm_unique_id': '0404540',\n",
       "  'issn_linking': '',\n",
       "  'country': 'Greece'},\n",
       " {'title': \"Palmar fibromatosis (Dupuytren's contracture). Ultrastructural and enzyme histochemical studies of 43 cases.\",\n",
       "  'issue': '405(1)',\n",
       "  'pages': '41-53',\n",
       "  'abstract': 'Forty three cases of palmar fibromatosis were studied by light and electron microscopy, enzyme histochemistry, and ultrastructural immunohistochemistry. By electron microscopy most of the cells composing the nodules in both the proliferative and the involutional stages were identical to myofibroblasts. The myofibroblasts in the involutional nodules often possessed microfilament aggregates probably representing contraction of micro(actin)filaments in the cytoplasm. The proliferative nodules revealed small perivascular haemorrhages and haemosiderin deposits accompanied by accumulation of macrophages and some lymphocytes; these inflammatory cells possibly secrete a certain growth factor inducing proliferation of genetically abnormal fibroblasts and myofibroblasts. Diaminopeptidase IV was detected in myofibroblasts and fibroblasts by enzyme histochemistry and ultrastructural immunohistochemistry; the enzyme may play a role in the metabolism of intercellular substances. Some perivascular mesenchymal cells, interpreted as variants of myofibroblasts, had moderate activity of alkaline phosphatase.',\n",
       "  'journal': 'Virchows Archiv. A, Pathological anatomy and histopathology',\n",
       "  'authors': 'Iwasaki|H|H|;Müller|H|H|;Stutte|H J|HJ|;Brennscheidt|U|U|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150573',\n",
       "  'mesh_terms': 'D000135:Acid Phosphatase; D000328:Adult; D000368:Aged; D000469:Alkaline Phosphatase; D018819:Dipeptidyl Peptidase 4; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D004387:Dupuytren Contracture; D005260:Female; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D018819:Dipeptidyl Peptidase 4',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00694924',\n",
       "  'references': '6311399;216266;7016984;390518;941544;5344150;429202;6253042;920873;5589645;6123345;569161;7016983;6787113;827084;7026668;14246134;5009249;5549896;5019444;13664703',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Virchows Arch A Pathol Anat Histopathol',\n",
       "  'nlm_unique_id': '8302198',\n",
       "  'issn_linking': '0174-7398',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Biochemical and ultrastructural changes in rat liver plasma membranes after temporary ischemia.',\n",
       "  'issue': '46(4)',\n",
       "  'pages': '269-82',\n",
       "  'abstract': \"In this study we have attempted to correlate reversible and irreversible cell damage induced by in vivo or in vitro ischemia with characteristics of the plasma membranes of liver parenchymal cells, as detected biochemically and ultrastructurally. The effects of in vivo or in vitro ischemia appeared to be similar. It was virtually impossible to isolate a substantial membrane fraction from ischemic livers, probably because of changes in the physical properties of the membranes by ischemia. The isolated membranes of ischemic liver cells show ultrastructural changes including the occurrence of many vesicular profiles and alterations in junctional complexes expressed by extended and smudged electron densities along the lateral surfaces. The microvilli of the bile canaliculi disappeared after only 15 min ischemia and cytoplasmic densities associated with junctional complexes also appeared extended and smudged. These changes correspond with the alterations observed in ischemic isolated membranes. After 30 min in vivo ischemia the activity of 5'-mononucleotidase used as a marker enzyme for plasma membranes, decreased by 75%, whereas the activity of thymidine 5'-phosphodiesterase was reduced only slightly. The changes in these enzyme activities were more prominent after in vitro ischemia than after in vivo. The morphological and biochemical changes observed in rat hepatocyte plasma membrane during the early stage of injury have no value in predicting the occurrence of necrosis in a later phase of the process since profound changes occur in plasma membrane properties after even short periods of ischemia (i.e. during the reversible stage).\",\n",
       "  'journal': 'Virchows Archiv. B, Cell pathology including molecular pathology',\n",
       "  'authors': 'Frederiks|W M|WM|;Myagkaya|G L|GL|;van Veen|H A|HA|;Vogels|I M|IM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150574',\n",
       "  'mesh_terms': 'D000818:Animals; D002462:Cell Membrane; D005454:Fluorescence Polarization; D007511:Ischemia; D008099:Liver; D008297:Male; D008560:Membrane Fluidity; D008563:Membrane Lipids; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D008563:Membrane Lipids',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF02890316',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Virchows Arch B Cell Pathol Incl Mol Pathol',\n",
       "  'nlm_unique_id': '9316922',\n",
       "  'issn_linking': '0340-6075',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'The role of intracellular lumina in the repolarization process of a colonic adenocarcinoma cell line.',\n",
       "  'issue': '46(4)',\n",
       "  'pages': '297-305',\n",
       "  'abstract': 'When glucose is added to the culture medium, some cells of the undifferentiated HT-29 line derived from a human colonic adenocarcinoma develop spherical structures, demonstrated to be intracellular by the ruthenium red staining method, which are bordered with microvilli, contain osmiophilic substances and resemble intracellular lumina. When glucose is replaced by galactose in the culture medium, the cells differentiate apical membranes bordered with microvilli. Our observations suggest that these new apical membranes correspond to the membranes of intracellular lumina which have opened outside the cells. We suggest that intracellular lumina may represent \"compensation\" for loss of polarity of epithelial cells and may be an important step in the repolarizing process of the cells.',\n",
       "  'journal': 'Virchows Archiv. B, Cell pathology including molecular pathology',\n",
       "  'authors': 'Remy|L|L|;Marvaldi|J|J|;Rua|S|S|;Secchi|J|J|;Lechene de la Porte|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150575',\n",
       "  'mesh_terms': 'D000230:Adenocarcinoma; D002454:Cell Differentiation; D002460:Cell Line; D003110:Colonic Neoplasms; D003593:Cytoplasm; D005690:Galactose; D005947:Glucose; D006801:Humans; D008871:Microvilli',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005947:Glucose; D005690:Galactose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF02890318',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Virchows Arch B Cell Pathol Incl Mol Pathol',\n",
       "  'nlm_unique_id': '9316922',\n",
       "  'issn_linking': '0340-6075',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Dimethylsulfoxide increases the survival and lysosomal stability of mouse peritoneal macrophages exposed to low-LET ionizing radiation and/or ionic iron in culture.',\n",
       "  'issue': '46(4)',\n",
       "  'pages': '307-20',\n",
       "  'abstract': 'Reactive oxygen-derived free radicals form excessively during irradiation of biological structures, but also normally in many cellular oxidative processes, albeit in small amounts. Unless scavenged by protective mechanisms, such radicals may induce peroxidation of polyunsaturated fatty acids resulting in membrane damage. The process may be catalysed to a considerable extent by transitional metals with the capacity to form redox systems, such as Fe3+ in equilibrium Fe2+. In the present study, it is shown that radiation by X-rays and/or exposure to ionic iron (Fe3+) causes decreased survival in parallel with lysosomal labilization of cultured mouse peritoneal macrophages (MPMs). The latter event was demonstrated as a reduced capacity of lysosomes in living MPMs to retain acridine orange during photo-oxidative stress caused by continuous exposure to blue light of short wavelength. The effects of X-irradiation, and/or lysosomal iron-loading, could be counteracted by the addition of the .OH-scavenging drug dimethylsulfoxide (DMSO) to the cell culture medium. The findings suggest that X-irradiation may damage certain sensitive G0 cells, such as Kupffer cells, serous cells of salivary glands and old macrophages, which normally have substantial concentrations of metals within their vacuolar apparatus, possibly by lysosomal damage involving .OH-mediated lipid peroxidation.',\n",
       "  'journal': 'Virchows Archiv. B, Cell pathology including molecular pathology',\n",
       "  'authors': 'Abok|K|K|;Rundquist|I|I|;Forsberg|B|B|;Brunk|U|U|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150576',\n",
       "  'mesh_terms': 'D000165:Acridine Orange; D000818:Animals; D002470:Cell Survival; D002478:Cells, Cultured; D004121:Dimethyl Sulfoxide; D005290:Ferric Compounds; D005609:Free Radicals; D008247:Lysosomes; D008264:Macrophages; D051379:Mice; D014965:X-Rays',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005290:Ferric Compounds; D005609:Free Radicals; D000165:Acridine Orange; D004121:Dimethyl Sulfoxide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF02890319',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Virchows Arch B Cell Pathol Incl Mol Pathol',\n",
       "  'nlm_unique_id': '9316922',\n",
       "  'issn_linking': '0340-6075',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Electron microscopic observations on primary hepatocyte cultures infected with herpes simplex virus types I and II.',\n",
       "  'issue': '46(4)',\n",
       "  'pages': '321-32',\n",
       "  'abstract': \"The replication cycle of the Herpes simplex virus (HSV) strains I and II has so far been described mainly in established proliferative cell cultures. Most of the biochemical data and ultrastructural cell changes regarding the virus-cell interaction have been obtained from 'permissive' cells which allow almost unrestricted viral multiplication. It seems obvious, however, that the in vivo viral infections are not represented adequately by these experiments. In order to achieve a more realistic view of the ultrastructural events during HSV infection of adult tissue, cell cultures were prepared from adult mouse and rat livers and infected with several HSV strains. Established 'permissive' cell lines (BHK and RK cells), served as controls. Although the main principles of viral attachment, replication and release of viral particles, were similar in hepatocytes and proliferating cells, marked differences were observed regarding the better preservation of the nuclear structures, the lower replication rate of viruses, the hypertrophy of the endoplasmic reticulum, and the changes in the Golgi apparatus. Summarizing, it can be stated that hepatocytes infected by HSV in cell culture display the well known general features of adult cells infected by viruses in vivo.\",\n",
       "  'journal': 'Virchows Archiv. B, Cell pathology including molecular pathology',\n",
       "  'authors': 'Dienes|H P|HP|;Ramadori|G|G|;Falke|D|D|;Thoenes|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150577',\n",
       "  'mesh_terms': 'D000818:Animals; D002467:Cell Nucleus; D002478:Cells, Cultured; D003593:Cytoplasm; D003896:Desmosomes; D005260:Female; D006561:Herpes Simplex; D008099:Liver; D008297:Male; D051379:Mice; D008854:Microscopy, Electron; D051381:Rats; D014779:Virus Replication',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF02890320',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Virchows Arch B Cell Pathol Incl Mol Pathol',\n",
       "  'nlm_unique_id': '9316922',\n",
       "  'issn_linking': '0340-6075',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Modification of mouse hemopoietic cell proliferation in vivo by a hemoregulatory pentapeptide (HP 5b). Relation to circadian rhythms.',\n",
       "  'issue': '46(4)',\n",
       "  'pages': '333-48',\n",
       "  'abstract': 'The effects on murine hemopoietic cell proliferation of hemoregulatory peptide 5b, a synthetic factor which inhibits granulopoiesis, have been studied in vivo by 3H-thymidine labeling, cell cycle analyses by flow cytometry and total cell counts per femur. Single injections of the peptide seemed to obliterate the normal circadian rhythm of bone marrow cell proliferation. By autoradiography, the main effect was an inhibition of myelopoietic cell proliferation, although erythropoiesis was also affected. This occurred in two ways: a) an immediate effect observed in the first 24 h after a single injection, and b) a delayed effect observed 6-12 days after a week of peptide infusion which could be a result of stem cell inhibition. A secondary accumulation of cells with G2 phase DNA content was seen regularly. Thus the hemoregulatory peptide seems to influence hemopoietic cell proliferation and has its main effect on myelopoiesis. However, inhibition is less marked than observed previously in stem cells.',\n",
       "  'journal': 'Virchows Archiv. B, Cell pathology including molecular pathology',\n",
       "  'authors': 'Laerum|O D|OD|;Paukovits|W R|WR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150578',\n",
       "  'mesh_terms': 'D000818:Animals; D002453:Cell Cycle; D002940:Circadian Rhythm; D004261:DNA Replication; D004920:Erythropoiesis; D005260:Female; D006131:Growth Inhibitors; D006410:Hematopoiesis; D006412:Hematopoietic Stem Cells; D007399:Interphase; D051379:Mice; D008809:Mice, Inbred C3H; D009842:Oligopeptides; D011761:Pyrrolidonecarboxylic Acid',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D006131:Growth Inhibitors; D009842:Oligopeptides; C040758:hemoregulatory peptide 5b; D011761:Pyrrolidonecarboxylic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF02890321',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Virchows Arch B Cell Pathol Incl Mol Pathol',\n",
       "  'nlm_unique_id': '9316922',\n",
       "  'issn_linking': '0340-6075',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Diagnosis and treatment of drug dependence].',\n",
       "  'issue': '37(11)',\n",
       "  'pages': '857-60',\n",
       "  'abstract': '',\n",
       "  'journal': 'Wiadomosci lekarskie (Warsaw, Poland : 1960)',\n",
       "  'authors': 'Termińska|K|K|;Mrowiec|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150579',\n",
       "  'mesh_terms': 'D000662:Amphetamines; D014151:Anti-Anxiety Agents; D001463:Barbiturates; D001569:Benzodiazepines; D006801:Humans; D009021:Morphine Dependence; D019966:Substance-Related Disorders',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000662:Amphetamines; D014151:Anti-Anxiety Agents; D001463:Barbiturates; D001569:Benzodiazepines',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Wiad Lek',\n",
       "  'nlm_unique_id': '9705467',\n",
       "  'issn_linking': '0043-5147',\n",
       "  'country': 'Poland'},\n",
       " {'title': 'The metabolism in animals and man of oxmetidine--a new histamine H2-receptor antagonist.',\n",
       "  'issue': '14(7)',\n",
       "  'pages': '509-14',\n",
       "  'abstract': 'The absorption, distribution, metabolism and excretion of [14C]oxmetidine in rat, dog and man has been studied following both i.v. and oral administration. Excretion is rapid and essentially complete in all three species. The biliary route is predominant. Distribution of radioactivity is widespread although none is seen in the brain. Metabolite patterns in urine from rat, dog and man have been compared by thin-layer chromatography. Metabolite patterns in urine and bile from rat and dog have been compared by high pressure liquid chromatography. Six major metabolites have been isolated and identified including two O-glucuronides and one N-glucuronide.',\n",
       "  'journal': 'Xenobiotica; the fate of foreign compounds in biological systems',\n",
       "  'authors': 'Cox|P J|PJ|;Heijbroek|W M|WM|;Taylor|D C|DC|;Wood|P J|PJ|;Cresswell|P R|PR|;Pepper|E S|ES|;Moore|P J|PJ|;Mitchell|R C|RC|;Blake|T J|TJ|;Dawborne|J S|JS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150580',\n",
       "  'mesh_terms': 'D000042:Absorption; D000818:Animals; D001646:Bile; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D004285:Dogs; D005243:Feces; D005260:Female; D006635:Histamine H2 Antagonists; D006801:Humans; D006868:Hydrolysis; D007093:Imidazoles; D007700:Kinetics; D009682:Magnetic Resonance Spectroscopy; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D014018:Tissue Distribution',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D006635:Histamine H2 Antagonists; D007093:Imidazoles; C027703:oxmetidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/00498258409151439',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Xenobiotica',\n",
       "  'nlm_unique_id': '1306665',\n",
       "  'issn_linking': '0049-8254',\n",
       "  'country': 'England'},\n",
       " {'title': 'The pharmacokinetics in man of SK&F 93319--a new antagonist of histamine H1 and H2 receptors.',\n",
       "  'issue': '14(7)',\n",
       "  'pages': '589-93',\n",
       "  'abstract': 'SK&F 93319, a potent histamine H1- and H2-receptor antagonist, is rapidly absorbed with a low rate of plasma clearance primarily by metabolism. Excretion is divided evenly between urine and faeces (probable biliary elimination) with little unchanged drug in the urine. Serum protein binding at low concentrations is very extensive and appears to restrict distribution of SK&F 93319. At higher concentrations (higher dose levels) reduced protein binding results in a marked proportional increase in available free drug with a consequent increase in distribution and clearance. Bioavailability is reduced at higher dose levels. The importance of factors contributing to non-linear pharmacokinetics and the potential clinical consequences are demonstrated.',\n",
       "  'journal': 'Xenobiotica; the fate of foreign compounds in biological systems',\n",
       "  'authors': 'Johnson|P|P|;Griffiths|R|R|;Lee|R M|RM|;McDowall|R D|RD|;Doyle|E|E|;Taylor|D C|DC|;Burland|W L|WL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150581',\n",
       "  'mesh_terms': 'D000328:Adult; D001682:Biological Availability; D001798:Blood Proteins; D005243:Feces; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D006801:Humans; D007700:Kinetics; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011485:Protein Binding; D011725:Pyridines',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001798:Blood Proteins; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D011725:Pyridines; C043465:icotidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/00498258409151453',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Xenobiotica',\n",
       "  'nlm_unique_id': '1306665',\n",
       "  'issn_linking': '0049-8254',\n",
       "  'country': 'England'},\n",
       " {'title': '[Recommendations for the diagnosis and therapy of status asthmaticus and severe asthma attacks in childhood].',\n",
       "  'issue': '78(19)',\n",
       "  'pages': '817-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Zeitschrift fur arztliche Fortbildung',\n",
       "  'authors': 'Wunderlich|P|P|;Leupold|W|W|;Thal|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150582',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000628:Aminophylline; D001249:Asthma; D002245:Carbon Dioxide; D002648:Child; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004630:Emergencies; D006801:Humans; D010100:Oxygen; D011239:Prednisolone; D013224:Status Asthmaticus',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D002245:Carbon Dioxide; D000628:Aminophylline; D011239:Prednisolone; D010100:Oxygen',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Z Arztl Fortbild (Jena)',\n",
       "  'nlm_unique_id': '0414004',\n",
       "  'issn_linking': '0044-2178',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Extent of drug compliance in Crohn disease patients--study of a special ambulatory care unit of a university clinic].',\n",
       "  'issue': '22(10)',\n",
       "  'pages': '573-9',\n",
       "  'abstract': \"Compliance with therapeutic regimes is an important factor in treatment of chronic diseases often overlooked by therapists. In 123 out-patients with Crohn's disease the reliability in taking the prescribed therapy with salazosulfapyridine (SASP) was studied over an one year period in a special out-patient clinic. 81,3% of the patients took SASP regularly. Sex and age of patients, activity of disease and the intake of other drugs had no influence on the compliance. The patients were fully informed regarding the nature of the illness, the effect of the drug prescribed and the side-effects which may occur. We conclude that these factors; the periodical check up in a special ambulance and a close relation between patient and physician may improve compliance to therapy.\",\n",
       "  'journal': 'Zeitschrift fur Gastroenterologie',\n",
       "  'authors': 'Karbach|U|U|;Degen|I|I|;Ewe|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150583',\n",
       "  'mesh_terms': 'D000328:Adult; D000553:Ambulatory Care; D001711:Biotransformation; D003424:Crohn Disease; D005260:Female; D005860:Germany, West; D006801:Humans; D008297:Male; D010349:Patient Compliance; D012460:Sulfasalazine',\n",
       "  'publication_types': \"D004740:English Abstract; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D012460:Sulfasalazine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Z Gastroenterol',\n",
       "  'nlm_unique_id': '0033370',\n",
       "  'issn_linking': '0044-2771',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Comments on the incidence of contact allergy].',\n",
       "  'issue': '59(19)',\n",
       "  'pages': '1283-6, 1289',\n",
       "  'abstract': 'Analysis of positive patch testing during the last years revealed increased occurrence of contact allergy against arnica. Our investigations were done at the Department of Dermatology of the General Hospital, Linz. We take the view that the frequency of this contact allergy represents the consequence of using household remedies containing arnica.',\n",
       "  'journal': 'Zeitschrift fur Hautkrankheiten',\n",
       "  'authors': 'Eberhartinger|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150584',\n",
       "  'mesh_terms': 'D000485:Allergens; D001317:Austria; D001453:Balsams; D003877:Dermatitis, Contact; D006229:Hand Dermatoses; D006801:Humans; D007868:Leg Dermatoses; D010328:Patch Tests; D010936:Plant Extracts; D011192:Potassium Dichromate',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000485:Allergens; D001453:Balsams; D010936:Plant Extracts; C025080:Peruvian balsam; D011192:Potassium Dichromate',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Z Hautkr',\n",
       "  'nlm_unique_id': '0367576',\n",
       "  'issn_linking': '0301-0481',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Processing of negatively formulated sentences in \"formal thought disorders\". A comparative study].',\n",
       "  'issue': '192(2)',\n",
       "  'pages': '134-50',\n",
       "  'abstract': '',\n",
       "  'journal': 'Zeitschrift fur Psychologie mit Zeitschrift fur angewandte Psychologie',\n",
       "  'authors': 'Funke|K|K|;Berg|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150585',\n",
       "  'mesh_terms': 'D000437:Alcoholism; D006801:Humans; D011939:Mental Recall; D011932:Reading; D012660:Semantics; D019966:Substance-Related Disorders; D013850:Thinking',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Z Psychol Z Angew Psychol',\n",
       "  'nlm_unique_id': '0153706',\n",
       "  'issn_linking': '0044-3409',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[William Thierry Preyer (1841-18970) as methodologist and methodic].',\n",
       "  'issue': '192(2)',\n",
       "  'pages': '170-81',\n",
       "  'abstract': '',\n",
       "  'journal': 'Zeitschrift fur Psychologie mit Zeitschrift fur angewandte Psychologie',\n",
       "  'authors': 'Sprung|H|H|;Sprung|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150586',\n",
       "  'mesh_terms': 'D005858:Germany; D049672:History, 19th Century; D010827:Physiology; D002666:Psychology, Child',\n",
       "  'publication_types': 'D019215:Biography; D004740:English Abstract; D016456:Historical Article; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Z Psychol Z Angew Psychol',\n",
       "  'nlm_unique_id': '0153706',\n",
       "  'issn_linking': '0044-3409',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[A heretofore undisclosed source of Preyer research].',\n",
       "  'issue': '192(2)',\n",
       "  'pages': '182-91',\n",
       "  'abstract': '',\n",
       "  'journal': 'Zeitschrift fur Psychologie mit Zeitschrift fur angewandte Psychologie',\n",
       "  'authors': 'Becker|K H|KH|;Schmidt|H D|HD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150587',\n",
       "  'mesh_terms': 'D004282:Documentation; D005858:Germany; D049672:History, 19th Century; D010827:Physiology; D002666:Psychology, Child',\n",
       "  'publication_types': 'D019215:Biography; D004740:English Abstract; D016456:Historical Article; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Z Psychol Z Angew Psychol',\n",
       "  'nlm_unique_id': '0153706',\n",
       "  'issn_linking': '0044-3409',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'ALAT, AP, ASAT, GGT, OCT activities and urea and total bilirubin concentrations in plasma of normal and ketotic dairy cows.',\n",
       "  'issue': '31(8)',\n",
       "  'pages': '567-76',\n",
       "  'abstract': '',\n",
       "  'journal': 'Zentralblatt fur Veterinarmedizin. Reihe A',\n",
       "  'authors': 'Kauppinen|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150588',\n",
       "  'mesh_terms': 'D020155:3-Hydroxybutyric Acid; D000090:Acetoacetates; D000138:Acidosis; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000818:Animals; D001219:Aspartate Aminotransferases; D001663:Bilirubin; D002417:Cattle; D002418:Cattle Diseases; D005260:Female; D006885:Hydroxybutyrates; D007662:Ketosis; D007774:Lactation; D009954:Ornithine Carbamoyltransferase; D011247:Pregnancy; D011644:Puerperal Disorders; D014166:Transferases; D014508:Urea; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000090:Acetoacetates; D006885:Hydroxybutyrates; C016635:acetoacetic acid; D014508:Urea; D014166:Transferases; D009954:Ornithine Carbamoyltransferase; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin; D020155:3-Hydroxybutyric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1439-0442.1984.tb01316.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Zentralbl Veterinarmed A',\n",
       "  'nlm_unique_id': '0331323',\n",
       "  'issn_linking': '0514-7158',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Association of schizophrenic and convulsive manifestations in children].',\n",
       "  'issue': '84(10)',\n",
       "  'pages': '1547-50',\n",
       "  'abstract': 'The authors studied 25 preschool children with schizophrenia and schizophreniform states associated with residual-organic damage to the brain who also presented various convulsive manifestations. Patients with this combination were far less numerous than patients with convulsive manifestations without schizophreniform symptoms and with schizophrenia without convulsive manifestations. With regard to paroxysmal phenomena per se, no significant differences were discovered in patients with the schizophreniform symptomatology versus patients with convulsive manifestations without symptoms of schizophrenia. The study showed that in the majority of cases, the patients had infantile schizophrenia against an organically altered background. In schizophreniform conditions that resulted from residual symptoms of the organic damage to the brain, the epileptiform syndrome was more stable. The schizophreniform symptomatology in some cases was associated with temporal lobe epilepsy. Differentiation of \"schizoepilepsy\" as a separate nosological entity was found to be unsubstantiated. Administration of neuroleptics induced enhancement of paroxysmal manifestations in some patients.',\n",
       "  'journal': 'Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)',\n",
       "  'authors': 'Vrono|M Sh|MSh|;Levina|A L|AL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150589',\n",
       "  'mesh_terms': 'D014150:Antipsychotic Agents; D001925:Brain Damage, Chronic; D002648:Child; D004569:Electroencephalography; D004833:Epilepsy, Temporal Lobe; D006801:Humans; D012561:Schizophrenia, Childhood; D012640:Seizures; D003294:Seizures, Febrile',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Zh Nevropatol Psikhiatr Im S S Korsakova',\n",
       "  'nlm_unique_id': '8710066',\n",
       "  'issn_linking': '0044-4588',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Treatment of the syndrome of disseminated intravascular coagulation in ischemic strokes].',\n",
       "  'issue': '84(9)',\n",
       "  'pages': '1325-9',\n",
       "  'abstract': 'A treatment modality of a new original design was used in 87 survivors of ischemic stroke. Apart from the standard remedies, the authors administered drugs affecting the syndrome of disseminated intravascular coagulation, such as dipyridamole, glutamic acid and phytin, with heparin and freshly frozen plasma containing antithrombin III employed in grave cases. Hemostatic parameters in the study patients were observed to normalize more rapidly compared with the control group.',\n",
       "  'journal': 'Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)',\n",
       "  'authors': 'Karlov|V A|VA|;Makarov|V A|VA|;Bova|I Ia|IIa|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150590',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D001803:Blood Transfusion; D002545:Brain Ischemia; D003131:Combined Modality Therapy; D004176:Dipyridamole; D004211:Disseminated Intravascular Coagulation; D005231:Fatty Acids, Unsaturated; D005260:Female; D005971:Glutamates; D018698:Glutamic Acid; D006493:Heparin; D006801:Humans; D008297:Male; D008875:Middle Aged; D010833:Phytic Acid; D010949:Plasma; D024505:Tocopherols; D014810:Vitamin E; D024502:alpha-Tocopherol',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005231:Fatty Acids, Unsaturated; D005971:Glutamates; C014642:linethol; D014810:Vitamin E; D018698:Glutamic Acid; D004176:Dipyridamole; D010833:Phytic Acid; D006493:Heparin; D024502:alpha-Tocopherol; D024505:Tocopherols',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Zh Nevropatol Psikhiatr Im S S Korsakova',\n",
       "  'nlm_unique_id': '8710066',\n",
       "  'issn_linking': '0044-4588',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[New directions in contemporary pharmacotherapy of parkinsonism (review)].',\n",
       "  'issue': '84(9)',\n",
       "  'pages': '1401-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952)',\n",
       "  'authors': 'Kurako|Iu L|IuL|;Volianskiĭ|V E|VE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150591',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D000978:Antiparkinson Agents; D001058:Apomorphine; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001971:Bromocriptine; D004359:Drug Therapy, Combination; D006801:Humans; D007980:Levodopa; D008090:Lisuride; D010096:Oxprenolol; D010300:Parkinson Disease; D010889:Piracetam; D010891:Piribedil; D011433:Propranolol; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D014151:Anti-Anxiety Agents; D000978:Antiparkinson Agents; D065105:Aromatic Amino Acid Decarboxylase Inhibitors; D001971:Bromocriptine; D007980:Levodopa; D010096:Oxprenolol; D005680:gamma-Aminobutyric Acid; D011433:Propranolol; D010891:Piribedil; D008090:Lisuride; D001058:Apomorphine; D010889:Piracetam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Zh Nevropatol Psikhiatr Im S S Korsakova',\n",
       "  'nlm_unique_id': '8710066',\n",
       "  'issn_linking': '0044-4588',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Pirenzepine depresses plasma noradrenaline in duodenal ulcer patients.',\n",
       "  'issue': '520()',\n",
       "  'pages': '41-4',\n",
       "  'abstract': 'The effect of pirenzepine--a selective antimuscarinic compound--on plasma catecholamine, serum gastrin and somatostatin concentrations was studied in duodenal ulcer patients. Plasma concentration of noradrenaline decreased significantly after injection of pirenzepine (10 mg intravenously), whereas the circulating levels of adrenaline, dopamine, gastrin and somatostatin remained unchanged. The results may be explained by a decreased activity in postganglionic sympathetic ganglia. This is in line with the recent observation in vitro that pirenzepine effectively blocks muscarinic receptors in some sympathetic ganglia.',\n",
       "  'journal': 'Acta chirurgica Scandinavica. Supplementum',\n",
       "  'authors': 'Graffner|H|H|;Farnebo|L O|LO|;Holst|J|J|;Järhult|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150592',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D004298:Dopamine; D004381:Duodenal Ulcer; D004837:Epinephrine; D005260:Female; D005755:Gastrins; D006801:Humans; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine; D010890:Pirenzepine; D013004:Somatostatin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000897:Anti-Ulcer Agents; D001570:Benzodiazepinones; D005755:Gastrins; D010890:Pirenzepine; D013004:Somatostatin; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Chir Scand Suppl',\n",
       "  'nlm_unique_id': '0370305',\n",
       "  'issn_linking': '0301-1860',\n",
       "  'country': 'Sweden'},\n",
       " {'title': \"A case of primary hyperparathyroidism, primary hyperaldosteronism and Cushing's disease.\",\n",
       "  'issue': '107(3)',\n",
       "  'pages': '371-4',\n",
       "  'abstract': \"The rare association of parathyroid adenoma with primary hyperaldosteronism, occurring in each of 2 patients, was recently reported from this unit. The present communication records the subsequent development, in one of these patients, of Cushing's syndrome with an anterior pituitary adenoma. Screening for other endocrine abnormalities was negative. A literature search failed to produce any other cases of the association of these three conditions in one patient.\",\n",
       "  'journal': 'Acta endocrinologica',\n",
       "  'authors': 'Herd|G W|GW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150593',\n",
       "  'mesh_terms': 'D000236:Adenoma; D000324:Adrenocorticotropic Hormone; D000328:Adult; D003480:Cushing Syndrome; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism; D006961:Hyperparathyroidism; D009377:Multiple Endocrine Neoplasia; D010282:Parathyroid Neoplasms; D010911:Pituitary Neoplasms',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D000324:Adrenocorticotropic Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1530/acta.0.1070371',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Endocrinol (Copenh)',\n",
       "  'nlm_unique_id': '0370312',\n",
       "  'issn_linking': '0001-5598',\n",
       "  'country': 'Denmark'},\n",
       " {'title': 'Simultaneous visualization of alkaline phosphatase and gamma-glutamyl transpeptidase in kidney sections.',\n",
       "  'issue': '75(1)',\n",
       "  'pages': '107-10',\n",
       "  'abstract': \"An histochemical method is presented to simultaneously localize, for the first time, alkaline phosphatase (ALP) and gamma-glutamyltranspeptidase (gamma-GT) in the kidney. The reaction product of ALP activity appears as a dark brown precipitate of lead sulfide, while a bright red copper chelate of an azo dye (Fast blue BBN salt) final product indicates sites of gamma-GT activity. The amalgamation of Mayahara's (ALP) and Rutenberg's (gamma-GT) techniques resulted in the demonstration of various categories of kidney tubules, according to the staining reaction of the cell brush borders: Black tubules where ALP predominates; Intermediate tubules showing a mixture of brown and red precipitates; Red tubules indicating a prevalence of gamma-GT activity; Negative tubules. A possible relation might exist between the staining characteristics observed and the different proximal tubule segments, thus allowing their distinction. In addition, this technique has the advantage to permit the concomitant study of ALP and gamma-GT distribution on the same tissue section instead of serial sections, so reducing the number of manipulations and observations as well as the amount of tissue required.\",\n",
       "  'journal': 'Acta histochemica',\n",
       "  'authors': 'Brière|N|N|;Martel|M|M|;Plante|G|G|;Petitclerc|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150594',\n",
       "  'mesh_terms': 'D000469:Alkaline Phosphatase; D000818:Animals; D002645:Chickens; D006224:Cricetinae; D004285:Dogs; D006651:Histocytochemistry; D007668:Kidney; D051379:Mice; D011817:Rabbits; D051381:Rats; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0065-1281(84)80077-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Histochem',\n",
       "  'nlm_unique_id': '0370320',\n",
       "  'issn_linking': '0065-1281',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Physiologic correlates of the ERG hyperventilatory response in dogs.',\n",
       "  'issue': '62(5)',\n",
       "  'pages': '808-18',\n",
       "  'abstract': 'Previous studies in man have shown that hyperventilation consistently enhances the amplitude of the electroretinogram (ERG) b-wave, but has little effect on the a-wave. The present study examined this phenomenon in the dog; central (centrifugal) and peripheral (sympathetic) neural effects and changes in arterial pO2 and blood pH were excluded as physiologic bases for the phenomenon. It was concluded, therefore, that the underlying mechanism must be decreased pCO2 (hypocapnia), although the specific site of action and the method by which the ERG b-wave is enhanced remain topics for future research.',\n",
       "  'journal': 'Acta ophthalmologica',\n",
       "  'authors': 'Murray|M J|MJ|;Borda|R P|RP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150595',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D001639:Bicarbonates; D004285:Dogs; D004596:Electroretinography; D005260:Female; D006863:Hydrogen-Ion Concentration; D006985:Hyperventilation; D008297:Male; D009900:Optic Nerve; D010313:Partial Pressure; D012160:Retina',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D001639:Bicarbonates',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1755-3768.1984.tb05809.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Ophthalmol (Copenh)',\n",
       "  'nlm_unique_id': '0370347',\n",
       "  'issn_linking': '0001-639X',\n",
       "  'country': 'Denmark'},\n",
       " {'title': 'Histopathological and immunohistochemical study of neuroendocrine tumors of the rectum.',\n",
       "  'issue': '34(5)',\n",
       "  'pages': '1059-77',\n",
       "  'abstract': 'A clinicopathological and immunohistochemical study was carried out on 32 cases of neuroendocrine tumors of the rectum. Typical carcinoids consisted of 27 cases, histologically showing uniform round to columnar cells forming solid alveolar nests and ribbon-like or trabecular arrangement. Neuroendocrine carcinomas consisted of 5 cases in which tumor cells with prominent nuclear atypism were arranged in a ribbon-like or trabecular fashion and formed gland-like structures. There were also small round tumor cells resembling lymphocytes. The prognosis of neuroendocrine carcinomas is very poor with marked tumor invasion of lymphatics and veins resulting in liver metastases and death within one year after operation. Thirty cases out of the 32 showed a positive argyrophil reaction, while immunohistochemistry of 29 cases revealed more than one peptide hormone in 23 cases. The most common hormone was somatostatin being present in 18 of the 23 tumors and glucagon in 16 of the 23 tumors. Gastrin/CCK and calcitonin were proven in 6 of the 23 tumors and in 4 of the 23 tumors, respectively. On the other hand, more than two hormones was present in 15 of the 23 tumors examined. Histologically, neuroendocrine tumors have a very wide spectrum. Histogenetically, typical carcinoids and neuroendocrine carcinomas are considered to be of the same origin with the former showing morphological and functional differentiation to endocrine cells and the latter being more undifferentiated.',\n",
       "  'journal': 'Acta pathologica japonica',\n",
       "  'authors': 'Shimoda|T|T|;Ishikawa|E|E|;Sano|T|T|;Watanabe|K|K|;Ikegami|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150596',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D002116:Calcitonin; D002276:Carcinoid Tumor; D002766:Cholecystokinin; D005260:Female; D005755:Gastrins; D005934:Glucagon; D006801:Humans; D008113:Liver Neoplasms; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D012004:Rectal Neoplasms; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005755:Gastrins; D013004:Somatostatin; D002116:Calcitonin; D005934:Glucagon; D002766:Cholecystokinin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1440-1827.1984.tb07636.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Pathol Jpn',\n",
       "  'nlm_unique_id': '0372637',\n",
       "  'issn_linking': '0001-6632',\n",
       "  'country': 'Australia'},\n",
       " {'title': '[Effects of 4 convulsants and anticonvulsants on GABA and glutamic acid contents in the rat cerebellum].',\n",
       "  'issue': '5(3)',\n",
       "  'pages': '147-50',\n",
       "  'abstract': '',\n",
       "  'journal': 'Zhongguo yao li xue bao = Acta pharmacologica Sinica',\n",
       "  'authors': 'Ren|Y F|YF|;Jin|D S|DS|;Zhou|T C|TC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150598',\n",
       "  'mesh_terms': 'D000818:Animals; D000927:Anticonvulsants; D002531:Cerebellum; D003292:Convulsants; D005971:Glutamates; D018698:Glutamic Acid; D008297:Male; D051381:Rats; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000927:Anticonvulsants; D003292:Convulsants; D005971:Glutamates; D018698:Glutamic Acid; D005680:gamma-Aminobutyric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Zhongguo Yao Li Xue Bao',\n",
       "  'nlm_unique_id': '8100330',\n",
       "  'issn_linking': '0253-9756',\n",
       "  'country': 'China'},\n",
       " {'title': 'Antiserum against formalin-fixed human milk fat globule glycoprotein for immunohistochemistry of normal and malignant apocrine epithelium.',\n",
       "  'issue': '92(5)',\n",
       "  'pages': '331-7',\n",
       "  'abstract': 'A rabbit antiserum was raised against formalin-fixed glycoprotein isolated by lectin affinity chromatography from human milk fat globules. After adsorption with erythrocytes and normal blood leukocytes the antiserum detected in immunoblotting of fresh mammary carcinoma tissue a major component of 75 000 dalton apparent molecular weight. The antiserum specifically decorated normal and malignant apocrine epithelium in sections of formalin-fixed tissues. The usefulness of such antisera for routine immunohistochemical diagnosis of metastatic carcinomas is demonstrated.',\n",
       "  'journal': 'Acta pathologica, microbiologica, et immunologica Scandinavica. Section A, Pathology',\n",
       "  'authors': 'Forsman|L M|LM|;Karhi|K K|KK|;Autero|M|M|;Gahmberg|C G|CG|;Andersson|L C|LC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150597',\n",
       "  'mesh_terms': \"D000941:Antigens; D001940:Breast; D001941:Breast Diseases; D001943:Breast Neoplasms; D004591:Electrophoresis, Polyacrylamide Gel; D004847:Epithelial Cells; D005260:Female; D005455:Fluorescent Antibody Technique; D006177:Gynecomastia; D006801:Humans; D008207:Lymphatic Metastasis; D008297:Male; D008565:Membrane Proteins; D008895:Milk, Human; D018396:Mucin-1; D010144:Paget's Disease, Mammary; D011247:Pregnancy\",\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000941:Antigens; D008565:Membrane Proteins; D018396:Mucin-1',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1699-0463.1984.tb04412.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Pathol Microbiol Immunol Scand A',\n",
       "  'nlm_unique_id': '8206622',\n",
       "  'issn_linking': '0108-0164',\n",
       "  'country': 'Denmark'},\n",
       " {'title': 'Nitroglycerin tolerance in vitro: effect on cGMP turnover in vascular smooth muscle.',\n",
       "  'issue': '55(3)',\n",
       "  'pages': '203-10',\n",
       "  'abstract': 'Bovine mesenteric arteries (BMA) were made tolerant to nitroglycerin (GTN) by incubation with high concentrations of GTN at elevated pH. This treatment has previously been shown to reduce the relaxant and cGMP-elevating action of a challenging dose of GTN. The stimulatory action of nitroprusside (NP) or GTN/cysteine on guanylate cyclase (GC) was reduced by 50-60% in GTN-tolerant vessels as compared to control vessels. The stimulatory action of GTN and NP on GC has been suggested to occur through formation of S-nitrosothiols, probably with a previous denitration step required for GTN. However, tolerance induction to GTN was not found to change the rate of nitrite formation from GTN, and exogenous addition of thiols in the GC assay, in order to increase S-nitrosothiol formation, did not restore the GC activity in tolerant vessels back to control level. This is suggested to indicate a direct effect of GTN tolerance on GC. Since the cGMP-phosphodiesterase activity was not affected in GTN-tolerant vessels, the reduced GC activity may be of a crucial importance for the reduced cGMP response in GTN-tolerant BMA as found earlier (Axelsson et al. 1982).',\n",
       "  'journal': 'Acta pharmacologica et toxicologica',\n",
       "  'authors': 'Axelsson|K L|KL|;Karlsson|J O|JO|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150599',\n",
       "  'mesh_terms': \"D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000818:Animals; D002417:Cattle; D006152:Cyclic GMP; D004361:Drug Tolerance; D000431:Ethanol; D006162:Guanylate Cyclase; D066298:In Vitro Techniques; D007700:Kinetics; D008638:Mesenteric Arteries; D009124:Muscle Proteins; D009131:Muscle, Smooth, Vascular; D009573:Nitrites; D005996:Nitroglycerin; D013997:Time Factors\",\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': \"D009124:Muscle Proteins; D009573:Nitrites; D000431:Ethanol; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D006162:Guanylate Cyclase; D005996:Nitroglycerin; D006152:Cyclic GMP\",\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1600-0773.1984.tb02038.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Pharmacol Toxicol (Copenh)',\n",
       "  'nlm_unique_id': '0370572',\n",
       "  'issn_linking': '0001-6683',\n",
       "  'country': 'Denmark'},\n",
       " {'title': 'A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver.',\n",
       "  'issue': '55(4)',\n",
       "  'pages': '287-96',\n",
       "  'abstract': 'The binding characteristics of 3H-dihydroalprenolol and 125I-iodocyanopindolol have been compared in a particulate fraction from regenerating rat liver. When total 3H-dihydroalprenolol binding and inhibition of total 3H-dihydroalprenolol binding by (-)isoprenaline, (-)alprenolol and (+/-)cyanopindolol was investigated, it was found that all agents were bound to two classes of saturable binding sites. In the inhibition studies, the presence of two binding components was not obvious until the data were transformed into Hofstee plots and these were decomposed, except in the case of (+/-)cyanopindolol. Only (+/-)cyanopindolol was found to distinguish clearly between the two saturable binding sites identified by 3H-dihydroalprenolol, as indicated by a broad plateau in the inhibition curve. When 125I-iodocyanopindolol was used as radioligand, only one saturable binding site was identified, even in the presence of less selective inhibiting ligands. The lower affinity component of 3H-dihydroalprenolol binding could be inhibited by 10 microM phentolamine. However, binding experiments with 3H-prazosin indicated that the lower affinity component was not identical with the alpha-adrenoceptor. Phentolamine did not influence 125I-iodocyanopindolol binding. Thus, due to its higher specific activity and a high degree of selectivity, 125I-iodocyanopindolol appears to be the ligand of choice.',\n",
       "  'journal': 'Acta pharmacologica et toxicologica',\n",
       "  'authors': 'Sandnes|D|D|;Westergren|T|T|;Sand|T E|TE|;Sager|G|G|;Refsnes|M|M|;Christoffersen|T|T|;Jacobsen|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150600',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000526:Alprenolol; D000818:Animals; D001667:Binding, Competitive; D004082:Dihydroalprenolol; D066298:In Vitro Techniques; D020120:Iodocyanopindolol; D007545:Isoproterenol; D007700:Kinetics; D008099:Liver; D008115:Liver Regeneration; D008297:Male; D008566:Membranes; D010869:Pindolol; D011224:Prazosin; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D004082:Dihydroalprenolol; D020120:Iodocyanopindolol; D000526:Alprenolol; D010869:Pindolol; D007545:Isoproterenol; D011224:Prazosin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1600-0773.1984.tb01984.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Pharmacol Toxicol (Copenh)',\n",
       "  'nlm_unique_id': '0370572',\n",
       "  'issn_linking': '0001-6683',\n",
       "  'country': 'Denmark'},\n",
       " {'title': 'Discrete regional distribution of biochemical markers for the dopamine, noradrenaline, serotonin, GABA and acetylcholine systems in the monkey brain (Cebus Apella). Effects of stress.',\n",
       "  'issue': '534()',\n",
       "  'pages': '1-27',\n",
       "  'abstract': 'Brains from Cebus Apella monkeys have been mapped biochemically using a cryo-section technique which enables exact micro-dissectioning of tissue. Two neurotransmitters; noradrenaline (NA) and gamma-amino-butyric acid (GABA) were measured by gas chromatography-masspectrometry technique. In addition biochemical markers reflecting metabolic activity in the dopamine (homovanillic acid, HVA, 3, 4-dihydroxyphenylacetic acid, DOPAC), serotonin (5-hydroxyindoleacetic acid, 5-HIAA), noradrenaline (4-hydroxy-3-methoxy-phenylglycol, HMPG), acetylcholine (choline acetyltransferase, CAT) and GABA (glutamic acid decarboxylase, GAD) transmitter systems were assayed. The distribution of these transmitter markers roughly corresponded to earlier studies in other non-human primates, whereas similar studies on the human brain generally show lower concentrations and enzyme activities. One monkey exposed to severe stress immediately before death deviated from the normal animals with regard to HVA, 5-HIAA, GAD and GABA. For the study of neuroleptic drugs, and notably their neurological side-effects, Cebus Apella monkeys have turned out to be particularly useful. In our laboratory we have employed this species of monkey to develop a model for acute dystonia and tardive dyskinesia (Gunne and Barany 1976, 1979, Barany et al. 1979). As a first step in the topological mapping of brain neuro-chemistry in these animals we here present data from normal monkeys, not treated with neuroleptics. During the ongoing project there was an unplanned \"stress experiment\" in one monkey, which had a nightly fight with a cage partner and had to be sacrificed the morning after due to severe wounds. The present communication describes a method for obtaining well-defined samples from monkey brains and presents the data on homovanillic acid (HVA), 3.4-dihydroxyphenylacetic acid (DOPAC), 5-hydroxyindoleacetic acid (5-HIAA), noradrenaline (NA), 4-hydroxy-3-methoxy-phenyl glycol (HMPG), choline acetyltransferase (ChAT), glutamic acid decarboxylase (GAD), and gamma-amino-butyric acid (GABA) in discrete regions from 7 drug-naive control monkeys. Also data from the stressed animal are presented.',\n",
       "  'journal': 'Acta physiologica Scandinavica. Supplementum',\n",
       "  'authors': 'Häggström|J E|JE|;Sjöquist|B|B|;Eckernäs|S A|SA|;Ingvast|A|A|;Gunne|L M|LM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150601',\n",
       "  'mesh_terms': 'D000818:Animals; D001921:Brain; D002428:Cebus; D018377:Neurotransmitter Agents; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D011985:Receptors, Serotonin; D013312:Stress, Physiological',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D011941:Receptors, Adrenergic; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D011985:Receptors, Serotonin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Physiol Scand Suppl',\n",
       "  'nlm_unique_id': '0376307',\n",
       "  'issn_linking': '0302-2994',\n",
       "  'country': 'England'},\n",
       " {'title': 'Sympathetic control of jejunal fluid and electrolyte transport. An experimental study in cats and rats.',\n",
       "  'issue': '535()',\n",
       "  'pages': '1-63',\n",
       "  'abstract': 'The study was performed to test the hypothesis that the sympathetic nerves to the small intestine might be involved in the feed-back control of extra-cellular fluid volume. In a series of experiments in anaesthetized cats, we studied how efferent stimulation of the splanchnic nerves affected jejunal fluid transport rate. The mechanisms behind the observed responses were analysed and we also attempted to determine the physiological role of the sympathetic supply to the jejunal mucosa. Splanchnic nerve stimulation (SNS) led to an increase in net fluid absorption provided that glucose was present in the jejunal lumen. In segments exposed to cholera toxin, SNS had a very pronounced inhibitory effect on net fluid secretion. The absorptive response was significant at a stimulation rate of 2 Hz and the maximal response occurred at 4-8 Hz. The effect was blocked by phentolamine, an alpha-adrenergic antagonist, and it was mimicked by a close intraarterial infusion of noradrenaline, an alpha-adrenergic agonist. The absorptive response to SNS was still present after blockade of the intestinal vasoconstrictor nerves with hexamethonium, indicating that the sympathetic pathways to the epithelium and to vascular smooth muscle may employ different ganglionic transmitter mechanisms. The increase in net fluid absorption induced by SNS was due to the inhibition of a secretory process. The response was not secondary to changes in intestinal blood flow. The effect of noradrenaline infusion was abolished after blockade of the intestinal nerves with tetrodotoxin, a finding which indicates that the sympathetic nerves may act by modulation of the activity in intramural secretory nervous pathways. Unloading of carotid sinus baroreceptors led to an increase in jejunal fluid absorption, a response which was abolished by division of the sympathetic fibres to the segment. Unloading of cardiac mechanoreceptors enhanced jejunal fluid absorption or decreased cholera secretion, effects which were abolished by previous cervical vagotomy or local alpha-adrenoreceptor blockade of the jejunal segment. Afferent stimulation of the right cardiac nerve led to an inhibition of net fluid absorption if the nerve was stimulated with high-threshold parameters at frequencies below 1 Hz.',\n",
       "  'journal': 'Acta physiologica Scandinavica. Supplementum',\n",
       "  'authors': 'Sjövall|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150602',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001692:Biological Transport; D002320:Cardiovascular Physiological Phenomena; D002346:Carotid Sinus; D002415:Cats; D004558:Electric Stimulation; D004573:Electrolytes; D005110:Extracellular Space; D006439:Hemodynamics; D007408:Intestinal Absorption; D007413:Intestinal Mucosa; D007419:Intestinal Secretions; D007422:Intestines; D007583:Jejunum; D008465:Mechanoreceptors; D011311:Pressoreceptors; D051381:Rats; D012018:Reflex; D013564:Sympathetic Nervous System; D014882:Water-Electrolyte Balance',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D004573:Electrolytes',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Physiol Scand Suppl',\n",
       "  'nlm_unique_id': '0376307',\n",
       "  'issn_linking': '0302-2994',\n",
       "  'country': 'England'},\n",
       " {'title': 'The cGMP system in irradiated animals. Changes in cGMP content and activities of guanylate cyclase and cyclic nucleotide phosphodiesterase.',\n",
       "  'issue': '23(5)',\n",
       "  'pages': '367-73',\n",
       "  'abstract': 'Changes in the functioning of the cGMP system of the thymocytes and liver of mice subjected to 8 Gy roentgen irradiation were found. Within one hour after irradiation an increase in the cGMP level in thymocytes was noted; two rises in the cGMP concentration in the liver were established, at 0.5 and 24 hours after irradiation. These changes in the cGMP level were correlated to an increase in the guanylate cyclase activities in the thymocytes and liver of the mice subjected to irradiation, and to a lesser extent to changes in the activities of cGMP phosphodiesterase in these tissues. A post-irradiation increase in the rat liver guanylate cyclase activity was also observed. A decrease in cGMP phosphodiesterase activity in the liver of the irradiated mice was followed by a change in the enzymatic kinetics and an increase in cGMP phosphodiesterase thermolability. The post-irradiation rise in guanylate cyclase activity was produced by activation of the enzyme.',\n",
       "  'journal': 'Acta radiologica. Oncology',\n",
       "  'authors': 'Sobolev|A S|AS|;Tertov|V V|VV|;Rybalkin|S D|SD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150603',\n",
       "  'mesh_terms': \"D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D000818:Animals; D002474:Cell-Free System; D006152:Cyclic GMP; D004789:Enzyme Activation; D006162:Guanylate Cyclase; D006358:Hot Temperature; D007700:Kinetics; D008099:Liver; D008297:Male; D051379:Mice; D051381:Rats; D013950:Thymus Gland; D013997:Time Factors; D014916:Whole-Body Irradiation\",\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': \"D015105:3',5'-Cyclic-AMP Phosphodiesterases; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D006162:Guanylate Cyclase; D006152:Cyclic GMP\",\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/02841868409136035',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Radiol Oncol',\n",
       "  'nlm_unique_id': '8209606',\n",
       "  'issn_linking': '0349-652X',\n",
       "  'country': 'Sweden'},\n",
       " {'title': 'Sertoli cells and Leydig cells in man.',\n",
       "  'issue': '88()',\n",
       "  'pages': '1-104',\n",
       "  'abstract': '',\n",
       "  'journal': 'Advances in anatomy, embryology, and cell biology',\n",
       "  'authors': 'Schulze|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150604',\n",
       "  'mesh_terms': 'D000328:Adult; D003456:Cryptorchidism; D003534:Cyproterone; D017373:Cyproterone Acetate; D004407:Dysgerminoma; D004967:Estrogens; D006801:Humans; D007248:Infertility, Male; D007985:Leydig Cells; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D012671:Seminiferous Tubules; D012708:Sertoli Cells; D013091:Spermatogenesis; D013724:Teratoma; D013736:Testicular Neoplasms',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D004967:Estrogens; D017373:Cyproterone Acetate; D003534:Cyproterone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/978-3-642-69869-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Adv Anat Embryol Cell Biol',\n",
       "  'nlm_unique_id': '0407712',\n",
       "  'issn_linking': '0301-5556',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Fronto- and laterobasal injuries in childhood and adolescence].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '187-92',\n",
       "  'abstract': 'Within a period of 5 years, the author treated, among 106 children and adolescents up to 15 years of age with craniocerebral injuries, 12 who had frontobasal and laterobasal lesions. These were extended comminuted fractures, impression fractures, linear fractures (fissures), ethmoidal fractures, as well as a petrosal bone fracture. Principal signs were rhinoliquorrhoea or otoliquorrhoea, traumatic disturbances of consciousness and intracranial air accumulations. Less frequently, traumatic shock, signs of CSF infection and concomitant eye injuries were seen. Surgical care (treatment of the dural defect and plastic occlusion by means of Lyodura, galea-periosteal flap or fascia lata) was mostly effected transfrontally, in two cases transethmoidally and in one case with combined technique. In two cases, primary frontal decomminution had to be followed by a transethmoidal second intervention to close a lesion of the dura in the region of the sphenoid sinus. Surgery was carried out as an immediate operation in case of open injuries and in massive liquorrhoea if the general condition of the patient was good. In all other cases, operation was delayed until the second week after injury.',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Kretschmer|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150605',\n",
       "  'mesh_terms': 'D000293:Adolescent; D001930:Brain Injuries; D002559:Cerebrospinal Fluid Rhinorrhea; D002648:Child; D002675:Child, Preschool; D004388:Dura Mater; D005004:Ethmoid Bone; D005260:Female; D005500:Follow-Up Studies; D005597:Fractures, Open; D005624:Frontal Bone; D006801:Humans; D008297:Male; D010579:Petrous Bone; D012887:Skull Fractures; D013345:Subarachnoid Hemorrhage; D014057:Tomography, X-Ray Computed',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Bacterial meningitis as a late complication of persistent traumatic cerebrospinal fluid fistulas].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '193-4',\n",
       "  'abstract': 'Report on two patients who suffered from bacterial meningitis 26 and 27 years after a severe headtrauma with consecutive cerebrospinal fluid fistulas. This is a rare cause, but must be considered if a bacterial meningitis of unknown origin is diagnosed.',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Süss|W|W|;Corradini|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150606',\n",
       "  'mesh_terms': 'D000328:Adult; D002559:Cerebrospinal Fluid Rhinorrhea; D005260:Female; D005624:Frontal Bone; D006801:Humans; D008297:Male; D008586:Meningitis, Pneumococcal; D008590:Meningoencephalitis; D008875:Middle Aged; D012887:Skull Fractures; D014057:Tomography, X-Ray Computed',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Osteosynthesis treatment of periorbital fractures with the mandibular mesh system].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '195-9',\n",
       "  'abstract': 'We report about 11 patients with periorbital fracture. Blow-out fracture and patients with fracture of the anterior wall of the frontal sinus. Treatment was operative osteosynthesis. We used for that the Mandibular Mesh System of 3M Company, Germany. We usually observed the patients for one year and got a firm unification of the fragments, as well a good cosmetic success from the beginning. We had not seen any complications caused by the osteosynthesis material. The author consider the most important advantages of this system to be the considerably smaller measurements, the possibility to form the osteosynthetical sheets out of a lattice, the higher solidity of Titanium and the good formability.',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Kurzeja|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150607',\n",
       "  'mesh_terms': 'D001860:Bone Plates; D001863:Bone Screws; D005260:Female; D005593:Fracture Fixation, Internal; D005597:Fractures, Open; D006801:Humans; D008297:Male; D009917:Orbital Fractures; D010256:Paranasal Sinuses; D011183:Postoperative Complications; D012887:Skull Fractures; D014945:Wound Healing',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Clinical problems of surgical infection. The Pirogov Institute for Emergency Medicine, Sofia].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '200-5',\n",
       "  'abstract': 'The aetiology, pathogenesis, diagnosis and therapy of sepsis are dealt with in this paper. These problems are discussed on the basis of 151 patients treated for sepsis. The cases with monoinfection are 73.6% and those with polyinfection are 24.4%. Monoinfection is caused mainly by Staphylococci -65,3%, followed by E. coli - 15.2%, Proteus - 13% and Klebsiella - 3.3%. For the cases of polyinfection the gram-negative bacteria are 3:1 in respect to the gram-positive bacteria. The bacteriological finding from the haemoculture (92.8% mono- and 7.2% polyinfection) is not equal to this from the input source. Here also the cases of monoinfection are mainly caused by Staphylococci - 70.9%, followed by Proteus - 7.7%, E. coli - 6%, Klebsiella aerogenes - 5.1% and Streptococcus 2.6%. The gram-negative bacteria prevail in the cases of polyinfection. The virulent aggressive infection, bacteria resistant to antibiotics, the aggressive local infection, hypoproteinemia, anaemia, diabetes, a prolonged corticosteroid treatment and unsuitable antibiotic treatment are discussed as main factors predisposing to sepsis. All the 151 patients were treated with the complex therapy, recommended in this paper. It includes a surgical cleaning-up of the initial nidus, intensive reasonable antibiotic treatment against the gram-positive and gram-negative aerobes and anaerobes. Additionally, substitution of infusion therapy, parenteral nutrition, regulation of the pathophysiological deviations and stimulating therapy are carried out. 74.2% from the patients were cured, 25.8% died. 16.6% of the patients who died had sepsis caused by gram-positive bacteria, and 46.1% had sepsis caused by gram-negative bacteria. 17% of the patients who died had septicaemia and 22% had septicopyaemia.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Popkirov|S|S|;Fitschev|G|G|;Aidemirska|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150608',\n",
       "  'mesh_terms': 'D001424:Bacterial Infections; D001431:Bacteriological Techniques; D003937:Diagnosis, Differential; D006801:Humans; D011379:Prognosis; D012306:Risk; D018805:Sepsis; D013530:Surgical Wound Infection',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Combined thoraco-abdominal injuries. Diagnosis, therapy, treatment results].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '206-10',\n",
       "  'abstract': '81 patients with combined thoraco-abdominal lesions had at the same time craniocerebral lesions (54 cases) and (in 70 cases) injuries of the locomotor system. These 64 men and 17 women had an average age of 44.8 years. In 72.9% surgical intervention was necessary in the regions of the thorax and abdomen at the same time, whereas in 18.5% of the cases surgery was required either at the thorax or at the abdomen only. Only 8.6% of the patients could be treated conservatively. 42 patients died (51.9%), two-thirds of these from direct organ lesion and one-third from an indirect organ lesion. The most frequent cause of death was craniocerebral trauma, ranking before thoracic and abdominal trauma.',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Dittel|K K|KK|;Rupf|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150609',\n",
       "  'mesh_terms': 'D000007:Abdominal Injuries; D000293:Adolescent; D000328:Adult; D000368:Aged; D005260:Female; D006801:Humans; D008099:Liver; D055370:Lung Injury; D008297:Male; D008875:Middle Aged; D011379:Prognosis; D013161:Splenic Rupture; D013898:Thoracic Injuries',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Long-term experience with brachial plexus anesthesia].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '211-4',\n",
       "  'abstract': 'In this work we report on our experience of more than 11 000 cases of plexus anaesthesia in the eight years 1976-1983. Particular care is taken to show how both the increase in experience and the amelioration in technology have led to an increase in the success rate. Our initial and current methods of axillary plexus block are described in detail, as are the most important signs relevant to the placing of the needle. Finally we discuss indications and contraindications, as well as possible complications and their prevention.',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Gerstein|J|J|;Hofmann-von Bandel|J|J|;Kleber-Baumann|M|M|;Clauberg|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150610',\n",
       "  'mesh_terms': 'D000765:Anesthesia, Conduction; D001132:Arm; D001917:Brachial Plexus; D006801:Humans; D008619:Mepivacaine; D009407:Nerve Block',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D008619:Mepivacaine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Use of volar veins in finger replantation].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '215-7',\n",
       "  'abstract': \"The number and the location of the venous anastomosis in finger replantation are discussed. The principle: 'two veins for one artery' has been given up in favour to do only one venous anastomosis. A vein on the palmar side should be preferred. Here the anastomosis is protected by a thicker layer of subcutanous tissue. In addition this technique allows to do the total vascular reconstruction without turning the hand. In a number of 84 finger replantations there was a failure rate of 9,5% by using only one vein for replantation. In 17 finger replantations using one volar vein we lost only one finger (5.9%).\",\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Stober|R|R|;Urbanski|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150611',\n",
       "  'mesh_terms': 'D000673:Amputation, Traumatic; D005383:Finger Injuries; D005385:Fingers; D006801:Humans; D008866:Microsurgery; D012092:Replantation; D014680:Veins; D014945:Wound Healing',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Late results of our treatment method in calcaneus fractures].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '218-26',\n",
       "  'abstract': 'The authors treated their patients, who had fractures of the calcaneus body in association with dislocation, by means of a new method: repositioning was effected by means of a special apparatus, retention via percutaneous screw osteosynthesis. Previously, they had used a Kirschner wire drilled from the tuber calcanei. The types of fracture differ very widely; the authors subdivide them into three groups, taking into consideration the involvement of the posterior talocalcaneal joint surfaces. The patients were subsequently followed up, and the results of 182 fractures of the calcaneum were evaluated, taking numerous different aspects into consideration. The authors were thus able to establish that the results of the treatment are greatly improved by accurate repositioning followed by percutaneous screw osteosynthesis.',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Zadravecz|G|G|;Szekeres|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150612',\n",
       "  'mesh_terms': 'D001863:Bone Screws; D002111:Calcaneus; D005260:Female; D005593:Fracture Fixation, Internal; D005597:Fractures, Open; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D014945:Wound Healing',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Significance of acute arthroscopy for the verification of fresh isolated cruciate ligament rupture].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '227-31',\n",
       "  'abstract': 'Arthroscopy for diagnosis in isolated rupture of the cruciate ligaments of the knee. Arthroscopy of the knee was performed in the years 1981 through 1983 in 1107 patients, arthroscopic meniscectomy in 340 patients. In acute traumatic haemarthrosis of the knee 74 \"isolated\" ruptures of the cruciate ligaments were found. The exact disclosure of these 74 cases gave a real isolated rupture of the anterior cruciate in 28.4%, an isolated rupture combined with meniscus tears and connected with flake fracture each in 20.3%. In 17.5% the exact diagnosis was a disruption of the anterior cruciate together with meniscus tears and flake fracture. Acute arthroscopy allows a more accurate diagnosis of injury to joint structures. If there was an intraligamentary rupture of the anterior cruciate and meniscus tear or flake fracture we did arthroscopic meniscectomy and removed the small flake. The substitution of the anterior cruciate was performed, if there were instability complains, later on at agreeable time for the patient.',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Benedetto|K P|KP|;Glötzer|W|W|;Sperner|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150613',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D001182:Arthroscopy; D002648:Child; D005260:Female; D006395:Hemarthrosis; D006801:Humans; D007718:Knee Injuries; D008023:Ligaments, Articular; D008297:Male; D008592:Menisci, Tibial; D008875:Middle Aged; D000070600:Tibial Meniscus Injuries',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Correction of rotation malposition following intramedullary nailing of the tibia].',\n",
       "  'issue': '14(5)',\n",
       "  'pages': '232-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Aktuelle Traumatologie',\n",
       "  'authors': 'Vogt|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150614',\n",
       "  'mesh_terms': 'D001860:Bone Plates; D005360:Fibula; D005594:Fracture Fixation, Intramedullary; D006801:Humans; D010027:Osteotomy; D011183:Postoperative Complications; D013977:Tibia; D013978:Tibial Fractures',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Traumatol',\n",
       "  'nlm_unique_id': '0421405',\n",
       "  'issn_linking': '0044-6173',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'The influence of lymphatic drainage in experimental Trypanosoma cruzi infection.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '207-14',\n",
       "  'abstract': 'The rapid disappearance of infective forms of Trypanosoma cruzi from the site of inoculation as well as the initial phase of infection produced by the parasite are not yet fully understood. To investigate this problem we used the hamster as an animal model considering the existence of the cheek pouch--a peculiar region devoid of lymphatic vessels. T. cruzi trypomastigotes were inoculated into the cheek pouch or into the footpad of animals previously infected or not with the same parasite. The results were followed from 3 up to 21 days postinoculation, by histological examination. In the cheek pouch of normal animals a large number of parasites could be seen up to 15 days post-inoculation and the inflammatory infiltrate had a focal distribution. Conversely, in the footpad the infiltrate was diffuse and no parasites could be detected. These observations indicate that the lymphatic system is the main route of T. cruzi dissemination from the site or inoculation. When hamsters were first inoculated in the footpad and 7 days later in the pouch, the inflammatory infiltrate at this point was less aggressive and no parasites could be detected.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Bijovsky|A T|AT|;Milder|R V|RV|;Abrahamsohn|I A|IA|;Sinhorini|I L|IL|;Mariano|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150615',\n",
       "  'mesh_terms': 'D000818:Animals; D014355:Chagas Disease; D002610:Cheek; D006224:Cricetinae; D004195:Disease Models, Animal; D005260:Female; D005528:Foot; D008208:Lymphatic System; D008297:Male; D008647:Mesocricetus; D014349:Trypanosoma cruzi',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Further studies on the cell surface charge of Trypanosoma cruzi.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '215-25',\n",
       "  'abstract': 'Trypanosoma cruzi has a negative surface which varies according to the ionic strength and the pH of the solution in which the cells are suspended. At low pH there is a decrease in the negative surface charge with an isoelectric point at pH 2.6 and 3.0 for epimastigote and trypomastigote forms, respectively. Below these pH values the cells have a positive surface charge. At higher pH there is an increase in the surface charge. Glutaraldehyde fixation did not interfere with the electrophoretic mobility (EPM) of the cells. Epimastigote and trypomastigote forms of T. cruzi have a characteristic EPM independent of the medium in which the cells were grown, the origin of the trypomastigotes or the strain of the parasite. Trypomastigotes have a higher negative surface charge than epimastigotes. Based on the change in the EPM of the cells treated with neuraminidase, is concluded that sialic acid is present on the cell surface of T. cruzi and that it is the main component responsible for the high negative surface charge of the trypomastigote form. Trypsin treatment also reduces the EPM of T. cruzi. Neuraminidase or trypsin-treated parasites recovered their normal EPM when incubated for 4 h in fresh culture medium. This process involves synthesis of protein since it is inhibited by puromycin.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Souto-Padrón|T|T|;de Carvalho|T U|TU|;Chiari|E|E|;de Souza|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150616',\n",
       "  'mesh_terms': 'D000818:Animals; D003470:Culture Media; D006863:Hydrogen-Ion Concentration; D007526:Isoelectric Point; D008564:Membrane Potentials; D051379:Mice; D009439:Neuraminidase; D009994:Osmolar Concentration; D014349:Trypanosoma cruzi; D014357:Trypsin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D003470:Culture Media; D009439:Neuraminidase; D014357:Trypsin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Failure of trypanosomal membrane antigens to induce protection against tsetse-transmitted Trypanosoma vivax or T. brucei in goats and rabbits.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '227-36',\n",
       "  'abstract': \"A purified protein, relative molecular weight 83 kilodalton (kD), and plasma membranes from Trypanosoma brucei were tested as potential vaccines against tsetse-transmitted T. vivax and T. brucei in goats and rabbits. The 83 kD protein was found in lysates of all clones of T. brucei examined, as well as in lysates of T. vivax, T. congolense and T. rhodesiense. Rabbits and goats were immunized with various amounts of antigen in Freund's complete adjuvant and boosted twice with antigen in Freund's incomplete adjuvant. Two weeks after the last inoculation, the goats were challenged with T. vivax-infected and the rabbits with T. brucei-infected Glossina morsitans morsitans. Although high antibody levels were detected in all the animals immunized with either antigen as measured by radioimmunoassay and immunodiffusion, they became infected and the course of disease was the same as that in unimmunized controls.\",\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Rovis|L|L|;Musoke|A J|AJ|;Moloo|S K|SK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150617',\n",
       "  'mesh_terms': 'D000818:Animals; D000953:Antigens, Protozoan; D002462:Cell Membrane; D006041:Goats; D007114:Immunization; D007303:Insect Vectors; D011506:Proteins; D011817:Rabbits; D014345:Trypanosoma; D014346:Trypanosoma brucei brucei; D014353:Trypanosomiasis, African; D014370:Tsetse Flies',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000953:Antigens, Protozoan; D011506:Proteins',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Cerebral trypanosomiasis in cattle with mixed Trypanosoma congolense and T. brucei brucei infections.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '237-46',\n",
       "  'abstract': 'Six Boran steers were infected simultaneously with Trypanosoma congolense and T. brucei brucei while another group of 3 was inoculated with T. b. brucei one year after infection with T. congolense. Three further steers were infected with T. b. brucei alone. Whereas, the six animals which received simultaneous infections developed clinical signs of cerebral trypanosomiasis as evidenced by depression, ataxia and occasional circling, those infected with T. b. brucei alone did not. At necropsy, 4 out of the 6 simultaneously infected animals had a mild to severe disseminated non-suppurative meningoencephalitis. Trypanosoma b. brucei was isolated from the cerebrospinal fluid (CSF) of three out of the four animals with histological lesions. Two of the cattle superinfected with T. b. brucei one year after infection with T. congolense also developed both clinical and histological evidence of cerebral trypanosomiasis. Trypanosoma congolense was isolated from the CSF of one of these 2 animals. Specific antibodies to the variable surface glycoproteins (VSGs) of the infecting T. b. brucei and T. congolense clones were found in the CSF of the 8 animals that developed cerebral trypanosomiasis. In these animals however, there was neither temporal nor quantitative correlation between VSG-specific antibodies in serum and in CSF, implying a de novo synthesis of antibodies to the infecting trypanosomes in the CSF.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Masake|R A|RA|;Nantulya|V M|VM|;Akol|G W|GW|;Musoke|A J|AJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150618',\n",
       "  'mesh_terms': 'D000818:Animals; D000906:Antibodies; D000918:Antibody Specificity; D002417:Cattle; D006023:Glycoproteins; D008297:Male; D008590:Meningoencephalitis; D014346:Trypanosoma brucei brucei; D014348:Trypanosoma congolense; D014353:Trypanosomiasis, African; D014354:Trypanosomiasis, Bovine; D014643:Variant Surface Glycoproteins, Trypanosoma',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000906:Antibodies; D006023:Glycoproteins; D014643:Variant Surface Glycoproteins, Trypanosoma',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'The appearance of isometamidium resistant Trypanosoma congolense in West Africa.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '247-52',\n",
       "  'abstract': 'The frequent reappearance of patent parasitemia, mainly Trypanosoma congolense, in cattle maintained under isometamidium prophylaxis in the Upper Volta indicated that drug-resistant forms might be appearing. To investigate this possibility, trypanosome stocks were isolated in mice, their isometamidium sensitivity estimated and compared to that of stocks isolated before drug use was widespread. Most T. congolense stocks isolated in 1982-1983 were 4-8 times less sensitive to isometamidium than those isolated in 1979-1980.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Pinder|M|M|;Authie|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150619',\n",
       "  'mesh_terms': 'D000818:Animals; D001769:Blood; D002050:Burkina Faso; D002417:Cattle; D004352:Drug Resistance, Microbial; D005260:Female; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D010617:Phenanthridines; D013636:Tanzania; D014348:Trypanosoma congolense',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D010617:Phenanthridines; C000702:isometamidium chloride',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Maintenance of Glossina morsitans morsitans on antiserum to procyclic trypanosomes reduces infection rates with homologous and heterologous Trypanosoma congolense stocks.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '253-7',\n",
       "  'abstract': 'Three experimental groups of male Glossina morsitans morsitans were infected at their first feed with procyclic forms of different stocks of Trypanosoma congolense and subsequently maintained on a diet containing rabbit antiserum to one of these stocks. Control flies were similarly infected but were then maintained on normal rabbit serum. Dissection of the flies 19-21 days post infection showed a reduction in both immature and mature infection rates in all groups fed on antiserum by comparison with control flies. These results suggest that vaccination with a single procyclic T. congolense strain could reduce transmission of both homologous and heterologous T. congolense strains which might, in certain epidemiological circumstances, provide an alternative or additional control method for African trypanosomiases.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Maudlin|I|I|;Turner|M J|MJ|;Dukes|P|P|;Miller|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150620',\n",
       "  'mesh_terms': 'D000818:Animals; D005247:Feeding Behavior; D007106:Immune Sera; D008297:Male; D011817:Rabbits; D014348:Trypanosoma congolense; D014353:Trypanosomiasis, African; D014370:Tsetse Flies; D014454:Uganda',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007106:Immune Sera',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Transmission and course of parasitemia of Babesia microti (Hannover I strain) in the bank vole (Clethrionomys glareolus) and field vole (Microtus agrestis)].',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '259-64',\n",
       "  'abstract': 'In Germany only M. agrestis has been found to be naturally infected with B. microti while in other European countries several rodent species were found as mammalian hosts. In the laboratory C. glareolus got easily infected by German strains of B. microti, if parasitized blood was inoculated. But results of this method are not transferable to natural conditions. Therefore this study was carried out. It was to prove whether C. glareolus is susceptible to B. microti transmitted by nymphs of I. ricinus, or not. To compare the results, M. agrestis was infected in the same way. Both of them proved to be susceptible. The parasitaemia lasted for months. In the beginning the rate of parasitaemia reached 2%, then decreased below 0.1%. The course of infection was variable. In blood smears B. microti could not be detected at all times, so that in field trials the infection rate in mice will often be underestimated. A connection between parasitaemia and gravidity or lactation was not observed under laboratory conditions.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Walter|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150621',\n",
       "  'mesh_terms': 'D000818:Animals; D001096:Arachnid Vectors; D003411:Arvicolinae; D001403:Babesia; D001404:Babesiosis; D001769:Blood; D005260:Female; D007774:Lactation; D011247:Pregnancy; D011270:Pregnancy, Animal; D012376:Rodent Diseases; D013987:Ticks',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Localization of the filaria Loa loa in the anterior chamber of the eye. Apropos of a case].',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '265-9',\n",
       "  'abstract': 'A live and active thread-like worm was seen in the anterior chamber of a 60-year-old congolese woman. The worm was extracted and recognized as an adult female Loa loa. Taking into account the presence of nonfertile eggs in the aqueous humor and in the uterus of the filarial worm, the authors think that the maturation of the worm from a larval form takes place inside the eye. However, this localization is exceptional.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Carme|B|B|;Kaya-Gandziami|G|G|;Pintart|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150622',\n",
       "  'mesh_terms': 'D000818:Animals; D000867:Anterior Chamber; D001082:Aqueous Humor; D003223:Congo; D005260:Female; D005368:Filariasis; D006801:Humans; D008117:Loa; D008118:Loiasis; D008875:Middle Aged',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Methyl 5(6)-4-2-pyridyl piperazino carbamoyl benzimidazole-2-carbamate--a new broad spectrum anthelmintic.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '279-86',\n",
       "  'abstract': \"Methyl 5(6)-4-2-pyridyl piperazino carbamoyl benzimidazole-2-carbamate (CDRI Comp. 81-470) was tested against various nematode and cestode infections in different experimental and domestic animals. The compound showed 100% effectivity against adult of Ancylostoma ceylanicum (hookworm) in hamsters (6.25 mg/kg p.o. X 1), Nippostrongylus brasiliensis (trichostrongylid) in rats (100 mg/kg p.o. X 3), Hymenolepis nana (cestode) in rats (25 mg/kg p.o. X 1) and Syphacia obvelata (oxyurid) in mice (12.5 mg/kg p.o. X 3). It was also found highly effective against artificial and natural helminth parasites of higher animals. The compound removed all, A. caninum and A. ceylanicum (hookworms) and Toxocara sp. (ascarid) from dogs at a dose of 10 mg/kg p.o. X 3; A. tubaeformis (hookworm) and Toxocara sp. at 25 mg/kg p.o. X 3 and 2.5 mg/kg p.o. X 3 respectively from cats and Ascaridia galli (ascarid) at 10 mg/kg p.o. X 3 from fowl. The compound in doses of 1500 mg/kg by oral route and 1000 mg/kg by i.p. route did not cause any mortality or produce adverse effect in mice. The expanded anthelmintic action and large therapeutic index indicate compound's great anthelmintic potentiality.\",\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Katiyar|J C|JC|;Visen|P K|PK|;Misra|A|A|;Gupta|S|S|;Bhaduri|A P|AP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150623',\n",
       "  'mesh_terms': 'D000818:Animals; D000829:Animals, Domestic; D000830:Animals, Laboratory; D000871:Anthelmintics; D001562:Benzimidazoles; D002219:Carbamates; D002415:Cats; D002590:Cestode Infections; D002645:Chickens; D006224:Cricetinae; D004285:Dogs; D005243:Feces; D005260:Female; D007411:Intestinal Diseases, Parasitic; D008297:Male; D051379:Mice; D009349:Nematode Infections; D051381:Rats; D013045:Species Specificity',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000871:Anthelmintics; D001562:Benzimidazoles; D002219:Carbamates; C043589:CDRI 81-470',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Scanning electron microscopy of Trichuris trichiura (Nematoda).',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '287-92',\n",
       "  'abstract': 'Trichuris trichiura was examined in the scanning electron microscope and revealed a double row of sucker-like structures at the anterior part. It is postulated that they may support the attachment of the worm in host tissues. The sheath of the spicule is covered with spikes and the vulval opening is surrounded by an elevated rim-like structure with indentations.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Zaman|V|V|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150624',\n",
       "  'mesh_terms': 'D000818:Animals; D005260:Female; D005835:Genitalia; D006801:Humans; D008297:Male; D008855:Microscopy, Electron, Scanning; D014257:Trichuriasis; D014258:Trichuris',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Breeding sites of Glossina palpalis s.1. pupae in a transitional woodland area in Ivory Coast].',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '293-301',\n",
       "  'abstract': 'Search for pupae of G. palpalis s.1. was conducted from February to December 1981 in the Bouaflé area, Ivory Coast. 1909 pupae were collected from 70 breeding sites after 518 hours of search. Pupae were found both in the dry and the rainy seasons. The vegetation and the nature of the soil seem to be two inseparable factors for the creation and the maintenance of Glossina breeding sites in the study area. In localities with high pig population density, a greater number of pupae were found either at the edge of the village or at a distance not exceeding 500 m from the houses. This observation confirms peridomestic behaviour of G. palpalis s.1. in these localities. On the contrary, in localities with low pig population density or without pigs, peridomestic breeding was not observed; all the pupae were found at a distance 500 m to 3 km away from the houses, in coffee and cocoa plantations and in woodlands. The epidemiological significance of the distribution of G. palpalis s.1. breeding sites in the study area is discussed.',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Sékétéli|A|A|;Kuzoe|F A|FA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150625',\n",
       "  'mesh_terms': \"D000818:Animals; D001522:Behavior, Animal; D007560:Cote d'Ivoire; D004463:Ecology; D005260:Female; D006813:Humidity; D012098:Reproduction; D012621:Seasons; D014197:Trees; D014370:Tsetse Flies\",\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Detection of antibodies against Candida albicans in Giardia lamblia infected individuals. Short communication.',\n",
       "  'issue': '41(3)',\n",
       "  'pages': '303-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Acta tropica',\n",
       "  'authors': 'Haralabidis|S T|ST|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150626',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000906:Antibodies; D000908:Antibodies, Fungal; D002176:Candida albicans; D002177:Candidiasis; D002648:Child; D002675:Child, Preschool; D004797:Enzyme-Linked Immunosorbent Assay; D005243:Feces; D005872:Giardia; D005873:Giardiasis; D006801:Humans; D007223:Infant',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000906:Antibodies; D000908:Antibodies, Fungal',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Trop',\n",
       "  'nlm_unique_id': '0370374',\n",
       "  'issn_linking': '0001-706X',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Trimepranol, a Czechoslovak-made beta blocker, in the treatment of acute myocardial infarction.',\n",
       "  'issue': '30(1-2)',\n",
       "  'pages': '117-23',\n",
       "  'abstract': '',\n",
       "  'journal': 'Acta Universitatis Carolinae. Medica',\n",
       "  'authors': 'Charvát|J|J|;Pavlovic|J|J|;Fiserová|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150627',\n",
       "  'mesh_terms': 'D000368:Aged; D001794:Blood Pressure; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D014290:Metipranolol; D008875:Middle Aged; D009203:Myocardial Infarction; D011412:Propanolamines',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D011412:Propanolamines; D014290:Metipranolol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Univ Carol Med (Praha)',\n",
       "  'nlm_unique_id': '2985169R',\n",
       "  'issn_linking': '0001-7116',\n",
       "  'country': 'Czech Republic'},\n",
       " {'title': 'A genealogical study from an area of endemic degeneration.',\n",
       "  'issue': '30(1-2)',\n",
       "  'pages': '43-63',\n",
       "  'abstract': '',\n",
       "  'journal': 'Acta Universitatis Carolinae. Medica',\n",
       "  'authors': 'Kremenová|J|J|;Reisenauer|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150628',\n",
       "  'mesh_terms': 'D000310:Adrenal Gland Neoplasms; D002277:Carcinoma; D003604:Czechoslovakia; D005260:Female; D005860:Germany, West; D006043:Goiter, Endemic; D006801:Humans; D008297:Male; D009377:Multiple Endocrine Neoplasia; D010375:Pedigree; D010673:Pheochromocytoma; D013781:Texas; D013964:Thyroid Neoplasms',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Acta Univ Carol Med (Praha)',\n",
       "  'nlm_unique_id': '2985169R',\n",
       "  'issn_linking': '0001-7116',\n",
       "  'country': 'Czech Republic'},\n",
       " {'title': 'The dodo you save may be your own.',\n",
       "  'issue': '54(4)',\n",
       "  'pages': '9-10, 13',\n",
       "  'abstract': '',\n",
       "  'journal': 'Alabama medicine : journal of the Medical Association of the State of Alabama',\n",
       "  'authors': 'Hyman|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150629',\n",
       "  'mesh_terms': \"D003363:Cost Control; D004465:Economic Competition; D004526:Efficiency; D006801:Humans; D008389:Marketing of Health Services; D010823:Physician Assistants; D010824:Physicians' Offices; D011369:Professional-Patient Relations\",\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ala Med',\n",
       "  'nlm_unique_id': '8310343',\n",
       "  'issn_linking': '0738-4947',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Mechanisms contributing to precipitation of unstable angina and acute myocardial infarction: implications regarding therapy.',\n",
       "  'issue': '54(10)',\n",
       "  'pages': '1245-52',\n",
       "  'abstract': 'Clinical and autopsy studies indicate that most patients who present with unstable angina or an acute myocardial infarction (AMI) have significant underlying coronary atherosclerosis. This review discusses 4 mechanisms that may contribute to the precipitation of these acute ischemic clinical syndromes: progression of atherosclerosis, acute coronary thrombosis, coronary artery spasm, and platelet aggregation. Numerous clinical trials using thrombolytic agents early during AMI have shown the incidence of thrombosis to be at least 60%. Other studies suggest that platelet aggregation frequently contributes to the evolution of AMI from unstable angina and that spasm may occasionally play a similar role. The therapeutic implications of these mechanisms are also considered in light of their potential to restore coronary artery blood flow (vs conventional methods thought mainly to reduce myocardial oxygen demand) and thereby limit the infarct process. The role of vasodilators, thrombolytic agents, antiplatelet drugs and beta-adrenergic blocking drugs are discussed. Finally, therapeutic guidelines for the treatment of acutely ill patients are constructed that emphasize the need for a comprehensive yet time-efficient treatment strategy that uses nitrates, calcium channel-blocking drugs, streptokinase, heparin, aspirin and, in selected patients in an unstable condition, emergency percutaneous transluminal coronary angioplasty and coronary artery bypass grafting.',\n",
       "  'journal': 'The American journal of cardiology',\n",
       "  'authors': 'Epstein|S E|SE|;Palmeri|S T|ST|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150630',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000787:Angina Pectoris; D000789:Angina, Unstable; D000800:Angioplasty, Balloon; D000818:Animals; D000925:Anticoagulants; D001241:Aspirin; D002121:Calcium Channel Blockers; D002986:Clinical Trials as Topic; D001026:Coronary Artery Bypass; D003327:Coronary Disease; D003329:Coronary Vasospasm; D003331:Coronary Vessels; D005343:Fibrinolytic Agents; D006801:Humans; D007263:Infusions, Parenteral; D009203:Myocardial Infarction; D009566:Nitrates; D010974:Platelet Aggregation; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D005343:Fibrinolytic Agents; D009566:Nitrates; D014665:Vasodilator Agents; D001241:Aspirin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0002-9149(84)80074-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Cardiol',\n",
       "  'nlm_unique_id': '0207277',\n",
       "  'issn_linking': '0002-9149',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Early intervention with a beta-blocking drug after acute myocardial infarction.',\n",
       "  'issue': '54(11)',\n",
       "  'pages': '11E-13E',\n",
       "  'abstract': 'Several controlled studies with long-term administration of beta blockers in postinfarction patients have demonstrated a reduction in cardiac events and mortality. During acute myocardial infarction (AMI), conventional treatment is directed mainly at such complications as pump failure and arrhythmias. Another approach attempts to influence the natural evolution of impending myocardial necrosis by interrupting the process in its reversible phase. In a double-blind trial with metoprolol in suspected or definite AMI, 1,395 patients were studied, 698 of whom received metoprolol and 697 placebo. The 3-month mortality was 36% lower in the metoprolol group (p = 0.024). A reduction in severe ventricular arrhythmias (ventricular fibrillation and tachycardia) was also seen. Chest pain was reduced and there was less need of analgesic drugs in the metoprolol group. Intervention within 12 hours resulted in a limitation of infarct size, a decreased need for furosemide and a shortened hospital stay. A significant reduction in mortality was maintained after 2 years of follow-up despite the same treatment in both groups between 3 and 24 months. Early institution of metoprolol in AMI has resulted in reduced mortality and morbidity.',\n",
       "  'journal': 'The American journal of cardiology',\n",
       "  'authors': 'Hjalmarson|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150631',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D002986:Clinical Trials as Topic; D006801:Humans; D008790:Metoprolol; D009203:Myocardial Infarction; D011379:Prognosis; D012306:Risk; D013997:Time Factors',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D008790:Metoprolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0002-9149(84)80305-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Cardiol',\n",
       "  'nlm_unique_id': '0207277',\n",
       "  'issn_linking': '0002-9149',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Short- and long-term influence of beta-adrenergic antagonists after acute myocardial infarction.',\n",
       "  'issue': '54(11)',\n",
       "  'pages': '16E-20E',\n",
       "  'abstract': 'After coronary arterial occlusion, catecholamines are released from storage depots in the left ventricle and injured myocardial cells are exposed to relatively high concentrations of catecholamines during the evolutionary period in which cell injury is becoming progressively more severe. In addition, in experimental animal models, there is a substantial increase in beta-adrenergic receptor density without any alteration in affinity within 1 hour of permanent coronary arterial occlusion. Recent data suggest that alpha-adrenergic receptor density increases within 30 to 60 minutes after coronary arterial occlusion in experimental animal models. The administration of catecholamines during the early phases of evolving myocardial injury can result in heightened adrenergic biochemical responses in severely injured compared with normally perfused tissue in the hearts of experimental animals. Thus, there is adequate rationale for anticipating that beta-adrenergic antagonists would protect ischemic myocardium and potentially reduce the incidence of life-threatening arrhythmias in individuals with evolving acute myocardial infarction (AMI). Studies in animal models demonstrate that the administration of beta-adrenergic antagonists in the first few minutes after coronary artery occlusion may reduce the ultimate extent of myocardial necrosis. Clinical data from several different trials in which beta-adrenergic antagonists were administered to (1) protect ischemic myocardium and preserve ventricular function and (2) reduce the severity of serious ventricular arrhythmias in patients with AMI are reviewed. The effects of longer-term administration of beta-adrenergic antagonists in patients after AMI in prolonging life and reducing risk of reinfarction are presented.',\n",
       "  'journal': 'The American journal of cardiology',\n",
       "  'authors': 'Willerson|J T|JT|;Buja|L M|LM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150632',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D002395:Catecholamines; D002986:Clinical Trials as Topic; D003327:Coronary Disease; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D006801:Humans; D008790:Metoprolol; D009203:Myocardial Infarction; D009206:Myocardium; D011433:Propranolol; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D013997:Time Factors; D013999:Timolol',\n",
       "  'publication_types': \"D016430:Clinical Trial; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.; D016454:Review\",\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D002395:Catecholamines; D011942:Receptors, Adrenergic, alpha; D011943:Receptors, Adrenergic, beta; D013999:Timolol; D011433:Propranolol; D008790:Metoprolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0002-9149(84)80307-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Cardiol',\n",
       "  'nlm_unique_id': '0207277',\n",
       "  'issn_linking': '0002-9149',\n",
       "  'country': 'United States'},\n",
       " {'title': \"Early intervention in acute myocardial infarction: one center's perspective.\",\n",
       "  'issue': '54(11)',\n",
       "  'pages': '2E-7E',\n",
       "  'abstract': 'Understanding of the phenomenon of acute myocardial infarction (AMI) and definition of proper treatment have changed radically in the past decade. AMI is regarded as an evolving event with an outcome that may be modifiable. Initial attempts at intervention involved reducing myocardial oxygen requirements and salvaging ischemic tissue. Studies of beta-blockade administration, which at first was considered contraindicated, have shown that such treatment may be beneficial and may also be safe in the postinfarction period. The hypothesis that the mass of infarct sustained is important to outcome is also under study, with use of such techniques as serial plasma creatine kinase (CK) determinations and ejection fraction for assessing infarct size. Analysis of isoforms of CK is a new area of interest that may facilitate early diagnosis and define the chronologic aspects of infarcts. Myocardial reperfusion with fibrolytic agents has yielded apparent benefit, but it is an aggressive and still experimental form of intervention. Positron tomography has been used for quantitative assessment of regional metabolism and perfusion. Initial results of reperfusion with clot-selective fibrinolytic agents, expected to reduce the risk of bleeding, indicate favorable effects on the heart and no evidence of systemic bleeding.',\n",
       "  'journal': 'The American journal of cardiology',\n",
       "  'authors': 'Sobel|B E|BE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150633',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase; D004285:Dogs; D005343:Fibrinolytic Agents; D005730:Ganglionic Blockers; D006801:Humans; D007527:Isoenzymes; D009203:Myocardial Infarction; D009206:Myocardium; D005996:Nitroglycerin; D010101:Oxygen Consumption; D010960:Plasminogen Activators; D011379:Prognosis; D011817:Rabbits; D013318:Stroke Volume; D013997:Time Factors; D014055:Tomography, Emission-Computed',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D005343:Fibrinolytic Agents; D005730:Ganglionic Blockers; D007527:Isoenzymes; D003402:Creatine Kinase; D010960:Plasminogen Activators; D005996:Nitroglycerin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0002-9149(84)80303-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Cardiol',\n",
       "  'nlm_unique_id': '0207277',\n",
       "  'issn_linking': '0002-9149',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Prophylactic antiarrhythmic therapy in acute myocardial infarction.',\n",
       "  'issue': '54(11)',\n",
       "  'pages': '8E-10E',\n",
       "  'abstract': 'Safe, effective prophylaxis of arrhythmias in acute myocardial infarction (AMI) is an important clinical goal. Despite rescue squads, out-of-hospital ventricular fibrillation (VF) has a poor prognosis. Even in-hospital VF has an important morbidity and mortality. Successful prophylactic therapy may also prevent infarct size enlargement associated with tachyarrhythmias. Several antiarrhythmic drugs have been investigated. In 3 studies, mortality was significantly reduced, but all of these have serious methodologic flaws and the validity of their conclusions is debatable. More reliance can be placed on 2 other studies which suggested that VF was significantly reduced by prophylactic therapy. However, in one of these studies, which used high-dose intravenous lidocaine, an unusually high incidence of VF was observed in the placebo-treated patients. The second study, reporting the use of metoprolol in AMI, was based on retrospective subset analysis. The reduction in VF was seen from the fourth day onwards and not during the acute phase of infarction. The favorable results with high-dose intravenous lidocaine are the basis for widespread use of prophylactic arrhythmia therapy in AMI. Uncontrolled observations provide some corroboration of the benefit. However, the claimed efficacy for lidocaine remains scientifically poorly substantiated and the safety of the high-dose regimen is controversial. Effective prophylaxis of arrhythmias in AMI could have important clinical benefit. However, the strategy would entail administration of a drug to many patients not at risk of arrhythmias (those without AMI) and to a number of patients in whom the complications of infarction are destined to develop.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'The American journal of cardiology',\n",
       "  'authors': 'Campbell|R W|RW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150634',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D001145:Arrhythmias, Cardiac; D006760:Hospitalization; D006801:Humans; D008012:Lidocaine; D009203:Myocardial Infarction; D011379:Prognosis; D012306:Risk; D014693:Ventricular Fibrillation',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D008012:Lidocaine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0002-9149(84)80304-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Cardiol',\n",
       "  'nlm_unique_id': '0207277',\n",
       "  'issn_linking': '0002-9149',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Transition from a hunter-gatherer to a settled lifestyle in the !Kung San: effect on iron, folate, and vitamin B12 nutrition.',\n",
       "  'issue': '40(6)',\n",
       "  'pages': '1295-303',\n",
       "  'abstract': \"In 1969 a group of hunter-gatherer San were studied (Am J Clin Nutr 1971;24:229-42). Their state of hematological nutrition was excellent with a negligible incidence of iron, folate, or vitamin B12 deficiency. A genetically and linguistically similar San community who have been settled for the past 15 yr were the subjects of the present study. Anemia, due in the main to iron and/or folate deficiency, has become more common. Alcoholism has become rife in both sexes and all age groups. Our findings show that a settled lifestyle has resulted in a significant deterioration in the San's hematological nutrition.\",\n",
       "  'journal': 'The American journal of clinical nutrition',\n",
       "  'authors': 'Fernandes-Costa|F J|FJ|;Marshall|J|J|;Ritchie|C|C|;van Tonder|S V|SV|;Dunn|D S|DS|;Jenkins|T|T|;Metz|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150635',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000469:Alkaline Phosphatase; D000740:Anemia; D001902:Botswana; D002648:Child; D005006:Ethnicity; D005260:Female; D005492:Folic Acid; D006801:Humans; D007501:Iron; D007774:Lactation; D008019:Life Style; D008297:Male; D008593:Menopause; D008875:Middle Aged; D009276:Namibia; D010272:Parasitic Diseases; D011247:Pregnancy; D012922:Social Change; D014805:Vitamin B 12; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005492:Folic Acid; D007501:Iron; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase; D014805:Vitamin B 12',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/ajcn/40.6.1295',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Clin Nutr',\n",
       "  'nlm_unique_id': '0376027',\n",
       "  'issn_linking': '0002-9165',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Managing skin damage induced by doxorubicin hydrochloride and daunorubicin hydrochloride.',\n",
       "  'issue': '41(11)',\n",
       "  'pages': '2410-4',\n",
       "  'abstract': 'The pathophysiology and mechanisms of toxicity of anthracycline-induced skin damage are reviewed, and the various available therapeutic interventions are discussed. Skin ulcers caused by the vesicant antineoplastic agents doxorubicin hydrochloride and daunorubicin hydrochloride begin slowly, and the extent of the tissue damage produced is often underestimated. Within a week, untreated infiltrations of these agents can advance to serious indurations and ulcerations, causing extensive damage to underlying structures such as tendons and bones. Two theories have been proposed to explain the mechanism of action of anthrocycline-induced tissue damage; one holds that doxorubicin-DNA complexes form causing cell death, and the other holds that these agents are reduced to free radicals that can cause cell-membrane damage. Nonpharmacologic treatment of extravasation consists of stopping the infusion at the first sign of a problem and attempting to aspirate fluid and drug back through the same needle. The application of ice packs for the next 24-72 hours is recommended. A variety of pharmacologic approaches have been evaluated to ameliorate tissue damage. Corticosteroids, sodium bicarbonate, beta-adrenergic agents, and dimethyl sulfoxide have been used with some success. Patients who do not respond to initial conservative treatments should be referred to a plastic surgeon for skin grafting and reconstruction. The best treatment for anthracycline toxicity is prevention.',\n",
       "  'journal': 'American journal of hospital pharmacy',\n",
       "  'authors': 'Cox|R F|RF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150636',\n",
       "  'mesh_terms': 'D000287:Administration, Topical; D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D001639:Bicarbonates; D003630:Daunorubicin; D004121:Dimethyl Sulfoxide; D004317:Doxorubicin; D005119:Extravasation of Diagnostic and Therapeutic Materials; D006801:Humans; D012871:Skin Diseases; D017693:Sodium Bicarbonate; D014810:Vitamin E',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000305:Adrenal Cortex Hormones; D000319:Adrenergic beta-Antagonists; D000893:Anti-Inflammatory Agents; D001639:Bicarbonates; D014810:Vitamin E; D004317:Doxorubicin; D017693:Sodium Bicarbonate; D004121:Dimethyl Sulfoxide; D003630:Daunorubicin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Hosp Pharm',\n",
       "  'nlm_unique_id': '0370474',\n",
       "  'issn_linking': '0002-9289',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Management of reflux esophageal disease.',\n",
       "  'issue': '77(5B)',\n",
       "  'pages': '106-10',\n",
       "  'abstract': 'Although frequent or prolonged exposure of the esophageal mucosa to gastric contents results in epithelial damage, it is also becoming clear that the pathophysiology of reflux esophageal disease may be multifactorial. The severity of this disease may relate to the frequency of reflux episodes, certainly to the duration of mucosal exposure to refluxed material, and probably to as yet unquantified factors of mucosal resistance and the specific noxiousness of refluxed gastroduodenal and pancreatic secretions. The phenomenon of esophageal clearance is a critical determinant in preservation of mucosal integrity, and a disturbance in this function may lead to severe signs and symptoms of reflux esophageal disease. A detailed analysis of the specific pathophysiologic abnormalities in individual patients may permit more \"tailored\" therapeutic approaches and more favorable results.',\n",
       "  'journal': 'The American journal of medicine',\n",
       "  'authors': 'Robinson|M G|MG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150637',\n",
       "  'mesh_terms': 'D001626:Bethanechol Compounds; D004943:Esophagogastric Junction; D005764:Gastroesophageal Reflux; D006635:Histamine H2 Antagonists; D006801:Humans; D006863:Hydrogen-Ion Concentration; D008787:Metoclopramide',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001626:Bethanechol Compounds; D006635:Histamine H2 Antagonists; D008787:Metoclopramide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Med',\n",
       "  'nlm_unique_id': '0267200',\n",
       "  'issn_linking': '0002-9343',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Indications for the use of parenteral H2-receptor antagonists.',\n",
       "  'issue': '77(5B)',\n",
       "  'pages': '111-5',\n",
       "  'abstract': 'Development of acute mucosal ulceration is a complex series of catabolic interactions. Hospitalized patients with duodenal or gastric ulcer, pathologic gastric hypersecretory states (such as Zollinger-Ellison syndrome), gastric outlet obstruction, esophagitis, severe gastritis or duodenitis, sepsis, trauma (particularly head injury or burns), and some patients receiving high-dose corticosteroids are at risk of developing acute stress ulcers. Treatment should be initiated as soon as the patient is identified as being at risk, because measures designed to prevent bleeding or perforation are more effective than those designed to stop bleeding once it supervenes and the cascade of multiple organ failure commences. The presence of acid will trigger the onset of this condition; however, ulceration will not occur if the intraluminal pH can be maintained above 5 by periodic antacid treatment or by H2-receptor blockade. The dosing regimen of antacid or of H2-receptor antagonist should not be fixed, but should be sufficient to keep the gastric pH higher than 5. Antagonists administered via a nasogastric tube are the first line of defense, but 30 to 50 percent of the most ill patients will also be treated parenterally with H2-receptor antagonists. Parenteral H2-receptor blockade therapy is indicated in these patients when the risk of acute or continued ulceration of esophageal, gastric, or duodenal mucosa is high and the oral administration of medication is either not possible or the response to such therapy is unreliable. Parenteral H2-receptor antagonists are rarely administered alone.',\n",
       "  'journal': 'The American journal of medicine',\n",
       "  'authors': 'Thompson|J C|JC|;Walker|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150638',\n",
       "  'mesh_terms': 'D000863:Antacids; D005745:Gastric Acidity Determination; D005753:Gastric Mucosa; D006635:Histamine H2 Antagonists; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D010437:Peptic Ulcer; D013312:Stress, Physiological',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000863:Antacids; D006635:Histamine H2 Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Med',\n",
       "  'nlm_unique_id': '0267200',\n",
       "  'issn_linking': '0002-9343',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Histamine H2-antagonist drug interactions in perspective: mechanistic concepts and clinical implications.',\n",
       "  'issue': '77(5B)',\n",
       "  'pages': '57-84',\n",
       "  'abstract': 'Histamine H2-antagonists have the ability to produce fundamental changes in the absorption and disposition of other drugs. However, there are similarities and differences between the H2-antagonists in this respect, depending on the process involved. By increasing the intragastric pH any H2-antagonist has the potential of altering the absorption of weak acids or weak bases. However, since the rise in intragastric pH is not immediate, as with antacids, this type of interaction might be avoided for concomitantly administered, rapidly absorbed drugs. Whereas cimetidine inhibits hepatic mixed-function oxidase drug metabolism, ranitidine does not have this characteristic. Clinical studies have found that cimetidine produces a 20 to 60 percent decrease in the clearance of 23 drugs (such as warfarin, theophylline, quinidine, phenytoin, imipramine, propranolol, nifedipine). Marketed and investigational H2-antagonist drugs differ in their ability to inhibit drug metabolism due to the combined characteristics of cytochrome P-450 binding affinity and therapeutic dosage. Cimetidine also inhibits the renal-tubular secretion of other weak bases (such as procainamide). Management suggestions are presented to help clinicans predict and avoid failure in drug therapy as a result of these drug interactions.',\n",
       "  'journal': 'The American journal of medicine',\n",
       "  'authors': 'Powell|J R|JR|;Donn|K H|KH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150639',\n",
       "  'mesh_terms': 'D000042:Absorption; D001682:Biological Availability; D002927:Cimetidine; D065607:Cytochrome P-450 Enzyme Inhibitors; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006635:Histamine H2 Antagonists; D006801:Humans; D007093:Imidazoles; D007668:Kidney; D008099:Liver; D008657:Metabolic Clearance Rate; D011899:Ranitidine; D014018:Tissue Distribution',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D065607:Cytochrome P-450 Enzyme Inhibitors; D006635:Histamine H2 Antagonists; D007093:Imidazoles; D002927:Cimetidine; D011899:Ranitidine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Med',\n",
       "  'nlm_unique_id': '0267200',\n",
       "  'issn_linking': '0002-9343',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Health and economic aspects of peptic ulcer disease.',\n",
       "  'issue': '77(5B)',\n",
       "  'pages': '8-14',\n",
       "  'abstract': 'The costs to society of peptic ulcer disease have become exorbitant. These costs are incurred either directly (hospitalization, physician care, and medication costs) or indirectly (loss of productivity due to absenteeism, the loss to society of functioning persons or death of productive persons). Although the results of many studies show that hospitalization for duodenal ulcer disease has decreased, the incidence of perforation, which may be a better index of the disease, has not changed significantly. For many patients and for society, peptic ulceration is a chronic and costly disease. The cost effectiveness of the available treatment modalities are variable and dependent on preventing recurrence. Medical treatment, including the use of antacids and the newer H2-receptor antagonists, seems to be promising. Cimetidine, for example, is effective in treating the acute stage of the disease, but some studies have shown that once the treatment period is over, the ulcers tend to recur. Ranitidine, a newer H2-receptor antagonist, is as effective as cimetidine for healing peptic ulcers and may be more useful as long-term therapy to prevent recurrences. If so, costs to society of this disease can be greatly reduced.',\n",
       "  'journal': 'The American journal of medicine',\n",
       "  'authors': 'Jensen|D M|DM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150640',\n",
       "  'mesh_terms': 'D000041:Absenteeism; D000863:Antacids; D002908:Chronic Disease; D003365:Costs and Cost Analysis; D004341:Drug Evaluation; D005743:Gastrectomy; D006635:Histamine H2 Antagonists; D006760:Hospitalization; D006801:Humans; D007558:Italy; D009426:Netherlands; D010437:Peptic Ulcer; D013548:Sweden; D014481:United States',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000863:Antacids; D006635:Histamine H2 Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Med',\n",
       "  'nlm_unique_id': '0267200',\n",
       "  'issn_linking': '0002-9343',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.',\n",
       "  'issue': '77(5B)',\n",
       "  'pages': '90-105',\n",
       "  'abstract': 'The H2-histamine receptor antagonists ranitidine and cimetidine were compared for their abilities to control gastric acid hypersecretion on a short- and long-term basis in 22 patients with gastric acid hypersecretory states. Nineteen patients had Zollinger-Ellison syndrome, one patient had systemic mastocytosis, and two patients had idiopathic hypersecretion. The rates of onset of the action of cimetidine and ranitidine were the same. The actions of both drugs were increased by anticholinergic agents, and there was a close correlation between the daily maintenance dose of each drug needed to control acid secretion. However, ranitidine was threefold more potent than cimetidine both in acute inhibition studies and in the median maintenance dose needed (1.2 g per day for ranitidine and 3.6 g per day for cimetidine). Sixty percent of the males developed breast changes or impotence while taking cimetidine and in all cases these changes disappeared when cimetidine was replaced by ranitidine. Treatment with high doses of cimetidine (one to 60 months; median, 11 months) or ranitidine (two to 31 months; median, 14 months) was not associated with hepatic or hematologic toxicity or alterations of serum gastrin concentrations, but ranitidine therapy was associated with a significantly lower serum creatinine level than seen with cimetidine therapy. The results show that both drugs can adequately inhibit acid secretion in patients with gastric hypersecretory states. Both are safe at high doses, but ranitidine is threefold more potent and does not cause the antiandrogen side effects frequently seen with high doses of cimetidine.',\n",
       "  'journal': 'The American journal of medicine',\n",
       "  'authors': 'Jensen|R T|RT|;Collen|M J|MJ|;McArthur|K E|KE|;Howard|J M|JM|;Maton|P N|PN|;Cherner|J A|JA|;Gardner|J D|JD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150641',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D002927:Cimetidine; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D007172:Erectile Dysfunction; D005744:Gastric Acid; D005753:Gastric Mucosa; D006177:Gynecomastia; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics; D011413:Propantheline; D000644:Quaternary Ammonium Compounds; D011899:Ranitidine; D013997:Time Factors; D014582:Urticaria Pigmentosa; D015043:Zollinger-Ellison Syndrome',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D010276:Parasympatholytics; D000644:Quaternary Ammonium Compounds; D011413:Propantheline; D002927:Cimetidine; D011899:Ranitidine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Med',\n",
       "  'nlm_unique_id': '0267200',\n",
       "  'issn_linking': '0002-9343',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Stimulatory effect of norepinephrine on ketogenesis in normal and insulin-deficient humans.',\n",
       "  'issue': '247(6 Pt 1)',\n",
       "  'pages': 'E732-9',\n",
       "  'abstract': \"Elevation of plasma norepinephrine concentrations to stress levels (1,800 pg/ml) resulted in normal subjects in a significant increase in ketone body production by 155% (determined by use of [14C]acetoacetate infusions), in a decrease of the metabolic clearance rate by 38%, hyperketonemia, and in increased plasma free fatty acid (FFA) levels by 57% after 75 min. Norepinephrine infusion during somatostatin-induced insulin deficiency resulted in an augmented and sustained increase in ketone body concentrations due to increased production and decreased peripheral clearance of ketone bodies. Norepinephrine's stimulatory effect on lipolysis waned with time, and its effect on ketogenesis in normal subjects was greater than its influence on plasma FFA levels, and thus presumably on hepatic FFA uptake, suggesting a direct stimulatory effect on hepatic ketogenesis. The data demonstrate that in normal humans the hyperketonemic effect of elevated plasma norepinephrine concentrations results from a combination of three factors: increased ketone body production from augmented FFA supply to the liver; accelerated hepatic ketogenesis; and modestly decreased metabolic clearance of ketone bodies. Acute insulin deficiency augments all these effects and results in progressive ketosis.\",\n",
       "  'journal': 'The American journal of physiology',\n",
       "  'authors': 'Keller|U|U|;Gerber|P P|PP|;Stauffacher|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150642',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000368:Aged; D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D005260:Female; D005934:Glucagon; D005990:Glycerol; D006801:Humans; D007263:Infusions, Parenteral; D007328:Insulin; D007657:Ketone Bodies; D007700:Kinetics; D007773:Lactates; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine; D013004:Somatostatin; D013268:Stimulation, Chemical',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D007657:Ketone Bodies; D007773:Lactates; D013004:Somatostatin; D005934:Glucagon; D005990:Glycerol; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/ajpendo.1984.247.6.E732',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Physiol',\n",
       "  'nlm_unique_id': '0370511',\n",
       "  'issn_linking': '0002-9513',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Age-related decrement in hormone-stimulated lipolysis.',\n",
       "  'issue': '247(6 Pt 1)',\n",
       "  'pages': 'E772-7',\n",
       "  'abstract': \"The ability of hormones to activate responses in a variety of tissues decreases with age. The mechanism(s) responsible for these alterations are unclear. We have confirmed that the ability of a beta-adrenergic receptor agonist to activate lipolysis in isolated rat adipocytes decreases with age. Maximum response to isoproterenol was greater in 2-mo-old rats (600 +/- 30 nmol of glycerol released/10(5) cells per h) than 12-mo-old rats (250 +/- 25 nmol/10(5) cells per h), P less than 0.001. Similarly, ACTH is less effective in activating lipolysis in the adipocytes from the older rats. However, the cAMP analogue 8-(4-chlorophenothio)adenosine 3',5'-monophosphate cyclic activated lipolysis equally in the two groups, suggesting that the deficit in adipocytes from the older rats was proximal to cAMP-dependent protein kinase activation. Both isoproterenol and ACTH were significantly less effective in promoting cAMP accumulation in adipocytes isolated from 12-mo-old rats. There was no difference in phosphodiesterase activity of the adipocytes between the two groups. beta-Adrenergic receptors were measured using the antagonist radioligand [125I]cyanopindolol. The number of beta-adrenergic receptors was actually increased in the adipocytes from 12-mo-old rats (26,000 +/- 2,600 receptors/cell) compared with cells from 2-mo-old rats (7,200 +/- 1,300 receptors/cell). The results suggest that diminished cAMP production is responsible for the diminished lipolytic response in the adipocytes of older rats. The mechanism responsible for this change is uncertain but cannot be explained by a loss in beta-adrenergic receptors.\",\n",
       "  'journal': 'The American journal of physiology',\n",
       "  'authors': 'Hoffman|B B|BB|;Chang|H|H|;Farahbakhsh|Z T|ZT|;Reaven|G M|GM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150643',\n",
       "  'mesh_terms': 'D000273:Adipose Tissue; D000318:Adrenergic beta-Agonists; D000324:Adrenocorticotropic Hormone; D000375:Aging; D000818:Animals; D001696:Biomechanical Phenomena; D002478:Cells, Cultured; D000242:Cyclic AMP; D005990:Glycerol; D006728:Hormones; D007545:Isoproterenol; D008066:Lipolysis; D008297:Male; D051381:Rats; D013268:Stimulation, Chemical',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D006728:Hormones; D000324:Adrenocorticotropic Hormone; D000242:Cyclic AMP; D007545:Isoproterenol; D005990:Glycerol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/ajpendo.1984.247.6.E772',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Physiol',\n",
       "  'nlm_unique_id': '0370511',\n",
       "  'issn_linking': '0002-9513',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Enteric neurophysiology.',\n",
       "  'issue': '247(6 Pt 1)',\n",
       "  'pages': 'G585-98',\n",
       "  'abstract': 'Enteric neurophysiology is an emerging subspecialty of gastrointestinal biology. As such, it offers many investigative challenges and opportunities for advancement of understanding of gastrointestinal function. This review is organized to present the current status of enteric neurophysiology, to explain the controversies, and to explore the directions in which the subspecialty appears to be advancing. Current concepts of structural-functional relationships of the neuronal constituents of the enteric nervous system are presented in conjunction with electrophysiological and synaptic mechanisms. Relations between electrical and synaptic behavior of the neurons and information handling and integrative function within the local circuits are explored. Emergent properties of the system are considered in view of indications that the subsets of internuncial circuits that control each gastrointestinal effector are interconnected to ensure appropriate behavior that achieves coordination for optimal performance of the whole organ.',\n",
       "  'journal': 'The American journal of physiology',\n",
       "  'authors': 'Wood|J D|JD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150644',\n",
       "  'mesh_terms': 'D000109:Acetylcholine; D000200:Action Potentials; D000818:Animals; D004594:Electrophysiology; D005724:Ganglia; D007421:Intestine, Small; D008564:Membrane Potentials; D009420:Nervous System; D009424:Nervous System Physiological Phenomena; D009433:Neural Inhibition; D009474:Neurons; D009482:Neurophysiology; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D012701:Serotonin; D013569:Synapses; D009626:Terminology as Topic; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.; D016454:Review\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D012701:Serotonin; D000109:Acetylcholine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/ajpgi.1984.247.6.G585',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Physiol',\n",
       "  'nlm_unique_id': '0370511',\n",
       "  'issn_linking': '0002-9513',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Activation of afferent renal nerves by intrarenal bradykinin in conscious rats.',\n",
       "  'issue': '247(6 Pt 2)',\n",
       "  'pages': 'R1003-8',\n",
       "  'abstract': 'Bradykinin was infused intravenously and into the right renal artery of conscious rats that were chronically instrumented with catheters and miniaturized pulsed-Doppler flow probes. The effects on regional hemodynamics were compared with those in animals in which the infused kidney was denervated as well as in animals anesthetized with pentobarbital sodium. In intact rats bradykinin (1 microgram/min) caused an immediate increase in mean arterial blood pressure (MAP, 27 +/- 4 mmHg), heart rate (HR, 67 +/- 11 beats/min), mesenteric resistance (MR, 32 +/- 10%), and both right (RRR, 42 +/- 14%) and left renal resistance (LRR 21 +/- 8%). These effects were significantly different from those during intravenous infusion of the same dose of bradykinin (MAP, 6 +/- 3 mmHg; HR, 31 +/- 7 beats/min; MR, -21 +/- 5%; RRR, 8 +/- 4%; LRR, 6 +/- 3%). Pentobarbital greatly attenuated the responses to intrarenal bradykinin. In conscious animals denervation of the infused kidney completely abolished the cardiovascular effects of intrarenal bradykinin. In a separate group of animals, chlorisondamine (7.5 mg/kg iv) completely blocked the increases in MAP and HR during intrarenal bradykinin (1 microgram/min). It is concluded that selective renal administration of bradykinin alters afferent renal nerve activity and that this results in hemodynamic changes consistent with efferent sympathetic activation.',\n",
       "  'journal': 'The American journal of physiology',\n",
       "  'authors': 'Smits|J F|JF|;Brody|M J|MJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150645',\n",
       "  'mesh_terms': 'D000344:Afferent Pathways; D000768:Anesthesia, General; D000818:Animals; D001794:Blood Pressure; D001920:Bradykinin; D002714:Chlorisondamine; D003243:Consciousness; D003714:Denervation; D005730:Ganglionic Blockers; D006339:Heart Rate; D007269:Injections, Intra-Arterial; D007668:Kidney; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D012077:Renal Artery; D012079:Renal Circulation; D014655:Vascular Resistance',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D005730:Ganglionic Blockers; D002714:Chlorisondamine; D001920:Bradykinin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/ajpregu.1984.247.6.R1003',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Physiol',\n",
       "  'nlm_unique_id': '0370511',\n",
       "  'issn_linking': '0002-9513',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Regulation of net amino acid exchange in sea urchin larvae.',\n",
       "  'issue': '247(6 Pt 2)',\n",
       "  'pages': 'R1029-37',\n",
       "  'abstract': 'Bacteria-free larvae of Strongylocentrotus purpuratus remove each of 14 free amino acids (FAA) from very dilute solution in seawater. When larvae are maintained in seawater, influx of radiolabeled FAA and net removal of substrate as determined by high-performance liquid chromatography (HPLC) occur at the same rate in those substrates examined. Exposure of larvae to high concentrations of glutamate, glycine, or serine (greater than 50 microM) produces large increases in these substrates in the internal pool of FAA. After incubation of larvae in high concentrations of serine, the rate of influx of 14C-labeled serine is decreased compared with unincubated controls. Comparison of influx of radiolabeled serine with net change in ambient serine as determined by HPLC indicates that the apparent change in rate of influx is a consequence of an increase in ambient serine with time and the resulting decrease in the specific activity of labeled serine. Analysis of data indicates that abnormally high internal serine leads to carrier-mediated efflux of serine as well as other neutral amino acids. The rate of such efflux is increased in the presence of increased levels of ambient serine.',\n",
       "  'journal': 'The American journal of physiology',\n",
       "  'authors': 'Davis|J P|JP|;Stephens|G C|GC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150646',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000818:Animals; D002250:Carbon Radioisotopes; D002851:Chromatography, High Pressure Liquid; D005971:Glutamates; D018698:Glutamic Acid; D005998:Glycine; D007814:Larva; D012617:Sea Urchins; D012694:Serine; D013997:Time Factors',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': 'D000596:Amino Acids; D002250:Carbon Radioisotopes; D005971:Glutamates; D018698:Glutamic Acid; D012694:Serine; D005998:Glycine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/ajpregu.1984.247.6.R1029',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Physiol',\n",
       "  'nlm_unique_id': '0370511',\n",
       "  'issn_linking': '0002-9513',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Mosquito circadian flight rhythms: differential effects of constant light.',\n",
       "  'issue': '247(6 Pt 2)',\n",
       "  'pages': 'R960-7',\n",
       "  'abstract': \"The flight activity of Culiseta incidens was automatically recorded in constant darkness and constant light after entrainment to light:dark 12:12 to determine the usefulness of a formal circadian pacemaker model in which the periods of two oscillators respond reciprocally to light intensity. Period at activity onset lengthened approximately 0.4 h from darkness to 0.1 lx, whereas period at offset shortened approximately 0.4 h. Thus within this range, the onset of the nocturnal active phase obeyed Aschoff's rule for nocturnal animals, and the offset (or onset of diurnal rest phase) obeyed the rule for diurnal animals. These data supported a model in which, as light intensity increases, the period of one oscillator (evening) increases while that of another (morning) decreases. This model, with additional assumptions, also provided a framework for mutually consistent explanations of other features among the data. These included long periods at 3.5 lx, short periods at 35 lx, a progressively earlier occurrence of inactivity with increasing light intensity, and a clear example of circa-bi-dian (approximately 2 days) rhythmicity.\",\n",
       "  'journal': 'The American journal of physiology',\n",
       "  'authors': 'Clopton|J R|JR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150647',\n",
       "  'mesh_terms': 'D000818:Animals; D002940:Circadian Rhythm; D009033:Culicidae; D003624:Darkness; D005426:Flight, Animal; D008027:Light; D010507:Periodicity',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/ajpregu.1984.247.6.R960',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Physiol',\n",
       "  'nlm_unique_id': '0370511',\n",
       "  'issn_linking': '0002-9513',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Postnatal development of myogenic contractile activity and excitatory innervation of rat urinary bladder.',\n",
       "  'issue': '247(6 Pt 2)',\n",
       "  'pages': 'R972-8',\n",
       "  'abstract': 'Bladder strips from newborn compared with adult rats exhibited marked differences in both myogenic properties and postganglionic excitatory innervation. In the first 2-wk of life myogenic contractile activity progressively changed from a quiescent state (at birth) to the asynchronous contractile activity typical of bladder strips from adult animals. After birth activation of muscarinic cholinoceptors changed the myogenic contractile activity in a manner similar to that observed at later stages of development. Neurogenic contractions of bladders from newborn animals were atropine sensitive in the whole range of frequencies studied. During the first 2 wk the atropine-resistant component of these contractions increased progressively to reach an adult-like condition, i.e., atropine-resistant contractions account for over 90% and approximately 60% of contractions elicited at 0.1 and 1-20 Hz, respectively.',\n",
       "  'journal': 'The American journal of physiology',\n",
       "  'authors': 'Maggi|C A|CA|;Santicioli|P|P|;Meli|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150648',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D001285:Atropine; D004351:Drug Resistance; D004558:Electric Stimulation; D006426:Hemicholinium 3; D018738:Hexamethonium; D006584:Hexamethonium Compounds; D009119:Muscle Contraction; D010830:Physostigmine; D000644:Quaternary Ammonium Compounds; D051381:Rats; D013779:Tetrodotoxin; D001743:Urinary Bladder',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D006584:Hexamethonium Compounds; D000644:Quaternary Ammonium Compounds; D006426:Hemicholinium 3; D018738:Hexamethonium; D013779:Tetrodotoxin; D001285:Atropine; D010830:Physostigmine; C028530:furtrethonium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1152/ajpregu.1984.247.6.R972',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Physiol',\n",
       "  'nlm_unique_id': '0370511',\n",
       "  'issn_linking': '0002-9513',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Seizures induced by abrupt discontinuation of alprazolam.',\n",
       "  'issue': '141(12)',\n",
       "  'pages': '1606-7',\n",
       "  'abstract': \"Two patients had grand mal seizures following abrupt discontinuation of short-term treatment with alprazolam. Alprazolam's pharmacokinetic and clinical properties are discussed in relation to withdrawal reactions.\",\n",
       "  'journal': 'The American journal of psychiatry',\n",
       "  'authors': 'Breier|A|A|;Charney|D S|DS|;Nelson|J C|JC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150649',\n",
       "  'mesh_terms': 'D000328:Adult; D000525:Alprazolam; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D004830:Epilepsy, Tonic-Clonic; D005260:Female; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008297:Male; D001523:Mental Disorders; D013375:Substance Withdrawal Syndrome',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D000525:Alprazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1176/ajp.141.12.1606',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Psychiatry',\n",
       "  'nlm_unique_id': '0370512',\n",
       "  'issn_linking': '0002-953X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Predictive value of the dexamethasone suppression test in mania.',\n",
       "  'issue': '141(12)',\n",
       "  'pages': '1610-2',\n",
       "  'abstract': 'Eighteen manic patients who had abnormal results on the dexamethasone suppression test at admission were retested before discharge, when they were clinically stable. Conversion to normal suppression predicted good outcome after discharge, whereas a persistently abnormal test predicted poor outcome.',\n",
       "  'journal': 'The American journal of psychiatry',\n",
       "  'authors': 'Godwin|C D|CD|;Greenberg|L B|LB|;Shukla|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150650',\n",
       "  'mesh_terms': 'D000328:Adult; D014150:Antipsychotic Agents; D001714:Bipolar Disorder; D003907:Dexamethasone; D005260:Female; D006801:Humans; D006854:Hydrocortisone; D008297:Male; D008875:Middle Aged; D010043:Outcome and Process Assessment, Health Care; D011336:Probability',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D003907:Dexamethasone; D006854:Hydrocortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1176/ajp.141.12.1610',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Psychiatry',\n",
       "  'nlm_unique_id': '0370512',\n",
       "  'issn_linking': '0002-953X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Alprazolam-related digoxin toxicity.',\n",
       "  'issue': '141(12)',\n",
       "  'pages': '1612-3',\n",
       "  'abstract': 'An elderly woman developed a high serum digoxin concentration resulting in toxicity when alprazolam was added to her digoxin therapy. The reduced renal clearance of digoxin is postulated as the mechanism for this interaction.',\n",
       "  'journal': 'The American journal of psychiatry',\n",
       "  'authors': 'Tollefson|G|G|;Lesar|T|T|;Grothe|D|D|;Garvey|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150651',\n",
       "  'mesh_terms': 'D000368:Aged; D000525:Alprazolam; D014151:Anti-Anxiety Agents; D001145:Arrhythmias, Cardiac; D001569:Benzodiazepines; D004077:Digoxin; D004347:Drug Interactions; D005260:Female; D006207:Half-Life; D006801:Humans; D007700:Kinetics',\n",
       "  'publication_types': \"D002363:Case Reports; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D004077:Digoxin; D000525:Alprazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1176/ajp.141.12.1612',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Psychiatry',\n",
       "  'nlm_unique_id': '0370512',\n",
       "  'issn_linking': '0002-953X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The potential toxicity of ipecac.',\n",
       "  'issue': '141(12)',\n",
       "  'pages': '1639',\n",
       "  'abstract': '',\n",
       "  'journal': 'The American journal of psychiatry',\n",
       "  'authors': 'Romig|R A|RA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150652',\n",
       "  'mesh_terms': 'D000856:Anorexia Nervosa; D004640:Emetine; D005260:Female; D006331:Heart Diseases; D006801:Humans; D007486:Ipecac',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D007486:Ipecac; C005963:cephaelin; D004640:Emetine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1176/ajp.141.12.aj141121639',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Psychiatry',\n",
       "  'nlm_unique_id': '0370512',\n",
       "  'issn_linking': '0002-953X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Practice characteristics of male and female physician assistants.',\n",
       "  'issue': '74(12)',\n",
       "  'pages': '1398-400',\n",
       "  'abstract': 'In a national survey of 3,294 non-military responding physician assistants, sociodemographic and practice characteristics of male and female physician assistants were compared. Differences by specialty, practice setting, size of community, and hours of work were generally similar in nature, but smaller in magnitude, than those reported for physicians, and may not be of practical significance.',\n",
       "  'journal': 'American journal of public health',\n",
       "  'authors': 'Oliver|D R|DR|;Carter|R D|RD|;Conboy|J E|JE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150653',\n",
       "  'mesh_terms': 'D000328:Adult; D005260:Female; D006801:Humans; D008297:Male; D008511:Medicine; D010823:Physician Assistants; D011365:Professional Practice Location; D012737:Sex Factors; D013038:Specialization; D011795:Surveys and Questionnaires; D013997:Time Factors; D014481:United States; D014931:Women, Working',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.2105/ajph.74.12.1398',\n",
       "  'references': '977939;489939;227954;10252513',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Public Health',\n",
       "  'nlm_unique_id': '1254074',\n",
       "  'issn_linking': '0090-0036',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Ockelbo disease in Sweden: epidemiological, clinical, and virological data from the 1982 outbreak.',\n",
       "  'issue': '33(6)',\n",
       "  'pages': '1203-11',\n",
       "  'abstract': 'An outbreak of Ockelbo disease, a syndrome with rash, arthralgia and moderate fever reactions, which occurred in Sweden 1982 is described. A virus, designated Edsbyn 5/82, isolated from mosquitoes and closely related to Sindbis virus (Togaviridae: Alphavirus) is the probable etiologic agent. Sixty-five patients with typical clinical manifestations of the disease became ill in August 1982 and exhibited antibody titer rises against both Edsbyn 5/82 and Sindbis viruses by indirect immunofluorescence and the mixed hemadsorption technique. With the latter method, but not by the neutralization tests, antibody titers were significantly higher against Edsbyn 5/82 virus than against Sindbis virus. Most cases occurred in central Sweden between the 60th and 63rd parallels. The frequency of antibody in healthy individuals (blood donors) within the endemic area was 2-3% and in foci with high incidence, antibody positivity reached 8%. Antibody frequencies continuously decreased south and north of this area. Antibody decline was followed in a group of 12 patients who had Ockelbo disease in 1981. Mixed hemadsorption titers were 4-6 times higher against Edsbyn 5/82 than against Sindbis virus. A 2- to 4-fold antibody decline took place from early convalescence to 20 months after onset.',\n",
       "  'journal': 'The American journal of tropical medicine and hygiene',\n",
       "  'authors': 'Espmark|A|A|;Niklasson|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150654',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D000914:Antibodies, Viral; D002648:Child; D009033:Culicidae; D004196:Disease Outbreaks; D005076:Exanthema; D005260:Female; D006382:Hemadsorption; D006801:Humans; D007303:Insect Vectors; D008297:Male; D008875:Middle Aged; D009500:Neutralization Tests; D012845:Sindbis Virus; D013548:Sweden; D014036:Togaviridae Infections',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.4269/ajtmh.1984.33.1203',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Trop Med Hyg',\n",
       "  'nlm_unique_id': '0370507',\n",
       "  'issn_linking': '0002-9637',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Association of a Sindbis-like virus with Ockelbo disease in Sweden.',\n",
       "  'issue': '33(6)',\n",
       "  'pages': '1212-7',\n",
       "  'abstract': 'An alphavirus isolated from Culiseta mosquitoes has been associated with Ockelbo disease, an exanthema arthralgia syndrome occurring in Sweden. The isolate was made from mosquitoes collected in Edsbyn (central Sweden), an area with considerable Ockelbo disease morbidity. This isolate proved to be indistinguishable from Sindbis virus by complement-fixation and hemagglutination-inhibition tests, and was antigenically related to Sindbis in plaque reduction neutralization tests. Patients with Ockelbo disease developed neutralizing antibodies to the virus in their convalescent sera, suggesting that it is the etiologic agent of the disease.',\n",
       "  'journal': 'The American journal of tropical medicine and hygiene',\n",
       "  'authors': 'Niklasson|B|B|;Espmark|A|A|;LeDuc|J W|JW|;Gargan|T P|TP|;Ennis|W A|WA|;Tesh|R B|RB|;Main|A J|AJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150655',\n",
       "  'mesh_terms': 'D000330:Aedes; D000524:Alphavirus; D000914:Antibodies, Viral; D003168:Complement Fixation Tests; D009033:Culicidae; D004683:Encephalomyelitis, Equine; D006385:Hemagglutination Inhibition Tests; D006801:Humans; D007303:Insect Vectors; D009500:Neutralization Tests; D012843:Simuliidae; D012845:Sindbis Virus; D013548:Sweden; D014036:Togaviridae Infections',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.4269/ajtmh.1984.33.1212',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Trop Med Hyg',\n",
       "  'nlm_unique_id': '0370507',\n",
       "  'issn_linking': '0002-9637',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Increased mosquito feeding on Rift Valley fever virus-infected lambs.',\n",
       "  'issue': '33(6)',\n",
       "  'pages': '1232-8',\n",
       "  'abstract': 'Experiments were conducted to determine whether or not mosquitoes exhibited an increase in feeding on Rift Valley fever (RVF) virus-infected lambs as compared to uninfected ones. Overall, when given a choice between a viremic lamb, or its uninfected twin, 65% (1,264/1,943) of the engorged female Culex pipiens obtained blood from the viremic lamb. This excess of feedings on viremic lambs was demonstrated regardless of the age of the lambs, or the time period between inoculation of the lambs and exposure to mosquitoes. With 3-day-old and 6- to 8-week-old lambs, 66% of the mosquitoes obtained blood from the viremic lamb. At 28, 48, and 52 hours after infection, the percentages of mosquitoes feeding on viremic lambs were 72, 68, and 64, respectively. Temperature, as measured by the difference in temperature of the viremic lamb minus that of the control lamb, was positively correlated with mosquito feedings on young lambs (3 days old), but not on older lambs (6 to 8 weeks old). When Cx. pipiens and Aedes taeniorhynchus were simultaneously given the opportunity to feed on 3-week-old lambs, a significantly higher percentage of engorged Cx. pipiens (94/108, 87%) fed on the viremic lamb than did engorged Ae. taeniorhynchus (187/350, 53%). The data generated by this study (e.g., an excess of feedings on the viremic lambs) warrant further study to determine the significance of this observation under field conditions.',\n",
       "  'journal': 'The American journal of tropical medicine and hygiene',\n",
       "  'authors': 'Turell|M J|MJ|;Bailey|C L|CL|;Rossi|C A|CA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150656',\n",
       "  'mesh_terms': 'D000330:Aedes; D000818:Animals; D001831:Body Temperature; D003465:Culex; D009033:Culicidae; D005247:Feeding Behavior; D005260:Female; D007303:Insect Vectors; D012295:Rift Valley Fever; D012296:Rift Valley fever virus; D012756:Sheep',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.4269/ajtmh.1984.33.1232',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Trop Med Hyg',\n",
       "  'nlm_unique_id': '0370507',\n",
       "  'issn_linking': '0002-9637',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Chronic renal failure: effect of hemodialysis on gastrointestinal hormones.',\n",
       "  'issue': '148(6)',\n",
       "  'pages': '732-5',\n",
       "  'abstract': 'Fifteen patients with chronic renal failure (serum creatinine level greater than 5 mg/dl) of long duration (more than 2 years) requiring hemodialysis were studied. Blood samples before and after 4 hours of hemodialysis were assayed for creatinine, blood urea nitrogen, potassium, calcium, glucose, insulin, gastrin, gastric inhibitory polypeptide, vasoactive intestinal polypeptide, pancreatic polypeptide, somatostatin, motilin, and neurotensin levels. Before dialysis, serum gastrin was minimally increased whereas gastric inhibitory polypeptide and pancreatic polypeptide were grossly increased compared with normal fasting values. Hemodialysis produced no changes in serum gastric inhibitory polypeptide, vasoactive intestinal polypeptide, pancreatic polypeptide, somatostatin, motilin, and neurotensin. Slight increases in serum insulin and gastrin levels may have occurred secondary to a dialysis-induced increase in the serum calcium level. The kidneys appear to be a major site of inactivation of insulin, gastrin, gastric inhibitory polypeptide, and pancreatic polypeptide. The gastrin level, although elevated in renal failure patients, may be suppressed by very high circulating levels of gastric inhibitory polypeptide.',\n",
       "  'journal': 'American journal of surgery',\n",
       "  'authors': \"Sirinek|K R|KR|;O'Dorisio|T M|TM|;Gaskill|H V|HV|;Levine|B A|BA|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150657',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D005749:Gastric Inhibitory Polypeptide; D005755:Gastrins; D005768:Gastrointestinal Hormones; D006801:Humans; D007328:Insulin; D007676:Kidney Failure, Chronic; D008875:Middle Aged; D009037:Motilin; D009496:Neurotensin; D010191:Pancreatic Polypeptide; D006435:Renal Dialysis; D013004:Somatostatin; D014660:Vasoactive Intestinal Peptide',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005755:Gastrins; D005768:Gastrointestinal Hormones; D007328:Insulin; D014660:Vasoactive Intestinal Peptide; D009496:Neurotensin; D013004:Somatostatin; D009037:Motilin; D005749:Gastric Inhibitory Polypeptide; D010191:Pancreatic Polypeptide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0002-9610(84)90426-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Am J Surg',\n",
       "  'nlm_unique_id': '0370473',\n",
       "  'issn_linking': '0002-9610',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Internal fixation of the thoracic and lumbar vertebrae].',\n",
       "  'issue': '28()',\n",
       "  'pages': '1-125',\n",
       "  'abstract': '',\n",
       "  'journal': 'Aktuelle Probleme in Chirurgie und Orthopadie',\n",
       "  'authors': 'Dick|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150658',\n",
       "  'mesh_terms': 'D005593:Fracture Fixation, Internal; D050723:Fractures, Bone; D005596:Fractures, Closed; D005597:Fractures, Open; D006801:Humans; D004204:Joint Dislocations; D008159:Lumbar Vertebrae; D013123:Spinal Fusion; D013904:Thoracic Vertebrae',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aktuelle Probl Chir Orthop',\n",
       "  'nlm_unique_id': '7705398',\n",
       "  'issn_linking': '0378-8504',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Comparison of ketamine and thiopental in healthy volunteers: effects on mental status, mood, and personality.',\n",
       "  'issue': '63(12)',\n",
       "  'pages': '1087-96',\n",
       "  'abstract': 'The purpose of this study was to compare the psychological effects of ketamine and thiopental anesthesia. In a double-blind comparison, 20 normal female volunteers were given 2.5 mg/kg ketamine intravenously and 20 were given 5.0 mg/kg thiopental intravenously. Subjects were assessed with a variety of objective and subjective psychological measures before, immediately after, and 24 hr, 2 weeks, and 4 months after anesthesia. Immediately after anesthesia, there was a significantly greater incidence of abnormalities of mental status in subjects given ketamine than in those who had received thiopental. Changes were generally short-lived and were no longer evident on the following day. No significant differences were found between the two groups with regard to long-term changes in personality. Changes in mental status are attributed to the slower, more uneven return to consciousness of the subjects receiving ketamine.',\n",
       "  'journal': 'Anesthesia and analgesia',\n",
       "  'authors': 'Moretti|R J|RJ|;Hassan|S Z|SZ|;Goodman|L I|LI|;Meltzer|H Y|HY|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150660',\n",
       "  'mesh_terms': 'D000328:Adult; D000704:Analysis of Variance; D004644:Emotions; D005260:Female; D006801:Humans; D007649:Ketamine; D005222:Mental Fatigue; D008609:Mental Status Schedule; D010465:Perception; D010551:Personality; D011569:Psychiatric Status Rating Scales; D013874:Thiopental; D013998:Time Perception',\n",
       "  'publication_types': \"D016430:Clinical Trial; D003160:Comparative Study; D018848:Controlled Clinical Trial; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D007649:Ketamine; D013874:Thiopental',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Anesth Analg',\n",
       "  'nlm_unique_id': '1310650',\n",
       "  'issn_linking': '0003-2999',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Ventilatory and analgesic effects of dezocine in humans.',\n",
       "  'issue': '61(6)',\n",
       "  'pages': '716-22',\n",
       "  'abstract': 'The respiratory depressant and analgesic effects of intravenous dezocine were evaluated in six healthy volunteers. Single 0.15 mg/kg doses were compared with identical amounts of morphine, and the two drugs were given in combination. Five successive 0.15 mg/kg doses of dezocine also were given to identify dose-effect relationships. Respiratory center sensitivity was monitored by carbon dioxide (CO2) rebreathing and mouth occlusion pressure (P0.1) measurement, while analgesia to experimental pain was tested with submaximal tourniquet ischemia. Single 0.15 mg/kg doses of dezocine produced significantly more tolerance to experimental pain and greater respiratory depression than a comparable dose of morphine in the first hour, but effects of both drugs were similar thereafter. Multiple doses of dezocine progressively increased pain tolerance from 46 +/- 14% above control with the first dose to 70 +/- 18% above control with the second dose (cumulative total 0.30 mg/kg). Additional dezocine doses did not result in significantly more analgesia. Depression of CO2 sensitivity followed a similar pattern. Morphine 0.15 mg/kg, when given to subjects who had received a prior dose of dezocine, produced no additional effect beyond that observed with dezocine. With the reverse sequence, dezocine increased the respiratory depression of morphine but also produced a dramatic increment in analgesia, which suggested an additive action. Dezocine is therefore an effective analgesic with morphine-like effects. In human subjects it appears to be a slightly more potent analgesic than morphine in identical clinical doses (0.15 mg/kg). Dezocine is similar to other agonist-antagonist analgesics in that it exhibits a ceiling effect for respiratory depression that parallels its analgesic activity.',\n",
       "  'journal': 'Anesthesiology',\n",
       "  'authors': 'Gal|T J|TJ|;DiFazio|C A|CA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150661',\n",
       "  'mesh_terms': 'D000328:Adult; D000701:Analgesics, Opioid; D019086:Bridged Bicyclo Compounds, Heterocyclic; D002245:Carbon Dioxide; D003516:Cycloparaffins; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D008297:Male; D009020:Morphine; D012119:Respiration; D013764:Tetrahydronaphthalenes',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000701:Analgesics, Opioid; D019086:Bridged Bicyclo Compounds, Heterocyclic; D003516:Cycloparaffins; D013764:Tetrahydronaphthalenes; D002245:Carbon Dioxide; D009020:Morphine; C010827:dezocine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/00000542-198412000-00015',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Anesthesiology',\n",
       "  'nlm_unique_id': '1300217',\n",
       "  'issn_linking': '0003-3022',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Exaggerated increase in serum potassium following succinylcholine in dogs with beta blockade.',\n",
       "  'issue': '61(6)',\n",
       "  'pages': '723-5',\n",
       "  'abstract': 'The authors tested in dogs the hypothesis that beta-adrenoceptor blockade might alter the time course or magnitude of serum potassium (K+) changes following the administration of succinylcholine (SCh). The results indicate that the normal increase in K+ induced by SCh (1 mg/kg intravenously) is exaggerated in the presence of propranolol-induced (0.25 mg/kg), beta-adrenoceptor blockade. Specifically, a peak increase of 1.7 mEq/1 (43%) over control K+ was noted in the beta-blocked dogs versus a 0.5 mEq/1 (13%) increase in control dogs. The peak increase in K+ occurred later in the beta-blocked dogs (60-90 min post-SCh) versus control dogs (30 min post-SCh). The authors postulate that these results reflect impairment of intracellular uptake of the SCh-induced acute K+ load secondary to beta-adrenoceptor blockade. Additionally, in a third group of dogs, diazepam in a dose of 0.5 mg/kg attenuated the K+ increases (1 mEq/1-24%) following SCh in beta-blocked dogs. Whether these data can be extrapolated to beta-adrenoceptor blocked patients remains a matter for further investigation. In the interim, periodic monitoring of K+ is warranted in any patient receiving medications known to alter the state of activity of the beta-adrenoceptor. In particular, careful consideration must be given to the potential impact of various interventions (SCh administration, K+ infusion) on K+ levels in beta-adrenoceptor blocked patients.',\n",
       "  'journal': 'Anesthesiology',\n",
       "  'authors': 'McCammon|R L|RL|;Stoelting|R K|RK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150662',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D001784:Blood Gas Analysis; D003975:Diazepam; D004285:Dogs; D004347:Drug Interactions; D011188:Potassium; D011433:Propranolol; D013390:Succinylcholine; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D011433:Propranolol; D013390:Succinylcholine; D003975:Diazepam; D011188:Potassium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/00000542-198412000-00016',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Anesthesiology',\n",
       "  'nlm_unique_id': '1300217',\n",
       "  'issn_linking': '0003-3022',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Cardiac function assessed by gated heart pool studies in an alcohol clinic population: a preliminary study.',\n",
       "  'issue': '8(5)',\n",
       "  'pages': '467-9',\n",
       "  'abstract': 'The nuclear gated heart pool scan was used to assess the left ventricular ejection fraction (LVEF) in 19 patients attending the Drug and Alcohol Unit for treatment of their alcoholism. Eighteen of the patients were asymptomatic and had no signs of cardiac impairment. In 14 subjects (13 asymptomatic), the LVEF was subnormal. Repeat studies were performed in 10 of the subjects following a period of 4-9 months of reduced intake of alcohol or abstinence. The LVEF improved in four subjects, remained unchanged in four, and actually decreased in two others despite a reduction in reported alcohol intake.',\n",
       "  'journal': 'Alcoholism, clinical and experimental research',\n",
       "  'authors': 'Read|R|R|;Bell|J|J|;Batey|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150659',\n",
       "  'mesh_terms': 'D000328:Adult; D000428:Alcohol Drinking; D000437:Alcoholism; D002302:Cardiac Output; D002310:Cardiomyopathy, Alcoholic; D004562:Electrocardiography; D005260:Female; D006334:Heart Function Tests; D006801:Humans; D008297:Male; D008875:Middle Aged; D011877:Radionuclide Imaging; D013667:Technetium; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013667:Technetium; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1530-0277.1984.tb05703.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Alcohol Clin Exp Res',\n",
       "  'nlm_unique_id': '7707242',\n",
       "  'issn_linking': '0145-6008',\n",
       "  'country': 'England'},\n",
       " {'title': 'Opioid analgesics in anesthesia: with special reference to their use in cardiovascular anesthesia.',\n",
       "  'issue': '61(6)',\n",
       "  'pages': '731-55',\n",
       "  'abstract': 'In this article, an attempt has been made to review the use of receptor stimulating pure agonist opioids in anesthesia, especially in patients with cardiovascular disease. Particular emphasis has been placed on the use of opioids in high doses to produce anesthesia, techniques that recently have become popular in cardiovascular anesthesia. A major benefit of opioid anesthesia is the cardiovascular stability obtained during induction and throughout operation, even in patients with severely impaired cardiac function. There is a considerable body of evidence to support this claim when fentanyl is used. Anesthetic doses of morphine are associated with a higher incidence of cardiovascular disturbances and other problems, and, therefore, more attention to detail is required in order to achieve adequate anesthesia and hemodynamic stability. Although other opioids have been used as sole or principal agents in anesthesia for cardiovascular surgery, none have gained widespread acceptance. Meperidine, for example, which is widely used in lower (nonanesthetic) doses as a supplement to nitrous oxide in cardiac and noncardiac surgery, has proved unsuitable because of severe hemodynamic disturbances when high doses are given. However, initial reports concerning two of the newer agonist opioids, sufentanil and alfentanil, suggest that they may prove to be suitable alternatives and perhaps provide advantages over morphine and fentanyl in patients with or without cardiovascular disease. Although cardiovascular stability usually can be assured in the chronically sick cardiac patient with opioid anesthesia, this is not always so with the healthier patient, particularly those presenting for coronary artery surgery. A frequently occurring problem in these patients is hypertension during or after sternotomy, which can result in myocardial ischemia and infarction. The incidence of severe hypertension (increases in systolic blood pressure greater than 20% of control values) can be reduced drastically by increasing the dose of opioid, e.g., up to 140 micrograms/kg of fentanyl. However, despite such large doses, some patients will continue to need treatment with vasodilators, inhalation anesthetics, or other supplements at certain periods during cardiovascular operations. The use of very large doses of opioids also will prolong postoperative respiratory depression. High doses of opioids can reduce or prevent the hormonal and metabolic responses to the stress of surgery. However, even very large doses of fentanyl or its newer analogues do not prevent marked increases in plasma catecholamine concentrations in response to cardiopulmonary bypass.(ABSTRACT TRUNCATED AT 400 WORDS)',\n",
       "  'journal': 'Anesthesiology',\n",
       "  'authors': 'Bovill|J G|JG|;Sebel|P S|PS|;Stanley|T H|TH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150663',\n",
       "  'mesh_terms': 'D015760:Alfentanil; D000522:Alphaprodine; D000701:Analgesics, Opioid; D000768:Anesthesia, General; D000818:Animals; D001364:Awareness; D001921:Brain; D006348:Cardiac Surgical Procedures; D005283:Fentanyl; D006439:Hemodynamics; D006728:Hormones; D006801:Humans; D008614:Meperidine; D009020:Morphine; D009127:Muscle Rigidity; D009458:Neuroleptanalgesia; D009469:Neuromuscular Junction; D012120:Respiration Disorders; D013312:Stress, Physiological; D017409:Sufentanil; D014656:Vascular Surgical Procedures',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000701:Analgesics, Opioid; D006728:Hormones; D000522:Alphaprodine; D015760:Alfentanil; D009020:Morphine; D008614:Meperidine; D017409:Sufentanil; D005283:Fentanyl',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Anesthesiology',\n",
       "  'nlm_unique_id': '1300217',\n",
       "  'issn_linking': '0003-3022',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Prevention of food allergies.',\n",
       "  'issue': '53(6 Pt 2)',\n",
       "  'pages': '683-8',\n",
       "  'abstract': \"Any rational approach to the prevention of food allergies must be based on the diversity of mechanisms which are involved in their pathogenesis. In addition to the IgE-mediated disorders which appear to be responsible for the largest number of cases, other immunologic (e.g., immune complex) and non-immunologic (e.g., enzymatic deficiencies) mechanisms appear to be involved. A preventive program should begin with a recognition that a potential problem exists and the identification of the individual at risk. This is accomplished by a careful documentation of IgE or other allergic reactivity in the individual or in family members. The prevention of intrauterine or postnatal sensitization is achieved by reduction in antigen transfer to the infant by maternal avoidance of potentially allergic foods in the last trimester and during lactation and by a restrictive infant diet. During the first years of infancy the encouragement of breast-feeding provides the dual benefit of eliminating one of the most common sensitizing food antigens, i.e., cow's milk protein, and providing passive s-IgA. The use of appropriate pharmacologic agents, e.g., cromolyn, may be yet another valuable adjunct in the prevention of food allergy.\",\n",
       "  'journal': 'Annals of allergy',\n",
       "  'authors': 'Bellanti|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150664',\n",
       "  'mesh_terms': 'D000936:Antigen-Antibody Complex; D000941:Antigens; D001942:Breast Feeding; D004205:Cromolyn Sodium; D003888:Desensitization, Immunologic; D004063:Digestion; D005260:Female; D005512:Food Hypersensitivity; D006634:Histamine H1 Antagonists; D006801:Humans; D007111:Immunity, Cellular; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007073:Immunoglobulin E; D007223:Infant; D007231:Infant, Newborn; D007408:Intestinal Absorption; D007774:Lactation; D008431:Maternal-Fetal Exchange; D011247:Pregnancy; D012306:Risk',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000936:Antigen-Antibody Complex; D000941:Antigens; D006634:Histamine H1 Antagonists; D007070:Immunoglobulin A; D007071:Immunoglobulin A, Secretory; D007073:Immunoglobulin E; D004205:Cromolyn Sodium',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Allergy',\n",
       "  'nlm_unique_id': '0372346',\n",
       "  'issn_linking': '0003-4738',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Role of isoenzymes among tumoral markers].',\n",
       "  'issue': '42(5)',\n",
       "  'pages': '329-35',\n",
       "  'abstract': '',\n",
       "  'journal': 'Annales de biologie clinique',\n",
       "  'authors': 'Assicot|M|M|;Bohuon|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150665',\n",
       "  'mesh_terms': 'D000135:Acid Phosphatase; D000469:Alkaline Phosphatase; D004796:Clinical Enzyme Tests; D003402:Creatine Kinase; D005634:Fructose-Bisphosphate Aldolase; D005964:Glucosyltransferases; D006801:Humans; D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase; D009369:Neoplasms; D011770:Pyruvate Kinase; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D007527:Isoenzymes; D007770:L-Lactate Dehydrogenase; D005723:gamma-Glutamyltransferase; D005964:Glucosyltransferases; D011770:Pyruvate Kinase; D003402:Creatine Kinase; D000469:Alkaline Phosphatase; D000135:Acid Phosphatase; D005634:Fructose-Bisphosphate Aldolase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Biol Clin (Paris)',\n",
       "  'nlm_unique_id': '2984690R',\n",
       "  'issn_linking': '0003-3898',\n",
       "  'country': 'France'},\n",
       " {'title': 'Absorption of ipecac alkaloids in emergency patients.',\n",
       "  'issue': '13(12)',\n",
       "  'pages': '1100-2',\n",
       "  'abstract': 'Syrup of ipecac contains the nauseant alkaloids emetine and cephaeline. Although thousands of doses are given yearly, no data exist on the absorption of these alkaloids in man. We gave 30 mL of USP Syrup to ten adult patients. Blood and urine samples were obtained at approximately one-half and two hours after administration, and the entire volume of vomitus was saved. The samples were then analyzed for cephaeline and emetine by a high-performance liquid chromatographic (HPLC) assay developed in our laboratory. All patients vomited within 30 minutes, but the amounts of alkaloid regurgitated varied from 22 +/- 14% in six patients to 80 +/- 16% in the remaining four. Only six patients had emetine or cephaeline in their blood by two hours (range, 5 to 73 ng/mL), although ten patients had detectable concentrations of the alkaloids in their urine. Measured over two hours, no patient eliminated more than 0.5% of the dose by the urinary route. In our study ipecac was absorbed by all who received it; the extent of absorption varied widely, and elimination by the renal route was small.',\n",
       "  'journal': 'Annals of emergency medicine',\n",
       "  'authors': 'Moran|D M|DM|;Crouch|D J|DJ|;Finkle|B S|BS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150666',\n",
       "  'mesh_terms': 'D000042:Absorption; D000328:Adult; D000368:Aged; D002851:Chromatography, High Pressure Liquid; D004630:Emergencies; D004640:Emetine; D005260:Female; D005766:Gastrointestinal Contents; D006801:Humans; D007486:Ipecac; D008297:Male; D011041:Poisoning; D014839:Vomiting',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007486:Ipecac; D004640:Emetine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0196-0644(84)80332-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Emerg Med',\n",
       "  'nlm_unique_id': '8002646',\n",
       "  'issn_linking': '0196-0644',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Recognition and management of poisoning with beta-adrenergic blocking agents.',\n",
       "  'issue': '13(12)',\n",
       "  'pages': '1123-31',\n",
       "  'abstract': '',\n",
       "  'journal': 'Annals of emergency medicine',\n",
       "  'authors': 'Weinstein|R S|RS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150667',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000319:Adrenergic beta-Antagonists; D000328:Adult; D000368:Aged; D001794:Blood Pressure; D003128:Coma; D003490:Cyanosis; D004837:Epinephrine; D005751:Gastric Lavage; D005934:Glucagon; D006207:Half-Life; D006339:Heart Rate; D006801:Humans; D007700:Kinetics; D008875:Middle Aged; D011433:Propranolol; D012640:Seizures; D014116:Toxicology',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D005934:Glucagon; D011433:Propranolol; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0196-0644(84)80337-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Emerg Med',\n",
       "  'nlm_unique_id': '8002646',\n",
       "  'issn_linking': '0196-0644',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Pneumomediastinum and retropneumoperitoneum: an unusual complication of syrup-of-ipecac-induced emesis.',\n",
       "  'issue': '13(12)',\n",
       "  'pages': '1148-51',\n",
       "  'abstract': 'A young woman returned to the emergency department two hours after discharge because of persistent vomiting and chest pain. Six hours earlier she had received syrup of ipecac to induce emesis following a drug overdose. Radiologic examination in the emergency department revealed pneumomediastinum and retropneumoperitoneum. A nasogastric tube was inserted in the emergency department. The patient was admitted to the ICU and placed on prophylactic antibiotics. Barium and gastrograffin esophagrams revealed no evidence of extravasation. Gastrointestinal endoscopy showed distal esophagitis. Gastroscopy and duodenoscopy were unremarkable. The patient did well following discharge.',\n",
       "  'journal': 'Annals of emergency medicine',\n",
       "  'authors': \"Wolowodiuk|O J|OJ|;McMicken|D B|DB|;O'Brien|P|P|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150668',\n",
       "  'mesh_terms': 'D000293:Adolescent; D002675:Child, Preschool; D004646:Emphysema; D005260:Female; D005773:Gastroscopy; D006801:Humans; D007486:Ipecac; D008297:Male; D008478:Mediastinal Emphysema; D010400:Penicillin G; D011859:Radiography; D012187:Retroperitoneal Space',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D007486:Ipecac; D010400:Penicillin G',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0196-0644(84)80341-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Emerg Med',\n",
       "  'nlm_unique_id': '8002646',\n",
       "  'issn_linking': '0196-0644',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Ipecac use in the elderly: the unanswered question.',\n",
       "  'issue': '13(12)',\n",
       "  'pages': '1152-4',\n",
       "  'abstract': 'An elderly patient experienced an intracerebral bleed temporally related to the administration of syrup of ipecac. The experience of the certified regional poison centers of the American Association of Poison Control Centers shows that this is an uncommon event. The use and safety of ipecac in the elderly has not been adequately addressed in the past.',\n",
       "  'journal': 'Annals of emergency medicine',\n",
       "  'authors': 'Klein-Schwartz|W|W|;Gorman|R L|RL|;Oderda|G M|GM|;Wedin|G P|GP|;Saggar|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150669',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D002543:Cerebral Hemorrhage; D005260:Female; D006801:Humans; D007223:Infant; D007486:Ipecac; D008396:Maryland; D008875:Middle Aged; D011039:Poison Control Centers; D012189:Retrospective Studies',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D007486:Ipecac',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0196-0644(84)80342-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Emerg Med',\n",
       "  'nlm_unique_id': '8002646',\n",
       "  'issn_linking': '0196-0644',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Anaerobic sepsis in infants].',\n",
       "  'issue': '21(3)',\n",
       "  'pages': '263-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Anales espanoles de pediatria',\n",
       "  'authors': 'Pérez Alvarez|F|F|;Bergadá Massó|A|A|;Crusi|J|J|;Batlle|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150670',\n",
       "  'mesh_terms': 'D001442:Bacteroides Infections; D016124:Eikenella corrodens; D006801:Humans; D007223:Infant; D001443:Prevotella melaninogenica; D018805:Sepsis',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'An Esp Pediatr',\n",
       "  'nlm_unique_id': '0420463',\n",
       "  'issn_linking': '0302-4342',\n",
       "  'country': 'Spain'},\n",
       " {'title': '[Biological and pharmacological data on aggressive behavior (application to mental pathology].',\n",
       "  'issue': '142(4)',\n",
       "  'pages': '542-54',\n",
       "  'abstract': '',\n",
       "  'journal': 'Annales medico-psychologiques',\n",
       "  'authors': 'Soulairac|A|A|;Lambinet|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150671',\n",
       "  'mesh_terms': 'D006916:5-Hydroxytryptophan; D000374:Aggression; D000818:Animals; D001522:Behavior, Animal; D001921:Brain; D006728:Hormones; D006801:Humans; D051379:Mice; D018377:Neurotransmitter Agents; D051381:Rats',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006728:Hormones; D018377:Neurotransmitter Agents; D006916:5-Hydroxytryptophan',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Med Psychol (Paris)',\n",
       "  'nlm_unique_id': '2984692R',\n",
       "  'issn_linking': '0003-4487',\n",
       "  'country': 'France'},\n",
       " {'title': '[Chronicity, chronicization, systematization of delusions].',\n",
       "  'issue': '142(5)',\n",
       "  'pages': '609-16',\n",
       "  'abstract': 'Chronicity in psychopathology is indicative of a term, a decay. Chronicization only leads the way to this term. Here, chronicization is taken literally as an inscription in the time course of delusions. The mechanism of systematization seems to be a central mark in the approach to chronic delusions. It is not an alienation or an irreversible closing but an attempted accommodation with reality in the life of psychotic subjects, irrespective of the delusional structure. The role of therapy and drug treatment as a follow-up may in that case assume another meaning.',\n",
       "  'journal': 'Annales medico-psychologiques',\n",
       "  'authors': 'Trapet|P|P|;Fernandez|C|C|;Galtier|M C|MC|;Gisselmann|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150672',\n",
       "  'mesh_terms': 'D014150:Antipsychotic Agents; D002908:Chronic Disease; D003702:Delusions; D006212:Hallucinations; D006801:Humans; D010259:Paranoid Disorders; D010554:Personality Disorders; D011613:Psychotherapy; D012565:Schizophrenic Psychology; D013997:Time Factors',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Med Psychol (Paris)',\n",
       "  'nlm_unique_id': '2984692R',\n",
       "  'issn_linking': '0003-4487',\n",
       "  'country': 'France'},\n",
       " {'title': '[Comparative study of 2 hypnotics, flunitrazepam and triazolam, on sleeping. Psychometric evaluation and pharmacokinetic correlation].',\n",
       "  'issue': '142(5)',\n",
       "  'pages': '688-96',\n",
       "  'abstract': '',\n",
       "  'journal': 'Annales medico-psychologiques',\n",
       "  'authors': 'Fayat-Picard|J|J|;Gardes|J P|JP|;Loustalan|J M|JM|;Gayral|L F|LF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150673',\n",
       "  'mesh_terms': 'D000328:Adult; D014151:Anti-Anxiety Agents; D001143:Arousal; D005260:Female; D005445:Flunitrazepam; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008297:Male; D011594:Psychometrics; D012890:Sleep; D014229:Triazolam',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D014229:Triazolam; D005445:Flunitrazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Med Psychol (Paris)',\n",
       "  'nlm_unique_id': '2984692R',\n",
       "  'issn_linking': '0003-4487',\n",
       "  'country': 'France'},\n",
       " {'title': '[Presence of autogenic characteristics in Culiseta (C.) annulata (Schrank, 1776) and new geographical mentions for Aedes caspius (Pallas, 1771) and Culiseta (C.) subochrea (Edwards, 1921)].',\n",
       "  'issue': '59(5)',\n",
       "  'pages': '535-8',\n",
       "  'abstract': '',\n",
       "  'journal': 'Annales de parasitologie humaine et comparee',\n",
       "  'authors': 'Capela|R A|RA|;Brandao Ribeiro|M E|ME|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150675',\n",
       "  'mesh_terms': 'D000330:Aedes; D000818:Animals; D009033:Culicidae; D005260:Female; D009865:Oocytes; D010053:Ovary; D012098:Reproduction',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1051/parasite/1984595535',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Parasitol Hum Comp',\n",
       "  'nlm_unique_id': '0376525',\n",
       "  'issn_linking': '0003-4150',\n",
       "  'country': 'France'},\n",
       " {'title': '[Experimental study of the effects of 6 nonamphetamine psychostimulants on effort hyperammonemia in the rat].',\n",
       "  'issue': '42(3)',\n",
       "  'pages': '265-70',\n",
       "  'abstract': '',\n",
       "  'journal': 'Annales pharmaceutiques francaises',\n",
       "  'authors': 'Guinard|F|F|;Foussard-Blanpin|O|O|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150676',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000641:Ammonia; D000818:Animals; D000697:Central Nervous System Stimulants; D008297:Male; D005082:Physical Exertion; D051381:Rats; D011919:Rats, Inbred Strains; D013550:Swimming',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000596:Amino Acids; D000697:Central Nervous System Stimulants; D000641:Ammonia',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Pharm Fr',\n",
       "  'nlm_unique_id': '2985176R',\n",
       "  'issn_linking': '0003-4509',\n",
       "  'country': 'France'},\n",
       " {'title': 'Acute circulatory insufficiency of previously operated testes.',\n",
       "  'issue': '73(4)',\n",
       "  'pages': '229-31',\n",
       "  'abstract': 'Conditions leading to circulatory disturbances of the testes following previous fixation after testicular torsion or after orchidopexy for retained testes are reported. Different methods of fixation are discussed, and recommendations as to operative procedures are made.',\n",
       "  'journal': 'Annales chirurgiae et gynaecologiae',\n",
       "  'authors': 'Kalsnes|R|R|;Fjøsne|H|H|;Kufaas|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150677',\n",
       "  'mesh_terms': 'D000293:Adolescent; D003456:Cryptorchidism; D006801:Humans; D008297:Male; D011183:Postoperative Complications; D013086:Spermatic Cord Torsion; D013737:Testis',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Chir Gynaecol',\n",
       "  'nlm_unique_id': '7609767',\n",
       "  'issn_linking': '0355-9521',\n",
       "  'country': 'Finland'},\n",
       " {'title': 'A new alkaline phosphatase isoenzyme abnormality.',\n",
       "  'issue': '21 ( Pt 5)()',\n",
       "  'pages': '352-6',\n",
       "  'abstract': \"We report on a new alkaline phosphatase isoenzyme abnormality occurring as an incidental finding in a male infant aged 4 months. Isoenzyme electrophoresis on cellulose acetate showed a prominent, diffuse alkaline phosphatase staining band in the alpha 1-globulin position together with a second band in the alpha 2/beta region and minor 'trailing' in the intermediate alpha 2 region. Normal liver and bone alkaline phosphatase were absent and intestinal phosphatase was not detected. On acrylamide gel electrophoresis a marked origin band was detectable suggesting the presence of high molecular weight enzyme. In addition, a series of compact bands in the alpha 2/beta position was present cathodal to the usual liver and bone isoenzymes. Total alkaline phosphatase activity was marginally elevated and was heat labile, L-phenylalanine resistant and partially L-homoarginine and L-leucine sensitive.\",\n",
       "  'journal': 'Annals of clinical biochemistry',\n",
       "  'authors': 'Mayne|P D|PD|;Foo|A Y|AY|;Michelson|R|R|;Kovar|I Z|IZ|;Rosalki|S B|SB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150678',\n",
       "  'mesh_terms': 'D000469:Alkaline Phosphatase; D001847:Bone Diseases; D004588:Electrophoresis, Cellulose Acetate; D006801:Humans; D007223:Infant; D007527:Isoenzymes; D007668:Kidney; D008107:Liver Diseases; D008297:Male; D009439:Neuraminidase; D017830:Octoxynol; D010206:Papain; D011092:Polyethylene Glycols; D014357:Trypsin; D014552:Urinary Tract Infections; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D007527:Isoenzymes; D011092:Polyethylene Glycols; D017830:Octoxynol; D005723:gamma-Glutamyltransferase; D000469:Alkaline Phosphatase; D009439:Neuraminidase; D014357:Trypsin; D010206:Papain',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/000456328402100502',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Clin Biochem',\n",
       "  'nlm_unique_id': '0324055',\n",
       "  'issn_linking': '0004-5632',\n",
       "  'country': 'England'},\n",
       " {'title': 'Interactions between beta-blockers and clonidine.',\n",
       "  'issue': '16(4)',\n",
       "  'pages': '181-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'Annals of clinical research',\n",
       "  'authors': 'Jounela|A J|AJ|;Lilja|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150679',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D003000:Clonidine; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D003000:Clonidine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Clin Res',\n",
       "  'nlm_unique_id': '0220042',\n",
       "  'issn_linking': '0003-4762',\n",
       "  'country': 'Finland'},\n",
       " {'title': 'Glutamate excretion triggering mechanism: a reinvestigation of the surfactant-induced modification of cell lipids.',\n",
       "  'issue': '135B(1)',\n",
       "  'pages': '53-67',\n",
       "  'abstract': 'Lipid alterations induced by surfactants to trigger glutamate excretion were investigated with an industrial strain of Corynebacterium glutamicum. The lipid composition of this strain was determined for cultures in a synthetic medium and in a complex medium. A distribution of complex lipids between the cell wall and the cell membrane is proposed. Depending on growth conditions, 70-85% of the cell fatty acids had saturated chains in cells grown with surfactants. In the synthetic medium up to 80% of the straight-chain fatty acids may have come from the acylated surfactant added to the induce excretion. In industrial fermentation, the maximal excretion rate corresponded to the highest saturated fatty acid content of cells. It was shown by radioactive labelling in the synthetic medium that the addition of the acylated surfactant induced the degradation of more than 50% of the phospholipids. Some phospholipid synthesis occurred at that time using the surfactant (saturated) fatty acids, but the membrane did nor recover its previous phospholipid content. A model is proposed to explain the mechanism of glutamate excretion triggering by surfactants.',\n",
       "  'journal': 'Annales de microbiologie',\n",
       "  'authors': 'Huchenq|A|A|;Marquet|M|M|;Welby|M|M|;Montrozier|H|H|;Goma|G|G|;Lanéelle|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150674',\n",
       "  'mesh_terms': 'D002462:Cell Membrane; D002473:Cell Wall; D055598:Chemical Phenomena; D002621:Chemistry; D003352:Corynebacterium; D003470:Culture Media; D003902:Detergents; D005227:Fatty Acids; D005285:Fermentation; D005971:Glutamates; D018698:Glutamic Acid; D008563:Membrane Lipids; D010743:Phospholipids; D013501:Surface-Active Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D003470:Culture Media; D003902:Detergents; D005227:Fatty Acids; D005971:Glutamates; D008563:Membrane Lipids; D010743:Phospholipids; D013501:Surface-Active Agents; D018698:Glutamic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0769-2609(84)80043-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Microbiol (Paris)',\n",
       "  'nlm_unique_id': '0354704',\n",
       "  'issn_linking': '0300-5410',\n",
       "  'country': 'France'},\n",
       " {'title': 'Calmodulin systems in neuronal excitability: a molecular approach to epilepsy.',\n",
       "  'issue': '16 Suppl()',\n",
       "  'pages': 'S104-14',\n",
       "  'abstract': 'Calmodulin is a major Ca2+ -binding protein that may mediate many Ca2+ -regulated processes in neuronal function. Calmodulin is present in the presynaptic nerve terminal in association with synaptic vesicles and in postsynaptic density fractions. Several calmodulin-regulated synaptic biochemical processes have been identified. These results indicate that calmodulin may modulate some aspects of neuronal excitability. Phenytoin, carbamazepine, and the benzodiazepines inhibit Ca2+ -calmodulin-regulated protein phosphorylation and neurotransmitter release by synaptic vesicles. A saturable, stereospecific membrane binding site has been identified for the benzodiazepines. The potency of the benzodiazepines to bind to these sites correlates with their ability to inhibit maximal electroshock-induced seizures. Phenytoin and carbamazepine can displace benzodiazepine binding from these binding sites. Binding to these \"anticonvulsant\" sites regulates Ca2+ -calmodulin-stimulated membrane protein phosphorylation and depolarization-dependent Ca2+ uptake in intact synaptosome preparations. These results provide evidence that major anticonvulsant drugs regulate Ca2+ -calmodulin systems at the synapse. Kindling alters Ca2+ -calmodulin protein phosphorylation in brain membrane. In addition, alterations in Ca2+ -calmodulin kinase systems have been associated with some strains of seizure-susceptible mice. Thus, evidence from multiple sources suggests that calmodulin-mediated processes may play a role in the development of altered neuronal excitability and in some forms of seizure disorders.',\n",
       "  'journal': 'Annals of neurology',\n",
       "  'authors': 'DeLorenzo|R J|RJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150680',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001569:Benzodiazepines; D001921:Brain; D002118:Calcium; D002135:Calcium-Binding Proteins; D002147:Calmodulin; D004827:Epilepsy; D006801:Humans; D009419:Nerve Tissue Proteins; D010766:Phosphorylation; D011963:Receptors, GABA-A; D013569:Synapses; D009435:Synaptic Transmission; D013572:Synaptic Vesicles',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D002135:Calcium-Binding Proteins; D002147:Calmodulin; D009419:Nerve Tissue Proteins; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/ana.410160716',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Neurol',\n",
       "  'nlm_unique_id': '7707449',\n",
       "  'issn_linking': '0364-5134',\n",
       "  'country': 'United States'},\n",
       " {'title': '(Na+ + K+)-ATPase: function, structure, and conformations.',\n",
       "  'issue': '16 Suppl()',\n",
       "  'pages': 'S121-7',\n",
       "  'abstract': 'Na+- and K+ -dependent adenosine triphosphatase [(Na+ + K+)-ATPase] plays a pivotal role in the homeostasis of Na+, K+, and Ca2+ in cells. Although the structural and enzymatic characteristics of this enzyme are being rapidly elucidated, the mechanisms underlying the vectorial movement of ions remain unclear. An understanding of the mechanism and localization of this enzyme is of importance in the study of epilepsy, since a possible defect leading to epilepsy may involve the inability of cellular elements to clear extracellular K+. Studies of conformational changes associated with the binding of specific ligands to the enzyme are being used to understand better the mechanism of the (Na+ + K+)-ATPase found in nervous tissue and transporting epithelia.',\n",
       "  'journal': 'Annals of neurology',\n",
       "  'authors': 'Stahl|W L|WL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150681',\n",
       "  'mesh_terms': 'D000818:Animals; D001921:Brain; D002463:Cell Membrane Permeability; D004827:Epilepsy; D006801:Humans; D007473:Ion Channels; D007527:Isoenzymes; D007700:Kinetics; D008968:Molecular Conformation; D008970:Molecular Weight; D018377:Neurotransmitter Agents; D010455:Peptides; D010743:Phospholipids; D011487:Protein Conformation; D000254:Sodium-Potassium-Exchanging ATPase; D009435:Synaptic Transmission',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D007473:Ion Channels; D007527:Isoenzymes; D018377:Neurotransmitter Agents; D010455:Peptides; D010743:Phospholipids; D000254:Sodium-Potassium-Exchanging ATPase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/ana.410160718',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Neurol',\n",
       "  'nlm_unique_id': '7707449',\n",
       "  'issn_linking': '0364-5134',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Ionic and acid-base regulation of neurons and glia during seizures.',\n",
       "  'issue': '16 Suppl()',\n",
       "  'pages': 'S135-44',\n",
       "  'abstract': 'Much evidence shows that glia regulates the cation and anion content of brain interstitial space. In rats the pH and bicarbonate (HCO3-) concentration of neurons and glia were derived from carbon 14-labeled HCO3- and dimethyloxazolidinedione uptake into brain and cerebrospinal fluid. Acetazolamide increases the total CO2 concentration in neurons and decreases the pH and HCO3- concentration in glia. Inhibition of glial carbonic anhydrase (CA) reduces conversion of neuronally derived CO2 to HCO3-, glial pH is lowered, and neuronal CO2 accumulates. CA therefore has an essential role in regulating pH in neurons, glia, and interstitial fluid. In audiogenic seizure mice, glial CA activity is increased and glial anion transport is reduced. As the mice age, seizure susceptibility, the increased CA activity, and the defect in anion transport disappear concurrently. The enhanced CA activity in the glial cells of these mice is an adaptive mechanism to overcome the defect in anion transport that results from a deficiency of HCO3- -dependent and Na+- and K+ -dependent adenosine triphosphatase. Pentylenetetrazol stimulates neurons in neonatal rats, but after 10 days of age, when glia is present, it too is stimulated and the seizures are attenuated. Cobalt implantation in the cortex of rats also induces a glial response that ameliorates the focal seizures produced by this procedure.',\n",
       "  'journal': 'Annals of neurology',\n",
       "  'authors': 'Woodbury|D M|DM|;Engstrom|F L|FL|;White|H S|HS|;Chen|C F|CF|;Kemp|J W|JW|;Chow|S Y|SY|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150682',\n",
       "  'mesh_terms': 'D000136:Acid-Base Equilibrium; D000251:Adenosine Triphosphatases; D000818:Animals; D027321:Anion Transport Proteins; D001639:Bicarbonates; D002256:Carbonic Anhydrases; D002540:Cerebral Cortex; D002712:Chlorides; D003035:Cobalt; D004827:Epilepsy; D005110:Extracellular Space; D006801:Humans; D007473:Ion Channels; D009457:Neuroglia; D009474:Neurons; D010433:Pentylenetetrazole; D012640:Seizures; D000254:Sodium-Potassium-Exchanging ATPase',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D027321:Anion Transport Proteins; D001639:Bicarbonates; D002712:Chlorides; D007473:Ion Channels; D003035:Cobalt; D000251:Adenosine Triphosphatases; C031652:anion-sensitive ATPases; D002256:Carbonic Anhydrases; D000254:Sodium-Potassium-Exchanging ATPase; D010433:Pentylenetetrazole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/ana.410160720',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Neurol',\n",
       "  'nlm_unique_id': '7707449',\n",
       "  'issn_linking': '0364-5134',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The new wave of research in the epilepsies.',\n",
       "  'issue': '16 Suppl()',\n",
       "  'pages': 'S145-58',\n",
       "  'abstract': 'In addition to yielding new routes of navigation, the workshops from which the material in this supplement comes developed a conceptual blueprint for priority challenges in epilepsy research. All participants called attention to the ultimate goal, namely, understanding the mechanisms of human epilepsies. And, foremost to achieving this goal is the search for polymorphisms of restriction endonuclease patterns in monogenic forms of epilepsies in an attempt to localize the abnormal gene, or genes, to a specific chromosome. In human temporal lobe epilepsy, a priority challenge is to record paroxysmal depolarization shifts in hippocampal slices in vitro, slices excised from the known site of epileptogenicity. Parallel experiments exploring biochemical membrane abnormalities in neuronal and glial membranes isolated from the hippocampal seizure focus are especially valuable. Together with genetic studies using restriction-fragment-length polymorphisms, these experiments should distinguish between the respective contributions of genetic and environmental factors in multifactorial forms of partial epilepsies, such as temporal lobe epilepsy. In the genesis and spread of human temporal lobe epilepsy, the role of kindling and the mirror focus must be resolved. Recent successful applications of positron emission tomography, single-photon-emission computed tomography, and nuclear magnetic resonance computed tomography show promise in finally constructing the ion transport pathways, neurotransmitter systems, and metabolic processes within the functioning brains of epileptic patients.',\n",
       "  'journal': 'Annals of neurology',\n",
       "  'authors': 'Delgado-Escueta|A V|AV|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150683',\n",
       "  'mesh_terms': 'D000818:Animals; D000927:Anticonvulsants; D002874:Chromosome Mapping; D004827:Epilepsy; D006624:Hippocampus; D006801:Humans; D007473:Ion Channels; D007696:Kindling, Neurologic; D008564:Membrane Potentials; D009433:Neural Inhibition; D009457:Neuroglia; D018377:Neurotransmitter Agents; D012106:Research; D013378:Substantia Nigra; D013570:Synaptic Membranes; D009435:Synaptic Transmission; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000927:Anticonvulsants; D007473:Ion Channels; D018377:Neurotransmitter Agents; D005680:gamma-Aminobutyric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/ana.410160721',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Neurol',\n",
       "  'nlm_unique_id': '7707449',\n",
       "  'issn_linking': '0364-5134',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Role of the gamma-aminobutyric acid receptor-ionophore complex in seizure disorders.',\n",
       "  'issue': '16 Suppl()',\n",
       "  'pages': 'S90-7',\n",
       "  'abstract': 'The possibility of a role for the inhibitory neurotransmitter gamma-aminobutyric acid (GABA) in seizure disorders has been strengthened by biochemical studies showing that various nervous system depressant drugs can modulate GABA receptor binding in vitro. In particular, two classes of anticonvulsant agents, the benzodiazepines and the barbiturates, have modulatory receptor sites on the GABA receptor-ionophore protein complex of the postsynaptic membrane. Furthermore, it is well established that direct block of GABA function causes seizures and that augmentation of GABA function can protect against seizure activity. Direct evidence for altered GABA synaptic markers has been obtained in some animal models of epilepsy, as well as in human focal epilepsy. We present preliminary evidence for a deficit in benzodiazepine receptor binding in the midbrain of seizure-susceptible Mongolian gerbils. These data would be consistent with an impairment of GABA-mediated inhibitory synaptic transmission that contributes to susceptibility to the genesis or spread of seizures in some kinds of epilepsy.',\n",
       "  'journal': 'Annals of neurology',\n",
       "  'authors': 'Olsen|R W|RW|;Snowman|A M|AM|;Lee|R|R|;Lomax|P|P|;Wamsley|J K|JK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150684',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D001463:Barbiturates; D001569:Benzodiazepines; D001667:Binding, Competitive; D001921:Brain; D004827:Epilepsy; D005849:Gerbillinae; D007476:Ionophores; D009433:Neural Inhibition; D011963:Receptors, GABA-A; D013569:Synapses; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001463:Barbiturates; D007476:Ionophores; D011963:Receptors, GABA-A; D001569:Benzodiazepines; D005680:gamma-Aminobutyric Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/ana.410160714',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Ann Neurol',\n",
       "  'nlm_unique_id': '7707449',\n",
       "  'issn_linking': '0364-5134',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Transplantation of nerve tissue into brain.',\n",
       "  'issue': '47(1-2)',\n",
       "  'pages': '23-32',\n",
       "  'abstract': '',\n",
       "  'journal': 'Applied neurophysiology',\n",
       "  'authors': 'Reif|A E|AE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150685',\n",
       "  'mesh_terms': 'D000818:Animals; D000954:Antigens, Surface; D001921:Brain; D006168:Guinea Pigs; D006183:H-2 Antigens; D051379:Mice; D008806:Mice, Inbred AKR; D008810:Mice, Inbred C57BL; D008815:Mice, Inbred Strains; D009417:Nerve Tissue; D009420:Nervous System; D011817:Rabbits; D051381:Rats; D011919:Rats, Inbred Strains; D018800:Thy-1 Antigens',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000954:Antigens, Surface; D006183:H-2 Antigens; D018800:Thy-1 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000101199',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Appl Neurophysiol',\n",
       "  'nlm_unique_id': '7600656',\n",
       "  'issn_linking': '',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Ethics in medical donations.',\n",
       "  'issue': '47(1-2)',\n",
       "  'pages': '73-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Applied neurophysiology',\n",
       "  'authors': 'Neville|R C|RC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150686',\n",
       "  'mesh_terms': 'D001921:Brain; D017690:Cell Transplantation; D004622:Embryo, Mammalian; D004992:Ethics, Medical; D006801:Humans; D009417:Nerve Tissue',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000101207',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Appl Neurophysiol',\n",
       "  'nlm_unique_id': '7600656',\n",
       "  'issn_linking': '',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Maternal drug histories and central nervous system anomalies.',\n",
       "  'issue': '59(11)',\n",
       "  'pages': '1052-60',\n",
       "  'abstract': \"Prescription data for the three months before the last menstrual period and for the first trimester of pregnancy were obtained for 764 mothers whose children had a defect of the central nervous system and for an equal number of mothers of control babies born from the same doctors' practices. There was a statistically significant difference overall between the numbers of mothers who were prescribed drugs in the study and control groups during the trimester before the last menstrual period but no such difference was found for the first pregnancy trimester, nor was there a significant difference for any specific group of drugs. For a composite group of non-steroid anti-inflammatory drugs, salicylates, and sulphasalazine there was a significant difference for the trimester before the last menstrual period. There are arguments against such an artificial grouping, however, and when the individual drugs were considered the comparisons were no longer significant. The odds ratios for all medicines containing folic acid taken in the trimester before the last menstrual period were considerably less than unity, in contrast with nearly all other comparisons. This supports a suggested protective effect against neural tube defects of folic acid supplements begun before the onset of pregnancy but the odds ratios of these comparisons were not statistically significant.\",\n",
       "  'journal': 'Archives of disease in childhood',\n",
       "  'authors': 'Winship|K A|KA|;Cahal|D A|DA|;Weber|J C|JC|;Griffin|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150687',\n",
       "  'mesh_terms': 'D000014:Abnormalities, Drug-Induced; D000015:Abnormalities, Multiple; D000293:Adolescent; D000328:Adult; D000893:Anti-Inflammatory Agents; D005260:Female; D005492:Folic Acid; D006801:Humans; D008423:Maternal Age; D008875:Middle Aged; D009436:Neural Tube Defects; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D012459:Salicylates; D012460:Sulfasalazine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000893:Anti-Inflammatory Agents; D012459:Salicylates; D012460:Sulfasalazine; D005492:Folic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/adc.59.11.1052',\n",
       "  'references': '476021;43760;6759273;6133211;6109522;7050874;59014;7332338;6133069;879205;671728;630297;6840794;922327;4994237;625707;7437804;4396080;861894;4619574;13655060;7093169;6129393;773181',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Dis Child',\n",
       "  'nlm_unique_id': '0372434',\n",
       "  'issn_linking': '0003-9888',\n",
       "  'country': 'England'},\n",
       " {'title': 'Histological changes in the testis following adult orchidopexy for unilateral cryptorchidism.',\n",
       "  'issue': '12(2-3)',\n",
       "  'pages': '231-4',\n",
       "  'abstract': 'In 10 adult male patients operated on for unilateral cryptorchidism, the testis was located in superficial inguinal pouch in 2 patients; intracanalicular in 5, and intraabdominally in 3 patients. Orchidopexy was performed on 8 patients; and orchiectomy on 2 patients for severe testicular atrophy. Normal spermatogenic function were found in 3 patients postoperatively. The best functional, anatomical, and cosmetic results were achieved in patients whose testis were located in the superficial inguinal pouch; while the worst results were found in intraabdominally located testis. A plea for early diagnosis and treatment of this entity in the tropics is reemphasized.',\n",
       "  'journal': 'Archives of andrology',\n",
       "  'authors': 'Duvie|S O|SO|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150688',\n",
       "  'mesh_terms': 'D000328:Adult; D002369:Castration; D003456:Cryptorchidism; D006801:Humans; D008297:Male; D013091:Spermatogenesis; D013737:Testis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/01485018409161181',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Androl',\n",
       "  'nlm_unique_id': '7806755',\n",
       "  'issn_linking': '0148-5016',\n",
       "  'country': 'England'},\n",
       " {'title': 'Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.',\n",
       "  'issue': '271(2)',\n",
       "  'pages': '180-8',\n",
       "  'abstract': 'Chronic treatment with haloperidol, physostigmine and scopolamine exerted different effects on the frequency of yawning induced by apomorphine (0.25 mg/kg, i.p.), physostigmine (0.2 mg/kg, i.p.) and pilocarpine (4 mg/kg, i.p.) as compared with chronic treatment with saline. Haloperidol decreased the apomorphine- and physostigmine-induced yawning but not the pilocarpine-induced yawning. Physostigmine reduced only the pilocarpine-induced yawning without affecting the apomorphine- and physostigmine-induced yawning. However, physostigmine showed the most rapid onset- and peak-time of yawning induced by a high dose of physostigmine (0.75 mg/kg, i.p.) as well as that of pilocarpine (8 mg/kg, i.p.), and potentiated apomorphine (1 mg/kg, i.p.)-induced stereotypy, as compared with that observed in the saline group. Scopolamine potentiated the physostigmine- and pilocarpine-induced yawning but not the apomorphine-induced yawning. A single pretreatment with scopolamine (0.5 mg/kg, i.p.), however, depressed these yawning responses. The results suggest that yawning induced by physostigmine, but not by pilocarpine, may be modified by long-term treatment with haloperidol. The stereotypy mediated by the postsynaptic dopaminergic system, but not the yawning mediated by the presynaptic system, may be altered by chronic treatment with physostigmine, while long-term treatment with scopolamine seems to produce a supersensitivity to cholinergic receptors.',\n",
       "  'journal': 'Archives internationales de pharmacodynamie et de therapie',\n",
       "  'authors': 'Ushijima|I|I|;Noda|Y|Y|;Mizuki|Y|Y|;Yamada|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150689',\n",
       "  'mesh_terms': 'D000818:Animals; D014150:Antipsychotic Agents; D001058:Apomorphine; D001522:Behavior, Animal; D006220:Haloperidol; D006801:Humans; D008297:Male; D010277:Parasympathomimetics; D010830:Physostigmine; D010862:Pilocarpine; D051381:Rats; D011919:Rats, Inbred Strains; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine; D012601:Scopolamine; D013239:Stereotyped Behavior',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D010277:Parasympathomimetics; D011950:Receptors, Cholinergic; D011954:Receptors, Dopamine; D010862:Pilocarpine; D010830:Physostigmine; D012601:Scopolamine; D006220:Haloperidol; D001058:Apomorphine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Int Pharmacodyn Ther',\n",
       "  'nlm_unique_id': '0405353',\n",
       "  'issn_linking': '0003-9780',\n",
       "  'country': 'Belgium'},\n",
       " {'title': 'Vasoconstrictor responses of isolated and perfused canine mesenteric arteries to alpha-adrenoceptor agonists.',\n",
       "  'issue': '271(2)',\n",
       "  'pages': '241-8',\n",
       "  'abstract': 'Using isolated and perfused canine mesenteric artery, vasoconstrictor responses to alpha-adrenoceptor stimulating agents were compared. The order of potencies for inducing vasoconstriction was epinephrine greater than norepinephrine greater than phenylephrine greater than methoxamine greater than dopamine much greater than tyramine greater than clonidine greater than or equal to xylazine. A selective alpha 2-stimulant, xylazine, did not induce any significant vasoconstrictor response. Tyramine produced only a slight vasoconstriction. Responses to norepinephrine, phenylephrine and methoxamine were competitively inhibited by phentolamine treatment. From these results, it is concluded that the adrenoceptor in the canine mesenteric artery may be characterized as an alpha 1-receptor and that release of norepinephrine by tyramine is not marked in this relatively large vessel.',\n",
       "  'journal': 'Archives internationales de pharmacodynamie et de therapie',\n",
       "  'authors': 'Chiba|S|S|;Tsukada|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150690',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000818:Animals; D004285:Dogs; D005260:Female; D066298:In Vitro Techniques; D008297:Male; D008638:Mesenteric Arteries; D010477:Perfusion; D010646:Phentolamine; D011189:Potassium Chloride; D014439:Tyramine; D014661:Vasoconstriction',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D011189:Potassium Chloride; D014439:Tyramine; D010646:Phentolamine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Int Pharmacodyn Ther',\n",
       "  'nlm_unique_id': '0405353',\n",
       "  'issn_linking': '0003-9780',\n",
       "  'country': 'Belgium'},\n",
       " {'title': '[Enucleation of five islet-cell tumors in multiple endocrine neoplasia type I: a case report].',\n",
       "  'issue': '53(3)',\n",
       "  'pages': '527-35',\n",
       "  'abstract': '',\n",
       "  'journal': 'Nihon geka hokan. Archiv fur japanische Chirurgie',\n",
       "  'authors': 'Kasahara|Y|Y|;Yamada|Y|Y|;Sudo|T|T|;Umemura|H|H|;Shiraha|S|S|;Kuyama|T|T|;Kawai|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150691',\n",
       "  'mesh_terms': 'D007516:Adenoma, Islet Cell; D000328:Adult; D005260:Female; D006801:Humans; D009377:Multiple Endocrine Neoplasia; D010190:Pancreatic Neoplasms; D011859:Radiography',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nihon Geka Hokan',\n",
       "  'nlm_unique_id': '0421143',\n",
       "  'issn_linking': '0003-9152',\n",
       "  'country': 'Japan'},\n",
       " {'title': '[Unstable angina caused by monotruncular stenosis of the anterior interventricular artery (87 cases). Results of medical and surgical treatment].',\n",
       "  'issue': '77(12)',\n",
       "  'pages': '1351-8',\n",
       "  'abstract': 'The aim of this study was to compare the medium-term results of medical therapy and aortocoronary bypass surgery in 87 patients selected on the following criteria: Clinical: unstable angina, defined as effort and/or resting angina appearing for the first time or increasing in severity within the previous 3 months, the last attack of chest pain occurring less than 8 days before admission to the Coronary Care Unit, with no signs of myocardial infarction before hospital admission and at coronary angiography. Coronary angiography: proximal isolated left anterior descending artery stenosis (greater than 70%). Thirty five patients were treated medically and 52 underwent coronary bypass surgery on the LAD artery: the results were compared at 18 and 24 months. Six patients were lost to follow-up, 2 from the medical group; the other 33 patients comprised group A. Four surgical patients were lost to follow-up, the other 48 patients comprised group B. The two groups had comparable clinical and epidemiological features. They differed in the incidence of hypertension which was more common in group A (p less than 0.01), in the better quality of the distal LAD artery in group B (p less than 0.01), and in the coexistence of less than 50% stenosis on the right coronary and left circumflex arteries which was commoner in group A (p less than 0.05). The mean follow-up period was comparable in the two groups (group A: 20.5 +/- 4.6 months; group B: 19.8 +/- 5.5 months).(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Archives des maladies du coeur et des vaisseaux',\n",
       "  'authors': 'Brau|J|J|;Bénacerraf|A|A|;Lévy|A|A|;Veau|P|P|;Rakotovao|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150692',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000787:Angina Pectoris; D000789:Angina, Unstable; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D017023:Coronary Angiography; D001026:Coronary Artery Bypass; D003331:Coronary Vessels; D004359:Drug Therapy, Combination; D004562:Electrocardiography; D006801:Humans; D009566:Nitrates; D011379:Prognosis; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D002121:Calcium Channel Blockers; D009566:Nitrates; D014665:Vasodilator Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Mal Coeur Vaiss',\n",
       "  'nlm_unique_id': '0406011',\n",
       "  'issn_linking': '0003-9683',\n",
       "  'country': 'France'},\n",
       " {'title': '[Effects of molsidomine during the cold test in stable coronary insufficiency under beta-blocker treatment].',\n",
       "  'issue': '77(12)',\n",
       "  'pages': '1383-9',\n",
       "  'abstract': 'The heart rate, cardiac output, coronary sinus blood flow, systolic and end diastolic left ventricular pressures, femoral arterial pressure and coronary oxygen arterio-venous difference were measured in 12 patients with stable coronary artery disease without cardiac failure on long-term betablocker therapy, before and 45 minutes after 2 or 3 mg sublingual molsidomine. The measurements were repeated in 8 patients during a cold pressor test. Under basal conditions, molsidomine decreased the systolic and end diastolic left ventricular pressures, mean femoral arterial pressure, cardiac output and double product. The coronary oxygen arterio-venous difference was unchanged. Coronary sinus flow and myocardial oxygen consumption decreased. In the 2 patients who were given 3 mg molsidomine, a progressive reduction in systolic left ventricular pressure to 70% or less than its initial value, necessitated immediate treatment with volume expanders. During the cold pressor test before molsidomine the systolic and end diastolic left ventricular pressures, mean femoral arterial pressure and the double product increased. Coronary sinus flow was unchanged overall: it decreased in 6 patients, increased in 2 patients and remained the same in 1 patient. Coronary resistance increased in 6 patients and decreased in only one patient. During the cold pressor test after molsidomine there was a significant reduction in the increase of systolic left ventricular pressure, mean femoral artery pressure and double product. Coronary sinus blood flow increased in 5 patients and decreased in only one case. Coronary resistance decreased in half the cases.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Archives des maladies du coeur et des vaisseaux',\n",
       "  'authors': 'Zygelman|M|M|;Neukirch|F|F|;Mérillon|J P|JP|;Dahan|M|M|;Trouillet|J L|JL|;Juliard|J M|JM|;Pansard|Y|Y|;Gourgon|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150693',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D000368:Aged; D003080:Cold Temperature; D003327:Coronary Disease; D006439:Hemodynamics; D006801:Humans; D008297:Male; D008875:Middle Aged; D008981:Molsidomine; D010069:Oxadiazoles; D013558:Sydnones; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D010069:Oxadiazoles; D013558:Sydnones; D014665:Vasodilator Agents; D008981:Molsidomine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Mal Coeur Vaiss',\n",
       "  'nlm_unique_id': '0406011',\n",
       "  'issn_linking': '0003-9683',\n",
       "  'country': 'France'},\n",
       " {'title': 'Family factors in schizophrenic relapse. Replication in California of British research on expressed emotion.',\n",
       "  'issue': '41(12)',\n",
       "  'pages': '1169-77',\n",
       "  'abstract': \"Our study of the emotional atmosphere of the homes of schizophrenic patients in southern California has replicated British findings concerning the influence of the family environment on the course of schizophrenia. As in the British studies, criticism and overinvolvement expressed by a key relative about the patient at the time of the key admission proved to be the best single predictor of symptomatic relapse in the nine months after discharge from the hospital. Replicating the British results, the association between relatives' expressed emotion and relapse was independent of all other variables investigated. Cross-cultural results concerning the prophylactic effects of medication suggest that clinicians should look to the emotional atmosphere in the home for explanations of medication failures.\",\n",
       "  'journal': 'Archives of general psychiatry',\n",
       "  'authors': 'Vaughn|C E|CE|;Snyder|K S|KS|;Jones|S|S|;Freeman|W B|WB|;Falloon|I R|IR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150694',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000359:Aftercare; D014150:Antipsychotic Agents; D001294:Attitude to Health; D002140:California; D003431:Cross-Cultural Comparison; D004644:Emotions; D005190:Family; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010359:Patient Readmission; D012008:Recurrence; D012107:Research Design; D012559:Schizophrenia; D012565:Schizophrenic Psychology; D012931:Social Environment; D006113:United Kingdom',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1001/archpsyc.1984.01790230055009',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Gen Psychiatry',\n",
       "  'nlm_unique_id': '0372435',\n",
       "  'issn_linking': '0003-990X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Considerations in beta-adrenergic blocker evaluation.',\n",
       "  'issue': '41(12)',\n",
       "  'pages': '1185-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Archives of general psychiatry',\n",
       "  'authors': 'Yudofsky|S|S|;Silver|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150695',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D001008:Anxiety Disorders; D006801:Humans; D001523:Mental Disorders; D010200:Panic; D011433:Propranolol',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D011433:Propranolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1001/archpsyc.1984.01790230071013',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Gen Psychiatry',\n",
       "  'nlm_unique_id': '0372435',\n",
       "  'issn_linking': '0003-990X',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Light- and electron-microscopic studies in congenital pseudarthrosis.',\n",
       "  'issue': '103(4)',\n",
       "  'pages': '269-77',\n",
       "  'abstract': 'This study presents the results of light- and electron-microscopic and enzyme histochemical investigations in ten cases of congenital pseudarthrosis of the lower limb. At the time of surgery, six of the ten patients had not been operated on previously. The characteristic histological feature of the \"sclerotic type\" of congenital pseudarthrosis was a marked fibromatous reaction consisting of cellular connective tissue. The constituent cells were arranged in bundles and had elongated nuclei. The number of nuclei per visual field was considerably higher in pathological specimens than in specimens from the uninvolved leg. In places, the histological appearance resembled somewhat that of palmar fibromatosis (Dupuytren\\'s disease). Destruction and absorption of bone were always found. Electron-microscopic analysis showed that a large number of the cells represented myofibroblasts. These findings were supported by the positive reaction of the cells for the enzyme diaminopeptidase IV, a marker enzyme for myofibroblasts [30]. As yet it is not possible to decide whether the constriction of the pseudarthritic bone is caused by a thickened myofibroblast-containing periosteum [40] or by the aggressive osteolytic component of the fibromatosis [12, 19, 41]. Furthermore, the relationship of congenital pseudarthrosis to fibrous dysplasia of bone is still unknown. Obviously, there are histological similarities between the two diseases, including the presence of osteolytic fibrous tissue in the medullary cavity and C-shaped bone trabeculae. However, the pattern of bone involvement and prognosis are different. Irrespective of the type of congenital pseudarthrosis, focal angiomatous hyperplasia was noted in some cases. This proliferation of blood vessels is most likely a reactive change.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Archives of orthopaedic and traumatic surgery. Archiv fur orthopadische und Unfall-Chirurgie',\n",
       "  'authors': 'Blauth|M|M|;Harms|D|D|;Schmidt|D|D|;Blauth|W|W|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150696',\n",
       "  'mesh_terms': 'D001842:Bone and Bones; D002648:Child; D002675:Child, Preschool; D003238:Connective Tissue; D003599:Cytoskeleton; D018819:Dipeptidyl Peptidase 4; D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D005260:Female; D005347:Fibroblasts; D006801:Humans; D007223:Infant; D008297:Male; D008854:Microscopy, Electron; D010521:Periosteum; D011542:Pseudarthrosis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004152:Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; D018819:Dipeptidyl Peptidase 4',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00387333',\n",
       "  'references': '18106747;13156228;413681;18148735;13275009;7443312;5968882;6855540;599045;6255401;13225181;7025495;4276732;15428485;14951626;5494405;1201357;13225180;14917708;4630257;7083685;13610959;1158929;4625468;14133712;13156229',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Orthop Trauma Surg',\n",
       "  'nlm_unique_id': '7803037',\n",
       "  'issn_linking': '0344-8444',\n",
       "  'country': 'Germany'},\n",
       " {'title': \"Femoro-internal carotid artery bypass for cerebral ischemia in takayasu's arteritis.\",\n",
       "  'issue': '119(12)',\n",
       "  'pages': '1426-9',\n",
       "  'abstract': \"In two patients with Takayasu's arteritis, severe cerebral ischemia was successfully treated by femoral to internal carotid artery bypass using a polytetrafluoroethylene (PTFE) graft through a subcutaneous tunnel. All of the arch branches were critically stenotic or occluded in both patients. The entire thoracic aorta was affected by the active inflammation process in one patient and there was marked calcification in the other patient. In these situations we hesitate to use the thoracic aorta as the donor site of bypass. Considering that Takayasu's arteritis affects the thoracic aorta and the proximal portions of its branches, the femoro-internal carotid artery bypass can be constructed without involving severely diseased vessels and can be expected to result in good cerebral revascularization.\",\n",
       "  'journal': 'Archives of surgery (Chicago, Ill. : 1960)',\n",
       "  'authors': 'Yamamoto|S|S|;Nozawa|T|T|;Aoki|H|H|;Isobe|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150697',\n",
       "  'mesh_terms': 'D000328:Adult; D001015:Aortic Arch Syndromes; D001167:Arteritis; D002343:Carotid Artery, Internal; D005260:Female; D005263:Femoral Artery; D006801:Humans; D002546:Ischemic Attack, Transient; D008875:Middle Aged; D013625:Takayasu Arteritis',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1001/archsurg.1984.01390240064011',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Surg',\n",
       "  'nlm_unique_id': '9716528',\n",
       "  'issn_linking': '0004-0010',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Clinical and morphological manifestations of the pathomorphosis of periarteritis nodosa].',\n",
       "  'issue': '46(10)',\n",
       "  'pages': '26-31',\n",
       "  'abstract': \"Clinical, immunological, morphological and immunomorphological data are provided showing the presence of induced (therapeutic) pathomorphosis in Kussmaul-Meier's disease. The conclusion is drawn that at present periarteritis nodosa is characterized by a chronic course with a domination of productive (immunocellular) vasculitis over necrotic (immunocomplex) vasculitis. It is shown that modern polychemotherapy of Kussmaul-Meier's disease favours mainly the correction of humoral immunity alterations while the pathology of cell immunity is retained. It is noted that long interruptions in therapy result in a reversion of the clinical-anatomical manifestations of periarteritis nodosa.\",\n",
       "  'journal': 'Arkhiv patologii',\n",
       "  'authors': 'Iarygin|N E|NE|;Shilkina|N P|NP|;Romanov|V A|VA|;Panchenko|S V|SV|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150698',\n",
       "  'mesh_terms': 'D000917:Antibody Formation; D002908:Chronic Disease; D006651:Histocytochemistry; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D007136:Immunoglobulins; D007958:Leukocyte Count; D008214:Lymphocytes; D010488:Polyarteritis Nodosa',\n",
       "  'publication_types': 'D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D007136:Immunoglobulins',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arkh Patol',\n",
       "  'nlm_unique_id': '0370604',\n",
       "  'issn_linking': '0004-1955',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Stereological analysis of the nonspecific endocytotic uptake of lipoproteins by aortic endothelium in the initial stages of experimental atherosclerosis in rabbits].',\n",
       "  'issue': '46(10)',\n",
       "  'pages': '36-42',\n",
       "  'abstract': 'Stereological analysis of vesicular transport of low density lipoproteins was performed by electronograms of the aorta endothelium from 42 rabbits in the course of experimental hypercholesterolemia. It was shown that nonspecific endocytosis was activated 1,6 times as compared to control and in some areas of endothelium up to 5-6 times at early stages of experimental hypercholesterolemia.',\n",
       "  'journal': 'Arkhiv patologii',\n",
       "  'authors': 'Bobryshev|Iu V|IuV|;Nagornev|V A|VA|;Klimov|A N|AN|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150699',\n",
       "  'mesh_terms': 'D000818:Animals; D001011:Aorta; D001161:Arteriosclerosis; D001692:Biological Transport; D004705:Endocytosis; D011992:Endosomes; D004727:Endothelium; D006937:Hypercholesterolemia; D008077:Lipoproteins, LDL; D008854:Microscopy, Electron; D011817:Rabbits; D013997:Time Factors',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D008077:Lipoproteins, LDL',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arkh Patol',\n",
       "  'nlm_unique_id': '0370604',\n",
       "  'issn_linking': '0004-1955',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Beta-adrenoceptor blocking agents and their effects on heart and blood vessels.',\n",
       "  'issue': '42(4)',\n",
       "  'pages': '237-42',\n",
       "  'abstract': '',\n",
       "  'journal': 'Arquivos brasileiros de cardiologia',\n",
       "  'authors': 'Clark|B J|BJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150700',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000818:Animals; D001665:Binding Sites; D002302:Cardiac Output; D002415:Cats; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D006339:Heart Rate; D006439:Hemodynamics; D006801:Humans; D009200:Myocardial Contraction; D010869:Pindolol; D011433:Propranolol; D013318:Stroke Volume',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D011433:Propranolol; D010869:Pindolol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arq Bras Cardiol',\n",
       "  'nlm_unique_id': '0421031',\n",
       "  'issn_linking': '0066-782X',\n",
       "  'country': 'Brazil'},\n",
       " {'title': 'Sensorineural hearing loss associated with ulcerative colitis. A case report.',\n",
       "  'issue': '110(12)',\n",
       "  'pages': '810-2',\n",
       "  'abstract': 'Autoimmune sensorineural hearing loss was first described in 1979. This may be secondary to a systemic autoimmune disease, or in some cases, to a direct autoimmune insult to the labyrinth. A case of active ulcerative colitis and progressive sensorineural hearing loss responded to corticosteroid therapy.',\n",
       "  'journal': 'Archives of otolaryngology (Chicago, Ill. : 1960)',\n",
       "  'authors': 'Weber|R S|RS|;Jenkins|H A|HA|;Coker|N J|NJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150701',\n",
       "  'mesh_terms': 'D001327:Autoimmune Diseases; D003093:Colitis, Ulcerative; D003181:Complement C4; D003602:Cytotoxicity, Immunologic; D006319:Hearing Loss, Sensorineural; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D008214:Lymphocytes; D008297:Male; D008875:Middle Aged; D012460:Sulfasalazine',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D003181:Complement C4; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D012460:Sulfasalazine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1001/archotol.1984.00800380040011',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arch Otolaryngol',\n",
       "  'nlm_unique_id': '0376526',\n",
       "  'issn_linking': '0003-9977',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Immunohistochemical demonstration of somatostatin in the pancreas of fetal and adult sheep.',\n",
       "  'issue': '37(1-2)',\n",
       "  'pages': '25-9',\n",
       "  'abstract': 'Pancreatic cells immunoreactive with rabbit anti-somatostatin serum were demonstrated in fetal and adult sheep by immunofluorescence histochemistry. Our observations provide evidence that in the sheep the pancreas is a major site of production of the hormone. It is suggested that the hormone may be important in modulating intra- and extra-islet function.',\n",
       "  'journal': 'Australian journal of biological sciences',\n",
       "  'authors': 'Reddy|S|S|;Oliver|J R|JR|;Elliott|R B|RB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150702',\n",
       "  'mesh_terms': 'D000818:Animals; D005260:Female; D005455:Fluorescent Antibody Technique; D006651:Histocytochemistry; D007120:Immunochemistry; D010179:Pancreas; D011247:Pregnancy; D012756:Sheep; D013004:Somatostatin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D013004:Somatostatin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Aust J Biol Sci',\n",
       "  'nlm_unique_id': '0370613',\n",
       "  'issn_linking': '0004-9417',\n",
       "  'country': 'Australia'},\n",
       " {'title': 'Questionnaire dimensions of spider phobia.',\n",
       "  'issue': '22(5)',\n",
       "  'pages': '575-80',\n",
       "  'abstract': '',\n",
       "  'journal': 'Behaviour research and therapy',\n",
       "  'authors': 'Watts|F N|FN|;Sharrock|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150703',\n",
       "  'mesh_terms': 'D000818:Animals; D003887:Desensitization, Psychologic; D006801:Humans; D010698:Phobic Disorders; D011581:Psychological Tests; D013112:Spiders',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0005-7967(84)90061-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Behav Res Ther',\n",
       "  'nlm_unique_id': '0372477',\n",
       "  'issn_linking': '0005-7967',\n",
       "  'country': 'England'},\n",
       " {'title': 'Preparation of analogues of NAD+ as substrates for a sensitive fluorimetric assay of nucleotide pyrophosphatase.',\n",
       "  'issue': '223(3)',\n",
       "  'pages': '715-21',\n",
       "  'abstract': '1,N6-Etheno derivatives of pyridine analogues of NAD+ were synthesized, characterized and tested as substrates for a fluorimetric assay of nucleotide pyrophosphatase (EC 3.6.1.9). Upon cleavage of their pyrophosphate bond, the fluorescence of pyridine-1,N6-ethenoadenine dinucleotide (epsilon PdAD+) and of 4-hydrazinocarbonyl-pyridine-1,N6-ethenoadenine dinucleotide (epsilon hy4PdAD+) increased respectively 15-and 73-fold, at pH 7.4. This property allows a convenient steady-state assay of nucleotide pyrophosphatase by continuous monitoring of reaction progress. Both compounds were good substrates of this class of enzyme. The relative insensitivity of the fluorescence of epsilon PdAD+ and epsilon hy4PdAD+ to pH changes allowed assays under conditions preserving cellular integrity. epsilon PdAD+ is useful as a substrate for measuring nucleotide pyrophosphatase activity on the outside of mammalian cells because it is not a substrate for the external NAD+ glycohydrolase. epsilon Hy4PdAD+ proved useful when high sensitivity was needed.',\n",
       "  'journal': 'The Biochemical journal',\n",
       "  'authors': 'Muller|C D|CD|;Tarnus|C|C|;Schuber|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150704',\n",
       "  'mesh_terms': 'D000227:Adenine Nucleotides; D002851:Chromatography, High Pressure Liquid; D005470:Fluorometry; D006868:Hydrolysis; D009243:NAD; D011755:Pyrophosphatases; D013053:Spectrophotometry',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000227:Adenine Nucleotides; D009243:NAD; C043655:pyridine 1,N(6)-ethenoadenine dinucleotide; C043656:4-hydrazinocarbonylpyridine-1,N(6)-ethenoadenine dinucleotide; D011755:Pyrophosphatases; C021899:nucleotide pyrophosphatase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1042/bj2230715',\n",
       "  'references': '4361750;4360250;241012;172889;815087;8110;187174;212424;6997723;6109518;6121793;6126430;6127995;6299131;6192807;13192100;13357477;13785321;4384461;4319696;4340748;4340904;4403504;4352059;1149736',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem J',\n",
       "  'nlm_unique_id': '2984726R',\n",
       "  'issn_linking': '0264-6021',\n",
       "  'country': 'England'},\n",
       " {'title': 'Binding kinetics of PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human platelets.',\n",
       "  'issue': '223(3)',\n",
       "  'pages': '901-9',\n",
       "  'abstract': 'The binding of [3H]PAF-acether (1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine) to intact human gel-filtered platelets was measured at 22 degrees C. Specific binding reached saturation within 15 min at high doses of [3H]PAF-acether (0.5-0.9 nM), whereas about 90 min were required when low doses (0.02-0.5 nM) were used. Above 1 nM, [3H]PAF-acether non-specific binding increased progressively, which together with the demonstration of a 3H-labelled metabolite suggested uptake and metabolism of [3H]PAF-acether. Equilibrium analysis revealed one class of specific receptors with a Ka of 18.86 +/- 4.82 X 10(9) M-1 and 242 +/- 64 binding sites per platelet. Non-equilibrium binding revealed a similar Ka (16.87 X 10(9) M-1). Specific binding became irreversible after prolonged incubation, a process that was enhanced at increasing concentrations of [3H]PAF-acether. Platelets made desensitized to PAF-acether by prior incubation with unlabelled PAF-acether failed to bind a second dose of PAF-acether (3H-labelled), suggesting that desensitization resulted from loss of available binding sites. Under the conditions of the binding studies, PAF-acether induced exposure of the fibrinogen receptor, aggregation (in a stirred suspension) and alterations in (poly)-phosphatidylinositides. These results suggest that PAF-acether initiates platelet responses via receptor-mediated processes.',\n",
       "  'journal': 'The Biochemical journal',\n",
       "  'authors': 'Kloprogge|E|E|;Akkerman|J W|JW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150705',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D001665:Binding Sites; D001792:Blood Platelets; D002118:Calcium; D002850:Chromatography, Gel; D005340:Fibrinogen; D006801:Humans; D007700:Kinetics; D010716:Phosphatidylinositols; D010972:Platelet Activating Factor; D010974:Platelet Aggregation; D011485:Protein Binding',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D010716:Phosphatidylinositols; D010972:Platelet Activating Factor; D005340:Fibrinogen; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1042/bj2230901',\n",
       "  'references': '5432063;4102401;4936093;5061935;4118412;59550;335211;567240;372237;489536;7350149;6987890;7373056;121258;7437025;6256372;7006608;6938950;7223864;6267133;7023317;7295320;6271236;7037068;6279627;6804126;6286773;7118885;7146619;7164036;6403793;6838557;6406629;6222507;6860678;6870274;6413803;6313047;13671378',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem J',\n",
       "  'nlm_unique_id': '2984726R',\n",
       "  'issn_linking': '0264-6021',\n",
       "  'country': 'England'},\n",
       " {'title': 'Glutamic acid and glutamine levels in serum and cerebrospinal fluid in hepatic encephalopathy.',\n",
       "  'issue': '32(2)',\n",
       "  'pages': '225-31',\n",
       "  'abstract': 'Significant elevation of glutamic acid and glutamine concentrations in CSF was observed in hepatic encephalopathic patients with fulminant hepatitis and liver cirrhosis. However, the ratios of CSF glutamic acid to CSF glutamine levels and of CSF to serum glutamic acid and glutamine levels were significantly higher only in cirrhotic patients with hepatic encephalopathy. CSF glutamine levels were positively correlated with blood ammonia and CSF tyrosine levels in cirrhotic patients. The results indicate that CSF glutamic acid and glutamine levels are important tools in diagnosing hepatic encephalopathy in severe liver disease.',\n",
       "  'journal': 'Biochemical medicine',\n",
       "  'authors': 'Watanabe|A|A|;Takei|N|N|;Higashi|T|T|;Shiota|T|T|;Nakatsukasa|H|H|;Fujiwara|M|M|;Sakata|T|T|;Nagashima|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150706',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000641:Ammonia; D005260:Female; D005971:Glutamates; D018698:Glutamic Acid; D005973:Glutamine; D006501:Hepatic Encephalopathy; D006505:Hepatitis; D006801:Humans; D008103:Liver Cirrhosis; D008297:Male; D008875:Middle Aged; D014443:Tyrosine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005971:Glutamates; D005973:Glutamine; D018698:Glutamic Acid; D014443:Tyrosine; D000641:Ammonia',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-2944(84)90076-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Med',\n",
       "  'nlm_unique_id': '0151424',\n",
       "  'issn_linking': '0006-2944',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Desensitization of beta-adrenergic receptor-coupled adenylate cyclase activity. Differences following exposure of cells to two full agonists.',\n",
       "  'issue': '33(22)',\n",
       "  'pages': '3579-84',\n",
       "  'abstract': 'The effects on the beta-adrenergic receptors of intact L6 muscle cells of exposure to agonists were investigated. Treatment of cells with isoproterenol decreased GTP-, isoproterenol-, and zinterol-stimulated adenylate cyclase activities, whereas exposure of cells to zinterol decreased only isoproterenol- and zinterol-stimulated activities. Although the effects of these two full agonists on GTP-stimulated adenylate cyclase activity were different, the time courses for development and reversal of the effects were similar. The decrease in agonist-stimulated adenylate cyclase activity observed in membranes prepared from cells previously exposed to isoproterenol or zinterol was due to both an increase in the concentration of agonist required for half-maximal activation and a decrease in the maximum level of activation. No effects on fluoride- or manganese-stimulated activities were observed following exposure of cells to either agonist. Decreases in GTP-stimulated adenylate cyclase activity were also observed following exposure of cells to epinephrine, Cc-25, fenoterol, norepinephrine, terbutaline, or metaproterenol, but not following incubation of cells with dobutamine or salmefamol. The results suggest that full agonists interacting with the same receptor can induce different changes in the components of the adenylate cyclase system. Desensitization following exposure to zinterol may result from modification of the receptor, whereas that following exposure to isoproterenol may be due to alterations in both the guanine nucleotide-binding protein and the receptor.',\n",
       "  'journal': 'Biochemical pharmacology',\n",
       "  'authors': 'Pittman|R N|RN|;Rabin|R A|RA|;Molinoff|P B|PB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150707',\n",
       "  'mesh_terms': 'D000262:Adenylyl Cyclases; D000318:Adrenergic beta-Agonists; D000818:Animals; D002460:Cell Line; D002462:Cell Membrane; D004983:Ethanolamines; D006165:Guanylyl Imidodiphosphate; D007545:Isoproterenol; D007700:Kinetics; D009132:Muscles; D011943:Receptors, Adrenergic, beta',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D004983:Ethanolamines; D011943:Receptors, Adrenergic, beta; D006165:Guanylyl Imidodiphosphate; C002904:zinterol; D000262:Adenylyl Cyclases; D007545:Isoproterenol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-2952(84)90140-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Pharmacol',\n",
       "  'nlm_unique_id': '0101032',\n",
       "  'issn_linking': '0006-2952',\n",
       "  'country': 'England'},\n",
       " {'title': 'Differences in the interaction of histamine H2 receptor antagonists and tricyclic antidepressants with adenylate cyclase from guinea pig gastric mucosa.',\n",
       "  'issue': '33(22)',\n",
       "  'pages': '3621-5',\n",
       "  'abstract': 'The interaction of adenylate cyclase with histamine H2 receptor agents and with tricyclic antidepressants was studied in guinea pig gastric mucosal membranes. The H2 receptor antagonist tiotidine acted as a competitive inhibitor of histamine-stimulated adenylate cyclase. The tricyclic antidepressants imipramine and amitryptyline were also competitive inhibitors. The dissociation constant of imipramine was the same whether histamine or dimaprit was used to activate the enzyme. In membrane preparations that had been stored frozen, there was a marked increase in the concentration of histamine or dimaprit required to cause half-maximal enzyme stimulation, and the dissociation constants of some classical H2 receptor antagonists were greatly increased. In contrast, the dissociation constants of the antidepressants were either unchanged or decreased. These results suggest that antidepressants are potent blockers of H2 receptors in gastric mucosal membranes, but there are differences between antidepressants and classical H2 receptor antagonists in their interaction with H2 receptors.',\n",
       "  'journal': 'Biochemical pharmacology',\n",
       "  'authors': 'Tsai|B S|BS|;Yellin|T O|TO|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150708',\n",
       "  'mesh_terms': 'D000262:Adenylyl Cyclases; D000818:Animals; D000929:Antidepressive Agents, Tricyclic; D002462:Cell Membrane; D017259:Dimaprit; D005748:Gastric Fundus; D005753:Gastric Mucosa; D006168:Guinea Pigs; D006632:Histamine; D006635:Histamine H2 Antagonists; D007488:Iprindole; D007700:Kinetics; D011970:Receptors, Histamine H2; D013890:Thiourea',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000929:Antidepressive Agents, Tricyclic; D006635:Histamine H2 Antagonists; D011970:Receptors, Histamine H2; D007488:Iprindole; D006632:Histamine; D000262:Adenylyl Cyclases; D013890:Thiourea; D017259:Dimaprit',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-2952(84)90147-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Pharmacol',\n",
       "  'nlm_unique_id': '0101032',\n",
       "  'issn_linking': '0006-2952',\n",
       "  'country': 'England'},\n",
       " {'title': 'Relationship between inductions of monooxygenase activity and gamma-glutamyltranspeptidase in rat hepatocyte primary cultures.',\n",
       "  'issue': '33(23)',\n",
       "  'pages': '3839-45',\n",
       "  'abstract': 'The proposition that changes in activity of gamma-glutamyltranspeptidase (GGT) in serum may provide a useful index of the extent of induction of liver drug-metabolizing enzymes by various drugs was examined by comparing control of GGT and monooxygenase activities in cultured hepatocytes. In rat hepatocyte monolayers maintained for up to 5 days the effects of xenobiotics and other factors on cellular GGT activity were compared with effects on a relatively broad measure of drug metabolism, the 7-ethoxycoumarin O-deethylase (ECD) activity of intact cells. A diverse group of drugs including phenobarbital and other barbiturates, diphenylhydantoin, glutethimide, aminopyrine and griseofulvin and the steroids dexamethasone and pregnenolone 16 alpha-carbonitrile were shown to induce both GGT and ECD under comparable culture conditions. Inductions of both activities were potentiated by glucocorticoids and depressed (where tested) by dibutyryl cyclic AMP. Some other hormones or nutrients modulated the activities differently. The magnitude of GGT induction by different drugs did not correlate with relative ECD induction and for several drugs the concentration-dependence of the two effects was different. Interpretation is complicated by the possible contribution of multiple forms of cytochrome P-450 to ECD activity but it seems unlikely that drugs which induce both GGT and drug metabolism do so via a common regulatory mechanism. For such drugs changes in serum GGT could provide only a crude guide to likely changes in drug metabolism. Some compounds including polycyclic hydrocarbons and warfarin induced ECD but had no associated effect on GGT in hepatocytes.',\n",
       "  'journal': 'Biochemical pharmacology',\n",
       "  'authors': 'Edwards|A M|AM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150709',\n",
       "  'mesh_terms': 'D000818:Animals; D003994:Bucladesine; D002478:Cells, Cultured; D003513:Cycloheximide; D003907:Dexamethasone; D007700:Kinetics; D008099:Liver; D008297:Male; D006899:Mixed Function Oxygenases; D009536:Niacinamide; D010634:Phenobarbital; D011285:Pregnenolone Carbonitrile; D051381:Rats; D011919:Rats, Inbred Strains; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D011285:Pregnenolone Carbonitrile; D009536:Niacinamide; D003994:Bucladesine; D003907:Dexamethasone; D003513:Cycloheximide; D006899:Mixed Function Oxygenases; D005723:gamma-Glutamyltransferase; D010634:Phenobarbital',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-2952(84)90049-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Pharmacol',\n",
       "  'nlm_unique_id': '0101032',\n",
       "  'issn_linking': '0006-2952',\n",
       "  'country': 'England'},\n",
       " {'title': 'Direct and indirect effects of sulfhydryl blocking agents on agonist and antagonist binding to central alpha 1- and alpha 2-adrenoceptors.',\n",
       "  'issue': '33(24)',\n",
       "  'pages': '3923-8',\n",
       "  'abstract': 'The effects of p-chloromercuribenzoate and N-ethylmaleimide were evaluated on the binding of (3H)-p-aminoclonidine, (3H)-rauwolscine and (3H)-prazosin on rat brain alpha-adrenergic receptors. Pretreatment of the particulate fraction with increasing concentrations of p-chloromercuribenzoate indicated that the binding of all three radioligands was similarly inhibited with an IC50 of about 30 microM. This effect was then reduced when agonist [(-)-norepinephrine] or antagonist (phentolamine) were present during the pretreatment. Pretreatment of the particulate fraction at N-ethylmaleimide concentrations less than 100 microM specifically decreased the (3H)-p-aminoclonidine binding while binding of antagonist was unchanged. N-ethylmaleimide produced binding changes similar to those induced by GTP in control membranes, i.e. interconversion of the alpha 2-adrenoceptors states from a high affinity to a low affinity for agonists. Norepinephrine but not phentolamine reduced the effects of N-ethylmaleimide when present during the pretreatment. Taken together, these results suggest that the alpha 1- and alpha 2-adrenoceptors possess, within or close by the recognition site, an --SH group which can be blocked at low concentrations by p-chloromercuribenzoate but not by N-ethylmaleimide. In contrast, the group alkylated by the latter does not seem to be located in the recognition site domain but rather at a site important for the coupling between the alpha 2-receptor and the GTP-binding protein.',\n",
       "  'journal': 'Biochemical pharmacology',\n",
       "  'authors': 'Quennedey|M C|MC|;Bockaert|J|J|;Rouot|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150710',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001921:Brain; D002729:Chloromercuribenzoates; D005033:Ethylmaleimide; D006160:Guanosine Triphosphate; D066298:In Vitro Techniques; D008297:Male; D011869:Radioligand Assay; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha; D013439:Sulfhydryl Reagents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000317:Adrenergic alpha-Antagonists; D002729:Chloromercuribenzoates; D011942:Receptors, Adrenergic, alpha; D013439:Sulfhydryl Reagents; D006160:Guanosine Triphosphate; D005033:Ethylmaleimide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-2952(84)90002-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Pharmacol',\n",
       "  'nlm_unique_id': '0101032',\n",
       "  'issn_linking': '0006-2952',\n",
       "  'country': 'England'},\n",
       " {'title': 'Alpha-adrenergic potentiation of beta-adrenergic stimulation of rat pineal N-acetyltransferase. Studies using cirazoline and fluorine analogs of norepinephrine.',\n",
       "  'issue': '33(24)',\n",
       "  'pages': '3947-50',\n",
       "  'abstract': 'Recent evidence indicates that melatonin production is controlled by norepinephrine acting via alpha 1-and beta 1-adrenoceptors on pinealocytes; activation of alpha 1-adrenoceptors appears to potentiate the effects of beta 1-adrenoceptor activation. However, alpha-adrenergic potentiation of beta 1-adrenergic activation has been demonstrated with only one alpha-adrenergic agonist. For this reason, this issue was reinvestigated using two other alpha-adrenergic agonists, 6-fluoronorepinephrine and cirazoline. Both compounds, which were found to have a high affinity for pineal alpha 1-adrenoceptors, potentiated the stimulatory effects of isoproterenol on pineal N-acetyltransferase. 6-Fluoronorepinephrine also potentiated the stimulation of N-acetyltransferase activity produced by another beta-adrenergic agonist, 2-fluoronorepinephrine. These findings support the hypothesis that pineal N-acetyltransferase activity is regulated by norepinephrine acting through both alpha 1- and beta 1-adrenoceptors.',\n",
       "  'journal': 'Biochemical pharmacology',\n",
       "  'authors': 'Sugden|D|D|;Weller|J L|JL|;Klein|D C|DC|;Kirk|K L|KL|;Creveling|C R|CR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150711',\n",
       "  'mesh_terms': 'D000123:Acetyltransferases; D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D000818:Animals; D004357:Drug Synergism; D007093:Imidazoles; D066298:In Vitro Techniques; D008297:Male; D009638:Norepinephrine; D010870:Pineal Gland; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D007093:Imidazoles; D011942:Receptors, Adrenergic, alpha; C024884:6-fluoronorepinephrine; D000123:Acetyltransferases; C014282:cirazoline; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-2952(84)90006-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Pharmacol',\n",
       "  'nlm_unique_id': '0101032',\n",
       "  'issn_linking': '0006-2952',\n",
       "  'country': 'England'},\n",
       " {'title': 'Beta adrenoceptors of human red blood cells, determination of their subtypes.',\n",
       "  'issue': '33(24)',\n",
       "  'pages': '4045-50',\n",
       "  'abstract': \"The characteristics of beta adrenergic receptors of human erythrocyte membranes were investigated using (-)125iodocyanopindolol as a radioligand. Inhibition of (-)125iodocyanopindolol specific binding was checked using either atenolol and metoprolol as beta 1 selective antagonists or ICI 118551 and IPS 339 as beta 2 selective antagonists. The results showed non linear Hofstee's plots suggesting that both beta 1 and beta 2 adrenergic receptors are present. Analysis of the data yielded a beta 1/beta 2 adrenergic receptor ratio of approximately 33/67. Thus it is concluded that beta 2 subtype is predominant on human erythrocyte membranes.\",\n",
       "  'journal': 'Biochemical pharmacology',\n",
       "  'authors': \"Bree|F|F|;Gault|I|I|;d'Athis|P|P|;Tillement|J P|JP|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150712',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D004912:Erythrocytes; D006801:Humans; D020120:Iodocyanopindolol; D007700:Kinetics; D010869:Pindolol; D011869:Radioligand Assay; D011943:Receptors, Adrenergic, beta',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D020120:Iodocyanopindolol; D010869:Pindolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-2952(84)90019-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochem Pharmacol',\n",
       "  'nlm_unique_id': '0101032',\n",
       "  'issn_linking': '0006-2952',\n",
       "  'country': 'England'},\n",
       " {'title': '[Conformation characteristics of gamma-glutamyl-containing peptides].',\n",
       "  'issue': '9(8)',\n",
       "  'pages': '1013-20',\n",
       "  'abstract': 'Conformational analysis, by the method of atom-atomic potentials, has been carried out for five tripeptides containing gamma-glutamyl bonds and having general formula Glu(gamma)-X-Gly. The spatial structures have been determined and the changes arising on varying the second residue have been analyzed. A comparison of possible conformations and biological activity in respect to a number of enzymes allows to conceive what structural features of these compounds are important for the substrate specificity of the enzymes. In particular, the active site topography has been surmised for glutathione synthetase (EC 6.3.2.3) and gamma-glutamyltranspeptidase (EC 2.3.2.2). The glutathione thiol group has been found to be exposed in all possible conformations that explains its accessibility for various reagents.',\n",
       "  'journal': 'Bioorganicheskaia khimiia',\n",
       "  'authors': 'Sandalova|T P|TP|;Belobrov|P I|PI|',\n",
       "  'pubdate': '1983',\n",
       "  'pmid': '6150713',\n",
       "  'mesh_terms': 'D001665:Binding Sites; D004151:Dipeptides; D005978:Glutathione; D005981:Glutathione Synthase; D009842:Oligopeptides; D011487:Protein Conformation; D013237:Stereoisomerism; D013379:Substrate Specificity; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D004151:Dipeptides; D009842:Oligopeptides; D005723:gamma-Glutamyltransferase; D005981:Glutathione Synthase; D005978:Glutathione; C017341:gamma-glutamylcysteine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Bioorg Khim',\n",
       "  'nlm_unique_id': '7804941',\n",
       "  'issn_linking': '0132-3423',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Maternal and fetal hemodynamics under simultaneous beta stimulation and beta1 blockade in a tocolysis model. Considerations on status of the neonatal beta receptor and transplacental passage of metoprolol].',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '1025-30',\n",
       "  'abstract': 'This report summarizes the clinical experiences in the treatment of preterm labor using the combination of hexoprenaline and the beta 1-antagonist metoprolol. We found a dose dependency in the antagonism of positive inotropic effects primarily induced by the beta-stimulator hexoprenaline. To verify the pharmacological properties of metoprolol in transplacental passage we evaluated the plasma concentration of metoprolol in umbilical cord blood. There is quite a low concentration of the beta-blocker nearly 24 h after the last course of administration. The beta 2-receptor density--determined by (+/-)-125-iodocyanopindolol (ICYP) binding--and beta 2-receptor responsiveness--assessed by cyclic AMP response to isoprenaline stimulation--in lymphocytes derived from neonatal blood were also investigated. These results were compared with identical investigations in adult lymphocytes. The results indicate that in neonates beta 2-receptor density and responsiveness is significantly diminished in comparison to the adult controls. The present investigations induce a new concept for the estimation of concomitant fetal cardiovascular reactions under maternal beta-blockade.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Siekmann|U|U|;Heilmann|L|L|;Brodde|O E|OE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150714',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D000328:Adult; D000242:Cyclic AMP; D005260:Female; D005312:Fetal Blood; D005333:Fetus; D006439:Hemodynamics; D006594:Hexoprenaline; D006801:Humans; D007231:Infant, Newborn; D008431:Maternal-Fetal Exchange; D008790:Metoprolol; D007752:Obstetric Labor, Premature; D010920:Placenta; D011247:Pregnancy; D011943:Receptors, Adrenergic, beta; D013997:Time Factors',\n",
       "  'publication_types': \"D004740:English Abstract; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D000319:Adrenergic beta-Antagonists; D011943:Receptors, Adrenergic, beta; D000242:Cyclic AMP; D006594:Hexoprenaline; D008790:Metoprolol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Effect of nisoldipine on electrophysiological parameters in patients pretreated with beta-blockers.',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '1035-7',\n",
       "  'abstract': 'The effect of the new 1,4-dihydropyridine calcium antagonist nisoldipine on electrophysiological parameters was investigated in 10 patients who were pretreated with a beta-blocker. 9 patients received atenolol (75 mg/d) and 1 patient pindolol (15 mg/d) at least for three days prior to the electro-physiological study. Before and after the intravenous injection of nisoldipine (1.5 micrograms/kg body weight) the sinus node function (spontaneous sinus node cycle length, sinus node recovery time, rate corrected sinus node recovery time), the conduction times from the high right atrium to the apex of the right ventricle, and the refractoriness of the different compartments of the heart were assessed. Arterial blood pressure was measured with the cuff method. Nisoldipine induced a slight but significant increase of the heart rate without effecting the blood pressure significantly. All other measured electrophysiological parameters remained unaltered, especially the conduction time of the av node. It is concluded that concerning electrophysiology nisoldipine can safely be combined with beta-blockers because this calcium antagonist does not exert an electrophysiological effect.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Klein|H H|HH|;Schwarck|H|H|;Rauschning|W|W|;Kreuzer|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150715',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D001794:Blood Pressure; D006328:Cardiac Catheterization; D003327:Coronary Disease; D004594:Electrophysiology; D005260:Female; D006329:Heart Conduction System; D006801:Humans; D008297:Male; D008875:Middle Aged; D009543:Nifedipine; D015737:Nisoldipine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D015737:Nisoldipine; D009543:Nifedipine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[The somatostatin infusion test for the evaluation of glucose utilization in bezafibrate medication].',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '1038-41',\n",
       "  'abstract': 'The utilisation of blood glucose may be used for definition of insulin resistance in type II diabetes mellitus. To evaluate this possibility we adapted an infusion test of somatostatin in 10 normal persons (age 26 +/- 3 years, relative body weight 26 +/- 10% according to Broca) in a randomized cross-over therapy with bezafibrate (3 X 200 mg/die). As the coefficient of variation (VC) of measured blood glucose continuously increased the best time of a steady state was between 90 and 130 min after beginning the infusion (mean VC 8.9%). While insulin remained nearly constant (41 (45; 38) microU/ml) blood glucose dropped by about 14% and reached a steady state of 89 (134; 45) mg/dl. During the therapy of bezafibrate blood glucose was significantly decreased by 36% 130 min after beginning the infusion. Although the effect was not significant during the whole time of the steady state it became evident by a negative correlation with lactate (r = -0.687) and pyruvate (r = -0.843). A correlation with a concomitant decrease of triglyceride and cholesterol also induced by bezafibrate could not be proven. The results show that the infusion test of somatostatin is fitted to measure a steady state of blood glucose and insulin and that it is possible by this technique to quantify a changed utilisation of blood glucose induced by specific therapy.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Vogelberg|K H|KH|;Müller|H J|HJ|;Hübinger|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150716',\n",
       "  'mesh_terms': 'D000328:Adult; D001629:Bezafibrate; D001786:Blood Glucose; D002096:C-Peptide; D003924:Diabetes Mellitus, Type 2; D005934:Glucagon; D006801:Humans; D007328:Insulin; D007333:Insulin Resistance; D013004:Somatostatin; D013997:Time Factors',\n",
       "  'publication_types': 'D016430:Clinical Trial; D004740:English Abstract; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D002096:C-Peptide; D007328:Insulin; D013004:Somatostatin; D005934:Glucagon; D001629:Bezafibrate',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Comparative study of the effect of famotidine and cimetidine on antipyrine pharmacokinetics in the human].',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '1041-2',\n",
       "  'abstract': 'In a randomized order the pharmacokinetics of antipyrine were studied following a 5 days treatment period with placebo, 1000 mg cimetidine and 40 mg famotidine daily, respectively in 7 healthy volunteers. In contrast to cimetidine, famotidine did not significantly affect the disposition of antipyrine in these subjects. Famotidine like the other guanidino-thiazole containing compound tiotidine appears to be free from this unwanted effect on drug metabolism in the liver.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Staiger|C|C|;Koroknay|B|B|;DeVries|J X|JX|;Weber|E|E|;Müller|P|P|;Simon|B|B|;Dammann|H G|HG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150717',\n",
       "  'mesh_terms': 'D000328:Adult; D000983:Antipyrine; D002927:Cimetidine; D015738:Famotidine; D005260:Female; D006634:Histamine H1 Antagonists; D006801:Humans; D007700:Kinetics; D008297:Male; D013844:Thiazoles',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D004740:English Abstract; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D006634:Histamine H1 Antagonists; D013844:Thiazoles; D015738:Famotidine; D002927:Cimetidine; D000983:Antipyrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Cytoprotection by somatostatin of normal and malignant clonogenic cells against the in vitro cytotoxicity of bischloroethylnitrosourea (BCNU).',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '939-43',\n",
       "  'abstract': 'The various pharmacological effects of somatostatin may be explained by the hypothesis that the paracrine peptide, by \"stabilizing\" cell membranes, inhibits the secretion of hormones as well as protects other cells (vascular endothelium, parenchyma) from different lesions (vasculo-, organo-, cytoprotection). This hypothesis was tested in vitro, using bischloroethyl-nitrosourea (BCNU)-intoxicated stem cells of normal mouse granulopoiesis and of the L 1210 leukemia. Clonogenic mouse bone marrow and L 1210 cells were grown in agar-containing glass capillaries. Using these colony assays and a ID90 of BCNU, cyclic somatostatin influenced the BCNU-cytotoxicity neither at simultaneous nor at subsequent application. However, when given 2 h prior to BCNU, the inhibition of colony growth was almost totally abolished. This cytoprotective effect was seen with normal granulopoietic as well as with leukemic cells. The effect did not show up, if the inactive linear somatostatin was used. N-acetyl-cysteine, a SH-compound applied as a chemoprotective adjunct, did not reveal a cytoprotective effect under identical experimental conditions, either. The results were discussed in view of common efforts to reduce the toxicity of cancer chemotherapy.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Maurer|H R|HR|;Meckert|C|C|;Ali-Osman|F|F|;Musil|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150718',\n",
       "  'mesh_terms': 'D000111:Acetylcysteine; D000818:Animals; D002330:Carmustine; D002470:Cell Survival; D002478:Cells, Cultured; D002999:Clone Cells; D006098:Granulocytes; D007939:Leukemia L1210; D051379:Mice; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013004:Somatostatin; D002330:Carmustine; D000111:Acetylcysteine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Synthesis of some substituted benzodiazepines as possible CNS depressant drugs.',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '943-5',\n",
       "  'abstract': 'A new series of 2,3-cyclopentano-3,4-dihydro-4-spirocyclopentano-1,5-benzodi azepine which are substituted in 5-position with beta-N-heterocycloethyl or gamma-N-heterocyclo-n-propyl groups have been synthesized and evaluated for their CNS depressant activity including anticonvulsant, analgesic and pentobarbital induced hypnosis. These compounds were also investigated for their ability to inhibit in vitro succinate dehydrogenase (SDH). In most of the compounds an appreciable CNS depressant activity has been found to be associated with the compounds possessing good SDH inhibitory activity. Low toxicity of these compounds was reflected by their high approximate LD50 values.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Dhasmana|A|A|;Mehrotra|S|S|;Gupta|T K|TK|;Bhargava|K P|KP|;Parmar|S S|SS|;Barthwal|J P|JP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150719',\n",
       "  'mesh_terms': 'D000700:Analgesics; D000818:Animals; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D001569:Benzodiazepines; D002492:Central Nervous System Depressants; D004357:Drug Synergism; D005260:Female; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D010424:Pentobarbital; D012890:Sleep; D013385:Succinate Dehydrogenase; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000700:Analgesics; D014151:Anti-Anxiety Agents; D000927:Anticonvulsants; D002492:Central Nervous System Depressants; D001569:Benzodiazepines; D013385:Succinate Dehydrogenase; D010424:Pentobarbital',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[The hypotensive effect of aromatic amidines and imidazolines].',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '958-67',\n",
       "  'abstract': 'Some amidine, diamidine and diimidazoline derivatives were tested on their ability to lower the blood pressure of the rat. Except for 5-amidino-2-phenylindole (271/179) all substances led to a short-lasting hypotension, the dose relationship of some of which was investigated. The biscationic character was a prerequisite for a strong hypotensive action. The predominantly peripheral origin of the blood pressure lowering action was shown for the substances pentamidine, diminazene, 6-amidino-2- (4-amidinophenyl)-indole (102/198), 5-amidino-2-(4-amidinophenyl) - benzofurane (150/49) and 2,6-diamidinoindole (261/115). A parasympathomimetic and histaminic efficiency could be excluded. The pressor effect of norepinephrine (noradrenaline) was reduced under the influence of pentamidine, diminacene and 102/198. With the dog 102/198 and 261/115 showed a diminution of heart rate and force as well as a vasodilatory effect. Using the rat, different cardiovascular parameters behaved analogous. Pentamidine, diminazene, 102/198 and 261/115 increased the force of contraction of the isolated rat atrium. Toxic effects were observed in doses as high as 0,5 mmol/l and l mmol/l. Pentamidine reduced the heart rate of the isolated atrium in a dose-dependent manner. Taking into account the in vitro results, the heart effects were interpreted as being reflectory. In the isolated rat aorta preparation the aforementioned substances in low doses shifted the dose-response curves of norepinephrine to the right, whereas higher doses also reduced the maximum contraction. Considering the results on the intact animal, a direct action of the diamidines on vascular smooth muscle was discussed.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Bielenberg|G W|GW|;Krieglstein|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150720',\n",
       "  'mesh_terms': 'D000578:Amidines; D000818:Animals; D000959:Antihypertensive Agents; D001285:Atropine; D001794:Blood Pressure; D003326:Coronary Circulation; D004285:Dogs; D004347:Drug Interactions; D006339:Heart Rate; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D066298:In Vitro Techniques; D009638:Norepinephrine; D051381:Rats; D012039:Regional Blood Flow; D013045:Species Specificity; D013116:Spinal Cord',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000578:Amidines; D000959:Antihypertensive Agents; D006634:Histamine H1 Antagonists; D007093:Imidazoles; D001285:Atropine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Studies on the metabolism of propafenone. 2nd comm.: studies on the biotransformation in the dog.',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '972-9',\n",
       "  'abstract': \"Following administration of 14C- and 2H-labelled propafenone hydrochloride (2-(2'-hydroxy-3'-propylaminopropoxy)-omega-phenyl-propiophenone hydrochloride) to beagle dogs, the metabolites were isolated from urine and bile and analysed by mass spectrometry. Reference substances were synthesized on the basis of the structures postulated from the mass spectra and compared with the substances isolated from the biological material. Propafenone was absorbed completely following i.d. administration and eliminated mainly with the bile. Within 28 h 10% of the dose was excreted with the urine and 87% with the bile. Propafenone was extensively metabolized. Less than 1% of the dose was recovered as unchanged substance in urine and bile. The urinary and biliary metabolites were almost exclusively conjugated. The main metabolite, accounting for more than 30% of the dose, was propafenone glucuronide, followed by conjugates of hydroxylated propafenone derivatives with glucuronic acid and sulphuric acid. 5-Hydroxy-propafenone, a propafenone derivative hydroxylated in the middle aromatic ring, and a derivative hydroxylated in the omega-phenyl ring each accounted for about 15% of the dose. Besides these monohydroxy metabolites, two other O-methylated catechol-like derivatives, substituted in the different aromatic rings were recovered. The remainder of the metabolic products identified were mainly substances resulting from degradation of the propoxyamine side chain.\",\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Hege|H G|HG|;Lietz|H|H|;Weymann|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150721',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D001646:Bile; D001711:Biotransformation; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D005243:Feces; D005260:Female; D008297:Male; D011405:Propafenone; D011427:Propiophenones',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D011427:Propiophenones; D011405:Propafenone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Estimation of the nonspecific cardiovascular toxicity of beta-adrenoceptor blocking drugs with different hydrophobic properties in the cat.',\n",
       "  'issue': '34(9)',\n",
       "  'pages': '980-3',\n",
       "  'abstract': 'The structure-activity relationship between the acute nonspecific cardiovascular depressant effects of the beta-adrenoceptor blocking drugs and their hydrophobic properties was evaluated experimentally for propranolol, pindolol, practolol, and atenolol, in the anaesthetized cat after preceding beta-adrenoceptor blockade. The LD50 values (geometric mean and range in mumol/kg i.v., each drug n = 5) for the nonspecific depression of max dp/dt were: 7.5 (5.6-9.1) for propranolol, 21 (15.5-28) for pindolol, 190 (115-290) for practolol, and 230 (170-400) for atenolol. The respective partition coefficients in octanol buffer (pH 7.0) as a measure of hydrophobicity were: propranolol 5.4, pindolol 0.20, practolol 0.025, and atenolol 0.0032. These experimental data showed a good fit into the regression equation obtained previously [18]. Practolol, in contrast, had a lower toxicity than calculated because of a pronounced intrinsic sympathomimetic activity (ISA), even after catecholamine depletion. The nonspecific cardiovascular toxicity of 15 other clinically used beta-adrenoceptor blocking drugs were estimated from their respective octanol buffer partition coefficients. The fall of the diastolic blood pressure was representative of the toxicity of the compounds. It is concluded that the cardiovascular toxicity is lowest in compounds with low hydrophobicity and with distinct ISA.',\n",
       "  'journal': 'Arzneimittel-Forschung',\n",
       "  'authors': 'Hellenbrecht|D|D|;Enenkel|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150722',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000758:Anesthesia; D000818:Animals; D000889:Anti-Arrhythmia Agents; D001794:Blood Pressure; D002319:Cardiovascular System; D002395:Catecholamines; D002415:Cats; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D006339:Heart Rate; D012995:Solubility; D013237:Stereoisomerism; D013329:Structure-Activity Relationship',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000889:Anti-Arrhythmia Agents; D002395:Catecholamines',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Arzneimittelforschung',\n",
       "  'nlm_unique_id': '0372660',\n",
       "  'issn_linking': '0004-4172',\n",
       "  'country': 'Germany'},\n",
       " {'title': '[Use of dynamic scintigraphy, x-ray computed tomography, ultrasonic scanning of the kidneys and determination of the enzyme activity and beta 2-microglobulin levels of the blood and urine of arterial hypertension patients].',\n",
       "  'issue': '7(2)',\n",
       "  'pages': '9-16',\n",
       "  'abstract': 'A total of 59 patients aged 16-74 years with arterial hypertension (AH) were examined. The AH duration was from 0.5 to 28 years. In 42 patients AH was stable, 17 patients had the syndrome of malignant AH. X-ray computerized renal tomography (CRT), dynamic renal scintigraphy (DRS), ultrasonic renal scanning (URS) were used in the study, furthermore, the activities of enzymes (beta-glucuronidase, alanine aminopeptidase, arylsulfatase A), beta 2-microglobulin (beta 2-MG) concentration were determined in the serum and urine. It has been found that combined use of the investigation methods largely increases diagnostic possibilities, significantly expands the data of such invasive procedures as excretory urography, aortography, renal biopsy, and in a number of cases it enables making the diagnosis without applying the invasive procedures. It is advisable to use URS and to determine the enzymatic activity and beta 2-MG concentration in the urine just at the first stage of examining the patients with AH (simultaneously with general clinical methods). When renal pathology is detected or suspected it is necessary to perform DRS. When voluminous process, \"mute\" kidney, cystic lesions, calculous chronic pyelonephritis are suspected CRT should be employed.',\n",
       "  'journal': \"Biulleten' Vsesoiuznogo kardiologicheskogo nauchnogo tsentra AMN SSSR\",\n",
       "  'authors': 'Arabidze|G G|GG|;Belichenko|O I|OI|;Megrelishvili|R I|RI|;Klimenko|V S|VS|;Mamytbekova|D Z|DZ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150723',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D000626:Aminopeptidases; D001192:Arylsulfatases; D018826:CD13 Antigens; D004796:Clinical Enzyme Tests; D005260:Female; D005921:Glomerulonephritis; D005966:Glucuronidase; D006801:Humans; D006973:Hypertension; D006974:Hypertension, Malignant; D006978:Hypertension, Renovascular; D007668:Kidney; D008297:Male; D008875:Middle Aged; D011704:Pyelonephritis; D011877:Radionuclide Imaging; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography; D001613:beta 2-Microglobulin',\n",
       "  'publication_types': 'D002363:Case Reports; D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D001613:beta 2-Microglobulin; D001192:Arylsulfatases; D005966:Glucuronidase; D000626:Aminopeptidases; D018826:CD13 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR',\n",
       "  'nlm_unique_id': '8003723',\n",
       "  'issn_linking': '',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Ketanserin in combination with beta-adrenergic receptor blocking agents in the treatment of essential hypertension.',\n",
       "  'issue': '18(5)',\n",
       "  'pages': '765-71',\n",
       "  'abstract': 'The antihypertensive properties of ketanserin, a 5-HT2 receptor antagonist, was investigated in combination with beta-adrenoceptor blockade. Ketanserin was given 40 mg twice daily to 10 hypertensive patients during 4 weeks in a double-blind placebo-controlled trial. Ketanserin significantly reduced supine and erect blood pressure compared to double-blind placebo, while no changes in heart rate were seen. When the blood pressure was assessed during 24 h at steady state conditions, the blood pressure reduction was maximal 1-2 h after tablet intake, corresponding to peak plasma concentrations of ketanserin. The blood pressure remained significantly reduced until next tablet intake (12 h). At steady state, on a 40 mg twice daily regimen, Css was 41.6 +/- 4.22, 36.9 +/- 5.19 and 39.8 +/- 4.81 ng/ml, Cmax 102.4 +/- 15.64 ng/ml and tmax 1.6 +/- 0.32 h. A slight sedation was observed in six patients. This side effect occurred 1-2 h after tablet intake and tended to subside with continued treatment.',\n",
       "  'journal': 'British journal of clinical pharmacology',\n",
       "  'authors': 'Hedner|T|T|;Persson|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150724',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000368:Aged; D000959:Antihypertensive Agents; D001794:Blood Pressure; D004359:Drug Therapy, Combination; D006339:Heart Rate; D006801:Humans; D006973:Hypertension; D007650:Ketanserin; D008297:Male; D008875:Middle Aged; D010880:Piperidines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D010880:Piperidines; D007650:Ketanserin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2125.1984.tb02540.x',\n",
       "  'references': '6112531;6261070;6800533;6283070;6126541;6182416;6130518;6833439;6135489;6615685;6353879;6628517;6319278;6373066;901695;7011110;6113280',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Clin Pharmacol',\n",
       "  'nlm_unique_id': '7503323',\n",
       "  'issn_linking': '0306-5251',\n",
       "  'country': 'England'},\n",
       " {'title': 'H2-receptor blockade and exercise-induced asthma.',\n",
       "  'issue': '18(5)',\n",
       "  'pages': '795-7',\n",
       "  'abstract': 'While in vitro studies suggest that H2-receptor blockade enhances mediator release from bronchial mast cells and leads to bronchoconstriction, in vivo studies have given conflicting results. Eight asthmatic subjects were given cimetidine 800 mg and placebo double-blind on different days. Baseline values of forced expiratory volume in one second (FEV1) were obtained before an 8 min standardized exercise test using a bicycle ergometer. Subjects inhaled cold, dry air and exercise on cimetidine and placebo days was matched for ventilation and thermal load. FEV1 was measured immediately, 5, 10, 15, and 20 min after exercise. No significant differences were observed between mean baseline FEV1, immediate post exercise FEV1, or maximum percentage fall from baseline after exercise on cimetidine or placebo days. Cimetidine does not appear to effect lung function or bronchial responses to cold air exercise challenge.',\n",
       "  'journal': 'British journal of clinical pharmacology',\n",
       "  'authors': 'Nogrady|S G|SG|;Hahn|A G|AG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150725',\n",
       "  'mesh_terms': 'D001249:Asthma; D001250:Asthma, Exercise-Induced; D002927:Cimetidine; D005541:Forced Expiratory Volume; D006635:Histamine H2 Antagonists; D006801:Humans',\n",
       "  'publication_types': 'D016430:Clinical Trial; D018848:Controlled Clinical Trial; D016428:Journal Article',\n",
       "  'chemical_list': 'D006635:Histamine H2 Antagonists; D002927:Cimetidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2125.1984.tb02545.x',\n",
       "  'references': '16695435;4126784;4142833;40584;629482;13094;371057;7249528;42333;7003797;438014;7281094;4105490;46921',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Clin Pharmacol',\n",
       "  'nlm_unique_id': '7503323',\n",
       "  'issn_linking': '0306-5251',\n",
       "  'country': 'England'},\n",
       " {'title': 'Carbon-13 nuclear magnetic resonance study of microtubule protein: evidence for a second colchicine site involved in the inhibition of microtubule assembly.',\n",
       "  'issue': '23(23)',\n",
       "  'pages': '5644-53',\n",
       "  'abstract': 'A 13C nuclear magnetic resonance study of bovine microtubule protein was carried out at 43 kG in the presence and absence of colchicine 13C labeled at the tropolone methoxy. Analysis indicated that tubulin has at least two colchicine binding sites: a quasi-irreversibly bound, high-affinity site (i.e., the KD less than 5 microM site generally accepted as the site of colchicine action) as well as a low-affinity site(s) (KD approximately 650 microM) with which free colchicine rapidly exchanges (greater than 100 s-1). The methoxy resonance is broadened to different apparent extents as a result of binding at these two sites (50- vs. 150-Hz broadening for the high- and low-affinity sites, respectively) but undergoes no change in chemical shift upon binding. The low-affinity sites are interpreted to be analogous to the sites deduced by Schmitt and Atlas [Schmitt, H., & Atlas, D. (1976) J. Mol. Biol. 102, 743-758] from labeling studies using bromocolchicine. These sites are likely to be the sites responsible for the abrupt halt in microtubule assembly (\"capping\") observed at high colchicine concentrations (greater than 20 microM)--a qualitatively different behavior from that observed at low colchicine concentrations [Sternlicht, H., Ringel, I., & Szasz, J. (1983) Biophys. J. 42, 255-267]. Carbon-13 spectra from the aliphatic carbons of microtubule protein consists of narrow resonances--many with line widths less than 30 Hz--superimposed on a broad background. The narrow resonances were assigned to flexible regions in nontubulin proteins [microtubule-associated proteins (MAPs)], in accord with an earlier 1H nuclear magnetic resonance study of microtubule protein [Woody, R. W., Clark, D. C., Roberts, G. C. K., Martin, S. R., & Bayley, P. M. (1983) Biochemistry 22, 2186-2192]. This assignment was supported by 13C NMR analysis of phosphocellulose-purified (MAP-depleted) tubulin as well as heat-stable MAPs. Aliphatic carbons in the MAP preparations were characterized by narrow resonances indicative of carbons with considerable motional freedom whereas the aliphatic regions of phosphocellulose-purified tubulin were, for the most part, characterized by broad resonances indicative of carbons with restricted mobility. However, a moderately narrow resonance (approximately less than 50-Hz line width) coincident with the C gamma resonance of glutamate was detected in 13C NMR spectra of tubulin which indicated that a fraction of the glutamic acid residues is relatively mobile.(ABSTRACT TRUNCATED AT 400 WORDS)',\n",
       "  'journal': 'Biochemistry',\n",
       "  'authors': 'Ringel|I|I|;Sternlicht|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150726',\n",
       "  'mesh_terms': 'D000818:Animals; D001665:Binding Sites; D001923:Brain Chemistry; D002417:Cattle; D003078:Colchicine; D005971:Glutamates; D018698:Glutamic Acid; D009682:Magnetic Resonance Spectroscopy; D008869:Microtubule-Associated Proteins; D014404:Tubulin',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005971:Glutamates; D008869:Microtubule-Associated Proteins; D014404:Tubulin; D018698:Glutamic Acid; D003078:Colchicine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1021/bi00318a040',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochemistry',\n",
       "  'nlm_unique_id': '0370623',\n",
       "  'issn_linking': '0006-2960',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Isolation and subunit composition of membrane inorganic pyrophosphatase from rat-liver mitochondria.',\n",
       "  'issue': '791(2)',\n",
       "  'pages': '198-204',\n",
       "  'abstract': 'The activity of inorganic pyrophosphatase (pyrophosphate phosphohydrolase, EC 3.6.1.1) extracted from rat-liver mitochondria with sodium cholate is distributed between three enzyme forms (I-III) which originally reside in the matrix (I) or the inner membrane (II and III). The three forms of pyrophosphatase were separated by means of hydroxyapatite chromatography. The Mr values for enzymes I-III, were 60 000, 120 000 and 210 000, respectively. Membrane pyrophosphatase II, which predominates, was purified to homogeneity. Its molecule consists of two subunits with Mr of 28 000 and 35 000 giving different peptide maps upon BrCN cleavage and polyacrylamide gel electrophoresis. The results suggest that pyrophosphatase II may represent a catalytic part of the membrane pyrophosphatase of these mitochondria.',\n",
       "  'journal': 'Biochimica et biophysica acta',\n",
       "  'authors': 'Volk|S E|SE|;Baykov|A A|AA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150727',\n",
       "  'mesh_terms': 'D000818:Animals; D019826:Cholic Acid; D002793:Cholic Acids; D002845:Chromatography; D003488:Cyanogen Bromide; D004591:Electrophoresis, Polyacrylamide Gel; D005590:Fractional Precipitation; D007526:Isoelectric Point; D008930:Mitochondria, Liver; D008970:Molecular Weight; D010446:Peptide Fragments; D011755:Pyrophosphatases; D051381:Rats',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D002793:Cholic Acids; D010446:Peptide Fragments; D011755:Pyrophosphatases; D019826:Cholic Acid; D003488:Cyanogen Bromide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0167-4838(84)90009-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochim Biophys Acta',\n",
       "  'nlm_unique_id': '0217513',\n",
       "  'issn_linking': '0006-3002',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Human mononuclear leukocyte transglutaminase activity is enhanced by streptococcal erythrogenic toxin and a staphylococcal mitogenic factor associated with toxic shock syndrome.',\n",
       "  'issue': '802(3)',\n",
       "  'pages': '385-9',\n",
       "  'abstract': 'Transglutaminase activity in human peripheral lymphocytes is enhanced after incubation of the cells with concanavalin A. Streptococcal proliferative factor toxin (erythrogenic toxin) from Streptococcus pyogenes and Toxic shock syndrome toxin from Staphylococcus aureus were purified and tested for their ability to enhance transglutaminase activity. Mononuclear leukocyte transglutaminase activity was enhanced 3-5-fold 30 min after incubation with either toxin. Enhancement occurred only when toxin was incubated with intact cells; addition of toxin to cell lysates was without effect. Transglutaminase was not measurable extracellularly. Histamine and dansyl cadaverine, competitive substrates for transglutaminase, inhibited [3H]putrescine incorporation into casein and [3H]thymidine incorporation into DNA. Incubation of lymphocytes with cycloheximide and either toxin or concanavalin A did not inhibit enzyme activity. These bacterial toxins, like phytomitogens, may perturb the cellular membrane and mediate their effect by transglutaminase-mediated cross-linking of membrane proteins.',\n",
       "  'journal': 'Biochimica et biophysica acta',\n",
       "  'authors': 'Zettergren|J G|JG|;Leifer|M J|MJ|;Nakashima|H|H|;Wuepper|K D|KD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150728',\n",
       "  'mesh_terms': 'D000217:Acyltransferases; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D002103:Cadaverine; D003208:Concanavalin A; D003513:Cycloheximide; D004768:Enterotoxins; D005098:Exotoxins; D006632:Histamine; D006801:Humans; D008565:Membrane Proteins; D009000:Monocytes; D011700:Putrescine; D018089:Superantigens; D013936:Thymidine; D011503:Transglutaminases',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001426:Bacterial Proteins; D001427:Bacterial Toxins; D004768:Enterotoxins; D005098:Exotoxins; D008565:Membrane Proteins; C117980:SpeA protein, Streptococcus pyogenes; D018089:Superantigens; C030107:enterotoxin F, Staphylococcal; C027951:erythrogenic toxin; D003208:Concanavalin A; D006632:Histamine; D003513:Cycloheximide; D000217:Acyltransferases; D011503:Transglutaminases; C008542:monodansylcadaverine; D002103:Cadaverine; D011700:Putrescine; D013936:Thymidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0304-4165(84)90354-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochim Biophys Acta',\n",
       "  'nlm_unique_id': '0217513',\n",
       "  'issn_linking': '0006-3002',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Arginine uptake by isolated rat liver mitochondria.',\n",
       "  'issue': '802(3)',\n",
       "  'pages': '407-12',\n",
       "  'abstract': 'The question of arginine uptake by mitochondria is important in that arginine is an allosteric effector of N-acetylglutamate synthetase. Thus, changes in mitochondrial arginine concentration have the potential for acutely modifying levels of N-acetylglutamate, a compound necessary for maximal activity of carbamyl phosphate synthesis. Mitochondria were isolated from chow-fed rats, incubated with [guanido-14C]arginine and were centrifuged through silicon oil into perchloric acid for determination of intramitochondrial metabolites. Arginine was separated from urea by cation-exchange resin. Mitochondrial water space was determined by [14C]urea arising from arginase activity associated with the mitochondrial preparations. Extramatrix space was determined by parallel incubations with [inulin-14C]carboxylic acid or [14C]sucrose. There was considerable degradation of arginine by arginase associated with the mitochondrial preparation. This was inhibited by 7 mM ornithine and 7 mM lysine. Arginine was concentrated intramitochondrially to 4-times the extramitochondrial levels. The concentration ratio was decreased in the presence of ornithine and lysine but not with citrulline, NH4Cl, glutamate, glutamate or leucine. No uptake was observed when mitochondria were incubated at 0 degree C. Mitochondria did not concentrate citrulline.',\n",
       "  'journal': 'Biochimica et biophysica acta',\n",
       "  'authors': 'Freedland|R A|RA|;Crozier|G L|GL|;Hicks|B L|BL|;Meijer|A J|AJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150729',\n",
       "  'mesh_terms': 'D000818:Animals; D001120:Arginine; D002956:Citrulline; D005971:Glutamates; D018698:Glutamic Acid; D005973:Glutamine; D008239:Lysine; D008297:Male; D008929:Mitochondria, Heart; D008930:Mitochondria, Liver; D009952:Ornithine; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005971:Glutamates; D005973:Glutamine; D002956:Citrulline; D018698:Glutamic Acid; D001120:Arginine; D009952:Ornithine; D008239:Lysine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0304-4165(84)90357-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochim Biophys Acta',\n",
       "  'nlm_unique_id': '0217513',\n",
       "  'issn_linking': '0006-3002',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Partial purification and characterization of a novel Mg2+-dependent ATPase present in the cytosol from human erythrocytes.',\n",
       "  'issue': '802(3)',\n",
       "  'pages': '490-500',\n",
       "  'abstract': 'Mg2+-ATPase activity was identified in the cytosol of human erythrocytes. A partial purification of this activity was achieved by an initial DEAE-Sephadex column chromatography, followed by gel filtration on Sephadex G-100 and then a second DEAE-Sephadex chromatography procedure. The enzyme appeared in the void volume of the Sephadex G-100 column and was retained on an Amicon XM100A ultrafiltration membrane. The molecular weight of the enzyme was estimated to be 113 000 from SD gels. The above purification protocol yielded an enzyme with an optimal pH between 7.6 and 8.2. The enzyme activity increased linearly between 30 and 44 degrees C. It was stable for several months at -20 degrees C. Magnesium was essential for activity, but the rate attainable with Mn2+ was at least as great as that due to Mg2+. No other divalent cation was able to substitute for Mg2+ or Mn2+. Neither low nor high Ca2+ concentrations significantly affected the enzymatic activity. Substrate specificity studies showed that ATP was the preferred substrate followed by CTP (46% of the rate produced by ATP). Hydrolysis of GTP, UTP, ITP and ADP was less than 10% of the rate seen with ATP. No phosphatase, pyrophosphatase, phosphodiesterase, hexokinase, phosphofructokinase or adenylate cyclase activity could be detected in this enzyme preparation. Calmodulin, which stimulates the (Ca2+ + Mg2+)-ATPase of the human erythrocyte membrane, failed to enhance the Mg2+-ATPase activity. Of considerable interest, the activity of this Mg2+-ATPase was enhanced approximately 5-fold by low concentrations of mercuric ion, p-hydroxymercuribenzoate and DTNB, but was much less sensitive to iodoacetamide.',\n",
       "  'journal': 'Biochimica et biophysica acta',\n",
       "  'authors': 'Mostafa|M H|MH|;Hanahan|D J|DJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150730',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D000255:Adenosine Triphosphate; D017301:Ca(2+) Mg(2+)-ATPase; D002147:Calmodulin; D002413:Cations, Divalent; D002850:Chromatography, Gel; D002852:Chromatography, Ion Exchange; D003600:Cytosol; D004912:Erythrocytes; D006461:Hemolysis; D006801:Humans; D007700:Kinetics; D009711:Nucleotides; D011863:Radioimmunoassay; D013439:Sulfhydryl Reagents; D013696:Temperature',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002147:Calmodulin; D002413:Cations, Divalent; D009711:Nucleotides; D013439:Sulfhydryl Reagents; D000255:Adenosine Triphosphate; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0304-4165(84)90368-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biochim Biophys Acta',\n",
       "  'nlm_unique_id': '0217513',\n",
       "  'issn_linking': '0006-3002',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'The mechanism of alpha-adrenergic agonist action in liver.',\n",
       "  'issue': '59(4)',\n",
       "  'pages': '511-57',\n",
       "  'abstract': '',\n",
       "  'journal': 'Biological reviews of the Cambridge Philosophical Society',\n",
       "  'authors': 'Reinhart|P H|PH|;Taylor|W M|WM|;Bygrave|F L|FL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150731',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000818:Animals; D002118:Calcium; D002451:Cell Compartmentation; D006801:Humans; D008099:Liver; D018129:Phosphatidylinositol Phosphates; D010716:Phosphatidylinositols; D051381:Rats; D011942:Receptors, Adrenergic, alpha',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D016454:Review\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D018129:Phosphatidylinositol Phosphates; D010716:Phosphatidylinositols; D011942:Receptors, Adrenergic, alpha; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1469-185x.1984.tb00413.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biol Rev Camb Philos Soc',\n",
       "  'nlm_unique_id': '0414576',\n",
       "  'issn_linking': '0006-3231',\n",
       "  'country': 'England'},\n",
       " {'title': 'A gas chromatographic/mass spectrometric assay for flutroline, a gamma-carboline antipsychotic agent, with direct derivatization on a moving needle injector.',\n",
       "  'issue': '11(9)',\n",
       "  'pages': '482-5',\n",
       "  'abstract': 'A method has been developed for the determination of flutroline in plasma using capillary gas chromatography and selected ion monitoring detection of the TMS derivative. The method is linear over the concentration range of 3-60 ng ml-1 and was used to define the drug pharmacokinetics and bioavailability in animals and man. A novel method for direct derivatization on the tip of a moving needle injector is described.',\n",
       "  'journal': 'Biomedical mass spectrometry',\n",
       "  'authors': 'Falkner|F C|FC|;Fouda|H G|HG|;Mullins|F G|FG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150732',\n",
       "  'mesh_terms': 'D014150:Antipsychotic Agents; D002243:Carbolines; D008401:Gas Chromatography-Mass Spectrometry; D006801:Humans; D007211:Indoles',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D002243:Carbolines; D007211:Indoles; C026240:flutroline',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1002/bms.1200110909',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biomed Mass Spectrom',\n",
       "  'nlm_unique_id': '0430246',\n",
       "  'issn_linking': '0306-042X',\n",
       "  'country': 'England'},\n",
       " {'title': '[Electrophysiological evaluation of mediator secretion and pool at an individual point of neuromuscular synapse release in the frog].',\n",
       "  'issue': '98(11)',\n",
       "  'pages': '520-3',\n",
       "  'abstract': 'The time-course of one-quantum end plate potentials during repetitive stimulation of the motor nerve (5-10 imp/sec) was studied under iontophoretic application of Ca2+ to the nerve ending with the aid of high-resistance exocellular microelectrodes. It was found that long-term stimulation was first accompanied by rapid and then by a slower decrease of transmitter release. After 2 to 3 minutes of stimulation the level of secretion reached a plateau. Blockade of acetylcholine synthesis by hemicholinium-3 did not affect the time-course of transmitter secretion drop but led to the disappearance of the plateau state. Electrophysiological study of transmitter exchange in an individual point of release provided the following values: the available transmitter pool 32-47 quanta, the mobilization pool 120-320 quanta, the rate of transmitter synthesis 0.3-1.0 quanta/s.',\n",
       "  'journal': \"Biulleten' eksperimental'noi biologii i meditsiny\",\n",
       "  'authors': 'Zefirov|A L|AL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150733',\n",
       "  'mesh_terms': 'D000200:Action Potentials; D000818:Animals; D004558:Electric Stimulation; D004594:Electrophysiology; D066298:In Vitro Techniques; D008564:Membrane Potentials; D009045:Motor Endplate; D009469:Neuromuscular Junction; D018377:Neurotransmitter Agents; D011898:Ranidae; D012584:Sciatic Nerve; D013569:Synapses',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biull Eksp Biol Med',\n",
       "  'nlm_unique_id': '0370627',\n",
       "  'issn_linking': '0365-9615',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Evidence for the presence of H+-ATPase in the membrane of brain synaptic vesicles in the rat].',\n",
       "  'issue': '98(11)',\n",
       "  'pages': '539-41',\n",
       "  'abstract': 'Mg-ATPase of rat brain synaptic vesicles (SV) is considerably (by 85%) inhibited by dicyclohexyl carbodiimide (200 microM), a blocker of proton pumps, whereas orthovanadate (100 microM) does not produce any influence on the enzyme. Oligomycin (5 micrograms/ml) does not alter Mg-ATPase activity of the SV, whereas N-ethylmaleimide (300 microM) reduces it to a moderate degree, namely by 35%. This indicates that Mg-ATPase of the SV differs from mitochondrial ATPase. The protonophore p-trichloromethoxycarbonyl cyanide phenylhydrazone (20 microM) and bicarbonate anions (20 mM) stimulate slightly (by 12 to 25%) Mg-ATPase of the SV. Bicarbonate (20 mM) raises 1.8-2.1-fold Mg-ATPase activity of the mitochondria isolated from rat brain. It is assumed that the membrane of brain SV contains proton ATPase (H+-ATPase) differing from mitochondrial H+-ATPase in some of the properties.',\n",
       "  'journal': \"Biulleten' eksperimental'noi biologii i meditsiny\",\n",
       "  'authors': \"Glebov|R N|RN|;Mel'nik|V I|VI|;Kryzhanovskiĭ|G N|GN|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150734',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D000818:Animals; D001921:Brain; D017301:Ca(2+) Mg(2+)-ATPase; D008565:Membrane Proteins; D008928:Mitochondria; D006180:Proton-Translocating ATPases; D011522:Protons; D051381:Rats; D000254:Sodium-Potassium-Exchanging ATPase; D013572:Synaptic Vesicles',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D008565:Membrane Proteins; D011522:Protons; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D006180:Proton-Translocating ATPases; D000254:Sodium-Potassium-Exchanging ATPase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biull Eksp Biol Med',\n",
       "  'nlm_unique_id': '0370627',\n",
       "  'issn_linking': '0365-9615',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Mast cells and cells producing alpha-endorphin in the mucosa of the antral section of the stomach].',\n",
       "  'issue': '98(11)',\n",
       "  'pages': '621-4',\n",
       "  'abstract': 'The distribution of mast cells, alpha-endorphine-producing cells (AER-cells) and argyrophilic cells in lamina propria of the antral mucosa was determined quantitatively in 13 normal men. The cells were detected by histochemical and immunohistochemical (PAP) methods. The form and site of AER-cells resembled those of mast cells and mucosal argyrophilic cells (in lamina propria). The authors assume that part of human gastric mucosal cells have argyrophilic properties and contain alpha-endorphine.',\n",
       "  'journal': \"Biulleten' eksperimental'noi biologii i meditsiny\",\n",
       "  'authors': 'Zverkov|I V|IV|;Vinogradov|V A|VA|;Aruin|L I|LI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150735',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D001706:Biopsy; D004723:Endorphins; D004847:Epithelial Cells; D004848:Epithelium; D005753:Gastric Mucosa; D006651:Histocytochemistry; D006801:Humans; D007124:Immunoenzyme Techniques; D008297:Male; D008407:Mast Cells; D011706:Pyloric Antrum; D018822:alpha-Endorphin',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D004723:Endorphins; D018822:alpha-Endorphin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biull Eksp Biol Med',\n",
       "  'nlm_unique_id': '0370627',\n",
       "  'issn_linking': '0365-9615',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': '[Quantitative characteristics of the transfer of the hematopoietic microenvironment].',\n",
       "  'issue': '98(12)',\n",
       "  'pages': '739-41',\n",
       "  'abstract': 'Heterotopic transplantation of marrow fragments results in the formation of new bone marrow organs. The amount of hemopoietic cells populating these organs is connected nonlinearly with the volume of the grafted tissue or with the number of transplanted marrow cells. Statistical analysis points out that the number of the populating cells depends on the radius of the initial bone marrow transplant. Thus, the previous data on the radiosensitivity of the microenvironmental transfering stromal cells and on their concentration obtained by measuring the size of the heterotopic bone marrow organs have turned out incorrect.',\n",
       "  'journal': \"Biulleten' eksperimental'noi biologii i meditsiny\",\n",
       "  'authors': 'Kuralesova|A I|AI|;Leontovich|A M|AM|;Krukovets|I L|IL|;Fridenshteĭn|A Ia|AIa|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150736',\n",
       "  'mesh_terms': 'D000818:Animals; D001853:Bone Marrow; D016026:Bone Marrow Transplantation; D002452:Cell Count; D018380:Hematopoietic Stem Cell Transplantation; D006412:Hematopoietic Stem Cells; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Biull Eksp Biol Med',\n",
       "  'nlm_unique_id': '0370627',\n",
       "  'issn_linking': '0365-9615',\n",
       "  'country': 'Russia (Federation)'},\n",
       " {'title': 'Evidence for a peripheral component in the sympatholytic effect of clonidine in rats.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '657-65',\n",
       "  'abstract': 'In an attempt to assess separately the peripheral and central effects of clonidine on cardiovascular parameters and plasma catecholamine levels, the selective alpha 2-adrenoceptor antagonist idazoxan (RX 781094) was given either intravenously (i.v.) or intracerebroventricularly (i.c.v.) to anaesthetized rats before administration of intravenous clonidine. Plasma noradrenaline and plasma growth hormone concentrations were used as indices of peripheral sympathetic nervous activity and central alpha-adrenoceptor stimulation, respectively. Peripheral and central administration of idazoxan antagonized the cardiovascular responses to i.v. clonidine, 5 micrograms kg-1. However, idazoxan was more effective against the hypotension than the bradycardia induced by clonidine. Idazoxan 300 micrograms kg-1 i.v. and 50 micrograms i.c.v. prevented clonidine-induced falls in plasma noradrenaline and adrenaline. The results suggest that 50 micrograms idazoxan i.c.v. caused some blockade of peripheral as well as central alpha 2-adrenoceptors. Idazoxan, 10 micrograms i.c.v., caused similar inhibition of the hypotensive response to clonidine as 300 micrograms kg-1 i.v. and 50 micrograms i.c.v. but did not significantly inhibit the clonidine-induced fall in plasma noradrenaline concentration. Animals pretreated with i.v. or i.c.v. idazoxan had significantly lower levels of plasma growth hormone than vehicle-treated rats. Idazoxan 10 micrograms and 50 micrograms i.c.v. suppressed growth hormone secretion to the same extent. These results suggest that stimulation of peripheral, prejunctional alpha 2-adrenoceptors in anaesthetized rats may contribute to the fall in plasma catecholamines produced by i.v. clonidine, and confirm that the hypotensive effect is centrally mediated.',\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Brown|M J|MJ|;Harland|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150737',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001794:Blood Pressure; D003000:Clonidine; D004146:Dioxanes; D004147:Dioxins; D004837:Epinephrine; D013006:Growth Hormone; D006339:Heart Rate; D019329:Idazoxan; D007275:Injections, Intravenous; D007276:Injections, Intraventricular; D008297:Male; D009638:Norepinephrine; D051381:Rats; D011919:Rats, Inbred Strains; D013565:Sympatholytics; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D004147:Dioxins; D013565:Sympatholytics; D013006:Growth Hormone; D003000:Clonidine; D009638:Norepinephrine; D019329:Idazoxan; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16219.x',\n",
       "  'references': '6291085;6125202;6132640;6135163;6136932;6137390;6195454;6138716;6139286;14097352;4156484;238001;5206;14389;25484;645884;7437906;6111465;6114446;6116198;7285505;6121540;7341285;6124635;7144924',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': 'The antagonism of histamine-induced tracheal and bronchial muscle contraction by diphenhydramine: effect of maturation.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '697-705',\n",
       "  'abstract': 'Airway reactivity in spontaneously breathing unanaesthetized female guinea-pigs was significantly reduced as a consequence of maturation. Threshold doses to histamine (% w/v base) were 0.08% +/- .01 and 0.27% +/- .04 in immature (110 g +/- 2; 1 week old) and mature (837 g +/- 29; 4 months old) animals, respectively. The potency of 2-(2-thiazolyl) ethylamine in tracheal tissues from mature animals was significantly less than that in tissues from immature animals (5.06 +/- .03 vs 5.26 +/- .07). There was no change in the potency of this agonist in bronchial tissues (5.0 +/- .09 vs 4.9 +/- .13). Diphenhydramine reduced tissue contractility in tracheal (30% at 0.1 microM; 50% at 3 microM) but not bronchial tissues. The antihistamine in concentrations ranging from 0.1 microM to 3 microM reduced the potency of histamine 2 to 50 fold in both tissues. Schild plots were linear but slopes were significantly less than unity. pA2 values +/- 95% fiducial limits derived from data from tracheal tissues of immature and mature animals using constrained Schild plots (unit slope) were 7.7 (7.6-7.7) and 7.1 (7.0-7.2), respectively (P less than 0.05). pA2 values for diphenhydramine in bronchial tissues using constrained Schild plots were 7.8 (7.7-7.9) and 7.5 (7.3-7.5), respectively (P less than 0.05). The data emphasize the unique nature of tracheal and bronchial tissues. We conclude that, with maturation, the characteristics of the histamine receptor change. We suggest that the remission of asthma which frequently occurs at puberty may be related to alteration in the properties of membrane receptors.',\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Douglas|J S|JS|;Duncan|P G|PG|;Mukhopadhyay|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150738',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D001980:Bronchi; D002217:Carbachol; D004155:Diphenhydramine; D006168:Guinea Pigs; D006632:Histamine; D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D066298:In Vitro Techniques; D009119:Muscle Contraction; D009130:Muscle, Smooth; D010991:Plethysmography; D014132:Trachea',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D006633:Histamine Antagonists; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D006632:Histamine; D004155:Diphenhydramine; D002217:Carbachol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16223.x',\n",
       "  'references': '5232334;4296170;5275474;5010419;4402440;4713710;4755232;4813888;1159632;686509;83145;6103723;7441507;6255127;7288597;6276926;6277666;6281029;6136415;14929325;13651579;13996119;13269701',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': '2-Alkyl analogue of idazoxan (RX 781094) with enhanced antagonist potency and selectivity at central alpha 2-adrenoceptors in the rat.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '707-12',\n",
       "  'abstract': 'Four 2-alkyl (methyl, ethyl, n-propyl and isopropenyl) analogues of idazoxan (RX 781094) have been synthesized and assessed in terms of their central alpha 2/alpha 1-adrenoceptor selectivity and alpha 2-adrenoceptor antagonist potency using both in vitro and in vivo tests in the rat. In cortical binding assays using [3H]-idazoxan and [3H]-prazosin, idazoxan had a 5 times greater alpha 2/alpha 1-selectivity than yohimbine. The 2-alkyl substituted analogues all showed improved selectivity, being between 17 and 29 times more selective than yohimbine for [3H]-idazoxan binding sites. In terms of central antagonist potency in vivo, the most favourable substitutions were 2-ethyl (RX 811033) and 2-n-propyl (RX 811054). Compared with yohimbine, these analogues were, respectively, 36 and 18 times more potent intravenously and 5 and 7.5 times more potent orally in their antagonism of guanoxabenz-induced mydriasis in the pentobarbitone-anaesthetized rat. All the analogues had a duration of action similar to that of idazoxan, which was significantly shorter than that of yohimbine. The results indicate that introduction of alkyl groups in the 2-position of idazoxan greatly increases the alpha 2/alpha 1-adrenoceptor selectivity as measured in binding studies. Improved alpha 2-adrenoceptor affinity and antagonist potency were particularly associated with the 2-ethyl and 2-n-propyl analogues.',\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Gadie|B|B|;Lane|A C|AC|;McCarthy|P S|PS|;Tulloch|I F|IF|;Walter|D S|DS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150739',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D002540:Cerebral Cortex; D004146:Dioxanes; D004147:Dioxins; D019329:Idazoxan; D066298:In Vitro Techniques; D007700:Kinetics; D008297:Male; D011224:Prazosin; D011807:Quinolizines; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D004147:Dioxins; D011807:Quinolizines; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; C038538:Wy 26703; D011224:Prazosin; D019329:Idazoxan',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16224.x',\n",
       "  'references': '4202581;6132640;6132641;6150740;6639682;6140052;6136932',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': 'Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '713-22',\n",
       "  'abstract': 'The profiles of four analogues of idazoxan have been examined at alpha-adrenoceptors and the results compared to those obtained with idazoxan and yohimbine. The compounds possessed either a methyl (RX 801079), ethyl (RX 811033), n-propyl (RX 811054) or isopropenyl (RX 811005) group at the two position of idazoxan. The rank order of antagonist potency against UK-14,304 at prejunctional alpha 2-adrenoceptors of the rat isolated vas deferens was RX 811054 greater than RX 811033 greater than idazoxan greater than RX 811005 greater than yohimbine = RX 801079. All compounds were competitive antagonists. The rank order of antagonist potency against noradrenaline at postjunctional alpha 1-adrenoceptors of the rat isolated anococcygeus muscle was RX 811054 = RX 811033 = idazoxan = yohimbine greater than RX 811005 = RX801079. All compounds were competitive antagonists. The rank order of alpha-adrenoceptor selectivity (alpha 2/alpha 1) was RX 811005 greater than RX 801079 greater than RX 811054 greater than RX 811033 greater than idazoxan greater than yohimbine. In pithed rats, intravenous administration of all compounds fully reversed the prejunctional alpha 2-adrenoceptor agonist effects of clonidine and guanabenz on electrically-induced contractions of the vas deferens and anococcygeus muscle respectively. In pithed rats the rank order of antagonist potency against UK-14,304 at cardiac prejunctional alpha 2-adrenoceptors was RX 811054 greater than RX 811033 greater than idazoxan greater than yohimbine greater than RX 811005 greater than RX 801079. In contrast, the rank order of antagonist potency against cirazoline pressor effects (vascular postjunctional alpha 1-adrenoceptors) was RX 811054 greater than RX 811033 greater than yohimbine greater than idazoxan greater than RX 811005 greater than RX 801079. The rank order of alpha 2-adrenoceptor selectivity was RX 811033 = RX 801079 = RX 801005 greater than RX 811054 greater than idazoxan greater than yohimbine. Although idazoxan produced contractions of the anococcygeus muscle and increased blood pressure in pithed rats, three of the analogues (RX 811005, RX 801079 and RX 811033) were inactive. In conclusion, alkyl substitution in the 2-position of idazoxan can enhance either alpha 2-adrenoceptor antagonist potency or selectivity or both and furthermore, the weak partial alpha 1-adrenoceptor agonist properties of idazoxan can be removed.',\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Doxey|J C|JC|;Roach|A G|AG|;Strachan|D A|DA|;Virdee|N K|NK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150740',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001794:Blood Pressure; D004146:Dioxanes; D004147:Dioxins; D004558:Electric Stimulation; D006339:Heart Rate; D019329:Idazoxan; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction; D009131:Muscle, Smooth, Vascular; D009132:Muscles; D051381:Rats; D011919:Rats, Inbred Strains; D013329:Structure-Activity Relationship; D014649:Vas Deferens; D015016:Yohimbine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D004147:Dioxins; D015016:Yohimbine; D019329:Idazoxan',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16225.x',\n",
       "  'references': '23192;6105621;6115759;6117656;6126583;13651579;6135473;6136932;6144048;6150739;6132640',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': 'Genetic heterogeneity of histamine H2-receptors in the mouse vas deferens.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '723-31',\n",
       "  'abstract': \"The ability of histamine to inhibit the overall contractile ('twitch') response of the isolated vas deferens of the mouse to electrical field stimulation (64 V pulse, 1 ms pulse width, frequency 0.2 Hz) was studied in nine inbred mouse strains. The strains were also characterized in terms of the potency of the histamine H2-receptor antagonist cimetidine in its inhibition of histamine-mediated effects. An apparently bimodal inter-strain variation (8-10 fold) in both characteristics was encountered, with three strains (SWR, A2G and C57BL/10ScSn) relatively sensitive (S) to both agonist and antagonist actions, and six (C3H, A, C57/BL6, DBA/2, Balb/C and 129/Sv) relatively insensitive (IS). These strain differences were independent of extracellular calcium concentration in the range 1.25-5 mM, and also independent of the frequency of tissue stimulation over the range 0.2-6.4 Hz. Representative S (SWR and A2G) and IS (DBA/2 and C3H) mouse vasa were also characterized in terms of their sensitivity to the agonist actions of dimaprit and the antagonist actions of tiotidine. In the S strain tissues, dimaprit produced 50% inhibition of the twitch response at 4.6-1.8 microM (mean +/- s.d.) and was able to elicit complete inhibition of the twitch response at concentrations greater than 100 microM, whereas 48.7 +/- 11.9 microM dimaprit was required to produce 50% inhibition of the twitch response in tissues from IS mice. In addition, the agonist actions of dimaprit were incomplete in the latter tissues, the drug eliciting no more than 75% inhibition of the twitch response at concentrations in the range 300-1000 microM. Tiotidine produced competitive antagonism of the actions of both histamine and dimaprit, the strain differences being of the same magnitude as those observed for cimetidine. 4 Mating of a representative S (SWR) and IS (129/Sv) strain produced F, mice with intermediate histamine and cimetidine sensitivities relative to the parental strains. A backcross of male F1 to female IS mice produced progeny displaying a range of histamine and cimetidine sensitivities representative of those seen in tissues from F1 and IS parental animals, however, the data were not bimodal. Thus, the backcross data provided no evidence to support single gene inheritance of histamine sensitivity and might suggest that more than one gene is responsible for these differences between S and IS mice.\",\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Calvete|J A|JA|;Donegan|J L|JL|;Hayes|R J|RJ|;Oates|N S|NS|;Sloan|T P|TP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150741',\n",
       "  'mesh_terms': 'D000818:Animals; D002118:Calcium; D002927:Cimetidine; D004558:Electric Stimulation; D014644:Genetic Variation; D006635:Histamine H2 Antagonists; D066298:In Vitro Techniques; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009119:Muscle Contraction; D009130:Muscle, Smooth; D011968:Receptors, Histamine; D011970:Receptors, Histamine H2; D013045:Species Specificity; D014649:Vas Deferens',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D006635:Histamine H2 Antagonists; D011968:Receptors, Histamine; D011970:Receptors, Histamine H2; D002927:Cimetidine; C023990:tiotidine; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16226.x',\n",
       "  'references': '235100;236796;963343;620687;638366;102532;13651579;158499;229720;43449;6114629;6116757;6118885;459695',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': 'Benzodiazepines modulate the A2 adenosine binding sites on 108CC15 neuroblastoma X glioma hybrid cells.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '791-8',\n",
       "  'abstract': \"We have demonstrated high affinity diazepam binding sites of the Ro5-4864 benzodiazepine receptor subtype on 108CC15 neuroblastoma X glioma hybrid cells. These cells were previously shown to have purinoceptors of the A2 adenosine subtype and we have now found that [3H]-adenosine can be displaced from this binding site by the benzodiazepines and related compounds that can also bind to the Ro5-4864 site. Diazepam was found to have no intrinsic activity at the A2-receptor as measured by the stimulation of adenosine 3':5'-cyclic monophosphate (cyclic AMP) production in this cell line. At concentrations sufficient to compete for the A2-receptor, diazepam was shown to facilitate, by approximately 2 fold, the stimulation of cyclic AMP by adenosine. These effects are not due to inhibition of adenosine uptake or phosphodiesterase activity, but are probably a consequence of modulation of the coupling of the A2-receptor to cyclic AMP production in this hybrid cell line.\",\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Snell|C R|CR|;Snell|P H|PH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150742',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D001667:Binding, Competitive; D002478:Cells, Cultured; D002998:Clonazepam; D000242:Cyclic AMP; D003975:Diazepam; D005910:Glioma; D006822:Hybrid Cells; D007700:Kinetics; D009447:Neuroblastoma; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D011983:Receptors, Purinergic; D020889:Rolipram',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D010726:Phosphodiesterase Inhibitors; D011760:Pyrrolidinones; D011956:Receptors, Cell Surface; D011963:Receptors, GABA-A; D011983:Receptors, Purinergic; D001569:Benzodiazepines; C014268:ID 690; D002998:Clonazepam; D000242:Cyclic AMP; D020889:Rolipram; D003975:Diazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16234.x',\n",
       "  'references': '7356447;6105006;6123548;6289073;7412473;4354003;6682534;4366112;6111732;4402069;1059094;6246535;20632;6265597;6269585;6103810;876354;86600;7452279;6263650;187926;14907707;4330379;430037;6111733;523502;713703;390284',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effects of caroverine and diltiazem on synaptic responses, L-glutamate-induced depolarization and potassium efflux in the frog spinal cord.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '813-20',\n",
       "  'abstract': 'The frog spinal cord was used to determine the characteristics of the actions of caroverine and diltiazem, two organic Ca2+-antagonists, on synaptic responses and L-glutamate-induced depolarization. Caroverine and diltiazem (10(-4)M) depressed the dorsal root potential (DR-DRP) induced by electrical stimulation of an adjacent dorsal root. Diltiazem also depressed the ventral root potential (DR-VRP), whereas caroverine augmented both the polysynaptic component in the ventral root reflex and the size of the DR-VRP. The root potentials induced by high frequency stimulation (20 Hz, for 1 s) were markedly depressed by these Ca2+-antagonists at a concentration of 10(-4)M. When the preparation was perfused with normal medium, the compounds depressed L-glutamate-induced depolarizations in ventral and dorsal roots. In preparations treated with tetrodotoxin (TTX) (2 X 10(-7)M), the antagonizing actions of the drugs against L-glutamate-induced depolarizations in the ventral root were markedly reduced or abolished, while significant antagonizing actions on the depolarization in the dorsal root were still observed. The increase in extracellular K+ activity induced by L-glutamate in the TTX-treated preparation was significantly reduced by the compounds. Caroverine and diltiazem had no effect on the presynaptic nerve spike and on the focal synaptic potential induced by a single stimulation of a dorsal root; however, the focal synaptic potential induced by high frequency stimulation (20 Hz, 1 s) was attenuated. Motoneuronal action potentials were abolished by the drugs, while the excitatory postsynaptic potential remained unaffected. 9 The present results suggest that caroverine and diltiazem are not specific L-glutamate antagonists in the frog spinal cord, but that they block the initiation of an action potential without affecting presynaptic nerve conduction, transmitter release or transmitter-receptor interactions. The inhibitory effects of these compounds on L-glutamate-induced K+-efflux are discussed with reference to their Ca2+-antagonizing actions.',\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Kudo|Y|Y|;Shibata|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150743',\n",
       "  'mesh_terms': 'D000818:Animals; D001552:Benzazepines; D004110:Diltiazem; D005071:Evoked Potentials; D005971:Glutamates; D018698:Glutamic Acid; D066298:In Vitro Techniques; D008839:Microelectrodes; D009046:Motor Neurons; D009467:Neuromuscular Depolarizing Agents; D011188:Potassium; D011810:Quinoxalines; D011892:Rana catesbeiana; D013126:Spinal Nerve Roots; D013569:Synapses; D013779:Tetrodotoxin; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001552:Benzazepines; D005971:Glutamates; D009467:Neuromuscular Depolarizing Agents; D011810:Quinoxalines; D014665:Vasodilator Agents; D018698:Glutamic Acid; D013779:Tetrodotoxin; D004110:Diltiazem; D011188:Potassium; C000957:caroverine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16237.x',\n",
       "  'references': '5426656;6133590;4825448;1080113;1263139;1086393;12537;212553;212554;366676;492485;227014;316102;6965722;7359406;7004114;6128143;4513416',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': 'ICI 118,551: an effective ocular hypotensive agent with selectivity for the ciliary process beta 2-adrenoceptor and with minimal cardiac side effects.',\n",
       "  'issue': '83(3)',\n",
       "  'pages': '821-9',\n",
       "  'abstract': 'Prior biochemical studies have shown that the ciliary process epithelium, which is involved in the secretion of aqueous humour, is rich in beta-adrenoceptors with pharmacological characteristics similar to those of the beta 2 subclass. The present experiments demonstrate that the beta-adrenoceptor antagonist, ICI 118,551, is a potent inhibitor of isoprenaline-stimulated adenylate cyclase activity measured in broken cell preparations of rabbit ciliary process. In rabbit cardiac muscle, however, ICI 118,551 is a relatively weak antagonist of isoprenaline-stimulated adenylate cyclase, being approximately 100 fold less potent than the non-selective beta-adrenoceptor antagonist, timolol. ICI 118,551 is also less potent than timolol in inhibiting isoprenaline-sensitive adenylate cyclase of rabbit lung. ICI 118,551 applied topically to eyes of unanaesthetized rabbits causes a dose-dependent decrease in intraocular pressure. Furthermore, in a blind crossover study in rabbits, topically applied ICI 118,551 decreased intraocular pressure for more than 6 h and was more effective than an identical dose of the clinically effective anti-glaucoma agent, timolol. Systemic absorption from topically-applied timolol, but not ICI 118,551, is sufficient to alter cardiac response to subcutaneous administration of isoprenaline. Furthermore, dose-response studies, using direct systemic administration of the two beta-adrenoceptor antagonists, revealed that ICI 118,551 is about 60 times less potent than timolol in blocking isoprenaline-induced cardio-acceleration. ICI 118,551, applied to one eye, causes a decrease in intraocular pressure in the contralateral eye, and systemic administration of ICI 118,551 results in decreased intraocular pressure in both eyes, data indicating that at least part of the ocular hypotensive effect of topical ICI 118,551 is mediated through systemic absorption. 8 These findings provide biochemical and physiological evidence that selective beta 2-adrenoceptor blockers such as ICI 118,551, used topically or systemically, may be useful as ocular hypotensive agents with decreased cardiac side-effects.',\n",
       "  'journal': 'British journal of pharmacology',\n",
       "  'authors': 'Nathanson|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150744',\n",
       "  'mesh_terms': 'D000067956:Adenylyl Cyclase Inhibitors; D000319:Adrenergic beta-Antagonists; D000818:Animals; D000959:Antihypertensive Agents; D002924:Ciliary Body; D006339:Heart Rate; D066298:In Vitro Techniques; D007429:Intraocular Pressure; D007545:Isoproterenol; D008168:Lung; D011412:Propanolamines; D011817:Rabbits; D011943:Receptors, Adrenergic, beta; D013999:Timolol',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000067956:Adenylyl Cyclase Inhibitors; D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D011412:Propanolamines; D011943:Receptors, Adrenergic, beta; C026777:ICI 118551; D013999:Timolol; D007545:Isoproterenol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1476-5381.1984.tb16238.x',\n",
       "  'references': '5120344;14907713;4202581;19116;37605;229209;6106143;6108938;6261257;6112155;6115904;6116512;6118346;6125583;6293532;6129943;6698752;6142724;4352294',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br J Pharmacol',\n",
       "  'nlm_unique_id': '7502536',\n",
       "  'issn_linking': '0007-1188',\n",
       "  'country': 'England'},\n",
       " {'title': 'Do antihypertensive drugs precipitate diabetes?',\n",
       "  'issue': '289(6457)',\n",
       "  'pages': '1495-7',\n",
       "  'abstract': 'A longitudinal population study of 1462 women aged 38-60 was carried out from 1968-9 to 1980-1 in Gothenburg, Sweden. The initial and follow up examinations included questions concerning history of diabetes and antihypertensive treatment. A considerably increased risk of developing diabetes was observed for subjects with hypertension taking diuretics (895 patient years), subjects taking beta blockers (682 patient years), and subjects taking a combination of diuretics and beta blockers (281 patient years) compared with subjects not taking antihypertensive drugs (13 855 control years). When diuretics and beta blockers were compared no difference was found in relative risk. Despite this increased risk, and because little is known about the relation between other forms of antihypertensive treatment and diabetes, diuretics and beta blockers should remain the treatments of choice in arterial hypertension.',\n",
       "  'journal': 'British medical journal (Clinical research ed.)',\n",
       "  'authors': 'Bengtsson|C|C|;Blohmé|G|G|;Lapidus|L|L|;Lindquist|O|O|;Lundgren|H|H|;Nyström|E|E|;Petersen|K|K|;Sigurdsson|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150745',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D000959:Antihypertensive Agents; D001786:Blood Glucose; D001835:Body Weight; D003920:Diabetes Mellitus; D004232:Diuretics; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006973:Hypertension; D008137:Longitudinal Studies; D008875:Middle Aged; D012306:Risk; D013548:Sweden',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D001786:Blood Glucose; D004232:Diuretics',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/bmj.289.6457.1495',\n",
       "  'references': '1251836;675187;7468582;6731044;6127000;6131004;6116241',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br Med J (Clin Res Ed)',\n",
       "  'nlm_unique_id': '8302911',\n",
       "  'issn_linking': '0267-0623',\n",
       "  'country': 'England'},\n",
       " {'title': 'Respiratory depression after alfentanil infusion.',\n",
       "  'issue': '289(6458)',\n",
       "  'pages': '1581-2',\n",
       "  'abstract': '',\n",
       "  'journal': 'British medical journal (Clinical research ed.)',\n",
       "  'authors': 'Sebel|R S|RS|;Lalor|J M|JM|;Flynn|P J|PJ|;Simpson|B A|BA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150746',\n",
       "  'mesh_terms': 'D000368:Aged; D015760:Alfentanil; D000701:Analgesics, Opioid; D005260:Female; D005283:Fentanyl; D006801:Humans; D007263:Infusions, Parenteral; D008297:Male; D008875:Middle Aged; D012131:Respiratory Insufficiency',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D000701:Analgesics, Opioid; D015760:Alfentanil; D005283:Fentanyl',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/bmj.289.6458.1581-a',\n",
       "  'references': '497071;6131685;6128948',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br Med J (Clin Res Ed)',\n",
       "  'nlm_unique_id': '8302911',\n",
       "  'issn_linking': '0267-0623',\n",
       "  'country': 'England'},\n",
       " {'title': 'Consensus development conference: coronary artery bypass surgery.',\n",
       "  'issue': '289(6459)',\n",
       "  'pages': '1690-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'British medical journal (Clinical research ed.)',\n",
       "  'authors': '',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150747',\n",
       "  'mesh_terms': 'D003226:Congresses as Topic; D001026:Coronary Artery Bypass; D006801:Humans; D011183:Postoperative Complications',\n",
       "  'publication_types': 'D016423:Congress; D016422:Letter',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/bmj.289.6459.1690',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Br Med J (Clin Res Ed)',\n",
       "  'nlm_unique_id': '8302911',\n",
       "  'issn_linking': '0267-0623',\n",
       "  'country': 'England'},\n",
       " {'title': 'The effects of feeding and rewarding brain stimulation on lateral hypothalamic unit activity in freely moving rats.',\n",
       "  'issue': '322(2)',\n",
       "  'pages': '201-11',\n",
       "  'abstract': 'In some medial forebrain bundle (MFB) sites, self-stimulation is often modulated by hunger or satiety. With electrodes in the nucleus accumbens (NAC) such modulation rarely occurs. The influence of food deprivation on MFB self-stimulation is the main basis for the hypothesis that electrical stimulation of the MFB can mimic the rewarding effect of food for hungry animals. To investigate this hypothesis, unit activity was recorded from the lateral hypothalamic area (LHA) of freely moving rats during rewarding stimulation at loci in both MFB and NAC, and during food ingestion. Of 63 neurons tested during MFB stimulation, 41 were inhibited, 19 were activated, and 3 were not influenced. NAC stimulation suppressed 8 of the 31 neurons tested, excited 16, and elicited no response in the remaining 7. During ingestion, 29 of the 63 neurons tested were inhibited and one was facilitated. Of 29 neurons suppressed by food, 20 were also inhibited by rewarding MFB stimulation, but 10 of 13 neurons inhibited by food were excited by rewarding NAC stimulation. Thus, most LHA neurons inhibited during feeding were also inhibited by rewarding MFB stimulation. Rewarding NAC stimulation, however, does not inhibit most LHA neurons that are inhibited by food. This result suggests that LHA neurons which are inhibited by food might be involved in mediation of the rewarding effect of electrical stimulation at some sites in the MFB. Nevertheless, self-stimulation may occur by activating reward processes other than those related to food, because rewarding NAC stimulation does not inhibit LHA neurons which are suppressed by food.',\n",
       "  'journal': 'Brain research',\n",
       "  'authors': 'Sasaki|K|K|;Ono|T|T|;Muramoto|K|K|;Nishino|H|H|;Fukuda|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150748',\n",
       "  'mesh_terms': 'D000200:Action Potentials; D000818:Animals; D001931:Brain Mapping; D004435:Eating; D007026:Hypothalamic Area, Lateral; D008297:Male; D008474:Medial Forebrain Bundle; D009434:Neural Pathways; D018377:Neurotransmitter Agents; D009714:Nucleus Accumbens; D051381:Rats; D011919:Rats, Inbred Strains; D012201:Reward; D012653:Self Stimulation; D012686:Septal Nuclei',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-8993(84)90110-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Brain Res',\n",
       "  'nlm_unique_id': '0045503',\n",
       "  'issn_linking': '0006-8993',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Pro-Leu-GlyNH2 affects dopamine and noradrenaline utilization in rat limbic-forebrain nuclei.',\n",
       "  'issue': '322(2)',\n",
       "  'pages': '213-8',\n",
       "  'abstract': 'The effects of Pro-Leu-GlyNH2 (PLG), administered i.c.v. in doses of 3.5, 35, 350 and 3500 pmol, were studied on the alpha-MPT-induced disappearance of catecholamines in microdissected rat brain nuclei. PLG, dose-dependently, increased dopamine disappearance in the nucleus caudatus and globus pallidus, whereas a decrease in dopamine disappearance was observed in the nucleus dorsomedialis. Noradrenaline disappearance was decreased in the medial septal nucleus, anterior hypothalamic area and lateral amygdala. A tendency towards an increase in noradrenaline disappearance was observed in the nucl. supraopticus. These data show that PLG has a central site of action. The effects of PLG on dopamine disappearance are comparable to those previously found with vasopressin, while the effects of PLG on noradrenaline utilization show a striking similarity with those previously obtained with oxytocin.',\n",
       "  'journal': 'Brain research',\n",
       "  'authors': 'van Heuven-Nolsen|D|D|;de Kloet|E R|ER|;Versteeg|D H|DH|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150749',\n",
       "  'mesh_terms': 'D000818:Animals; D001921:Brain; D004298:Dopamine; D007276:Injections, Intraventricular; D008032:Limbic System; D009075:MSH Release-Inhibiting Hormone; D008297:Male; D008781:Methyltyrosines; D009638:Norepinephrine; D051381:Rats; D011919:Rats, Inbred Strains; D009435:Synaptic Transmission; D019805:alpha-Methyltyrosine',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D008781:Methyltyrosines; D019805:alpha-Methyltyrosine; D009075:MSH Release-Inhibiting Hormone; D004298:Dopamine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-8993(84)90111-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Brain Res',\n",
       "  'nlm_unique_id': '0045503',\n",
       "  'issn_linking': '0006-8993',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '[Correction of posttraumatic loss of soft tissue in the area of the calf and foot].',\n",
       "  'issue': '82(5)',\n",
       "  'pages': '1310-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Bratislavske lekarske listy',\n",
       "  'authors': 'Maris|F|F|;Zboja|S|S|;Fedeles|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150751',\n",
       "  'mesh_terms': 'D000328:Adult; D005260:Female; D018409:Foot Injuries; D006801:Humans; D007869:Leg Injuries; D008297:Male; D008722:Methods; D016038:Skin Transplantation; D013524:Surgical Flaps',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Bratisl Lek Listy',\n",
       "  'nlm_unique_id': '0065324',\n",
       "  'issn_linking': '0006-9248',\n",
       "  'country': 'Slovakia'},\n",
       " {'title': \"Primate model of Parkinson's disease: alterations in multiple opioid systems in the basal ganglia.\",\n",
       "  'issue': '322(2)',\n",
       "  'pages': '356-60',\n",
       "  'abstract': \"A motor disorder similar to idiopathic Parkinson's Disease develops in rhesus monkeys after several daily repeated doses of N-methyl-4-phenyl, 1,2,3,6-tetrahydropyridine (MPTP). The concentrations of peptides derived from proenkephalin A, proenkephalin B, substance P and somatostatin were measured by specific radioimmunoassays in the basal ganglia of MPTP-treated monkeys. In MPTP-treated monkeys, dynorphin B concentration was reduced in the caudate. In the putamen, the concentrations of peptides derived from both proenkephalin A and proenkephalin B were decreased. In the globus pallidus, the concentrations of all opioid peptides tend to be increased, reaching significance only for alpha-neo-endorphin. In the substantia nigra, only Met-enkephalin concentration was reduced, while other peptides derived from either proenkephalin A or proenkephalin B were not changed. Substance P and somatostatin were not changed in any brain area examined. Some of the symptoms associated with Parkinson's Disease may be related to altered activity of endogenous opiates in basal ganglia.\",\n",
       "  'journal': 'Brain research',\n",
       "  'authors': 'Zamir|N|N|;Skofitsch|G|G|;Bannon|M J|MJ|;Helke|C J|CJ|;Kopin|I J|IJ|;Jacobowitz|D M|DM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150750',\n",
       "  'mesh_terms': 'D000818:Animals; D001479:Basal Ganglia; D004399:Dynorphins; D004723:Endorphins; D004743:Enkephalin, Leucine; D004744:Enkephalin, Methionine; D005260:Female; D008253:Macaca mulatta; D008297:Male; D009714:Nucleus Accumbens; D010300:Parkinson Disease; D011498:Protein Precursors; D013378:Substantia Nigra',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D004723:Endorphins; D011498:Protein Precursors; D004744:Enkephalin, Methionine; D004743:Enkephalin, Leucine; C025681:alpha-neoendorphin; D004399:Dynorphins; C033453:enkephalin-Met, Arg(6)-Gly(7)-Leu(8)-; C036200:rimorphin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0006-8993(84)90133-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Brain Res',\n",
       "  'nlm_unique_id': '0045503',\n",
       "  'issn_linking': '0006-8993',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Characteristics of skeletal muscle ecto-ATPase in situ.',\n",
       "  'issue': '62(10)',\n",
       "  'pages': '1015-26',\n",
       "  'abstract': \"The properties of a cell surface nucleoside 5'-triphosphatase have been studied in small, intact, frog skeletal muscles, as a means of distinguishing the enzyme from other adenosine 5'-triphosphatases and of understanding its behaviour in the muscle membrane. The ectoenzyme in situ was shown to be a Ca2+- or Mg2+-activated ATPase liberating 7.5 +/- 0.4 (mean +/- SEM, n = 30) mumol of inorganic phosphate/g of muscle per 20 min, when the muscle was exposed to 2 mM ATP and 2 mM Ca2+ in Ringer's solution. The apparent Km for Mg2+ was 0.74 mM and for Ca2+ was 0.23 mM. A residual ATPase activity (20%) was found in the complete absence of divalent cations suggesting the existence of two ATPase types. A broad specificity toward nucleoside 5'-triphosphates was exhibited by the ecto-ATPase, but there was no nonspecific phosphatase activity. The enzyme was inhibited by La3+ and Cd2+, but was insensitive to ouabain, 2,4-dinitrophenol, oligomycin, and ruthenium red. Thus the ectoenzyme was not a Na+, K+-transport ATPase, was not an ATPase of mitochondrial origin, or a Ca2+-transport enzyme. Insulin had no effect. Inhibition by mersalyl, carbodiimide, and polar and cross-linking nonpolar nitrobenzene derivatives suggested that, for maximum activity, this membrane-bound enzyme required free sulfhydryl groups, certain free carboxyls, and an appreciable degree of hydrophobicity in its microenvironment.\",\n",
       "  'journal': 'Canadian journal of biochemistry and cell biology = Revue canadienne de biochimie et biologie cellulaire',\n",
       "  'authors': 'Manery|J F|JF|;Dryden|E E|EE|;Still|J S|JS|;Madapallimattam|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150752',\n",
       "  'mesh_terms': 'D009597:4-Nitrophenylphosphatase; D000251:Adenosine Triphosphatases; D000818:Animals; D002118:Calcium; D004139:Dinitrofluorobenzene; D007328:Insulin; D007811:Lanthanum; D008274:Magnesium; D009132:Muscles; D009711:Nucleotides; D011894:Rana pipiens; D014302:Trinitrobenzenesulfonic Acid',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007328:Insulin; D009711:Nucleotides; D007811:Lanthanum; D014302:Trinitrobenzenesulfonic Acid; D004139:Dinitrofluorobenzene; D009597:4-Nitrophenylphosphatase; D000251:Adenosine Triphosphatases; C027201:ectoATPase; D008274:Magnesium; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1139/o84-130',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Can J Biochem Cell Biol',\n",
       "  'nlm_unique_id': '8302763',\n",
       "  'issn_linking': '0714-7511',\n",
       "  'country': 'Canada'},\n",
       " {'title': 'Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.',\n",
       "  'issue': '48(4)',\n",
       "  'pages': '381-9',\n",
       "  'abstract': 'Two dogs were diagnosed as malignant hyperthermia susceptible based on increased susceptibility (P less than 0.001) of biopsied muscle to caffeine-induced contracture. Erythrocytes from malignant hyperthermia and normal dogs were then examined for an antioxidant system deficiency. Values for serum muscle enzymes, reticulocytes and corpuscular hemoglobin were mildly elevated. Osmotic fragility was increased: hemolysis occurred at a NaCl concentration 10 mM higher than for normal dogs (P less than 0.001). A 35% glucose-6-phosphate dehydrogenase deficiency (P less than 0.001) with a 40% compensatory increase (P less than 0.01) in 6-phosphogluconate dehydrogenase activity was found. The membrane Ca2+-activated ATPase activity was abnormal: 100% increased with a 40% decreased Arrhenius activation energy (P less than 0.005) and increased thermostability. A 40% increased intracellular accumulation of total Ca2+ occurred in response to in vitro energy depletion in erythrocytes from one malignant hyperthermia dog (P less than 0.01). The multifactorial pattern of inheritance and the broad spectrum of malignant hyperthermia susceptibility are proposed to result from an antioxidant system deficit unmasking or aggravating an intrinsic muscle membrane anomaly. An individual from a family with a history of malignant hyperthermia or unexplained anesthetic death should be considered malignant hyperthermia susceptible if erythrocyte osmotic fragility is abnormal and there is a mild, unexplained elevation in serum creatine kinase.',\n",
       "  'journal': 'Canadian journal of comparative medicine : Revue canadienne de medecine comparee',\n",
       "  'authors': \"O'Brien|P J|PJ|;Forsyth|G W|GW|;Olexson|D W|DW|;Thatte|H S|HS|;Addis|P B|PB|\",\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150753',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002118:Calcium; D000252:Calcium-Transporting ATPases; D003937:Diagnosis, Differential; D004198:Disease Susceptibility; D004283:Dog Diseases; D004285:Dogs; D004910:Erythrocyte Membrane; D004912:Erythrocytes; D005954:Glucosephosphate Dehydrogenase; D006706:Homeostasis; D008305:Malignant Hyperthermia; D009996:Osmotic Fragility',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D005954:Glucosephosphate Dehydrogenase; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '391720;13061491;6992527;13967893;7340576;6846875;17422273;7094350;6762057;510535;5080613;130084;6124239;7070707;6458341;6066618;7288598;17422267;6125163;6821655;6117080;4758363;7378148;599093;4433061;4782558;391722;14264615;13105646;7156171;6886007;1100438;13441;4704063;4272689;391721;4140360;6999950;621430;573559;460305;6892980;7109537;6453544;1257632;6112944;514315;4753682;7291194;14131784;7271037;7236474;4818200;37532;738969',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Can J Comp Med',\n",
       "  'nlm_unique_id': '0151747',\n",
       "  'issn_linking': '0008-4050',\n",
       "  'country': 'Canada'},\n",
       " {'title': 'Adaptational changes in Staphylococcus aureus MF31 grown above its maximum temperature when protected by NaCl: physiological studies.',\n",
       "  'issue': '30(9)',\n",
       "  'pages': '1105-11',\n",
       "  'abstract': 'Staphylococcus aureus MF31 can grow at 46 degrees C, 2 degrees C above its normal maximum temperature of growth if 1 M NaCl is added to the medium. In the present work we show that monosodium glutamate, proline, threonine, aspartic acid, and betaine (in order of decreasing effectiveness) also enabled cells to grow at 46 degrees C. Cells grown at 46 degrees C in he presence of salt (protected or P cells) accumulated glutamate more rapidly than cells grown at 37 degrees C without salt (normal or N cells) and contained an increased amino acid pool. The principal constituents of this pool were dicarboxylic amino acids and proline. Turbidimetric evidence suggests that NaCl caused plasmolysis in S. aureus. The P cells, although grown in 1 M NaCl, had about the same Cl- and K+ content as the N cells grown without added NaCl. P cells had increased heat resistance but high concentrations of CaCl2 in the heating menstruum reduced their D55 value from a maximum of 214 min to less than 30 s. We suggest that growth at 46 degrees C in 1 M NaCl can be explained, in part at least, by the increased amino acid pool internal to the cell and the external osmotic support given by Cl- anions excluded by the cell.',\n",
       "  'journal': 'Canadian journal of microbiology',\n",
       "  'authors': 'Hurst|A|A|;Ofori|E|E|;El-Banna|A A|AA|;Harwig|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150754',\n",
       "  'mesh_terms': 'D000222:Adaptation, Physiological; D000596:Amino Acids; D001622:Betaine; D001692:Biological Transport; D005971:Glutamates; D018698:Glutamic Acid; D007700:Kinetics; D012965:Sodium Chloride; D013211:Staphylococcus aureus; D013696:Temperature',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000596:Amino Acids; D005971:Glutamates; D018698:Glutamic Acid; D001622:Betaine; D012965:Sodium Chloride',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1139/m84-173',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Can J Microbiol',\n",
       "  'nlm_unique_id': '0372707',\n",
       "  'issn_linking': '0008-4166',\n",
       "  'country': 'Canada'},\n",
       " {'title': 'Positive serological evidence that Hantaan virus, the etiologic agent of hemorrhagic fever with renal syndrome, is endemic in Canada.',\n",
       "  'issue': '30(9)',\n",
       "  'pages': '1137-40',\n",
       "  'abstract': 'Hemorrhagic fever with renal syndrome is endemic in most parts of the world. The etiological agent in known as Hantaan virus. More than 2000 Canadian sera from all age groups and provinces were tested for the presence of antibody to this virus by the indirect immunofluorescent antibody technique. The frequency of seropositivity ranged from 0.3 to 4.0%, with the national average being 1.4%. Newfoundland and New Brunswick in the Atlantic region had the highest positivity, being higher than hyperendemic areas in Korea. The inland provinces of Ontario, Manitoba, and Alberta had only 0.5% positives to Hantaan virus. In contrast, approximately 1.5% of sera from Saskatchewan, Quebec, and British Columbia were positive. No correlation in positivity was found between geography or sex, but positivity did increase with age. The highest titres were found in the group aged 65 to 93 years.',\n",
       "  'journal': 'Canadian journal of microbiology',\n",
       "  'authors': 'Lee|H W|HW|;Seong|I W|IW|;Baek|L J|LJ|;McLeod|D A|DA|;Seo|S S|SS|;Kang|C Y|CY|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150755',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000914:Antibodies, Viral; D001116:Arenaviridae; D002170:Canada; D002648:Child; D005260:Female; D005455:Fluorescent Antibody Technique; D006480:Hemorrhagic Fever with Renal Syndrome; D006801:Humans; D008297:Male; D008875:Middle Aged; D012703:Serotyping',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013486:Research Support, U.S. Gov't, Non-P.H.S.\",\n",
       "  'chemical_list': 'D000914:Antibodies, Viral',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1139/m84-178',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Can J Microbiol',\n",
       "  'nlm_unique_id': '0372707',\n",
       "  'issn_linking': '0008-4166',\n",
       "  'country': 'Canada'},\n",
       " {'title': 'The question of lithium/neuroleptic toxicity.',\n",
       "  'issue': '29(7)',\n",
       "  'pages': '601-4',\n",
       "  'abstract': 'The question of lithium-haloperidol incompatibility has been debated for a number of years now. The difficulty remains in distinguishing a combined toxicity syndrome, rather than toxicity to either agent alone. The authors reviewed a further case of adverse drug response following the concomitant use of lithium and haloperidol. It is their conclusion that a combined toxicity syndrome does exist, although it remains for future investigations to determine whether this effect is additive or synergistic. Finally, the possibility of underlying organic susceptibility is raised with reference to the case presented here.',\n",
       "  'journal': 'Canadian journal of psychiatry. Revue canadienne de psychiatrie',\n",
       "  'authors': 'Jeffries|J|J|;Remington|G|G|;Wilkins|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150756',\n",
       "  'mesh_terms': 'D000328:Adult; D014150:Antipsychotic Agents; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006220:Haloperidol; D006801:Humans; D008094:Lithium; D008297:Male',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D008094:Lithium; D006220:Haloperidol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/070674378402900711',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Can J Psychiatry',\n",
       "  'nlm_unique_id': '7904187',\n",
       "  'issn_linking': '0706-7437',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The use of carbamazepine as an adjunctive medication in the treatment of affective disorders: a clinical report.',\n",
       "  'issue': '29(7)',\n",
       "  'pages': '605-8',\n",
       "  'abstract': 'This is a report of an open clinical trial of Carbamazepine in the treatment of patients who suffered from affective disorders and who did not have an adequate response to Lithium or other medications. Our findings suggest that Carbamazepine can be a useful adjunctive medication when used in combination with Lithium and other psychotropic medications. The characteristics of the patients who responded were examined. The clinical state of the patients at the point of intervention varied; eight patients were manic and four patients were depressed. Four patients were judged to have had markedly effective responses, four showed an effective response and in four there was a slightly effective response. From the duration of the trials it was evident that in cases where Carbamazepine produced a good response its effect was seen as early as two weeks. The mean daily dose used varied from 300-1300 mgs. Because of the open nature of this trial, Carbamazepine was not withdrawn except in one instance.',\n",
       "  'journal': 'Canadian journal of psychiatry. Revue canadienne de psychiatrie',\n",
       "  'authors': 'Kwamie|Y|Y|;Persad|E|E|;Stancer|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150757',\n",
       "  'mesh_terms': 'D000328:Adult; D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D001714:Bipolar Disorder; D002220:Carbamazepine; D003866:Depressive Disorder; D004351:Drug Resistance; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008094:Lithium; D008297:Male; D008875:Middle Aged; D011618:Psychotic Disorders',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D002220:Carbamazepine; D008094:Lithium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/070674378402900712',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Can J Psychiatry',\n",
       "  'nlm_unique_id': '7904187',\n",
       "  'issn_linking': '0706-7437',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Diet and drug interactions in the treatment of mental illness--a review.',\n",
       "  'issue': '29(7)',\n",
       "  'pages': '609-13',\n",
       "  'abstract': \"Drug-diet interactions in the treatment of mental illness are reviewed from two perspectives: the potential effects of drugs on a person's nutritional status, and the effect of diet on drug action through modification of its absorption or various stages of its metabolism. As mental illness is often chronic and recurrent, requiring long-term drug therapy, it is important to become aware of the effects of drugs and their possible interactions with other important factors such as food.\",\n",
       "  'journal': 'Canadian journal of psychiatry. Revue canadienne de psychiatrie',\n",
       "  'authors': 'Awad|A G|AG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150758',\n",
       "  'mesh_terms': 'D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D001066:Appetite; D003069:Coffee; D004032:Diet; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D007408:Intestinal Absorption; D007668:Kidney; D008094:Lithium; D008099:Liver; D001523:Mental Disorders; D010640:Phenothiazines; D011619:Psychotropic Drugs; D011736:Pyridoxine',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000929:Antidepressive Agents, Tricyclic; D014150:Antipsychotic Agents; D003069:Coffee; D010640:Phenothiazines; D011619:Psychotropic Drugs; D008094:Lithium; D011736:Pyridoxine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/070674378402900713',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Can J Psychiatry',\n",
       "  'nlm_unique_id': '7904187',\n",
       "  'issn_linking': '0706-7437',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Enhancement of phenotypic instability by alpha-difluoromethylornithine and butylated hydroxyanisole in rapidly induced rat liver lesions.',\n",
       "  'issue': '25(2)',\n",
       "  'pages': '145-51',\n",
       "  'abstract': 'The effects of alpha-difluoromethylornithine (DFMO), butylated hydroxyanisole (BHA), sodium phenobarbital (PB) and 2-acetylaminofluorene (AAF) administration on the further development of rat liver nodular lesions induced in a short-term system were investigated. The results clearly demonstrated an association between DFMO and BHA treatment with reduction in numbers of persisting nodules as assayed histopathologically and by analysis of gamma-glutamyltranspeptidase (gamma GT) and glucose-6-phosphate dehydrogenase (G6PDH) positive populations. PB and to a lesser extent AAF, on the other hand, appeared to exert an opposite effect, apparently enhancing the phenotypic stability of the nodular putative preneoplastic lesions.',\n",
       "  'journal': 'Cancer letters',\n",
       "  'authors': 'Moore|M A|MA|;Tsuda|H|H|;Ogiso|T|T|;Mera|Y|Y|;Ito|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150759',\n",
       "  'mesh_terms': 'D015073:2-Acetylaminofluorene; D000818:Animals; D000840:Anisoles; D002083:Butylated Hydroxyanisole; D004052:Diethylnitrosamine; D000518:Eflornithine; D005954:Glucosephosphate Dehydrogenase; D008099:Liver; D008114:Liver Neoplasms, Experimental; D008297:Male; D009952:Ornithine; D065108:Ornithine Decarboxylase Inhibitors; D010634:Phenobarbital; D010641:Phenotype; D051381:Rats; D011916:Rats, Inbred F344; D013268:Stimulation, Chemical; D013997:Time Factors; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000840:Anisoles; D065108:Ornithine Decarboxylase Inhibitors; D002083:Butylated Hydroxyanisole; D004052:Diethylnitrosamine; D015073:2-Acetylaminofluorene; D009952:Ornithine; D005954:Glucosephosphate Dehydrogenase; D005723:gamma-Glutamyltransferase; D010634:Phenobarbital; D000518:Eflornithine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/s0304-3835(84)80039-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cancer Lett',\n",
       "  'nlm_unique_id': '7600053',\n",
       "  'issn_linking': '0304-3835',\n",
       "  'country': 'Ireland'},\n",
       " {'title': 'Astroglial cells: glucocorticoid target cells in the brain.',\n",
       "  'issue': '7(4)',\n",
       "  'pages': '296-302',\n",
       "  'abstract': \"Glutamine synthetase (GS), an enzyme localized in astroglial cells in the brain, is directly implicated in brain detoxification. An ontogenic study of GS activity was performed in homogenates from four distinct brain areas in comparison with the respective astrocytes obtained in primary cultures. GS was induced by hydrocortisone in the astrocytes of all brain areas studied; only cerebellum and cerebral hemisphere astroglial cells had a higher specific activity when compared with the corresponding homogenates. N6O2-Dibutyryl adenosine 3',5'-cyclic monophosphate (dBc AMP), insulin, soluble brain factors, and noradrenaline (NA) were also able to modulate GS activity. Brain factors as well as dBc AMP interfered with hydrocortisone induction of GS. Regulation by hydrocortisone paralleled the variation in its concentration in brain during development. We conclude that astroglial cells are target cells for glucocorticoids, which may modulate ammonia detoxification in these cells.\",\n",
       "  'journal': 'Clinical neuropharmacology',\n",
       "  'authors': 'Tardy|M|M|;Rolland|B|B|;Fages|C|C|;Caldani|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150760',\n",
       "  'mesh_terms': 'D000818:Animals; D001253:Astrocytes; D002478:Cells, Cultured; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids; D005974:Glutamate-Ammonia Ligase; D051379:Mice; D013347:Subcellular Fractions; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005938:Glucocorticoids; D005974:Glutamate-Ammonia Ligase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Neuropharmacol',\n",
       "  'nlm_unique_id': '7607910',\n",
       "  'issn_linking': '0362-5664',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Effect of dexamethasone on glutamine synthetase and glial fibrillary acidic protein in normal and transformed astrocytes.',\n",
       "  'issue': '7(4)',\n",
       "  'pages': '303-6',\n",
       "  'abstract': 'The effect of dexamethasone on astrocyte differentiation was investigated in vitro, using cultures of normal and transformed astrocytes. The astrocyte-enriched proteins glutamine synthetase (GS) and glial fibrillary acidic (GFA) protein were used as markers of astrocyte differentiation. Ethanol, the vehicle for dexamethasone, decreases GS activity and increases GFA protein concentration in cultures of the established cell line U251MG and in the majority of cultures of transformed astrocytes derived from varying grades of astrocytoma. Ethanol has no effect on primary cultures of astrocytes derived from immature rat brain. Dexamethasone increases GS activity and decreases GFA protein concentration in cultures of U251MG and a grade IV astrocytoma-derived culture, in comparison with ethanol control. Our results show differential effects of two factors on cell-specific proteins in normal and transformed astrocytes.',\n",
       "  'journal': 'Clinical neuropharmacology',\n",
       "  'authors': 'Weir|M D|MD|;Thomas|D G|DG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150761',\n",
       "  'mesh_terms': 'D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes; D002454:Cell Differentiation; D002478:Cells, Cultured; D003907:Dexamethasone; D005904:Glial Fibrillary Acidic Protein; D005974:Glutamate-Ammonia Ligase; D051381:Rats',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005904:Glial Fibrillary Acidic Protein; D003907:Dexamethasone; D005974:Glutamate-Ammonia Ligase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1097/00002826-198412000-00005',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Neuropharmacol',\n",
       "  'nlm_unique_id': '7607910',\n",
       "  'issn_linking': '0362-5664',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Catecholamine-synthesizing enzymes in paraganglia of aged Fischer-344 rats. Immunohistochemistry and fluorescence microscopy.',\n",
       "  'issue': '238(2)',\n",
       "  'pages': '217-20',\n",
       "  'abstract': 'The catecholamine-synthesizing enzymes, tyrosine hydroxylase, dopamine-beta-hydroxylase and phenylethanolamine-N-methyltransferase were examined by immunohistochemistry in hypertrophied paraganglia of aged male Fischer-344 rats. All paraganglionic cells reacted with antibodies against tyrosine hydroxylase. Dopamine beta-hydroxylase was identified in most paraganglionic cells, indicating that they synthesized norepinephrine. A variable number of paraganglia were positive for phenylethanolamine-N-methyltransferase, which suggested that they synthesized epinephrine. The formaldehyde-induced fluorescence method demonstrated greenish-yellow fluorescence or yellowish-brown fluorescence. The intensity of the fluorescence was in the same range as in adrenal medullary cells. The observations indicate that paraganglia are capable of synthesizing epinephrine.',\n",
       "  'journal': 'Cell and tissue research',\n",
       "  'authors': 'Partanen|M|M|;Rapoport|S I|SI|;Reis|D J|DJ|;Joh|T H|TH|;Stolk|J M|JM|;Linnoila|I|I|;Teitelman|G|G|;Hervonen|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150762',\n",
       "  'mesh_terms': 'D000818:Animals; D002838:Chromaffin System; D004299:Dopamine beta-Hydroxylase; D007124:Immunoenzyme Techniques; D008856:Microscopy, Fluorescence; D010233:Paraganglia, Chromaffin; D010625:Phenylethanolamine N-Methyltransferase; D051381:Rats; D011916:Rats, Inbred F344; D011919:Rats, Inbred Strains; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D014446:Tyrosine 3-Monooxygenase; D004299:Dopamine beta-Hydroxylase; D010625:Phenylethanolamine N-Methyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00217291',\n",
       "  'references': '7031223;569437;7020323;4825476;29697;6162566;4389496;7305034;4631087;24279940;4147606;21018;19605278;14220015;237128;5452308;7035256;5656462;1022722;941850;6160735;4398764;33743;5029377;12170593;5542038',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cell Tissue Res',\n",
       "  'nlm_unique_id': '0417625',\n",
       "  'issn_linking': '0302-766X',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Development of immunoreactive somatostatin in C-cell complexes in the thyroid gland of the dog.',\n",
       "  'issue': '238(2)',\n",
       "  'pages': '263-9',\n",
       "  'abstract': 'In connection with our previous finding that an intense immunoreaction to somatostatin transiently appears in thyroid C cells of the dog during early fetal periods, the present study investigated C-cell complexes in thyroid glands from early fetuses to adults in an attempt to clarify whether the transient appearance of immunoreactivity to somatostatin is dependent on the degree of differentiation of C cells. C-cell complexes retain their fetal characteristics; even in the complexes of postnatal dogs, there are numerous undifferentiated cells, immature C cells and primitive follicular cells, which are not yet organized into follicles. Neither the degree of differentiation of C cells nor that of other constituent elements of the complexes affected the developmental pattern of somatostatin immunoreactivity in C cells. The C cells located in complexes displayed the same pattern of developmental changes in immunoreactivity to somatostatin as the cells in thyroid parenchyma. In the C-cell complexes of early fetal dogs a very intense immunoreactivity for somatostatin was observed; almost all calcitonin-positive cells were also somatostatin positive. The immunoreactivity to somatostatin progressively decreased with age. In the postnatal complexes the number of somatostatin-positive cells was very small compared with that of calcitonin-positive cells.',\n",
       "  'journal': 'Cell and tissue research',\n",
       "  'authors': 'Kameda|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150763',\n",
       "  'mesh_terms': 'D000818:Animals; D000831:Animals, Newborn; D002116:Calcitonin; D002454:Cell Differentiation; D007124:Immunoenzyme Techniques; D013004:Somatostatin; D013961:Thyroid Gland',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013004:Somatostatin; D002116:Calcitonin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00217298',\n",
       "  'references': '334709;378263;6129819;4104028;6993005;6994887;7030141;88429;6104538;6763510;105881;6143519;489420',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cell Tissue Res',\n",
       "  'nlm_unique_id': '0417625',\n",
       "  'issn_linking': '0302-766X',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Somatostatin in the brain and the pituitary of some teleosts. Immunocytochemical identification and the effect of starvation.',\n",
       "  'issue': '238(2)',\n",
       "  'pages': '289-96',\n",
       "  'abstract': 'Immunocytochemical investigations show that somatostatin (SRIF)-like immunoreactive material is present in the brain and the pituitary of nine different species of teleosts. In the brain, immunoreactive perikarya and fibers are observed in the preoptic periventricular nucleus, the entopeduncular nucleus, the anterior periventricular nucleus, and the nucleus lateralis tuberis. In the pituitary, SRIF-like-immunoreactive fibers occur in the proximal pars distalis (PPD), which contains the growth hormone (GH)-secreting cells. Nerve fibers are scattered among GH cells (cyprinids), or end on the basal lamina at the neuroglandular interface of the PPD (eel, salmonids). In the eel, the proximal neurohypophysis does not penetrate deeply into the PPD that is very poorly vascularized. In some species, e.g. Myoxocephalus, SRIF-like immunoreactive fibers are also observed in the caudal neurohypophysis, and even among MSH cells of the pars intermedia. In long-term starved carps and eels, the amount of SRIF-like material in the pituitary is clearly reduced. A possible role of SRIF in the concomitant stimulation of GH cells is discussed.',\n",
       "  'journal': 'Cell and tissue research',\n",
       "  'authors': 'Olivereau|M|M|;Ollevier|F|F|;Vandesande|F|F|;Olivereau|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150764',\n",
       "  'mesh_terms': 'D000818:Animals; D001921:Brain; D005399:Fishes; D007124:Immunoenzyme Techniques; D010902:Pituitary Gland; D013004:Somatostatin; D013217:Starvation',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D013004:Somatostatin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00217300',\n",
       "  'references': '4379424;4997611;328151;2860048;6406907;4447975;4463706;571798;6137283;114314;7471185;499752;4193488;979655;6292724;7026355;6173210;4442692;376398;6862173;6894287;6148147;6124310;6362609;499075;6618153;902177',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cell Tissue Res',\n",
       "  'nlm_unique_id': '0417625',\n",
       "  'issn_linking': '0302-766X',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Immunocytological localization of a somatostatin-like substance in the brain of the giant slug, Limax maximus L.',\n",
       "  'issue': '238(2)',\n",
       "  'pages': '349-53',\n",
       "  'abstract': 'Immunocytological tests reveal the presence of a somatostatin-like substance in perikarya and axons in the brain of the giant slug Limax maximus L. Controls carried out on adjacent sections with absorbed antiserum or different antibodies raised against several biologically active peptides of vertebrates (ACTH-17-39, alpha- and beta endorphin, alpha- and beta MSH, methionin-enkephalin, TRH) demonstrate the specificity of the \"staining\". However, some cells are both somatostatin- and FMRF-amide-positive. In the cerebral ganglia, the right Z-area cells, responsible for the synthesis of the maturation hormone (MH) are strongly somatostatin-positive. These results suggest a similarity between the MH and the somatostatin-like material contained in the Z-area cells. The simultaneous presence of two peptides in one and the same cell, the nature (elementary granules or soluble product) of the material, and its site of release are discussed.',\n",
       "  'journal': 'Cell and tissue research',\n",
       "  'authors': 'Marchand|C R|CR|;Sokolove|P G|PG|;Dubois|M P|MP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150765',\n",
       "  'mesh_terms': 'D000818:Animals; D001921:Brain; D004744:Enkephalin, Methionine; D019835:FMRFamide; D005455:Fluorescent Antibody Technique; D007124:Immunoenzyme Techniques; D008974:Mollusca; D009842:Oligopeptides; D013004:Somatostatin',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D009842:Oligopeptides; D013004:Somatostatin; D004744:Enkephalin, Methionine; D019835:FMRFamide',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00217307',\n",
       "  'references': '6131013;7186531;6176023;5454872;6112067;112215;6104654;165422;947221;6168739',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cell Tissue Res',\n",
       "  'nlm_unique_id': '0417625',\n",
       "  'issn_linking': '0302-766X',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Expression of preprosomatostatin in heterologous cells: biosynthesis, posttranslational processing, and secretion of mature somatostatin.',\n",
       "  'issue': '39(3 Pt 2)',\n",
       "  'pages': '547-55',\n",
       "  'abstract': 'Somatostatin is a 14 amino acid peptide hormone that is synthesized as part of a larger precursor, preprosomatostatin, which comprises about 120 amino acids. The overall organization of the precursor is conserved in many species in that it consists of a signal peptide followed by a proregion of 90-100 amino acids and the mature hormone is located at the carboxyl terminus of the molecule. To understand the role of the propeptide in generating the mature hormone, we have used gene-transfer experiments to introduce angler fish preprosomatostatin into mammalian cells. Here we report the results of transfection of COS-7 cells with an SV40 expression vector containing preprosomatostatin cDNA cloned into the VP-1 late gene. Analysis of the parameters of somatostatin gene expression showed that COS cells synthesized prosomatostatin, which was detected intracellularly; the prosomatostatin, was proteolytically processed to mature somatostatin; and the mature hormone was secreted by the COS cells into the tissue culture medium. Our results suggest that COS cells, which do not normally secrete polypeptide hormones, contain the necessary proteolytic processing enzymes to convert preprosomatostatin to the mature hormone and the cellular apparatus necessary for its secretion.',\n",
       "  'journal': 'Cell',\n",
       "  'authors': 'Warren|T G|TG|;Shields|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150766',\n",
       "  'mesh_terms': 'D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D004247:DNA; D004262:DNA Restriction Enzymes; D005399:Fishes; D007668:Kidney; D010957:Plasmids; D014176:Protein Biosynthesis; D011498:Protein Precursors; D011499:Protein Processing, Post-Translational; D013539:Simian virus 40; D013004:Somatostatin; D014162:Transfection',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D011498:Protein Precursors; D013004:Somatostatin; D004247:DNA; D004262:DNA Restriction Enzymes',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0092-8674(84)90461-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cell',\n",
       "  'nlm_unique_id': '0413066',\n",
       "  'issn_linking': '0092-8674',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Biotransformation of oxyprothepine by the monoxygenase system in the liver of rats].',\n",
       "  'issue': '33(9)',\n",
       "  'pages': '385-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Ceskoslovenska farmacie',\n",
       "  'authors': 'Paulíková|I|I|;Helia|O|O|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150767',\n",
       "  'mesh_terms': 'D000818:Animals; D001711:Biotransformation; D003988:Dibenzothiepins; D066298:In Vitro Techniques; D008099:Liver; D008297:Male; D010105:Oxygenases; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D003988:Dibenzothiepins; D010105:Oxygenases',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Cesk Farm',\n",
       "  'nlm_unique_id': '0372720',\n",
       "  'issn_linking': '0009-0530',\n",
       "  'country': 'Czech Republic'},\n",
       " {'title': 'Early liver alterations induced by the sex-dependent hepatocarcinogen beta-blocker ZAMI 1305.',\n",
       "  'issue': '52(2)',\n",
       "  'pages': '203-12',\n",
       "  'abstract': 'Liver alterations occurring after 1, 6 or 10 days of treatment with the hepatocarcinogen beta-blocker DL-1-(2-nitro-3-methyl-phenoxy)-3-tert-butyl-amino-propan-2-ol (ZAMI 1305) were studied in male and female Wistar rats. In agreement with its sex-dependent oncogenicity, ZAMI 1305 administration causes DNA damage in the liver of the female but not of the male rat, with the only exception of 2 out of 4 males treated for 6 days. In female rat, the amount of DNA damage increases from 1 to 6 days of treatment, being unchanged at 10 days; a small portion of DNA is however damaged. ZAMI 1305 administration to female rat induces also: (i) an increase of the relative liver weight, of the DNA and RNA synthesizing activity; (ii) a decrease of the number of hepatocytes in mitosis; (iii) a minimal oval cell hyperplasia. When the same parameters were studied in ZAMI 1305-treated male rats, they were unaffected or changed to a less extent in respect to female rats.',\n",
       "  'journal': 'Chemico-biological interactions',\n",
       "  'authors': 'Presta|M|M|;Mazzocchi|C|C|;Ziliani|S|S|;Zavanella|T|T|;Ragnotti|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150768',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000818:Animals; D001219:Aspartate Aminotransferases; D002273:Carcinogens; D002467:Cell Nucleus; D004261:DNA Replication; D005260:Female; D008099:Liver; D008297:Male; D011412:Propanolamines; D051381:Rats; D011919:Rats, Inbred Strains; D012737:Sex Factors; D014158:Transcription, Genetic',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D002273:Carcinogens; D011412:Propanolamines; C028475:ZAMI 1305; D001219:Aspartate Aminotransferases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0009-2797(84)90073-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Chem Biol Interact',\n",
       "  'nlm_unique_id': '0227276',\n",
       "  'issn_linking': '0009-2797',\n",
       "  'country': 'Ireland'},\n",
       " {'title': 'Development of a gonorrhoea vaccine: prospects, strategies and tactics.',\n",
       "  'issue': '62(5)',\n",
       "  'pages': '671-80',\n",
       "  'abstract': '',\n",
       "  'journal': 'Bulletin of the World Health Organization',\n",
       "  'authors': 'Gotschlich|E C|EC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150769',\n",
       "  'mesh_terms': 'D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D005260:Female; D010861:Fimbriae, Bacterial; D006801:Humans; D008297:Male; D009344:Neisseria gonorrhoeae; D010447:Peptide Hydrolases; D012697:Serine Endopeptidases',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000942:Antigens, Bacterial; D000954:Antigens, Surface; D001425:Bacterial Outer Membrane Proteins; D001428:Bacterial Vaccines; D010447:Peptide Hydrolases; D012697:Serine Endopeptidases; C021433:IgA-specific serine endopeptidase',\n",
       "  'keywords': 'Antibodies; Antibody Formation; Biology; Delivery Of Health Care; Diseases--prevention and control; Examinations And Diagnoses; Health; Health Services; Immunity; Immunity, Natural; Immunization; Immunologic Factors; Infections; Laboratory Examinations And Diagnoses; Measurement; Medicine; Physiology; Prevalence; Preventive Medicine; Primary Health Care; Public Health; Reproductive Tract Infections; Sexually Transmitted Diseases--analysis; Sexually Transmitted Diseases--prevention and control; Vaccination',\n",
       "  'doi': '',\n",
       "  'references': '412791;4209721;4198720;14047217;415006',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '028862; 00140455',\n",
       "  'medline_ta': 'Bull World Health Organ',\n",
       "  'nlm_unique_id': '7507052',\n",
       "  'issn_linking': '0042-9686',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Studies in constitutionally tall adolescents: somatostatin decrease associated with growth hormone increase after TRH injection.',\n",
       "  'issue': '21(4)',\n",
       "  'pages': '459-63',\n",
       "  'abstract': \"The paradoxical GH response to TRH observed in certain adolescents with constitutional tall stature is associated with a 60% fall in plasma levels of somatostatin. Conversely, those tall subjects who do not show a GH increase after TRH, or during a saline control infusion maintain steady levels of somatostatin in plasma. It is thus hypothesized that the GH release after TRH is due to a decreased inhibitory effect of somatostatin at the pituitary level and that this reduced effect may play an aetiological role in certain children with 'constitutional' tall stature.\",\n",
       "  'journal': 'Clinical endocrinology',\n",
       "  'authors': 'Garcia Blanco|M|M|;Evain Brion|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150770',\n",
       "  'mesh_terms': 'D000293:Adolescent; D001827:Body Height; D002648:Child; D005260:Female; D006130:Growth Disorders; D013006:Growth Hormone; D006801:Humans; D008297:Male; D010455:Peptides; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D010455:Peptides; C029993:somatostatin-like peptides; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D013006:Growth Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2265.1984.tb03232.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Endocrinol (Oxf)',\n",
       "  'nlm_unique_id': '0346653',\n",
       "  'issn_linking': '0300-0664',\n",
       "  'country': 'England'},\n",
       " {'title': 'Studies on the mechanisms of somatostatin release after insulin induced hypoglycaemia in man.',\n",
       "  'issue': '21(6)',\n",
       "  'pages': '667-75',\n",
       "  'abstract': 'Insulin-induced hypoglycaemia, which stimulates gastric acid secretion, is associated with an increase in circulating somatostatin levels in man. In order to assess the mechanisms involved in this rise, six normal volunteers connected to a Biostator for continuous glucose monitoring were studied, on three separate occasions. On each occasion after basal blood sampling, 0.15 i.u./kg body weight of insulin was administered i.v. and further samples were obtained intermittently over 150 min. On one occasion, dextrose was infused by the Biostator to prevent hypoglycaemia, while on the other two, a constant infusion of either normal saline or the specific H2 antagonist cimetidine was administered. Insulin plus dextrose caused no significant changes in circulating somatostatin levels, whereas insulin plus saline was associated with a marked, sustained and significant rise in all subjects; insulin plus cimetidine also produced a rise but it was delayed; the area under the curve was significantly (P less than 0.05) greater with insulin plus saline than with insulin plus cimetidine. These results show that in man insulin itself does not stimulate somatostatin secretion directly, but indirectly via hypoglycaemia. Further, the inhibition of gastric acid secretion with cimetidine reduces somatostatin release during insulin-induced hypoglycaemia. This suggests that gastric acid may mediate somatostatin secretion associated with insulin-induced hypoglycaemia.',\n",
       "  'journal': 'Clinical endocrinology',\n",
       "  'authors': 'Webb|S|S|;Levy|I|I|;Wass|J A|JA|;Llorens|A|A|;Penman|E|E|;Casamitjana|R|R|;Wu|P|P|;Gaya|J|J|;Martínez|M J|MJ|;Rivera|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150771',\n",
       "  'mesh_terms': 'D000328:Adult; D001786:Blood Glucose; D002927:Cimetidine; D005744:Gastric Acid; D005934:Glucagon; D005947:Glucose; D013006:Growth Hormone; D006801:Humans; D006854:Hydrocortisone; D007003:Hypoglycemia; D007328:Insulin; D008297:Male; D012636:Secretory Rate; D013004:Somatostatin',\n",
       "  'publication_types': 'D016430:Clinical Trial; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; D002927:Cimetidine; D013006:Growth Hormone; D005934:Glucagon; D005947:Glucose; D006854:Hydrocortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2265.1984.tb01409.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Endocrinol (Oxf)',\n",
       "  'nlm_unique_id': '0346653',\n",
       "  'issn_linking': '0300-0664',\n",
       "  'country': 'England'},\n",
       " {'title': 'Growth hormone responsiveness to human pancreatic growth hormone releasing factor in acromegaly: modulatory effects of basal hormone levels and of concomitant somatostatin administration.',\n",
       "  'issue': '21(6)',\n",
       "  'pages': '701-7',\n",
       "  'abstract': 'Human pancreatic growth hormone releasing factor 1-44 (hpGRF), 100 micrograms was administered as an i.v. bolus injection to eleven patients with acromegaly. The mean serum growth hormone (GH) levels rose (P less than 0.001) from 54 +/- 20 ng/ml to 215 +/- 126 ng/ml (+/- SEM) 20 min after the injection. Although the maximum response of GH levels was highly variable it correlated positively with the individual GH levels (P less than 0.01, Rs = +0.80). Thus the higher the GH levels, the greater the responsiveness to hpGRF. Administration of somatostatin (SRIF), 300 micrograms/h, lowered basal GH levels from 76 +/- 38 ng/ml to 13 +/- 5 ng/ml (P less than 0.01) after 1 h. hpGRF administration during concomitant SRIF infusion also led to highly variable growth hormone responses. The maximum GH responses again correlated positively with the GH level before hpGRF after 1 h of SRIF administration (P less than 0.05, Rs = +0.79). GH responses to hpGRF were completely blocked by SRIF in three out of four patients whose GH levels decreased to normal levels during SRIF infusion. Our data illustrate that the pituitary in acromegaly is normally responsive to both SRIF and hpGRF but at a higher setting of basal GH levels.',\n",
       "  'journal': 'Clinical endocrinology',\n",
       "  'authors': 'Pieters|G F|GF|;Smals|A E|AE|;Hermus|A R|AR|;Smals|A G|AG|;Benraad|T J|TJ|;Kloppenborg|P W|PW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150772',\n",
       "  'mesh_terms': 'D000172:Acromegaly; D000328:Adult; D005260:Female; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments; D012636:Secretory Rate; D013004:Somatostatin',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D010446:Peptide Fragments; D013004:Somatostatin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2265.1984.tb01412.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Endocrinol (Oxf)',\n",
       "  'nlm_unique_id': '0346653',\n",
       "  'issn_linking': '0300-0664',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effect of pancreatic growth hormone releasing factors on GH secretion by human somatotrophic pituitary tumours in cell culture.',\n",
       "  'issue': '21(6)',\n",
       "  'pages': '709-18',\n",
       "  'abstract': 'Human pancreatic growth hormone releasing factors (hpGRF(1-40) and hpGRF(1-44) significantly stimulated GH secretion when added to cell cultures of human somatotrophic pituitary tumours for 2 h. There was little difference in potency between the two peptides, and the response of different tumours varied, ranging from 30% to 500% increases in GH secretion over control levels. This stimulatory effect was blocked by somatostatin (SRIF) and bromocriptine. The suppressive effect of bromocriptine, but not of SRIF, was overcome by high doses of hpGRF(1-44). TRH stimulated GH secretion by one of three somatotrophic tumours in cell culture, and it was found to potentiate the stimulatory effects of hpGRF(1-44). These results demonstrate that hpGRFs increase serum GH levels in man by a direct action at the pituitary somatotroph level.',\n",
       "  'journal': 'Clinical endocrinology',\n",
       "  'authors': 'Adams|E F|EF|;Bhuttacharji|S C|SC|;Halliwell|C L|CL|;Loizou|M|M|;Birch|G|G|;Mashiter|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150773',\n",
       "  'mesh_terms': 'D000328:Adult; D001971:Bromocriptine; D002478:Cells, Cultured; D005260:Female; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone; D006801:Humans; D008297:Male; D008875:Middle Aged; D010446:Peptide Fragments; D010911:Pituitary Neoplasms; D012636:Secretory Rate; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D010446:Peptide Fragments; C036893:somatotropin releasing factor 40; D001971:Bromocriptine; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1365-2265.1984.tb01413.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Endocrinol (Oxf)',\n",
       "  'nlm_unique_id': '0346653',\n",
       "  'issn_linking': '0300-0664',\n",
       "  'country': 'England'},\n",
       " {'title': 'Hepatotoxicity of sodium valproate.',\n",
       "  'issue': '19()',\n",
       "  'pages': '192-7',\n",
       "  'abstract': 'Repeated clinical and biochemical evaluations of liver function were performed on 60 patients taking sodium valproate. No clinical evidence of liver disease was found. Biochemical abnormalities were frequently found, but they were far more common in patients treated with multiple anticonvulsants than in patients on valproate alone. A control group of patients taking phenytoin or carbamazepine monotherapy also had a high incidence of biochemical abnormalities. A group of patients started on valproate therapy 6 years previously was followed up. No evidence of liver disease was found in this group. It was concluded that biochemical abnormalities of liver function in patients receiving valproate are not progressive, and in many cases relate to the intake of other drugs. The finding of abnormal liver function tests is not necessarily an indication for ceasing valproate.',\n",
       "  'journal': 'Clinical and experimental neurology',\n",
       "  'authors': 'Berkovic|S F|SF|;Bladin|P F|PF|;Jones|D B|DB|;Smallwood|R A|RA|;Vajda|F J|FJ|',\n",
       "  'pubdate': '1983',\n",
       "  'pmid': '6150774',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D002220:Carbamazepine; D056486:Chemical and Drug Induced Liver Injury; D002648:Child; D005340:Fibrinogen; D006801:Humans; D008875:Middle Aged; D010672:Phenytoin; D011446:Prospective Studies; D012189:Retrospective Studies; D014635:Valproic Acid; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D002220:Carbamazepine; D014635:Valproic Acid; D010672:Phenytoin; D005340:Fibrinogen; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Exp Neurol',\n",
       "  'nlm_unique_id': '7909724',\n",
       "  'issn_linking': '0196-6383',\n",
       "  'country': 'Australia'},\n",
       " {'title': 'Dilatation in the carotid vascular territory of the cat in response to activation of cell bodies in the locus coeruleus.',\n",
       "  'issue': '20()',\n",
       "  'pages': '63-72',\n",
       "  'abstract': 'Electrical stimulation of the locus coeruleus in the monkey results in a frequency-dependent vasoconstriction in the internal carotid circulation, and a frequency-dependent vasodilatation in the external carotid circulation. In the cat we have studied the extracerebral vasodilator response using electrical stimulation at appropriately high frequencies. Further investigations reported here demonstrate that 1-glutamate, a non-specific neuronal excitant, reproduces the dilator response in the cat. This clearly shows that the response to electric stimulation of the locus coeruleus, previously reported, is due to excitation of cell bodies rather than fibres of passage.',\n",
       "  'journal': 'Clinical and experimental neurology',\n",
       "  'authors': 'Goadsby|P J|PJ|;Lambert|G A|GA|;Lance|J W|JW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150775',\n",
       "  'mesh_terms': 'D000818:Animals; D001931:Brain Mapping; D002339:Carotid Arteries; D002415:Cats; D004558:Electric Stimulation; D005154:Facial Nerve; D005260:Female; D005971:Glutamates; D018698:Glutamic Acid; D008125:Locus Coeruleus; D008297:Male; D013116:Spinal Cord; D009435:Synaptic Transmission; D014664:Vasodilation; D014666:Vasomotor System',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005971:Glutamates; D018698:Glutamic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Exp Neurol',\n",
       "  'nlm_unique_id': '7909724',\n",
       "  'issn_linking': '0196-6383',\n",
       "  'country': 'Australia'},\n",
       " {'title': 'Granulomatous interstitial nephritis after floctafenin.',\n",
       "  'issue': '22(4)',\n",
       "  'pages': '213-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Clinical nephrology',\n",
       "  'authors': 'Vanhille|P|P|;Lemaitre|V|V|;Fleury|D|D|;Kleinknecht|D|D|;Pallot|J L|JL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150777',\n",
       "  'mesh_terms': 'D000368:Aged; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009395:Nephritis, Interstitial; D062367:ortho-Aminobenzoates',\n",
       "  'publication_types': 'D002363:Case Reports; D016422:Letter',\n",
       "  'chemical_list': 'D062367:ortho-Aminobenzoates',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Nephrol',\n",
       "  'nlm_unique_id': '0364441',\n",
       "  'issn_linking': '0301-0430',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Functional and morphological suppressor T cell deficit in acute GVHD.',\n",
       "  'issue': '58(3)',\n",
       "  'pages': '611-8',\n",
       "  'abstract': 'Bone marrow transplantation (BMT) is currently used to treat patients with severe haematological disorders. One of its major complications is acute graft versus host disease (aGVHD). In this report we show that, during the early stages of lymphoid cell repopulation, an excess of suppressor T cell activity and a deficit of helper T cell activity are easily demonstrated by functional studies in healthy BMT recipients. On the contrary, in patients with active signs of aGVHD, a loss of suppressor T cells, as assessed by coculturing recipient T cells with donor B cells in an in vitro pokeweed mitogen (PWM) dependent Ig secreting assay, is detected. The loss of suppressor T cells in these patients is revealed also by the analysis of peripheral blood lymphocytes with the OKT5 suppressor cytotoxic monoclonal antibody (MoAb) but not with the OKT8 suppressor cytotoxic MoAb. Our data demonstrate that in several BMT recipients, during active aGVHD, a suppressor T cell deficit can be demonstrated both functionally and phenotypically.',\n",
       "  'journal': 'Clinical and experimental immunology',\n",
       "  'authors': 'Di Padova|F|F|;Gratwohl|A|A|;Corneo|M|M|;Speck|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150776',\n",
       "  'mesh_terms': 'D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal; D016026:Bone Marrow Transplantation; D002478:Cells, Cultured; D002648:Child; D005260:Female; D006086:Graft vs Host Disease; D006801:Humans; D007136:Immunoglobulins; D008297:Male; D011043:Pokeweed Mitogens; D013601:T-Lymphocytes; D050378:T-Lymphocytes, Regulatory; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000911:Antibodies, Monoclonal; D007136:Immunoglobulins; D011043:Pokeweed Mitogens',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '323367;6361120;381925;90805;6985782;6986176;6444649;6966400;6937154;6800422;6460536;6211202;6211673;6343226;6343227;6346483;6346614;6352107;34791',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Exp Immunol',\n",
       "  'nlm_unique_id': '0057202',\n",
       "  'issn_linking': '0009-9104',\n",
       "  'country': 'England'},\n",
       " {'title': 'Creatinine serum concentrations and H2-receptor antagonists.',\n",
       "  'issue': '22(4)',\n",
       "  'pages': '214-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Clinical nephrology',\n",
       "  'authors': 'Rocci|M L|ML|;Vlasses|P H|PH|;Ferguson|R K|RK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150778',\n",
       "  'mesh_terms': 'D002927:Cimetidine; D003404:Creatinine; D006635:Histamine H2 Antagonists; D006801:Humans; D008297:Male; D011899:Ranitidine',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D006635:Histamine H2 Antagonists; D002927:Cimetidine; D011899:Ranitidine; D003404:Creatinine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Nephrol',\n",
       "  'nlm_unique_id': '0364441',\n",
       "  'issn_linking': '0301-0430',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Subdural empyema. A review of 48 patients.',\n",
       "  'issue': '86(4)',\n",
       "  'pages': '255-63',\n",
       "  'abstract': 'The data of 48 patients with a subdural empyema, treated in the period 1946-1980, have been reviewed in order to evaluate factors that influenced the outcome. A delay in diagnosis and surgical treatment, plus a severe disturbance of consciousness at the moment of surgery, all had a negative bearing on the subsequent outcome. The mode of operation also had an influence on the outcome in this series. In those patients with a severely disturbed level of consciousness at the time of surgery, the outcome was more favourable if multiple burr-holes were performed rather than a craniotomy. In patients with a minor disturbance of consciousness, however, this difference was not apparent.',\n",
       "  'journal': 'Clinical neurology and neurosurgery',\n",
       "  'authors': 'Mauser|H W|HW|;Tulleken|C A|CA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150779',\n",
       "  'mesh_terms': 'D001921:Brain; D013354:Empyema, Subdural; D005260:Female; D006801:Humans; D008297:Male; D011877:Radionuclide Imaging; D014057:Tomography, X-Ray Computed',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0303-8467(84)90286-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Neurol Neurosurg',\n",
       "  'nlm_unique_id': '7502039',\n",
       "  'issn_linking': '0303-8467',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Barrier contraception.',\n",
       "  'issue': '11(3)',\n",
       "  'pages': '641-60',\n",
       "  'abstract': 'Barrier contraception is a safe, effective, reversible form of contraception acceptable to many couples. The use of barrier contraception may protect against carcinoma of the cervix and sexually transmitted diseases. Distribution and education in the use of barrier contraception does not always require medical supervision. This must make it an attractive form of contraception for agencies supporting family planning programmes in developing countries. The only marketed recent advance in barrier contraception is the collatex sponge. Effectiveness rates range between 9 and 27 pregnancies per 100 woman-years. This is unlikely to make it the first choice of contraception for couples who would find an unintended pregnancy a severe problem, but the sponge will be acceptable to couples who are simply trying to delay a pregnancy. The new surge of interest in barrier contraception could lead to safer more effective forms of contraception being made available to women without medical supervision. This would have many advantages, but could also detract from the ability of family planning clinics to play an important role in preventative medicine for women.',\n",
       "  'journal': 'Clinics in obstetrics and gynaecology',\n",
       "  'authors': 'Mills|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150780',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D003267:Contraception; D003273:Contraceptive Devices; D003274:Contraceptive Devices, Female; D003275:Contraceptive Devices, Male; D005260:Female; D006801:Humans; D008297:Male; D014677:Pharmaceutical Vehicles; D012749:Sexually Transmitted Diseases; D013089:Spermatocidal Agents; D002583:Uterine Cervical Neoplasms',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D014677:Pharmaceutical Vehicles; D013089:Spermatocidal Agents',\n",
       "  'keywords': 'Barrier Methods; Cervical Cap; Condom; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Methods; Economic Factors; Family Planning; Research And Development; Spermicidal Contraceptive Agents; Technology; Vaginal Barrier Methods; Vaginal Diaphragm; Vaginal Sponge',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '030611; 00149458',\n",
       "  'medline_ta': 'Clin Obstet Gynaecol',\n",
       "  'nlm_unique_id': '7509601',\n",
       "  'issn_linking': '0306-3356',\n",
       "  'country': 'England'},\n",
       " {'title': 'Anti-rheumatic drug interactions.',\n",
       "  'issue': '10(2)',\n",
       "  'pages': '251-75',\n",
       "  'abstract': '',\n",
       "  'journal': 'Clinics in rheumatic diseases',\n",
       "  'authors': 'Day|R O|RO|;Graham|G G|GG|;Champion|G D|GD|;Lee|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150784',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000493:Allopurinol; D000818:Animals; D000863:Antacids; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D002927:Cimetidine; D004232:Diuretics; D004338:Drug Combinations; D004347:Drug Interactions; D005938:Glucocorticoids; D006046:Gold; D006801:Humans; D007004:Hypoglycemic Agents; D010396:Penicillamine; D011339:Probenecid; D013442:Sulfinpyrazone; D014665:Vasodilator Agents',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D000863:Antacids; D000893:Anti-Inflammatory Agents; D000925:Anticoagulants; D004232:Diuretics; D004338:Drug Combinations; D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D014665:Vasodilator Agents; D000493:Allopurinol; D006046:Gold; D002927:Cimetidine; D010396:Penicillamine; D011339:Probenecid; D013442:Sulfinpyrazone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Rheum Dis',\n",
       "  'nlm_unique_id': '7604943',\n",
       "  'issn_linking': '0307-742X',\n",
       "  'country': 'England'},\n",
       " {'title': 'Electrophysiological aspects of synaptic transmission at the electromotor junction of Torpedo marmorata.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '505-11',\n",
       "  'abstract': 'Miniature and stimulus-evoked electroplaque potentials were recorded in Torpedo electrocytes intracellularly and extracellularly and analysed quantitatively. Tetrodotoxin reversibly blocked stimulus evoked potentials but hardly affected spontaneous miniature potentials in amplitude and frequency. The quantum content of stimulus-evoked potentials varied between 150 and 400 in normal saline and decreased in low Ca2+ high Mg2+ solution. Quantal release conformed to binomial statistics and allowed determination of the release parameters p and n. Analysis of the time constant of decay of spontaneous miniature electroplaque currents showed variation around a mean of 0.75 +/- 0.16 msec (SD) which was greatly prolonged by application of neostigmine.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Erdelyi|L|L|;Krenz|W D|WD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150785',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D002118:Calcium; D004557:Electric Organ; D005071:Evoked Potentials; D005260:Female; D008274:Magnesium; D008297:Male; D009046:Motor Neurons; D009388:Neostigmine; D013569:Synapses; D009435:Synaptic Transmission; D013779:Tetrodotoxin; D014101:Torpedo',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D009388:Neostigmine; D013779:Tetrodotoxin; D008274:Magnesium; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90438-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Oxygen consumption in the tortoise, Testudo hermanni G., subjected to sudden temperature changes in summer and autumn.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '513-7',\n",
       "  'abstract': 'A respirometer for long-term measurements of oxygen consumption in terrestrial vertebrates is described. The tortoise, Testudo hermanni Gmelin, investigated in summer and autumn, presents a day-night rhythm of oxygen consumption at 28 and 18 degrees C but not at 8 degrees C. The standard metabolic rate presents an important and constant thermal dependence in the range 8-18-28 degrees C.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Kirsch|R|R|;Vivien-Roels|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150786',\n",
       "  'mesh_terms': 'D000064:Acclimatization; D000818:Animals; D002940:Circadian Rhythm; D008297:Male; D010101:Oxygen Consumption; D012621:Seasons; D013696:Temperature; D014426:Turtles',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90439-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Buspirone, a novel nonbenzodiazepine anxiolytic.',\n",
       "  'issue': '3(6)',\n",
       "  'pages': '600-7',\n",
       "  'abstract': \"The chemistry, pharmacology, pharmacokinetics, clinical efficacy, adverse effects, dosage, administration, and availability of buspirone hydrochloride, a novel nonbenzodiazepine anxiolytic, are reviewed. Buspirone hydrochloride is an azaspirodecanedione anxiolytic. The exact mechanism of its anxiolytic action is unknown. It does not appear to influence the benzodiazepine-gamma-aminobutyric acid-chloride ionophore complex as the benzodiazepines do. It antagonizes striatal-dopamine autoreceptors, and it may act as a midbrain modulator exerting selective anxiolytic activity. Buspirone is rapidly absorbed after oral administration. Administration with food appears to slow the rate of drug absorption and increase the amount of unchanged drug reaching the systemic circulation. Buspirone's elimination half-life is 2.5-3 hours. It is extensively metabolized, with less than 1% of an administered dose excreted as unchanged drug. The contribution of its metabolites to its anxiolytic effects is unknown. Buspirone has been shown to be as effective as diazepam and clorazepate and more effective than placebo in the treatment of generalized anxiety. Buspirone lacks the sedative, muscle relaxant, and anticonvulsive effects of the benzodiazepines. Its adverse effects are minimal, with dizziness, nervousness, and headaches as the most common side effects. Buspirone does not impair driving skills, interact with alcohol or concomitant medications, or produce physiologic dependence. It appears to have little potential for abuse. The average daily adult dose is 15-20 mg. Buspirone hydrochloride is an effective drug in the treatment of generalized anxiety disorder that is comparable with the conventional benzodiazepine anxiolytics.\",\n",
       "  'journal': 'Clinical pharmacy',\n",
       "  'authors': 'Kastenholz|K V|KV|;Crismon|M L|ML|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150781',\n",
       "  'mesh_terms': 'D014151:Anti-Anxiety Agents; D001007:Anxiety; D002065:Buspirone; D055598:Chemical Phenomena; D002621:Chemistry; D005569:Formularies as Topic; D006801:Humans; D007700:Kinetics; D011569:Psychiatric Status Rating Scales; D011743:Pyrimidines',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D011743:Pyrimidines; D002065:Buspirone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Pharm',\n",
       "  'nlm_unique_id': '8207437',\n",
       "  'issn_linking': '0278-2677',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The effect of cortisol on stimulation of enzymatic activity and absorption of amino acids in the small intestine of adult hamsters.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '525-8',\n",
       "  'abstract': 'The s.c. administration of cortisol to hamsters (50 mg/kg body wt/day for 4 days) produces a significant increase in maltase sucrase, alkaline phosphatase and leucineaminopeptidase activity in intestinal mucosa. Lactase activity is unaffected by cortisol. Gamma-glutamyltranspeptidase activity increases slightly in females but remains unchanged in males. Cortisol causes increase in proline and glycine absorption without changing the absorption of lysine.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Andrés|M D|MD|;Rebolledo|E|E|;Taboada|M C|MC|;Fernandez Otero|M P|MP|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150787',\n",
       "  'mesh_terms': 'D000469:Alkaline Phosphatase; D000596:Amino Acids; D000818:Animals; D006224:Cricetinae; D005260:Female; D006854:Hydrocortisone; D006867:Hydrolases; D007408:Intestinal Absorption; D007413:Intestinal Mucosa; D007421:Intestine, Small; D007931:Leucyl Aminopeptidase; D008297:Male; D013393:Sucrase; D000520:alpha-Glucosidases; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000596:Amino Acids; D005723:gamma-Glutamyltransferase; D006867:Hydrolases; D000469:Alkaline Phosphatase; D000520:alpha-Glucosidases; D013393:Sucrase; D007931:Leucyl Aminopeptidase; D006854:Hydrocortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90441-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': \"Buspirone's advantages over benzodiazepine anxiolytics.\",\n",
       "  'issue': '3(6)',\n",
       "  'pages': '654-5',\n",
       "  'abstract': '',\n",
       "  'journal': 'Clinical pharmacy',\n",
       "  'authors': 'Ereshefsky|L|L|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150783',\n",
       "  'mesh_terms': 'D014151:Anti-Anxiety Agents; D001007:Anxiety; D001569:Benzodiazepines; D002065:Buspirone; D006801:Humans; D011743:Pyrimidines',\n",
       "  'publication_types': 'D016421:Editorial',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D011743:Pyrimidines; D001569:Benzodiazepines; D002065:Buspirone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Pharm',\n",
       "  'nlm_unique_id': '8207437',\n",
       "  'issn_linking': '0278-2677',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Incidence of next-day anterograde amnesia caused by flurazepam hydrochloride and triazolam.',\n",
       "  'issue': '3(6)',\n",
       "  'pages': '622-5',\n",
       "  'abstract': \"The incidence of next-day anterograde amnesia was evaluated in hospitalized patients who received flurazepam hydrochloride or triazolam. A blinded observer assessed memory and daytime drowsiness in 154 patients after the bedtime ingestion of flurazepam hydrochloride (n = 54), triazolam (n = 49), or no hypnotic drug (n = 51). The hypnotic agents were administered before midnight. At approximately 0800 the next morning, the patients were shown a picture of an object on colored construction paper and asked to remember it as well as the color of the background. Both the observer and patient assessed drowsiness using the Stanford Sleepiness Scale. The observer also made a note of the items on the patient's breakfast tray. Patients were then revisited at 1100 and asked to recall the object in the picture, the color of the background, and at least three items from their breakfast tray. Ten of the 54 patients in the flurazepam group failed to recall all three items compared with only two in the triazolam group and two in the control group. The 14 patients who experienced memory impairment were significantly more drowsy at 0800 than those who were able to recall the items. Next-day anterograde amnesia occurred more frequently in patients who received flurazepam hydrochloride than in those who received triazolam or no hypnotic drug. This effect may be related to the next-day drowsiness caused by flurazepam and its slowly eliminated active metabolite.\",\n",
       "  'journal': 'Clinical pharmacy',\n",
       "  'authors': 'Juhl|R P|RP|;Daugherty|V M|VM|;Kroboth|P D|PD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150782',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D000647:Amnesia; D014151:Anti-Anxiety Agents; D005260:Female; D005479:Flurazepam; D006801:Humans; D008297:Male; D008875:Middle Aged; D007319:Sleep Initiation and Maintenance Disorders; D014229:Triazolam',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D014229:Triazolam; D005479:Flurazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Clin Pharm',\n",
       "  'nlm_unique_id': '8207437',\n",
       "  'issn_linking': '0278-2677',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Seasonal kidney and plasma renin concentration in Testudo hermanni Gmelin.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '529-31',\n",
       "  'abstract': 'Seasonal plasma and kidney renin concentration was studied by radioimmunoassay of angiotensin I in the terrestrial chelonian Testudo hermanni Gmelin under several methodological conditions (different substrates, pH, temperature). Evidence has been found for seasonal variations of the renin levels in relation to the physiological phase of the animals: active animals demonstrated high renal and plasma renin concentration, while lower values were obtained in hibernating animals.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Vallarino|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150788',\n",
       "  'mesh_terms': 'D000064:Acclimatization; D000818:Animals; D005260:Female; D006605:Hibernation; D007668:Kidney; D007700:Kinetics; D012083:Renin; D012621:Seasons; D014426:Turtles',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D012083:Renin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90442-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Erythrocytic organic phosphates: diel and seasonal cycles in the frog, Rana berlandieri.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '533-8',\n",
       "  'abstract': 'Hemoglobin (Hb) concentration, hematocrit (Hct), total organic phosphates (Ptot), nucleoside triphosphates (NTP), 2,3-diphosphoglycerate (DPG), and \"inositol polyphosphates\" (IPP) were measured in the erythrocytes of adult frogs at different times of day in winter and summer after acclimatization to 15 degrees C and an LD 12:12 photoperiod. The same measurements were also made on animals acclimated to LD 16:8 in summer. All of the measured parameters varied significantly at different times of the day and between seasons in animals acclimated to an LD 12:12 photoperiod. Summer animals acclimated to LD 16:8 showed significant diel cycles only in Hct and Hb.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Hutchison|V H|VH|;Hazard|E S|ES|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150789',\n",
       "  'mesh_terms': 'D019794:2,3-Diphosphoglycerate; D000064:Acclimatization; D000818:Animals; D002940:Circadian Rhythm; D004163:Diphosphoglyceric Acids; D004912:Erythrocytes; D006400:Hematocrit; D006454:Hemoglobins; D007295:Inositol Phosphates; D011898:Ranidae; D012265:Ribonucleotides; D012621:Seasons; D013403:Sugar Phosphates',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D004163:Diphosphoglyceric Acids; D006454:Hemoglobins; D007295:Inositol Phosphates; D012265:Ribonucleotides; D013403:Sugar Phosphates; D019794:2,3-Diphosphoglycerate',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90443-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Metabolic rate and body temperature of adult and juvenile hyrax (Procavia capensis).',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '539-45',\n",
       "  'abstract': 'Resting metabolic rates (RMR) below thermoneutrality in adult hyrax acclimated to 26, 15 and 10 degrees C remained unchanged, i.e. thermal conductance (K) remained constant. Conductance in juveniles decreased with acclimation to lower ambient temperatures (Ta). Body temperature (Tb) dropped by 3.8 degrees C in adults exposed to Ta of 30-5 degrees C. The decrease was constant. Body temperature fell by 1.5 degrees C in juveniles exposed to Ta of 30-20 degrees C but stabilized between 20 and 5 degrees C. The labile Tb, associated with behavioural strategies and lower than predicted RMR, can be seen as an energy-conserving mechanism of particular importance during winter conditions.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'McNairn|I S|IS|;Fairall|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150790',\n",
       "  'mesh_terms': 'D000064:Acclimatization; D000375:Aging; D000818:Animals; D001831:Body Temperature; D001833:Body Temperature Regulation; D002940:Circadian Rhythm; D004734:Energy Metabolism; D005260:Female; D007043:Hyraxes; D008297:Male; D008322:Mammals; D013696:Temperature',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90444-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Reconsideration of the indirect measurements of intracellular Na and K concentrations in the rat skeletal muscles.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '551-4',\n",
       "  'abstract': 'The intracellular Na and K concentrations ([Na]i, [K]i) of extensor digitrum longus (EDL) and soleus (SOL) muscles of 3- to 52-week-old rats were estimated flame-photometrically. The extracellular space of 3-week-old rat muscles was significantly greater than that of 15-week-old rat muscles. The [K]i of the both muscles decreased gradually with age while [Na]i remained nearly constant. EDL had higher [K]i and lower [Na]i than SOL and the sum of the concentrations of [K]i and [Na]i was significantly greater in EDL than in SOL throughout the age period tested. Significant measurement errors were found in muscles from the youngest age group, where samples weighed less than 50 mg. A method for calculation of corrected [Na]i and [K]i values is discussed.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Nagaoka|R|R|;Yamashita|S|S|;Akaike|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150791',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D001835:Body Weight; D005260:Female; D008297:Male; D024510:Muscle Development; D009132:Muscles; D009929:Organ Size; D010783:Photometry; D011188:Potassium; D051381:Rats; D011919:Rats, Inbred Strains; D012964:Sodium',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D012964:Sodium; D011188:Potassium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90446-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effects of ethanol, fructose, and ethanol plus fructose infusions on plasma glucose concentration and glucose turnover in monkeys (Macaca fascicularis) as measured by [6-3H]glucose.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '555-61',\n",
       "  'abstract': 'Six adult, female, cynomolgus monkeys were fasted for 64 hr and then continuously infused with [6-3H]glucose to determine the rates of glucose turnover and clearance while they were also being infused with ethanol (110 mumol/min/kg), 1,3-butanediol (110 mumol/min/kg), fructose (30 mumol/min/kg) or ethanol plus fructose (110 and 30 mumol/min/kg) respectively. Both ethanol and 1,3-butanediol infusions decreased the glucose turnover rate (the steady-state input-output rate from the plasma glucose pool) and the plasma glucose concentration by halving the glucose production rate. In contrast, fructose infusions increased the glucose turnover rate and glucose concentration by increasing the glucose production rate by 20%. The plasma clearance rate of glucose was lowest when the animals were infused with ethanol plus fructose; this suggests that acetate from ethanol oxidation may have a glucose-sparing effect if normoglycemia is maintained.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Armstrong|M K|MK|;Romsos|D R|DR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150792',\n",
       "  'mesh_terms': 'D000818:Animals; D001786:Blood Glucose; D000431:Ethanol; D005260:Female; D005632:Fructose; D007700:Kinetics; D007773:Lactates; D019344:Lactic Acid; D008252:Macaca fascicularis; D011773:Pyruvates; D019289:Pyruvic Acid; D013997:Time Factors; D014316:Tritium',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001786:Blood Glucose; D007773:Lactates; D011773:Pyruvates; D014316:Tritium; D005632:Fructose; D019344:Lactic Acid; D000431:Ethanol; D019289:Pyruvic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90447-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'A comparative study of bicarbonate secretion by ileum and colon of Oryctolagus cuniculus. Influence of caecal pH.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '567-9',\n",
       "  'abstract': 'The influence of caecal pH on movements of bicarbonate ion in rabbit colon and ileum has been studied. A net secretion of bicarbonate is noted in both intestinal segments (at higher rates in colon than in ileum) in our experimental conditions. The bicarbonate secretion rate is lowered when bicarbonate is added to caecum. The introduction of acetic acid at caecal level increased bicarbonate secretion rate both in ileum as in colon.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Galindo|M C|MC|;García|J A|JA|;Lisbona|F|F|;Campos|M S|MS|;Mataix|F J|FJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150793',\n",
       "  'mesh_terms': 'D000085:Acetates; D019342:Acetic Acid; D000818:Animals; D001639:Bicarbonates; D002432:Cecum; D002712:Chlorides; D003106:Colon; D006863:Hydrogen-Ion Concentration; D007082:Ileum; D007413:Intestinal Mucosa; D008297:Male; D009928:Organ Specificity; D010477:Perfusion; D011188:Potassium; D011817:Rabbits; D012964:Sodium',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D000085:Acetates; D001639:Bicarbonates; D002712:Chlorides; D012964:Sodium; D019342:Acetic Acid; D011188:Potassium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90449-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Active secretion of bicarbonate by rabbit colon.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '571-3',\n",
       "  'abstract': 'A serosa-mucosa movement of bicarbonate against concentration gradient was detected at this intestinal level. This movement is partially dependent on oxidative phosphorylation since it is abolished by DNP administration, but as it is not affected by acetazolamide administration it can be supposed as dependent on carbonic anhydrase activity.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'García|J A|JA|;Galindo|M C|MC|;Lisbona|F|F|;Campos|M S|MS|;López|M A|MA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150794',\n",
       "  'mesh_terms': 'D019297:2,4-Dinitrophenol; D000818:Animals; D001639:Bicarbonates; D003106:Colon; D004140:Dinitrophenols; D004573:Electrolytes; D005260:Female; D007413:Intestinal Mucosa; D007700:Kinetics; D008297:Male; D010085:Oxidative Phosphorylation; D011817:Rabbits',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001639:Bicarbonates; D004140:Dinitrophenols; D004573:Electrolytes; D019297:2,4-Dinitrophenol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90450-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Sympathetic and adrenocorticoid influences on diet-induced thermogenesis and brown fat activity in the rat.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '575-9',\n",
       "  'abstract': 'Bilateral adrenalectomy markedly reduced body weight and energy gain and energetic efficiency of adult cafeteria-fed rats but enhanced the thermogenic response to food and stimulated brown fat activity. These changes were totally prevented by replacement of the animals with corticosterone (1 mg/rat/day). Unilateral denervation of the sympathetic nerves supplying the interscapular brown adipose tissue abolished the enhanced activity resulting from adrenalectomy and inhibited thermogenic activity in brown fat from cafeteria rats with intact adrenals, but had no effect in adrenalectomised animals treated with a high dose of corticosterone.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Rothwell|N J|NJ|;Stock|M J|MJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150795',\n",
       "  'mesh_terms': 'D002001:Adipose Tissue, Brown; D000315:Adrenalectomy; D000818:Animals; D001833:Body Temperature Regulation; D003345:Corticosterone; D004032:Diet; D004435:Eating; D004734:Energy Metabolism; D008297:Male; D010101:Oxygen Consumption; D051381:Rats; D011919:Rats, Inbred Strains; D013564:Sympathetic Nervous System',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D003345:Corticosterone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90451-1',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Adrenal response to ACTH stimulation in Rusa deer (Cervus rusa timorensis).',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '581-4',\n",
       "  'abstract': 'Resting cortisol values in immobilized mature Rusa stags (Cervus rusa timorensis) and the response to synthetic ACTH were investigated. The mean level of cortisol in mature Rusa stags was found to be 3.80 ng/ml (SD = 0.87, N = 18). Over the range 0.37-6.0 i.u. the adrenal response to ACTH challenge was linearly related to the log dose ACTH administered (r = 0.998). More than 6 i.u. of ACTH caused maximal stimulation of the adrenal gland. Rusa deer appear to be much more sensitive to ACTH administration than other species.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'van Mourik|S|S|;Stelmasiak|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150796',\n",
       "  'mesh_terms': 'D000311:Adrenal Glands; D000324:Adrenocorticotropic Hormone; D000818:Animals; D003670:Deer; D006854:Hydrocortisone; D007700:Kinetics',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000324:Adrenocorticotropic Hormone; D006854:Hydrocortisone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90452-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Serum proteins of the free-ranging European bison.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '597-600',\n",
       "  'abstract': 'The paper presents the values of total protein (TP) and protein fractions in the serum of 57 European bisons from the Białowieza Primeval Forest, 47 of these animals being free-ranging and 10 living in enclosures. It was found that the amount of TP and amount of alpha 1- and gamma-globulin fractions are significantly lower in adult females than males. The amount of TP and gamma-globulin fraction increase significantly with age in all examined Europeans bisons, whereas the amount of alpha 1- and alpha 2-globulin fractions increase only in free-ranging animals.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Wołk|E|E|;Józefczak|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150797',\n",
       "  'mesh_terms': 'D000818:Animals; D000835:Animals, Wild; D001798:Blood Proteins; D002417:Cattle; D005260:Female; D008297:Male; D012709:Serum Albumin; D012712:Serum Globulins; D013045:Species Specificity',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D001798:Blood Proteins; D012709:Serum Albumin; D012712:Serum Globulins',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90455-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'The structure and insulation properties of the reindeer fur.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '601-9',\n",
       "  'abstract': 'The structure of the fur of the reindeer (6 adults, 4 calves) was studied with light and scanning electron microscopy and skin and rectal temperatures were measured in 216 living animals at varying ambient temperatures (-28 to +15 degrees C) and also on excised skin samples in the laboratory (temperature range -20 to +20 degrees C, wind 0 or 10 m/sec, 5 different directions). Guard hair count and length varied according to the site of excision and were on average 2000/cm2 and 12 mm on the foreleg, 1000/cm2 and 30 mm on the abdomen and 1700/cm2 and 30 mm on the back. The corresponding counts in the calves were higher but the hairs were shorter. The rectal temperatures ranged from 38 to 40 degrees C independently of the ambient temperature. The dependence of the skin temperature on the ambient temperature was complex in living animals. The dependence was strongest in the legs. The skin temperature of the excised samples depended rather linearly on the ambient temperature. It is concluded that the reindeer can maintain its body temperature also in severe cold although the extremities show characteristics of heterothermia.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Timisjärvi|J|J|;Nieminen|M|M|;Sippola|A L|AL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150798',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D000831:Animals, Newborn; D001831:Body Temperature; D001833:Body Temperature Regulation; D005260:Female; D006197:Hair; D008297:Male; D008855:Microscopy, Electron, Scanning; D012053:Reindeer; D012881:Skin Temperature',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90456-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'The mouse taste cell response to five sugar stimuli.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '625-30',\n",
       "  'abstract': 'Intracellular recordings of mouse taste cell responses were made using glass microelectrodes filled with procion yellow dye solution. Only responses recorded from taste buds with fluorescent cells, as observed in subsequent histological preparations, were used in this study. The mouse taste cell depolarizes when stimulated with sucrose and is accompanied by either a resistance increase or no change. On the other hand, a NaCl stimulus produces a depolarization, hyperpolarization or null response and is accompanied by either a membrane resistance decrease or no change. Four sugars other than sucrose (maltose, fructose, glucose and lactose) produced the depolarization or null responses and were accompanied by an increase or no change in membrane resistance. From the above observations, it is suggested that each taste cell produces its own characteristic response profiles and membrane resistance changes for the five sugars and NaCl tested.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Tonosaki|K|K|;Funakoshi|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150799',\n",
       "  'mesh_terms': 'D000818:Animals; D005632:Fructose; D005947:Glucose; D007785:Lactose; D008320:Maltose; D051379:Mice; D008815:Mice, Inbred Strains; D013395:Sucrose; D013649:Taste; D013650:Taste Buds',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D005632:Fructose; D013395:Sucrose; D008320:Maltose; D005947:Glucose; D007785:Lactose',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90459-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Brain, blood and rectal temperature during whole body cooling.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '631-4',\n",
       "  'abstract': 'To determine if rectal temperature is an adequate index of brain temperature during changing thermal conditions, we measured rectal, cerebral cortical, and carotid arterial blood temperatures simultaneously during whole body cooling in adult cats. The mean steady state rectal, brain and carotid arterial temperatures at the onset of cooling were: 39.2 +/- 0.2, 38.5 +/- 0.2, and 38.3 +/- 0.3 degrees C, respectively. Rectal temperature decreased faster than both brain and arterial blood, while only a small temperature difference was observed between brain and arterial blood, brain always exceeding blood. Rectal temperature cannot be considered an adequate index of brain temperature. Carotid arterial temperature is a better estimate of brain temperature.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Kiley|J P|JP|;Eldridge|F L|FL|;Millhorn|D E|DE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150800',\n",
       "  'mesh_terms': 'D000818:Animals; D001831:Body Temperature; D001833:Body Temperature Regulation; D002339:Carotid Arteries; D002415:Cats; D002540:Cerebral Cortex; D003080:Cold Temperature; D005260:Female; D009928:Organ Specificity; D012007:Rectum',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90460-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Renal excretion of urea in response to changes in nitrogen intake in desert (black Bedouin) and non-desert (Swiss Saanen) goats.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '651-4',\n",
       "  'abstract': 'Renal responses were compared between desert (black Bedouin) and non-desert (Swiss Saanen) goats fed Lucerne hay ad. lib., Lucerne hay restricted to 65% of the ad. lib. consumption and wheat straw. Reduced feeding in both breeds resulted in proportional reduction in glomerular filtration rate (GFR) and the amount of urea excreted with no change in the percentage of urea reabsorbed. In both breeds appreciably less urea was filtered at the glomerulus when a low-nitrogen diet was fed compared with a high nitrogen diet and the percentage of filtered urea reabsorbed increased from about 55 to about 90%. In both breeds the reduction in GFR is quantitatively more important than the increase in the percentage of filtered urea reabsorbed in regard to renal urea conservation. The results indicate no qualitative differences between desert and non-desert breeds of goat. The advantages of the Bedouin over the Saanen goats is related to the lower GFR values in the Bedouin goat and mainly their ability to reduce its GFR much more than the Saanen goats in response to lower nitrogen intake.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Silanikove|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150801',\n",
       "  'mesh_terms': 'D000064:Acclimatization; D000818:Animals; D003889:Desert Climate; D004032:Diet; D005919:Glomerular Filtration Rate; D006041:Goats; D007668:Kidney; D009584:Nitrogen; D013045:Species Specificity; D014508:Urea',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D014508:Urea; D009584:Nitrogen',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90464-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Erythrocyte phosphate composition and osmotic fragility in the Australian lungfish, Neoceratodus fosteri, and osteoglossid, Scleropages schneichardti.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '667-71',\n",
       "  'abstract': 'The packed cell volume (PCV), hemoglobin concentration (g/dl) and mean corpuscular volume (MCV) in the Australian lungfish, Neoceratodus fosteri, and in one of three Australian osteoglossids, Scleropages schneichardti, were 32.3 and 29.9; 10.5 and 10.0; and 407 and 176 micron 3 respectively. Total acid-soluble phosphates (TPi) from the red blood cells (RBC) of the lungfish and osteoglossid were 35.3 and 18.1 mumol/cm3 RBC respectively. Inorganic phosphate (Pi), adenosine triphosphate (ATP) and guanosine triphosphate (GTP) represented 16.4, 39.7 and 17.8% of the cell phosphates in the lungfish respectively. Inositol bisphosphate was not present in extracts of the red cells of N. fosteri, in contrast to the red cells of Lepidosiren paradoxa and Protopterus aethiopicus, in which it was first observed. In the osteoglossid, Pi and ATP represented 37.6 and 46.4% of the erythrocyte phosphate, respectively, with only traces of GTP present. ATP is the predominant organic phosphate in the red cells of both species. The osmotic fragility of erythrocytes of N. fosteri are quite resistant to hemolysis, with hemolysis beginning at 35-30 mM and a complete hemolysis occurring at 20 mM NaCl. The red cells of S. schneichardti begin to hemolyze at 95-90 mM with hemolysis continuing to completion at 60 mM NaCl.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Isaacks|R E|RE|;Kim|H D|HD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150802',\n",
       "  'mesh_terms': 'D000227:Adenine Nucleotides; D000244:Adenosine Diphosphate; D000249:Adenosine Monophosphate; D000255:Adenosine Triphosphate; D000818:Animals; D001315:Australia; D004912:Erythrocytes; D005399:Fishes; D006160:Guanosine Triphosphate; D006454:Hemoglobins; D010710:Phosphates; D013045:Species Specificity',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000227:Adenine Nucleotides; D006454:Hemoglobins; D010710:Phosphates; D000249:Adenosine Monophosphate; D000244:Adenosine Diphosphate; D006160:Guanosine Triphosphate; D000255:Adenosine Triphosphate',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90466-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Further evidence for behaviorly induced hypoxic conditions in subordinate mice.',\n",
       "  'issue': '79(4)',\n",
       "  'pages': '695-9',\n",
       "  'abstract': 'When two male mice fight to establish social rank, the subordinate exhibits marked splenomegaly, reticulocytosis and decreased hematocrit. Individuals were isolated at weaning, paired 3 weeks later for two 30-min encounter periods daily for up to 3 weeks. After 2 days and 1 week encounter periods, subordinates had significantly decreased levels of hemoglobin in the kidney compared to dominants and controls. Subordinates had increased ATP levels in blood after 1, 2 and 3 weeks of encounter, bone marrow erythroid hyperplasia, as well as a substantial increase in the erythropoietin titre and Fe99 incorporation in spleen and blood.',\n",
       "  'journal': 'Comparative biochemistry and physiology. A, Comparative physiology',\n",
       "  'authors': 'Cane|L S|LS|;Hilton|F K|FK|;Gray|R D|RD|;Harris|B W|BW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150803',\n",
       "  'mesh_terms': 'D000255:Adenosine Triphosphate; D000374:Aggression; D000818:Animals; D001853:Bone Marrow; D004291:Dominance-Subordination; D004920:Erythropoiesis; D006454:Hemoglobins; D006801:Humans; D000860:Hypoxia; D007501:Iron; D007668:Kidney; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D012930:Social Dominance; D013154:Spleen',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D006454:Hemoglobins; D000255:Adenosine Triphosphate; D007501:Iron',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0300-9629(84)90471-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol A Comp Physiol',\n",
       "  'nlm_unique_id': '1276312',\n",
       "  'issn_linking': '0300-9629',\n",
       "  'country': 'England'},\n",
       " {'title': 'Some properties of isolated mitochondrial ATPase from salmon heart.',\n",
       "  'issue': '79(2)',\n",
       "  'pages': '263-7',\n",
       "  'abstract': 'A soluble Mg-dependent ATPase, similar to the mitochondrial ATPase from beef heart, has been isolated from heart mitochondria of salmon (Salmo salar). The salmon heart ATPase has 5 subunits with molecular weights similar to the beef heart enzyme, but the Stoke\\'s radius of the intact salmon enzyme is larger. The salmon heart ATPase is less temperature labile than the beef heart enzyme. The salmon heart ATPase is strongly inhibited by ADP, and the inhibition is highly temperature dependent. The ITPase activity is also inhibited by IDP (Ki = 180 micron). 2,4-Dinitrophenol in small concentrations stimulates the ITPase activity as well as the ATPase activity of the \"washed\" salmon heart enzyme. However, in an enzyme preparation which had been freed of most of the bound nucleotides by dialysis in the presence of glycerol (Roveri et al., 1980) the ITPase activity is not stimulated by 2,4-dinitrophenol.',\n",
       "  'journal': 'Comparative biochemistry and physiology. B, Comparative biochemistry',\n",
       "  'authors': 'Thomassen|J M|JM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150804',\n",
       "  'mesh_terms': 'D019297:2,4-Dinitrophenol; D000251:Adenosine Triphosphatases; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D004140:Dinitrophenols; D007700:Kinetics; D046911:Macromolecular Substances; D008929:Mitochondria, Heart; D008970:Molecular Weight; D012474:Salmon; D013816:Thermodynamics',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D004140:Dinitrophenols; D046911:Macromolecular Substances; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D019297:2,4-Dinitrophenol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0305-0491(84)90024-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol B',\n",
       "  'nlm_unique_id': '2984730R',\n",
       "  'issn_linking': '0305-0491',\n",
       "  'country': 'England'},\n",
       " {'title': 'The effect of prolonged fasting on total lipid synthesis and enzyme activities in the liver of the European eel (Anguilla anguilla).',\n",
       "  'issue': '79(2)',\n",
       "  'pages': '285-9',\n",
       "  'abstract': 'The extent of fatty acid synthesis from [1-14C]acetate in liver slices was reduced 6-fold when eels were fasted for 1-7 weeks and 20-fold when fasted for 39 weeks; thereafter hepatic lipogenesis seemed to remain constant for up to 95 weeks of fasting. After a 1-3 week fast some hepatic enzyme activities were reduced (acetyl-CoA carboxylase decreased 2-fold and fatty acid synthetase declined 5-fold), while others remained unchanged (glucose-6-phosphate dehydrogenase, 6-phosphogluconate dehydrogenase, alpha-glycerol phosphate dehydrogenase as well as malic enzyme and ATP-citrate lyase). The optimum temperature for measuring both total lipid synthesis and lipogenic enzyme activity in eel liver was found to be 30 degrees C.',\n",
       "  'journal': 'Comparative biochemistry and physiology. B, Comparative biochemistry',\n",
       "  'authors': 'Abraham|S|S|;Hansen|H J|HJ|;Hansen|F N|FN|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150805',\n",
       "  'mesh_terms': 'D001275:ATP Citrate (pro-S)-Lyase; D000085:Acetates; D019342:Acetic Acid; D000103:Acetyl-CoA Carboxylase; D000811:Anguilla; D000818:Animals; D005215:Fasting; D064429:Fatty Acid Synthases; D005954:Glucosephosphate Dehydrogenase; D005993:Glycerolphosphate Dehydrogenase; D008055:Lipids; D008099:Liver; D008291:Malate Dehydrogenase; D010734:Phosphogluconate Dehydrogenase; D010743:Phospholipids',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000085:Acetates; D008055:Lipids; D010743:Phospholipids; D005993:Glycerolphosphate Dehydrogenase; D008291:Malate Dehydrogenase; D010734:Phosphogluconate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D064429:Fatty Acid Synthases; D001275:ATP Citrate (pro-S)-Lyase; D000103:Acetyl-CoA Carboxylase; D019342:Acetic Acid',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0305-0491(84)90027-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol B',\n",
       "  'nlm_unique_id': '2984730R',\n",
       "  'issn_linking': '0305-0491',\n",
       "  'country': 'England'},\n",
       " {'title': 'Protein and amino acid catabolism in Trypanosoma cruzi.',\n",
       "  'issue': '79(3)',\n",
       "  'pages': '309-20',\n",
       "  'abstract': '',\n",
       "  'journal': 'Comparative biochemistry and physiology. B, Comparative biochemistry',\n",
       "  'authors': 'Cazzulo|J J|JJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150806',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000818:Animals; D002474:Cell-Free System; D005969:Glutamate Dehydrogenase; D005971:Glutamates; D018698:Glutamic Acid; D007700:Kinetics; D009243:NAD; D010447:Peptide Hydrolases; D011506:Proteins; D000637:Transaminases; D014349:Trypanosoma cruzi',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D016454:Review\",\n",
       "  'chemical_list': 'D000596:Amino Acids; D005971:Glutamates; D011506:Proteins; D009243:NAD; D018698:Glutamic Acid; D005969:Glutamate Dehydrogenase; D000637:Transaminases; D010447:Peptide Hydrolases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0305-0491(84)90381-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol B',\n",
       "  'nlm_unique_id': '2984730R',\n",
       "  'issn_linking': '0305-0491',\n",
       "  'country': 'England'},\n",
       " {'title': 'Tyrosine aminotransferase activity of frog (Rana esculenta) liver. III. A circannual study.',\n",
       "  'issue': '79(3)',\n",
       "  'pages': '369-74',\n",
       "  'abstract': 'A circannual study of tyrosine aminotransferase and other metabolic enzymes in frog liver is reported. The subcellular distribution of all enzymatic activities under investigation was also studied. Results show significant oscillations of all enzymatic activities throughout the year; in particular tyrosine aminotransferase has a marked summer maximum. The subcellular distribution of tyrosine aminotransferase shows significant variations: the soluble activity of the enzyme presents a bimodal circannual distribution, which has its counterpart in an increased activity of heavier fractions.',\n",
       "  'journal': 'Comparative biochemistry and physiology. B, Comparative biochemistry',\n",
       "  'authors': 'Scapin|S|S|;Autuori|F|F|;Baldini|P|P|;Incerpi|S|S|;Luly|P|P|;Sartori|C|C|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150807',\n",
       "  'mesh_terms': 'D000135:Acid Phosphatase; D000818:Animals; D003576:Electron Transport Complex IV; D005260:Female; D005952:Glucose-6-Phosphatase; D007770:L-Lactate Dehydrogenase; D008099:Liver; D008297:Male; D010507:Periodicity; D011893:Rana esculenta; D012621:Seasons; D014444:Tyrosine Transaminase; D014503:Urate Oxidase',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D007770:L-Lactate Dehydrogenase; D014503:Urate Oxidase; D003576:Electron Transport Complex IV; D014444:Tyrosine Transaminase; D000135:Acid Phosphatase; D005952:Glucose-6-Phosphatase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0305-0491(84)90390-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Comp Biochem Physiol B',\n",
       "  'nlm_unique_id': '2984730R',\n",
       "  'issn_linking': '0305-0491',\n",
       "  'country': 'England'},\n",
       " {'title': 'Lipid metabolism in fungi.',\n",
       "  'issue': '11(3)',\n",
       "  'pages': '209-71',\n",
       "  'abstract': 'So far, reviews that have appeared on fungal lipids present data mainly on the lipid composition of these organisms and the influence of lipids on their physiology. These reviews provide little information about the enzymes of lipid metabolism in these organisms and it is assumed, by most workers, that lipid synthesis in all fungi takes place as in Saccharomyces cervesiae, the only fungus in which the complete pathways of phospholipid biosynthesis have been worked out. During the last few years, literature has accumulated on lipid metabolic enzymes of other fungi, as investigators became increasingly interested in this area of research. The present review, after an introduction, will be divided into different sections and each section will deal, comparatively, with various aspects of fungal lipid metabolism and physiology. This review will, therefore, bring out the differences or similarities of lipid metabolism in diverse fungal species.',\n",
       "  'journal': 'Critical reviews in microbiology',\n",
       "  'authors': 'Chopra|A|A|;Khuller|G K|GK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150809',\n",
       "  'mesh_terms': 'D000103:Acetyl-CoA Carboxylase; D064429:Fatty Acid Synthases; D005227:Fatty Acids; D005658:Fungi; D005991:Glycerol Kinase; D006017:Glycolipids; D008049:Lipase; D050356:Lipid Metabolism; D008245:Lysophospholipase; D009154:Mutation; D010711:Phosphatidate Phosphatase; D010712:Phosphatidic Acids; D010740:Phospholipases; D010743:Phospholipids; D010727:Phosphoric Diester Hydrolases; D013107:Sphingolipids; D013261:Sterols',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D016454:Review\",\n",
       "  'chemical_list': 'D005227:Fatty Acids; D006017:Glycolipids; D010712:Phosphatidic Acids; D010743:Phospholipids; D013107:Sphingolipids; D013261:Sterols; D064429:Fatty Acid Synthases; D005991:Glycerol Kinase; D010740:Phospholipases; D008049:Lipase; D008245:Lysophospholipase; D010711:Phosphatidate Phosphatase; D010727:Phosphoric Diester Hydrolases; C020677:glycerophosphocholine phosphodiesterase; D000103:Acetyl-CoA Carboxylase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/10408418409105904',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Crit Rev Microbiol',\n",
       "  'nlm_unique_id': '8914274',\n",
       "  'issn_linking': '1040-841X',\n",
       "  'country': 'England'},\n",
       " {'title': 'An in vivo model for dissociating alpha 2-and DA2-adrenoceptor activity in an ocular adnexa: utility of the cat nictitating membrane preparation.',\n",
       "  'issue': '3(11)',\n",
       "  'pages': '1289-98',\n",
       "  'abstract': 'Recent reports from this laboratory indicate that dopamine (DA2) agonists can lower intraocular pressure (IOP) in rabbits, monkeys and rats. This communication suggests that the cat nictitating membrane (CNM) preparation is a useful model for localizing the site(s) and mechanism(s) of action of dopamine (DA2) agonists and that this model can be used to discriminate between alpha 2 and DA2 activity. This in vivo preparation consists of indirect (neuronal)- and direct (agonist)-induced activation of the CNM by: 1) pre- and postganglionic stimulation of sympathetic nerves and 2) injection of norepinephrine (NEPI) into the external carotid artery (i.a.). A variety of DA2-agonists (ergolines, azepines, aminotetralins, aporphines) can cause dose-dependent depression of neuronally mediated contractions with minimal effects on contractions elicited by NEPI i.a. Characteristically, DA2-agonists depressed contractions elicited by low frequency (2 & 4 Hz) stimulation more than high frequency (6 & 8 Hz) stimulation. For example, the inhibitory effects of an ergoline derivative LY141865 on neuronally mediated contractions of the CNM could be reversed (or prevented) by relatively selective DA2 antagonists, such as sulpiride and domperidone, but not by relatively selective alpha 2-antagonists, such as yohimbine and rauwolscine. Interestingly, alpha 2-adrenoceptor agonists, such as clonidine and xylazine, caused less depression of nerve-stimulated responses than did DA2-agonists at the same dose. This modest suppression by alpha 2-agonists could be inhibited by yohimbine but not by sulpiride or domperidone. These results with the CNM document the presence of DA2 receptors on sympathetic neurons innervating an ocular adnexa and demonstrate a model for dissociating DA2 from alpha 2 activity.',\n",
       "  'journal': 'Current eye research',\n",
       "  'authors': 'Potter|D E|DE|;Burke|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150810',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000818:Animals; D002415:Cats; D004873:Ergolines; D005260:Female; D008297:Male; D008954:Models, Biological; D009119:Muscle Contraction; D009474:Neurons; D009541:Nictitating Membrane; D019257:Quinpirole; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D004873:Ergolines; D011942:Receptors, Adrenergic, alpha; D011954:Receptors, Dopamine; D019257:Quinpirole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.3109/02713688409007415',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Eye Res',\n",
       "  'nlm_unique_id': '8104312',\n",
       "  'issn_linking': '0271-3683',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effects of foods and nutrients on brain neurotransmitters.',\n",
       "  'issue': '13()',\n",
       "  'pages': '103-12',\n",
       "  'abstract': '',\n",
       "  'journal': 'Current concepts in nutrition',\n",
       "  'authors': 'Wurtman|R J|RJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150811',\n",
       "  'mesh_terms': 'D000596:Amino Acids; D000818:Animals; D001693:Biological Transport, Active; D001921:Brain; D002794:Choline; D004298:Dopamine; D006801:Humans; D007700:Kinetics; D009474:Neurons; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D009747:Nutritional Physiological Phenomena; D010300:Parkinson Disease; D011388:Prolactin; D012701:Serotonin; D014364:Tryptophan; D014443:Tyrosine',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000596:Amino Acids; D018377:Neurotransmitter Agents; D012701:Serotonin; D014443:Tyrosine; D014364:Tryptophan; D011388:Prolactin; D002794:Choline; D004298:Dopamine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Concepts Nutr',\n",
       "  'nlm_unique_id': '0347207',\n",
       "  'issn_linking': '0090-0443',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Congenital dysfibrinogenemia.',\n",
       "  'issue': '14()',\n",
       "  'pages': '65-130',\n",
       "  'abstract': '',\n",
       "  'journal': 'Current problems in clinical biochemistry',\n",
       "  'authors': 'Rupp|C|C|;Beck|E A|EA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150812',\n",
       "  'mesh_terms': 'D000347:Afibrinogenemia; D000595:Amino Acid Sequence; D001777:Blood Coagulation; D001780:Blood Coagulation Tests; D002241:Carbohydrates; D005176:Factor XIII; D005340:Fibrinogen; D005341:Fibrinolysin; D005344:Fibrinopeptide A; D005345:Fibrinopeptide B; D014644:Genetic Variation; D006801:Humans; D046911:Macromolecular Substances; D010446:Peptide Fragments; D013917:Thrombin; D011503:Transglutaminases',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D002241:Carbohydrates; D046911:Macromolecular Substances; D010446:Peptide Fragments; D005344:Fibrinopeptide A; D005345:Fibrinopeptide B; D005340:Fibrinogen; D005176:Factor XIII; D011503:Transglutaminases; D013917:Thrombin; D005341:Fibrinolysin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Curr Probl Clin Biochem',\n",
       "  'nlm_unique_id': '0353507',\n",
       "  'issn_linking': '0300-1725',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Neuroleptics, extrapyramidal symptoms, and serum-calcium levels.',\n",
       "  'issue': '25(6)',\n",
       "  'pages': '539-45',\n",
       "  'abstract': '',\n",
       "  'journal': 'Comprehensive psychiatry',\n",
       "  'authors': 'el-Defrawi|M H|MH|;Craig|T J|TJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150808',\n",
       "  'mesh_terms': 'D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents; D001480:Basal Ganglia Diseases; D002118:Calcium; D006801:Humans; D008297:Male; D001523:Mental Disorders; D008875:Middle Aged; D012306:Risk',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D002118:Calcium',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0010-440x(84)90034-8',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Compr Psychiatry',\n",
       "  'nlm_unique_id': '0372612',\n",
       "  'issn_linking': '0010-440X',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Preliminary report on the susceptibility of mosquitoes to Brugia pahangi].',\n",
       "  'issue': '17(3)',\n",
       "  'pages': '156-60',\n",
       "  'abstract': 'A comparative study on the susceptibility of eight species of four genera of mosquitoes to Brugia pahangi was carried out. Aedes aegypti (Liverpool strain), Aedes togoi, Armigeres subalbatus and Mansonia uniformis (Taiwan strains) were found with the third-stage larvae 14 days after feeding on infected rats (Sprague-Dawley). The remaining of Aedes aegypti, Aedes albopictus, Aedes pseudoalbopictus, Culex p. fatigans and Culex annutus (Taiwan strains) were found refractory to infection. To determine the infectivity of the four susceptible species, the mosquitoes were fed on the same rat (mf. density 70/20 cmm blood). They were dissected and examined 14 days later. Significantly higher numbers of infective-stage larvae per infected mosquito were found in Armigeres subalbatus (42.6), Aedes togoi (8.8), Aedes aegypti (Liverpool strain) (7.6) and Mansonia uniformis (3.3).',\n",
       "  'journal': 'Zhonghua Minguo wei sheng wu ji mian yi xue za zhi = Chinese journal of microbiology and immunology',\n",
       "  'authors': 'Wu|C C|CC|;Ho|C M|CM|;Fan|P C|PC|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150813',\n",
       "  'mesh_terms': 'D000818:Animals; D002009:Brugia; D009033:Culicidae; D005370:Filarioidea; D007303:Insect Vectors; D051381:Rats',\n",
       "  'publication_types': \"D004740:English Abstract; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi',\n",
       "  'nlm_unique_id': '8008067',\n",
       "  'issn_linking': '0253-2662',\n",
       "  'country': 'China (Republic : 1949- )'},\n",
       " {'title': '[44 aneurysms of digestive arteries].',\n",
       "  'issue': '110(5)',\n",
       "  'pages': '565-70',\n",
       "  'abstract': '',\n",
       "  'journal': \"Chirurgie; memoires de l'Academie de chirurgie\",\n",
       "  'authors': 'Cormier|J M|JM|;Laurian|C|C|;Chapelier|A|A|;Fichelle|J M|JM|;Gigou|F|F|;Ricco|J B|JB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150814',\n",
       "  'mesh_terms': 'D000783:Aneurysm; D001161:Arteriosclerosis; D004064:Digestive System; D006801:Humans; D011859:Radiography; D013625:Takayasu Arteritis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Chirurgie',\n",
       "  'nlm_unique_id': '0236600',\n",
       "  'issn_linking': '0001-4001',\n",
       "  'country': 'France'},\n",
       " {'title': 'Naltrexone disposition in man after subcutaneous administration.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '677-82',\n",
       "  'abstract': 'The metabolism, excretion, and pharmacokinetics of [15,16-3H2]naltrexone were studied in six human males after sc administration of the hydrochloride salt. Biological fluids were analyzed by a combination of high performance liquid chromatography with liquid scintillation measurement of radioactivity. After administration, naltrexone was rapidly absorbed into the systemic circulation. The mean absorption rate constant was 0.091 +/- 0.008 min-1 (half-life of 7.6 min). In general the metabolic, excretory, and pharmacokinetic patterns for naltrexone were similar to those observed after iv administration of naltrexone to man. The terminal phase plasma rate constant was 0.413 +/- 0.035 hr-1 (half-life of 1.68 hr) for parent drug and 0.0786 +/- 0.0090 hr-1 (half-life of 8.8 hr) for the major metabolite, 6 beta-naltrexone. An average of 76 +/- 6% (+/- SD) of the total radioactivity was recovered in the urine within 72 hr after administration. Naltrexone was found in the urine in both the free (3.4 +/- 0.8% of dose) and conjugated (6.8 +/- 2.1% of dose) form. 6 beta-Naltrexol was present in urine largely in the unconjugated form (28 +/- 7% of dose) but the conjugated form was also found (12 +/- 3% of dose).',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Wall|M E|ME|;Perez-Reyes|M|M|;Brine|D R|DR|;Cook|C E|CE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150815',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000328:Adult; D006801:Humans; D007279:Injections, Subcutaneous; D007700:Kinetics; D008297:Male; D009270:Naloxone; D009271:Naltrexone',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D009270:Naloxone; D009271:Naltrexone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The pharmacokinetics of indecainide in mice, rats, dogs, and monkeys.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '683-90',\n",
       "  'abstract': 'The pharmacokinetics of indecainide, a new antiarrhythmic agent, were studied in mice, rats, dogs, and monkeys. The drug was well absorbed in all species tested resulting in peak plasma levels of drug within 2 hr. The plasma half-life of indecainide after acute oral administration was 3-5 hr in rats, dogs, and monkeys but considerably shorter in mice. The plasma half-life of indecainide was dose-dependent in dogs and increased slightly with chronic dosing. Peak plasma levels of drug were also dose-dependent in dogs and monkeys. Fecal elimination was the primary route of excretion of the drug in rats and mice after oral dosing. Fifty per cent of the dose was excreted in the bile of rats which was then subject to enterohepatic circulation. Urinary elimination was the predominant excretory route in the dog. Tissue distribution of radioactivity in rats showed that tissues which first encounter the drug have the highest levels of radioactivity. The highest concentrations were found in the stomach, intestine, liver, and kidney, whereas very low levels were observed in the fat and brain. Except for liver and kidney, only very low levels were present after 24 hr.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Lindstrom|T D|TD|;Whitaker|G W|GW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150816',\n",
       "  'mesh_terms': 'D000818:Animals; D000889:Anti-Arrhythmia Agents; D004285:Dogs; D005449:Fluorenes; D007700:Kinetics; D008253:Macaca mulatta; D051379:Mice; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000889:Anti-Arrhythmia Agents; D005449:Fluorenes; C042398:indecainide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Metabolism of the antiarrhythmic agent, indecainide, in rats, dogs, and monkeys.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '691-7',\n",
       "  'abstract': 'The biotransformation of indecainide, a potent new antiarrhythmic agent, has been studied in rats and dogs. Indecainide was excreted in the urine primarily as the unchanged compound. The major urinary metabolite was desisopropyl indecainide which accounted for approximately 5% of the urinary radioactivity in both species. This metabolite was also detected in the plasma of rats, dogs, and monkeys. Peak plasma levels of the amine metabolite were 15 and 19% of the peak plasma levels of indecainide in rats and dogs, respectively. Loss of isopropylamine resulted in the formation of an aldehyde intermediate which was stabilized as the cyclic acylaminocarbinol. An acidic metabolite presumably derived from oxidation of the aldehyde was detected as well as a cyclic imide metabolite. An additional minor metabolite corresponding to N-formyl indecainide was observed in the urine but the mechanism of its formation is unknown.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Lindstrom|T D|TD|;Lacefield|W B|WB|;Whitaker|G W|GW|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150817',\n",
       "  'mesh_terms': 'D000818:Animals; D000889:Anti-Arrhythmia Agents; D002845:Chromatography; D004285:Dogs; D005260:Female; D005449:Fluorenes; D008253:Macaca mulatta; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000889:Anti-Arrhythmia Agents; D005449:Fluorenes; C042398:indecainide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Disposition of [14C]tri-o-cresyl phosphate and its metabolites in various tissues of the male cat following a single dermal application.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '705-11',\n",
       "  'abstract': 'The disposition and metabolism of a single dermal dose of 50 mg (5.8 muCi)/kg of tri-o-cresyl [phenyl-U-14C]phosphate (TOCP) were investigated in adult male cats. TOCP was applied on a preclipped area on the back of the animals neck. Three treated cats were sacrificed at each time interval 0.5, 1, 2, 5, and 10 days following application. Plasma, brain, spinal cord, sciatic nerve, liver, kidneys, and lungs were extracted and analyzed for TOCP and its various metabolites by high performance liquid chromatography and liquid scintillation counting. TOCP reached its highest concentration in plasma at 12 hr, while its metabolites attained their maximum concentration levels between 24 and 48 hr after dosing. The disappearance of TOCP from the plasma followed a monoexponential kinetics with a half-life of 1.2 days. Di-o-cresyl hydrogen phosphate and o-cresyl dihydrogen phosphate were the major metabolites in the plasma while dihydroxymethyl TOCP was present in trace amounts. Appreciable concentrations of saligenin cyclic-o-tolyl phosphate, which is believed to be the active neurotoxic metabolite, were detected in the plasma at all time points. TOCP was the predominant compound in the brain, spinal cord, and sciatic nerve, while the liver, kidneys, and lungs contained mostly metabolites. The major metabolite identified in the liver, kidneys, and lungs was o-hydroxybenzoic acid (salicylic acid) followed by di-o-cresyl hydrogen phosphate whereas di-o-cresyl hydrogen phosphate and o-cresyl dihydrogen phosphate were the most abundant metabolites in the brain, spinal cord, and sciatic nerve.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Nomeir|A A|AA|;Abou-Donia|M B|MB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150819',\n",
       "  'mesh_terms': 'D000287:Administration, Topical; D000818:Animals; D002415:Cats; D002490:Central Nervous System; D003408:Cresols; D007668:Kidney; D007700:Kinetics; D008099:Liver; D008168:Lung; D008297:Male; D010968:Plasticizers; D012584:Sciatic Nerve; D014317:Tritolyl Phosphates',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D003408:Cresols; D010968:Plasticizers; D014317:Tritolyl Phosphates; C025541:tri-o-cresyl phosphate',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Kinetics of meperidine N-demethylation in the perfused rat liver preparation.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '698-704',\n",
       "  'abstract': 'Meperidine and normeperidine elimination was studied in the once-through perfused rat liver preparation. Biliary excretion of these bases was minimal, and nonlinear metabolism of meperidine (extraction ratio of 1.0 to 0.89 at 1 to 19 micrograms/ml) and normeperidine (extraction ratio of 0.6 to 0.1 at 1 to 25 micrograms/ml) was observed when input concentration was increased. The rate of efflux of normeperidine in hepatic venous blood represented an increasing proportion of the rate of presentation and the rate of loss of meperidine (34 to 92%) at increasing meperidine input concentration. But when the data were corrected for the nonlinear sequential metabolism of normeperidine, the rate of N-demethylation accounted completely for the rate of metabolism of meperidine. These N-demethylation rates obeyed Michaelis-Menten behavior, and appeared to be saturated at input meperidine concentration greater than 5 micrograms/ml.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Babiak|L M|LM|;Cherry|W F|WF|;Fayz|S|S|;Pang|K S|KS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150818',\n",
       "  'mesh_terms': 'D000818:Animals; D002800:Cholinesterase Inhibitors; D066298:In Vitro Techniques; D007700:Kinetics; D008099:Liver; D008614:Meperidine; D010089:Oxidoreductases, N-Demethylating; D010477:Perfusion; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002800:Cholinesterase Inhibitors; D008614:Meperidine; D010089:Oxidoreductases, N-Demethylating; C002752:normeperidine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The effect of pregnancy and treatment with 17 beta-estradiol on the transport of organic anions into isolated rat hepatocytes.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '713-6',\n",
       "  'abstract': 'The uptake of the bile acid taurocholate (TC), and the organic anions, estradiol-17 beta (beta-D-glucuronide) (E217G), estradiol-3-(beta-D-glucuronide) (E23G), estriol-16 alpha (beta-D-glucuronide) (E316G), and morphine glucuronide (MG) were evaluated in hepatocytes isolated from nonpregnant female, pregnant (19-21 days of gestation) and E2-treated (1 mg/kg/day sc for 14 days) rats. Pregnancy significantly decreased the uptake of TC, E217G, E23G, and MG whereas E2 treatment decreased only the uptake of E217G. The Vmax (nmol/min/mg protein) for E217G uptake was significantly decreased from 1.45 +/- 0.2 (mean +/- SE) in hepatocytes from nonpregnant female rats to 0.70 +/- 0.11 and 0.64 +/- 0.13 in cells from pregnant and E2-treated rats, respectively. The Vmax for uptake of TC was decreased, but not significantly, from 0.56 +/- 0.16 in hepatocytes from nonpregnant female rats to 0.34 +/- 0.08 in cells from pregnant rats.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Brock|W J|WJ|;Vore|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150820',\n",
       "  'mesh_terms': 'D000818:Animals; D001692:Biological Transport; D004958:Estradiol; D005260:Female; D008099:Liver; D008297:Male; D011247:Pregnancy; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D004958:Estradiol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Human erythrocyte membrane thiol methyltransferase. S-methylation of captopril, N-acetylcysteine, and 7 alpha-thio-spirolactone.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '717-24',\n",
       "  'abstract': 'Thiol methylation is an important pathway in the biotransformation of sulfhydryl drugs such as captopril. Human red blood cell (RBC) membranes contain a thiol methyltransferase (TMT) activity that catalyzes the S-methylation of 2-mercaptoethanol (2-ME). These experiments were performed to determine whether human RBC membranes contained enzymes that could catalyze the S-methylation of thiol drugs, and, if so, to determine whether those enzymes were similar to the RBC membrane TMT that catalyzes the S-methylation of 2-ME. Human RBC membranes were able to catalyze the methylation of captopril, N-acetylcysteine, and 7 alpha-thio-spirolactone, a sulfhydryl metabolite of spironolactone. Those activities and 2-ME TMT were similar with respect to subcellular distribution, inhibitor sensitivity, and thermal stability. When activities of the methyltransferase enzymes for 2-ME and for the three thiol drugs were measured in RBC membranes from 19 individual subjects, there were highly significant correlations among all four activities (r greater than 0.96 for all comparisons). These observations suggested either that a single enzyme in the human RBC membrane catalyzed the S-methylation of all of these compounds, or, less likely, that these were four separate activities regulated in parallel with similar properties. Experiments were then performed to identify the products of the enzyme reactions. The product of the reaction performed with 7 alpha-thio-spirolactone was the expected S-methyl derivative, 7 alpha-thiomethyl-spirolactone. However, it was found that lipophilic conjugates of the S-methyl derivatives of captopril and N-acetylcysteine were formed during the in vitro enzyme reaction.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Keith|R A|RA|;Jardine|I|I|;Kerremans|A|A|;Weinshilboum|R M|RM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150821',\n",
       "  'mesh_terms': 'D000111:Acetylcysteine; D000328:Adult; D002216:Captopril; D002851:Chromatography, High Pressure Liquid; D004910:Erythrocyte Membrane; D006801:Humans; D013058:Mass Spectrometry; D008745:Methylation; D008780:Methyltransferases; D013148:Spironolactone; D013438:Sulfhydryl Compounds',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D013438:Sulfhydryl Compounds; D013148:Spironolactone; C033554:7 alpha-thiospironolactone; D002216:Captopril; D008780:Methyltransferases; C022742:thiol S-methyltransferase; D000111:Acetylcysteine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'A comparative study of the disposition of nicotine and its metabolites in three inbred strains of mice.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '725-31',\n",
       "  'abstract': 'The disposition of nicotine, cotinine, and nicotine N-oxide was investigated in male C57BL, DBA, and C3H mice following an ip injection of nicotine (1.0 mg/ml). The half-lives (t1/2) of nicotine in blood were 5.9 to 6.9 min. The rapid elimination of nicotine was accompanied by a rapid accumulation of metabolites; maximal concentrations of cotinine in blood (204 to 364 ng/ml) were achieved in 10 min and nicotine N-oxide (23 ng/ml in C3H mice) in 15 min. The t1/2 in blood was 20.1 to 39.8 min for cotinine and 18.4 min for nicotine N-oxide. The t1/2 values for nicotine in brain were similar to those in blood, but the values for liver were slightly larger (6.3 to 9.2 min) and interstrain differences were significant. A large strain-related difference in the t1/2 for cotinine was found; the metabolite was eliminated from the blood of DBA mice at only about one-half the rate determined for the other strains. The t1/2 for nicotine N-oxide in liver ranged from 12.7 to 27.3 min; the values were significantly different with C57BL greater than DBA greater than C3H. Strain-related differences were also observed in response to chronic exposure to cigarette smoke. The t1/2 of injected nicotine appeared to be slightly decreased in C57BL and DBA mice but was increased by 60% in livers of C3H mice compared to a control group.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Petersen|D R|DR|;Norris|K J|KJ|;Thompson|J A|JA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150822',\n",
       "  'mesh_terms': 'D000818:Animals; D001921:Brain; D003367:Cotinine; D003497:Cyclic N-Oxides; D007700:Kinetics; D008099:Liver; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D008811:Mice, Inbred DBA; D009538:Nicotine',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D003497:Cyclic N-Oxides; C024270:nicotine 1-N-oxide; D009538:Nicotine; D003367:Cotinine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Reductive metabolism of furazolidone by Escherichia coli and rat liver in vitro.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '732-41',\n",
       "  'abstract': 'The metabolism of furazolidone by rat liver and Escherichia coli was characterized in vitro under aerobic and anaerobic incubation conditions. Rat liver 9000g supernatant rapidly metabolized 14C-furazo-lidone to more polar metabolites in the presence or absence of oxygen when NADPH was provided as a cofactor. At least five polar radiolabeled metabolites were detected in these incubations by high pressure liquid chromatography. Moreover, a significant (30-40%) proportion of the total radiolabeled metabolites remained tightly associated with liver protein despite repeated organic solvent extractions of the tissue. The major solvent-extractable metabolites produced under aerobic and anaerobic incubation conditions were isolated and analyzed by mass spectrometry. The mass spectra indicated that these derivatives possessed the same chemical structure. Subsequently, this metabolite was unequivocally identified as 3-(4-cyano-2-oxobutylideneamino)-2-oxazolidinone, an end product of reductive metabolism of the nitro group of furazolidone. The formation of the reduced metabolite under aerobic conditions indicated that this metabolic pathway was markedly less sensitive to oxygen than many previously studied nitroreduction reactions catalyzed by mammalian enzymes. This NADPH-dependent, oxygen-insensitive nitroreductase activity was further localized to the microsomal fraction of rat liver. E. coli also rapidly metabolized furazolidone (FZN) to a complex series of metabolites, including the reduced cyano metabolite, under both aerobic and anaerobic conditions. Sonic lysis of the bacteria released an NADPH-dependent, oxygen-insensitive nitroreductase which converted FZN to the cyano metabolite and other unidentified derivatives. The complete reduction of FZN by the solubilized bacterial enzyme was strongly inhibited by the addition of the thiol nucleophile glutathione to the incubation medium.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Abraham|R T|RT|;Knapp|J E|JE|;Minnigh|M B|MB|;Wong|L K|LK|;Zemaitis|M A|MA|;Alvin|J D|JD|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150823',\n",
       "  'mesh_terms': 'D000818:Animals; D004926:Escherichia coli; D005664:Furazolidone; D066298:In Vitro Techniques; D008099:Liver; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005664:Furazolidone; C043287:3-(4-cyano-2-oxobutylideneamino)-2-oxazolidinone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'In vitro metabolism of mono-2-ethylhexyl phthalate by microsomal enzymes. Similarity to omega- and (omega-1) oxidation of fatty acids.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '742-8',\n",
       "  'abstract': 'Mono-2-ethylhexyl pthalate (MEHP) is oxidized to omega-, omega-1-, and omega-2-hydroxylation products as well as (very slightly) to a dicarboxylic acid by washed microsomes from rat liver and kidney, and rabbit but not rat lung. The reactions involve molecular oxygen, are strongly inhibited by carbon monoxide and oxidized cytochrome c, and NADPH is preferred over NADH. Piperonyl butoxide inhibits hydroxylation of MEHP, but clofibrate does not. The differential effects of inducers (phenobarbital and clofibrate) and inhibitors (sodium laurate, n-decane, metyrapone) on terminal and subterminal hydroxylation as well as differences in apparent Km for the two suggest that rat liver contains at least two different MEHP hydroxylases. Comparisons of tissue distribution, susceptibility to inhibitors, and induction properties suggest that the hydroxylation of MEHP is more likely to be mediated by the P-450 isozymes associated with omega- and (omega-1)-hydroxylation of fatty acids than with those that utilize hydrocarbons as substrates.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Albro|P W|PW|;Chae|K|K|;Philpot|R|R|;Corbett|J T|JT|;Schroeder|J|J|;Jordan|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150824',\n",
       "  'mesh_terms': 'D000818:Animals; D002994:Clofibrate; D042926:Cytochrome P-450 CYP4A; D003577:Cytochrome P-450 Enzyme System; D004051:Diethylhexyl Phthalate; D006900:Hydroxylation; D066298:In Vitro Techniques; D007527:Isoenzymes; D007700:Kinetics; D008297:Male; D008861:Microsomes; D006899:Mixed Function Oxygenases; D010795:Phthalic Acids; D011817:Rabbits; D051381:Rats; D014018:Tissue Distribution',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D007527:Isoenzymes; D010795:Phthalic Acids; D003577:Cytochrome P-450 Enzyme System; D004051:Diethylhexyl Phthalate; D006899:Mixed Function Oxygenases; D042926:Cytochrome P-450 CYP4A; C016599:mono-(2-ethylhexyl)phthalate; D002994:Clofibrate',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Isolation, purification, and structure identification of glucuronic acid conjugates of propranolol and alprenolol and their ring-hydroxylated metabolites.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '749-54',\n",
       "  'abstract': 'The purpose of this study was to develop a procedure for the isolation, purification, and structure identification of glucuronic acid conjugates of propranolol and alprenolol and their active metabolites, 4-hydroxypropranolol and 4-hydroxyalprenolol. As both aliphatic and aromatic glucuronides may be formed from 4-hydroxypropranolol and 4-hydroxyalprenolol, the structure identification of these conjugates has to be based on the intact conjugates. Using DEAE-Sephadex anion-exchange chromatography, milligram quantities of these glucuronides were isolated from urine of dogs pretreated with propranolol and alprenolol, respectively. A high degree of purification was achieved by reversed-phase HPLC. Structure identification of the methyl ester-trimethylsilyl derivatives was accomplished by electron impact GC/MS. Only one 4-hydroxypropranolol glucuronide was found, having the glucuronic acid linked to the aromatic hydroxyl group. For 4-hydroxyalprenolol glucuronide, however, two structures were identified, one with the glucuronic acid linked to the aromatic hydroxyl group, and the other with the glucuronic acid linked to the aliphatic hydroxyl group of the side chain. Using this analytical approach, 4-hydroxypropranolol glucuronide was identified in the urine of patients on propranolol therapy. In man, as in the dog, only the aromatic glucuronide was found, i.e. containing an unsubstituted beta-blocking side chain.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Bai|S A|SA|;Walle|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150825',\n",
       "  'mesh_terms': 'D000526:Alprenolol; D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D006801:Humans; D011433:Propranolol',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'C043293:alprenolol glucuronide; C022056:propranolol glucuronide; C043291:4-hydroxyalprenolol glucuronide; D000526:Alprenolol; C043288:4-hydroxypropranolol glucuronide; D011433:Propranolol',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Covalent binding of benzo(a)pyrene in perfused rat lung following systemic and intratracheal administration.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '760-6',\n",
       "  'abstract': 'Covalent binding of benzo(a)pyrene to DNA, RNA, and protein of perfused rat lung after intratracheal administration of the substrate was about 50% of that obtained by direct addition of the substrate into the perfusate. Systemic availability of benzo(a)pyrene by absorption from the intratracheal sites was found to be 25%. During single pass perfusion of rat lung as well as in the combined liver-lung recirculating perfusion system, covalent binding after intratracheal exposure to benzo(a)pyrene was reduced to 50-75%. These experiments point out the relative importance of systemic versus inhalation exposure to benzo(a)pyrene in the development of lesions on the lung macromolecules. The elimination capacity of the perfused lung was found to be relatively high as compared to the liver. At constant benzo(a)pyrene infusion by a single pass medium, clearance values of the 5,6-benzoflavone-induced lung with 7.8 ml/min reach almost half of those of a 5,6-benzoflavone-induced liver (15.9 ml/min). The extraction ratios in lung both during bolus administration in the recirculating system and during constant infusion in the nonrecirculating system are 0.25 and 0.29, respectively, and thus amount to half of those measured in the liver (0.45 and 0.53, respectively). Though the liver is able to exert a protective effect against covalent binding of benzo(a)pyrene in the lung, this protection is not complete, and significant amounts of benzo(a)pyrene are expected to escape metabolic transformation by the liver representing a risk for the lung from the circulatory site in addition to that from the respiratory site.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Foth|H|H|;Mollière|M|M|;Kahl|R|R|;Jähnchen|E|E|;Kahl|G F|GF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150827',\n",
       "  'mesh_terms': 'D000818:Animals; D001564:Benzo(a)pyrene; D007700:Kinetics; D008099:Liver; D008168:Lung; D008297:Male; D010477:Perfusion; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001564:Benzo(a)pyrene',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Evidence of stereospecificity in the in vivo methylation of [14C](+/-)-nicotine in the guinea pig.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '755-9',\n",
       "  'abstract': \"In vivo metabolism of [14C]nicotine to N-methylnicotinium ion in the guinea pig appears to be a stereospecific biotransformation, involving only the R-(+)-isomer. The detection and quantitation of urinary radiolabeled nicotine metabolites after ip injection of either [N-14CH3](+/-)-nicotine or [2'-14C](+/-)-nicotine, was carried out on an HPLC cation-exchange analytical system. Utilizing the recently discovered phenomenon of differential enantiomeric association, the stereo-chemistry of the methylation pathway was determined. Significant differences in the tissue distribution of 14C label from the [N-14CH3]-vs. [2'-14C]nicotine-treated animals were observed 24 hr after nicotine administration. An unidentified metabolite with high affinity on cation-exchange chromatography, was detected as a metabolite of [2'-14C](+/-)-nicotine, but was not observed as a metabolite of [N-14CH3](+/-)-nicotine.\",\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Cundy|K C|KC|;Godin|C S|CS|;Crooks|P A|PA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150826',\n",
       "  'mesh_terms': 'D000818:Animals; D002851:Chromatography, High Pressure Liquid; D006168:Guinea Pigs; D008297:Male; D008745:Methylation; D009538:Nicotine; D013237:Stereoisomerism; D014018:Tissue Distribution',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D009538:Nicotine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Further structural analysis of urinary metabolites of suprofen in the rat.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '767-71',\n",
       "  'abstract': 'The urinary metabolites of 2-(4-(2-thienylcarbonyl)phenyl)propionic acid (suprofen, S) in rats were analyzed by radio-GC, GC/MS, or 1H NMR technique. Radio-GC analysis of trimethylsilylated materials after TLC separation of intact urine showed the presence of three radioactive peaks with the retention times corresponding to the authentic S, 2-(4-(2-thienylhydroxymethyl)phenyl)propionic acid, and 2-(4-carboxyphenyl)propionic acid. About 40% of the total radioactivity appearing in the 0-24-hr urine was accounted for by the three metabolites and their conjugates. The identification of these metabolites was confirmed by comparison of the MS spectra of urine, in which rats were administered an equimolar mixture of S and S[phenyl-d4], with those of synthetic standards. The labile metabolites of S, corresponding to about 32% of the total radioactivity appearing in the 0-24-hr urine, were isolated and purified by ether extraction from the fresh urine and GC/MS or HPLC. GC/MS of the methylated metabolite revealed the consistent presence of the ion peaks at m/z 304, 245, 217, and 141, indicative of a dimethylated product with monohydroxy group on the thiophene ring. Analysis of the 1H NMR spectrum demonstrated the metabolite to be 2-(4-(5-hydroxy-2-thienylcarbonyl)phenyl)propionic acid.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Mori|Y|Y|;Sakai|Y|Y|;Kuroda|N|N|;Yokoya|F|F|;Toyoshi|K|K|;Horie|M|M|;Baba|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150828',\n",
       "  'mesh_terms': 'D000818:Animals; D055598:Chemical Phenomena; D002621:Chemistry; D008297:Male; D010666:Phenylpropionates; D051381:Rats; D011919:Rats, Inbred Strains; D013496:Suprofen',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D010666:Phenylpropionates; D013496:Suprofen',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '772-81',\n",
       "  'abstract': 'The excretion and biotransformation of ketanserin, a novel serotonin S2-receptor blocking agent used in hypertension and related diseases, were studied after single po (1 or 10 mg/kg) and iv (2.5 mg/kg) administration in rats and dogs, using two different radiolabels. Orally administered ketanserin was well absorbed and almost completely metabolized in both species. The excretion of the metabolites was rapid and amounted to about 90% within 4 days. In the various groups of rats and dogs, excretion of the radioactivity with the feces (48 to 67%) exceeded that with urine (27 to 43%). In po dosed bile-cannulated rats, 57% was excreted with the bile within 24 hr, whereas about 30 to 40% of the biliary radioactivity was subjected to enterohepatic circulation. The major urinary, biliary, and fecal metabolites were characterized by HPLC and mass spectrometric analysis. The main metabolic pathways of ketanserin were the aromatic hydroxylation at the quinazolinedione moiety, the oxidative N-dealkylation at the piperidine nitrogen, reduction of the ketone function and piperidine oxidation, followed by ring scission. The mass balance of the metabolites, as estimated by reversed-phase HPLC with on-line radioactivity detection, was very similar between male and female rats, as well as between rats po dosed at 10 mg/kg and iv dosed at 2.5 mg/kg. In rats, major urinary metabolites resulted from the N-dealkylation pathway, whereas hydroxyketanserin was the main biliary and fecal metabolite. In dogs, the N-dealkylation pathway was less abundant, whereas higher doses resulted in smaller relative amounts of hydroxylated metabolites and larger relative amounts of ketanserin-ol, resulting from the ketone reduction. Dog plasma levels of ketanserin-ol exceeded those of the parent drug from about 5 hr after po dosing.',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Meuldermans|W|W|;Hendrickx|J|J|;Lauwers|W|W|;Swysen|E|E|;Hurkmans|R|R|;Knaeps|F|F|;Woestenborghs|R|R|;Heykants|J|J|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150829',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000818:Animals; D001646:Bile; D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D004285:Dogs; D005243:Feces; D005260:Female; D007275:Injections, Intravenous; D007650:Ketanserin; D008297:Male; D010880:Piperidines; D051381:Rats; D011919:Rats, Inbred Strains; D012702:Serotonin Antagonists',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D010880:Piperidines; D012702:Serotonin Antagonists; D007650:Ketanserin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Cimetidine and dapsone acetylation.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '782-3',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Wright|J T|JT|;Goodman|R P|RP|;Bethel|A M|AM|;Lambert|C M|CM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150830',\n",
       "  'mesh_terms': 'D000107:Acetylation; D002927:Cimetidine; D003622:Dapsone; D006801:Humans',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D002927:Cimetidine; D003622:Dapsone',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Structures of metabolites isolated from urine of mice treated with the antiviral agent, 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5-methyluracil.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '784-6',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Feinberg|A|A|;Vidal|P M|PM|;Fox|J J|JJ|;Watanabe|K A|KA|;Chun|M W|MW|;Field|F H|FH|;Bencsath|A|A|;Chait|B|B|;Philips|F S|FS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150831',\n",
       "  'mesh_terms': 'D000818:Animals; D000998:Antiviral Agents; D001086:Arabinofuranosyluracil; D055598:Chemical Phenomena; D002621:Chemistry; D008297:Male; D051379:Mice; D014529:Uridine',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000998:Antiviral Agents; D001086:Arabinofuranosyluracil; C034935:clevudine; D014529:Uridine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'The influence of haloperidol and aminooxyacetic acid on etonitazene, alcohol, diazepam and barbital consumption.',\n",
       "  'issue': '14(2)',\n",
       "  'pages': '179-86',\n",
       "  'abstract': 'Four groups of rats were given free choice between water and solutions of either 3 micrograms/ml etonitazene, 5% ethanol (v/v), 0.1 mg/ml diazepam or 3 mg/ml barbital for 10-14 days. With the exception of barbital, some rats spontaneously preferred the drug solutions to water. This preference was reduced by addition of 7 micrograms/ml haolperidol. In a forced drug fluid consumption procedure, the daily administration of 15 mg/kg i.p. of the gamma-aminobutyric acid (GABA)-transaminase blocker aminooxyacetic acid (AOAA) led to a reduction of ethanol and diazepam intake, but not of etonitazene and barbital. It is suggested that the diminished consumption of ethanol and diazepam as caused by GABA-T-inhibition may also be mediated by dopamine which seems to act indirectly, via benzodiazepine receptors and GABA neurons.',\n",
       "  'journal': 'Drug and alcohol dependence',\n",
       "  'authors': 'Fuchs|V|V|;Burbes|E|E|;Coper|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150837',\n",
       "  'mesh_terms': 'D000085:Acetates; D000428:Alcohol Drinking; D000625:Aminooxyacetic Acid; D000818:Animals; D001462:Barbital; D001463:Barbiturates; D001562:Benzimidazoles; D001921:Brain; D003975:Diazepam; D005260:Female; D006220:Haloperidol; D006801:Humans; D051381:Rats; D011919:Rats, Inbred Strains; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D012646:Self Administration; D019966:Substance-Related Disorders',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000085:Acetates; D001463:Barbiturates; D001562:Benzimidazoles; D011954:Receptors, Dopamine; D011963:Receptors, GABA-A; D000625:Aminooxyacetic Acid; D001462:Barbital; D006220:Haloperidol; D003975:Diazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0376-8716(84)90043-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Alcohol Depend',\n",
       "  'nlm_unique_id': '7513587',\n",
       "  'issn_linking': '0376-8716',\n",
       "  'country': 'Ireland'},\n",
       " {'title': 'Effects of oxygen on the disposition of nitrofurantoin in intact rat lung.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '787-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Minchin|R F|RF|;Ho|P C|PC|;Boyd|M R|MR|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150832',\n",
       "  'mesh_terms': 'D000818:Animals; D008168:Lung; D009582:Nitrofurantoin; D010100:Oxygen; D051381:Rats',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D009582:Nitrofurantoin; D010100:Oxygen',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Leukocyte uptake of daunomycin.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '790-1',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Styrt|B|B|;Klempner|M S|MS|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150833',\n",
       "  'mesh_terms': 'D003630:Daunorubicin; D004912:Erythrocytes; D006801:Humans; D007700:Kinetics; D007962:Leukocytes; D008214:Lymphocytes; D009504:Neutrophils; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D003630:Daunorubicin',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Prolonged hypnotic response to triazolam-cimetidine combination in an elderly patient.',\n",
       "  'issue': '18(12)',\n",
       "  'pages': '980-1',\n",
       "  'abstract': 'An 82-year-old white female developed a 36-hour episode of unresponsiveness/drowsiness after a single dose of triazolam 0.5 mg in combination with cimetidine. This case illustrates the need for careful dose-titration of drug therapy in the elderly, particularly when a drug with the potential to impair drug metabolism is coadministered. Cimetidine, when coadministered with triazolam, may increase the intensity and duration of action of single doses of triazolam.',\n",
       "  'journal': 'Drug intelligence & clinical pharmacy',\n",
       "  'authors': 'Parker|W A|WA|;MacLachlan|R A|RA|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150838',\n",
       "  'mesh_terms': 'D000368:Aged; D014151:Anti-Anxiety Agents; D002927:Cimetidine; D004347:Drug Interactions; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives; D008862:Microsomes, Liver; D013997:Time Factors; D014229:Triazolam',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D006993:Hypnotics and Sedatives; D014229:Triazolam; D002927:Cimetidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1177/106002808401801206',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Intell Clin Pharm',\n",
       "  'nlm_unique_id': '0212457',\n",
       "  'issn_linking': '0012-6578',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Effect of bisoprolol in coronary heart disease. Effect on cardiovascular parameters and ischemic ST depression: studies on the duration of the effect].',\n",
       "  'issue': '109(50)',\n",
       "  'pages': '1914-7',\n",
       "  'abstract': 'A beta-adrenoceptor antagonist, bisoprolol, was given by mouth, 5 and 10 mg doses per 24 hours, in a double-blind randomized cross-over trial to 12 patients with stable coronary-heart disease. Ischaemia criteria proved not reproducible in control ergometry tests on two patients, leaving ten patients for further evaluation. On two days, one week apart, bicycle ergometry was undertaken until the occurrence of ST segment depression of at least 0.3 mV, often associated with angina. Four, eight and 24 hours after the drug had been taken, the ergometry was repeated to the same maximal Watt level and duration of exercise. Heart rate and pressure-rate product at rest, as well as the same parameters including ST segment depressions immediately at the end of exercise, significantly fell after bisoprolol during the entire trial period independently of the dose. There was no sign of reduced effectiveness 24 hours after drug intake. The results indicate that treatment of stable angina with bisoprolol can be achieved with a single daily dose.',\n",
       "  'journal': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "  'authors': 'Prager|G|G|;Wagner|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150839',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000368:Aged; D000787:Angina Pectoris; D017298:Bisoprolol; D002986:Clinical Trials as Topic; D003327:Coronary Disease; D004562:Electrocardiography; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D011412:Propanolamines',\n",
       "  'publication_types': 'D016430:Clinical Trial; D004740:English Abstract; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D017298:Bisoprolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1055/s-2008-1069478',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dtsch Med Wochenschr',\n",
       "  'nlm_unique_id': '0006723',\n",
       "  'issn_linking': '0012-0472',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Direct detection of 1-(beta-D-glucopyranosyl)phenobarbital in human urine.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '792-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Soine|W H|WH|;Bhargava|V O|VO|;Garrettson|L K|LK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150834',\n",
       "  'mesh_terms': 'D000368:Aged; D055598:Chemical Phenomena; D002621:Chemistry; D002675:Child, Preschool; D005260:Female; D006801:Humans; D010634:Phenobarbital',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'C043855:phenobarbital-N-glucoside; C043290:1-(2,3,4,6-tetraacetyl-beta-D-glucopyranosyl)phenobarbital; D010634:Phenobarbital',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': '[Importance of intravenous cholegraphy. Cholecystography and cholangiography].',\n",
       "  'issue': '109(50)',\n",
       "  'pages': '1927-30',\n",
       "  'abstract': '',\n",
       "  'journal': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "  'authors': 'Rasenack|U|U|;Laubenberger|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150840',\n",
       "  'mesh_terms': 'D000284:Administration, Oral; D000305:Adrenal Cortex Hormones; D000707:Anaphylaxis; D002758:Cholangiography; D002765:Cholecystography; D002769:Cholelithiasis; D003287:Contrast Media; D006634:Histamine H1 Antagonists; D006801:Humans; D007275:Injections, Intravenous; D009325:Nausea; D014463:Ultrasonography; D014839:Vomiting',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000305:Adrenal Cortex Hormones; D003287:Contrast Media; D006634:Histamine H1 Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1055/s-2008-1069481',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dtsch Med Wochenschr',\n",
       "  'nlm_unique_id': '0006723',\n",
       "  'issn_linking': '0012-0472',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Metabolism of suprofen in the dog.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '795-7',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Sakai|Y|Y|;Mori|Y|Y|;Toyoshi|K|K|;Horie|M|M|;Baba|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150835',\n",
       "  'mesh_terms': 'D000818:Animals; D002250:Carbon Radioisotopes; D002851:Chromatography, High Pressure Liquid; D002855:Chromatography, Thin Layer; D004285:Dogs; D007700:Kinetics; D010666:Phenylpropionates; D013496:Suprofen',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D002250:Carbon Radioisotopes; D010666:Phenylpropionates; D013496:Suprofen',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Reversible metabolism of D-penicillamine in the rat.',\n",
       "  'issue': '12(6)',\n",
       "  'pages': '798-9',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drug metabolism and disposition: the biological fate of chemicals',\n",
       "  'authors': 'Bourke|C E|CE|;Miners|J O|JO|;Birkett|D J|DJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150836',\n",
       "  'mesh_terms': 'D000818:Animals; D003545:Cysteine; D008297:Male; D010396:Penicillamine; D051381:Rats; D011919:Rats, Inbred Strains',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'C030163:penicillamine cysteine disulfide; D010396:Penicillamine; D003545:Cysteine',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drug Metab Dispos',\n",
       "  'nlm_unique_id': '9421550',\n",
       "  'issn_linking': '0090-9556',\n",
       "  'country': 'United States'},\n",
       " {'title': \"[Autoantibodies against the exocrine pancreas and against intestinal goblet cells in the diagnosis of Crohn's disease and ulcerative colitis].\",\n",
       "  'issue': '109(51-52)',\n",
       "  'pages': '1963-9',\n",
       "  'abstract': \"It was demonstrated by indirect immunofluorescence that Crohn's disease and ulcerative colitis are serologically distinct. In 59 patients with Crohn's disease, confirmed by endoscopy and histology, 23 (39%) had serum autoantibodies against exocrine pancreas; in 17 (29%) the titre was 1 : 100 or higher. In 46 patients with confirmed ulcerative colitis pancreas antibodies were demonstrated only twice, in 100 healthy control subjects only 3 times, with titres less than 1 : 100. Pancreas antibodies do not occur in high concentrations in pancreatitis; titres higher than 1 : 100 therefore suggest Crohn's disease. The pancreas antibodies of patients with Crohn's disease were predominantly immunoglobulins IgA and IgG, twice they were IgD and once IgM, never IgE. In 6 patients the pancreas antibodies fixed complement. Autoantibodies against intestinal goblet cells were found only in patients with ulcerative colitis (13 of 46 = 28%). The titres range was from 1 : 10 to 1 : 1000. The goblet-cell antibodies consisted only of IgA and IgG, never reacting with complement. These results indicate that determining pancreas and goblet-cell antibodies alone will make it possible to diagnose either Crohn's disease or ulcerative colitis in more than a quarter of patients with chronic inflammatory intestinal disease.\",\n",
       "  'journal': 'Deutsche medizinische Wochenschrift (1946)',\n",
       "  'authors': 'Stöcker|W|W|;Otte|M|M|;Ulrich|S|S|;Normann|D|D|;Stöcker|K|K|;Jantschek|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150841',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000368:Aged; D001323:Autoantibodies; D003093:Colitis, Ulcerative; D003168:Complement Fixation Tests; D003424:Crohn Disease; D004338:Drug Combinations; D004848:Epithelium; D005260:Female; D005944:Glucosamine; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D007413:Intestinal Mucosa; D008297:Male; D008875:Middle Aged; D010179:Pancreas; D012698:Serologic Tests; D012460:Sulfasalazine',\n",
       "  'publication_types': \"D004740:English Abstract; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001323:Autoantibodies; D004338:Drug Combinations; D007070:Immunoglobulin A; D007074:Immunoglobulin G; C028423:Salazopyrine; D012460:Sulfasalazine; D005944:Glucosamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1055/s-2008-1069485',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dtsch Med Wochenschr',\n",
       "  'nlm_unique_id': '0006723',\n",
       "  'issn_linking': '0012-0472',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Cardiovascular drug withdrawal syndromes. A potential problem with calcium antagonists?',\n",
       "  'issue': '28(5)',\n",
       "  'pages': '371-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Drugs',\n",
       "  'authors': 'Raftery|E B|EB|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150842',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D003000:Clonidine; D006801:Humans; D013375:Substance Withdrawal Syndrome; D013564:Sympathetic Nervous System',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D003000:Clonidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.2165/00003495-198428050-00001',\n",
       "  'references': '6166800;17362;6782480;1097925;436208;530309;51414;1244260;341676;745521;793849;4729721;435689;16681;371644;4697628;6402134;4828609;6814227;4617579;5086971',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Drugs',\n",
       "  'nlm_unique_id': '7600076',\n",
       "  'issn_linking': '0012-6667',\n",
       "  'country': 'New Zealand'},\n",
       " {'title': '[Treatment of schizophrenia].',\n",
       "  'issue': '100(20)',\n",
       "  'pages': '1329-38',\n",
       "  'abstract': '',\n",
       "  'journal': 'Duodecim; laaketieteellinen aikakauskirja',\n",
       "  'authors': 'Alanen|Y O|YO|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150843',\n",
       "  'mesh_terms': 'D014150:Antipsychotic Agents; D003131:Combined Modality Therapy; D005196:Family Therapy; D006801:Humans; D011613:Psychotherapy; D012559:Schizophrenia',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Duodecim',\n",
       "  'nlm_unique_id': '0373207',\n",
       "  'issn_linking': '0012-7183',\n",
       "  'country': 'Finland'},\n",
       " {'title': '[Histochemical appearance of gamma-glutamyltranspeptidase in the rat liver after transplacental exposure to diethylnitrosamine and postnatal administration of phenobarbital].',\n",
       "  'issue': '6(5)',\n",
       "  'pages': '30-3',\n",
       "  'abstract': 'Phenobarbital administration during 7 weeks after partial hepatectomy is shown to be a sufficient promoting factor for induction of hyperplastic nodules in the rat liver initiated by the single DENA injection to pregnant rats. Histochemical distribution of gamma-glutamyltranspeptidase was a marker for identification of hyperplastic nodules.',\n",
       "  'journal': \"Eksperimental'naia onkologiia\",\n",
       "  'authors': 'Vinarchuk|M P|MP|;Kononenko|L I|LI|;Bykorez|A I|AI|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150844',\n",
       "  'mesh_terms': 'D000818:Animals; D004052:Diethylnitrosamine; D004790:Enzyme Induction; D005260:Female; D006498:Hepatectomy; D006651:Histocytochemistry; D006965:Hyperplasia; D008099:Liver; D010634:Phenobarbital; D011247:Pregnancy; D011297:Prenatal Exposure Delayed Effects; D051381:Rats; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D004052:Diethylnitrosamine; D005723:gamma-Glutamyltransferase; D010634:Phenobarbital',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eksp Onkol',\n",
       "  'nlm_unique_id': '8406659',\n",
       "  'issn_linking': '0204-3564',\n",
       "  'country': 'Ukraine'},\n",
       " {'title': 'Direct effects of diphenylhydantoin (phenytoin) on the ion-transporting ATPases of cultured osteoblast-like cells.',\n",
       "  'issue': '25(6)',\n",
       "  'pages': '773-8',\n",
       "  'abstract': 'Diphenylhydantoin (phenytoin) added to cultures of osteoblast-like cells at a concentration of 10 microM, at the high end of the therapeutic range in plasma of unbound phenytoin (4-8 microM), caused reductions in Na+, K+-ATPase and alkaline phosphatase activities and increases in Ca2+-ATPase and HCO3--ATPase activities in homogenates of whole cells and in subcellular fractions of cultured osteoblast-like cells. These data suggest that, if these changes occur in vivo, the osteomalacia associated with treatment with diphenylhydantoin may be mediated in part by direct effects on the ability of bone cells to transport ions.',\n",
       "  'journal': 'Epilepsia',\n",
       "  'authors': 'Anderson|R E|RE|;Woodbury|D M|DM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150845',\n",
       "  'mesh_terms': 'D000251:Adenosine Triphosphatases; D001692:Biological Transport; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D002478:Cells, Cultured; D006801:Humans; D007477:Ions; D010006:Osteoblasts; D010672:Phenytoin',\n",
       "  'publication_types': \"D016428:Journal Article; D013486:Research Support, U.S. Gov't, Non-P.H.S.; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D007477:Ions; D010672:Phenytoin; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1528-1157.1984.tb03490.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '85076527',\n",
       "  'medline_ta': 'Epilepsia',\n",
       "  'nlm_unique_id': '2983306R',\n",
       "  'issn_linking': '0013-9580',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Mutagen sensitivity, smoking habits and enzyme induction in healthy middle-aged men.',\n",
       "  'issue': '35(2)',\n",
       "  'pages': '421-9',\n",
       "  'abstract': 'Unscheduled DNA synthesis (UDS) (excision-repair) of N-acetoxy-2-acetylaminofluorene (NA-AAF) damage to the DNA of human lymphocytes and levels of 3H-labeled NA-AAF bound to the DNA (carcinogen binding) of lymphocytes after 18 hr of culturing were measured in a consecutive subsample of healthy middle-aged males attending a multiphasic health screening program at the Department of Preventive Medicine in Malmö during 3 weeks in November-December 1981, and compared relative to their smoking habits, body weight, serum cholesterol, and gamma-glutamyltransferase levels as well as aryl hydrocarbon hydroxylase inducibility. This study group numbered 66 males and was uniform in sex, age, and investigation time. No case of significant arterial hypertension was present. The UDS and carcinogen binding results showed no correlation with the other factors measured, with the exception of smoking which was strongly (P less than 0.01) associated with increasing levels of both the UDS and carcinogen binding values. It is concluded that under ordinary circumstances smoking may represent the most important exogenous factor which may modulate risk to cardiovascular disease and cancer by influencing individual mutagen sensitivity.',\n",
       "  'journal': 'Environmental research',\n",
       "  'authors': 'Trell|E|E|;Janzon|L|L|;Pero|R W|RW|;Bryngelsson|C|C|;Bryngelsson|T|T|;Korsgaard|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150846',\n",
       "  'mesh_terms': 'D000099:Acetoxyacetylaminofluorene; D000328:Adult; D001189:Aryl Hydrocarbon Hydroxylases; D001835:Body Weight; D002784:Cholesterol; D004247:DNA; D004790:Enzyme Induction; D006801:Humans; D008214:Lymphocytes; D008297:Male; D009152:Mutagenicity Tests; D012907:Smoking; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000099:Acetoxyacetylaminofluorene; D004247:DNA; D002784:Cholesterol; D001189:Aryl Hydrocarbon Hydroxylases; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0013-9351(84)90149-x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Environ Res',\n",
       "  'nlm_unique_id': '0147621',\n",
       "  'issn_linking': '0013-9351',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Influence of long-term beta receptor stimulation with prenalterol on intrinsic heart rate in rats.',\n",
       "  'issue': '53(1)',\n",
       "  'pages': '48-52',\n",
       "  'abstract': 'Previous studies have shown that the intrinsic heart rate (IHR) may undergo changes, e.g., decrease after long-term endurance training. The mechanism for this adaptation is not known. In this study, rats were subjected to long-term oral treatment with the beta receptor stimulating drug prenalterol. During the treatment period heart rates at rest and during submaximal exercise were measured. Heart rate after 30 min rest and also 2 min after exercise was higher in the treated animals, due to the beta stimulation. The treated rats had a significantly lower heart rate increase during exercise than untreated controls, consistent with a partial beta-blocking effect of the drug in states with a high endogenous sympathetic activity. Therefore, the animals were not trained but only exposed to the increased stimulation of cardiac beta receptors accomplished by the drug while at rest. After 25 weeks, prenalterol was withdrawn and the IHR was measured in situ after a denervation procedure. The treatment with prenalterol had not altered the IHR. Our previous results from training studies indicate that a heart rate increase above a certain level or the stimulation for a lower setting of the IHR as seen after endurance training. In this study chronic beta receptor stimulation with prenalterol did not influence the IHR, which supports that hypothesis.',\n",
       "  'journal': 'European journal of applied physiology and occupational physiology',\n",
       "  'authors': 'Nylander|E|E|;Dahlström|U|U|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150847',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000818:Animals; D002316:Cardiotonic Agents; D005080:Exercise Test; D005260:Female; D006339:Heart Rate; D007545:Isoproterenol; D008790:Metoprolol; D005082:Physical Exertion; D011217:Practolol; D011294:Prenalterol; D051381:Rats; D011919:Rats, Inbred Strains; D011943:Receptors, Adrenergic, beta; D013268:Stimulation, Chemical',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D002316:Cardiotonic Agents; D011943:Receptors, Adrenergic, beta; D008790:Metoprolol; D007545:Isoproterenol; D011294:Prenalterol; D011217:Practolol',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00964689',\n",
       "  'references': '6851402;976256;488085;6215116;6127890;6461550;6812253;6119002;6109017;6102602;4403886;902154;20239456;4771582;6127902;931903;4340389;5596760;7129988;5572416;7446173;6121296',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Appl Physiol Occup Physiol',\n",
       "  'nlm_unique_id': '0410266',\n",
       "  'issn_linking': '0301-5548',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Metabolic changes induced by combined prolonged exercise and low-calorie intake in man.',\n",
       "  'issue': '53(2)',\n",
       "  'pages': '121-7',\n",
       "  'abstract': 'Thirteen middle-aged women and 10 men walked 344 km during 7 days. The daily walking distances were 57, 53, 67, 53, 41, 36, and 37 km at an average speed of 3.5 km X h-1. During the hike the subjects drank water, mineral drinks, and juices ad libitum. Except for some natural products, no food intake was allowed. During the hike the body weight and serum protein concentration of the subjects decreased by about 7%, on average. Serum triglyceride and total cholesterol decreased drastically, about 30-40% during the hike, but HDL-cholesterol showed a tendency to increase, giving a 40% increment in HDL/total cholesterol ratio. Serum free fatty acids rose 1.5-2 times above the starting level. Serum glucose and evening insulin levels decreased significantly during the hike. Serum cortisol in evening samples after the daily walking and plasma norepinephrine concentrations were significantly increased, reflecting the immediate daily response to the combined fasting and walking. Serum testosterone levels decreased in men but not in women, indicating the involvement of the LH-testis pathway in the decrease obtained. Serum ASAT activity rose to about three times the starting level during the hike, whereas gamma-GT activity gradually decreased. These marked metabolic changes caused by combined fasting and several days exercise were in many respects (as in cholesterol, HDL/total cholesterol ratio or testosterone levels) more pronounced than those earlier reported to be caused by exercise or fasting alone.',\n",
       "  'journal': 'European journal of applied physiology and occupational physiology',\n",
       "  'authors': 'Marniemi|J|J|;Vuori|I|I|;Kinnunen|V|V|;Rahkila|P|P|;Vainikka|M|M|;Peltonen|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150848',\n",
       "  'mesh_terms': 'D000328:Adult; D001219:Aspartate Aminotransferases; D001786:Blood Glucose; D001835:Body Weight; D002784:Cholesterol; D008076:Cholesterol, HDL; D002149:Energy Intake; D004734:Energy Metabolism; D004837:Epinephrine; D005215:Fasting; D005230:Fatty Acids, Nonesterified; D005260:Female; D006801:Humans; D007328:Insulin; D008297:Male; D008875:Middle Aged; D009638:Norepinephrine; D005082:Physical Exertion; D013739:Testosterone; D014280:Triglycerides; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D001786:Blood Glucose; D008076:Cholesterol, HDL; D005230:Fatty Acids, Nonesterified; D007328:Insulin; D014280:Triglycerides; D013739:Testosterone; D002784:Cholesterol; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D009638:Norepinephrine; D004837:Epinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00422574',\n",
       "  'references': '596247;6889494;835378;5764805;4369123;7382830;6851992;710393;177229;7014593;223589;975577;5769;7416061;7414251;4745354;220492;835366;4557055;10110;994720;4858166',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Appl Physiol Occup Physiol',\n",
       "  'nlm_unique_id': '0410266',\n",
       "  'issn_linking': '0301-5548',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Synthesis in vitro of precursors of the catalytic subunits of acetylcholinesterase from Torpedo marmorata and Electrophorus electricus.',\n",
       "  'issue': '145(3)',\n",
       "  'pages': '519-24',\n",
       "  'abstract': 'We translated poly(A-rich messenger RNA prepared from the electric organs of Electrophorus electricus and Torpedo marmorata in a reticulocyte lysate system. In the case of Electrophorus, which appears to contain only one type of acetylcholinesterase catalytic subunit, an anti-(Electrophorus acetylcholinesterase) antiserum precipitated a single 65-kDa polypeptide from the products translation obtained in vitro. In the case of Torpedo, where a number of distinct catalytic subunits corresponding to different fractions of the enzyme have been described, an anti-(Torpedo acetylcholinesterase) antiserum precipitated two main polypeptides, 61 kDa and 65 kDa, both of which could be displaced by unlabelled purified Torpedo acetylcholinesterase. Synthesis in vitro thus appears to produce a single type of precursor of the acetylcholinesterase catalytic subunit for Electrophorus, and at least two distinct precursors for Torpedo, suggesting that several mRNAs code for the catalytic subunits in the latter species.',\n",
       "  'journal': 'European journal of biochemistry',\n",
       "  'authors': 'Sikorav|J L|JL|;Grassi|J|J|;Bon|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150849',\n",
       "  'mesh_terms': 'D000110:Acetylcholinesterase; D000818:Animals; D000918:Antibody Specificity; D002384:Catalysis; D011232:Chemical Precipitation; D004557:Electric Organ; D004593:Electrophorus; D004792:Enzyme Precursors; D007120:Immunochemistry; D066298:In Vitro Techniques; D011061:Poly A; D014176:Protein Biosynthesis; D012333:RNA, Messenger; D011863:Radioimmunoassay; D014101:Torpedo',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D004792:Enzyme Precursors; D012333:RNA, Messenger; D011061:Poly A; D000110:Acetylcholinesterase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1432-1033.1984.tb08587.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Biochem',\n",
       "  'nlm_unique_id': '0107600',\n",
       "  'issn_linking': '0014-2956',\n",
       "  'country': 'England'},\n",
       " {'title': 'Biosynthesis of intestinal microvillar proteins. Expression of aminopeptidase N along the crypt-villus axis.',\n",
       "  'issue': '145(3)',\n",
       "  'pages': '653-8',\n",
       "  'abstract': 'The expression of pig small-intestinal aminopeptidase N (EC 3.4.11.2) along the crypt-villus axis was studied in tangential sections of [35S]-methionine-labelled, organ-cultured explants. The only detectable molecular forms of aminopeptidase N along the crypt-villus axis were polypeptides of Mr 140 000 and 166 000, representing the enzyme in a transient and mature form respectively. The synthesis was at a very low level in the crypt region in experiments with labelling periods ranging from 10 min to 3 h. These findings indicate that crypt cells are not fully committed to the expression of aminopeptidase N, either in its mature or in any other immunoreactive molecular form. The expression of aminopeptidase N was markedly stimulated by dexamethasone (1 microgram/ml). During labelling periods of 3 h, dexamethasone caused an approximately threefold increase in the expression of the enzyme in the crypt cells and a moderate increase of about 20% in the villus cells. Whereas the latter can possibly be ascribed to a general protective effect of dexamethasone on villus architecture, these experiments indicate that crypt cells of mucosa from adult individuals exhibit the same sensitivity to glucocorticoids as does the intestinal epithelium during the prenatal and early postnatal phase.',\n",
       "  'journal': 'European journal of biochemistry',\n",
       "  'authors': 'Danielsen|E M|EM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150850',\n",
       "  'mesh_terms': 'D000626:Aminopeptidases; D000818:Animals; D018826:CD13 Antigens; D003907:Dexamethasone; D007120:Immunochemistry; D007413:Intestinal Mucosa; D008715:Methionine; D008871:Microvilli; D009924:Organ Culture Techniques; D013552:Swine',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D003907:Dexamethasone; D008715:Methionine; D000626:Aminopeptidases; D018826:CD13 Antigens',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1111/j.1432-1033.1984.tb08606.x',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Biochem',\n",
       "  'nlm_unique_id': '0107600',\n",
       "  'issn_linking': '0014-2956',\n",
       "  'country': 'England'},\n",
       " {'title': 'Vasculitis: immunological aspects.',\n",
       "  'issue': '23(6)',\n",
       "  'pages': '389-93',\n",
       "  'abstract': 'The laboratory approach to patients with a vasculitic syndrome is of limited help in defining the diagnosis but may provide clues as to the pathogenesis (immune complex-mediated or cell-mediated reaction). Serial determinations of immune complexes or complement levels can also serve as the basis for assessment of disease activity and therapeutic interventions in some patients. In addition to angiographic findings there is only one way of establishing a tentative diagnosis of vasculitis: by histological demonstration.',\n",
       "  'journal': 'European neurology',\n",
       "  'authors': 'Hasler|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150851',\n",
       "  'mesh_terms': 'D000936:Antigen-Antibody Complex; D001172:Arthritis, Rheumatoid; D003165:Complement System Proteins; D003240:Connective Tissue Diseases; D003450:Cryoglobulins; D014890:Granulomatosis with Polyangiitis; D006801:Humans; D007111:Immunity, Cellular; D010488:Polyarteritis Nodosa; D012217:Rheumatoid Factor; D014657:Vasculitis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000936:Antigen-Antibody Complex; D003450:Cryoglobulins; D003165:Complement System Proteins; D012217:Rheumatoid Factor',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000115719',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur Neurol',\n",
       "  'nlm_unique_id': '0150760',\n",
       "  'issn_linking': '0014-3022',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Cerebral angiography in vasculitis affecting the nervous system.',\n",
       "  'issue': '23(6)',\n",
       "  'pages': '400-6',\n",
       "  'abstract': 'Of 199 patients with clinico-laboratory evidence of vasculitis, 42 were submitted to cerebral angiography; 35 angiograms were abnormal, but only 21 were characteristic of the particular disease process. A pattern consistent with vasculitis diagnosed in 19 angiograms, was due to neoplasm in 4 and neurofibromatosis, DXT and amphetamines each in 1 case. Moya-Moya type collaterals shown in 20 angiograms were due to the idiopathic disease in 10 but due to non-inflammatory pathologies in 7. Fibromuscular dysplasia shown in 28 angiograms was an incidental finding in 20 of these. Of 56 cerebral angiograms for ischaemic stroke in patients under 15 years old, 17 were normal and only 8 vascular lesions were likely to have been of inflammatory origin. In routine clinical practice cerebral angiography, though essential in the management of mycotic aneurysm and in the diagnosis of Moya-Moya disease isolated vasculitis and fibromuscular dysplasia, plays only a limited role in the diagnosis of other types of vasculitis.',\n",
       "  'journal': 'European neurology',\n",
       "  'authors': 'Kendall|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150852',\n",
       "  'mesh_terms': 'D000293:Adolescent; D000328:Adult; D000785:Aneurysm, Infected; D002545:Brain Ischemia; D001932:Brain Neoplasms; D002340:Carotid Artery Diseases; D002533:Cerebral Angiography; D002539:Cerebral Arterial Diseases; D002544:Cerebral Infarction; D005352:Fibromuscular Dysplasia; D006801:Humans; D002532:Intracranial Aneurysm; D009072:Moyamoya Disease; D010488:Polyarteritis Nodosa; D014657:Vasculitis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000115721',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur Neurol',\n",
       "  'nlm_unique_id': '0150760',\n",
       "  'issn_linking': '0014-3022',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Cytostatic drugs in the treatment of severe vasculitides. Indications, results and risks.',\n",
       "  'issue': '23(6)',\n",
       "  'pages': '407-9',\n",
       "  'abstract': 'The indications for cytostatic drugs in the treatment of cerebral vasculitis are discussed as well as the possible risks of long-term immunosuppressive therapy.',\n",
       "  'journal': 'European neurology',\n",
       "  'authors': 'Kaeser|H E|HE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150853',\n",
       "  'mesh_terms': 'D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D001379:Azathioprine; D003520:Cyclophosphamide; D004359:Drug Therapy, Combination; D013700:Giant Cell Arteritis; D014890:Granulomatosis with Polyangiitis; D006801:Humans; D008180:Lupus Erythematosus, Systemic; D010488:Polyarteritis Nodosa; D011241:Prednisone; D014657:Vasculitis',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000305:Adrenal Cortex Hormones; D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D001379:Azathioprine; D011241:Prednisone',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1159/000115722',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur Neurol',\n",
       "  'nlm_unique_id': '0150760',\n",
       "  'issn_linking': '0014-3022',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Are leg ulcers in rheumatoid arthritis due to vasculitis?',\n",
       "  'issue': '6(3)',\n",
       "  'pages': '288-90',\n",
       "  'abstract': \"Five patients with severe rheumatoid arthritis are reported in whom leg ulcers were not apparently associated with vasculitis. The conventional explanation for these ulcers deserves review. Patients with rheumatoid arthritis may develop 'gravitational' leg ulceration and pressure sores on their legs. In addition, they may develop ulcers on the lower aspects of the legs and around the ankles which are well demarcated, punched out, painful and slow to heal. These ulcers usually occur in patients with longstanding, severe, seropositive disease. They are presently considered to be due to a necrotising arteritis causing dermal infarction, since they are frequently associated with other clinical features of rheumatoid vasculitis. Wilkinson has commented that 'biopsies are seldom taken from leg ulcers'. In this paper we report five patients with severe rheumatoid arthritis who developed such leg ulcers in the absence of other clinical evidence of vasculitis and in whom biopsies of the ulcers failed to reveal vasculitis. A case is summarised as illustrative of the five patients, whose relevant histories, clinical findings, and laboratory investigations are summarised in Table 1.\",\n",
       "  'journal': 'European journal of rheumatology and inflammation',\n",
       "  'authors': 'Nishikawa|J A|JA|',\n",
       "  'pubdate': '1983',\n",
       "  'pmid': '6150854',\n",
       "  'mesh_terms': 'D000368:Aged; D001172:Arthritis, Rheumatoid; D001706:Biopsy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007871:Leg Ulcer; D008297:Male; D008875:Middle Aged; D010488:Polyarteritis Nodosa',\n",
       "  'publication_types': 'D002363:Case Reports; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Rheumatol Inflamm',\n",
       "  'nlm_unique_id': '7805765',\n",
       "  'issn_linking': '0140-1610',\n",
       "  'country': 'England'},\n",
       " {'title': 'Bucindolol: effects on blood pressure, airways resistance and serum creatine phosphokinase.',\n",
       "  'issue': '27(3)',\n",
       "  'pages': '265-8',\n",
       "  'abstract': 'The effect of bucindolol on pulse, blood pressure and airways resistance was studied in eight patients. One hour after 150 mg bucindolol, a significant decrease in supine, standing and post-exercise blood pressure was observed. No change in blood pressure occurred 10 to 14 h after doses ranging from 50-150 mg indicating that bucindolol has a relatively short duration of action. A dose related inhibition of exercise induced tachycardia was observed consistant with beta-receptor blocking activity. However, there was no change in the resting pulse indicating partial sympathomimetic activity. There was no increase in airways resistance at all doses of bucindolol. Serum creatine phosphokinase increased beyond normal limits in 3 out of 6 patients studied, probably due to a direct effect upon skeletal muscle.',\n",
       "  'journal': 'European journal of clinical pharmacology',\n",
       "  'authors': 'Gill|J S|JS|;Beevers|D G|DG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150855',\n",
       "  'mesh_terms': 'D000319:Adrenergic beta-Antagonists; D000328:Adult; D000368:Aged; D000403:Airway Resistance; D001794:Blood Pressure; D003402:Creatine Kinase; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011412:Propanolamines',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C024307:bucindolol; D003402:Creatine Kinase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00542157',\n",
       "  'references': '25075;6102523;519436;131139;6786636;63714;14207902;6860529;22216522;6125185;4425917;28308;7314090;4404413',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Clin Pharmacol',\n",
       "  'nlm_unique_id': '1256165',\n",
       "  'issn_linking': '0031-6970',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Preliminary clinical pharmacological studies of S3341, a new hypotensive agent, and comparison with clonidine in normal males.',\n",
       "  'issue': '27(3)',\n",
       "  'pages': '281-6',\n",
       "  'abstract': 'S3341, a new hypotensive agent which binds to alpha2-receptors in animal brain preparations, was studied in normal healthy male volunteers. A dose ranging study with 15 and 25 micrograms/kg of S3341 was performed in a double blind, placebo controlled randomised and balanced manner with 3 subjects. A decrease or BP without noticeable sedation (assessed by visual analogue scales) was seen. One, 2 mg of S3341, 0.1 and 0.2 mg of clonidine were then compared in a double blind, placebo controlled, randomised and balanced manner in 10 subjects. BP, heart rate, systolic time intervals (STI), critical flicker frequency, choice reaction time, pursuit rotor, stimulated salivary volume, and dryness of mouth and sedation with visual analogue scales, were measured at 0, 1.5, 3.0, 4.5 and 6.0 h after drug administration. The relationship between decreases in BP and sedation was assessed by linear regression analysis, with the former as the independent (predictor) response and the latter as the dependent (response) variate. Both drugs produced a similar decrease of BP which was significantly different from placebo. Changes in psychomotor function tests were not significant. Both drugs produced dryness of mouth and sedation which were significantly different from placebo but changes were less with S3341. Clonidine showed a significantly steeper slope than S3341 in the relationship between decreases in BP and sedation. This must be interpreted with caution as there was wide variation in the correlation between decreases in BP and sedation, but it may be possible to achieve lesser sedation with S3341.',\n",
       "  'journal': 'European journal of clinical pharmacology',\n",
       "  'authors': 'Weerasuriya|K|K|;Shaw|E|E|;Turner|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150856',\n",
       "  'mesh_terms': 'D000316:Adrenergic alpha-Agonists; D000328:Adult; D000959:Antihypertensive Agents; D001794:Blood Pressure; D002490:Central Nervous System; D003000:Clonidine; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D006801:Humans; D008297:Male; D010080:Oxazoles; D000077769:Rilmenidine',\n",
       "  'publication_types': \"D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000316:Adrenergic alpha-Agonists; D000959:Antihypertensive Agents; D010080:Oxazoles; D003000:Clonidine; D000077769:Rilmenidine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00542160',\n",
       "  'references': '5722106;444386;598422;973963;6116834;7082499;6890374;341940;729618;1245090;4154847;4851039;619947',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Clin Pharmacol',\n",
       "  'nlm_unique_id': '1256165',\n",
       "  'issn_linking': '0031-6970',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Placental transfer of pinazepam and its metabolite N-desmethyldiazepam in women at term.',\n",
       "  'issue': '27(3)',\n",
       "  'pages': '307-10',\n",
       "  'abstract': 'Placental transfer of pinazepam and its metabolite N-desmethyldiazepam was investigated in 25 pregnant women at term. Pinazepam was administered orally as a single (10 mg) dose to 13 women, or in multiple doses of 5 mg daily to 12 women. The dose-delivery interval ranged between 1 and 26 h for the single dose, and the period between the last of the multiple doses and delivery was 1.4 to 24 h. Pinazepam and N-desmethyldiazepam were measured in plasma obtained from the umbilical vein and from the mother, at delivery. Pinazepam was only detectable in plasma after the 10 mg dose. The drug did not reach an apparent equilibrium between fetal and maternal plasma. The average (+/- SEM) cord/maternal ratio of plasma pinazepam concentrations was 0.64 +/- 0.07. N-desmethyldiazepam was detectable on each occasion. Its concentration in the plasma from the cord vein became higher than that in the maternal specimens 1-2 h after administration of the parent drug. Little N-desmethyldiazepam was excreted in breast milk.',\n",
       "  'journal': 'European journal of clinical pharmacology',\n",
       "  'authors': 'Pacifici|G M|GM|;Cuoci|L|L|;Guarneri|M|M|;Fornaro|P|P|;Arcidiacono|G|G|;Cappelli|N|N|;Moggi|G|G|;Placidi|G F|GF|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150857',\n",
       "  'mesh_terms': 'D000328:Adult; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D001570:Benzodiazepinones; D003975:Diazepam; D005260:Female; D006801:Humans; D007743:Labor, Obstetric; D008431:Maternal-Fetal Exchange; D008895:Milk, Human; D003708:Nordazepam; D010920:Placenta; D011247:Pregnancy',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D001570:Benzodiazepinones; D001569:Benzodiazepines; C010763:pinazepam; D003708:Nordazepam; D003975:Diazepam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00542165',\n",
       "  'references': '5043428;598407;5673330;6809477;699483;4753234;16030;4792202;4822345;7398730;6126360;758245;36829;4146365;42422;6124406;5812780;14135294;4719971;1126114;37090;7378242;989345;5044095;6418547;14135295;1157438',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Clin Pharmacol',\n",
       "  'nlm_unique_id': '1256165',\n",
       "  'issn_linking': '0031-6970',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Idazoxan (RX 781094) selectively antagonizes alpha 2-adrenoceptors on rat central neurons.',\n",
       "  'issue': '105(3-4)',\n",
       "  'pages': '265-72',\n",
       "  'abstract': 'We have studied the alpha-adrenoceptor antagonist effects of idazoxan (RX 781094) in extracellular recordings from single locus coeruleus and dorsal raphe neurons of chloral hydrate-anesthetized rats. Idazoxan blocked alpha 2 responses with an ED50 of 14 +/- 8 micrograms/kg i.v., while the potency at alpha 1-receptors was only 420 +/- 190 micrograms/kg. A similar alpha 2 selectivity was seen when idazoxan was applied microiontophoretically. Idazoxan at doses which blocked alpha 1-receptors had little or no effect on locus coeruleus responses to morphine or dorsal raphe responses to LSD. When sodium pentobarbital was used as the anesthetic, systemically administered idazoxan slowed the firing rate of locus coeruleus cells, but iontophoretic experiments showed this to be an interaction with the anesthetic and not a direct agonist effect. We conclude that in rat brain idazoxan is a pure antagonist and that it has a selectivity for alpha 2- over alpha 1-receptors markedly superior to piperoxane, yohimbine, or rauwolscine.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Freedman|J E|JE|;Aghajanian|G K|GK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150858',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001794:Blood Pressure; D001921:Brain; D004146:Dioxanes; D004147:Dioxins; D004305:Dose-Response Relationship, Drug; D019329:Idazoxan; D008125:Locus Coeruleus; D008297:Male; D009474:Neurons; D010424:Pentobarbital; D010656:Phenylephrine; D011903:Raphe Nuclei; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D004146:Dioxanes; D004147:Dioxins; D011942:Receptors, Adrenergic, alpha; D010656:Phenylephrine; D010424:Pentobarbital; D019329:Idazoxan',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90618-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Control of transmitter release in guinea-pig vas deferens by prejunctional P1-purinoceptors.',\n",
       "  'issue': '105(3-4)',\n",
       "  'pages': '293-9',\n",
       "  'abstract': \"The specific P1-purinoceptor agonist 2-chloroadenosine (3 X 10(-7) M to 3 X 10(-6) M) reduced the magnitude of excitatory junction potentials (e.j.p.s) recorded from guinea-pig vas deferens in response to field stimulation of the sympathetic nerves, but did not have any direct effect on the resting membrane potential. Trains of pulses (2-16 Hz) for 20 s produced a biphasic contractile response, both phases of which were reduced by 2-chloroadenosine (10(-7) to 10(-5) M) by up to 45%. In contrast, the same concentrations of 2-chloroadenosine enhanced by about 20% the contractile response of the vas deferens to exogenously applied adenosine 5'-triphosphate (ATP) and noradrenaline (NA). The specific P1-purinoceptor antagonist 8-phenyltheophylline (8-PT) reversed the inhibitory effect of 2-chloroadenosine on e.j.p. magnitude, partially reversed the inhibitory action of 2-chloroadenosine on both phases of the contractile response to nerve stimulation, and partially reversed the enhancing effect of 2-chloroadenosine on responses to exogenous ATP and NA. We propose that release of ATP and NA (as cotransmitters) from sympathetic nerves can be modulated by prejunctional P1-purinoceptors.\",\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Sneddon|P|P|;Meldrum|L A|LA|;Burnstock|G|G|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150859',\n",
       "  'mesh_terms': 'D015762:2-Chloroadenosine; D000225:Adenine; D000241:Adenosine; D000255:Adenosine Triphosphate; D000818:Animals; D004176:Dipyridamole; D004558:Electric Stimulation; D006168:Guinea Pigs; D066298:In Vitro Techniques; D008297:Male; D009119:Muscle Contraction; D018377:Neurotransmitter Agents; D009638:Norepinephrine; D017981:Receptors, Neurotransmitter; D011983:Receptors, Purinergic; D013806:Theophylline; D014649:Vas Deferens',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D017981:Receptors, Neurotransmitter; D011983:Receptors, Purinergic; D015762:2-Chloroadenosine; C010192:9-(2-hydroxy-3-nonyl)adenine; D004176:Dipyridamole; D000255:Adenosine Triphosphate; D013806:Theophylline; C028322:8-phenyltheophylline; D000225:Adenine; D000241:Adenosine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90621-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Anxiolytic activity on locus coeruleus-mediated suppression of muricidal aggression.',\n",
       "  'issue': '105(3-4)',\n",
       "  'pages': '323-6',\n",
       "  'abstract': 'The evidence suggests that stimulation of brain noradrenergic neurons plays an inhibitory role in rat mouse-killing (muricidal) aggression. Anxiolytic benzodiazepines inhibit locus coeruleus activity and previous data showed that chlordiazepoxide was capable of antagonizing the locus coeruleus-mediated suppression of muricidal aggression. The present experiments showed that this effect is common to new anxiolytic triazolobenzodiazepines and to other non-benzodiazepine derivatives with anxiolytic activity. In this framework, 10 mg/kg of buspirone, of 1-pyrimidine-piperazine and of MJ-13805 proved to be as active as 2.5 mg/kg of alprazolam and as 5 mg/kg of chlordiazepoxide in inhibiting the locus coeruleus-mediated suppression of muricidal aggression.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Kozak|W|W|;Valzelli|L|L|;Garattini|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150860',\n",
       "  'mesh_terms': 'D000374:Aggression; D000818:Animals; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D006801:Humans; D008125:Locus Coeruleus; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011963:Receptors, GABA-A',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D011963:Receptors, GABA-A; D001569:Benzodiazepines',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90625-3',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Beta-adrenergic drug induced hyperplasia in the immature rat parotid and submandibular glands.',\n",
       "  'issue': '105(3-4)',\n",
       "  'pages': '327-31',\n",
       "  'abstract': 'In this study the proliferative response of rat parotid (PRG) and submandibular (SMG) gland acinar cells to beta-adrenergic stimulation with Isoproterenol (a non-selective beta-agonist) or terbutaline (a relatively selective beta 2-agonist) was determined during the 4th-5th postnatal weeks in intact and guanethidine-sympathectomized (Sx) rats. Rats were divided into 2 age groups (21 and 28 days) and 6 experimental groups (control-intact (C), guanethidine-treated (Sx), intact + TER (C + TER), intact + Isoproterenol (C + IPR), guanethidine-treated + TER (Sx + TER), and guanethidine-treated + isoproterenol (Sx + IPR]. Intact and Sx rats were treated with either IPR or TER for 3 days (days 21, 22, and 23 or days 28, 29 and 30). On day 24 or 31 all rats were injected with [3H]-thymidine and killed 1 h later. PRG of Sx and C + TER rats showed no significant differences from controls in wet weight while SMG from Sx rats demonstrated a reduced wet weight compared to C rats. [3H]Thymidine labelling index and mitotic index were not significantly different in Sx and C + TER rats in either PRG or SMG. C + IPR rats showed increased wet weight, labelling and mitotic index compared to controls (P less than 0.01). Sx + IPR increased values over controls (P less than 0.01) and above C + IPR values (P less than 0.01). Sx + TER values were significantly higher than controls.(ABSTRACT TRUNCATED AT 250 WORDS)',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Klein|R M|RM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150861',\n",
       "  'mesh_terms': 'D000318:Adrenergic beta-Agonists; D000818:Animals; D002455:Cell Division; D005260:Female; D006965:Hyperplasia; D007545:Isoproterenol; D009929:Organ Size; D010306:Parotid Gland; D051381:Rats; D011919:Rats, Inbred Strains; D011943:Receptors, Adrenergic, beta; D013363:Submandibular Gland; D013562:Sympathectomy; D013726:Terbutaline',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000318:Adrenergic beta-Agonists; D011943:Receptors, Adrenergic, beta; D007545:Isoproterenol; D013726:Terbutaline',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90626-5',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': '5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain.',\n",
       "  'issue': '105(3-4)',\n",
       "  'pages': '339-42',\n",
       "  'abstract': 'The dopamine D1-receptor antagonist SCH 23390 was a potent competitive antagonist of 5HT-induced vasoconstriction in the isolated perfused rat tail artery preparation (pA2 8.17) but a very weak antagonist of phenylephrine-induced responses (pA2 5.94). In rat brain cerebral cortex, SCH 23390 inhibited 5-HT2-sensitive [3H]spiperone binding with an IC50 of 112 nM. Binding of [3H]5HT to 5HT1 receptors in the cortex was inhibited by SCH 23390 with an IC50 of 2.49 microM. SCH 23390 has significant affinity for 5HT receptors in addition to the reported selective dopamine D1-receptor antagonist properties.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Hicks|P E|PE|;Schoemaker|H|H|;Langer|S Z|SZ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150862',\n",
       "  'mesh_terms': 'D000818:Animals; D014150:Antipsychotic Agents; D001552:Benzazepines; D001921:Brain; D066298:In Vitro Techniques; D008297:Male; D009131:Muscle, Smooth, Vascular; D051381:Rats; D011919:Rats, Inbred Strains; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists; D014661:Vasoconstriction',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014150:Antipsychotic Agents; D001552:Benzazepines; D011985:Receptors, Serotonin; D012702:Serotonin Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90628-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Trifluoperazine antagonizes postsynaptic alpha 1-but not alpha 2-adrenoceptor-mediated pressor responses in the rat.',\n",
       "  'issue': '105(3-4)',\n",
       "  'pages': '343-6',\n",
       "  'abstract': 'The specificity of the alpha-adrenergic blockade by trifluoperazine was tested in pithed rats. Trifluoperazine reduced the pressor effects of (-)-noradrenaline. The log dose-response curve to methoxamine, an alpha 1-agonist, was shifted to the right whereas the vasopressor responses to BHT-920, an alpha 2-agonist, were unaffected by trifluoperazine. It was concluded that trifluoperazine acts as a peripheral vascular alpha 1-antagonist in the rat.',\n",
       "  'journal': 'European journal of pharmacology',\n",
       "  'authors': 'Pruneau|D|D|;Mainguy|Y|Y|;Roy|F|F|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150863',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D001381:Azepines; D001794:Blood Pressure; D004305:Dose-Response Relationship, Drug; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D011942:Receptors, Adrenergic, alpha; D014268:Trifluoperazine',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D001381:Azepines; D011942:Receptors, Adrenergic, alpha; D014268:Trifluoperazine; C024763:talipexole',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-2999(84)90629-0',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Eur J Pharmacol',\n",
       "  'nlm_unique_id': '1254354',\n",
       "  'issn_linking': '0014-2999',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Malaria prophylaxis in travellers: the current position.',\n",
       "  'issue': '40(12)',\n",
       "  'pages': '1357-62',\n",
       "  'abstract': 'Malaria prevention is a main challenge for physicians, nurses, health officers and tour operators. The attack rate of malaria in travellers is 1-10/10,000 departures, and the case fatality rate of imported malaria is around 0.5/100. Travellers should be informed about the risk they are going to take, how to protect against mosquito bites, about the antimalarials they will have to take and what to do when a malaria breakthrough should occur. The 4-aminoquinolines (chloroquine, amodiaquine) remain the drug of choice for the prevention of Plasmodium vivax and of sensitive P. falciparum infections. The problem is to find an effective and safe drug combination for travellers to areas where P. falciparum is either resistant to chloroquine, to Fansidar (the combination of pyrimethamine plus sulfadoxine) or to both. These travellers will probably best be protected by an individually tailored drug combination, which includes amodiaquine or mefloquine as baseline drugs, and a supplementation with Fansidar, Maloprim (the combination of pyrimethamine with dapsone), paludrine or an antibiotic.',\n",
       "  'journal': 'Experientia',\n",
       "  'authors': 'Stürchler|D|D|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150865',\n",
       "  'mesh_terms': 'D000349:Africa; D000655:Amodiaquine; D000962:Antimalarials; D001208:Asia; D002738:Chloroquine; D009033:Culicidae; D004351:Drug Resistance; D005260:Female; D006801:Humans; D007223:Infant; D007299:Insect Bites and Stings; D007843:Latin America; D008288:Malaria; D010963:Plasmodium falciparum; D010966:Plasmodium vivax; D011247:Pregnancy; D011319:Primaquine; D002727:Proguanil; D012306:Risk; D014195:Travel',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D000962:Antimalarials; D000655:Amodiaquine; D002738:Chloroquine; D011319:Primaquine; D002727:Proguanil',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF01951889',\n",
       "  'references': '7038925;6344762;6118658;120043;359493;6141378;6114294;6356500;6133056;6126742;6128616;6353687;6124728;6761005;6141423;6292443;7052190;6124713;6359904;6122905;6131328;6758224;6355315;6751111',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Experientia',\n",
       "  'nlm_unique_id': '0376547',\n",
       "  'issn_linking': '0014-4754',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Hypothalamic tyrosine hydroxylase activity, plasma gonadotropin and prolactin levels after aminooxyacetic acid in ovariectomized rats.',\n",
       "  'issue': '40(12)',\n",
       "  'pages': '1422-3',\n",
       "  'abstract': 'Plasma concentrations of gonadotropin, prolactin and hypothalamic tyrosine hydroxylase (TH) activity were measured in ovariectomized rats treated with aminooxyacetic acid (AOAA), a drug which elevates brain GABA levels. Hypothalamic TH activity was significantly increased with a significant decrease in prolactin (Prl) release. Plasma levels of gonadotropins were not modified by AOAA. These results support an inhibitory action of GABA on Prl release possibly mediated through hypothalamic dopamine.',\n",
       "  'journal': 'Experientia',\n",
       "  'authors': 'Babu|G N|GN|;Vijayan|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150866',\n",
       "  'mesh_terms': 'D000085:Acetates; D000625:Aminooxyacetic Acid; D000818:Animals; D002369:Castration; D005260:Female; D005640:Follicle Stimulating Hormone; D006065:Gonadotropins, Pituitary; D007031:Hypothalamus; D007986:Luteinizing Hormone; D011388:Prolactin; D051381:Rats; D011919:Rats, Inbred Strains; D014446:Tyrosine 3-Monooxygenase; D005680:gamma-Aminobutyric Acid',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000085:Acetates; D006065:Gonadotropins, Pituitary; D000625:Aminooxyacetic Acid; D005680:gamma-Aminobutyric Acid; D011388:Prolactin; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D014446:Tyrosine 3-Monooxygenase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF01951923',\n",
       "  'references': '4153578;4838374;7207005;688015;6118104;688014;849735;4698285;5545077;6994856;467336;570492;467332',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Experientia',\n",
       "  'nlm_unique_id': '0376547',\n",
       "  'issn_linking': '0014-4754',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Translation of mRNA for human lymphotoxin in microinjected Xenopus oocytes.',\n",
       "  'issue': '178(2)',\n",
       "  'pages': '257-63',\n",
       "  'abstract': 'Synthesis and secretion of biologically active human lymphotoxin (LT) can be detected in Xenopus laevis oocytes following their inoculation with poly(A+) RNA from human stimulated peripheral blood lymphocytes, but not in oocytes inoculated with RNA from unstimulated lymphocytes or from fibroblastoid cells. In size-fractionating mRNA of stimulated lymphocytes most LT activity is found to be coded for by RNA with an approximate sedimentation value of 19 S.',\n",
       "  'journal': 'FEBS letters',\n",
       "  'authors': 'Wallach|D|D|;Hahn|T|T|;Budilovsky|S|S|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150867',\n",
       "  'mesh_terms': 'D000818:Animals; D002460:Cell Line; D002470:Cell Survival; D002499:Centrifugation, Density Gradient; D005260:Female; D006801:Humans; D008214:Lymphocytes; D008233:Lymphotoxin-alpha; D008845:Microinjections; D009865:Oocytes; D010835:Phytohemagglutinins; D011061:Poly A; D014176:Protein Biosynthesis; D012333:RNA, Messenger; D014982:Xenopus laevis',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D008233:Lymphotoxin-alpha; D010835:Phytohemagglutinins; D012333:RNA, Messenger; D011061:Poly A',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-5793(84)80612-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'FEBS Lett',\n",
       "  'nlm_unique_id': '0155157',\n",
       "  'issn_linking': '0014-5793',\n",
       "  'country': 'England'},\n",
       " {'title': 'The biology of Plasmodium in the mosquito.',\n",
       "  'issue': '40(12)',\n",
       "  'pages': '1330-43',\n",
       "  'abstract': '',\n",
       "  'journal': 'Experientia',\n",
       "  'authors': 'Sinden|R E|RE|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150864',\n",
       "  'mesh_terms': 'D000818:Animals; D002462:Cell Membrane; D002467:Cell Nucleus; D009033:Culicidae; D003593:Cytoplasm; D004912:Erythrocytes; D005260:Female; D005718:Gametogenesis; D008297:Male; D008854:Microscopy, Electron; D008870:Microtubules; D008938:Mitosis; D010961:Plasmodium; D012469:Salivary Glands; D014612:Vaccines; D014617:Vacuoles; D015053:Zygote',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D016454:Review\",\n",
       "  'chemical_list': 'D014612:Vaccines',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF01951886',\n",
       "  'references': '6350869;6033538;539716;7218185;37101;385856;5003557;396729;6193427;5547075;13783536;342682;7033252;4810;7048650;556175;376818;6191269;5643354;4943293;7119992;96355;23512;6683783;6813461;376812;365562;7121602;369268;6803217;4206880;320542;5652907;986561;6882061;551260;351177;396730;815435;4578977;6935685;7010688;31425;19955;14902779;6350527;6646806;7037440;794460;6339949;13210371;6957883;395108;369264;4632461;7050700;26586;5969101;120770;7268860;43087;4398586;403087;4197159;4607047;5145109;1253879;13796224;6370003;14151438;4957849;4898756;324786;14846794;44096;14933379;4380662;1118188;7310746;4591782;7026723;13136412;415447;6141715;6994664;13897014;4610107;4321621;4579580;4138523;4548393;418187;4987037;14794969;14125166;6715423;5071070;39127;959832;4614726;4606913;7469303;4887539;4602986;1090717;6189951;13796468;566918;864828;4172530;6832279;6383093;21234;795106;4614723;6364466;4915499;17781902;6502527;4591216;6174361;13826613;5794450;919692;364785;6768578',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Experientia',\n",
       "  'nlm_unique_id': '0376547',\n",
       "  'issn_linking': '0014-4754',\n",
       "  'country': 'Switzerland'},\n",
       " {'title': 'Potentiation of actomyosin ATPase activity by filamin.',\n",
       "  'issue': '178(2)',\n",
       "  'pages': '311-4',\n",
       "  'abstract': 'It was found that thin filaments from chicken gizzard muscle activate skeletal muscle myosin Mg2+-ATPase to a greater extent than does the complex of chicken gizzard actin and tropomyosin. The protein factor responsible for this additional activation has been now identified as the high Mr actin binding protein, filamin.',\n",
       "  'journal': 'FEBS letters',\n",
       "  'authors': 'Sosiński|J|J|;Szpacenko|A|A|;Dabrowska|R|R|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150868',\n",
       "  'mesh_terms': 'D000205:Actomyosin; D000251:Adenosine Triphosphatases; D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002352:Carrier Proteins; D055598:Chemical Phenomena; D002627:Chemistry, Physical; D002645:Chickens; D003285:Contractile Proteins; D003599:Cytoskeleton; D004789:Enzyme Activation; D064448:Filamins; D005895:Gizzard, Avian; D008840:Microfilament Proteins; D009130:Muscle, Smooth; D009132:Muscles; D011817:Rabbits',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002352:Carrier Proteins; D003285:Contractile Proteins; D064448:Filamins; D008840:Microfilament Proteins; C032254:fodrin; D000205:Actomyosin; D000251:Adenosine Triphosphatases; D017301:Ca(2+) Mg(2+)-ATPase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0014-5793(84)80623-7',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'FEBS Lett',\n",
       "  'nlm_unique_id': '0155157',\n",
       "  'issn_linking': '0014-5793',\n",
       "  'country': 'England'},\n",
       " {'title': '[Changes in antimicrosomal antibody, serum thyroglobulin and thyrotropin binding inhibitor immunoglobulin in a patient with silent thyroiditis who experienced four thyrotoxic episodes].',\n",
       "  'issue': '60(8)',\n",
       "  'pages': '939-49',\n",
       "  'abstract': \"Serial changes of thyroid hormones, TSH, anti-thyroidal antibodies, serum Tg and TBII were studied in a patient with silent thyroiditis who experienced four episodes of transient thyrotoxicosis in a follow-up period of five years. The titers of MCHA were high in the thyrotoxic episodes and further increased in the following hypothyroid phases. In the euthyroid phase it became lower. The serum level of Tg was normal or moderated elevated in the thyrotoxic episodes, and it further elevated in the hypothyroid phase. Surgical biopsy, performed in the euthyroid phase about one year after the forth thyrotoxic episode, revealed the findings of Hashimoto's disease. Two different types of transient thyrotoxic episode, one with positive TBII and high uptake and the other with negative TBII and low uptake, were observed in the same patient with silent thyroiditis. In the beginning of the clinical course, the patient showed positive TBII, high 131I-uptake (77%) in the second episode of thyrotoxicosis, no response of TSH to TRH administration and absence of T3-suppressibility. The value of TBII gradually became normal and was negative at the forth episode of thyrotoxicosis when 131I-uptake was low (1.3%). After this last episode, TSH response to TRH administration was normal in euthyroid phase and augmented in hypothyroid phase. The presence of transient positive TBII and of histological changes of Hashimoto's disease was suggestive of the close relationship between Graves' and Hashimoto's diseases.\",\n",
       "  'journal': 'Nihon Naibunpi Gakkai zasshi',\n",
       "  'authors': 'Yamamoto|M|M|;Saito|S|S|;Sakurada|T|T|;Kaise|K|K|;Kaise|N|N|;Yoshida|K|K|;Fukazawa|H|H|;Suzuki|M|M|;Nomura|T|T|;Itagaki|Y|Y|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150869',\n",
       "  'mesh_terms': 'D000906:Antibodies; D005260:Female; D006801:Humans; D006980:Hyperthyroidism; D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D008861:Microsomes; D008875:Middle Aged; D013954:Thyroglobulin; D013966:Thyroiditis',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': 'D000906:Antibodies; D007074:Immunoglobulin G; D018828:Immunoglobulins, Thyroid-Stimulating; D013954:Thyroglobulin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1507/endocrine1927.60.8_939',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Nihon Naibunpi Gakkai Zasshi',\n",
       "  'nlm_unique_id': '0413717',\n",
       "  'issn_linking': '0029-0661',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Mutilated teeth.',\n",
       "  'issue': '11(9)',\n",
       "  'pages': '555-62',\n",
       "  'abstract': '',\n",
       "  'journal': 'Dental update',\n",
       "  'authors': 'Whittaker|D K|DK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150870',\n",
       "  'mesh_terms': 'D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D007284:Inlays; D008297:Male; D012652:Self Mutilation; D014070:Tooth; D014075:Tooth Discoloration; D014081:Tooth Extraction; D018677:Tooth Injuries',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Dent Update',\n",
       "  'nlm_unique_id': '7805969',\n",
       "  'issn_linking': '0305-5000',\n",
       "  'country': 'England'},\n",
       " {'title': 'Carcinogenic evaluation of estazolam via diet in CD strain Sprague-Dawley rats and B6C3F1 mice for 2 years.',\n",
       "  'issue': '4(5)',\n",
       "  'pages': '827-42',\n",
       "  'abstract': 'A comparative toxicity and carcinogenicity study was carried out for 2 years with estazolam, a benzodiazepine, via diet in Sprague-Dawley rats (0.5, 2, and 10 mg/kg/day) and in B6C3F1 mice (0.8, 3, and 10 mg/kg/day). In rats, no biologically significant changes were seen with respect to mortality, clinical signs, food consumption, or occurrence of palpable masses. Body weight gain in females (10 mg/kg/day) was depressed 12.6% and reflected a maximum-tolerated dosage (females). Spontaneous and incidental nonneoplastic lesions were consistent with aging in this species and unrelated to drug treatment. No biologically significant differences in tumor incidences occurred. Mice were more responsive to estazolam as suggested by (1) increased mortality (males) at 10 mg/kg/day, (2) increased food consumption and body weight gains (females), (3) withdrawal signs characterized by hyperactivity/aggressiveness and convulsions, and (4) appearance of dose-related nodular hyperplasia of the liver due to the relatively high dosages used coupled with the propensity of benzodiazepines to enhance liver enzyme induction. Several spontaneous benign and malignant tumors observed in all groups were not considered to be drug related. Based on the findings in these studies, estazolam was not considered to be carcinogenic when administered via diet to either rats at 0.5, 2, and 10 mg/kg/day or to mice at 0.8, 3, and 10 mg/kg/day for 2 consecutive years.',\n",
       "  'journal': 'Fundamental and applied toxicology : official journal of the Society of Toxicology',\n",
       "  'authors': 'Kimura|E T|ET|;Fort|F L|FL|;Buratto|B|B|;Tekeli|S|S|;Kesterson|J W|JW|;Heyman|I A|IA|;Cusick|P K|PK|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150872',\n",
       "  'mesh_terms': 'D000818:Animals; D014151:Anti-Anxiety Agents; D001835:Body Weight; D004032:Diet; D004435:Eating; D004949:Estazolam; D005260:Female; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009374:Neoplasms, Experimental; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D014151:Anti-Anxiety Agents; D004949:Estazolam',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0272-0590(84)90105-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fundam Appl Toxicol',\n",
       "  'nlm_unique_id': '8200838',\n",
       "  'issn_linking': '0272-0590',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Pancreatic polypeptide and other hormones in pancreas of obese (ob/ob) mice.',\n",
       "  'issue': '27(4)',\n",
       "  'pages': '454-9',\n",
       "  'abstract': 'The insulin, glucagon, somatostatin and pancreatic polypeptide content of acid-ethanol extracts of pancreas from lean and obese (ob/ob) mice of various ages was determined by radioimmunoassay. Rat and mouse pancreatic polypeptide react weakly with antibodies to avian, bovine and canine pancreatic polypeptide, but immunoassay for this peptide was possible using an antibody to the carboxyl-terminal hexapeptide of bovine pancreatic polypeptide and amino-terminal labelled bovine pancreatic polypeptide as tracer. The insulin, glucagon and pancreatic polypeptide content of pancreas from obese mice was greater than that of lean controls. The increase in insulin content uniformly involved ventral, dorsal and splenic lobes. Glucagon content was elevated primarily in the splenic lobe. Pancreatic polypeptide content was most significantly elevated in the splenic lobe where pancreatic polypeptide cells are infrequent in normal lean mice and this was accompanied by increased numbers of pancreatic polypeptide cells per islet in this lobe.',\n",
       "  'journal': 'Diabetologia',\n",
       "  'authors': 'Tomita|T|T|;Doull|V|V|;Kimmel|J R|JR|;Pollock|H G|HG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150871',\n",
       "  'mesh_terms': 'D000375:Aging; D000818:Animals; D001786:Blood Glucose; D004285:Dogs; D005934:Glucagon; D007328:Insulin; D007515:Islets of Langerhans; D051379:Mice; D008820:Mice, Obese; D010179:Pancreas; D010191:Pancreatic Polypeptide; D011863:Radioimmunoassay; D013004:Somatostatin; D013045:Species Specificity',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D001786:Blood Glucose; D007328:Insulin; D013004:Somatostatin; D010191:Pancreatic Polypeptide; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1007/BF00273910',\n",
       "  'references': '891771;6352724;387502;7177927;4266834;369875;340309;13713149;357891;390711;4115740;337488;56779;13827385;5630191;411725;6988454;1194289;4877145;4733239;4281399;379887;4914667;7297848;4884801;6998818;376284;7380112',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Diabetologia',\n",
       "  'nlm_unique_id': '0006777',\n",
       "  'issn_linking': '0012-186X',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Promotive effect of primary and secondary bile acids on the induction of gamma-glutamyl transpeptidase-positive liver cell foci as a possible endogenous factor for hepatocarcinogenesis in rats.',\n",
       "  'issue': '75(10)',\n",
       "  'pages': '871-5',\n",
       "  'abstract': 'The promoting effects of 5 bile acids on liver carcinogenesis were investigated in male Fischer rats initially treated with diethylnitrosamine (DEN). Two weeks after a single dose of DEN (200 mg/kg, intraperitoneally), rats were given bile acids for 8 weeks. At 3 weeks following DEN administration, all rats were subjected to partial hepatectomy. Among the bile acids tested, cholic acid (CA) and deoxycholic acid (DCA) exerted promoting activity as evidenced by significantly increased values of gamma-glutamyl transpeptidase-positive (gamma-GT+) foci as compared with the corresponding controls given DEN alone. In contrast, the other 3 bile acids tested, chenodeoxycholic acid (CDCA), lithocholic acid (LCA) and ursodeoxycholic acid (UDCA), did not significantly increase the level of gamma-GT+ foci over that induced by DEN alone. It is noteworthy that only bile acids of the same metabolic pathway, CA as a primary bile acid and DCA as a secondary bile acid, showed promoting effects whereas CDCA and its metabolic derivatives, LCA and UDCA, were inactive. The results indicate that CA and DCA might act as endogenous promoters of hepatocarcinogenesis in pathological conditions with increased levels of serum bile acids.',\n",
       "  'journal': 'Gan',\n",
       "  'authors': 'Tsuda|H|H|;Masui|T|T|;Imaida|K|K|;Fukushima|S|S|;Ito|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150873',\n",
       "  'mesh_terms': 'D000818:Animals; D001647:Bile Acids and Salts; D004052:Diethylnitrosamine; D004790:Enzyme Induction; D008099:Liver; D008114:Liver Neoplasms, Experimental; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D013329:Structure-Activity Relationship; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D001647:Bile Acids and Salts; D004052:Diethylnitrosamine; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gan',\n",
       "  'nlm_unique_id': '0151745',\n",
       "  'issn_linking': '0016-450X',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Modifying potential of thirty-one chemicals on the short-term development of gamma-glutamyl transpeptidase-positive foci in diethylnitrosamine-initiated rat liver.',\n",
       "  'issue': '75(10)',\n",
       "  'pages': '876-83',\n",
       "  'abstract': \"The modifying potential of 31 different compounds on the development of gamma-glutamyl transpeptidase-positive (gamma-GT+) liver cell lesions was compared in an in vivo short-term assay system. Rats were initially given a single dose (200 mg/kg) of diethylnitrosamine intraperitoneally and 2 weeks later were treated with test compounds for 6 weeks and then sacrificed, all rats being subjected to partial hepatectomy at week 3. Modifying potential was scored by comparing the number and area (mm2)/cm2 of induced gamma-GT+ foci with those of the corresponding control group given DEN alone. 2-Acetylaminofluorene, 3'-methyl-4-dimethylaminoazobenzene, dimethylnitrosamine, phenobarbital, barbital, dipyrone and deoxycholic acid caused a significant enhancement of both the number and area of foci. 4-Acetylaminofluorene, ethionine, benzo[alpha]pyrene, disulfiram and cholic acid had a moderate enhancing effect, whereas slight, but not unequivocal, increases in gamma-GT+ foci were observed after captafol, glutathione, sodium ascorbate and taurine administration. In contrast, acetaminophen, ethoxyquin, butylated hydroxyanisole, butylated hydroxytoluene, and ethyl alcohol showed clear inhibitory effects. It is concluded that the present short-term in vivo system has practical application for the screening of modifying agents for liver tumorigenesis including hepatocarcinogens.\",\n",
       "  'journal': 'Gan',\n",
       "  'authors': 'Tsuda|H|H|;Hasegawa|R|R|;Imaida|K|K|;Masui|T|T|;Moore|M A|MA|;Ito|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150874',\n",
       "  'mesh_terms': 'D000818:Animals; D002273:Carcinogens; D004052:Diethylnitrosamine; D008099:Liver; D008114:Liver Neoplasms, Experimental; D008297:Male; D009602:Nitrosamines; D051381:Rats; D011916:Rats, Inbred F344; D013329:Structure-Activity Relationship; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D002273:Carcinogens; D009602:Nitrosamines; D004052:Diethylnitrosamine; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gan',\n",
       "  'nlm_unique_id': '0151745',\n",
       "  'issn_linking': '0016-450X',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'On the mechanism of central stimulation action of fencamfamine.',\n",
       "  'issue': '15(5)',\n",
       "  'pages': '407-10',\n",
       "  'abstract': 'The stereotypy induced by fencamfamine (10 mg/kg i.p.) was compared in different groups of rats which had been pretreated with catecholaminergic drugs. Pretreatment with alpha-methyl-p-tyrosine (alpha-MpT) did not abolish the stereotypy, however the combination of alpha-MpT plus reserpine decreased, while reserpine alone increased this response. Pretreatment with haloperidol or metoclopramide reduced the intensity of stereotyped behaviour induced by fencamfamine, while phenoxybenzamine increased this behaviour. Fencamfamine showed low affinity for binding sites of [3H]haloperidol and [3H]dihydroergocriptine. These results support the view that fencamfamine is an indirectly acting drug of the non-amphetamine class, which releases both norepinephrine (NE) and dopamine (DA) from presynaptic terminals leading to stereotyped behaviour.',\n",
       "  'journal': 'General pharmacology',\n",
       "  'authors': 'DeLucia|R|R|;Bernardi|M M|MM|;Scavone|C|C|;Aizenstein|M L|ML|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150875',\n",
       "  'mesh_terms': 'D000818:Animals; D001667:Binding, Competitive; D001921:Brain; D000697:Central Nervous System Stimulants; D004088:Dihydroergotoxine; D004298:Dopamine; D006220:Haloperidol; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D009636:Norbornanes; D009638:Norepinephrine; D051381:Rats; D011919:Rats, Inbred Strains; D013239:Stereotyped Behavior',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D000697:Central Nervous System Stimulants; D009636:Norbornanes; D004088:Dihydroergotoxine; D006220:Haloperidol; C020900:fencamfamine; D004298:Dopamine; D009638:Norepinephrine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0306-3623(84)90039-9',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gen Pharmacol',\n",
       "  'nlm_unique_id': '7602417',\n",
       "  'issn_linking': '0306-3623',\n",
       "  'country': 'England'},\n",
       " {'title': 'Effect of temperature on the responsiveness of cutaneous veins to the extract of Ruscus aculeatus.',\n",
       "  'issue': '15(5)',\n",
       "  'pages': '431-4',\n",
       "  'abstract': 'In canine cutaneous veins cooling augments and warming depresses the responses to sympathetic nerve stimulation. In these veins the extract of Ruscus aculeatus (Ruscus) causes contractions due to alpha-adrenergic activation. To determine the effects of temperature on the response to Ruscus, rings of canine saphenous veins were studied at 24 degrees, 37 degrees and 41 degrees C. At 37 degrees C, Ruscus caused an increase in isometric tension which was depressed by prazosin and rauwolscine. Cooling inhibited the response to Ruscus, while warming augmented it. Rauwolscine potentiated, and prazosin reversed the effect of cooling on contractions evoked by Ruscus. Prazosin reduced, and rauwolscine augmented the effect of warming. These experiments demonstrate that temperature affects the venoconstriction induced by Ruscus in an opposite fashion as that to sympathetic nerve activation, presumably because the alpha 1-adrenergic component of the response to Ruscus predominates.',\n",
       "  'journal': 'General pharmacology',\n",
       "  'authors': 'Rubanyi|G|G|;Marcelon|G|G|;Vanhoutte|P M|PM|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150876',\n",
       "  'mesh_terms': 'D000317:Adrenergic alpha-Antagonists; D000818:Animals; D004285:Dogs; D004347:Drug Interactions; D066298:In Vitro Techniques; D009131:Muscle, Smooth, Vascular; D010936:Plant Extracts; D011224:Prazosin; D011942:Receptors, Adrenergic, alpha; D012501:Saphenous Vein; D013696:Temperature; D014661:Vasoconstriction; D015016:Yohimbine',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D000317:Adrenergic alpha-Antagonists; D010936:Plant Extracts; D011942:Receptors, Adrenergic, alpha; D015016:Yohimbine; D011224:Prazosin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0306-3623(84)90045-4',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gen Pharmacol',\n",
       "  'nlm_unique_id': '7602417',\n",
       "  'issn_linking': '0306-3623',\n",
       "  'country': 'England'},\n",
       " {'title': 'Evidence for dopaminergic and serotonergic regulation of prolactin cell activity in the trout Salmo gairdneri.',\n",
       "  'issue': '56(2)',\n",
       "  'pages': '231-9',\n",
       "  'abstract': 'The control of prolactin (PRL) cell activity in Salmo gairdneri was investigated in vivo and in vitro. In some in vivo experiments treatment was followed by estimation of pituitary PRL content by gel electrophoresis or of PRL cell nuclear area by light microscopy. In the remainder, treatment was followed by incubation of the pituitary glands in drug-free medium for estimation of PRL synthesis and release. The dopamine precursor, L-dopa (20 mg/kg), reduced pituitary PRL content. Conversely, the dopamine-receptor blocker, domperidone (10 mg/kg), increased total PRL content and amount released in the subsequent incubation. The initial serotonin precursor, L-tryptophan (75 mg/kg), increased pituitary PRL content and PRL cell nuclear area. 5-HTP (20 mg/kg), the immediate serotonin precursor, increased both percentage PRL release and total PRL levels during subsequent incubation. Pargyline (25 mg/kg) treatment to inhibit serotonin catabolism elevated PRL levels in pituitary and medium during subsequent incubation. The serotonin synthesis blocker, parachlorophenylalanine (pCPA; 100 mg/kg), nonsignificantly reduced PRL cell nuclear area. When this was followed by incubation, percentage PRL release and total PRL fell significantly. During in vitro incubation, dopamine (2 micrograms/ml) reduced the release of PRL into the medium, while serotonin (10(-5) M) increased PRL release. These results suggest that both an inhibitory dopaminergic and a stimulatory serotonergic system may be involved in PRL cell regulation in S. gairdneri. The lack of any significant effect of cortisol (1 microgram/ml), somatostatin (300 ng/ml). GABA (100 mg/ml) and TRH 100 ng/ml) on PRL release in vitro suggested little or no involvement of these putative regulatory factors in PRL cell regulation.',\n",
       "  'journal': 'General and comparative endocrinology',\n",
       "  'authors': 'James|V A|VA|;Wigham|T|T|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150877',\n",
       "  'mesh_terms': 'D006916:5-Hydroxytryptophan; D000818:Animals; D004294:Domperidone; D004298:Dopamine; D010134:Fenclonine; D007980:Levodopa; D010902:Pituitary Gland; D011388:Prolactin; D012487:Salmonidae; D012701:Serotonin; D013004:Somatostatin; D013973:Thyrotropin-Releasing Hormone; D014337:Trout; D014364:Tryptophan',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D012701:Serotonin; D007980:Levodopa; D013004:Somatostatin; D004294:Domperidone; D013973:Thyrotropin-Releasing Hormone; D014364:Tryptophan; D011388:Prolactin; D006916:5-Hydroxytryptophan; D010134:Fenclonine; D004298:Dopamine',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0016-6480(84)90035-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gen Comp Endocrinol',\n",
       "  'nlm_unique_id': '0370735',\n",
       "  'issn_linking': '0016-6480',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Comparative effects of somatostatin-28 and somatostatin-14 on basal growth hormone release and pancreatic function in immature ducks (Anas platyrhynchos).',\n",
       "  'issue': '56(2)',\n",
       "  'pages': '265-70',\n",
       "  'abstract': 'The 30-min infusion of somatostatin (SRIF)-14 or SRIF-28 (800 ng/kg/min) in 7- to 8-week-old ducklings reduced the basal level of plasma growth hormone (GH). The magnitude of the GH suppression induced by SRIF-14 was similar to that elicited by SRIF-28. \"Rebound\" GH secretion was observed 30 min after infusion, the GH concentration being elevated above the basal level. The increase in GH secretion after SRIF-14 infusion was greater than that induced by SRIF-28. Plasma insulin and free fatty acid (FFA) levels were similarly reduced after 10 and 30 min of SRIF-14 or SRIF-28 infusion. Following infusion the FFA levels returned to the pretreatment concentration, whereas the insulin concentration in both groups remained suppressed 30 min after infusion. The insulin level was still suppressed 60 min after SRIF-14 infusion, but not after SRIF-28 infusion. The infusion of SRIF-14 resulted in a marked, progressive increase in the glucagon concentration, which was reduced in birds infused with SRIF-28 and accompanied by hypoglycaemia. Following SRIF-28 infusion a \"rebound\" in the glucagon concentration occurred and remained elevated for at least 60 min. These results demonstrate comparative effects of SRIF-14 and SRIF-28 on the basal release of pituitary GH and pancreatic insulin and glucagon, and in particular they suggest that SRIF-28 is more potent in inhibiting pancreatic A cell activity.',\n",
       "  'journal': 'General and comparative endocrinology',\n",
       "  'authors': 'Strosser|M T|MT|;Harvey|S|S|;Foltzer|C|C|;Mialhe|P|P|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150878',\n",
       "  'mesh_terms': 'D000818:Animals; D001481:Basal Metabolism; D004372:Ducks; D005230:Fatty Acids, Nonesterified; D005934:Glucagon; D013006:Growth Hormone; D007003:Hypoglycemia; D007328:Insulin; D000078790:Insulin Secretion; D010179:Pancreas; D013004:Somatostatin; D053561:Somatostatin-28',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D005230:Fatty Acids, Nonesterified; D007328:Insulin; D013004:Somatostatin; D053561:Somatostatin-28; D013006:Growth Hormone; D005934:Glucagon',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0016-6480(84)90040-6',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gen Comp Endocrinol',\n",
       "  'nlm_unique_id': '0370735',\n",
       "  'issn_linking': '0016-6480',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Tissue-specific and pretranslational character of variants of the rosy locus control element in Drosophila melanogaster.',\n",
       "  'issue': '108(4)',\n",
       "  'pages': '953-68',\n",
       "  'abstract': 'Prior reports from this laboratory have described the experimental basis for our understanding of the genetic organization of the rosy locus (ry:3-52.0) of Drosophila melanogaster, as a bipartite genetic entity consisting of a structural element that codes for the xanthine dehydrogenase (XDH) peptide and a contiguous, cis-acting control element. The present report describes our progress in the analysis of the control element and its variants. Characterization of the control element variants reveals that, with respect to late third instar larval tissue distribution of XDH activity and cross-reacting material, i409H is associated with a large, tissue-specific increase in fat body which is not observed in malpighian tubules. Further data are presented in support of the inference that this differential expression must reflect differential production of XDH-specific RNA transcripts.--Gel blot analyses are described which demonstrate that the phenotypic effects associated with variation in the rosy locus control element relate to differences in accumulation of XDH-specific poly-A+ RNA and do not relate to differences in rosy DNA template numbers.--Experiments are described that provide for unambiguous mapping of control element sites through the use of half-tetrad recombination experiments and the recovery and phenotypic characterization of the reciprocal products of exchange between control element site variants. Thus, we are able to order the sites as follows: kar-i1005 i409-ry.',\n",
       "  'journal': 'Genetics',\n",
       "  'authors': 'Clark|S H|SH|;Daniels|S|S|;Rushlow|C A|CA|;Hilliker|A J|AJ|;Chovnick|A|A|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150879',\n",
       "  'mesh_terms': 'D000818:Animals; D002874:Chromosome Mapping; D004247:DNA; D004331:Drosophila melanogaster; D005260:Female; D005786:Gene Expression Regulation; D005796:Genes; D005809:Genes, Regulator; D007814:Larva; D008297:Male; D008317:Malpighian Tubules; D009928:Organ Specificity; D011061:Poly A; D012333:RNA, Messenger; D014968:Xanthine Dehydrogenase',\n",
       "  'publication_types': \"D016428:Journal Article; D013487:Research Support, U.S. Gov't, P.H.S.\",\n",
       "  'chemical_list': 'D012333:RNA, Messenger; D011061:Poly A; D004247:DNA; D014968:Xanthine Dehydrogenase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1093/genetics/108.4.953',\n",
       "  'references': '6149972;6432335;6409418;7039847;6162108;826445;98258;109351;826444;4217748;5512365',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Genetics',\n",
       "  'nlm_unique_id': '0374636',\n",
       "  'issn_linking': '0016-6731',\n",
       "  'country': 'United States'},\n",
       " {'title': 'Molecular cloning of a cDNA for Chinese hamster ovary asparagine synthetase.',\n",
       "  'issue': '30(1-3)',\n",
       "  'pages': '1-9',\n",
       "  'abstract': 'In previous reports we have described the isolation and characterization of a number of Chinese hamster ovary (CHO) cell mutants resistant to the amino acid analogue albizziin (Alb). Multistep mutants were derived which showed a high degree of drug resistance and expressed increased levels of asparagine synthetase (AS) levels up to 300-fold over that of the parental cell line. Karyotypic analysis of these mutants revealed homogeneously staining regions (HSRs) usually indicative of gene amplification. In the present work, we provide further proof for gene amplification by showing that the mutants greatly overproduce functional AS mRNA, as evidenced by in vitro translation of purified mRNA and immunoprecipitation of AS. By using these overproducing mutants as sources of mRNA coupled with velocity centrifugation, we have been able to greatly enrich for AS sequences in our mRNA preparations to the point where they represent 1-5% of the total message. This facilitated cloning and selection of the cDNA sequences complementary to the gene. Utilizing these cloned cDNAs, we have demonstrated a correlation between gene copy number and enzyme expression in the parent and Alb-resistant mutants, thus providing direct evidence that drug resistance is due to gene amplification.',\n",
       "  'journal': 'Gene',\n",
       "  'authors': 'Ray|P N|PN|;Siminovitch|L|L|;Andrulis|I L|IL|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150880',\n",
       "  'mesh_terms': 'D000818:Animals; D001217:Aspartate-Ammonia Ligase; D002460:Cell Line; D003001:Cloning, Molecular; D006224:Cricetinae; D003412:Cricetulus; D004247:DNA; D005260:Female; D005784:Gene Amplification; D008025:Ligases; D009154:Mutation; D010053:Ovary; D012333:RNA, Messenger',\n",
       "  'publication_types': \"D003160:Comparative Study; D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "  'chemical_list': 'D012333:RNA, Messenger; D004247:DNA; D008025:Ligases; D001217:Aspartate-Ammonia Ligase',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0378-1119(84)90098-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gene',\n",
       "  'nlm_unique_id': '7706761',\n",
       "  'issn_linking': '0378-1119',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Isolation of a cDNA clone containing a sequence complementary to the intestinal calcium-binding protein of the chick.',\n",
       "  'issue': '30(1-3)',\n",
       "  'pages': '233-6',\n",
       "  'abstract': 'The present work describes the construction of a cDNA library in pBR322 plasmid from an mRNA population enriched for the intestinal calcium-binding protein (CaBP) mRNA of the chick. We report the isolation of one recombinant clone containing a vitamin D-regulated sequence, which is complementary to part of the CaBP mRNA. Northern blot hybridization experiments allowed us to identify a 1900 nucleotide RNA species as the CaBP mRNA.',\n",
       "  'journal': 'Gene',\n",
       "  'authors': 'Ferrari|S|S|;Battini|R|R|;Leone|A|A|;Ferrari|S|S|;Torelli|G|G|;Barbiroli|B|B|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150881',\n",
       "  'mesh_terms': 'D000818:Animals; D001483:Base Sequence; D002135:Calcium-Binding Proteins; D002645:Chickens; D003001:Cloning, Molecular; D004247:DNA; D007413:Intestinal Mucosa; D009693:Nucleic Acid Hybridization; D011061:Poly A; D012333:RNA, Messenger',\n",
       "  'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "  'chemical_list': 'D002135:Calcium-Binding Proteins; D012333:RNA, Messenger; D011061:Poly A; D004247:DNA',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1016/0378-1119(84)90125-2',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gene',\n",
       "  'nlm_unique_id': '7706761',\n",
       "  'issn_linking': '0378-1119',\n",
       "  'country': 'Netherlands'},\n",
       " {'title': 'Prostaglandins and ulcerative colitis.',\n",
       "  'issue': '25(12)',\n",
       "  'pages': '1399-413',\n",
       "  'abstract': '',\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Rampton|D S|DS|;Hawkey|C J|CJ|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150882',\n",
       "  'mesh_terms': 'D000818:Animals; D016718:Arachidonic Acid; D001095:Arachidonic Acids; D003093:Colitis, Ulcerative; D016861:Cyclooxygenase Inhibitors; D004285:Dogs; D005231:Fatty Acids, Unsaturated; D006801:Humans; D007213:Indomethacin; D007414:Intestinal Neoplasms; D007420:Intestine, Large; D011453:Prostaglandins; D011898:Ranidae; D051381:Rats; D012460:Sulfasalazine',\n",
       "  'publication_types': 'D016428:Journal Article; D016454:Review',\n",
       "  'chemical_list': 'D001095:Arachidonic Acids; D016861:Cyclooxygenase Inhibitors; D005231:Fatty Acids, Unsaturated; D011453:Prostaglandins; D016718:Arachidonic Acid; D012460:Sulfasalazine; D007213:Indomethacin',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.12.1399',\n",
       "  'references': '7317691;6120182;6948953;6949849;7038488;6123357;6806104;6808592;6810465;6750616;6822511;6826100;6131017;6131674;6303887;4222870;5765565;4179885;5717966;4189236;5435265;4920061;4325309;4404481;4646291;4708640;4577412;4758659;4359941;47052;1140624;1140625;53480;4854;6674;948621;790919;186353;832785;871372;69189;72239;597665;6407032;6305757;6345283;6135423;6136395;6618097;6578172;6313115;6414618;6416544;6416934;6319219;6591772;14022607;14226223;74266;631275;665632;356764;212132;29685;30669;30671;101423;213967;730074;367886;374175;109510;450050;38173;315090;40410;40848;7350030;6243108;6101317;6243592;6101568;6965522;6245315;7377005;7377010;6770608;6250050;6250176;6893366;6106653;7429111;7429322;6107336;7449585;6256142;7010075;7227779;7227851;6112777;6112788;6113614;6114012;6114307;6268915;7285509;6117846',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': 'More about refractory duodenal ulcers.',\n",
       "  'issue': '25(12)',\n",
       "  'pages': '1433-4',\n",
       "  'abstract': '',\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Guslandi|M|M|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150884',\n",
       "  'mesh_terms': 'D000535:Aluminum; D000897:Anti-Ulcer Agents; D004351:Drug Resistance; D004381:Duodenal Ulcer; D006635:Histamine H2 Antagonists; D006801:Humans; D013392:Sucralfate',\n",
       "  'publication_types': 'D016422:Letter',\n",
       "  'chemical_list': 'D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D013392:Sucralfate; D000535:Aluminum',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.12.1433',\n",
       "  'references': '6329922;6428982;6376292',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': 'Assessing the safety of drugs for the long-term treatment of peptic ulcers.',\n",
       "  'issue': '25(12)',\n",
       "  'pages': '1416-23',\n",
       "  'abstract': '',\n",
       "  'journal': 'Gut',\n",
       "  'authors': 'Wormsley|K G|KG|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150883',\n",
       "  'mesh_terms': 'D000818:Animals; D000897:Anti-Ulcer Agents; D004285:Dogs; D004341:Drug Evaluation; D004353:Drug Evaluation, Preclinical; D005744:Gastric Acid; D005753:Gastric Mucosa; D006635:Histamine H2 Antagonists; D006801:Humans; D051379:Mice; D010437:Peptic Ulcer; D051381:Rats; D012449:Safety; D013274:Stomach Neoplasms; D013997:Time Factors',\n",
       "  'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't; D016454:Review\",\n",
       "  'chemical_list': 'D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists',\n",
       "  'keywords': '',\n",
       "  'doi': '10.1136/gut.25.12.1416',\n",
       "  'references': '6991290;6994084;7419004;7430384;7433915;6777721;7453750;7456998;7007657;6110040;6970978;6164300;7231123;6941398;6788282;7254431;7271214;6116003;7291981;6117419;6118570;7317080;7319200;7325600;7039332;7046098;7091121;7046984;7095690;7099223;6896647;6981444;6812688;7139550;7173716;6600428;7152460;6402234;6131307;6828041;6831466;6131752;6404468;6132928;6189574;6136806;6616162;6616751;6618097;6688799;6633569;6356324;6416435;6139573;6197001;6317738;6692353;6366382;6371547;6539288;6588501;6152747;6152748;4942982;4275056;1090478;1097321;131424;963531;908869;76069;580360;643057;719332;725518;420981;427769;428714;439021;86721;572003;461480;476923;7367858',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Gut',\n",
       "  'nlm_unique_id': '2985108R',\n",
       "  'issn_linking': '0017-5749',\n",
       "  'country': 'England'},\n",
       " {'title': '[Sensory transplants of the sole of the foot].',\n",
       "  'issue': '16(4)',\n",
       "  'pages': '215-7',\n",
       "  'abstract': 'The covering of defects of the sole of the foot and the heel with pedicled and free neurovascular flaps such as the dorsalis pedis flap, the forearm flap and the pulp neurovascular flap shows good success because of early pain sensation re-ulceration can be prevented. Clinical cases are demonstrated.',\n",
       "  'journal': 'Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...',\n",
       "  'authors': 'Stock|W|W|;Biemer|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150885',\n",
       "  'mesh_terms': 'D000673:Amputation, Traumatic; D002648:Child; D005528:Foot; D018409:Foot Injuries; D006801:Humans; D008297:Male; D008866:Microsurgery; D012867:Skin; D013524:Surgical Flaps; D014945:Wound Healing',\n",
       "  'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "  'chemical_list': '',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Handchir Mikrochir Plast Chir',\n",
       "  'nlm_unique_id': '8302815',\n",
       "  'issn_linking': '0722-1819',\n",
       "  'country': 'Germany'},\n",
       " {'title': 'Presynaptic alpha 1- and postsynaptic alpha 2-receptors in the rabbit vas deferens.',\n",
       "  'issue': '30(1)',\n",
       "  'pages': '1-10',\n",
       "  'abstract': '',\n",
       "  'journal': 'Fukushima journal of medical science',\n",
       "  'authors': 'Nakanishi|H|H|;Takahashi|K|K|;Yokoyama|N|N|;Ono|T|T|;Nakahata|N|N|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150886',\n",
       "  'mesh_terms': 'D000818:Animals; D008297:Male; D009119:Muscle Contraction; D018377:Neurotransmitter Agents; D011817:Rabbits; D011942:Receptors, Adrenergic, alpha; D013570:Synaptic Membranes; D009435:Synaptic Transmission; D014649:Vas Deferens',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D018377:Neurotransmitter Agents; D011942:Receptors, Adrenergic, alpha',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Fukushima J Med Sci',\n",
       "  'nlm_unique_id': '0374626',\n",
       "  'issn_linking': '0016-2590',\n",
       "  'country': 'Japan'},\n",
       " {'title': 'Association of gamma-glutamyltransferase with plasma lipoprotein and lipid-protein complex in cholestasis.',\n",
       "  'issue': '31(5)',\n",
       "  'pages': '204-7',\n",
       "  'abstract': 'Distribution of plasma gamma-glutamyltransferase (GGT) activity among lipoproteins was studied by ultracentrifugation and polyacrylamide gradient gel electrophoresis of plasma from 2 normal controls, 7 patients with intrahepatic cholestasis, and 5 patients with biliary obstruction. Half the total plasma activity was associated with lipoproteins, and more than 90 per cent of the residue activity with macromolecular lipid-protein complex. Healthy subjects had the highest GGT activity in HDL, intermediate activity in LDL, and the lowest in VLDL. In cholestasis, GGT activity increased mainly by the following two mechanisms: 1) the appearance of cholestatic lipoproteins carrying GGT, such as lipoprotein X or Slow-Migrating HDL, or increase in concentration of lipid-protein complex with GGT activity and 2) increase in GGT activity per unit weight of HDL.',\n",
       "  'journal': 'Hepato-gastroenterology',\n",
       "  'authors': 'Watanabe|M|M|;Taketa|K|K|;Izumi|M|M|;Nagashima|H|H|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150887',\n",
       "  'mesh_terms': 'D002779:Cholestasis; D004591:Electrophoresis, Polyacrylamide Gel; D006801:Humans; D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D005723:gamma-Glutamyltransferase',\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': 'D008074:Lipoproteins; D008075:Lipoproteins, HDL; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D005723:gamma-Glutamyltransferase',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hepatogastroenterology',\n",
       "  'nlm_unique_id': '8007849',\n",
       "  'issn_linking': '0172-6390',\n",
       "  'country': 'Greece'},\n",
       " {'title': 'The effect of an octapeptide somatostatin analogue (SMS 201-995) and somatostatin-14 (SST-14) on pentagastrin-stimulated gastric acid secretion: a comparative study in man.',\n",
       "  'issue': '31(5)',\n",
       "  'pages': '227-9',\n",
       "  'abstract': 'Using an open, randomised study design, the efficacy and tolerance of SMS 201-995 (a synthetic octapeptide SST-14 analogue with a plasma half-life of 45 min) was compared with that of SST-14 in inhibiting pentagastrin-stimulated gastric acid secretion. In 10 healthy volunteers gastric acid secretion was stimulated for 3.5 hours by an infusion of 3 microgram kg-1 h-1 pentagastrin. One hour after the start of pentagastrin a 2-hour i.v. infusion of either SST-14 (3.5 microgram kg-1 h-1) or one of 4 dosages of SMS 201-995 (0.14, 0.28, 0.56 or 1.12 microgram kg-1 h-1) was started. SMS 201-995 inhibited acid secretion in a dose-dependent manner. The inhibition achieved with the 0.56 and 1.12 microgram kg-1 h-1 dosages was comparable with that obtained with 3.5 microgram kg-1 h-1 SST-14. SMS 201-995 (1.12 microgram kg-1 h-1) appeared to have a longer duration of action than SST-14. No side effects were recorded under either of the test substances.',\n",
       "  'journal': 'Hepato-gastroenterology',\n",
       "  'authors': 'Whitehouse|I|I|;Beglinger|C|C|;Fried|M|M|;Gyr|K|K|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150888',\n",
       "  'mesh_terms': 'D000328:Adult; D005260:Female; D005744:Gastric Acid; D006801:Humans; D008297:Male; D015282:Octreotide; D010418:Pentagastrin; D011957:Receptors, Opioid; D013004:Somatostatin',\n",
       "  'publication_types': 'D016430:Clinical Trial; D003160:Comparative Study; D016428:Journal Article; D016449:Randomized Controlled Trial',\n",
       "  'chemical_list': 'D011957:Receptors, Opioid; D013004:Somatostatin; D010418:Pentagastrin; D015282:Octreotide',\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hepatogastroenterology',\n",
       "  'nlm_unique_id': '8007849',\n",
       "  'issn_linking': '0172-6390',\n",
       "  'country': 'Greece'},\n",
       " {'title': 'Influence of D-galactosamine and alpha-naphthylisothiocyanate on the activities of some intestinal enzymes.',\n",
       "  'issue': '31(5)',\n",
       "  'pages': '236-8',\n",
       "  'abstract': 'The activities of lactase, sucrase, maltase and gamma-glutamyl transferase (gamma-GT) were determined in homogenates of rat jejunal mucosa 24 h after acute administrations of D-galactosamine (GALN) (1.855 mmol/kg; i.p. injection) and alpha-naphthyl-isocyanate (ANIT) (0.540 mmol/kg; given by gastric tube). The animals were fasted either 24 h or 72 h prior to sacrifice. In rats fasted only 24 h, GALN treatment resulted in a pronounced decrease in lactase and in a moderate elevation of sucrase and maltase. ANIT clearly reduced lactase and, to a lesser extent, sucrase, while it increased maltase. Seventy-two hour fasting has a modifying role. All disaccharidase activities tended to decrease, except for maltase in the ANIT treated group, where an increase was recorded. gamma-GT showed no significant changes after either GALN or ANIT treatment in rats fasted 24 h. However, the 72-hour food deprivation diminished it in ANIT intoxication. It is obvious that the intestinal enzymes are influenced by the hepatic damage produced by GALN and ANIT.',\n",
       "  'journal': 'Hepato-gastroenterology',\n",
       "  'authors': 'Ivanov|E|E|;Petrova|S|S|;Adjarov|D|D|;Naidenova|E|E|',\n",
       "  'pubdate': '1984',\n",
       "  'pmid': '6150889',\n",
       "  'mesh_terms': \"D015058:1-Naphthylisothiocyanate; D015720:5'-Nucleotidase; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D000818:Animals; D001219:Aspartate Aminotransferases; D001663:Bilirubin; D005688:Galactosamine; D007413:Intestinal Mucosa; D007583:Jejunum; D008107:Liver Diseases; D008297:Male; D009708:Nucleotidases; D051381:Rats; D011919:Rats, Inbred Strains; D013393:Sucrase; D013861:Thiocyanates; D000520:alpha-Glucosidases; D001616:beta-Galactosidase; D005723:gamma-Glutamyltransferase\",\n",
       "  'publication_types': 'D016428:Journal Article',\n",
       "  'chemical_list': \"D013861:Thiocyanates; D015058:1-Naphthylisothiocyanate; D005688:Galactosamine; D005723:gamma-Glutamyltransferase; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D009708:Nucleotidases; D000469:Alkaline Phosphatase; D015720:5'-Nucleotidase; D000520:alpha-Glucosidases; D001616:beta-Galactosidase; D013393:Sucrase; D001663:Bilirubin\",\n",
       "  'keywords': '',\n",
       "  'doi': '',\n",
       "  'references': '',\n",
       "  'delete': False,\n",
       "  'affiliations': '',\n",
       "  'pmc': '',\n",
       "  'other_id': '',\n",
       "  'medline_ta': 'Hepatogastroenterology',\n",
       "  'nlm_unique_id': '8007849',\n",
       "  'issn_linking': '0172-6390',\n",
       "  'country': 'Greece'},\n",
       " ...]"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pubmed_dict"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "abstracts = [_['abstract'] for _ in pubmed_dict]\n",
    "nlm_ids = [_['nlm_unique_id'] for _ in pubmed_dict]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "vectorizer = TfidfVectorizer()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {},
   "outputs": [],
   "source": [
    "abstracts_tfidf = vectorizer.fit_transform(abstracts)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_consine_similarity_tf_idf(vectorizer,abstracts_tfidf, query):\n",
    "    query_tfidf = vectorizer.transform([query])\n",
    "    cosine_similarities = cosine_similarity(query_tfidf, abstracts_tfidf).flatten()\n",
    "    return cosine_similarities"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_top_n_cosine_similarity_tf_idf_docs(vectorizer, abstracts_tfidf, query, n=10):\n",
    "    cosine_similarities = get_consine_similarity_tf_idf(vectorizer,abstracts_tfidf, query)\n",
    "    related_docs_indices = cosine_similarities.argsort()[:-n - 1:-1]\n",
    "    return [(index, cosine_similarities[index]) for index in related_docs_indices]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_top_n_nlm_ids_cosine_similarity_tf_idf_docs(vectorizer, abstracts_tfidf, query, n=10):\n",
    "    related_docs_indices = get_top_n_cosine_similarity_tf_idf_docs(vectorizer, abstracts_tfidf, query, n)\n",
    "    return [(nlm_ids[index], score) for index, score in related_docs_indices]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {},
   "outputs": [],
   "source": [
    "def get_full_nlm_docs_cosine_similarity_tf_idf_docs(vectorizer, abstracts_tfidf, query, n=10):\n",
    "    related_docs_indices = get_top_n_cosine_similarity_tf_idf_docs(vectorizer, abstracts_tfidf, query, n)\n",
    "    return [(pubmed_dict[index], score) for index, score in related_docs_indices]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 49,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[({'title': 'Ca2+-Ca2+ exchange catalyzed by the membrane-bound Ca2+, Mg2+-ATPase of sarcoplasmic reticulum vesicles.',\n",
       "   'issue': '24()',\n",
       "   'pages': '423-34',\n",
       "   'abstract': 'Sarcoplasmic reticulum vesicles were preloaded with either 45Ca2+ or unlabeled Ca2+ X 45Ca2+ efflux and influx, together with phosphorylation of the membrane-bound Ca2+, Mg2+-ATPase, were determined in the presence of either ATP and ADP or acetyl phosphate. ATP induced 45Ca2+ efflux. This ATP-induced 45Ca2+ efflux depended on ADP, external Ca2+, and Mg2+. The Ca2+ concentration dependence of the efflux was quite similar to the Ca2+ concentration dependence of the ATP-induced 45Ca2+ influx and the enzyme phosphorylation. The rate of the efflux was proportional to the steady level of the phosphoenzyme. The affinity for free ADP in this efflux was extremely high, being in good agreement with the affinity for free ADP in the transphosphorylation from the phosphoenzyme to ADP. These results show that the ATP-induced 45Ca2+ efflux represents the Ca2+-Ca2+ exchange (between the external medium and the internal medium) mediated by the phosphoenzyme. In this exchange, Mg2+ was essential for the exposure of the bound Ca2+ of the phosphoenzyme to the internal medium. 45Ca2+ efflux and influx were also activated by acetyl phosphate. This acetyl phosphate-induced efflux required the external Ca2+. The Ca2+ concentration dependence of the efflux agreed closely with that of the enzyme phosphorylation by acetyl phosphate. Furthermore, the rate of the efflux was proportional to the steady level of the phosphoenzyme. These and other findings show that the acetyl phosphate-induced 45Ca2+ efflux represents the Ca2+-Ca2+ exchange mediated by the phosphoenzyme and further demonstrate the direct dissociation of Ca2+ from the Ca2+-bound phosphoenzyme to the external medium in this Ca2+-Ca2+ exchange. The rate of the acetyl phosphate-induced, phosphoenzyme-mediated Ca2+ efflux was much slower than that of the ATP-, ADP-induced, phosphoenzyme-mediated Ca2+ efflux. This is consistent with our previous conclusion that the Ca2+ binding site is partially occluded upon the phosphorylation of the enzyme.',\n",
       "   'journal': 'Current topics in cellular regulation',\n",
       "   'authors': 'Kanazawa|T|T|;Takakuwa|Y|Y|',\n",
       "   'pubdate': '1984',\n",
       "   'pmid': '6149890',\n",
       "   'mesh_terms': 'D000818:Animals; D017301:Ca(2+) Mg(2+)-ATPase; D002118:Calcium; D002132:Calcium Radioisotopes; D000252:Calcium-Transporting ATPases; D007700:Kinetics; D009132:Muscles; D010755:Organophosphates; D010766:Phosphorylation; D011817:Rabbits; D012519:Sarcoplasmic Reticulum',\n",
       "   'publication_types': 'D016428:Journal Article',\n",
       "   'chemical_list': 'D002132:Calcium Radioisotopes; D010755:Organophosphates; C011632:acetyl phosphate; D017301:Ca(2+) Mg(2+)-ATPase; D000252:Calcium-Transporting ATPases; D002118:Calcium',\n",
       "   'keywords': '',\n",
       "   'doi': '10.1016/b978-0-12-152824-9.50044-7',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Curr Top Cell Regul',\n",
       "   'nlm_unique_id': '2984740R',\n",
       "   'issn_linking': '0070-2137',\n",
       "   'country': 'United States'},\n",
       "  0.4033874387734705),\n",
       " ({'title': 'Hyperthyroidism complicating pregnancy: results of treatment by antithyroid drugs in 77 pregnancies.',\n",
       "   'issue': '87(11)',\n",
       "   'pages': '970-5',\n",
       "   'abstract': 'Seventy-seven pregnancies (79 infants) complicated by hyperthyroidism were seen at three Dublin Maternity Hospitals during a 25 year period. Hyperthyroidism was diagnosed following conception in 14 pregnancies. Treatment was with carbimazole alone in 73 pregnancies, in a usual dose of 5 to 10 mg daily. The total fetal loss was 15.2 per cent with a perinatal loss of 5.1 per cent. The perinatal loss in patients treated with carbimazole alone was 4.1 per cent (excluding one death due to congenital malformation). Four infants (5.1 per cent) had goitre and 57 (85.1 per cent) of the surviving infants were above the 25th centile for gestational age. Spontaneous premature labour occurred in 7 pregnancies (9.1 per cent). There was a relative excess of infants with a birth weight less than the 25th centile, of neonatal goitre and premature labour after pregnancy in which treatment was started following conception. Hyperthyroidism complicating pregnancy can be treated effectively with antithyroid drugs given alone and in the minimal effective dose.',\n",
       "   'journal': 'British journal of obstetrics and gynaecology',\n",
       "   'authors': 'Sugrue|D|D|;Drury|M I|MI|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159916',\n",
       "   'mesh_terms': 'D013956:Antithyroid Agents; D001724:Birth Weight; D002231:Carbimazole; D005260:Female; D005313:Fetal Death; D006042:Goiter; D006801:Humans; D006980:Hyperthyroidism; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases; D011247:Pregnancy; D011248:Pregnancy Complications',\n",
       "   'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "   'chemical_list': 'D013956:Antithyroid Agents; D002231:Carbimazole',\n",
       "   'keywords': '',\n",
       "   'doi': '10.1111/j.1471-0528.1980.tb04460.x',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Br J Obstet Gynaecol',\n",
       "   'nlm_unique_id': '7503752',\n",
       "   'issn_linking': '0306-5456',\n",
       "   'country': 'England'},\n",
       "  0.0),\n",
       " ({'title': 'Toxicology studies of fenbufen.',\n",
       "   'issue': '30(4A)',\n",
       "   'pages': '721-5',\n",
       "   'abstract': \"The acute, subacute, and chronic toxicity of gamma-oxo[1,1'-biphenyl]-4-butanoic acid (fenbufen), a new orally and parenterally effective non-steroidal antiinflammatory, analgesic, and antipyretic agent, was investigated in mice, rats, and dogs. In these studies, the gastrointestinal and renal changes associated with toxic doses of fenbufen resembled those described for this class of drug. In coadministration studies, there were no evidences of specific adverse interactions when fenbufen was given with dicoumarol or with triamcinolone; however, coadministration of acetylsalicylic acid (ASA) and fenbufen resulted in decreased plasma concentrations of fenbufen-related materials and a possible increase in the incidence of gastrointestinal hemorrhages or ulcers.\",\n",
       "   'journal': 'Arzneimittel-Forschung',\n",
       "   'authors': 'Bolte|H F|HF|;Koralek|A V|AV|;Traitor|C E|CE|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159904',\n",
       "   'mesh_terms': 'D000818:Animals; D000893:Anti-Inflammatory Agents; D001241:Aspirin; D001713:Biphenyl Compounds; D001728:Dicumarol; D004347:Drug Interactions; D005260:Female; D008297:Male; D051379:Mice; D010654:Phenylbutyrates; D011422:Propionates; D051381:Rats; D013045:Species Specificity; D013997:Time Factors; D014221:Triamcinolone',\n",
       "   'publication_types': 'D016428:Journal Article',\n",
       "   'chemical_list': 'D000893:Anti-Inflammatory Agents; D001713:Biphenyl Compounds; D010654:Phenylbutyrates; D011422:Propionates; D014221:Triamcinolone; D001728:Dicumarol; C010725:fenbufen; D001241:Aspirin',\n",
       "   'keywords': '',\n",
       "   'doi': '',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Arzneimittelforschung',\n",
       "   'nlm_unique_id': '0372660',\n",
       "   'issn_linking': '0004-4172',\n",
       "   'country': 'Germany'},\n",
       "  0.0),\n",
       " ({'title': 'Extracorporeal interferon therapy in malignant melanoma. Significant economies of interferon in an extracorporeal chamber.',\n",
       "   'issue': '30(8)',\n",
       "   'pages': '1245-6',\n",
       "   'abstract': 'A new method is described for interferon therapy. The procedure involves immobilization of interferon with maintained activity to the surfaces of an extracorporeal perfusion chamber made from polymethylmethacrylate, having a surface area of 0.5 m2 and housing 150 ml blood. The interferon activity remains for at least 3 weeks in a chamber used in patients. Three cases of malignant melanoma, stage II, were treated for 35 to 50 h. The treatment induced increased natural killer activity against melanoma target cells (cytotoxicity index +45--65%) which lasted even after cessation of therapy. the drastic reduction in costs for this type of interferon therapy is underlined.',\n",
       "   'journal': 'Arzneimittel-Forschung',\n",
       "   'authors': 'Langvad|E|E|;Hydén|H|H|;Petersen|J K|JK|;Jordal|R|R|;Olsen|G|G|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159905',\n",
       "   'mesh_terms': 'D003365:Costs and Cost Analysis; D005112:Extracorporeal Circulation; D006801:Humans; D007372:Interferons; D007694:Killer Cells, Natural; D008545:Melanoma; D013997:Time Factors',\n",
       "   'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "   'chemical_list': 'D007372:Interferons',\n",
       "   'keywords': '',\n",
       "   'doi': '',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Arzneimittelforschung',\n",
       "   'nlm_unique_id': '0372660',\n",
       "   'issn_linking': '0004-4172',\n",
       "   'country': 'Germany'},\n",
       "  0.0),\n",
       " ({'title': \"[Method of determination of proteins with Coomassie brilliant blue G 250. I. General characteristics and comparative analysis with the biuret method and Lowry's method].\",\n",
       "   'issue': '56(2)',\n",
       "   'pages': '160-5',\n",
       "   'abstract': \"Bradford (1977) described a new sensitive easy rapid method for protein assay, depending on colour change of the stain Coomassie Brilliant Blue G 250. In this study Bradford's method was compared with the Lowry et al. 91951) and biuret methods. Coomassie method appears to be as sensitive as Lowry, as simple as biuret. Another advantage is a very short time of performing.\",\n",
       "   'journal': 'Bollettino della Societa italiana di biologia sperimentale',\n",
       "   'authors': 'Serra|S|S|;Morgante|L|L|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159906',\n",
       "   'mesh_terms': 'D008722:Methods; D011506:Proteins; D012710:Serum Albumin, Bovine; D013194:Staining and Labeling',\n",
       "   'publication_types': 'D003160:Comparative Study; D016428:Journal Article',\n",
       "   'chemical_list': 'D011506:Proteins; D012710:Serum Albumin, Bovine',\n",
       "   'keywords': '',\n",
       "   'doi': '',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Boll Soc Ital Biol Sper',\n",
       "   'nlm_unique_id': '7506962',\n",
       "   'issn_linking': '0037-8771',\n",
       "   'country': 'Italy'},\n",
       "  0.0),\n",
       " ({'title': '[Method of determination of proteins with Coomassie brilliant blue G 250. II. Influence of pH and inorganic ions].',\n",
       "   'issue': '56(2)',\n",
       "   'pages': '166-70',\n",
       "   'abstract': 'The influences of pH and inorganic ions on the protein assay method of Bradford were investigated. Absorbance of bovine serum albumine appears to be increasing with the increase of pH. This effect is consistent with the hypothesis of Reissner et al. (1975), that colour change of the stain is a function of hydrogen ion concentration, but acquires statistical significance only for extreme basic pH. Among the tested inorganic ions, only Fe++ and NH4+ shows some interference. These dysadvantages could be corrected by appropriate blanks.',\n",
       "   'journal': 'Bollettino della Societa italiana di biologia sperimentale',\n",
       "   'authors': 'Serra|S|S|;Morgante|L|L|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159907',\n",
       "   'mesh_terms': 'D006863:Hydrogen-Ion Concentration; D008722:Methods; D009994:Osmolar Concentration; D011506:Proteins; D012710:Serum Albumin, Bovine; D012996:Solutions; D013194:Staining and Labeling',\n",
       "   'publication_types': 'D016428:Journal Article',\n",
       "   'chemical_list': 'D011506:Proteins; D012996:Solutions; D012710:Serum Albumin, Bovine',\n",
       "   'keywords': '',\n",
       "   'doi': '',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Boll Soc Ital Biol Sper',\n",
       "   'nlm_unique_id': '7506962',\n",
       "   'issn_linking': '0037-8771',\n",
       "   'country': 'Italy'},\n",
       "  0.0),\n",
       " ({'title': \"[Clinical significance of pyridoxine administration in L-dopa therapy of Parkinsonism (author's transl)].\",\n",
       "   'issue': '32(10)',\n",
       "   'pages': '991-1000',\n",
       "   'abstract': '',\n",
       "   'journal': 'No to shinkei = Brain and nerve',\n",
       "   'authors': 'Namba|S|S|;Ishimitsu|H|H|;Nakasone|S|S|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159908',\n",
       "   'mesh_terms': 'D000328:Adult; D000368:Aged; D000818:Animals; D001923:Brain Chemistry; D002262:Carboxy-Lyases; D004298:Dopamine; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D006897:Hydroxyindoleacetic Acid; D007980:Levodopa; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease; D011736:Pyridoxine; D051381:Rats',\n",
       "   'publication_types': 'D002363:Case Reports; D004740:English Abstract; D016428:Journal Article',\n",
       "   'chemical_list': 'D007980:Levodopa; D006897:Hydroxyindoleacetic Acid; D002262:Carboxy-Lyases; D011736:Pyridoxine; D004298:Dopamine',\n",
       "   'keywords': '',\n",
       "   'doi': '',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'No To Shinkei',\n",
       "   'nlm_unique_id': '0413550',\n",
       "   'issn_linking': '0006-8969',\n",
       "   'country': 'Japan'},\n",
       "  0.0),\n",
       " ({'title': 'Solubility and distribution of halothane in human blood.',\n",
       "   'issue': '52(9)',\n",
       "   'pages': '851-62',\n",
       "   'abstract': 'The interactions of halothane with five major constituents of human blood were studied by equilibrium dialysis. Haemoglobin, albumin, red cell membranes and triglycerides were found to contribute significantly to the solubility, and thus the transport, of halothane in whole blood. At physiological concentrations, gamma-globulin had no detectable effect on the solubility of halothane. Absorption isotherms of halothane binding to haemoglobin and albumin suggest a possible positive co-operative effect, but complete saturation of the binding sites was not observed even when the aqueous phase was saturated with halothane. The number of halothane molecules bound per albumin molecule was not significantly affected by the presence of oleic acid. For red cell ghosts and triglyceride-rich micelles (chylomicrons and very low density lipoprotein), the adsorption isotherms suggested that halothane is solubilized within the hydrophobic regions. The distribution of halothane between cells and plasma calculated from the above equilibrium dialysis results was in reasonable agreement with the distribution in whole blood determined by an independent method.',\n",
       "   'journal': 'British journal of anaesthesia',\n",
       "   'authors': 'Pang|Y C|YC|;Reid|P E|PE|;Brooks|D E|DE|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159909',\n",
       "   'mesh_terms': 'D000042:Absorption; D000327:Adsorption; D002914:Chylomicrons; D003956:Dialysis; D004910:Erythrocyte Membrane; D006221:Halothane; D006454:Hemoglobins; D006801:Humans; D008079:Lipoproteins, VLDL; D012709:Serum Albumin; D012995:Solubility; D005719:gamma-Globulins',\n",
       "   'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "   'chemical_list': 'D002914:Chylomicrons; D006454:Hemoglobins; D008079:Lipoproteins, VLDL; D012709:Serum Albumin; D005719:gamma-Globulins; D006221:Halothane',\n",
       "   'keywords': '',\n",
       "   'doi': '10.1093/bja/52.9.851',\n",
       "   'references': '',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Br J Anaesth',\n",
       "   'nlm_unique_id': '0372541',\n",
       "   'issn_linking': '0007-0912',\n",
       "   'country': 'England'},\n",
       "  0.0),\n",
       " ({'title': 'Serum beta 2-microglobulin in myelomatosis: potential value in stratification and monitoring.',\n",
       "   'issue': '42(4)',\n",
       "   'pages': '510-5',\n",
       "   'abstract': 'In a longitudinal study of the evolution of serum beta 2-microglobulin (beta 2-m) levels in 37 patients with myelomatosis, those patients with a level of < 4 mg/l at first presentation had a median survival of 46 months, whereas those with an initial level of > mg/l had a median survival of 15 months. THe beta 2-m appeared to be independent of the level of the paraprotein and its class, as seen in a vertical study of 129 patients. Analysis of the influence of a rising serum creatinine on the serum beta 2-m indicates that beta 2-m production is excessive in advanced disease with or without renal failure. Practical application of the measurement of serum beta 2-m in the stratification and monitoring of patients is suggested.',\n",
       "   'journal': 'British journal of cancer',\n",
       "   'authors': 'Norfolk|D|D|;Child|J A|JA|;Cooper|E H|EH|;Kerruish|S|S|;Ward|A M|AM|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159910',\n",
       "   'mesh_terms': 'D001609:Beta-Globulins; D003404:Creatinine; D004739:England; D005260:Female; D006801:Humans; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D008137:Longitudinal Studies; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma; D011379:Prognosis; D001613:beta 2-Microglobulin',\n",
       "   'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "   'chemical_list': 'D001609:Beta-Globulins; D007070:Immunoglobulin A; D007074:Immunoglobulin G; D001613:beta 2-Microglobulin; D003404:Creatinine',\n",
       "   'keywords': '',\n",
       "   'doi': '10.1038/bjc.1980.273',\n",
       "   'references': '4134761;1175123;1182674;57015;23482;83581;465365',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Br J Cancer',\n",
       "   'nlm_unique_id': '0370635',\n",
       "   'issn_linking': '0007-0920',\n",
       "   'country': 'England'},\n",
       "  0.0),\n",
       " ({'title': 'Effect of sodium butyrate on synthesis of specific proteins by human breast-carcinoma cells.',\n",
       "   'issue': '42(4)',\n",
       "   'pages': '616-9',\n",
       "   'abstract': '',\n",
       "   'journal': 'British journal of cancer',\n",
       "   'authors': 'Grieve|R J|RJ|;Woods|K L|KL|;Mann|P R|PR|;Smith|S C|SC|;Wilson|G D|GD|;Howell|A|A|',\n",
       "   'pubdate': '1980',\n",
       "   'pmid': '6159911',\n",
       "   'mesh_terms': 'D001943:Breast Neoplasms; D002087:Butyrates; D002272:Carcinoembryonic Antigen; D002452:Cell Count; D002460:Cell Line; D006063:Chorionic Gonadotropin; D015292:Glycoprotein Hormones, alpha Subunit; D006801:Humans; D007768:Lactalbumin; D008854:Microscopy, Electron; D009363:Neoplasm Proteins; D010446:Peptide Fragments',\n",
       "   'publication_types': \"D016428:Journal Article; D013485:Research Support, Non-U.S. Gov't\",\n",
       "   'chemical_list': 'D002087:Butyrates; D002272:Carcinoembryonic Antigen; D006063:Chorionic Gonadotropin; D015292:Glycoprotein Hormones, alpha Subunit; D009363:Neoplasm Proteins; D010446:Peptide Fragments; D007768:Lactalbumin',\n",
       "   'keywords': '',\n",
       "   'doi': '10.1038/bjc.1980.287',\n",
       "   'references': '4758660;4357887;1188362;2548;1250386;859583;799907;140761;876359;560263;196218;200351;22554;212193;421715;570644;471049;92331;389635',\n",
       "   'delete': False,\n",
       "   'affiliations': '',\n",
       "   'pmc': '',\n",
       "   'other_id': '',\n",
       "   'medline_ta': 'Br J Cancer',\n",
       "   'nlm_unique_id': '0370635',\n",
       "   'issn_linking': '0007-0920',\n",
       "   'country': 'England'},\n",
       "  0.0)]"
      ]
     },
     "execution_count": 49,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "get_full_nlm_docs_cosine_similarity_tf_idf_docs(vectorizer, abstracts_tfidf, 'phosphoenzyme')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3.8.13 64-bit ('3.8.13')",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.13"
  },
  "orig_nbformat": 4,
  "vscode": {
   "interpreter": {
    "hash": "110cc1dee26208153f2972f08a2ad52b6a56238dc66d48e87fb757ef2996db56"
   }
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
